data_2k4y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k4y _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 121.09 0.272 . . . . 64.44 113.672 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.1 pt -106.8 174.77 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.448 -0.945 . . . . 65.02 108.448 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.75 147.73 28.23 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 119.811 -1.185 . . . . 74.5 111.267 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.419 HD23 HD22 ' A' ' 56' ' ' LEU . 44.0 tp -62.65 -17.97 61.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.369 0.604 . . . . 74.43 110.94 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.682 ' ND2' ' HA ' ' A' ' 71' ' ' LYS . 7.8 p30 -75.44 -10.99 59.94 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.572 -0.74 . . . . 70.54 110.895 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -101.81 9.53 40.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.044 -0.525 . . . . 73.43 110.747 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.1 t -103.19 160.27 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.01 -0.541 . . . . 72.54 109.602 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.511 ' CG ' ' H ' ' A' ' 12' ' ' ILE . 12.6 tt0 -112.13 -176.85 3.02 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.226 -0.287 . . . . 73.33 110.226 -177.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.511 ' H ' ' CG ' ' A' ' 11' ' ' GLU . 40.8 pt -66.85 150.38 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.709 0.633 . . . . 73.02 112.709 -171.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 68.3 mttm 51.93 48.99 21.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.078 -0.965 . . . . 74.12 112.343 174.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.7 m -127.37 153.7 45.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.705 -0.68 . . . . 75.15 109.6 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -112.45 129.23 56.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.237 0.541 . . . . 60.25 111.023 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.539 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 15.4 m -137.47 152.65 27.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.114 -0.948 . . . . 65.32 109.795 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.71 ' HB2' HD13 ' A' ' 78' ' ' LEU . 1.9 tmtp? -105.94 140.85 38.32 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.112 -0.495 . . . . 74.42 110.27 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -77.75 95.16 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.314 -0.857 . . . . 74.5 110.207 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.86 HD12 ' HB3' ' A' ' 76' ' ' GLU . 17.3 mt -63.49 -55.95 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.595 -0.729 . . . . 64.34 110.004 175.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.22 -177.19 33.1 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.398 -0.905 . . . . 51.41 112.91 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.507 HG23 ' HG2' ' A' ' 28' ' ' ARG . 22.4 mt -129.08 161.52 38.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.392 -0.966 . . . . 64.23 108.392 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.44 90.56 1.03 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.683 0.754 . . . . 71.35 109.582 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.866 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 36.6 Cg_endo -61.43 162.45 20.61 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.412 2.741 . . . . 74.22 113.864 -167.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 65.38 5.68 3.28 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.903 -1.044 . . . . 75.14 112.193 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.513 ' HB3' HG23 ' A' ' 27' ' ' VAL . 1.0 OUTLIER -77.15 -4.67 45.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.69 0.281 . . . . 64.22 111.503 179.076 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 88.6 tttt 71.24 -45.66 0.62 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.494 0.718 . . . . 71.14 110.941 -174.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 25' ' ' SER . 31.5 m -66.72 -16.73 21.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.069 0.461 . . . . 74.2 109.92 173.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.866 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 4.4 tmt_? -57.87 -37.96 74.89 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.115 -0.698 . . . . 75.21 109.115 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.456 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 6.3 tpp180 -64.82 -46.22 82.89 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 115.62 -0.718 . . . . 72.4 109.969 174.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HZ1' ' CD ' ' A' ' 69' ' ' GLU . 84.9 tttt -55.41 -48.74 73.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.609 -0.723 . . . . 71.03 110.834 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 72' ' ' ASP . 78.3 mt -59.89 -48.65 86.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.957 -0.565 . . . . 74.34 111.139 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -38.17 90.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 64.31 110.837 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.86 -32.9 74.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.788 -0.642 . . . . 74.5 111.048 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -17.74 64.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.046 -0.525 . . . . 74.22 111.09 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.25 12.51 29.05 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.513 -0.851 . . . . 71.31 112.558 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.1 mt -91.51 126.71 44.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.079 0.466 . . . . 74.05 110.035 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.11 169.79 21.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.671 -0.695 . . . . 75.42 111.014 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -61.33 109.12 1.05 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.825 -0.625 . . . . 73.35 110.562 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.67 ' HA2' ' HE3' ' A' ' 17' ' ' LYS . . . 119.64 -9.85 11.53 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.761 -0.733 . . . . 63.12 113.092 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 m -71.48 149.24 46.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.02 0.438 . . . . 75.52 110.737 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -98.08 132.77 43.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.726 -0.67 . . . . 74.13 110.147 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.443 ' HB ' HG21 ' A' ' 16' ' ' VAL . 45.0 mm -108.93 121.66 62.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.461 -0.791 . . . . 73.13 110.343 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -111.31 112.15 23.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.329 -0.619 . . . . 74.45 109.329 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 51.3 mm -75.59 121.22 26.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.351 -0.611 . . . . 75.2 109.351 176.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.56 -53.25 6.42 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.847 -0.798 . . . . 60.23 108.847 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.442 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . -172.77 179.05 44.5 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.731 -0.947 . . . . 73.4 110.731 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -118.37 156.96 28.03 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.166 -0.679 . . . . 73.13 109.166 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.27 157.37 77.76 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 110.038 -0.356 . . . . 70.21 110.038 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -59.18 -12.38 15.84 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.734 2.289 . . . . 74.13 112.77 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.5 mmt -99.89 -2.35 35.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.48 . . . . 71.33 110.486 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.01 -16.06 56.42 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.197 -0.525 . . . . 73.33 111.894 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -150.52 137.76 11.68 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 108.64 -0.874 . . . . 70.3 108.64 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.04 -164.95 4.02 Favored 'Cis proline' 0 CA--C 1.531 0.36 0 C-N-CA 123.734 -1.361 . . . . 71.1 113.25 1.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.4 mt -119.03 147.34 22.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.862 -0.608 . . . . 71.4 109.975 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.89 119.45 36.52 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.089 -0.337 . . . . 53.22 110.089 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.419 HD22 HD23 ' A' ' 7' ' ' LEU . 5.9 mp -117.04 154.65 30.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.816 0.341 . . . . 73.03 110.731 -176.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -128.28 105.13 8.13 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.337 -0.616 . . . . 74.23 109.337 170.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.481 ' N ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -142.6 160.33 40.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.197 -0.911 . . . . 74.24 109.871 -175.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? 75.15 -56.91 0.61 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.973 0.795 . . . . 72.31 109.574 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 173.91 -1.01 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.71 -0.677 . . . . 74.12 111.901 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -142.46 155.09 45.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.236 0.541 . . . . 75.34 111.956 -173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 m -86.81 135.8 33.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.312 -0.858 . . . . 73.3 111.011 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.446 HD11 HD12 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -160.36 158.38 29.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.324 -0.398 . . . . 52.43 110.197 175.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.8 t -102.76 123.77 47.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.452 0.644 . . . . 73.42 111.62 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.436 ' CD2' HD12 ' A' ' 63' ' ' LEU . 4.1 mm? -112.64 158.0 20.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.924 -1.035 . . . . 74.22 108.812 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -86.51 159.35 19.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.057 0.455 . . . . 73.45 110.521 -175.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.481 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 0.9 OUTLIER -58.95 -28.74 66.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.682 -0.69 . . . . 74.2 110.026 176.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.5 m -59.2 -46.73 87.66 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.126 -0.488 . . . . 60.01 111.248 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.419 ' CD ' ' HZ1' ' A' ' 30' ' ' LYS . 4.2 mp0 -68.43 -41.99 79.56 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.186 0.517 . . . . 74.14 110.241 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.64 -21.55 64.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.661 -0.699 . . . . 65.34 111.304 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.682 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 54.2 tttm -79.4 -18.43 52.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.348 -0.387 . . . . 75.01 110.9 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.479 ' HB3' HD12 ' A' ' 31' ' ' ILE . 4.1 t70 -97.25 -9.8 27.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.246 0.546 . . . . 75.35 110.582 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.4 mt -96.78 121.99 47.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.982 -0.554 . . . . 74.24 110.481 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.8 mt -99.34 118.65 36.45 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.865 -0.42 . . . . 62.23 109.865 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.539 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 24.1 m -124.26 159.14 30.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.423 0.63 . . . . 65.4 112.474 -173.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.86 ' HB3' HD12 ' A' ' 19' ' ' ILE . 9.3 pt-20 -111.89 138.54 48.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.215 -0.902 . . . . 61.4 110.147 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.529 ' HA ' HG13 ' A' ' 16' ' ' VAL . 43.2 t -75.06 121.49 26.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.404 -0.362 . . . . 72.25 110.267 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.71 HD13 ' HB2' ' A' ' 17' ' ' LYS . 82.2 mt . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 121.313 0.578 . . . . 71.34 111.313 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.893 0 N-CA-C 112.453 -0.259 . . . . 73.44 112.453 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 pt -105.45 171.77 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.451 -0.574 . . . . 64.22 109.451 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.02 156.35 35.96 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 119.974 -1.108 . . . . 60.4 111.717 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.563 HD22 HG11 ' A' ' 75' ' ' VAL . 3.0 tm? -59.88 -26.52 65.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.508 0.67 . . . . 73.33 109.718 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.52 ' HB2' ' HG2' ' A' ' 67' ' ' LYS . 9.2 p30 -73.23 -8.94 57.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.499 -0.773 . . . . 65.31 111.417 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -103.47 1.0 31.84 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.496 -0.32 . . . . 73.41 111.612 -174.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 11' ' ' GLU . 20.9 t -81.54 157.31 4.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 61.12 111.501 -174.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.416 ' N ' HG12 ' A' ' 10' ' ' VAL . 8.0 tp10 -80.59 164.77 22.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.25 -0.886 . . . . 73.44 110.127 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.0 pt -79.25 138.09 20.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.102 -0.499 . . . . 75.31 111.116 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt 59.69 44.17 14.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.534 -0.757 . . . . 73.54 111.422 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.8 t -113.67 171.13 7.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.406 -0.815 . . . . 72.23 109.692 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -129.02 113.31 15.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.207 -0.451 . . . . 65.54 109.886 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 77' ' ' VAL . 18.4 m -123.01 160.35 25.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.449 0.642 . . . . 74.3 112.252 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -106.75 144.09 33.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.747 -1.115 . . . . 74.11 110.303 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.5 t -86.12 104.05 13.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.049 -0.523 . . . . 71.52 109.731 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.6 mt -59.37 -49.46 83.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.541 -0.754 . . . . 74.21 110.33 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.24 175.34 43.52 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.777 -0.725 . . . . 54.23 112.438 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.654 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 22.0 mt -97.6 159.79 3.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.307 -0.627 . . . . 64.22 109.307 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.404 ' N ' HG23 ' A' ' 21' ' ' ILE . 45.2 t -99.42 90.84 1.27 Allowed Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 109.555 -0.535 . . . . 73.41 109.555 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.948 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 33.1 Cg_exo -58.19 167.25 4.79 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.932 3.088 . . . . 75.45 114.165 -170.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 64.59 15.99 10.02 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.79 -1.096 . . . . 71.4 110.828 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.561 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 23.3 t -87.5 165.12 15.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.607 -0.724 . . . . 73.43 110.067 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -21.83 46.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.944 -0.391 . . . . 63.34 109.944 175.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 31' ' ' ILE . 35.2 m -104.74 -3.69 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.285 -0.416 . . . . 72.13 111.554 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.948 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 3.6 tmm_? -50.73 -51.6 48.35 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.093 0.245 . . . . 62.41 110.929 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -63.85 -45.63 88.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.59 -0.277 . . . . 74.03 110.535 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -50.45 -53.48 29.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 52.43 111.129 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 73' ' ' ILE . 46.7 mm -58.68 -47.81 87.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.631 -0.713 . . . . 74.51 111.752 -177.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.599 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 4.6 ppp? -73.86 -28.17 61.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.916 0.388 . . . . 61.42 111.072 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.89 -28.65 64.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.276 0.56 . . . . 75.22 109.883 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 81.0 mtp -81.49 1.03 35.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.294 -0.866 . . . . 75.44 111.44 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.66 -7.53 53.53 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.616 -0.802 . . . . 71.33 113.132 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 32' ' ' MET . 21.6 mt -84.08 130.36 36.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.772 0.32 . . . . 64.33 110.232 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.601 HG23 ' H ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -148.05 -85.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.182 -0.463 . . . . 61.14 111.473 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.601 ' H ' HG23 ' A' ' 37' ' ' VAL . 17.9 mtp180 -145.44 131.23 19.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.232 -0.44 . . . . 75.32 109.922 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.03 -4.08 86.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.567 -0.825 . . . . 60.25 112.156 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 m -64.29 144.07 57.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.607 -0.516 . . . . 55.32 109.607 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -117.47 133.93 55.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.968 0.413 . . . . 74.52 110.94 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.832 HG12 HD13 ' A' ' 58' ' ' LEU . 74.4 mt -119.68 136.06 58.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.599 -0.728 . . . . 73.05 111.312 -174.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -98.12 116.43 30.32 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.727 -0.471 . . . . 73.11 109.727 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.526 HD12 HD21 ' A' ' 7' ' ' LEU . 50.5 mm -82.64 104.61 11.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.623 -0.51 . . . . 71.43 109.623 177.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -76.85 -34.03 57.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.91 0.386 . . . . 74.14 110.724 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.35 171.56 31.72 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.564 -0.827 . . . . 64.23 112.196 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HG2' HG22 ' A' ' 54' ' ' ILE . 40.6 mtmt -124.39 148.63 47.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.012 -0.736 . . . . 75.41 109.012 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.47 156.94 49.59 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.093 -0.336 . . . . 74.22 110.093 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.65 -14.17 25.04 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.525 2.15 . . . . 63.01 112.456 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.9 mtt -93.76 -6.17 46.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 73.4 110.205 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.67 -10.37 59.84 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.378 -0.689 . . . . 55.5 111.378 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -145.43 133.01 10.33 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 108.981 -0.748 . . . . 60.34 108.981 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -84.7 -172.32 9.18 Favored 'Cis proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.341 -1.524 . . . . 52.22 112.866 -0.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.563 HG22 ' HG2' ' A' ' 47' ' ' LYS . 59.4 mt -114.21 142.07 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.232 -0.44 . . . . 72.15 110.11 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.07 115.55 30.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.071 0.462 . . . . 75.52 110.415 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.613 HD23 HG23 ' A' ' 42' ' ' ILE . 5.7 mp -113.13 156.42 23.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.968 -0.56 . . . . 74.11 110.327 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 16.4 ttm180 -119.08 106.73 12.69 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.18 -1.044 . . . . 64.23 108.18 167.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.832 HD13 HG12 ' A' ' 42' ' ' ILE . 41.8 tp -137.36 146.75 44.9 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.579 -0.737 . . . . 73.31 110.219 -173.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.433 ' HD3' ' OH ' ' A' ' 61' ' ' TYR . 53.1 ttt180 65.67 12.48 8.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.37 -0.832 . . . . 71.24 110.646 176.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.5 -12.12 36.04 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 121.009 -0.615 . . . . 64.43 113.116 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.433 ' OH ' ' HD3' ' A' ' 59' ' ' ARG . 27.4 p90 -134.52 155.85 49.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.635 0.731 . . . . 63.21 112.448 -177.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -79.96 143.26 34.32 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.933 -1.03 . . . . 74.5 110.974 175.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -157.57 151.31 24.09 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.255 -0.646 . . . . 73.23 109.255 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -113.95 134.15 55.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.07 0.462 . . . . 70.1 110.952 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 pp -133.13 167.09 20.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.671 -0.695 . . . . 75.14 109.697 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -77.71 148.53 34.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.202 0.525 . . . . 72.43 111.766 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.52 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 14.8 tmtt? -62.31 -35.52 79.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.197 -0.911 . . . . 70.11 111.355 -176.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.2 m -67.86 -30.77 70.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.689 0.255 . . . . 73.05 111.689 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.25 -31.82 55.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.153 0.502 . . . . 61.54 109.809 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 7' ' ' LEU . . . -65.51 -21.53 66.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.758 -0.656 . . . . 72.04 110.712 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.408 ' HA ' HD21 ' A' ' 8' ' ' ASN . 0.9 OUTLIER -69.55 -30.87 68.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.853 -0.612 . . . . 73.23 110.44 176.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.8 2.63 22.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.046 -0.525 . . . . 73.24 111.399 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 31' ' ' ILE . 59.5 mt -115.98 114.96 47.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.99 -0.55 . . . . 74.5 109.81 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.0 mt -94.71 121.9 36.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.338 -0.392 . . . . 74.53 110.079 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.563 HG11 HD22 ' A' ' 7' ' ' LEU . 30.3 m -120.98 158.89 23.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.78 0.8 . . . . 63.4 112.424 -173.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.94 126.58 47.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.444 -1.253 . . . . 73.14 109.206 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.473 ' HA ' HG12 ' A' ' 16' ' ' VAL . 11.0 p -74.59 127.07 36.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.902 -0.59 . . . . 74.2 110.51 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.341 0.591 . . . . 71.24 110.898 -178.723 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.444 -0.807 0 N-CA-C 111.956 -0.458 . . . . 74.04 111.956 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.3 pt -133.03 179.49 4.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.782 -0.451 . . . . 74.25 109.782 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.17 151.01 48.2 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.263 -0.97 . . . . 40.12 111.008 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.571 HD13 HD21 ' A' ' 56' ' ' LEU . 3.1 tm? -57.06 -33.15 66.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 42.41 110.461 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.433 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 9.2 p30 -77.13 -10.15 59.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.33 -0.396 . . . . 71.33 111.762 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.37 -9.81 37.47 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.975 0.417 . . . . 64.23 110.953 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.6 t -77.94 159.42 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.973 -0.558 . . . . 75.14 110.406 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.509 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 29.9 tt0 -103.42 173.97 6.07 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.146 -0.316 . . . . 74.4 110.146 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.58 HG22 ' HA2' ' A' ' 46' ' ' GLY . 40.2 pt -72.99 153.78 7.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 112.21 0.448 . . . . 71.25 112.21 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 51.4 49.24 21.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.194 -0.912 . . . . 72.44 111.998 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.9 m -134.06 152.8 52.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.282 -0.872 . . . . 73.52 109.001 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -109.34 140.85 42.5 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.318 -0.553 . . . . 74.54 110.254 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 77' ' ' VAL . 29.3 m -132.57 174.86 12.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.793 -0.639 . . . . 72.21 110.677 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -134.34 139.11 45.42 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.0 -0.546 . . . . 73.14 110.324 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.662 ' HA ' HG13 ' A' ' 75' ' ' VAL . 35.0 t -75.54 93.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.428 -0.805 . . . . 72.34 110.257 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.523 HD12 ' OE2' ' A' ' 76' ' ' GLU . 47.9 mm -80.94 -56.8 5.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.553 -0.749 . . . . 73.41 111.312 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.86 158.97 22.84 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.23 -0.986 . . . . 42.43 112.908 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.639 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 68.7 mt -127.43 156.34 39.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.757 -0.831 . . . . 73.52 108.757 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.5 t -103.14 90.21 2.36 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 120.748 0.309 . . . . 74.25 110.33 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.639 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 29.2 Cg_exo -61.18 171.51 3.95 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.147 2.565 . . . . 63.11 112.441 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 63.81 21.14 12.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.873 -0.603 . . . . 65.24 111.007 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.763 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 22.6 t -88.54 153.39 21.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.907 -0.588 . . . . 74.44 109.702 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -93.28 -3.1 54.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.901 0.382 . . . . 73.22 110.069 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 32.8 m -113.5 -2.42 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 116.145 -0.479 . . . . 73.21 110.537 174.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.763 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 15.0 ttp180 -54.09 -42.4 69.33 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.927 0.394 . . . . 73.33 110.285 175.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.52 -38.96 92.0 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 115.98 -0.555 . . . . 64.44 110.958 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.66 ' HG2' ' OE2' ' A' ' 69' ' ' GLU . 21.1 tptm -55.41 -54.02 48.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.294 0.568 . . . . 71.13 110.363 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.715 HG22 HD11 ' A' ' 36' ' ' ILE . 65.3 mt -62.78 -40.98 90.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.055 -0.975 . . . . 74.52 110.939 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ttt -67.65 -32.4 73.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.968 -0.56 . . . . 75.53 110.985 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -73.12 -26.29 61.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.083 -0.508 . . . . 74.45 110.114 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 60.9 mtt -69.12 -27.66 65.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.4 0.619 . . . . 61.45 110.167 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.08 18.82 11.51 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.641 -0.709 . . . . 75.43 112.12 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.715 HD11 HG22 ' A' ' 31' ' ' ILE . 39.5 mt -88.93 124.27 41.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.162 0.506 . . . . 75.11 110.118 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.01 161.12 41.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.349 -0.841 . . . . 75.13 109.438 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -64.23 121.57 14.58 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.201 -0.296 . . . . 55.12 110.201 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.97 -20.32 11.63 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.866 -0.683 . . . . 74.32 111.929 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.4 m -72.92 147.97 44.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.199 -0.297 . . . . 73.42 110.199 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -105.85 144.86 31.98 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.786 -0.45 . . . . 53.53 109.786 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.645 HG23 HD22 ' A' ' 56' ' ' LEU . 73.0 mt -129.89 128.53 65.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.209 -0.45 . . . . 63.25 111.213 -174.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.541 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 69.4 t80 -96.69 108.08 20.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.145 -0.48 . . . . 74.13 109.866 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.443 HD12 HD21 ' A' ' 7' ' ' LEU . 46.3 mm -75.68 111.75 12.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.92 -0.4 . . . . 74.03 109.92 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -73.59 -53.25 10.93 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.636 -0.505 . . . . 62.52 109.636 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.58 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 179.23 177.54 47.74 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.396 -0.82 . . . . 70.31 111.772 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -123.02 143.22 50.09 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.283 -0.636 . . . . 74.33 109.283 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . . . -59.99 156.59 36.06 Favored Pre-proline 0 C--N 1.326 -0.421 0 O-C-N 123.186 0.304 . . . . 73.24 110.206 177.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 48' ' ' ALA . 10.6 Cg_endo -54.41 -24.85 37.07 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.096 2.53 . . . . 70.21 113.105 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.5 mtt -84.41 -13.33 52.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.117 0.484 . . . . 72.3 110.796 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.82 -2.68 80.26 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.338 -0.705 . . . . 43.45 111.338 -173.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.746 ' HB2' ' HB2' ' A' ' 67' ' ' LYS . 5.4 t70 -151.15 135.17 9.46 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.267 -0.642 . . . . 74.31 109.267 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -82.67 179.91 25.14 Favored 'Cis proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.564 -1.432 . . . . 74.41 112.436 -1.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.02 141.71 23.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.327 -0.62 . . . . 62.02 109.327 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.84 113.38 26.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.985 0.421 . . . . 74.12 110.834 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.645 HD22 HG23 ' A' ' 42' ' ' ILE . 2.2 mp -117.43 133.85 55.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.04 -0.527 . . . . 72.23 110.201 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.721 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 46.3 ttt180 -97.47 105.48 17.63 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.887 -0.782 . . . . 72.35 108.887 173.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.536 ' HB3' HG12 ' A' ' 42' ' ' ILE . 3.3 pp -139.86 151.71 45.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.279 -0.419 . . . . 73.33 110.75 -174.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 71.44 -19.93 0.24 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.065 0.546 . . . . 73.11 111.703 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 150.58 -26.65 1.07 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.27 -0.49 . . . . 73.24 112.212 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -140.85 166.86 23.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.001 0.429 . . . . 74.5 111.182 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.721 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.3 m -85.58 138.45 32.17 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.107 -0.497 . . . . 61.43 111.871 -176.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.9 mt -134.54 159.06 42.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.558 -0.746 . . . . 75.25 109.471 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p -104.73 122.2 45.2 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.154 0.502 . . . . 74.1 111.361 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.9 tp -109.19 145.47 35.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.861 -0.609 . . . . 62.54 109.504 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 66' ' ' ARG . 8.8 mmm180 -77.53 149.3 34.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.601 0.239 . . . . 75.14 110.541 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.746 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 13.3 tmtt? -57.81 -36.96 72.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 62.43 110.646 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.3 m -62.84 -48.1 80.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.97 -0.559 . . . . 75.12 110.49 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.66 ' OE2' ' HG2' ' A' ' 30' ' ' LYS . 36.9 mt-10 -67.13 -30.96 71.1 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.788 -0.642 . . . . 73.41 110.551 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 8' ' ' ASN . . . -60.68 -21.26 62.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.316 -0.856 . . . . 71.33 111.876 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -81.31 -23.73 37.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.926 0.394 . . . . 75.22 110.532 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.34 -5.45 47.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.073 -0.512 . . . . 61.4 111.445 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.516 HG21 HG12 ' A' ' 75' ' ' VAL . 43.8 mm -122.22 126.22 73.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.516 -0.311 . . . . 71.22 110.772 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.1 mt -108.15 120.79 43.36 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.052 -0.522 . . . . 72.54 109.969 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.662 HG13 ' HA ' ' A' ' 18' ' ' VAL . 22.0 m -126.47 151.26 32.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.127 -0.488 . . . . 71.44 111.531 -173.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.523 ' OE2' HD12 ' A' ' 19' ' ' ILE . 14.6 pt-20 -91.39 138.78 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.437 -0.579 . . . . 73.53 109.437 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.633 ' HA ' HG12 ' A' ' 16' ' ' VAL . 24.3 t -87.64 109.9 20.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 120.916 0.388 . . . . 63.45 110.454 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 121.318 0.58 . . . . 45.54 110.695 -178.525 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.454 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.506 0 CA-C-O 120.824 0.124 . . . . 64.13 112.812 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.4 pt -101.67 160.83 3.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.614 -0.513 . . . . 63.21 109.614 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.01 147.53 30.59 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.142 -1.028 . . . . 54.31 111.283 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.698 HD12 HD11 ' A' ' 44' ' ' ILE . 36.9 tp -60.01 -26.81 66.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.017 0.437 . . . . 73.22 110.853 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.423 ' ND2' ' HA ' ' A' ' 71' ' ' LYS . 9.2 p30 -78.14 -9.8 59.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.148 -0.478 . . . . 73.01 111.011 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -90.34 -13.96 34.08 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.16 0.505 . . . . 75.42 109.932 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.5 t -77.86 154.88 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.613 -0.721 . . . . 71.14 110.49 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -103.76 170.87 7.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.741 -0.663 . . . . 73.41 110.278 -175.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.3 pt -71.72 146.91 11.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.012 -0.54 . . . . 72.44 111.116 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 13' ' ' LYS . 33.7 ttmt 59.04 63.96 1.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.8 0.81 . . . . 75.52 110.333 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 m -136.0 151.2 49.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.034 -0.985 . . . . 72.43 109.836 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -118.14 110.88 18.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.136 0.493 . . . . 72.52 110.017 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.576 HG11 ' HA ' ' A' ' 77' ' ' VAL . 27.0 m -123.69 167.38 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.719 -0.673 . . . . 75.22 111.801 -173.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.589 ' HB2' HD21 ' A' ' 78' ' ' LEU . 81.0 tttt -117.96 145.83 44.42 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.094 -0.957 . . . . 61.33 110.126 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.569 ' HA ' HG13 ' A' ' 75' ' ' VAL . 45.9 t -82.15 97.96 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.131 -0.486 . . . . 65.1 110.266 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.845 HD13 ' HB2' ' A' ' 76' ' ' GLU . 42.6 mt -61.03 -48.59 88.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.816 -0.629 . . . . 70.44 109.991 175.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.68 160.73 31.03 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.489 -0.778 . . . . 62.03 112.31 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.689 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 58.5 mt -98.04 157.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.164 -0.68 . . . . 74.22 109.164 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.9 t -102.45 89.71 1.85 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 120.982 0.42 . . . . 72.5 110.144 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.904 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 21.1 Cg_exo -64.93 170.05 10.86 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.026 2.484 . . . . 71.51 112.367 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 64.25 7.55 3.59 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.638 -0.71 . . . . 75.24 111.879 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.595 ' O ' ' HB3' ' A' ' 28' ' ' ARG . 1.3 m -91.7 154.19 19.15 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.648 -0.871 . . . . 75.14 108.648 170.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -69.61 -45.59 68.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.702 0.287 . . . . 62.33 111.065 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.525 ' HB ' ' HG3' ' A' ' 69' ' ' GLU . 24.5 m -78.03 -6.79 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.065 0.46 . . . . 62.44 110.815 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.904 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -57.07 -36.7 70.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.682 -0.69 . . . . 65.05 111.373 178.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -67.23 -39.27 86.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.117 0.484 . . . . 72.2 110.007 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.531 ' HG2' ' HE1' ' A' ' 34' ' ' MET . 85.3 tttt -63.12 -46.67 86.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.384 -0.826 . . . . 72.24 110.107 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 27' ' ' VAL . 68.9 mt -57.55 -48.2 83.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.603 -0.726 . . . . 71.32 111.445 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.61 -37.19 85.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.958 0.409 . . . . 60.31 110.81 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.26 -30.99 69.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 61.41 110.562 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.769 ' HE3' ' HB3' ' A' ' 65' ' ' LEU . 62.0 mtt -58.6 -32.29 68.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.047 -0.524 . . . . 73.22 110.887 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.41 1.82 7.71 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.617 -0.802 . . . . 64.53 112.208 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.442 HG22 HG23 ' A' ' 18' ' ' VAL . 63.1 mt -84.65 133.1 30.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.873 0.368 . . . . 64.32 110.31 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.744 HG23 ' H ' ' A' ' 38' ' ' ARG . 1.4 m -129.04 -74.86 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.911 -0.586 . . . . 74.11 111.03 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.744 ' H ' HG23 ' A' ' 37' ' ' VAL . 49.2 ttp180 -169.12 138.29 2.09 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.22 -0.659 . . . . 73.3 109.22 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.04 17.22 77.0 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.578 -0.82 . . . . 63.24 111.671 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 m -81.44 151.03 28.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.936 -0.394 . . . . 72.52 109.936 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -95.62 133.32 39.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.898 0.38 . . . . 63.35 110.728 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.4 mt -123.55 116.06 47.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.803 -0.635 . . . . 71.11 110.381 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.522 ' HE2' ' HG2' ' A' ' 45' ' ' GLU . 44.5 t80 -95.15 108.06 20.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.007 -0.542 . . . . 73.43 109.569 174.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.698 HD11 HD12 ' A' ' 7' ' ' LEU . 49.1 mm -75.3 105.87 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.119 -0.697 . . . . 74.35 109.119 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.522 ' HG2' ' HE2' ' A' ' 43' ' ' TYR . 0.4 OUTLIER -73.83 -61.14 1.95 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.123 -0.695 . . . . 72.24 109.123 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.01 162.56 35.9 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.649 -0.786 . . . . 73.11 112.203 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -125.52 153.0 44.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.202 -0.666 . . . . 70.35 109.202 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.72 156.42 89.12 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.589 -0.522 . . . . 72.34 109.589 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.68 -35.39 57.37 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.701 2.267 . . . . 75.11 112.574 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 tpt -65.43 -22.85 66.81 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.182 0.515 . . . . 75.14 111.264 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.27 -2.98 63.67 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 111.024 -0.831 . . . . 40.5 111.024 -174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -143.32 132.75 11.71 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.996 -0.742 . . . . 72.02 108.996 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -89.56 176.63 20.01 Favored 'Cis proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.704 -1.373 . . . . 74.02 113.023 0.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.6 mp -105.75 130.97 56.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.728 -0.669 . . . . 75.35 109.804 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.66 113.6 26.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.501 -0.318 . . . . 74.24 110.248 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.596 HD23 HD22 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -129.49 172.15 11.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.459 -0.337 . . . . 74.42 110.938 -178.029 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.658 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 35.4 ttm180 -129.23 117.24 20.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.841 -0.429 . . . . 71.54 109.841 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -135.95 148.7 48.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.54 -0.3 . . . . 71.55 110.58 -177.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.6 tpt85 69.09 -19.59 0.17 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.22 0.608 . . . . 72.22 111.997 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 143.34 -24.27 2.2 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.606 -0.598 . . . . 44.25 111.606 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -115.49 156.76 25.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.098 0.475 . . . . 75.44 111.401 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.658 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 46.7 t -93.8 146.81 23.61 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.751 -0.659 . . . . 63.21 110.477 176.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.3 mt -144.82 160.25 41.57 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.284 -0.871 . . . . 74.03 109.571 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.8 t -118.89 128.04 54.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.679 -0.489 . . . . 54.44 109.679 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.769 ' HB3' ' HE3' ' A' ' 34' ' ' MET . 2.0 pp -125.94 166.91 16.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.251 -0.432 . . . . 72.02 111.268 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.58 163.11 24.9 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.562 -0.745 . . . . 73.01 111.191 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.81 -22.39 64.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.404 -0.816 . . . . 62.12 109.998 174.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.2 m -66.14 -50.97 62.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.815 -0.629 . . . . 75.21 110.99 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.525 ' HG3' ' HB ' ' A' ' 27' ' ' VAL . 1.6 mp0 -58.26 -40.73 82.59 Favored 'General case' 0 N--CA 1.46 0.066 0 CA-C-O 121.075 0.464 . . . . 71.44 110.359 175.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.66 65.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.85 -0.614 . . . . 61.21 111.511 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.423 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 1.2 tmmt? -83.25 -32.29 26.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.285 -0.416 . . . . 65.3 110.633 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -96.95 9.33 42.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.285 0.476 . . . . 73.03 112.285 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.505 HG21 HG12 ' A' ' 75' ' ' VAL . 79.9 mt -113.24 120.85 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.22 -0.289 . . . . 73.11 110.22 174.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.0 mt -105.56 121.37 43.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.251 -0.431 . . . . 70.41 109.95 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.569 HG13 ' HA ' ' A' ' 18' ' ' VAL . 23.6 m -132.54 174.59 13.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.027 -0.533 . . . . 73.13 111.643 -174.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.845 ' HB2' HD13 ' A' ' 19' ' ' ILE . 35.4 tt0 -143.14 145.08 32.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.271 -0.877 . . . . 52.44 108.891 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.576 ' HA ' HG11 ' A' ' 16' ' ' VAL . 11.1 p -71.92 141.01 17.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.0 0.429 . . . . 71.34 110.661 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 17' ' ' LYS . 68.1 mt . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.116 -0.493 . . . . 75.4 111.527 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.752 0 N-CA-C 112.154 -0.379 . . . . 74.34 112.154 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.1 pt -109.84 169.91 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.757 -0.46 . . . . 72.23 109.757 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.95 158.21 46.14 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.11 -1.043 . . . . 65.23 111.294 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.3 tp -65.81 -18.39 65.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.761 0.315 . . . . 71.2 111.214 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.487 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 33.8 p30 -92.63 0.16 57.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.797 0.332 . . . . 53.21 111.311 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.48 5.98 31.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.926 0.393 . . . . 65.42 110.684 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 t -88.72 157.34 3.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.01 0.433 . . . . 54.13 110.951 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -101.74 164.55 11.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.663 -0.698 . . . . 71.11 110.166 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.429 HG22 ' HA2' ' A' ' 46' ' ' GLY . 36.2 pt -75.87 166.53 2.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.951 -0.568 . . . . 63.11 111.16 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.3 mttm 65.91 9.42 6.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.783 -0.644 . . . . 74.5 111.41 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 m -111.7 148.23 33.88 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.226 -0.443 . . . . 71.02 110.811 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -105.73 123.93 48.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.812 -0.631 . . . . 74.13 109.496 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 m -119.17 167.81 12.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.132 -0.485 . . . . 73.22 110.57 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.54 ' HB2' HD23 ' A' ' 78' ' ' LEU . 84.3 tttt -133.58 141.12 47.54 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.768 -0.651 . . . . 73.42 109.982 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.559 ' HA ' HG11 ' A' ' 75' ' ' VAL . 43.4 t -76.52 95.74 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.377 -0.829 . . . . 73.31 110.2 -177.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.76 HD11 ' HB2' ' A' ' 76' ' ' GLU . 36.2 mt -57.46 -49.83 79.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.569 -0.741 . . . . 62.34 109.639 174.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.559 ' HA2' ' HG2' ' A' ' 38' ' ' ARG . . . -173.26 164.57 36.44 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.659 -0.781 . . . . 62.23 112.622 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.69 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 37.9 mt -85.38 158.97 3.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.733 -0.84 . . . . 74.52 108.733 176.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.3 91.71 1.84 Allowed Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.679 -0.489 . . . . 61.42 109.679 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.69 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 72.1 Cg_exo -49.62 169.08 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 124.226 3.284 . . . . 70.41 114.073 -173.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 66.27 19.93 11.04 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.953 -1.021 . . . . 73.43 109.302 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.993 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 42.1 t -84.03 152.06 24.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.489 -1.232 . . . . 61.14 110.248 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 11.1 mptt -98.11 -23.56 15.68 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.159 -0.682 . . . . 65.2 109.159 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -97.25 -7.81 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.559 -0.746 . . . . 62.42 111.039 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.993 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 8.4 tmm_? -46.77 -47.92 20.71 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.079 0.4 . . . . 75.21 112.079 176.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -70.27 -28.47 65.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.962 0.41 . . . . 71.01 110.455 -177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -73.46 -48.26 34.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.726 -0.67 . . . . 50.4 110.364 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.507 HD13 HD11 ' A' ' 73' ' ' ILE . 85.7 mt -60.5 -42.1 90.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.525 -0.761 . . . . 74.23 111.182 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ttt -65.9 -30.1 70.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 74.51 110.579 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.75 -32.88 70.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.889 -0.596 . . . . 73.21 110.146 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.8 mtt -63.24 -29.07 70.48 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.934 -0.576 . . . . 74.14 110.43 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.5 5.1 12.92 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.79 -0.641 . . . . 74.44 112.365 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.488 ' HB ' HG21 ' A' ' 31' ' ' ILE . 43.3 mt -90.42 126.59 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.992 0.425 . . . . 72.42 110.436 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.1 m -141.1 -177.67 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.489 -0.778 . . . . 65.32 110.268 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.559 ' HG2' ' HA2' ' A' ' 20' ' ' GLY . 46.0 mtt85 -69.78 114.75 8.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 72.42 110.313 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.39 -8.67 22.5 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.534 -0.841 . . . . 63.14 112.812 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 m -70.41 142.69 52.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.041 0.448 . . . . 72.42 110.412 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -106.45 137.47 44.37 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.61 -0.723 . . . . 72.13 110.218 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.739 HG12 ' HB3' ' A' ' 58' ' ' LEU . 66.1 mt -129.5 131.41 67.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.71 -0.677 . . . . 71.25 111.293 -172.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.527 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 53.3 t80 -96.95 125.9 41.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.696 -0.483 . . . . 64.11 109.696 171.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.6 mm -87.24 99.48 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.574 -0.528 . . . . 73.23 109.574 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.15 -41.94 24.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.653 -0.703 . . . . 65.02 110.497 -176.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 172.74 -172.91 45.32 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.432 -0.667 . . . . 65.35 111.432 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.838 ' HE2' ' HA2' ' A' ' 51' ' ' GLY . 13.9 ptmt -151.0 165.89 32.36 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.246 -0.65 . . . . 73.03 109.246 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.47 156.42 82.23 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.771 -0.455 . . . . 64.01 109.771 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.49 -32.14 51.71 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.797 2.331 . . . . 74.54 113.086 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 45.5 ttm -86.6 -8.67 57.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.426 0.631 . . . . 75.14 110.367 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.838 ' HA2' ' HE2' ' A' ' 47' ' ' LYS . . . 95.71 -11.27 68.35 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.618 -0.719 . . . . 52.43 112.477 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -131.87 127.53 21.26 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-O 120.841 0.353 . . . . 71.14 110.271 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -83.61 170.33 53.17 Favored 'Cis proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.918 -1.701 . . . . 60.43 112.718 -1.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.492 HG23 ' HB3' ' A' ' 47' ' ' LYS . 41.0 mt -98.57 141.99 15.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.849 -0.797 . . . . 75.42 108.849 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.99 102.9 14.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.033 0.444 . . . . 74.34 110.313 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.716 HD21 HG23 ' A' ' 42' ' ' ILE . 4.5 mp -108.4 162.01 14.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.0 -0.545 . . . . 65.0 109.941 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.681 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 75.3 ttt180 -132.51 100.66 5.04 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.878 -0.786 . . . . 63.14 108.878 173.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.739 ' HB3' HG12 ' A' ' 42' ' ' ILE . 2.9 pp -127.36 149.76 49.91 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.827 -0.624 . . . . 73.11 110.856 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.456 ' HD3' ' OH ' ' A' ' 61' ' ' TYR . 52.4 ttt180 70.26 -22.44 0.17 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.532 0.52 . . . . 72.42 112.13 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 141.52 -3.58 2.13 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.927 -0.654 . . . . 61.43 112.141 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.456 ' OH ' ' HD3' ' A' ' 59' ' ' ARG . 16.9 p90 -138.28 158.33 44.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.162 0.506 . . . . 72.41 111.328 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.681 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 34.8 t -87.14 147.15 25.75 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.532 -0.758 . . . . 73.45 110.126 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 54.1 tp -155.52 147.73 23.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.579 -0.737 . . . . 75.01 109.775 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 4.1 m -97.48 133.55 41.91 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.07 0.462 . . . . 63.31 110.71 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.685 HD22 HD12 ' A' ' 56' ' ' LEU . 3.8 mm? -123.09 150.12 43.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.609 -0.723 . . . . 70.43 110.178 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 66' ' ' ARG . 22.9 mmt180 -81.87 161.44 23.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.141 0.496 . . . . 71.03 111.222 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.39 -36.89 85.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 71.4 110.898 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.9 m -70.33 -43.27 70.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.442 . . . . 54.1 111.005 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.15 -35.07 79.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.261 0.553 . . . . 73.2 110.482 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 8' ' ' ASN . . . -68.03 -22.19 64.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.525 -0.761 . . . . 71.14 111.358 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -76.36 -29.23 57.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.168 0.508 . . . . 73.22 110.267 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.11 9.18 5.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.751 -0.659 . . . . 62.32 111.629 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.507 HD11 HD13 ' A' ' 31' ' ' ILE . 62.5 mt -128.23 131.27 69.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.327 -0.397 . . . . 64.23 110.55 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.2 mt -107.23 125.71 51.47 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.275 -0.421 . . . . 72.23 109.87 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 18' ' ' VAL . 27.4 m -129.81 160.31 40.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.307 0.575 . . . . 62.04 111.948 -175.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.76 ' HB2' HD11 ' A' ' 19' ' ' ILE . 6.5 tp10 -120.76 146.6 46.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.956 -1.02 . . . . 72.31 109.104 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -91.09 133.63 32.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.911 0.386 . . . . 74.52 110.094 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' A' ' 17' ' ' LYS . 4.0 mm? . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 121.09 0.471 . . . . 74.05 111.342 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.629 0 N-CA-C 112.046 -0.422 . . . . 74.12 112.046 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 pt -124.89 179.41 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.389 -0.597 . . . . 75.32 109.389 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.42 154.13 41.91 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.464 -1.35 . . . . 61.44 111.598 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.9 tp -60.67 -27.56 67.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.964 0.411 . . . . 70.14 110.796 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -71.86 -15.16 62.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 53.41 111.533 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.26 -3.9 54.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.877 0.37 . . . . 74.12 110.823 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.7 t -90.36 159.39 2.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.345 -0.389 . . . . 64.44 110.375 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.63 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 22.1 tt0 -98.29 171.97 7.86 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.502 -0.555 . . . . 75.14 109.502 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.63 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 38.4 pt -79.83 177.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.457 -0.338 . . . . 61.54 110.474 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 pttm 52.79 21.16 1.83 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.414 1.085 . . . . 73.31 112.423 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.2 m -121.53 153.03 38.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.8 0.334 . . . . 62.51 110.726 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -108.97 132.0 54.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.081 0.467 . . . . 71.14 109.843 176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.831 HG13 ' HA ' ' A' ' 77' ' ' VAL . 33.7 m -129.79 162.51 37.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.696 -0.684 . . . . 72.35 110.495 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.431 ' HB3' HD12 ' A' ' 78' ' ' LEU . 39.0 ttmt -115.6 143.86 44.73 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.281 -0.872 . . . . 73.21 109.231 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.806 ' HA ' HG11 ' A' ' 75' ' ' VAL . 53.8 t -73.53 95.87 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.855 -0.611 . . . . 72.14 109.947 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.4 mm -64.84 -40.98 90.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.247 -0.888 . . . . 72.14 109.891 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.97 -178.36 44.77 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.466 -0.873 . . . . 74.53 112.334 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.695 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 48.9 mt -128.34 159.3 39.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.364 -0.976 . . . . 70.21 108.364 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -100.1 90.81 1.44 Allowed Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.864 0.364 . . . . 55.24 110.157 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.695 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 17.5 Cg_exo -65.23 -178.56 0.86 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.335 2.69 . . . . 73.11 112.903 -173.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 61.97 25.52 15.32 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.816 0.817 . . . . 64.41 109.77 -173.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.839 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 10.8 t -115.02 150.66 35.5 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.59 -1.186 . . . . 72.42 109.64 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 3.8 mppt? -81.63 -32.73 31.81 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.597 -0.52 . . . . 73.05 109.597 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 31' ' ' ILE . 27.2 m -79.22 -19.95 12.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 64.22 110.652 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.839 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 5.7 tmm_? -52.28 -43.37 64.39 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.076 0.465 . . . . 74.45 109.826 172.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -59.41 -47.35 85.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.459 -0.792 . . . . 64.5 110.42 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 34' ' ' MET . 87.0 tttt -57.39 -47.19 82.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.209 -0.905 . . . . 71.45 111.028 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.492 HG23 ' HB ' ' A' ' 36' ' ' ILE . 75.9 mt -58.18 -44.77 88.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.566 -0.743 . . . . 73.44 111.409 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 55.2 mtt -71.59 -28.76 64.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.466 -0.334 . . . . 75.44 111.179 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.2 -31.96 72.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.237 0.541 . . . . 75.14 110.003 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 97.6 mmm -73.64 -9.18 58.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.462 -0.79 . . . . 74.22 111.057 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.5 -3.38 46.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.771 -0.728 . . . . 54.11 112.508 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.648 HG23 HG21 ' A' ' 18' ' ' VAL . 58.7 mt -88.06 129.72 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.911 0.386 . . . . 65.11 110.403 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.722 HG22 ' H ' ' A' ' 38' ' ' ARG . 1.0 OUTLIER -144.21 -75.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.837 -0.62 . . . . 75.24 111.437 -178.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.722 ' H ' HG22 ' A' ' 37' ' ' VAL . 24.7 ttt180 -150.86 140.18 21.34 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.602 -0.518 . . . . 73.11 109.602 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.06 19.25 69.82 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.776 -0.726 . . . . 54.3 112.106 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 m -85.28 146.72 26.91 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.948 -0.39 . . . . 65.22 109.948 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -90.99 127.8 36.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.866 0.365 . . . . 74.14 111.067 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.8 mm -126.22 114.87 40.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.44 -0.8 . . . . 75.25 109.609 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.806 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 39.3 t80 -106.3 119.34 38.99 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.559 -0.534 . . . . 75.12 109.559 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.427 HD12 HD12 ' A' ' 56' ' ' LEU . 14.6 mm -82.01 99.18 4.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.297 -0.41 . . . . 74.22 110.029 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -82.95 -22.58 33.73 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.154 -0.618 . . . . 73.42 110.364 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.79 -173.93 34.47 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.81 -0.71 . . . . 74.33 112.139 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.757 ' HG2' HG23 ' A' ' 54' ' ' ILE . 53.1 mtpt -126.8 160.3 31.28 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.442 -0.577 . . . . 53.32 109.442 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.18 151.23 94.24 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.712 -0.477 . . . . 51.44 109.712 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -51.4 -30.81 35.91 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.965 2.443 . . . . 61.43 113.215 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.0 tpt -76.09 -19.85 58.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.121 0.486 . . . . 65.01 111.223 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.58 -7.6 57.95 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.213 -0.755 . . . . 42.42 111.213 -174.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -152.42 132.61 7.35 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 108.9 -0.778 . . . . 74.24 108.9 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.71 -172.52 10.31 Favored 'Cis proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.567 -1.431 . . . . 53.44 112.98 0.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.757 HG23 ' HG2' ' A' ' 47' ' ' LYS . 53.5 mt -109.02 141.85 23.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.764 -0.653 . . . . 73.22 109.325 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.12 106.2 18.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.962 0.41 . . . . 70.42 110.998 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -105.72 135.77 46.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.132 -0.486 . . . . 71.12 110.059 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.806 ' HB3' ' HB3' ' A' ' 43' ' ' TYR . 2.3 tmt_? -86.56 114.37 23.24 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.794 -0.817 . . . . 72.4 108.794 175.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.6 tp -136.57 146.82 46.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.726 -0.67 . . . . 74.21 110.271 -175.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 71.05 -56.75 0.62 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.487 0.715 . . . . 65.0 110.762 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.51 -36.94 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.41 -0.676 . . . . 51.44 111.41 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.434 ' HE2' HD22 ' A' ' 63' ' ' LEU . 29.6 p90 -124.34 176.59 6.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.759 0.314 . . . . 74.23 110.4 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.801 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -93.11 140.81 29.11 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.491 0.552 . . . . 63.44 112.491 -175.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.434 HD22 ' HE2' ' A' ' 61' ' ' TYR . 75.6 mt -137.04 148.12 46.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.267 -0.879 . . . . 73.12 109.28 174.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 5.7 p -88.52 128.68 35.56 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.291 0.567 . . . . 72.31 111.829 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -121.5 157.76 29.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.253 -1.017 . . . . 73.42 108.253 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -80.22 156.34 26.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.56 0.695 . . . . 73.11 112.159 -169.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.708 ' HZ3' ' HB3' ' A' ' 67' ' ' LYS . 6.6 ttpm? -57.46 -28.19 63.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.669 -1.151 . . . . 71.24 110.975 174.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.1 m -61.25 -51.82 67.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.858 -0.61 . . . . 75.44 110.395 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' O ' HG13 ' A' ' 73' ' ' ILE . 1.7 mp0 -63.52 -30.54 71.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.94 -0.573 . . . . 72.21 111.111 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.16 -21.79 62.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.335 -0.393 . . . . 70.52 111.69 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.08 -42.45 38.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.398 0.618 . . . . 72.43 109.642 177.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.09 -10.37 53.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.392 -0.822 . . . . 71.43 112.018 -170.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.505 HG21 HG13 ' A' ' 75' ' ' VAL . 74.2 mt -90.27 113.09 25.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.923 -0.399 . . . . 74.03 109.923 174.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.5 mt -97.01 112.07 24.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.243 0.545 . . . . 71.33 110.484 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.806 HG11 ' HA ' ' A' ' 18' ' ' VAL . 29.4 m -132.34 167.7 25.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.758 -0.655 . . . . 72.4 110.203 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -140.23 145.96 38.04 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.123 -0.695 . . . . 74.4 109.123 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.831 ' HA ' HG13 ' A' ' 16' ' ' VAL . 47.9 t -67.88 103.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.019 -0.537 . . . . 63.25 110.415 -177.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.431 HD12 ' HB3' ' A' ' 17' ' ' LYS . 26.6 mt . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 115.759 -0.655 . . . . 71.04 111.184 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.79 0 N-CA-C 111.441 -0.664 . . . . 71.42 111.441 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.7 pt -107.88 163.07 5.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 110.176 -0.305 . . . . 73.24 110.176 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.26 157.83 53.51 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.732 -0.747 . . . . 61.01 111.755 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.492 HD23 HD12 ' A' ' 56' ' ' LEU . 52.4 tp -61.52 -23.47 65.95 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.938 0.399 . . . . 74.3 111.195 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -87.15 -7.12 58.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.562 -0.29 . . . . 65.44 111.192 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -95.97 0.14 51.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.913 0.387 . . . . 71.15 110.67 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.606 HG13 HG11 ' A' ' 16' ' ' VAL . 12.1 t -90.0 163.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 74.22 110.812 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.437 ' N ' HG12 ' A' ' 10' ' ' VAL . 30.4 tt0 -83.53 165.12 19.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.259 -0.428 . . . . 62.31 109.988 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.439 HG13 ' HZ3' ' A' ' 13' ' ' LYS . 19.7 pt -85.93 163.18 2.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.076 -0.511 . . . . 54.1 110.826 -177.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.439 ' HZ3' HG13 ' A' ' 12' ' ' ILE . 37.6 mtmm 59.45 25.21 13.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.005 0.431 . . . . 73.31 111.301 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.7 m -108.87 159.95 16.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.182 -0.463 . . . . 71.4 110.511 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.509 ' HG2' HD12 ' A' ' 78' ' ' LEU . 42.2 tttm -116.48 119.23 34.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.716 -0.846 . . . . 74.05 108.716 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.606 HG11 HG13 ' A' ' 10' ' ' VAL . 28.8 m -125.19 155.86 34.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.038 0.447 . . . . 64.41 112.011 -170.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -117.4 142.63 46.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.478 -0.783 . . . . 73.41 110.27 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.795 ' HA ' HG13 ' A' ' 75' ' ' VAL . 68.0 t -83.06 97.68 4.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.735 -0.666 . . . . 63.11 110.617 -176.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.4 mt -58.09 -54.38 33.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.2 -0.909 . . . . 71.54 110.358 173.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.36 165.66 34.46 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.375 -0.917 . . . . 37.46 113.076 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 22' ' ' VAL . 58.6 mt -119.75 158.8 21.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.879 -0.786 . . . . 70.15 108.879 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 25' ' ' SER . 62.0 t -99.96 91.75 1.75 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.018 0.437 . . . . 74.01 110.028 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.685 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 37.6 Cg_endo -62.53 171.23 5.81 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.211 2.607 . . . . 37.46 113.308 -173.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 66.1 -15.73 0.12 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.004 0.922 . . . . 74.3 112.486 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -66.72 154.3 41.05 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 110.116 -0.327 . . . . 74.24 110.116 175.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 26' ' ' LYS . 72.1 mmtt -69.01 -30.51 68.92 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 111.942 0.349 . . . . 74.04 111.942 -175.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.687 HG21 ' HA ' ' A' ' 69' ' ' GLU . 20.5 m -83.39 -13.41 11.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.886 -0.326 . . . . 74.34 111.336 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.685 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 1.3 tmt_? -58.03 -48.41 80.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.379 -0.373 . . . . 74.14 111.085 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -62.48 -36.34 82.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.094 0.473 . . . . 73.24 110.79 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 34' ' ' MET . 61.5 tttm -66.29 -50.2 64.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.469 -0.787 . . . . 75.33 110.683 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.685 HD12 HD12 ' A' ' 73' ' ' ILE . 70.7 mt -66.37 -42.05 89.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.757 -0.656 . . . . 74.3 111.478 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.477 ' HE1' HG13 ' A' ' 37' ' ' VAL . 83.8 mtp -70.44 -28.75 65.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.633 0.254 . . . . 75.11 111.17 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -67.59 -28.21 67.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.199 0.523 . . . . 73.23 109.891 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 91.7 mmm -73.82 -16.44 61.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.524 -0.762 . . . . 74.44 111.062 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.3 -13.94 21.05 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.592 -0.813 . . . . 63.43 112.865 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.0 mt -78.64 129.33 37.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.71 0.291 . . . . 44.4 110.418 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.767 HG22 ' H ' ' A' ' 38' ' ' ARG . 2.1 m -139.21 -77.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.992 -0.549 . . . . 74.52 111.972 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.767 ' H ' HG22 ' A' ' 37' ' ' VAL . 1.4 tmm_? -149.44 125.44 10.62 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.048 -0.723 . . . . 71.32 109.048 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.33 -14.33 59.69 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.713 -0.756 . . . . 75.33 111.988 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.12 138.31 58.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.32 -0.622 . . . . 71.15 109.32 176.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -123.34 147.45 47.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.359 0.6 . . . . 54.53 111.258 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.77 HG23 ' HB3' ' A' ' 56' ' ' LEU . 44.3 mt -136.35 152.66 30.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.116 -0.947 . . . . 73.24 110.046 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -99.65 137.7 37.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.76 -0.459 . . . . 74.23 109.76 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.4 mm -87.76 103.12 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.431 -0.35 . . . . 71.34 110.585 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -71.67 -39.06 70.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.123 -0.489 . . . . 71.44 110.423 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.73 -175.95 34.92 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.93 -0.652 . . . . 51.14 111.927 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -127.65 152.28 47.87 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.001 -0.37 . . . . 73.53 110.001 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.593 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . . . -65.28 165.55 17.1 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.157 -0.474 . . . . 74.43 110.444 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 48' ' ' ALA . 9.5 Cg_endo -51.53 -32.59 44.33 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.903 2.402 . . . . 64.03 113.014 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.5 mtt -89.52 -4.15 58.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.978 0.418 . . . . 74.21 110.991 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.32 5.83 89.55 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.219 -0.752 . . . . 74.45 111.219 -173.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 52.9 t0 -148.39 121.15 4.56 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.9 -0.778 . . . . 70.1 108.9 -176.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.522 ' HB3' ' HD2' ' A' ' 66' ' ' ARG . 91.5 Cg_endo -86.41 -169.9 6.28 Favored 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.537 -1.443 . . . . 72.21 113.311 1.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.406 HD11 ' N ' ' A' ' 54' ' ' ILE . 4.4 mp -112.63 145.61 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.424 -0.807 . . . . 74.24 109.504 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.45 108.15 20.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.873 0.368 . . . . 75.04 110.798 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.77 ' HB3' HG23 ' A' ' 42' ' ' ILE . 2.2 mm? -102.06 146.14 28.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.464 -0.569 . . . . 64.24 109.464 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 21.8 ttt180 -116.79 114.17 23.57 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.478 -0.489 . . . . 70.34 110.442 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 60' ' ' GLY . 6.0 tt -149.23 156.02 41.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.895 -0.78 . . . . 72.44 108.895 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' A' ' 58' ' ' LEU . 79.6 ttt180 74.64 -21.84 0.28 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.309 0.576 . . . . 74.21 110.412 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 146.88 -40.92 0.99 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.719 -0.673 . . . . 73.41 111.6 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -116.57 168.55 10.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.143 0.497 . . . . 73.42 111.201 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.2 m -85.74 139.03 31.68 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.395 -0.82 . . . . 64.35 111.556 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.4 mt -134.49 158.75 43.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.669 -0.696 . . . . 60.43 109.309 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.1 m -100.85 138.48 37.84 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.072 0.463 . . . . 70.53 111.305 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.4 mt -127.76 134.64 49.51 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.357 -0.838 . . . . 63.42 108.909 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.522 ' HD2' ' HB3' ' A' ' 53' ' ' PRO . 25.3 mmm180 -64.9 153.5 40.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.686 -0.233 . . . . 74.31 110.655 -176.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -33.86 67.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.782 0.325 . . . . 65.31 110.192 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.4 m -57.66 -45.8 85.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.932 -0.577 . . . . 44.32 110.711 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.687 ' HA ' HG21 ' A' ' 27' ' ' VAL . 32.6 mt-10 -66.29 -44.54 83.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.227 0.537 . . . . 73.23 109.856 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.33 -22.31 66.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.486 -0.779 . . . . 74.44 111.614 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -81.31 -24.53 37.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.134 0.493 . . . . 74.23 110.608 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -95.25 12.81 27.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.255 0.55 . . . . 65.12 110.599 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.685 HD12 HD12 ' A' ' 31' ' ' ILE . 65.2 mt -121.6 119.57 59.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.65 -0.705 . . . . 71.22 109.669 176.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.7 mt -102.64 122.35 44.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.7 -0.482 . . . . 73.11 109.7 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.795 HG13 ' HA ' ' A' ' 18' ' ' VAL . 31.0 m -132.97 173.13 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.276 0.56 . . . . 74.03 112.3 -172.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.68 160.46 38.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.153 -0.93 . . . . 71.24 109.449 174.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.61 134.06 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.13 0.49 . . . . 74.51 111.534 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.509 HD12 ' HG2' ' A' ' 15' ' ' LYS . 81.6 mt . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 115.842 -0.617 . . . . 74.01 110.978 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 121.409 0.449 . . . . 75.21 113.892 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 pt -137.03 176.33 8.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.055 -1.091 . . . . 71.32 108.055 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.77 148.71 42.07 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.7 -1.238 . . . . 75.5 111.054 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.625 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 2.0 tm? -57.24 -29.82 64.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.504 0.668 . . . . 73.42 109.799 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.635 HD21 ' HA ' ' A' ' 71' ' ' LYS . 8.7 p30 -71.36 -14.11 62.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.482 -0.781 . . . . 61.13 111.364 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -101.59 3.99 40.5 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.417 -0.356 . . . . 70.34 111.06 -174.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.9 t -83.74 155.45 3.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.112 0.482 . . . . 75.11 110.236 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.565 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 17.3 tt0 -95.02 175.09 6.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.798 -0.637 . . . . 74.42 110.452 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.565 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 23.7 pt -75.09 145.69 10.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.236 -0.438 . . . . 62.34 111.69 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 59.12 24.42 12.76 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.433 -0.803 . . . . 72.23 112.17 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 m -108.45 147.54 31.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.082 -0.508 . . . . 62.2 109.831 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -109.66 149.83 29.15 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.954 -0.387 . . . . 74.24 109.954 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.901 HG12 ' HA ' ' A' ' 77' ' ' VAL . 28.4 m -140.25 178.3 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.14 0.495 . . . . 75.42 110.987 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.675 ' HB2' HD13 ' A' ' 78' ' ' LEU . 7.1 ttpm? -133.06 140.4 47.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.545 -0.752 . . . . 72.32 110.138 176.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.66 ' HA ' HG11 ' A' ' 75' ' ' VAL . 47.6 t -73.14 97.67 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.605 -0.725 . . . . 63.11 110.073 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.7 mm -79.75 -49.34 19.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.693 -0.685 . . . . 73.43 110.951 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -152.55 168.08 31.54 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.818 -1.182 . . . . 72.1 113.646 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.636 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 50.0 mm -124.39 157.42 31.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.023 -1.103 . . . . 64.34 108.023 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 t -102.62 90.32 2.18 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 120.849 0.357 . . . . 73.24 110.218 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.636 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 74.2 Cg_exo -49.71 159.33 1.54 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.774 2.983 . . . . 73.21 113.875 -171.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 64.84 69.86 0.49 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.308 -0.86 . . . . 70.4 110.945 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 9.3 t -149.57 162.98 39.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.366 -0.834 . . . . 73.25 109.137 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -73.27 -45.13 57.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.358 0.599 . . . . 74.25 109.55 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.427 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 27.8 m -78.71 -20.54 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.488 -0.778 . . . . 63.11 111.573 -176.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.646 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 2.1 tmt_? -50.87 -43.98 59.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.257 0.551 . . . . 70.23 109.654 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 29' ' ' ARG . 8.5 tpt180 -71.8 -44.21 64.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.591 -0.731 . . . . 71.52 110.614 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -60.59 -45.96 92.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.429 -0.805 . . . . 63.15 111.926 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 34' ' ' MET . 65.8 mt -68.68 -41.19 82.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.062 -0.517 . . . . 72.23 111.181 -177.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.1 ttt -72.26 -28.47 63.15 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.66 -0.416 . . . . 75.5 110.371 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.8 -38.94 87.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.131 0.491 . . . . 40.32 109.944 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 6.9 mmt -56.81 -29.42 62.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.262 -0.881 . . . . 71.23 111.363 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.51 13.31 22.82 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.763 -0.732 . . . . 52.04 111.975 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -90.51 134.17 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.925 -0.398 . . . . 75.33 109.925 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 m -137.48 -177.86 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.081 -0.509 . . . . 72.34 110.547 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -64.52 131.46 47.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.366 -0.379 . . . . 74.11 110.119 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.61 -21.58 36.35 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.556 -0.831 . . . . 74.4 112.56 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.1 m -68.2 146.49 53.33 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.896 0.379 . . . . 72.5 110.342 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -95.88 132.06 41.56 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.472 0.653 . . . . 53.42 110.916 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.58 HD12 ' HB3' ' A' ' 58' ' ' LEU . 48.7 mm -121.11 122.49 67.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.059 -0.973 . . . . 74.13 109.458 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.662 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 14.9 t80 -102.47 118.35 36.67 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.702 -0.481 . . . . 74.45 109.702 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 mm -85.19 100.16 8.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.487 -0.561 . . . . 73.31 109.487 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.38 -42.0 65.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.207 -0.664 . . . . 73.42 109.207 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.486 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 170.27 -169.44 42.25 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.243 -0.743 . . . . 64.41 111.243 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.727 ' HG3' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -146.1 162.92 36.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.395 -0.594 . . . . 64.3 109.395 175.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.501 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . . . -61.28 160.83 20.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 O-C-N 123.486 0.491 . . . . 42.44 110.315 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 48' ' ' ALA . 9.3 Cg_endo -52.81 -26.54 31.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.151 2.567 . . . . 73.53 113.47 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.8 ttt -93.45 -7.64 43.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.087 0.47 . . . . 75.34 110.877 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.727 ' HA2' ' HG3' ' A' ' 47' ' ' LYS . . . 89.05 -1.54 83.09 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.923 -0.656 . . . . 41.13 112.092 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -145.71 125.86 7.09 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.216 -0.661 . . . . 74.51 109.216 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.93 178.56 31.54 Favored 'Cis proline' 0 C--O 1.236 0.382 0 C-N-CA 123.029 -1.655 . . . . 64.03 112.842 -0.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.685 HG21 ' HB3' ' A' ' 47' ' ' LYS . 19.8 mt -114.92 141.83 30.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 72.24 109.813 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.59 109.73 21.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.995 0.426 . . . . 62.43 110.322 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.6 mt -120.58 135.58 55.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.293 -0.412 . . . . 71.33 110.945 -173.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.662 ' HB3' ' HB3' ' A' ' 43' ' ' TYR . 4.2 tmt_? -92.34 100.83 13.33 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.986 -1.116 . . . . 75.34 107.986 172.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.58 ' HB3' HD12 ' A' ' 42' ' ' ILE . 2.0 pp -138.78 156.59 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.643 -0.708 . . . . 73.2 110.811 -174.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? 71.34 -44.76 0.6 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.909 0.756 . . . . 75.33 110.707 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.69 -19.13 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 116.23 -0.441 . . . . 54.44 112.02 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -137.96 168.9 18.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.988 0.423 . . . . 74.1 111.436 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.659 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.2 m -85.27 126.71 33.92 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.627 -0.715 . . . . 74.0 110.534 175.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 52.9 tp -145.23 148.87 33.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.657 -0.702 . . . . 74.15 109.224 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 21.8 t -95.01 125.96 40.02 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.181 0.515 . . . . 70.45 110.99 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.12 168.18 11.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.266 -0.879 . . . . 73.21 109.397 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.472 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 30.4 mmt180 -77.53 153.48 33.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.157 0.503 . . . . 73.31 111.673 -177.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -60.08 -34.78 73.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.525 -0.761 . . . . 75.35 109.986 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.4 m -61.66 -36.26 80.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.302 -0.863 . . . . 73.04 110.91 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.472 ' HG3' ' HB2' ' A' ' 66' ' ' ARG . 40.7 mt-10 -69.97 -41.89 73.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.458 0.647 . . . . 75.52 110.079 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.77 -21.52 66.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.212 -0.904 . . . . 75.22 111.497 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.635 ' HA ' HD21 ' A' ' 8' ' ' ASN . 61.2 tttm -71.32 -25.21 62.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.792 0.33 . . . . 74.44 111.226 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.61 -4.47 57.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.074 0.464 . . . . 74.45 111.194 -174.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' A' ' 7' ' ' LEU . 21.1 mt -104.54 125.4 59.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.15 -0.477 . . . . 74.42 110.655 -178.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.1 mt -102.99 115.77 31.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.52 -0.548 . . . . 62.52 109.52 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.66 HG11 ' HA ' ' A' ' 18' ' ' VAL . 19.7 m -130.65 150.1 34.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.142 -0.481 . . . . 74.13 111.461 -174.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -99.49 139.87 34.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.453 -0.573 . . . . 55.02 109.453 171.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.901 ' HA ' HG12 ' A' ' 16' ' ' VAL . 40.9 t -73.95 113.63 12.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.033 0.444 . . . . 73.22 110.583 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.675 HD13 ' HB2' ' A' ' 17' ' ' LYS . 47.5 mt . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.964 -0.562 . . . . 75.12 110.939 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.691 0 CA-C-O 120.933 0.185 . . . . 61.32 113.271 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.4 pt -97.91 167.34 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.499 -0.926 . . . . 74.51 108.499 172.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.46 143.46 29.37 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 119.276 -1.44 . . . . 41.33 111.482 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 7' ' ' LEU . 8.2 tt -61.73 -26.84 68.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.32 0.581 . . . . 65.11 109.935 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.573 HD21 ' HA ' ' A' ' 71' ' ' LYS . 6.8 p30 -67.76 -14.63 63.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 73.45 110.7 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.97 -2.95 39.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.115 -0.493 . . . . 74.43 111.309 -176.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 11' ' ' GLU . 34.1 t -78.09 159.69 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.956 0.408 . . . . 73.13 110.459 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.449 ' N ' HG12 ' A' ' 10' ' ' VAL . 28.0 tt0 -102.61 173.77 6.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.873 -0.603 . . . . 73.13 110.169 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.576 HG22 ' HA2' ' A' ' 46' ' ' GLY . 33.9 pt -76.42 149.8 6.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.35 0.5 . . . . 72.24 112.35 -173.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 53.8 31.02 12.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.174 -0.921 . . . . 75.4 112.142 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.7 m -121.2 145.86 47.39 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.261 -0.644 . . . . 75.15 109.261 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -110.45 137.97 47.46 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.343 0.592 . . . . 74.41 111.727 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.738 HG13 ' HA ' ' A' ' 77' ' ' VAL . 16.2 m -137.5 163.63 30.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.167 -0.924 . . . . 74.24 109.247 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 41' ' ' GLU . 38.4 ttpt -118.96 141.55 48.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.059 0.457 . . . . 74.22 111.241 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.466 ' HA ' HG11 ' A' ' 75' ' ' VAL . 47.0 t -73.91 93.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.995 -1.002 . . . . 75.3 110.121 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.1 -38.85 56.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.538 -0.755 . . . . 54.44 110.445 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.42 153.27 24.59 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.087 -1.054 . . . . 74.23 113.441 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.0 mt -114.7 158.25 15.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.177 -1.046 . . . . 73.43 108.177 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 22' ' ' VAL . 7.5 p -100.18 91.84 1.86 Allowed Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 121.761 0.791 . . . . 62.02 110.243 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.913 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 29.3 Cg_endo -60.01 166.67 8.41 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.907 2.404 . . . . 74.1 112.544 -174.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 66.52 11.9 8.38 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.388 -0.824 . . . . 73.1 111.226 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.835 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 34.7 t -85.51 157.45 20.42 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.429 -0.582 . . . . 62.53 109.429 174.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -69.0 -43.83 74.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.162 -0.681 . . . . 71.31 109.162 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.3 m -77.94 -15.68 14.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.353 -0.84 . . . . 75.1 110.969 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.913 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -52.46 -43.17 64.78 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.592 -0.276 . . . . 55.32 110.311 176.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -71.06 -41.64 70.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.413 . . . . 65.42 110.956 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -54.1 -45.12 71.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.315 0.579 . . . . 75.43 110.945 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.749 HD12 HD12 ' A' ' 73' ' ' ILE . 86.9 mt -65.8 -46.85 87.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.042 -0.981 . . . . 64.11 112.054 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 51.1 mtt -73.33 -29.37 62.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.726 0.298 . . . . 73.44 111.121 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.89 -28.69 69.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.266 0.555 . . . . 73.41 110.109 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 20.8 ttm -76.87 -20.78 55.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.597 -0.729 . . . . 75.02 110.69 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.7 15.23 15.57 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.659 -0.781 . . . . 50.41 112.901 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.511 ' HB ' HG22 ' A' ' 31' ' ' ILE . 25.8 mt -96.3 129.25 46.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.849 0.357 . . . . 74.35 110.298 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.6 m -134.28 -177.96 2.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.932 -0.576 . . . . 74.25 110.592 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -67.78 139.6 56.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.263 -0.273 . . . . 73.2 110.263 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.35 -2.17 87.46 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.035 -0.603 . . . . 39.02 112.789 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m -75.44 133.88 41.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.166 -0.679 . . . . 74.31 109.166 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 17' ' ' LYS . 5.1 pt-20 -104.57 129.07 52.69 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.28 0.562 . . . . 70.13 109.934 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.629 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 63.0 mt -118.17 132.84 66.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.023 -0.989 . . . . 73.24 110.578 -171.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -92.01 104.12 16.56 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.056 -0.72 . . . . 75.12 109.056 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.8 mm -74.21 97.47 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.183 -0.673 . . . . 63.44 109.183 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.427 ' OE2' ' HB2' ' A' ' 57' ' ' ARG . 50.0 mt-10 -66.47 -39.5 88.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.885 0.374 . . . . 74.3 110.618 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.576 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 170.19 172.69 36.89 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.355 -0.926 . . . . 73.31 112.215 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.639 ' HG2' HG12 ' A' ' 54' ' ' ILE . 46.1 mtmt -110.0 165.05 12.03 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.331 -0.618 . . . . 75.23 109.331 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.474 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -66.79 164.54 32.96 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.844 -0.428 . . . . 74.11 109.844 174.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 84.9 Cg_exo -42.79 -49.16 6.91 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.223 2.616 . . . . 74.41 113.704 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.3 ttt -84.96 -10.86 56.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.893 0.378 . . . . 74.21 111.028 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.98 2.92 39.39 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.917 -0.659 . . . . 73.24 112.774 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -151.68 128.51 5.43 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 110.074 -0.343 . . . . 64.31 110.074 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -82.72 -165.85 4.54 Favored 'Cis proline' 0 CA--C 1.532 0.392 0 C-N-CA 123.414 -1.494 . . . . 72.14 113.088 2.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.639 HG12 ' HG2' ' A' ' 47' ' ' LYS . 52.7 mt -120.51 147.46 24.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.448 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -103.11 111.23 23.49 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.836 0.351 . . . . 61.12 110.351 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.629 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 2.2 mp -117.07 129.99 56.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.184 -0.462 . . . . 74.43 110.006 -176.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 23.8 ttm180 -101.43 115.28 30.14 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.647 -0.421 . . . . 71.41 110.402 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.574 ' HG ' HG12 ' A' ' 42' ' ' ILE . 5.5 mp -116.76 145.88 43.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.868 -0.605 . . . . 63.3 109.748 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 64.2 -77.97 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.729 0.643 . . . . 75.33 110.852 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.13 9.57 0.35 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.348 -0.453 . . . . 71.31 112.068 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -147.28 154.97 41.61 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.298 0.57 . . . . 74.44 111.137 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.754 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 21.8 t -93.7 144.32 25.51 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.508 -0.769 . . . . 63.04 111.855 -175.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.4 154.74 44.65 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.488 -1.233 . . . . 60.44 108.767 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -116.12 114.53 24.63 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 120.972 0.415 . . . . 74.44 111.916 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.548 ' HG ' HD12 ' A' ' 56' ' ' LEU . 3.6 pp -122.25 167.23 13.48 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.484 -0.562 . . . . 73.53 109.484 174.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 -86.34 163.93 17.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.518 0.675 . . . . 73.41 112.27 -174.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.457 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 1.4 tmtp? -64.5 -20.94 66.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.953 -1.021 . . . . 72.23 110.277 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 m -69.1 -50.92 43.84 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.12 -0.491 . . . . 71.21 110.652 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.76 -36.46 78.99 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.3 0.571 . . . . 54.13 109.956 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.94 -21.68 66.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.336 -0.847 . . . . 75.51 111.862 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.573 ' HA ' HD21 ' A' ' 8' ' ' ASN . 88.8 tttt -84.28 -22.9 30.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.152 0.501 . . . . 74.34 110.526 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.487 ' HB3' HG12 ' A' ' 22' ' ' VAL . 4.6 m-20 -87.09 -14.18 42.14 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.875 -0.602 . . . . 72.1 110.919 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.749 HD12 HD12 ' A' ' 31' ' ' ILE . 40.1 mm -95.92 122.61 47.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.128 -0.487 . . . . 62.24 110.546 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.2 mt -100.61 114.96 29.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.053 -0.521 . . . . 60.04 109.871 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.549 HG13 HG22 ' A' ' 73' ' ' ILE . 24.9 m -118.71 161.12 17.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.087 -0.506 . . . . 73.1 111.241 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -118.75 145.56 45.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.713 -0.676 . . . . 65.33 109.305 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.738 ' HA ' HG13 ' A' ' 16' ' ' VAL . 39.3 t -72.34 123.01 26.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.76 -0.654 . . . . 64.42 110.545 -176.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 75.23 111.593 -177.889 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.668 0 CA-C-O 121.072 0.262 . . . . 72.33 112.687 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.5 pt -122.77 179.22 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.89 -0.781 . . . . 63.21 108.89 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 73' ' ' ILE . . . -77.45 151.7 38.49 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 119.805 -1.188 . . . . 52.12 111.884 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 7' ' ' LEU . 2.9 tm? -60.09 -32.62 71.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.297 0.57 . . . . 71.34 109.483 177.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.576 HD21 ' HA ' ' A' ' 71' ' ' LYS . 8.6 p30 -70.27 -15.59 62.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.461 -0.79 . . . . 74.32 111.094 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -92.58 -3.9 54.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.074 0.464 . . . . 74.13 110.658 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.4 t -91.33 158.79 2.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.98 -0.748 . . . . 63.3 108.98 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.58 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 24.8 tt0 -108.01 175.52 5.45 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.239 -0.282 . . . . 71.54 110.239 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.58 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 32.5 pt -68.83 153.59 8.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.24 -0.436 . . . . 64.23 111.691 -175.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 60.64 41.21 15.57 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.301 -0.863 . . . . 73.22 110.914 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 m -128.56 149.77 50.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.149 -0.932 . . . . 75.43 109.638 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HG2' HD11 ' A' ' 78' ' ' LEU . 85.8 tttt -115.37 132.4 56.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.043 -0.354 . . . . 53.15 110.043 177.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.798 HG12 ' HA ' ' A' ' 77' ' ' VAL . 26.6 m -133.04 162.62 39.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.254 0.55 . . . . 74.22 111.226 -176.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.579 ' HB2' HD21 ' A' ' 78' ' ' LEU . 19.8 ttmm -112.22 138.75 48.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.415 -0.811 . . . . 75.32 109.435 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.725 ' HA ' HG13 ' A' ' 75' ' ' VAL . 60.7 t -75.65 95.96 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.619 -0.719 . . . . 72.23 110.038 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.6 mm -61.05 -40.44 85.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.678 -0.692 . . . . 60.31 109.823 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.75 168.65 39.74 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.416 -0.897 . . . . 70.44 112.32 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.712 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 43.9 mt -105.28 159.38 5.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 108.606 -0.886 . . . . 74.42 108.606 176.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 25' ' ' SER . 58.4 t -99.22 92.36 1.71 Allowed Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.106 0.479 . . . . 74.32 110.471 -177.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.712 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 27.8 Cg_exo -60.53 178.31 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.561 2.841 . . . . 72.5 112.816 -174.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 66.73 -32.2 0.18 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.461 0.705 . . . . 63.13 112.026 -173.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 23' ' ' PRO . 1.3 m -63.24 153.36 34.88 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 120.97 0.414 . . . . 37.91 110.86 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -71.92 -49.25 39.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.789 -0.641 . . . . 64.54 110.493 -174.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.567 HG11 ' HG2' ' A' ' 69' ' ' GLU . 11.5 m -72.99 -15.44 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.39 -0.368 . . . . 74.2 110.831 -174.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.645 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -53.8 -45.87 70.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.907 -0.588 . . . . 63.45 111.003 178.149 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -72.25 -33.01 67.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.369 0.604 . . . . 64.44 110.17 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -63.8 -41.85 97.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.378 -0.828 . . . . 65.53 110.508 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.624 ' HA ' ' HE2' ' A' ' 34' ' ' MET . 82.9 mt -64.39 -36.42 77.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.713 -0.676 . . . . 74.54 110.9 177.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 67.7 mtt -67.67 -32.61 73.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 73.45 110.629 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -63.34 -31.89 73.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.946 -0.57 . . . . 54.13 110.492 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.624 ' HE2' ' HA ' ' A' ' 31' ' ' ILE . 65.9 mtm -76.53 -23.98 53.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.962 -0.563 . . . . 62.04 111.169 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.02 36.68 2.12 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.297 -0.954 . . . . 71.32 113.358 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.489 ' HB ' HG23 ' A' ' 31' ' ' ILE . 63.7 mt -122.14 136.1 60.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.468 -0.568 . . . . 73.34 109.468 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.742 HG22 ' H ' ' A' ' 38' ' ' ARG . 1.6 m -135.67 -84.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.321 0.489 . . . . 63.4 112.321 -176.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.742 ' H ' HG22 ' A' ' 37' ' ' VAL . 43.5 ttp180 -156.56 141.12 16.83 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.362 -0.607 . . . . 75.15 109.362 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.71 -0.29 65.89 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 111.429 -0.669 . . . . 73.32 111.429 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.453 HG23 HD22 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -72.6 142.67 48.39 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.387 -0.598 . . . . 73.31 109.387 178.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.49 130.98 52.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.167 0.508 . . . . 73.43 111.606 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.537 HG22 HD23 ' A' ' 56' ' ' LEU . 25.6 mm -120.24 128.16 75.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.34 -0.845 . . . . 71.51 110.898 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -101.12 120.67 40.56 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.447 -0.575 . . . . 75.44 109.447 171.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 44' ' ' ILE . 3.9 mp -85.45 101.62 10.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.226 -0.657 . . . . 72.22 109.226 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.84 -53.29 27.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.275 0.56 . . . . 74.15 110.383 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.26 -177.37 41.01 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.673 -0.694 . . . . 52.51 111.773 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.446 ' HG2' HG22 ' A' ' 54' ' ' ILE . 52.0 mtpt -133.26 152.0 51.92 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.136 -0.69 . . . . 62.52 109.136 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.49 156.34 71.16 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.575 -0.528 . . . . 71.55 109.575 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.35 -30.14 19.42 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.77 2.313 . . . . 60.24 113.176 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.801 ' HA ' ' HE3' ' A' ' 50' ' ' MET . 23.2 mmt -91.29 0.98 57.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.489 -0.323 . . . . 71.51 111.697 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.01 -9.14 73.55 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.892 -0.67 . . . . 64.03 111.999 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -144.01 130.54 10.19 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.685 -0.487 . . . . 74.53 109.685 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.541 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . 91.6 Cg_endo -84.11 -169.26 6.65 Favored 'Cis proline' 0 CA--C 1.533 0.44 0 C-N-CA 123.474 -1.469 . . . . 71.14 112.918 0.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.446 HG22 ' HG2' ' A' ' 47' ' ' LYS . 60.7 mt -119.3 143.2 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.896 -0.593 . . . . 71.31 110.284 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.09 111.83 24.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.896 0.379 . . . . 73.4 110.808 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.537 HD23 HG22 ' A' ' 42' ' ' ILE . 5.9 mp -105.68 171.92 7.08 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.136 -0.69 . . . . 71.12 109.136 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 23.7 ttt180 -151.18 128.79 11.48 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.242 -0.651 . . . . 75.22 109.242 176.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.596 HD21 ' HG3' ' A' ' 59' ' ' ARG . 1.2 tt -131.93 137.41 47.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.01 -0.541 . . . . 74.51 109.83 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.596 ' HG3' HD21 ' A' ' 58' ' ' LEU . 55.8 mtt180 61.15 -80.25 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.795 -1.093 . . . . 53.21 111.667 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -147.78 14.75 1.37 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.016 -0.611 . . . . 74.25 111.759 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -140.01 145.96 38.46 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.677 0.751 . . . . 75.45 111.899 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 33.5 t -74.22 155.22 38.54 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.396 -1.275 . . . . 72.51 110.667 176.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.8 mt -139.7 140.21 36.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.783 -0.644 . . . . 71.13 109.424 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.8 t -118.99 130.2 55.55 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.811 0.339 . . . . 62.44 110.735 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 pp -144.65 164.64 30.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.76 -0.655 . . . . 72.55 110.386 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.541 ' HD3' ' HB3' ' A' ' 53' ' ' PRO . 25.9 mmt180 -83.73 158.68 21.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.37 0.605 . . . . 63.41 111.616 -176.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -39.47 70.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.95 -1.023 . . . . 72.44 111.117 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -65.38 -34.45 78.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.302 -0.408 . . . . 74.32 111.233 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.567 ' HG2' HG11 ' A' ' 27' ' ' VAL . 33.9 mt-10 -74.38 -32.76 62.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.297 0.57 . . . . 74.4 109.86 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.99 -21.1 65.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.452 -0.795 . . . . 75.45 111.19 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.576 ' HA ' HD21 ' A' ' 8' ' ' ASN . 22.1 ttmm -74.32 -34.17 63.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.494 . . . . 74.22 110.392 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -85.51 14.59 5.38 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.196 -0.456 . . . . 60.25 111.574 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.473 HG22 HG12 ' A' ' 75' ' ' VAL . 60.4 mt -118.96 124.23 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.381 . . . . 74.42 110.222 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 99.0 mt -103.47 120.73 41.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 75.55 110.243 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.725 HG13 ' HA ' ' A' ' 18' ' ' VAL . 22.4 m -133.95 157.51 41.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.207 0.527 . . . . 71.22 111.791 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -117.82 143.32 46.38 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.958 -0.756 . . . . 70.43 108.958 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.798 ' HA ' HG12 ' A' ' 16' ' ' VAL . 38.5 t -70.94 125.55 29.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.128 -0.487 . . . . 62.32 110.595 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' A' ' 17' ' ' LYS . 56.3 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 75.42 111.008 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.757 -0.137 . . . . 71.43 112.757 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.8 pt -110.11 171.44 2.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.689 0.281 . . . . 73.33 110.304 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 73' ' ' ILE . . . -76.91 153.11 41.51 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 120.47 -0.871 . . . . 43.42 111.22 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.49 HD21 ' CD1' ' A' ' 56' ' ' LEU . 50.1 tp -59.21 -28.01 66.26 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.185 0.517 . . . . 75.4 110.684 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.439 ' ND2' ' HG3' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -75.38 -4.53 39.92 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.86 -0.609 . . . . 73.33 111.831 178.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.439 ' HG3' ' ND2' ' A' ' 8' ' ' ASN . 44.5 mt-10 -102.1 5.87 40.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.931 0.396 . . . . 72.2 110.801 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 t -97.03 157.32 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.064 -0.517 . . . . 71.32 109.967 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -99.64 164.89 11.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.62 0.247 . . . . 71.24 110.341 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.7 pt -69.39 151.03 10.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.444 . . . . 71.55 111.048 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt 60.26 51.45 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.948 0.88 . . . . 62.15 110.536 -177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 m -132.37 153.08 51.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.142 -0.935 . . . . 73.42 109.759 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -113.44 119.09 36.39 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.803 -0.443 . . . . 65.35 109.803 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.763 HG13 ' HA ' ' A' ' 77' ' ' VAL . 29.1 m -130.76 179.56 4.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.11 -0.495 . . . . 65.41 110.503 -178.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.721 ' HB2' HD11 ' A' ' 78' ' ' LEU . 39.3 ttpt -143.04 144.53 32.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.876 0.37 . . . . 75.03 111.064 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.639 ' HA ' HG11 ' A' ' 75' ' ' VAL . 45.8 t -76.9 95.66 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.598 -0.728 . . . . 74.31 110.673 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.896 HD11 ' HB2' ' A' ' 76' ' ' GLU . 50.1 mt -57.33 -49.33 80.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 70.52 109.988 173.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.59 149.16 7.22 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.54 -0.755 . . . . 74.11 112.258 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.627 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 56.9 mt -83.95 159.68 3.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.516 -0.55 . . . . 75.13 109.516 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 25' ' ' SER . 48.3 t -99.17 93.71 2.29 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 122.757 0.423 . . . . 73.41 110.03 -177.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.994 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 77.6 Cg_exo -49.27 164.26 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.911 3.074 . . . . 72.32 114.271 -173.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 67.28 -11.96 0.27 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.116 0.967 . . . . 75.5 112.92 -175.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 1.2 m -63.72 155.1 31.12 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 120.926 0.393 . . . . 73.22 110.822 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -69.46 -17.29 63.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.16 -0.473 . . . . 75.43 112.164 -173.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 31' ' ' ILE . 30.9 m -112.47 6.32 8.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.664 -0.244 . . . . 74.14 111.43 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.994 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 5.2 tmm_? -58.76 -57.18 14.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.877 0.37 . . . . 74.3 110.771 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -71.5 -36.1 70.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.041 -0.527 . . . . 75.24 110.123 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -58.77 -46.39 87.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.266 -0.879 . . . . 75.33 111.276 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.609 HD13 HD13 ' A' ' 73' ' ' ILE . 99.4 mt -66.51 -42.34 89.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.048 0.452 . . . . 75.12 111.278 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 63.7 mtt -67.53 -36.67 81.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.336 -0.393 . . . . 63.43 110.781 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.01 -30.14 68.46 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 54.22 110.445 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.404 ' HE1' HD22 ' A' ' 63' ' ' LEU . 7.3 ttt -63.04 -34.6 77.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.615 -0.721 . . . . 55.14 110.859 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.67 20.26 1.74 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.307 -0.949 . . . . 51.1 113.178 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.514 HD12 HG21 ' A' ' 31' ' ' ILE . 61.1 mt -105.51 134.84 45.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.719 -0.475 . . . . 53.45 109.719 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.73 177.56 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.389 -0.369 . . . . 72.32 110.835 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -78.7 128.97 34.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.079 0.466 . . . . 63.42 110.26 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.75 5.61 66.38 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.802 -0.713 . . . . 44.01 112.235 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.5 m -68.8 138.65 54.97 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.501 -0.555 . . . . 75.32 109.501 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -96.14 125.45 40.68 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.855 -0.611 . . . . 71.54 109.449 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.2 mt -107.36 120.57 58.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.347 -0.842 . . . . 72.23 110.969 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.556 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 74.4 t80 -93.52 106.88 18.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.821 -0.807 . . . . 72.32 108.821 173.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.438 HD13 HD23 ' A' ' 56' ' ' LEU . 18.6 mm -70.04 104.01 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.183 -0.673 . . . . 74.25 109.183 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -76.38 -61.51 1.93 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.832 0.349 . . . . 72.24 110.401 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.21 158.55 29.13 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.227 -0.987 . . . . 61.42 112.356 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.608 ' HG2' HG12 ' A' ' 54' ' ' ILE . 54.2 mtpt -97.55 151.83 19.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.258 -0.645 . . . . 74.13 109.258 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.53 156.35 32.6 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 110.131 -0.322 . . . . 65.11 110.131 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.0 -32.51 18.32 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.246 2.63 . . . . 61.43 113.752 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.8 ttm -89.42 -11.35 43.38 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.936 0.398 . . . . 73.44 111.172 -177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.45 -14.7 32.81 Favored Glycine 0 C--N 1.328 0.115 0 C-N-CA 120.909 -0.662 . . . . 50.54 112.513 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -149.41 138.96 12.93 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.44 -0.578 . . . . 75.04 109.44 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.8 -164.73 3.94 Favored 'Cis proline' 0 C--N 1.346 0.429 0 C-N-CA 124.15 -1.188 . . . . 73.1 112.636 -0.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.608 HG12 ' HG2' ' A' ' 47' ' ' LYS . 38.2 mt -123.97 134.98 65.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 74.03 110.416 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -91.44 118.93 30.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.372 -0.376 . . . . 70.52 110.255 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.49 ' CD1' HD21 ' A' ' 7' ' ' LEU . 23.1 mt -121.22 137.02 54.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.213 -0.449 . . . . 73.11 110.747 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.609 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 3.9 tmt_? -101.45 109.36 21.18 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.73 -0.841 . . . . 70.4 108.73 175.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 pp -144.64 152.12 40.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.318 -0.401 . . . . 73.02 110.96 -175.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 72.51 -45.29 0.62 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.931 0.77 . . . . 75.5 111.379 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.58 -21.84 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.064 -0.588 . . . . 72.11 112.355 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -145.0 172.4 13.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.01 0.433 . . . . 72.33 111.188 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -84.91 140.88 30.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.539 -0.755 . . . . 71.41 111.208 175.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.404 HD22 ' HE1' ' A' ' 34' ' ' MET . 24.2 tp -143.5 154.66 43.86 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.452 -0.573 . . . . 71.14 109.452 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 p -91.81 121.24 33.25 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.923 0.392 . . . . 74.14 111.767 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.41 HD23 HD12 ' A' ' 56' ' ' LEU . 3.9 mm? -118.59 141.98 48.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.144 -0.48 . . . . 73.22 109.851 175.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.45 162.15 15.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.767 0.318 . . . . 74.33 110.722 -177.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -55.85 -33.0 64.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.643 -0.708 . . . . 72.25 110.999 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.1 m -59.48 -56.57 20.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 64.5 110.739 177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.412 ' HA ' HG21 ' A' ' 27' ' ' VAL . 2.5 mp0 -64.94 -36.79 85.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.081 0.467 . . . . 74.11 110.713 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.2 66.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.648 -0.706 . . . . 74.01 111.813 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -83.01 -32.21 27.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.684 0.278 . . . . 74.5 110.9 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.38 -2.05 56.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.26 -0.427 . . . . 38.71 111.706 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.609 HD13 HD13 ' A' ' 31' ' ' ILE . 68.8 mt -106.42 122.7 60.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.572 -0.285 . . . . 73.01 110.582 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.5 mt -95.03 122.25 37.49 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.913 0.387 . . . . 73.41 110.216 176.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.639 HG11 ' HA ' ' A' ' 18' ' ' VAL . 28.3 m -129.74 167.45 24.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.944 -0.571 . . . . 71.02 111.142 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.896 ' HB2' HD11 ' A' ' 19' ' ' ILE . 41.9 tt0 -129.07 146.01 51.13 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.227 -0.657 . . . . 53.34 109.227 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.763 ' HA ' HG13 ' A' ' 16' ' ' VAL . 10.3 p -76.14 129.5 37.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.275 0.56 . . . . 75.44 110.682 -178.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.721 HD11 ' HB2' ' A' ' 17' ' ' LYS . 86.2 mt . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.879 -0.6 . . . . 75.2 109.997 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 112.507 -0.237 . . . . 54.11 112.507 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.0 pt -107.19 174.32 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.789 -0.448 . . . . 75.41 109.789 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.62 156.66 35.2 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.107 -1.044 . . . . 63.34 111.654 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.55 HD12 HG22 ' A' ' 16' ' ' VAL . 61.6 tp -61.62 -26.25 67.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.237 0.542 . . . . 64.13 110.635 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -72.83 -10.87 60.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.666 . . . . 65.22 111.217 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -98.16 0.34 45.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.92 0.39 . . . . 75.14 110.885 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.483 HG21 HG11 ' A' ' 16' ' ' VAL . 6.1 t -103.18 158.1 4.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.393 -0.595 . . . . 63.32 109.393 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -106.1 170.58 7.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.103 0.478 . . . . 65.03 111.241 -176.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 31.7 pt -64.02 157.82 4.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.427 -0.806 . . . . 70.31 113.154 -171.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 60.69 32.1 20.23 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.34 -0.845 . . . . 70.14 111.918 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.4 m -124.36 151.49 44.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.957 -0.565 . . . . 74.24 109.784 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HB2' ' CD2' ' A' ' 43' ' ' TYR . 36.5 ttmt -103.44 130.18 50.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.956 0.407 . . . . 71.52 110.287 176.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.55 HG22 HD12 ' A' ' 7' ' ' LEU . 33.1 m -119.01 165.79 13.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.864 -0.607 . . . . 73.34 110.628 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.62 ' HB2' HD13 ' A' ' 78' ' ' LEU . 69.2 tttt -123.07 135.65 54.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.638 -0.71 . . . . 64.4 110.205 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.77 95.38 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.309 -0.859 . . . . 62.12 110.7 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.816 HD11 ' HB3' ' A' ' 76' ' ' GLU . 28.7 mt -65.64 -49.06 80.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.766 -0.652 . . . . 70.24 109.75 174.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.52 176.31 44.77 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.601 -0.809 . . . . 75.5 112.74 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.661 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 54.6 mt -120.48 159.24 22.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.275 -1.009 . . . . 71.4 108.275 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.553 ' HB ' ' OD2' ' A' ' 72' ' ' ASP . 48.8 t -100.41 90.14 1.34 Allowed Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 121.363 0.602 . . . . 74.21 109.618 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.661 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 34.8 Cg_exo -56.57 163.33 7.03 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.6 2.866 . . . . 72.53 113.698 -170.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 65.96 16.62 10.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.624 -1.171 . . . . 73.12 111.24 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.545 ' O ' ' HB3' ' A' ' 28' ' ' ARG . 1.3 m -88.65 151.8 22.23 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.397 -0.594 . . . . 63.41 109.397 171.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -75.38 -38.96 59.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.895 0.379 . . . . 74.13 110.145 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 31' ' ' ILE . 33.9 m -67.25 -19.6 25.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 72.2 110.771 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.545 ' HB3' ' O ' ' A' ' 25' ' ' SER . 3.1 tmm_? -58.29 -32.49 68.47 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.689 -0.687 . . . . 73.41 110.25 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -64.8 -47.39 78.23 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.385 -0.598 . . . . 71.44 109.385 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -60.47 -50.01 75.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.492 -0.776 . . . . 64.51 110.637 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 27' ' ' VAL . 86.5 mt -53.34 -52.79 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.545 -0.752 . . . . 73.02 111.917 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 64.5 mtt -70.62 -33.01 70.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.557 -0.292 . . . . 54.43 111.305 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.03 -22.44 61.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.408 0.623 . . . . 62.45 110.135 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.8 tpt -78.29 -22.35 48.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.434 -0.803 . . . . 64.23 110.563 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.55 5.49 20.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.758 -0.734 . . . . 73.15 112.831 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.419 HG12 ' HG ' ' A' ' 58' ' ' LEU . 41.2 mt -93.56 129.47 43.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.821 -0.437 . . . . 72.1 109.821 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.728 HG21 ' H ' ' A' ' 38' ' ' ARG . 2.8 m -133.05 -74.83 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.623 0.601 . . . . 72.43 112.623 -176.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.728 ' H ' HG21 ' A' ' 37' ' ' VAL . 61.6 ttt180 -165.28 128.62 2.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.955 -0.387 . . . . 74.15 109.955 -174.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.29 5.97 73.68 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.961 -0.638 . . . . 74.11 112.006 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.5 m -74.04 144.92 44.87 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.987 -0.375 . . . . 72.12 109.987 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -94.27 129.8 40.78 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.053 0.454 . . . . 73.23 110.282 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.74 HG12 HD23 ' A' ' 58' ' ' LEU . 73.8 mt -119.83 116.37 50.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.523 -0.762 . . . . 71.04 109.899 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.407 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 9.0 t80 -100.92 119.44 38.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.175 -0.676 . . . . 72.22 109.175 177.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.5 mt -77.03 125.02 36.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 120.703 0.287 . . . . 64.22 110.233 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -85.65 -59.54 2.28 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.839 0.352 . . . . 64.22 110.346 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.67 171.92 42.34 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.813 -0.708 . . . . 74.12 112.109 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -123.56 145.1 49.14 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.012 -0.366 . . . . 72.12 110.012 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -69.29 163.66 56.01 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.188 -0.46 . . . . 54.15 109.778 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 8.1 Cg_endo -50.66 -38.51 55.8 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 123.027 2.485 . . . . 73.23 113.468 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.657 ' HE3' ' HB3' ' A' ' 52' ' ' ASP . 50.7 ttp -86.14 -10.74 54.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.216 0.532 . . . . 73.13 110.659 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.87 -2.95 73.27 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.564 -0.614 . . . . 63.5 111.564 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.657 ' HB3' ' HE3' ' A' ' 50' ' ' MET . 11.8 t70 -141.36 132.12 13.25 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 108.889 -0.782 . . . . 73.14 108.889 177.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.57 -179.96 27.11 Favored 'Cis proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.036 -1.652 . . . . 72.52 112.391 -0.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.7 mt -113.48 145.37 19.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.167 -0.47 . . . . 71.14 110.03 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.29 119.39 38.68 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.036 -0.357 . . . . 72.32 110.036 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.541 HD22 HD21 ' A' ' 7' ' ' LEU . 5.4 mp -118.11 167.59 11.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.141 -0.481 . . . . 72.12 109.895 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.643 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 33.0 ttt-85 -125.59 105.7 9.21 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.893 -1.151 . . . . 72.54 107.893 167.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.74 HD23 HG12 ' A' ' 42' ' ' ILE . 3.2 tm? -122.84 145.57 48.32 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.674 -0.693 . . . . 73.12 109.967 -170.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.607 ' HB2' HD12 ' A' ' 58' ' ' LEU . 2.4 tmt_? 70.51 -69.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.214 -0.903 . . . . 71.42 110.021 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.69 2.08 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.905 -0.664 . . . . 63.22 112.52 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -148.49 165.26 31.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.859 0.361 . . . . 74.41 110.799 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.643 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 32.1 t -75.78 145.08 41.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.511 0.672 . . . . 74.31 111.347 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.5 mt -146.2 157.04 43.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.696 -1.138 . . . . 73.34 108.598 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 t -120.62 125.27 47.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.299 0.571 . . . . 64.14 110.721 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.27 175.85 5.93 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.314 -0.857 . . . . 74.44 109.312 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.625 ' HB2' ' OE1' ' A' ' 69' ' ' GLU . 41.7 mmt180 -90.75 167.09 12.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.103 0.478 . . . . 74.23 110.31 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.43 -22.59 67.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.582 -0.735 . . . . 73.12 109.604 174.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.7 m -64.1 -52.32 59.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.242 -0.89 . . . . 65.54 110.97 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.625 ' OE1' ' HB2' ' A' ' 66' ' ' ARG . 1.9 mp0 -60.16 -41.95 93.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.153 0.502 . . . . 53.31 110.675 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.77 -22.5 67.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.56 -0.745 . . . . 74.24 111.504 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -75.2 -34.92 61.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.409 -0.36 . . . . 64.42 111.114 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.553 ' OD2' ' HB ' ' A' ' 22' ' ' VAL . 14.5 t70 -80.26 -44.69 19.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 73.25 111.421 -174.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.456 HG22 HG12 ' A' ' 75' ' ' VAL . 48.3 mt -61.42 118.5 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.97 -0.559 . . . . 73.22 111.44 -176.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.2 mt -91.24 119.4 31.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 73.24 109.871 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.535 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 23.7 m -129.08 158.17 41.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.927 0.394 . . . . 73.03 111.964 -174.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.816 ' HB3' HD11 ' A' ' 19' ' ' ILE . 19.3 pt-20 -115.11 151.72 33.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.831 -0.622 . . . . 72.31 109.632 173.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.2 t -80.26 115.84 23.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.988 0.423 . . . . 62.22 111.109 -174.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.62 HD13 ' HB2' ' A' ' 17' ' ' LYS . 40.2 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.898 -0.592 . . . . 71.52 111.53 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.763 0 N-CA-C 112.092 -0.403 . . . . 50.21 112.092 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.6 pt -96.04 163.29 2.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.752 -0.462 . . . . 74.21 109.752 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.23 137.58 45.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.466 -0.873 . . . . 70.42 112.209 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.491 HD12 HG21 ' A' ' 75' ' ' VAL . 44.7 tp -60.25 -25.02 65.35 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 122.986 0.515 . . . . 55.51 112.022 -175.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 9.1 p30 -78.46 -9.81 59.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.721 0.296 . . . . 74.25 110.857 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -99.31 -7.44 26.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.277 -0.42 . . . . 75.35 111.071 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.715 HG12 HG12 ' A' ' 16' ' ' VAL . 14.4 t -77.72 160.3 4.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.93 -0.577 . . . . 72.31 110.293 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.429 ' N ' HG11 ' A' ' 10' ' ' VAL . 31.7 tt0 -80.41 168.44 18.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 62.12 110.448 -177.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.4 ' HA ' ' CG2' ' A' ' 44' ' ' ILE . 33.5 pt -93.5 161.08 2.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.005 -0.543 . . . . 75.34 110.954 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 69.3 5.07 4.92 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.164 0.586 . . . . 70.1 111.611 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -107.12 156.89 18.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.851 0.358 . . . . 54.2 110.993 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HB2' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -107.91 130.97 54.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.008 -0.542 . . . . 74.25 110.341 178.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.738 HG11 ' HA ' ' A' ' 77' ' ' VAL . 27.2 m -127.6 161.31 35.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.739 -0.664 . . . . 73.22 110.911 -177.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.727 ' HD3' ' HG2' ' A' ' 41' ' ' GLU . 9.7 tptm -113.26 138.53 49.87 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.596 -0.729 . . . . 64.4 109.922 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.918 ' HA ' HG12 ' A' ' 75' ' ' VAL . 60.1 t -80.58 94.24 2.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.517 -0.765 . . . . 73.11 109.902 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.36 -52.69 34.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.013 -0.994 . . . . 73.14 110.106 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.23 133.95 4.0 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 119.966 -1.111 . . . . 74.15 113.245 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.428 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 68.3 mt -80.64 158.19 4.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 107.598 -1.26 . . . . 74.34 107.598 169.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 25' ' ' SER . 49.8 t -100.27 91.13 1.59 Allowed Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 121.015 0.436 . . . . 61.11 110.086 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.524 ' C ' ' H ' ' A' ' 25' ' ' SER . 35.8 Cg_endo -62.57 178.51 0.92 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.397 2.732 . . . . 73.14 113.061 -173.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 67.02 -16.19 0.14 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.436 -0.802 . . . . 72.21 111.741 -174.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -73.13 161.87 30.1 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.938 0.399 . . . . 72.33 110.926 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -78.84 -46.24 19.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.991 -0.55 . . . . 65.31 110.61 -176.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.674 HG21 ' HA ' ' A' ' 69' ' ' GLU . 23.3 m -68.13 -18.0 22.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.908 -0.587 . . . . 73.22 110.648 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.454 ' HE ' ' HB3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -53.7 -34.33 58.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.35 -0.841 . . . . 74.0 111.296 178.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -68.37 -42.07 79.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.45 -0.341 . . . . 54.22 111.06 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 34' ' ' MET . 34.0 tttp -73.56 -33.31 64.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.459 -0.337 . . . . 71.21 110.399 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 27' ' ' VAL . 88.5 mt -59.62 -48.31 87.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.174 -0.466 . . . . 53.42 110.719 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 64.9 mtt -68.79 -28.6 66.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 63.32 110.626 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.51 -40.57 76.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 71.32 110.429 176.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.452 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 65.6 mtt -61.93 -34.05 75.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.594 -0.73 . . . . 74.25 110.588 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.69 17.99 5.82 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.818 -0.706 . . . . 62.5 112.248 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.823 HD13 HD22 ' A' ' 58' ' ' LEU . 47.8 mt -101.03 127.46 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.197 0.523 . . . . 73.52 110.386 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.27 -176.53 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.273 -0.876 . . . . 63.34 110.084 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -70.6 109.45 4.88 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.867 -0.419 . . . . 73.24 109.867 175.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.411 ' O ' ' HE3' ' A' ' 17' ' ' LYS . . . 120.8 -9.24 10.58 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 121.042 -0.599 . . . . 53.33 111.739 -176.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.4 m -73.63 149.57 41.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.663 -0.495 . . . . 74.2 109.663 174.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.727 ' HG2' ' HD3' ' A' ' 17' ' ' LYS . 55.5 mt-10 -115.69 134.85 54.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.215 -0.448 . . . . 70.35 110.102 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.577 HG23 HD23 ' A' ' 56' ' ' LEU . 48.2 mm -118.66 126.02 74.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.468 -0.787 . . . . 70.05 110.757 -173.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -104.57 115.79 30.96 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.796 -0.816 . . . . 75.13 108.796 173.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.4 ' CG2' ' HA ' ' A' ' 12' ' ' ILE . 44.5 mm -73.35 106.39 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.92 0.391 . . . . 71.14 110.702 -176.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -75.73 -36.65 59.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.181 -0.674 . . . . 73.0 109.181 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.63 -179.47 39.33 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.783 -0.723 . . . . 61.33 112.371 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -126.59 150.64 48.76 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.442 -0.577 . . . . 72.12 109.442 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.28 165.48 17.4 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.412 -0.358 . . . . 73.44 111.453 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.0 -31.85 83.8 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.571 2.181 . . . . 74.33 112.094 175.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -86.11 -5.31 59.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.207 0.527 . . . . 71.21 110.262 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.48 -34.45 5.65 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.212 -0.755 . . . . 44.14 111.212 -174.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.556 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 4.2 p-10 -137.97 152.31 71.86 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 108.959 -0.756 . . . . 75.03 108.959 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 73.0 Cg_endo -72.26 173.3 53.47 Favored 'Cis proline' 0 C--O 1.234 0.288 0 C-N-CA 123.457 -1.476 . . . . 73.53 113.158 4.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.629 ' HB ' HD12 ' A' ' 56' ' ' LEU . 16.3 mm -97.04 147.32 6.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.514 -0.766 . . . . 73.43 109.304 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.51 111.24 23.88 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.314 -0.624 . . . . 61.51 109.314 174.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.629 HD12 ' HB ' ' A' ' 54' ' ' ILE . 2.3 mp -121.88 144.92 48.56 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.516 -0.311 . . . . 73.43 110.292 -175.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 54.9 mtt180 -100.1 108.14 20.22 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.344 -0.984 . . . . 63.43 108.344 166.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.823 HD22 HD13 ' A' ' 36' ' ' ILE . 2.4 pp -121.78 134.3 54.92 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.602 -0.727 . . . . 73.55 110.858 -173.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.468 ' HD3' ' OH ' ' A' ' 61' ' ' TYR . 50.3 ttt180 65.02 6.06 3.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.283 -0.872 . . . . 74.41 110.839 178.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.58 -19.58 9.72 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 116.019 -0.537 . . . . 64.34 112.794 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.468 ' OH ' ' HD3' ' A' ' 59' ' ' ARG . 4.4 p90 -127.67 148.97 50.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.359 0.599 . . . . 71.12 112.213 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.3 m -70.8 137.68 49.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.186 -0.915 . . . . 65.41 111.989 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.692 ' HB3' HD23 ' A' ' 58' ' ' LEU . 9.4 tt -150.99 148.86 28.89 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.689 -0.856 . . . . 65.02 108.689 176.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.1 t -115.07 132.14 56.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.179 0.514 . . . . 72.44 111.566 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.04 165.49 24.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.351 -0.841 . . . . 62.14 109.391 174.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -84.45 169.33 14.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.453 0.644 . . . . 73.31 112.384 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.556 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 37.0 ttmt -54.49 -35.09 62.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.751 -1.113 . . . . 73.31 111.704 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.1 t -66.15 -46.24 78.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.58 -0.282 . . . . 65.23 110.647 -176.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.674 ' HA ' HG21 ' A' ' 27' ' ' VAL . 1.9 mp0 -63.33 -43.92 96.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.942 0.401 . . . . 74.01 110.347 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 8' ' ' ASN . . . -66.49 -22.03 66.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 62.44 111.27 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -74.69 -29.04 61.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.102 -0.499 . . . . 71.45 110.883 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -93.46 19.72 8.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.946 0.403 . . . . 73.02 111.109 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.5 mt -126.04 117.6 49.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.602 -0.518 . . . . 72.15 109.602 174.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.7 mt -103.15 121.41 42.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.745 0.307 . . . . 74.13 110.205 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.918 HG12 ' HA ' ' A' ' 18' ' ' VAL . 35.6 m -137.09 172.58 14.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.968 0.414 . . . . 74.4 111.78 -174.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -143.37 156.68 44.74 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.427 -0.953 . . . . 75.42 108.427 171.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.738 ' HA ' HG11 ' A' ' 16' ' ' VAL . 11.8 p -64.71 147.92 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.003 0.43 . . . . 54.03 111.548 -175.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 17' ' ' LYS . 23.5 mt . . . . . 0 C--O 1.233 0.22 0 CA-C-N 116.038 -0.528 . . . . 63.44 112.394 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.233 0 N-CA-C 111.605 -0.598 . . . . 55.25 111.605 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.2 pt -85.03 167.76 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.688 -0.856 . . . . 73.13 108.688 175.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.75 146.83 40.79 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 119.429 -1.367 . . . . 52.15 111.076 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.4 tp -65.28 -17.79 64.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.309 0.576 . . . . 64.51 110.173 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -76.56 -20.54 56.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.749 -0.659 . . . . 74.52 110.358 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -89.09 -10.68 46.46 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.173 -0.467 . . . . 70.44 110.532 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 11' ' ' GLU . 17.1 t -84.45 160.43 3.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.906 -0.588 . . . . 72.31 110.087 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.818 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 28.5 tt0 -122.44 -173.58 2.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.668 0.27 . . . . 63.22 110.409 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.818 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 40.8 pt -68.93 154.04 8.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 113.322 0.86 . . . . 73.44 113.322 -170.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.4 mttt 59.86 22.14 11.09 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.57 -1.196 . . . . 74.55 113.256 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 m -104.74 155.4 18.92 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.428 -0.582 . . . . 54.32 109.428 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -115.06 136.7 52.83 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.488 -0.485 . . . . 72.04 110.0 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.814 HG12 ' HA ' ' A' ' 77' ' ' VAL . 29.9 m -140.17 -179.57 2.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.698 -0.683 . . . . 74.31 110.167 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -148.99 146.17 27.67 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.832 -0.432 . . . . 73.45 109.832 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.503 ' HA ' HG11 ' A' ' 75' ' ' VAL . 26.1 t -74.01 93.14 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.238 0.542 . . . . 71.14 110.146 -178.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.4 mm -81.64 -38.94 16.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.341 -0.845 . . . . 75.54 110.283 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.4 169.6 25.82 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.569 -0.824 . . . . 64.53 112.881 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.64 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 69.7 mt -136.9 155.26 32.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.613 -0.884 . . . . 73.21 108.613 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.0 t -103.26 91.37 3.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.872 0.368 . . . . 74.31 110.584 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.64 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 35.9 Cg_exo -59.06 172.99 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.375 2.717 . . . . 73.31 113.03 -175.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 60.18 26.3 15.71 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.715 -0.675 . . . . 72.01 111.328 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.767 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 15.6 t -104.15 142.77 33.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.228 -0.442 . . . . 72.13 110.412 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -79.04 -27.03 43.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.874 0.368 . . . . 75.44 110.222 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.6 m -84.97 -19.93 8.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 65.42 110.62 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.767 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 2.0 tmt_? -54.21 -35.15 62.08 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.426 -0.352 . . . . 75.32 110.641 174.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -57.03 -56.64 19.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.992 -0.549 . . . . 74.51 110.444 174.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -54.6 -46.82 73.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.475 -0.784 . . . . 71.41 111.135 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.467 HG23 ' HB ' ' A' ' 36' ' ' ILE . 96.1 mt -57.54 -53.45 44.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.331 -0.849 . . . . 74.04 111.806 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.447 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 77.1 mtp -75.04 -28.45 60.44 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.769 -0.372 . . . . 75.43 111.093 -176.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.54 -32.16 73.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.329 0.585 . . . . 75.42 109.932 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.2 mtt -78.23 -3.81 44.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.359 -0.837 . . . . 65.22 111.774 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.65 4.7 45.86 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.635 -0.793 . . . . 64.01 112.947 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.467 ' HB ' HG23 ' A' ' 31' ' ' ILE . 30.1 mt -89.08 124.04 41.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.975 0.417 . . . . 73.32 110.395 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.421 HG11 ' HE3' ' A' ' 32' ' ' MET . 28.1 m -143.81 168.81 11.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.581 -0.736 . . . . 74.34 110.055 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -66.96 108.39 2.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.052 0.453 . . . . 75.53 110.232 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.5 -18.69 4.6 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.823 -0.704 . . . . 63.51 111.855 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.2 m -75.27 143.87 42.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.927 0.394 . . . . 75.35 110.47 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -102.76 142.52 33.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.995 -0.548 . . . . 71.21 109.736 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.794 HG12 HD11 ' A' ' 58' ' ' LEU . 65.1 mt -123.96 126.1 71.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.817 -0.629 . . . . 74.25 110.939 -173.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -106.58 117.11 33.2 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.038 -0.727 . . . . 75.41 109.038 174.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.7 mm -76.47 114.95 17.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.842 0.353 . . . . 71.44 110.432 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -76.97 -46.51 23.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.251 0.548 . . . . 74.13 109.936 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.659 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 170.82 -170.94 43.56 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.606 -0.725 . . . . 71.43 111.668 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.605 ' HG2' HG22 ' A' ' 54' ' ' ILE . 51.7 mtpt -132.83 137.17 46.65 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.026 -0.731 . . . . 73.52 109.026 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . . . -58.87 158.48 16.32 Favored Pre-proline 0 C--N 1.328 -0.359 0 O-C-N 123.422 0.451 . . . . 75.13 110.943 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 48' ' ' ALA . 9.2 Cg_endo -52.91 -30.96 50.34 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.349 2.699 . . . . 71.23 113.625 -177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.9 ttt -94.48 4.62 53.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.425 0.631 . . . . 70.23 110.433 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.28 3.65 90.61 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 116.035 -0.53 . . . . 75.14 112.38 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -154.04 132.73 6.88 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.288 -0.634 . . . . 64.34 109.288 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.77 -178.03 21.59 Favored 'Cis proline' 0 C--O 1.235 0.373 0 C-N-CA 123.076 -1.635 . . . . 71.24 112.59 0.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.605 HG22 ' HG2' ' A' ' 47' ' ' LYS . 52.6 mt -104.24 126.46 58.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.576 -0.527 . . . . 73.21 109.576 177.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.51 102.84 9.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.183 0.516 . . . . 62.11 110.249 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 62' ' ' SER . 32.5 mt -112.81 146.05 39.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.781 -0.645 . . . . 55.32 110.399 -177.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 45.3 ttt180 -114.21 102.92 10.59 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.581 -0.896 . . . . 71.32 108.581 169.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.794 HD11 HG12 ' A' ' 42' ' ' ILE . 8.3 tt -123.7 147.01 47.84 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.35 -0.841 . . . . 74.55 110.351 -173.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.484 ' HB2' HD23 ' A' ' 58' ' ' LEU . 3.2 tmt_? 71.03 -51.68 0.68 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.306 -0.861 . . . . 64.55 110.907 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.67 -18.23 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.178 -0.534 . . . . 70.13 112.141 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -131.43 166.19 21.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.279 0.561 . . . . 75.03 110.974 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 41.9 t -82.79 144.61 30.03 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.16 -0.927 . . . . 75.34 110.401 177.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.6 tp -148.77 147.97 29.43 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.177 -0.92 . . . . 73.02 109.369 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -93.69 112.27 24.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.456 0.646 . . . . 71.3 110.805 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.441 HD22 HD13 ' A' ' 56' ' ' LEU . 4.0 mm? -111.06 144.1 40.73 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.153 -0.93 . . . . 63.41 109.218 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -87.86 170.09 11.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.123 0.487 . . . . 73.34 111.123 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -58.26 -33.07 68.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.31 -0.859 . . . . 72.45 110.571 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.453 ' HB2' ' OE1' ' A' ' 69' ' ' GLU . 10.3 m -57.62 -55.33 36.2 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.614 -0.721 . . . . 72.2 110.905 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' OE1' ' HB2' ' A' ' 68' ' ' SER . 1.9 mp0 -65.74 -40.1 91.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 73.32 110.749 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.57 -30.66 69.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.926 -0.579 . . . . 65.15 111.292 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -66.15 -38.58 88.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.008 0.433 . . . . 73.14 111.098 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.17 9.06 29.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.933 -0.576 . . . . 74.53 112.122 -173.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.585 HG23 HG13 ' A' ' 75' ' ' VAL . 66.8 mt -112.41 117.0 54.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.893 -0.41 . . . . 74.11 109.893 175.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.7 mt -97.82 111.7 23.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.039 0.447 . . . . 74.14 110.171 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.585 HG13 HG23 ' A' ' 73' ' ' ILE . 29.4 m -126.88 146.15 33.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.155 -0.475 . . . . 73.35 111.268 -176.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -107.18 139.8 41.04 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.398 -0.593 . . . . 63.43 109.398 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.814 ' HA ' HG12 ' A' ' 16' ' ' VAL . 40.8 t -71.22 104.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.093 -0.503 . . . . 73.2 110.369 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.8 mt . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 115.989 -0.551 . . . . 72.4 111.375 -177.889 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.593 0 CA-C-O 120.961 0.201 . . . . 37.41 112.884 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.8 pt -100.84 167.09 2.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.404 -0.591 . . . . 73.55 109.404 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 73' ' ' ILE . . . -69.61 145.84 42.72 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.19 -1.005 . . . . 73.24 111.704 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.489 HD23 HD11 ' A' ' 44' ' ' ILE . 2.2 tm? -54.95 -38.19 67.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.335 0.588 . . . . 74.04 109.909 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.465 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 34.9 t30 -61.54 -18.92 61.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.498 -0.774 . . . . 73.14 111.499 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -105.52 5.86 31.82 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.283 -0.417 . . . . 75.22 111.775 -171.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.429 HG11 ' N ' ' A' ' 11' ' ' GLU . 21.5 t -86.2 159.52 3.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.42 -0.355 . . . . 75.13 110.103 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.513 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 25.2 tt0 -85.42 171.75 11.57 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.626 -0.509 . . . . 73.2 109.626 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.513 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 35.7 pt -86.83 150.63 3.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.942 0.401 . . . . 75.14 111.72 -173.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 56.55 66.17 1.25 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.138 -0.937 . . . . 64.43 111.596 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -152.02 158.32 42.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.662 -1.154 . . . . 74.42 109.339 174.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HG2' ' HD1' ' A' ' 43' ' ' TYR . 65.6 mttp -105.76 131.25 53.34 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.843 0.354 . . . . 74.34 110.183 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.646 HG13 ' HA ' ' A' ' 77' ' ' VAL . 30.9 m -128.03 155.59 39.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.033 -0.53 . . . . 70.41 110.691 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -119.59 141.44 49.28 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.819 -0.628 . . . . 73.45 109.961 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.637 ' HA ' HG13 ' A' ' 75' ' ' VAL . 42.0 t -74.63 97.05 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.454 -0.794 . . . . 72.3 110.428 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.807 HD11 ' HB2' ' A' ' 76' ' ' GLU . 27.9 mt -62.67 -41.8 93.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.476 -0.784 . . . . 73.34 109.991 173.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.92 166.01 38.0 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.528 -0.844 . . . . 70.11 112.662 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.693 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 54.5 mt -107.62 160.32 6.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.595 -0.891 . . . . 73.22 108.595 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.11 90.8 1.19 Allowed Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.594 -0.521 . . . . 64.52 109.594 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.693 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 34.3 Cg_exo -56.59 167.01 3.1 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.882 3.055 . . . . 73.34 113.564 -170.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 65.17 15.26 9.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.186 -0.915 . . . . 72.53 110.208 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.939 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 37.0 t -67.6 152.87 44.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.075 -0.966 . . . . 75.53 109.732 176.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -87.74 -16.44 34.22 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.171 -0.678 . . . . 75.14 109.171 177.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.12 3.15 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.615 -0.721 . . . . 73.55 111.71 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.939 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 4.7 tmt_? -52.04 -40.85 61.71 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 110.11 -0.33 . . . . 64.1 110.11 173.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -58.41 -44.07 88.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.503 . . . . 73.31 110.611 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.447 ' HD3' ' HG2' ' A' ' 69' ' ' GLU . 88.8 tttt -62.86 -46.49 87.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.256 0.55 . . . . 71.24 110.258 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.534 HG22 HD13 ' A' ' 36' ' ' ILE . 82.6 mt -62.23 -46.14 97.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.298 -0.865 . . . . 74.55 111.262 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -39.84 93.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.055 -0.52 . . . . 73.24 110.553 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.82 -39.86 95.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.805 -0.634 . . . . 74.23 110.945 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.538 ' SD ' HD13 ' A' ' 65' ' ' LEU . 52.9 mtt -69.84 -13.23 62.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.181 -0.463 . . . . 74.34 111.557 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.78 36.9 5.4 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.626 -0.797 . . . . 71.24 112.89 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.534 HD13 HG22 ' A' ' 31' ' ' ILE . 40.4 mt -110.03 124.75 67.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.868 0.366 . . . . 73.33 110.333 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -145.09 177.38 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.606 -0.724 . . . . 74.32 109.693 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.442 ' C ' ' HD3' ' A' ' 38' ' ' ARG . 4.2 tmt_? -64.53 130.28 43.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.856 0.36 . . . . 74.21 110.145 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.01 -15.93 60.02 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.96 -0.638 . . . . 71.32 112.612 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.7 m -79.37 148.74 31.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.962 -0.385 . . . . 74.3 109.962 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -104.08 148.36 26.34 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.164 0.507 . . . . 74.23 110.734 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.412 HG12 ' HB3' ' A' ' 58' ' ' LEU . 79.6 mt -127.91 123.9 61.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.265 -0.88 . . . . 74.41 109.423 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.746 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 50.8 t80 -88.78 114.36 25.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.97 0.414 . . . . 65.53 110.378 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.489 HD11 HD23 ' A' ' 7' ' ' LEU . 21.1 mm -81.34 107.03 13.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.803 -0.635 . . . . 75.51 109.302 176.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -83.16 -53.26 5.91 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.776 -0.824 . . . . 64.14 108.776 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.76 147.43 6.56 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.311 -0.947 . . . . 64.42 112.607 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.565 ' HG2' HG21 ' A' ' 54' ' ' ILE . 51.6 mtpt -88.67 149.14 23.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.353 -0.98 . . . . 73.3 108.353 173.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.77 156.42 24.86 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 110.491 -0.189 . . . . 72.42 110.491 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.88 -16.84 27.57 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.681 2.254 . . . . 75.15 111.94 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.1 ttm -92.43 -12.55 31.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.65 -0.704 . . . . 75.03 110.275 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.75 -29.38 11.44 Favored Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 115.846 -0.616 . . . . 54.33 111.869 -177.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -142.17 147.56 44.49 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 108.923 -0.769 . . . . 73.55 108.923 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -79.71 -179.27 25.71 Favored 'Cis proline' 0 C--O 1.236 0.381 0 C-N-CA 123.317 -1.535 . . . . 74.1 112.472 -0.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.565 HG21 ' HG2' ' A' ' 47' ' ' LYS . 33.3 mt -113.23 124.75 70.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.92 -0.4 . . . . 65.44 109.92 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.08 106.78 11.36 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.908 0.385 . . . . 73.11 110.61 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 62' ' ' SER . 63.8 mt -119.64 142.26 48.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.098 -0.501 . . . . 75.21 110.808 -175.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.746 ' HB3' ' HB3' ' A' ' 43' ' ' TYR . 36.1 ttt180 -110.97 100.97 9.58 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.67 -0.863 . . . . 73.41 108.67 171.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.426 HD21 HD11 ' A' ' 36' ' ' ILE . 3.2 pp -131.41 151.21 51.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.81 -0.632 . . . . 75.31 110.616 -173.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? 71.66 -39.39 0.45 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.37 0.668 . . . . 73.04 111.174 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 170.64 -27.35 0.11 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.152 -0.547 . . . . 74.44 112.262 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -124.46 169.15 12.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.971 0.415 . . . . 75.34 111.346 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 46.5 t -99.48 146.8 25.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.583 -0.735 . . . . 71.31 110.894 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -164.6 161.3 20.92 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.282 -0.872 . . . . 75.01 109.425 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.94 116.89 31.07 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.07 0.462 . . . . 75.15 111.625 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.538 HD13 ' SD ' ' A' ' 34' ' ' MET . 4.1 mm? -98.15 158.84 15.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.757 -0.656 . . . . 63.4 110.881 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -81.87 156.19 24.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.15 -0.477 . . . . 63.53 111.383 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -53.83 -45.21 70.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.728 -0.669 . . . . 70.31 110.982 173.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.2 m -57.77 -50.39 73.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.592 -0.731 . . . . 53.35 111.958 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.447 ' HG2' ' HD3' ' A' ' 30' ' ' LYS . 2.2 mp0 -71.79 -31.06 66.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 74.25 111.536 -175.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 8' ' ' ASN . . . -68.69 -23.11 64.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.25 0.463 . . . . 73.41 112.25 -173.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -87.19 -11.28 50.31 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.957 -0.697 . . . . 62.12 110.682 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.56 0.93 35.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.179 -0.464 . . . . 74.21 111.021 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.477 ' O ' ' HA2' ' A' ' 6' ' ' GLY . 59.5 mt -118.52 126.48 75.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.951 -0.568 . . . . 64.31 109.984 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.2 mt -103.15 122.32 44.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.072 -0.344 . . . . 75.34 110.072 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.637 HG13 ' HA ' ' A' ' 18' ' ' VAL . 29.8 m -131.38 164.3 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.714 0.635 . . . . 75.34 112.714 -172.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.807 ' HB2' HD11 ' A' ' 19' ' ' ILE . 3.7 tp10 -111.21 136.9 49.61 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.916 -1.038 . . . . 73.11 109.477 173.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.646 ' HA ' HG13 ' A' ' 16' ' ' VAL . 46.8 t -82.66 104.67 11.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.534 -0.543 . . . . 42.13 109.534 178.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.8 mt . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 121.224 0.535 . . . . 44.13 110.938 -175.671 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.687 0 N-CA-C 112.097 -0.401 . . . . 74.02 112.097 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.2 pt -134.02 173.64 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.685 0.279 . . . . 74.15 110.318 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.65 157.85 38.48 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.59 -0.814 . . . . 70.3 111.099 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 7' ' ' LEU . 2.0 tm? -54.65 -35.22 63.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.089 0.471 . . . . 73.32 110.67 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -71.58 -11.95 61.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.126 -0.488 . . . . 73.25 111.871 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -99.26 -5.6 29.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.765 0.317 . . . . 72.53 111.259 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 11' ' ' GLU . 15.5 t -77.21 162.57 4.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.259 -0.428 . . . . 72.04 110.564 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.414 ' N ' HG12 ' A' ' 10' ' ' VAL . 23.4 tt0 -96.74 170.27 9.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.627 -0.508 . . . . 73.22 109.627 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.1 pt -76.65 146.63 8.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.835 0.35 . . . . 73.43 111.533 -174.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 61.16 25.65 15.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.378 -0.828 . . . . 73.44 111.925 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.5 m -105.13 148.1 27.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.928 -0.578 . . . . 63.41 109.592 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.516 ' HG2' HD12 ' A' ' 78' ' ' LEU . 45.5 tttm -105.43 126.1 51.73 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.78 -0.452 . . . . 72.33 109.78 -177.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.535 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 17.6 m -131.71 162.87 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.3 0.571 . . . . 72.0 111.634 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.681 ' HE3' ' HA2' ' A' ' 39' ' ' GLY . 2.1 tmtp? -122.36 145.19 48.49 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.5 -0.773 . . . . 72.13 110.094 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.5 t -73.4 97.49 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.094 -0.503 . . . . 71.23 110.872 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.526 HD12 ' HB2' ' A' ' 76' ' ' GLU . 45.6 mt -54.51 -46.96 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 115.619 -0.718 . . . . 71.52 109.616 170.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.46 173.42 39.72 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.328 -0.851 . . . . 71.34 112.451 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.1 mt -96.94 157.9 3.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.36 -0.608 . . . . 72.23 109.36 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.2 91.76 1.83 Allowed Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.764 -0.458 . . . . 53.2 109.764 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.09 165.48 0.88 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 124.055 3.17 . . . . 71.14 113.783 -171.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.468 ' H ' ' NH1' ' A' ' 28' ' ' ARG . 0.5 OUTLIER 64.88 24.06 12.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.093 -0.958 . . . . 74.53 111.486 -177.355 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.541 ' OG ' HG22 ' A' ' 27' ' ' VAL . 40.7 t -93.14 150.97 20.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.653 -0.703 . . . . 72.25 109.778 173.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -82.39 -18.17 42.95 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.933 -0.395 . . . . 73.11 109.933 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.562 HG23 ' HA ' ' A' ' 69' ' ' GLU . 11.2 m -94.75 -9.44 9.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.34 -0.391 . . . . 55.23 110.343 176.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.468 ' NH1' ' H ' ' A' ' 24' ' ' GLU . 52.2 ttp180 -50.6 -49.09 57.39 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.272 0.558 . . . . 70.21 110.121 170.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -62.06 -37.44 84.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.205 -0.907 . . . . 75.14 110.499 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -62.36 -44.99 95.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.726 -0.67 . . . . 74.14 110.824 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.449 HG13 HD11 ' A' ' 73' ' ' ILE . 47.5 mm -63.91 -48.32 86.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.761 -0.654 . . . . 73.24 111.247 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.9 mmt -64.84 -33.41 75.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 75.42 110.732 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.38 -28.14 68.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.871 -0.604 . . . . 73.14 110.361 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 82.6 mmm -81.58 -8.82 59.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.762 -0.654 . . . . 74.43 110.95 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.07 24.79 47.14 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.747 -0.74 . . . . 75.42 112.534 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mt -102.09 134.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.733 -0.469 . . . . 74.13 109.733 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.14 169.99 20.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.18 0.514 . . . . 62.41 111.598 -175.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.423 ' C ' ' HD3' ' A' ' 38' ' ' ARG . 4.1 tmt_? -68.28 110.49 4.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.783 -0.644 . . . . 61.43 109.541 175.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.681 ' HA2' ' HE3' ' A' ' 17' ' ' LYS . . . 132.32 -16.7 4.87 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.763 -0.732 . . . . 74.42 111.952 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 m -71.12 148.9 46.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.877 0.37 . . . . 74.41 110.547 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.431 ' C ' HD13 ' A' ' 42' ' ' ILE . 40.3 mt-10 -100.04 132.35 45.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.962 -0.563 . . . . 74.14 110.361 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.629 HG13 ' HB3' ' A' ' 58' ' ' LEU . 2.0 mp -118.98 122.12 68.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.31 0.576 . . . . 71.31 110.179 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.691 ' HB3' ' HB2' ' A' ' 57' ' ' ARG . 82.3 t80 -96.13 116.78 29.51 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.654 -0.869 . . . . 75.51 108.654 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.2 mm -71.7 101.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.683 -0.488 . . . . 74.11 109.683 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.34 -33.58 69.73 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.365 -0.605 . . . . 74.23 109.365 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.32 150.54 5.6 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.652 -0.785 . . . . 75.34 112.563 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -88.93 154.42 20.25 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.474 -0.936 . . . . 72.45 108.474 173.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.88 151.98 51.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.593 -0.521 . . . . 73.55 109.593 175.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.79 -23.91 61.0 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.49 2.127 . . . . 74.1 111.81 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ttt -86.0 -17.84 34.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.761 -0.654 . . . . 74.14 110.213 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.05 -23.64 20.72 Favored Glycine 0 C--N 1.33 0.2 0 CA-C-N 116.06 -0.518 . . . . 74.34 112.795 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.43 ' OD1' ' HA ' ' A' ' 53' ' ' PRO . 28.9 t70 -145.91 137.0 12.6 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.233 -0.654 . . . . 74.41 109.233 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.43 ' HA ' ' OD1' ' A' ' 52' ' ' ASP . 4.2 Cg_exo -81.53 -168.84 6.95 Favored 'Cis proline' 0 CA--C 1.534 0.49 0 C-N-CA 124.157 -1.185 . . . . 64.21 113.194 0.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 64' ' ' SER . 57.8 mt -121.17 142.86 35.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 73.12 110.138 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.34 112.95 25.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.928 0.394 . . . . 74.33 110.652 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 62' ' ' SER . 4.0 mp -107.7 132.32 53.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 73.52 110.741 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.691 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 27.7 mmt180 -90.33 100.48 13.31 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.27 -0.641 . . . . 65.14 109.27 173.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.629 ' HB3' HG13 ' A' ' 42' ' ' ILE . 2.8 pp -137.66 142.6 41.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.984 -0.553 . . . . 74.4 110.016 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 70.63 -4.12 1.75 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.332 0.587 . . . . 71.14 110.42 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 133.26 -41.22 1.5 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.959 -0.564 . . . . 37.36 112.303 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -113.26 159.53 19.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.46 0.648 . . . . 71.45 111.985 -175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 36.1 t -82.25 148.09 28.57 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.879 -1.055 . . . . 72.12 110.289 173.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 42.1 tp -151.08 146.38 26.13 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.554 -0.748 . . . . 64.13 109.793 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -89.01 113.99 25.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.199 0.524 . . . . 75.05 111.64 -178.404 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.492 HD21 HD12 ' A' ' 56' ' ' LEU . 3.6 mm? -112.89 157.16 21.78 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.067 -0.716 . . . . 73.3 109.067 174.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -84.3 160.8 20.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.864 0.364 . . . . 64.31 111.131 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.459 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 1.6 tmtp? -55.39 -28.44 54.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.627 -0.715 . . . . 52.44 110.667 175.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.8 m -56.6 -56.87 15.94 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.365 -0.38 . . . . 72.53 110.494 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.562 ' HA ' HG23 ' A' ' 27' ' ' VAL . 1.8 mp0 -63.61 -40.19 96.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.095 0.474 . . . . 70.15 110.353 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 67' ' ' LYS . . . -62.86 -20.97 65.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.572 -0.74 . . . . 74.21 111.648 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.477 ' C ' ' HD2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -79.22 -39.05 34.2 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.058 -0.349 . . . . 70.52 110.058 177.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -89.76 8.44 31.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.196 -0.457 . . . . 75.12 112.2 -171.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.449 HD11 HG13 ' A' ' 31' ' ' ILE . 47.1 mm -115.07 113.02 42.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.872 -0.418 . . . . 73.02 109.872 175.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.7 mt -93.45 126.44 38.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.776 -0.453 . . . . 60.45 109.776 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.535 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 18.6 m -128.14 153.27 37.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.277 0.561 . . . . 73.12 112.124 -174.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.526 ' HB2' HD12 ' A' ' 19' ' ' ILE . 42.2 tt0 -119.6 144.33 47.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.004 -0.998 . . . . 73.3 108.812 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.442 ' HA ' HG11 ' A' ' 16' ' ' VAL . 9.3 p -70.38 136.66 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.071 0.462 . . . . 75.15 111.076 -176.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 17' ' ' LYS . 40.8 mt . . . . . 0 C--N 1.327 -0.374 0 N-CA-C 112.284 0.476 . . . . 64.13 112.284 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.004 0 N-CA-C 111.912 -0.475 . . . . 61.43 111.912 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.8 pt -125.24 168.12 18.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.948 -0.76 . . . . 73.23 108.948 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.24 149.1 50.77 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.027 -1.082 . . . . 72.21 111.033 177.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.672 HD21 HD11 ' A' ' 44' ' ' ILE . 2.7 tm? -54.43 -33.18 58.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.389 0.614 . . . . 73.52 109.89 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' A' ' 71' ' ' LYS . 8.7 p30 -70.62 -19.46 62.82 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.574 -0.739 . . . . 72.4 111.307 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -92.23 -8.12 46.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.903 0.382 . . . . 74.04 110.789 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.1 t -80.28 157.62 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.112 -0.495 . . . . 74.55 110.029 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.59 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 21.1 tt0 -94.81 176.81 6.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.793 -0.447 . . . . 75.12 109.793 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.59 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 39.9 pt -84.73 160.5 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 112.23 0.455 . . . . 71.32 112.23 -173.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 60.59 46.92 8.89 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.121 -0.945 . . . . 64.53 111.998 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.7 m -145.53 154.06 41.79 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.583 -0.735 . . . . 73.34 109.636 174.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.647 ' HB3' ' HD1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -109.22 130.89 55.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.34 0.59 . . . . 72.44 110.802 178.674 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.564 HG13 ' HA ' ' A' ' 77' ' ' VAL . 27.1 m -132.28 163.73 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.133 -0.94 . . . . 63.51 110.343 -177.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.431 ' HB2' HD21 ' A' ' 78' ' ' LEU . 29.8 ttpt -115.48 143.48 45.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.992 -0.549 . . . . 75.21 110.656 -177.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.556 ' HA ' HG13 ' A' ' 75' ' ' VAL . 52.8 t -77.61 98.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.509 -0.768 . . . . 72.43 110.048 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.789 HD13 ' HB3' ' A' ' 76' ' ' GLU . 39.8 mt -57.41 -54.69 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.638 -0.71 . . . . 72.45 110.453 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -161.6 178.01 37.65 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.158 -0.928 . . . . 73.34 111.34 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 53.6 mt -113.2 155.84 14.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.963 -0.384 . . . . 70.03 109.963 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.8 t -101.82 91.27 2.26 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.213 -0.662 . . . . 75.41 109.213 175.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.691 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 25.7 Cg_endo -59.22 -168.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.844 3.029 . . . . 61.33 113.773 -172.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 68.3 -43.86 0.49 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.571 -0.741 . . . . 74.43 112.371 -173.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.576 ' OG ' HG23 ' A' ' 27' ' ' VAL . 8.6 t -55.57 145.19 23.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.219 0.533 . . . . 72.1 111.725 -176.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.842 ' HD3' ' H ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -71.73 -29.68 64.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.567 -0.742 . . . . 62.43 109.805 173.071 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.669 HG21 ' HA ' ' A' ' 69' ' ' GLU . 11.4 m -79.84 -17.37 12.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.948 0.404 . . . . 75.35 110.049 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.691 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 2.8 tmm_? -55.18 -36.93 66.4 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.064 -0.516 . . . . 70.45 109.999 169.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -71.48 -40.07 70.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.292 0.568 . . . . 73.41 109.805 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.628 ' HG2' ' OE2' ' A' ' 69' ' ' GLU . 23.5 tptm -53.05 -48.04 67.96 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 114.988 -1.005 . . . . 74.54 111.021 177.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 27' ' ' VAL . 61.5 mt -50.99 -53.29 14.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.566 -0.743 . . . . 73.31 111.386 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 59.3 mtt -66.76 -35.39 79.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 73.42 111.371 -178.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.83 -38.58 89.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.943 0.401 . . . . 61.44 110.022 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.6 tpt -65.75 -25.57 67.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.472 -0.786 . . . . 75.32 110.961 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.87 8.09 11.09 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.756 -0.735 . . . . 41.23 112.744 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.417 ' HB ' ' CG2' ' A' ' 31' ' ' ILE . 37.4 mt -104.61 133.28 49.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.711 -0.477 . . . . 71.33 109.711 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.653 HG23 ' H ' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -129.78 -85.89 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 112.092 0.404 . . . . 70.24 112.092 -177.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.653 ' H ' HG23 ' A' ' 37' ' ' VAL . 45.4 ttm180 -153.99 117.56 4.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.964 0.412 . . . . 64.44 110.263 -177.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.43 -1.05 68.89 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.492 -0.861 . . . . 74.55 111.534 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.0 m -66.65 140.85 57.94 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.675 -0.491 . . . . 74.34 109.675 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.504 ' HG2' HD11 ' A' ' 78' ' ' LEU . 35.5 mt-10 -107.07 128.15 54.11 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.803 -0.635 . . . . 71.45 110.029 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.679 HG23 HD23 ' A' ' 56' ' ' LEU . 77.5 mt -121.48 136.28 58.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.317 -0.856 . . . . 73.12 110.535 -172.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.647 ' HD1' ' HB3' ' A' ' 15' ' ' LYS . 37.4 t80 -100.87 105.88 17.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.262 -0.426 . . . . 72.43 109.869 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.672 HD11 HD21 ' A' ' 7' ' ' LEU . 50.4 mm -70.54 120.92 19.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.941 -0.392 . . . . 73.42 109.941 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -89.96 -65.82 0.98 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.09 -0.504 . . . . 65.45 110.516 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.403 ' HA2' ' CG2' ' A' ' 12' ' ' ILE . . . -159.06 173.44 35.92 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.687 -0.768 . . . . 74.41 112.027 -177.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HG2' HG22 ' A' ' 54' ' ' ILE . 58.3 mtpt -129.52 146.98 51.28 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.32 -0.622 . . . . 75.33 109.32 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.67 157.13 68.42 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.497 -0.557 . . . . 64.12 109.497 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -52.3 -29.74 39.76 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.82 2.347 . . . . 73.24 113.196 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -82.43 -7.95 59.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 74.03 110.821 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.11 -8.34 78.62 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.012 -0.835 . . . . 74.54 111.012 -173.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.769 ' HB2' ' HB2' ' A' ' 67' ' ' LYS . 5.9 t70 -139.29 128.98 14.26 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.014 -0.593 . . . . 73.54 109.797 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -87.0 -174.32 9.8 Favored 'Cis proline' 0 C--O 1.237 0.459 0 C-N-CA 123.374 -1.511 . . . . 74.12 113.05 0.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.473 HG22 ' HG2' ' A' ' 47' ' ' LYS . 4.6 mp -112.86 140.78 30.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.791 -0.641 . . . . 55.25 109.31 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.65 106.76 19.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.025 0.441 . . . . 61.33 110.839 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.679 HD23 HG23 ' A' ' 42' ' ' ILE . 3.1 mp -105.51 134.27 48.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.836 -0.62 . . . . 74.13 109.381 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 39.6 mtt180 -98.19 119.98 37.81 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.982 0.42 . . . . 72.43 110.114 175.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.42 ' HG ' HD21 ' A' ' 63' ' ' LEU . 3.4 pp -139.43 140.58 37.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.431 -0.804 . . . . 75.03 109.999 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 46.7 ttm-85 65.9 -0.25 1.38 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.31 -0.859 . . . . 71.4 111.993 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.05 -52.02 0.56 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.468 -0.872 . . . . 55.25 113.585 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -120.87 177.33 5.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.871 0.367 . . . . 73.51 111.722 -173.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.439 ' C ' HD22 ' A' ' 63' ' ' LEU . 30.2 t -88.18 142.9 27.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.596 0.712 . . . . 74.53 112.226 -175.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.439 HD22 ' C ' ' A' ' 62' ' ' SER . 3.2 mm? -134.68 143.54 47.29 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.342 -1.299 . . . . 54.33 108.928 176.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 p -99.33 119.91 38.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.078 0.466 . . . . 62.34 111.695 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.505 HD12 HD12 ' A' ' 56' ' ' LEU . 9.0 mp -114.72 151.42 33.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.86 -0.609 . . . . 70.51 109.423 175.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.489 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 46.8 mmm-85 -75.61 159.81 30.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.32 0.581 . . . . 75.22 111.745 -174.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.769 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -61.94 -33.58 74.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.246 -0.888 . . . . 60.34 110.611 179.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 41.7 m -73.3 -35.47 66.13 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.978 -0.555 . . . . 73.23 111.204 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.669 ' HA ' HG21 ' A' ' 27' ' ' VAL . 39.4 mt-10 -70.11 -43.01 71.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.351 0.596 . . . . 65.52 109.401 176.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.71 -21.25 65.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.386 -0.825 . . . . 65.22 111.072 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.443 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 1.8 ttpm? -70.74 -35.64 72.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.076 -0.511 . . . . 64.35 110.517 176.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -84.46 14.44 4.51 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.586 -0.734 . . . . 73.44 111.204 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.405 HG12 HD13 ' A' ' 31' ' ' ILE . 54.7 mt -125.8 120.47 57.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.897 -0.592 . . . . 65.05 109.909 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.1 mt -104.01 126.1 50.88 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.955 -0.387 . . . . 75.53 109.955 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.556 HG13 ' HA ' ' A' ' 18' ' ' VAL . 23.9 m -129.51 157.44 42.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.318 0.58 . . . . 74.43 112.372 -174.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.789 ' HB3' HD13 ' A' ' 19' ' ' ILE . 14.0 pt-20 -119.22 153.35 35.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.265 -0.88 . . . . 73.03 109.681 176.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.564 ' HA ' HG13 ' A' ' 16' ' ' VAL . 13.1 p -77.92 133.09 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.988 0.423 . . . . 61.42 111.024 -177.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.504 HD11 ' HG2' ' A' ' 41' ' ' GLU . 96.9 mt . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 121.362 0.601 . . . . 61.53 110.826 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.728 0 CA-C-O 121.03 0.239 . . . . 53.51 112.6 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 pt -115.37 173.07 3.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.808 -0.812 . . . . 73.5 108.808 176.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.45 143.2 29.08 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 119.865 -1.16 . . . . 61.43 111.72 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.467 HD12 HD12 ' A' ' 44' ' ' ILE . 39.5 tp -63.61 -24.71 67.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.2 0.524 . . . . 73.34 110.548 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -76.52 -14.39 60.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.853 -0.612 . . . . 74.51 110.604 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.85 -4.63 56.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.339 0.59 . . . . 74.33 110.012 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.5 t -98.26 162.28 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.505 -0.771 . . . . 62.15 109.399 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.776 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 24.8 tt0 -124.77 -172.0 2.47 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.98 -0.288 . . . . 72.44 110.79 -177.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.776 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 31.6 pt -63.35 154.13 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 113.445 0.906 . . . . 73.02 113.445 -170.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 63.02 27.1 15.77 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.965 -1.016 . . . . 62.15 111.962 173.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.6 m -102.42 152.66 20.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.259 -0.428 . . . . 65.1 110.53 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -124.17 110.92 15.28 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.235 -0.654 . . . . 71.43 109.235 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.494 HG11 ' HA ' ' A' ' 77' ' ' VAL . 30.4 m -128.32 174.17 12.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.534 -0.757 . . . . 70.01 110.687 -174.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 37.5 ttmt -129.18 140.98 51.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.154 -0.475 . . . . 75.23 110.595 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.545 HG12 HG21 ' A' ' 73' ' ' ILE . 48.7 t -73.36 96.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.319 -0.855 . . . . 64.24 110.619 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.8 mm -63.29 -44.9 99.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.76 -0.655 . . . . 65.32 109.908 174.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.93 172.08 44.51 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.233 -0.984 . . . . 74.33 112.671 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.593 ' HB ' ' NH1' ' A' ' 28' ' ' ARG . 49.4 mt -127.77 158.98 39.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 108.068 -1.086 . . . . 73.2 108.068 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.425 ' O ' ' HB2' ' A' ' 25' ' ' SER . 38.2 t -101.19 91.3 1.96 Allowed Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.058 0.456 . . . . 75.51 111.254 -175.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.622 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 24.4 Cg_endo -59.94 171.55 2.86 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.696 2.264 . . . . 64.42 112.35 -177.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 68.93 -5.28 1.05 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.682 -0.69 . . . . 74.33 111.488 -175.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 1.2 m -78.74 156.77 28.72 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.955 -0.387 . . . . 73.3 109.955 173.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -75.33 -31.43 60.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.894 0.378 . . . . 75.22 110.599 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.511 ' HB ' ' HG3' ' A' ' 69' ' ' GLU . 29.6 m -81.47 -21.61 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 70.34 110.77 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.622 ' HG2' ' HA ' ' A' ' 23' ' ' PRO . 17.7 tpt180 -53.02 -43.78 66.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.94 -0.573 . . . . 61.12 110.465 175.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -59.43 -44.65 92.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.587 -0.733 . . . . 64.33 110.771 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 34' ' ' MET . 88.6 tttt -63.85 -48.93 74.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.818 -0.628 . . . . 75.51 110.931 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 27' ' ' VAL . 82.1 mt -57.33 -45.81 85.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.822 -0.627 . . . . 71.01 111.392 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 95.4 mmm -68.57 -35.5 77.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.795 0.331 . . . . 71.31 110.593 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -66.32 -39.96 89.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.99 -0.55 . . . . 74.42 110.255 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.484 ' HE1' HD12 ' A' ' 63' ' ' LEU . 91.0 mmm -60.52 -34.73 74.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.818 -0.628 . . . . 74.22 110.735 176.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.58 13.82 9.29 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.64 -0.791 . . . . 73.45 112.894 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.7 mt -89.64 127.1 42.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.86 0.362 . . . . 74.32 110.052 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.36 173.13 14.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.722 -0.672 . . . . 64.03 110.675 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.59 135.27 57.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.185 -0.461 . . . . 75.0 110.619 178.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.24 -12.09 66.89 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.908 -0.587 . . . . 73.12 112.662 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.3 m -73.29 142.24 47.17 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.859 -0.423 . . . . 71.12 109.859 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -94.39 136.14 35.02 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.065 0.459 . . . . 65.22 109.785 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.2 mm -116.74 117.82 56.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.643 -0.708 . . . . 75.1 110.463 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 63.4 t80 -95.52 119.48 34.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.854 -0.612 . . . . 74.54 109.436 174.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.467 HD12 HD12 ' A' ' 7' ' ' LEU . 26.3 mm -76.3 101.88 2.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.612 -0.514 . . . . 51.13 109.612 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -70.35 -42.83 71.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.934 -0.575 . . . . 71.11 109.601 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 169.75 177.78 40.42 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.889 -0.672 . . . . 75.34 111.956 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -117.97 143.09 46.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.132 -0.692 . . . . 72.54 109.132 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.64 158.46 31.13 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.605 -0.271 . . . . 63.55 110.394 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -45.41 -41.73 17.8 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.201 2.6 . . . . 72.21 113.419 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.7 ttt -71.22 -21.97 62.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 74.35 111.382 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.59 -7.22 42.31 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.728 -0.949 . . . . 71.01 110.728 -172.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.5 ' OD1' ' HA ' ' A' ' 53' ' ' PRO . 21.8 t70 -155.54 139.25 11.2 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.838 -0.801 . . . . 74.15 108.838 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.5 ' HA ' ' OD1' ' A' ' 52' ' ' ASP . 4.1 Cg_exo -79.45 -170.19 8.51 Favored 'Cis proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.829 -1.321 . . . . 75.24 113.05 2.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.5 mt -116.39 137.5 49.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.713 -0.676 . . . . 74.23 109.904 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.03 111.65 20.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.291 -0.413 . . . . 60.24 110.287 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.6 mt -114.04 135.96 53.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.967 -0.561 . . . . 75.23 109.903 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 44.4 ttt180 -94.83 107.4 19.41 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.698 -0.482 . . . . 73.22 109.698 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -132.69 153.63 50.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.271 -0.422 . . . . 73.24 110.288 -177.539 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.537 ' HB2' HD23 ' A' ' 58' ' ' LEU . 0.2 OUTLIER 70.62 -55.63 0.63 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.773 0.671 . . . . 70.31 110.631 -178.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.53 -33.03 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 116.116 -0.493 . . . . 74.31 111.956 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -125.85 165.58 18.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.822 0.344 . . . . 75.4 110.938 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.706 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 47.7 t -86.28 145.82 26.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.243 0.544 . . . . 75.1 110.973 -178.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.484 HD12 ' HE1' ' A' ' 34' ' ' MET . 91.1 mt -145.31 161.22 40.14 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.052 -0.976 . . . . 75.45 109.483 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -97.17 121.18 38.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.044 0.449 . . . . 65.34 110.741 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.42 143.31 49.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.355 -0.839 . . . . 75.52 109.389 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.479 ' HA ' ' HB3' ' A' ' 53' ' ' PRO . 37.4 mmt180 -71.82 155.14 40.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.073 0.463 . . . . 72.23 110.898 -177.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -56.27 -30.9 63.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.381 -0.827 . . . . 72.05 111.045 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.9 p -63.81 -37.87 89.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 44.41 111.607 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.511 ' HG3' ' HB ' ' A' ' 27' ' ' VAL . 1.6 mp0 -73.87 -39.39 63.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.003 0.43 . . . . 74.21 110.554 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.16 -23.64 66.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.202 0.525 . . . . 72.35 110.734 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -62.99 -33.9 76.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.79 -0.641 . . . . 74.14 111.74 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -88.65 -5.24 58.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.128 0.49 . . . . 72.14 111.78 -168.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.545 HG21 HG12 ' A' ' 18' ' ' VAL . 65.6 mt -105.13 115.58 47.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.192 -0.458 . . . . 64.1 110.899 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.485 ' N ' HD21 ' A' ' 74' ' ' LEU . 2.7 mm? -86.67 126.87 34.83 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.633 -0.506 . . . . 70.24 109.633 174.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.49 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 24.2 m -130.15 153.72 39.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.877 0.37 . . . . 72.11 111.574 -176.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -102.52 148.49 25.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.283 -0.636 . . . . 75.52 109.283 173.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.494 ' HA ' HG11 ' A' ' 16' ' ' VAL . 53.6 t -89.3 114.51 27.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.864 0.364 . . . . 65.41 110.187 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--N 1.324 -0.504 0 CA-C-O 121.192 0.52 . . . . 64.43 111.343 -177.751 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 112.07 -0.412 . . . . 61.03 112.07 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.6 pt -115.74 168.19 7.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.987 -0.375 . . . . 74.04 109.987 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.07 143.65 41.73 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.311 -0.947 . . . . 73.52 111.924 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 7' ' ' LEU . 2.6 tm? -58.3 -34.31 70.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.214 0.53 . . . . 74.42 109.841 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -69.78 -14.36 62.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.73 -0.668 . . . . 70.04 111.387 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -96.12 -2.86 45.66 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.809 0.338 . . . . 73.24 111.122 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 11' ' ' GLU . 16.5 t -90.76 159.21 2.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.234 -0.439 . . . . 51.01 110.208 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.412 ' N ' HG12 ' A' ' 10' ' ' VAL . 27.9 tt0 -89.98 166.0 13.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.155 -0.475 . . . . 74.31 110.266 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.9 pt -77.48 162.87 4.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.185 -0.462 . . . . 71.1 110.599 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt 60.55 30.09 19.49 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.192 0.597 . . . . 74.14 111.014 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.6 m -120.88 151.67 39.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.68 -0.691 . . . . 74.21 110.3 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -109.59 127.4 54.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.097 -0.501 . . . . 73.2 109.698 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.434 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 22.5 m -128.97 173.54 13.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.261 -0.427 . . . . 72.04 111.099 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.804 ' HE3' HD21 ' A' ' 78' ' ' LEU . 29.9 ttmt -126.5 140.29 52.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.907 -0.588 . . . . 65.21 110.689 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.88 96.85 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.604 -0.726 . . . . 74.12 110.345 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.1 mm -92.36 -52.77 9.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.405 -0.816 . . . . 73.02 110.894 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.81 160.55 22.83 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.207 -0.997 . . . . 72.11 112.945 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.711 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 71.8 mt -142.4 158.12 19.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.801 -1.185 . . . . 72.21 107.801 -178.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.0 t -100.62 91.42 1.81 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.65 0.262 . . . . 74.12 110.65 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.711 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 31.4 Cg_exo -57.57 159.06 17.63 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.26 2.64 . . . . 75.25 112.732 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 62.62 74.5 0.43 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.521 -0.763 . . . . 75.43 110.155 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.454 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 28.9 t -159.26 153.52 23.81 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.134 -0.939 . . . . 62.42 109.599 -176.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -68.97 -22.6 64.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.833 0.349 . . . . 72.15 110.344 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 31' ' ' ILE . 25.2 m -95.77 -20.34 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.495 -0.32 . . . . 72.24 110.684 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.603 ' CD ' ' HA ' ' A' ' 23' ' ' PRO . 2.0 tpm_? -50.33 -54.45 21.41 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.184 -0.462 . . . . 74.13 111.074 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -65.61 -37.07 85.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.971 -0.559 . . . . 64.3 110.992 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -66.32 -45.05 81.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.327 -0.397 . . . . 72.23 111.23 -174.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.473 ' HA ' ' HE3' ' A' ' 34' ' ' MET . 79.2 mt -59.71 -45.83 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.347 -0.388 . . . . 75.12 110.834 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.574 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 2.2 ttt -71.98 -33.16 67.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.328 -0.397 . . . . 71.42 110.675 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -68.27 -24.66 64.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.031 -0.531 . . . . 63.13 110.079 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.473 ' HE3' ' HA ' ' A' ' 31' ' ' ILE . 63.0 mtm -79.64 2.32 22.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.786 -0.643 . . . . 63.44 111.441 178.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.63 -8.06 59.81 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.696 -0.764 . . . . 37.66 112.763 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 32' ' ' MET . 63.2 mt -81.5 137.42 21.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.864 0.364 . . . . 74.2 110.371 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.756 HG22 ' H ' ' A' ' 38' ' ' ARG . 1.9 m -133.78 -85.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.201 -0.454 . . . . 74.02 111.152 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.756 ' H ' HG22 ' A' ' 37' ' ' VAL . 17.8 ttm180 -153.37 140.68 19.59 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.985 -0.746 . . . . 73.21 108.985 175.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.58 -9.81 69.66 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.634 -0.793 . . . . 74.32 111.278 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -64.82 147.09 53.89 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.755 -0.461 . . . . 72.43 109.755 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -97.28 147.4 24.18 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.234 0.54 . . . . 63.22 111.541 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.587 HG12 ' HB3' ' A' ' 58' ' ' LEU . 64.5 mt -130.81 118.23 41.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.027 -0.988 . . . . 71.22 109.479 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.6 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 64.0 t80 -105.0 106.18 16.56 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.317 -0.401 . . . . 74.22 109.985 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.555 HG12 HD21 ' A' ' 56' ' ' LEU . 52.6 mt -75.31 102.35 2.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.235 -0.654 . . . . 74.51 109.235 177.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -85.54 -24.62 27.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.968 0.413 . . . . 71.52 110.906 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.12 -172.09 40.66 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.844 -0.693 . . . . 65.44 112.265 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.654 ' HG2' HG21 ' A' ' 54' ' ' ILE . 54.5 mtpt -123.49 159.08 29.85 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.737 -0.838 . . . . 74.43 108.737 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.82 152.14 87.44 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.64 -0.504 . . . . 75.34 109.64 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.91 -9.66 12.53 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.816 2.344 . . . . 37.66 112.999 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 55.7 ttp -97.29 -4.62 38.39 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.325 0.583 . . . . 74.5 110.318 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.67 -12.74 67.67 Favored Glycine 0 N--CA 1.454 -0.128 0 CA-C-N 115.988 -0.551 . . . . 72.54 111.958 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.543 ' OD2' ' HB2' ' A' ' 67' ' ' LYS . 11.4 t70 -152.32 136.51 10.22 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.344 -0.984 . . . . 70.11 108.344 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.455 ' HB3' ' HA ' ' A' ' 66' ' ' ARG . 3.5 Cg_exo -81.25 -167.96 6.31 Favored 'Cis proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.817 -1.326 . . . . 75.14 112.401 -1.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.654 HG21 ' HG2' ' A' ' 47' ' ' LYS . 46.8 mt -109.98 134.1 53.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.991 -0.55 . . . . 75.01 110.091 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.51 107.29 18.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.021 0.439 . . . . 65.0 110.167 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.555 HD21 HG12 ' A' ' 44' ' ' ILE . 28.8 mt -120.21 131.97 55.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.041 -0.527 . . . . 61.54 110.295 -177.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.779 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 27.9 ttt-85 -93.29 99.97 12.41 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.765 -0.828 . . . . 64.22 108.765 171.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.587 ' HB3' HG12 ' A' ' 42' ' ' ILE . 1.1 pp -119.13 146.0 45.49 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.084 -0.507 . . . . 74.11 110.461 -176.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 73.01 -45.87 0.63 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.895 0.747 . . . . 73.34 111.069 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.47 -26.42 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.293 -0.479 . . . . 74.45 112.152 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -121.45 157.74 29.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.855 0.36 . . . . 75.14 111.147 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.779 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -89.61 133.41 34.64 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.891 -0.595 . . . . 71.34 111.361 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.4 mt -141.98 152.02 43.06 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.552 -0.749 . . . . 71.22 109.475 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -88.86 110.81 21.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.203 0.525 . . . . 75.22 110.886 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.83 145.8 28.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.501 -0.772 . . . . 74.21 108.963 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.455 ' HA ' ' HB3' ' A' ' 53' ' ' PRO . 10.3 mpt_? -80.68 163.34 23.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.977 0.418 . . . . 75.51 110.338 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.72 ' HB2' ' HZ1' ' A' ' 67' ' ' LYS . 4.5 ttmp? -47.76 -38.39 15.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.349 -0.841 . . . . 71.41 111.917 176.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.5 m -59.46 -50.78 72.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.251 -0.432 . . . . 74.32 111.766 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.42 ' O ' HG13 ' A' ' 73' ' ' ILE . 1.8 mp0 -63.66 -49.0 74.91 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.29 0.369 . . . . 74.22 110.795 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.55 -22.55 65.26 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.157 0.503 . . . . 65.53 111.481 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.884 ' HZ1' ' HB3' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -78.95 -23.2 44.75 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.0 -0.546 . . . . 55.43 110.705 -179.169 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -102.48 12.86 35.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 74.12 111.736 -175.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.432 HG21 HG13 ' A' ' 75' ' ' VAL . 61.9 mt -113.57 127.26 71.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.293 -0.412 . . . . 71.4 110.212 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.71 123.27 49.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.044 0.45 . . . . 73.24 109.923 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.434 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 28.2 m -129.56 160.04 40.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 112.324 0.49 . . . . 61.23 112.324 -170.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -106.28 159.02 16.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.591 -0.731 . . . . 63.4 109.305 172.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -83.75 124.61 39.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.775 0.322 . . . . 74.43 110.668 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.804 HD21 ' HE3' ' A' ' 17' ' ' LYS . 46.3 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.923 0.392 . . . . 65.5 111.01 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.85 0 CA-C-O 121.052 0.251 . . . . 42.25 112.95 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.2 pt -125.97 179.33 3.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.185 -0.672 . . . . 74.24 109.185 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.93 145.49 31.18 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.024 -1.084 . . . . 70.31 110.942 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.939 HD23 HD22 ' A' ' 56' ' ' LEU . 51.7 tp -57.55 -30.85 65.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.982 0.42 . . . . 75.02 111.587 -176.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.529 ' ND2' ' HG3' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -71.25 -6.51 40.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.408 -0.36 . . . . 54.45 111.97 179.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.529 ' HG3' ' ND2' ' A' ' 8' ' ' ASN . 44.1 mt-10 -103.55 2.22 33.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.619 0.247 . . . . 53.24 111.145 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.8 t -88.08 157.55 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.877 0.37 . . . . 71.41 110.797 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.52 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 32.1 tt0 -99.27 176.02 5.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.957 -0.565 . . . . 65.43 110.12 -178.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.52 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 40.9 pt -79.95 159.31 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.854 0.359 . . . . 72.31 111.943 -175.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 59.55 35.79 22.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.379 -0.828 . . . . 74.2 111.15 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -130.94 151.27 51.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.269 -0.423 . . . . 70.02 110.809 -177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.759 ' HG2' ' HD1' ' A' ' 43' ' ' TYR . 32.6 mtmt -109.07 130.18 55.48 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.238 0.542 . . . . 62.01 110.563 176.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.674 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 7.0 m -129.4 142.9 42.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.198 -0.91 . . . . 62.3 109.617 176.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HB2' HD11 ' A' ' 78' ' ' LEU . 30.5 ttpt -104.5 142.62 34.3 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.059 0.457 . . . . 64.41 110.486 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.477 ' HA ' HG13 ' A' ' 75' ' ' VAL . 37.0 t -74.75 96.6 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.524 -0.762 . . . . 74.24 110.769 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.696 HD12 ' HB3' ' A' ' 76' ' ' GLU . 16.9 mt -58.72 -42.92 86.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.7 0.762 . . . . 72.15 108.951 171.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.29 170.66 39.95 Favored Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 114.55 -1.205 . . . . 72.22 111.911 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.736 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 14.5 mt -114.23 161.92 12.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.399 -1.334 . . . . 75.03 107.399 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.53 91.84 1.15 Allowed Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.252 0.548 . . . . 74.41 110.377 -174.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.736 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 31.6 Cg_exo -57.26 169.83 1.95 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.812 3.008 . . . . 73.42 113.414 -170.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 65.89 13.61 9.12 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.18 -0.918 . . . . 54.53 110.113 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.501 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 14.7 t -98.89 134.9 41.1 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.566 -0.743 . . . . 61.32 109.354 174.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -68.13 -15.61 63.66 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.334 -0.394 . . . . 75.14 111.295 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 31' ' ' ILE . 27.8 m -94.96 -28.14 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.557 -0.457 . . . . 74.51 110.736 174.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.501 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 3.8 tmt_? -54.1 -47.0 72.26 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.263 0.554 . . . . 75.21 109.845 174.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.9 ttt-85 -55.77 -47.33 77.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.187 -0.915 . . . . 65.24 110.433 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.58 -44.76 95.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.308 -0.86 . . . . 72.22 111.408 -177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.477 HD13 ' CG1' ' A' ' 73' ' ' ILE . 60.3 mt -64.74 -47.62 87.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.516 -0.766 . . . . 61.31 111.411 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 2.3 ttt -68.48 -32.87 73.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.089 0.471 . . . . 64.31 110.545 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.07 -23.62 64.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.815 -0.63 . . . . 64.15 110.612 177.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 22.2 ttm -75.62 -19.62 59.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.835 -0.621 . . . . 75.42 110.65 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.4 -5.06 13.31 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.418 -0.896 . . . . 72.5 112.825 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 32' ' ' MET . 44.6 mt -84.79 125.12 40.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.086 0.469 . . . . 73.12 110.298 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.05 -178.0 2.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.687 -0.688 . . . . 74.32 110.91 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -68.51 116.45 9.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.077 -0.51 . . . . 74.45 110.897 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.14 -2.47 44.01 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.887 -0.597 . . . . 63.53 113.018 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.9 m -75.72 148.34 38.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.858 0.329 . . . . 73.24 110.126 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -95.81 125.22 40.22 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.087 -0.506 . . . . 73.2 110.193 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.7 mt -100.66 114.83 40.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.475 -0.784 . . . . 72.41 109.748 176.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.759 ' HD1' ' HG2' ' A' ' 15' ' ' LYS . 37.1 t80 -91.26 105.09 17.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.121 -0.491 . . . . 74.32 110.105 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.62 HD12 HD11 ' A' ' 7' ' ' LEU . 47.8 mm -80.53 96.37 2.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.071 -0.714 . . . . 75.11 109.071 175.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.05 -26.89 33.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.983 0.421 . . . . 72.42 110.708 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.05 176.84 47.72 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.32 -0.943 . . . . 64.24 112.57 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.747 ' HG2' HG22 ' A' ' 54' ' ' ILE . 56.2 mtpt -133.62 158.22 43.76 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.756 -0.831 . . . . 73.02 108.756 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.85 156.84 63.97 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.501 -0.185 . . . . 62.11 110.501 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.98 -33.74 73.98 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.809 2.339 . . . . 72.4 112.729 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.1 ttm -87.68 -7.65 57.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.134 0.492 . . . . 72.33 110.875 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.89 -15.3 60.88 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 121.13 -0.557 . . . . 71.32 112.075 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -140.3 131.54 14.15 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.38 -0.6 . . . . 73.22 109.38 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.06 -170.08 7.94 Favored 'Cis proline' 0 CA--C 1.531 0.33 0 C-N-CA 124.124 -1.199 . . . . 71.35 113.217 1.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.747 HG22 ' HG2' ' A' ' 47' ' ' LYS . 41.1 mt -110.07 145.08 17.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.766 -0.652 . . . . 61.43 110.005 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.89 104.16 15.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.197 0.523 . . . . 61.05 110.706 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.939 HD22 HD23 ' A' ' 7' ' ' LEU . 7.9 mp -99.93 164.01 12.2 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.477 -0.783 . . . . 71.51 110.27 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.595 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 27.8 ttm180 -142.35 111.73 6.59 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.703 -0.851 . . . . 74.21 108.703 171.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -136.5 149.48 48.19 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.793 0.33 . . . . 73.2 110.823 -177.336 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 62.89 2.72 1.04 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.581 -0.736 . . . . 71.4 111.676 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.67 -14.2 11.69 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.803 -0.713 . . . . 61.31 112.861 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.415 ' HD1' HD22 ' A' ' 63' ' ' LEU . 7.5 p90 -128.01 150.73 49.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.447 0.642 . . . . 75.01 112.385 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 47.9 t -84.46 144.63 28.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.093 -0.958 . . . . 73.15 111.969 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.477 HD21 ' C ' ' A' ' 62' ' ' SER . 3.4 mm? -135.11 144.37 47.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.897 -1.047 . . . . 73.44 109.757 177.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.47 110.01 21.41 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.349 -0.387 . . . . 74.21 110.194 175.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.588 HD22 HD21 ' A' ' 56' ' ' LEU . 2.9 pp -124.55 160.77 27.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.76 0.314 . . . . 71.3 110.46 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 6.1 mpt_? -80.17 161.98 24.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.564 0.697 . . . . 73.12 112.214 -169.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -57.89 -54.85 42.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.725 -1.125 . . . . 71.44 111.459 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.0 m -75.4 -11.71 60.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.033 0.444 . . . . 74.32 111.175 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 66' ' ' ARG . 20.8 tt0 -79.76 -42.45 24.5 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.835 -0.802 . . . . 73.54 108.835 176.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 7' ' ' LEU . . . -69.71 -21.15 63.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.817 -1.083 . . . . 64.34 111.157 174.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -59.01 -26.61 64.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.86 -0.609 . . . . 72.4 112.017 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.4 -3.19 57.31 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.331 0.586 . . . . 54.41 110.622 -177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.496 HG21 HG12 ' A' ' 75' ' ' VAL . 51.7 mt -101.83 128.58 54.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.104 -0.498 . . . . 64.53 110.722 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.0 mt -106.7 118.01 35.55 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.847 -0.427 . . . . 75.11 109.847 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.674 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 15.3 m -129.15 146.13 34.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.935 0.398 . . . . 72.53 111.957 -174.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.696 ' HB3' HD12 ' A' ' 19' ' ' ILE . 9.7 pt-20 -100.67 139.06 36.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.852 -0.613 . . . . 73.15 110.164 176.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.624 ' HA ' HG12 ' A' ' 16' ' ' VAL . 39.5 t -75.12 112.11 12.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.149 -0.478 . . . . 50.25 110.572 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 17' ' ' LYS . 90.6 mt . . . . . 0 C--N 1.327 -0.375 0 CA-C-O 121.249 0.547 . . . . 73.22 110.918 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.8 mtt . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.073 0.463 . . . . 74.33 110.903 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.9 p -148.7 -178.33 6.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.58 -0.736 . . . . 74.1 109.314 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.01 111.13 2.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.088 -0.708 . . . . 64.44 109.088 171.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.3 141.75 33.01 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.551 -0.749 . . . . 64.44 113.672 -170.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.1 pt -106.8 174.77 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.448 -0.945 . . . . 65.02 108.448 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.75 147.73 28.23 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 119.811 -1.185 . . . . 74.5 111.267 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.419 HD23 HD22 ' A' ' 56' ' ' LEU . 44.0 tp -62.65 -17.97 61.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.369 0.604 . . . . 74.43 110.94 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.682 ' ND2' ' HA ' ' A' ' 71' ' ' LYS . 7.8 p30 -75.44 -10.99 59.94 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.572 -0.74 . . . . 70.54 110.895 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -101.81 9.53 40.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.044 -0.525 . . . . 73.43 110.747 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.1 t -103.19 160.27 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.01 -0.541 . . . . 72.54 109.602 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.511 ' CG ' ' H ' ' A' ' 12' ' ' ILE . 12.6 tt0 -112.13 -176.85 3.02 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.226 -0.287 . . . . 73.33 110.226 -177.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.511 ' H ' ' CG ' ' A' ' 11' ' ' GLU . 40.8 pt -66.85 150.38 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.709 0.633 . . . . 73.02 112.709 -171.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 68.3 mttm 51.93 48.99 21.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.078 -0.965 . . . . 74.12 112.343 174.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.7 m -127.37 153.7 45.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.705 -0.68 . . . . 75.15 109.6 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -112.45 129.23 56.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.237 0.541 . . . . 60.25 111.023 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.539 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 15.4 m -137.47 152.65 27.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.114 -0.948 . . . . 65.32 109.795 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.71 ' HB2' HD13 ' A' ' 78' ' ' LEU . 1.9 tmtp? -105.94 140.85 38.32 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.112 -0.495 . . . . 74.42 110.27 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -77.75 95.16 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.314 -0.857 . . . . 74.5 110.207 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.86 HD12 ' HB3' ' A' ' 76' ' ' GLU . 17.3 mt -63.49 -55.95 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.595 -0.729 . . . . 64.34 110.004 175.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.22 -177.19 33.1 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.398 -0.905 . . . . 51.41 112.91 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.507 HG23 ' HG2' ' A' ' 28' ' ' ARG . 22.4 mt -129.08 161.52 38.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.392 -0.966 . . . . 64.23 108.392 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.44 90.56 1.03 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.683 0.754 . . . . 71.35 109.582 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.866 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 36.6 Cg_endo -61.43 162.45 20.61 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.412 2.741 . . . . 74.22 113.864 -167.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 65.38 5.68 3.28 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.903 -1.044 . . . . 75.14 112.193 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.513 ' HB3' HG23 ' A' ' 27' ' ' VAL . 1.0 OUTLIER -77.15 -4.67 45.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.69 0.281 . . . . 64.22 111.503 179.076 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 88.6 tttt 71.24 -45.66 0.62 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.494 0.718 . . . . 71.14 110.941 -174.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 25' ' ' SER . 31.5 m -66.72 -16.73 21.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.069 0.461 . . . . 74.2 109.92 173.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.866 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 4.4 tmt_? -57.87 -37.96 74.89 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.115 -0.698 . . . . 75.21 109.115 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.456 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 6.3 tpp180 -64.82 -46.22 82.89 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 115.62 -0.718 . . . . 72.4 109.969 174.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HZ1' ' CD ' ' A' ' 69' ' ' GLU . 84.9 tttt -55.41 -48.74 73.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.609 -0.723 . . . . 71.03 110.834 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 72' ' ' ASP . 78.3 mt -59.89 -48.65 86.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.957 -0.565 . . . . 74.34 111.139 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -38.17 90.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 64.31 110.837 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.86 -32.9 74.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.788 -0.642 . . . . 74.5 111.048 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -17.74 64.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.046 -0.525 . . . . 74.22 111.09 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.25 12.51 29.05 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.513 -0.851 . . . . 71.31 112.558 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.1 mt -91.51 126.71 44.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.079 0.466 . . . . 74.05 110.035 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.11 169.79 21.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.671 -0.695 . . . . 75.42 111.014 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -61.33 109.12 1.05 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.825 -0.625 . . . . 73.35 110.562 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.67 ' HA2' ' HE3' ' A' ' 17' ' ' LYS . . . 119.64 -9.85 11.53 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.761 -0.733 . . . . 63.12 113.092 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 m -71.48 149.24 46.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.02 0.438 . . . . 75.52 110.737 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -98.08 132.77 43.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.726 -0.67 . . . . 74.13 110.147 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.443 ' HB ' HG21 ' A' ' 16' ' ' VAL . 45.0 mm -108.93 121.66 62.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.461 -0.791 . . . . 73.13 110.343 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -111.31 112.15 23.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.329 -0.619 . . . . 74.45 109.329 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 51.3 mm -75.59 121.22 26.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.351 -0.611 . . . . 75.2 109.351 176.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.56 -53.25 6.42 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.847 -0.798 . . . . 60.23 108.847 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.442 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . -172.77 179.05 44.5 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.731 -0.947 . . . . 73.4 110.731 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -118.37 156.96 28.03 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.166 -0.679 . . . . 73.13 109.166 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.27 157.37 77.76 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 110.038 -0.356 . . . . 70.21 110.038 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -59.18 -12.38 15.84 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.734 2.289 . . . . 74.13 112.77 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.5 mmt -99.89 -2.35 35.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.48 . . . . 71.33 110.486 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.01 -16.06 56.42 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.197 -0.525 . . . . 73.33 111.894 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -150.52 137.76 11.68 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 108.64 -0.874 . . . . 70.3 108.64 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.04 -164.95 4.02 Favored 'Cis proline' 0 CA--C 1.531 0.36 0 C-N-CA 123.734 -1.361 . . . . 71.1 113.25 1.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.4 mt -119.03 147.34 22.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.862 -0.608 . . . . 71.4 109.975 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.89 119.45 36.52 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.089 -0.337 . . . . 53.22 110.089 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.419 HD22 HD23 ' A' ' 7' ' ' LEU . 5.9 mp -117.04 154.65 30.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.816 0.341 . . . . 73.03 110.731 -176.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -128.28 105.13 8.13 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.337 -0.616 . . . . 74.23 109.337 170.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.481 ' N ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -142.6 160.33 40.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.197 -0.911 . . . . 74.24 109.871 -175.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? 75.15 -56.91 0.61 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.973 0.795 . . . . 72.31 109.574 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 173.91 -1.01 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.71 -0.677 . . . . 74.12 111.901 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -142.46 155.09 45.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.236 0.541 . . . . 75.34 111.956 -173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 m -86.81 135.8 33.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.312 -0.858 . . . . 73.3 111.011 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.446 HD11 HD12 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -160.36 158.38 29.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.324 -0.398 . . . . 52.43 110.197 175.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.8 t -102.76 123.77 47.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.452 0.644 . . . . 73.42 111.62 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.436 ' CD2' HD12 ' A' ' 63' ' ' LEU . 4.1 mm? -112.64 158.0 20.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.924 -1.035 . . . . 74.22 108.812 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -86.51 159.35 19.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.057 0.455 . . . . 73.45 110.521 -175.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.481 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 0.9 OUTLIER -58.95 -28.74 66.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.682 -0.69 . . . . 74.2 110.026 176.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.5 m -59.2 -46.73 87.66 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.126 -0.488 . . . . 60.01 111.248 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.419 ' CD ' ' HZ1' ' A' ' 30' ' ' LYS . 4.2 mp0 -68.43 -41.99 79.56 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.186 0.517 . . . . 74.14 110.241 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.64 -21.55 64.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.661 -0.699 . . . . 65.34 111.304 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.682 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 54.2 tttm -79.4 -18.43 52.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.348 -0.387 . . . . 75.01 110.9 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.479 ' HB3' HD12 ' A' ' 31' ' ' ILE . 4.1 t70 -97.25 -9.8 27.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.246 0.546 . . . . 75.35 110.582 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.4 mt -96.78 121.99 47.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.982 -0.554 . . . . 74.24 110.481 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.8 mt -99.34 118.65 36.45 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.865 -0.42 . . . . 62.23 109.865 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.539 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 24.1 m -124.26 159.14 30.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.423 0.63 . . . . 65.4 112.474 -173.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.86 ' HB3' HD12 ' A' ' 19' ' ' ILE . 9.3 pt-20 -111.89 138.54 48.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.215 -0.902 . . . . 61.4 110.147 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.529 ' HA ' HG13 ' A' ' 16' ' ' VAL . 43.2 t -75.06 121.49 26.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.404 -0.362 . . . . 72.25 110.267 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.71 HD13 ' HB2' ' A' ' 17' ' ' LYS . 82.2 mt -99.37 -25.07 14.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.313 0.578 . . . . 71.34 111.313 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.6 mt -96.29 113.93 25.57 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.595 -0.73 . . . . 72.05 112.405 -174.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -142.83 115.11 8.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.59 -0.732 . . . . 73.22 109.247 168.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -149.23 -75.64 0.16 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.621 -0.511 . . . . 71.33 109.621 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -173.16 83.86 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.801 -0.814 . . . . 64.53 108.801 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -54.4 134.1 45.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.25 -0.886 . . . . 71.34 112.339 -170.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.81 121.12 18.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.26 -0.882 . . . . 74.15 109.962 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -92.52 -7.87 46.08 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.702 -0.399 . . . . 73.35 110.653 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.9 m170 . . . . . 0 C--O 1.246 0.919 0 CA-C-O 118.577 -0.725 . . . . 74.55 109.229 171.908 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.795 0.331 . . . . 61.35 110.576 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.638 HG22 HG11 ' A' ' 77' ' ' VAL . 25.7 m -66.26 137.86 57.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.347 -0.388 . . . . 64.1 110.226 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.3 148.86 29.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.295 -0.411 . . . . 75.02 110.635 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.21 112.02 3.43 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.869 -0.681 . . . . 73.44 112.453 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 pt -105.45 171.77 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.451 -0.574 . . . . 64.22 109.451 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.02 156.35 35.96 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 119.974 -1.108 . . . . 60.4 111.717 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.563 HD22 HG11 ' A' ' 75' ' ' VAL . 3.0 tm? -59.88 -26.52 65.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.508 0.67 . . . . 73.33 109.718 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.52 ' HB2' ' HG2' ' A' ' 67' ' ' LYS . 9.2 p30 -73.23 -8.94 57.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.499 -0.773 . . . . 65.31 111.417 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -103.47 1.0 31.84 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.496 -0.32 . . . . 73.41 111.612 -174.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 11' ' ' GLU . 20.9 t -81.54 157.31 4.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 61.12 111.501 -174.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.416 ' N ' HG12 ' A' ' 10' ' ' VAL . 8.0 tp10 -80.59 164.77 22.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.25 -0.886 . . . . 73.44 110.127 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.0 pt -79.25 138.09 20.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.102 -0.499 . . . . 75.31 111.116 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt 59.69 44.17 14.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.534 -0.757 . . . . 73.54 111.422 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.8 t -113.67 171.13 7.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.406 -0.815 . . . . 72.23 109.692 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -129.02 113.31 15.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.207 -0.451 . . . . 65.54 109.886 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 77' ' ' VAL . 18.4 m -123.01 160.35 25.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.449 0.642 . . . . 74.3 112.252 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -106.75 144.09 33.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.747 -1.115 . . . . 74.11 110.303 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.5 t -86.12 104.05 13.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.049 -0.523 . . . . 71.52 109.731 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.6 mt -59.37 -49.46 83.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.541 -0.754 . . . . 74.21 110.33 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.24 175.34 43.52 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.777 -0.725 . . . . 54.23 112.438 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.654 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 22.0 mt -97.6 159.79 3.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.307 -0.627 . . . . 64.22 109.307 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.404 ' N ' HG23 ' A' ' 21' ' ' ILE . 45.2 t -99.42 90.84 1.27 Allowed Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 109.555 -0.535 . . . . 73.41 109.555 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.948 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 33.1 Cg_exo -58.19 167.25 4.79 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.932 3.088 . . . . 75.45 114.165 -170.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 64.59 15.99 10.02 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.79 -1.096 . . . . 71.4 110.828 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.561 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 23.3 t -87.5 165.12 15.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.607 -0.724 . . . . 73.43 110.067 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -21.83 46.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.944 -0.391 . . . . 63.34 109.944 175.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 31' ' ' ILE . 35.2 m -104.74 -3.69 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.285 -0.416 . . . . 72.13 111.554 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.948 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 3.6 tmm_? -50.73 -51.6 48.35 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.093 0.245 . . . . 62.41 110.929 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -63.85 -45.63 88.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.59 -0.277 . . . . 74.03 110.535 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -50.45 -53.48 29.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 52.43 111.129 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 73' ' ' ILE . 46.7 mm -58.68 -47.81 87.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.631 -0.713 . . . . 74.51 111.752 -177.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.599 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 4.6 ppp? -73.86 -28.17 61.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.916 0.388 . . . . 61.42 111.072 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.89 -28.65 64.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.276 0.56 . . . . 75.22 109.883 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 81.0 mtp -81.49 1.03 35.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.294 -0.866 . . . . 75.44 111.44 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.66 -7.53 53.53 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.616 -0.802 . . . . 71.33 113.132 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 32' ' ' MET . 21.6 mt -84.08 130.36 36.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.772 0.32 . . . . 64.33 110.232 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.601 HG23 ' H ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -148.05 -85.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.182 -0.463 . . . . 61.14 111.473 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.601 ' H ' HG23 ' A' ' 37' ' ' VAL . 17.9 mtp180 -145.44 131.23 19.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.232 -0.44 . . . . 75.32 109.922 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.03 -4.08 86.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.567 -0.825 . . . . 60.25 112.156 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 m -64.29 144.07 57.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.607 -0.516 . . . . 55.32 109.607 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -117.47 133.93 55.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.968 0.413 . . . . 74.52 110.94 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.832 HG12 HD13 ' A' ' 58' ' ' LEU . 74.4 mt -119.68 136.06 58.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.599 -0.728 . . . . 73.05 111.312 -174.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -98.12 116.43 30.32 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.727 -0.471 . . . . 73.11 109.727 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.526 HD12 HD21 ' A' ' 7' ' ' LEU . 50.5 mm -82.64 104.61 11.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.623 -0.51 . . . . 71.43 109.623 177.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -76.85 -34.03 57.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.91 0.386 . . . . 74.14 110.724 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.35 171.56 31.72 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.564 -0.827 . . . . 64.23 112.196 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HG2' HG22 ' A' ' 54' ' ' ILE . 40.6 mtmt -124.39 148.63 47.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.012 -0.736 . . . . 75.41 109.012 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.47 156.94 49.59 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.093 -0.336 . . . . 74.22 110.093 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.65 -14.17 25.04 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.525 2.15 . . . . 63.01 112.456 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.9 mtt -93.76 -6.17 46.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 73.4 110.205 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.67 -10.37 59.84 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.378 -0.689 . . . . 55.5 111.378 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -145.43 133.01 10.33 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 108.981 -0.748 . . . . 60.34 108.981 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -84.7 -172.32 9.18 Favored 'Cis proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.341 -1.524 . . . . 52.22 112.866 -0.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.563 HG22 ' HG2' ' A' ' 47' ' ' LYS . 59.4 mt -114.21 142.07 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.232 -0.44 . . . . 72.15 110.11 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.07 115.55 30.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.071 0.462 . . . . 75.52 110.415 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.613 HD23 HG23 ' A' ' 42' ' ' ILE . 5.7 mp -113.13 156.42 23.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.968 -0.56 . . . . 74.11 110.327 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 16.4 ttm180 -119.08 106.73 12.69 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.18 -1.044 . . . . 64.23 108.18 167.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.832 HD13 HG12 ' A' ' 42' ' ' ILE . 41.8 tp -137.36 146.75 44.9 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.579 -0.737 . . . . 73.31 110.219 -173.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.433 ' HD3' ' OH ' ' A' ' 61' ' ' TYR . 53.1 ttt180 65.67 12.48 8.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.37 -0.832 . . . . 71.24 110.646 176.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.5 -12.12 36.04 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 121.009 -0.615 . . . . 64.43 113.116 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.433 ' OH ' ' HD3' ' A' ' 59' ' ' ARG . 27.4 p90 -134.52 155.85 49.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.635 0.731 . . . . 63.21 112.448 -177.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -79.96 143.26 34.32 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.933 -1.03 . . . . 74.5 110.974 175.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -157.57 151.31 24.09 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.255 -0.646 . . . . 73.23 109.255 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -113.95 134.15 55.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.07 0.462 . . . . 70.1 110.952 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 pp -133.13 167.09 20.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.671 -0.695 . . . . 75.14 109.697 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -77.71 148.53 34.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.202 0.525 . . . . 72.43 111.766 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.52 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 14.8 tmtt? -62.31 -35.52 79.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.197 -0.911 . . . . 70.11 111.355 -176.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.2 m -67.86 -30.77 70.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.689 0.255 . . . . 73.05 111.689 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.25 -31.82 55.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.153 0.502 . . . . 61.54 109.809 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 7' ' ' LEU . . . -65.51 -21.53 66.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.758 -0.656 . . . . 72.04 110.712 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' HA ' HD21 ' A' ' 8' ' ' ASN . 0.9 OUTLIER -69.55 -30.87 68.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.853 -0.612 . . . . 73.23 110.44 176.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.8 2.63 22.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.046 -0.525 . . . . 73.24 111.399 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 31' ' ' ILE . 59.5 mt -115.98 114.96 47.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.99 -0.55 . . . . 74.5 109.81 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.0 mt -94.71 121.9 36.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.338 -0.392 . . . . 74.53 110.079 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.563 HG11 HD22 ' A' ' 7' ' ' LEU . 30.3 m -120.98 158.89 23.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.78 0.8 . . . . 63.4 112.424 -173.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.94 126.58 47.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.444 -1.253 . . . . 73.14 109.206 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.638 HG11 HG22 ' A' ' 2' ' ' THR . 11.0 p -74.59 127.07 36.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.902 -0.59 . . . . 74.2 110.51 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.2 mt -92.71 -11.23 34.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.341 0.591 . . . . 71.24 110.898 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.1 tt -81.48 79.54 8.06 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.697 -0.683 . . . . 73.31 109.24 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.84 82.16 2.37 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.363 -0.835 . . . . 74.33 109.718 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -84.7 -47.71 10.19 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.413 -1.329 . . . . 74.14 107.413 172.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -155.79 130.66 9.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.218 -1.355 . . . . 73.41 108.148 167.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -58.27 -22.24 51.78 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.215 0.322 . . . . 72.22 110.914 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 t60 67.89 89.27 0.1 Allowed 'General case' 0 C--O 1.23 0.071 0 CA-C-N 115.842 -0.617 . . . . 74.02 111.679 166.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -86.69 -39.08 16.38 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.55 -0.537 . . . . 74.12 109.55 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.0 m170 . . . . . 0 C--O 1.244 0.799 0 CA-C-N 115.379 -0.828 . . . . 65.2 109.536 175.585 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 110.069 -0.345 . . . . 70.43 110.069 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.2 p -75.6 82.54 2.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.668 0.747 . . . . 70.42 111.411 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -112.89 78.71 1.15 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.337 -0.847 . . . . 71.55 109.609 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 76' ' ' GLU . . . -120.12 125.83 6.44 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.034 -0.984 . . . . 74.04 111.956 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.3 pt -133.03 179.49 4.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.782 -0.451 . . . . 74.25 109.782 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.17 151.01 48.2 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.263 -0.97 . . . . 40.12 111.008 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.571 HD13 HD21 ' A' ' 56' ' ' LEU . 3.1 tm? -57.06 -33.15 66.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 42.41 110.461 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.433 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 9.2 p30 -77.13 -10.15 59.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.33 -0.396 . . . . 71.33 111.762 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.37 -9.81 37.47 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.975 0.417 . . . . 64.23 110.953 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.6 t -77.94 159.42 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.973 -0.558 . . . . 75.14 110.406 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.509 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 29.9 tt0 -103.42 173.97 6.07 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.146 -0.316 . . . . 74.4 110.146 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.58 HG22 ' HA2' ' A' ' 46' ' ' GLY . 40.2 pt -72.99 153.78 7.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 112.21 0.448 . . . . 71.25 112.21 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 51.4 49.24 21.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.194 -0.912 . . . . 72.44 111.998 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.459 ' HA ' HD12 ' A' ' 79' ' ' LEU . 17.9 m -134.06 152.8 52.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.282 -0.872 . . . . 73.52 109.001 174.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -109.34 140.85 42.5 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.318 -0.553 . . . . 74.54 110.254 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 77' ' ' VAL . 29.3 m -132.57 174.86 12.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.793 -0.639 . . . . 72.21 110.677 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -134.34 139.11 45.42 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.0 -0.546 . . . . 73.14 110.324 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.662 ' HA ' HG13 ' A' ' 75' ' ' VAL . 35.0 t -75.54 93.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.428 -0.805 . . . . 72.34 110.257 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.523 HD12 ' OE2' ' A' ' 76' ' ' GLU . 47.9 mm -80.94 -56.8 5.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.553 -0.749 . . . . 73.41 111.312 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.86 158.97 22.84 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.23 -0.986 . . . . 42.43 112.908 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.639 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 68.7 mt -127.43 156.34 39.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.757 -0.831 . . . . 73.52 108.757 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.5 t -103.14 90.21 2.36 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 120.748 0.309 . . . . 74.25 110.33 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.639 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 29.2 Cg_exo -61.18 171.51 3.95 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.147 2.565 . . . . 63.11 112.441 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 63.81 21.14 12.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.873 -0.603 . . . . 65.24 111.007 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.763 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 22.6 t -88.54 153.39 21.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.907 -0.588 . . . . 74.44 109.702 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -93.28 -3.1 54.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.901 0.382 . . . . 73.22 110.069 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 32.8 m -113.5 -2.42 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 116.145 -0.479 . . . . 73.21 110.537 174.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.763 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 15.0 ttp180 -54.09 -42.4 69.33 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.927 0.394 . . . . 73.33 110.285 175.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.52 -38.96 92.0 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 115.98 -0.555 . . . . 64.44 110.958 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.66 ' HG2' ' OE2' ' A' ' 69' ' ' GLU . 21.1 tptm -55.41 -54.02 48.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.294 0.568 . . . . 71.13 110.363 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.715 HG22 HD11 ' A' ' 36' ' ' ILE . 65.3 mt -62.78 -40.98 90.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.055 -0.975 . . . . 74.52 110.939 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ttt -67.65 -32.4 73.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.968 -0.56 . . . . 75.53 110.985 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -73.12 -26.29 61.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.083 -0.508 . . . . 74.45 110.114 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 60.9 mtt -69.12 -27.66 65.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.4 0.619 . . . . 61.45 110.167 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.08 18.82 11.51 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.641 -0.709 . . . . 75.43 112.12 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.715 HD11 HG22 ' A' ' 31' ' ' ILE . 39.5 mt -88.93 124.27 41.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.162 0.506 . . . . 75.11 110.118 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.01 161.12 41.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.349 -0.841 . . . . 75.13 109.438 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -64.23 121.57 14.58 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.201 -0.296 . . . . 55.12 110.201 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.97 -20.32 11.63 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.866 -0.683 . . . . 74.32 111.929 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.4 m -72.92 147.97 44.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.199 -0.297 . . . . 73.42 110.199 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -105.85 144.86 31.98 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.786 -0.45 . . . . 53.53 109.786 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.645 HG23 HD22 ' A' ' 56' ' ' LEU . 73.0 mt -129.89 128.53 65.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.209 -0.45 . . . . 63.25 111.213 -174.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.541 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 69.4 t80 -96.69 108.08 20.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.145 -0.48 . . . . 74.13 109.866 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.443 HD12 HD21 ' A' ' 7' ' ' LEU . 46.3 mm -75.68 111.75 12.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.92 -0.4 . . . . 74.03 109.92 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -73.59 -53.25 10.93 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.636 -0.505 . . . . 62.52 109.636 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.58 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 179.23 177.54 47.74 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.396 -0.82 . . . . 70.31 111.772 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -123.02 143.22 50.09 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.283 -0.636 . . . . 74.33 109.283 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . . . -59.99 156.59 36.06 Favored Pre-proline 0 C--N 1.326 -0.421 0 O-C-N 123.186 0.304 . . . . 73.24 110.206 177.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 48' ' ' ALA . 10.6 Cg_endo -54.41 -24.85 37.07 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.096 2.53 . . . . 70.21 113.105 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.5 mtt -84.41 -13.33 52.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.117 0.484 . . . . 72.3 110.796 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.82 -2.68 80.26 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.338 -0.705 . . . . 43.45 111.338 -173.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.746 ' HB2' ' HB2' ' A' ' 67' ' ' LYS . 5.4 t70 -151.15 135.17 9.46 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.267 -0.642 . . . . 74.31 109.267 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -82.67 179.91 25.14 Favored 'Cis proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.564 -1.432 . . . . 74.41 112.436 -1.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.02 141.71 23.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.327 -0.62 . . . . 62.02 109.327 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.84 113.38 26.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.985 0.421 . . . . 74.12 110.834 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.645 HD22 HG23 ' A' ' 42' ' ' ILE . 2.2 mp -117.43 133.85 55.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.04 -0.527 . . . . 72.23 110.201 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.721 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 46.3 ttt180 -97.47 105.48 17.63 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.887 -0.782 . . . . 72.35 108.887 173.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.536 ' HB3' HG12 ' A' ' 42' ' ' ILE . 3.3 pp -139.86 151.71 45.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.279 -0.419 . . . . 73.33 110.75 -174.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 71.44 -19.93 0.24 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.065 0.546 . . . . 73.11 111.703 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 150.58 -26.65 1.07 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.27 -0.49 . . . . 73.24 112.212 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -140.85 166.86 23.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.001 0.429 . . . . 74.5 111.182 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.721 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.3 m -85.58 138.45 32.17 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.107 -0.497 . . . . 61.43 111.871 -176.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.9 mt -134.54 159.06 42.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.558 -0.746 . . . . 75.25 109.471 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p -104.73 122.2 45.2 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.154 0.502 . . . . 74.1 111.361 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.9 tp -109.19 145.47 35.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.861 -0.609 . . . . 62.54 109.504 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 66' ' ' ARG . 8.8 mmm180 -77.53 149.3 34.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.601 0.239 . . . . 75.14 110.541 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.746 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 13.3 tmtt? -57.81 -36.96 72.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 62.43 110.646 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.3 m -62.84 -48.1 80.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.97 -0.559 . . . . 75.12 110.49 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.66 ' OE2' ' HG2' ' A' ' 30' ' ' LYS . 36.9 mt-10 -67.13 -30.96 71.1 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.788 -0.642 . . . . 73.41 110.551 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 8' ' ' ASN . . . -60.68 -21.26 62.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.316 -0.856 . . . . 71.33 111.876 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -81.31 -23.73 37.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.926 0.394 . . . . 75.22 110.532 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.34 -5.45 47.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.073 -0.512 . . . . 61.4 111.445 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.516 HG21 HG12 ' A' ' 75' ' ' VAL . 43.8 mm -122.22 126.22 73.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.516 -0.311 . . . . 71.22 110.772 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.1 mt -108.15 120.79 43.36 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.052 -0.522 . . . . 72.54 109.969 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.662 HG13 ' HA ' ' A' ' 18' ' ' VAL . 22.0 m -126.47 151.26 32.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.127 -0.488 . . . . 71.44 111.531 -173.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.523 ' OE2' HD12 ' A' ' 19' ' ' ILE . 14.6 pt-20 -91.39 138.78 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.437 -0.579 . . . . 73.53 109.437 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.633 ' HA ' HG12 ' A' ' 16' ' ' VAL . 24.3 t -87.64 109.9 20.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 120.916 0.388 . . . . 63.45 110.454 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.3 mt -78.56 -25.59 45.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.318 0.58 . . . . 45.54 110.695 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 14' ' ' SER . 62.4 mt -111.51 83.94 1.86 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.543 -0.753 . . . . 53.24 110.993 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -136.3 130.94 33.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.685 -0.689 . . . . 75.14 109.389 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -134.29 89.18 2.53 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.692 -0.855 . . . . 72.3 108.692 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -49.14 109.82 0.3 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.069 -0.969 . . . . 75.25 113.601 -169.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -135.74 -80.66 0.42 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.07 -0.968 . . . . 75.32 109.605 169.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -102.16 58.94 0.82 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.371 -0.603 . . . . 63.53 109.371 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -164.64 102.01 0.81 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.572 -0.74 . . . . 74.33 110.443 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 . . . . . 0 C--O 1.245 0.862 0 CA-C-O 118.122 -0.942 . . . . 75.21 109.867 175.915 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.0 ttp . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.854 -0.424 . . . . 73.11 109.854 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.5 m -96.64 132.07 42.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.615 -0.513 . . . . 62.41 109.615 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -126.82 98.12 5.24 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.849 -0.426 . . . . 72.12 109.849 -176.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.454 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . -67.03 108.71 2.55 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.787 -0.642 . . . . 64.13 112.812 -177.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.4 pt -101.67 160.83 3.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.614 -0.513 . . . . 63.21 109.614 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.01 147.53 30.59 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.142 -1.028 . . . . 54.31 111.283 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.698 HD12 HD11 ' A' ' 44' ' ' ILE . 36.9 tp -60.01 -26.81 66.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.017 0.437 . . . . 73.22 110.853 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.423 ' ND2' ' HA ' ' A' ' 71' ' ' LYS . 9.2 p30 -78.14 -9.8 59.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.148 -0.478 . . . . 73.01 111.011 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -90.34 -13.96 34.08 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.16 0.505 . . . . 75.42 109.932 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.5 t -77.86 154.88 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.613 -0.721 . . . . 71.14 110.49 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -103.76 170.87 7.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.741 -0.663 . . . . 73.41 110.278 -175.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.3 pt -71.72 146.91 11.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.012 -0.54 . . . . 72.44 111.116 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 13' ' ' LYS . 33.7 ttmt 59.04 63.96 1.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.8 0.81 . . . . 75.52 110.333 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 m -136.0 151.2 49.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.034 -0.985 . . . . 72.43 109.836 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -118.14 110.88 18.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.136 0.493 . . . . 72.52 110.017 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.576 HG11 ' HA ' ' A' ' 77' ' ' VAL . 27.0 m -123.69 167.38 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.719 -0.673 . . . . 75.22 111.801 -173.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.589 ' HB2' HD21 ' A' ' 78' ' ' LEU . 81.0 tttt -117.96 145.83 44.42 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.094 -0.957 . . . . 61.33 110.126 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.569 ' HA ' HG13 ' A' ' 75' ' ' VAL . 45.9 t -82.15 97.96 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.131 -0.486 . . . . 65.1 110.266 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.845 HD13 ' HB2' ' A' ' 76' ' ' GLU . 42.6 mt -61.03 -48.59 88.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.816 -0.629 . . . . 70.44 109.991 175.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.68 160.73 31.03 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.489 -0.778 . . . . 62.03 112.31 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.689 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 58.5 mt -98.04 157.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.164 -0.68 . . . . 74.22 109.164 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.9 t -102.45 89.71 1.85 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 120.982 0.42 . . . . 72.5 110.144 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.904 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 21.1 Cg_exo -64.93 170.05 10.86 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.026 2.484 . . . . 71.51 112.367 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 64.25 7.55 3.59 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.638 -0.71 . . . . 75.24 111.879 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.595 ' O ' ' HB3' ' A' ' 28' ' ' ARG . 1.3 m -91.7 154.19 19.15 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.648 -0.871 . . . . 75.14 108.648 170.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -69.61 -45.59 68.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.702 0.287 . . . . 62.33 111.065 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.525 ' HB ' ' HG3' ' A' ' 69' ' ' GLU . 24.5 m -78.03 -6.79 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.065 0.46 . . . . 62.44 110.815 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.904 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -57.07 -36.7 70.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.682 -0.69 . . . . 65.05 111.373 178.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -67.23 -39.27 86.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.117 0.484 . . . . 72.2 110.007 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.531 ' HG2' ' HE1' ' A' ' 34' ' ' MET . 85.3 tttt -63.12 -46.67 86.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.384 -0.826 . . . . 72.24 110.107 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 27' ' ' VAL . 68.9 mt -57.55 -48.2 83.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.603 -0.726 . . . . 71.32 111.445 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.61 -37.19 85.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.958 0.409 . . . . 60.31 110.81 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.26 -30.99 69.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 61.41 110.562 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.769 ' HE3' ' HB3' ' A' ' 65' ' ' LEU . 62.0 mtt -58.6 -32.29 68.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.047 -0.524 . . . . 73.22 110.887 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.41 1.82 7.71 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.617 -0.802 . . . . 64.53 112.208 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.442 HG22 HG23 ' A' ' 18' ' ' VAL . 63.1 mt -84.65 133.1 30.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.873 0.368 . . . . 64.32 110.31 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.744 HG23 ' H ' ' A' ' 38' ' ' ARG . 1.4 m -129.04 -74.86 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.911 -0.586 . . . . 74.11 111.03 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.744 ' H ' HG23 ' A' ' 37' ' ' VAL . 49.2 ttp180 -169.12 138.29 2.09 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.22 -0.659 . . . . 73.3 109.22 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.04 17.22 77.0 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.578 -0.82 . . . . 63.24 111.671 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 m -81.44 151.03 28.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.936 -0.394 . . . . 72.52 109.936 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -95.62 133.32 39.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.898 0.38 . . . . 63.35 110.728 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.4 mt -123.55 116.06 47.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.803 -0.635 . . . . 71.11 110.381 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.522 ' HE2' ' HG2' ' A' ' 45' ' ' GLU . 44.5 t80 -95.15 108.06 20.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.007 -0.542 . . . . 73.43 109.569 174.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.698 HD11 HD12 ' A' ' 7' ' ' LEU . 49.1 mm -75.3 105.87 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.119 -0.697 . . . . 74.35 109.119 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.522 ' HG2' ' HE2' ' A' ' 43' ' ' TYR . 0.4 OUTLIER -73.83 -61.14 1.95 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.123 -0.695 . . . . 72.24 109.123 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.01 162.56 35.9 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.649 -0.786 . . . . 73.11 112.203 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -125.52 153.0 44.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.202 -0.666 . . . . 70.35 109.202 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.72 156.42 89.12 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.589 -0.522 . . . . 72.34 109.589 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.68 -35.39 57.37 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.701 2.267 . . . . 75.11 112.574 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 tpt -65.43 -22.85 66.81 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.182 0.515 . . . . 75.14 111.264 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.27 -2.98 63.67 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 111.024 -0.831 . . . . 40.5 111.024 -174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -143.32 132.75 11.71 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.996 -0.742 . . . . 72.02 108.996 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -89.56 176.63 20.01 Favored 'Cis proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.704 -1.373 . . . . 74.02 113.023 0.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.6 mp -105.75 130.97 56.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.728 -0.669 . . . . 75.35 109.804 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.66 113.6 26.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.501 -0.318 . . . . 74.24 110.248 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.596 HD23 HD22 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -129.49 172.15 11.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.459 -0.337 . . . . 74.42 110.938 -178.029 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.658 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 35.4 ttm180 -129.23 117.24 20.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.841 -0.429 . . . . 71.54 109.841 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -135.95 148.7 48.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.54 -0.3 . . . . 71.55 110.58 -177.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.6 tpt85 69.09 -19.59 0.17 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.22 0.608 . . . . 72.22 111.997 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 143.34 -24.27 2.2 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.606 -0.598 . . . . 44.25 111.606 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -115.49 156.76 25.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.098 0.475 . . . . 75.44 111.401 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.658 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 46.7 t -93.8 146.81 23.61 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.751 -0.659 . . . . 63.21 110.477 176.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.3 mt -144.82 160.25 41.57 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.284 -0.871 . . . . 74.03 109.571 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.8 t -118.89 128.04 54.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.679 -0.489 . . . . 54.44 109.679 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.769 ' HB3' ' HE3' ' A' ' 34' ' ' MET . 2.0 pp -125.94 166.91 16.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.251 -0.432 . . . . 72.02 111.268 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.58 163.11 24.9 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.562 -0.745 . . . . 73.01 111.191 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.81 -22.39 64.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.404 -0.816 . . . . 62.12 109.998 174.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.2 m -66.14 -50.97 62.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.815 -0.629 . . . . 75.21 110.99 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.525 ' HG3' ' HB ' ' A' ' 27' ' ' VAL . 1.6 mp0 -58.26 -40.73 82.59 Favored 'General case' 0 N--CA 1.46 0.066 0 CA-C-O 121.075 0.464 . . . . 71.44 110.359 175.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.03 -21.66 65.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.85 -0.614 . . . . 61.21 111.511 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.423 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 1.2 tmmt? -83.25 -32.29 26.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.285 -0.416 . . . . 65.3 110.633 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -96.95 9.33 42.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.285 0.476 . . . . 73.03 112.285 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.505 HG21 HG12 ' A' ' 75' ' ' VAL . 79.9 mt -113.24 120.85 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.22 -0.289 . . . . 73.11 110.22 174.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.0 mt -105.56 121.37 43.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.251 -0.431 . . . . 70.41 109.95 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.569 HG13 ' HA ' ' A' ' 18' ' ' VAL . 23.6 m -132.54 174.59 13.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.027 -0.533 . . . . 73.13 111.643 -174.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.845 ' HB2' HD13 ' A' ' 19' ' ' ILE . 35.4 tt0 -143.14 145.08 32.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.271 -0.877 . . . . 52.44 108.891 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.608 HG22 ' H ' ' A' ' 79' ' ' LEU . 11.1 p -71.92 141.01 17.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.0 0.429 . . . . 71.34 110.661 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 17' ' ' LYS . 68.1 mt -85.75 -0.18 54.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.116 -0.493 . . . . 75.4 111.527 -178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.608 ' H ' HG22 ' A' ' 77' ' ' VAL . 3.9 tt -72.46 90.24 1.3 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.702 -0.681 . . . . 75.21 110.147 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 68.51 120.25 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 O-C-N 124.126 0.891 . . . . 74.55 111.153 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -83.66 35.34 0.51 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.043 -0.526 . . . . 73.35 110.89 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -136.25 121.99 19.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.239 -0.652 . . . . 73.21 109.239 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -88.84 104.29 16.79 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.37 0.605 . . . . 75.1 111.726 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -87.62 75.64 9.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.37 -0.832 . . . . 74.41 109.19 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -79.09 -3.19 44.15 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.681 -0.69 . . . . 74.43 112.148 -173.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.267 -0.873 . . . . 75.31 109.696 173.188 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.809 ' HA ' ' HE3' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.767 -0.457 . . . . 64.31 109.767 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.8 m -79.33 105.58 10.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.914 0.388 . . . . 75.41 111.207 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -138.63 120.44 15.34 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.627 -0.508 . . . . 74.42 109.627 174.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.92 145.49 16.19 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.445 -0.883 . . . . 74.34 112.154 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.1 pt -109.84 169.91 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.757 -0.46 . . . . 72.23 109.757 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.95 158.21 46.14 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.11 -1.043 . . . . 65.23 111.294 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.3 tp -65.81 -18.39 65.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.761 0.315 . . . . 71.2 111.214 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.487 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 33.8 p30 -92.63 0.16 57.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.797 0.332 . . . . 53.21 111.311 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.48 5.98 31.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.926 0.393 . . . . 65.42 110.684 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 t -88.72 157.34 3.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.01 0.433 . . . . 54.13 110.951 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -101.74 164.55 11.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.663 -0.698 . . . . 71.11 110.166 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.429 HG22 ' HA2' ' A' ' 46' ' ' GLY . 36.2 pt -75.87 166.53 2.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.951 -0.568 . . . . 63.11 111.16 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.3 mttm 65.91 9.42 6.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.783 -0.644 . . . . 74.5 111.41 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 m -111.7 148.23 33.88 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.226 -0.443 . . . . 71.02 110.811 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -105.73 123.93 48.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.812 -0.631 . . . . 74.13 109.496 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 m -119.17 167.81 12.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.132 -0.485 . . . . 73.22 110.57 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.54 ' HB2' HD23 ' A' ' 78' ' ' LEU . 84.3 tttt -133.58 141.12 47.54 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.768 -0.651 . . . . 73.42 109.982 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.559 ' HA ' HG11 ' A' ' 75' ' ' VAL . 43.4 t -76.52 95.74 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.377 -0.829 . . . . 73.31 110.2 -177.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.76 HD11 ' HB2' ' A' ' 76' ' ' GLU . 36.2 mt -57.46 -49.83 79.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.569 -0.741 . . . . 62.34 109.639 174.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.559 ' HA2' ' HG2' ' A' ' 38' ' ' ARG . . . -173.26 164.57 36.44 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.659 -0.781 . . . . 62.23 112.622 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.69 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 37.9 mt -85.38 158.97 3.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.733 -0.84 . . . . 74.52 108.733 176.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.3 91.71 1.84 Allowed Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.679 -0.489 . . . . 61.42 109.679 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.69 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 72.1 Cg_exo -49.62 169.08 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 124.226 3.284 . . . . 70.41 114.073 -173.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 66.27 19.93 11.04 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.953 -1.021 . . . . 73.43 109.302 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.993 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 42.1 t -84.03 152.06 24.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.489 -1.232 . . . . 61.14 110.248 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 11.1 mptt -98.11 -23.56 15.68 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.159 -0.682 . . . . 65.2 109.159 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -97.25 -7.81 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.559 -0.746 . . . . 62.42 111.039 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.993 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 8.4 tmm_? -46.77 -47.92 20.71 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.079 0.4 . . . . 75.21 112.079 176.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -70.27 -28.47 65.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.962 0.41 . . . . 71.01 110.455 -177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -73.46 -48.26 34.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.726 -0.67 . . . . 50.4 110.364 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.507 HD13 HD11 ' A' ' 73' ' ' ILE . 85.7 mt -60.5 -42.1 90.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.525 -0.761 . . . . 74.23 111.182 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ttt -65.9 -30.1 70.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 74.51 110.579 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.75 -32.88 70.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.889 -0.596 . . . . 73.21 110.146 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.8 mtt -63.24 -29.07 70.48 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.934 -0.576 . . . . 74.14 110.43 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.5 5.1 12.92 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.79 -0.641 . . . . 74.44 112.365 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.488 ' HB ' HG21 ' A' ' 31' ' ' ILE . 43.3 mt -90.42 126.59 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.992 0.425 . . . . 72.42 110.436 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.1 m -141.1 -177.67 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.489 -0.778 . . . . 65.32 110.268 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.559 ' HG2' ' HA2' ' A' ' 20' ' ' GLY . 46.0 mtt85 -69.78 114.75 8.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 72.42 110.313 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.39 -8.67 22.5 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.534 -0.841 . . . . 63.14 112.812 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 m -70.41 142.69 52.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.041 0.448 . . . . 72.42 110.412 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -106.45 137.47 44.37 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.61 -0.723 . . . . 72.13 110.218 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.739 HG12 ' HB3' ' A' ' 58' ' ' LEU . 66.1 mt -129.5 131.41 67.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.71 -0.677 . . . . 71.25 111.293 -172.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.527 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 53.3 t80 -96.95 125.9 41.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.696 -0.483 . . . . 64.11 109.696 171.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.6 mm -87.24 99.48 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.574 -0.528 . . . . 73.23 109.574 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.15 -41.94 24.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.653 -0.703 . . . . 65.02 110.497 -176.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 172.74 -172.91 45.32 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.432 -0.667 . . . . 65.35 111.432 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.838 ' HE2' ' HA2' ' A' ' 51' ' ' GLY . 13.9 ptmt -151.0 165.89 32.36 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.246 -0.65 . . . . 73.03 109.246 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.47 156.42 82.23 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.771 -0.455 . . . . 64.01 109.771 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.49 -32.14 51.71 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.797 2.331 . . . . 74.54 113.086 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 45.5 ttm -86.6 -8.67 57.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.426 0.631 . . . . 75.14 110.367 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.838 ' HA2' ' HE2' ' A' ' 47' ' ' LYS . . . 95.71 -11.27 68.35 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.618 -0.719 . . . . 52.43 112.477 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -131.87 127.53 21.26 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-O 120.841 0.353 . . . . 71.14 110.271 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -83.61 170.33 53.17 Favored 'Cis proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.918 -1.701 . . . . 60.43 112.718 -1.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.492 HG23 ' HB3' ' A' ' 47' ' ' LYS . 41.0 mt -98.57 141.99 15.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.849 -0.797 . . . . 75.42 108.849 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.99 102.9 14.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.033 0.444 . . . . 74.34 110.313 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.716 HD21 HG23 ' A' ' 42' ' ' ILE . 4.5 mp -108.4 162.01 14.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.0 -0.545 . . . . 65.0 109.941 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.681 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 75.3 ttt180 -132.51 100.66 5.04 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.878 -0.786 . . . . 63.14 108.878 173.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.739 ' HB3' HG12 ' A' ' 42' ' ' ILE . 2.9 pp -127.36 149.76 49.91 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.827 -0.624 . . . . 73.11 110.856 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.456 ' HD3' ' OH ' ' A' ' 61' ' ' TYR . 52.4 ttt180 70.26 -22.44 0.17 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.532 0.52 . . . . 72.42 112.13 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 141.52 -3.58 2.13 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.927 -0.654 . . . . 61.43 112.141 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.456 ' OH ' ' HD3' ' A' ' 59' ' ' ARG . 16.9 p90 -138.28 158.33 44.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.162 0.506 . . . . 72.41 111.328 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.681 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 34.8 t -87.14 147.15 25.75 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.532 -0.758 . . . . 73.45 110.126 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 54.1 tp -155.52 147.73 23.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.579 -0.737 . . . . 75.01 109.775 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 4.1 m -97.48 133.55 41.91 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.07 0.462 . . . . 63.31 110.71 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.685 HD22 HD12 ' A' ' 56' ' ' LEU . 3.8 mm? -123.09 150.12 43.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.609 -0.723 . . . . 70.43 110.178 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 66' ' ' ARG . 22.9 mmt180 -81.87 161.44 23.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.141 0.496 . . . . 71.03 111.222 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.39 -36.89 85.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 71.4 110.898 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.9 m -70.33 -43.27 70.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.442 . . . . 54.1 111.005 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.15 -35.07 79.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.261 0.553 . . . . 73.2 110.482 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 8' ' ' ASN . . . -68.03 -22.19 64.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.525 -0.761 . . . . 71.14 111.358 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -76.36 -29.23 57.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.168 0.508 . . . . 73.22 110.267 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.11 9.18 5.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.751 -0.659 . . . . 62.32 111.629 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.507 HD11 HD13 ' A' ' 31' ' ' ILE . 62.5 mt -128.23 131.27 69.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.327 -0.397 . . . . 64.23 110.55 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.2 mt -107.23 125.71 51.47 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.275 -0.421 . . . . 72.23 109.87 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 18' ' ' VAL . 27.4 m -129.81 160.31 40.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.307 0.575 . . . . 62.04 111.948 -175.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.76 ' HB2' HD11 ' A' ' 19' ' ' ILE . 6.5 tp10 -120.76 146.6 46.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.956 -1.02 . . . . 72.31 109.104 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.549 HG22 ' H ' ' A' ' 79' ' ' LEU . 10.0 p -91.09 133.63 32.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.911 0.386 . . . . 74.52 110.094 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' A' ' 17' ' ' LYS . 4.0 mm? -78.01 -18.22 56.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.09 0.471 . . . . 74.05 111.342 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.549 ' H ' HG22 ' A' ' 77' ' ' VAL . 89.1 mt -72.6 149.0 44.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.587 -0.733 . . . . 75.23 109.776 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 82' ' ' HIS . 2.6 mp0 -52.06 136.07 30.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.542 0.527 . . . . 71.34 110.564 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -77.58 38.49 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.163 0.506 . . . . 75.02 111.69 -175.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.447 ' H ' ' C ' ' A' ' 80' ' ' GLU . 61.8 t60 -151.45 -25.58 0.2 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.29 -0.868 . . . . 74.23 108.743 174.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -66.66 -29.64 69.71 Favored 'General case' 0 N--CA 1.46 0.033 0 CA-C-N 115.605 -0.725 . . . . 74.34 109.152 173.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.3 99.66 8.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.939 -0.763 . . . . 74.21 108.939 174.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -107.07 -40.73 5.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.668 -0.697 . . . . 75.31 112.246 -169.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 . . . . . 0 C--O 1.246 0.872 0 N-CA-C 109.079 -0.712 . . . . 75.53 109.079 -167.503 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.9 mtt . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 110.02 -0.363 . . . . 74.53 110.02 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.5 m -73.37 104.58 4.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.295 -0.411 . . . . 74.32 111.203 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -132.89 158.65 42.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.797 -0.446 . . . . 62.31 109.797 173.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.61 153.99 26.14 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.844 -0.693 . . . . 74.12 112.046 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 pt -124.89 179.41 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.389 -0.597 . . . . 75.32 109.389 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.42 154.13 41.91 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.464 -1.35 . . . . 61.44 111.598 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.9 tp -60.67 -27.56 67.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.964 0.411 . . . . 70.14 110.796 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -71.86 -15.16 62.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 53.41 111.533 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.26 -3.9 54.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.877 0.37 . . . . 74.12 110.823 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.7 t -90.36 159.39 2.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.345 -0.389 . . . . 64.44 110.375 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.63 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 22.1 tt0 -98.29 171.97 7.86 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.502 -0.555 . . . . 75.14 109.502 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.63 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 38.4 pt -79.83 177.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.457 -0.338 . . . . 61.54 110.474 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 pttm 52.79 21.16 1.83 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.414 1.085 . . . . 73.31 112.423 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.2 m -121.53 153.03 38.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.8 0.334 . . . . 62.51 110.726 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.464 ' HZ2' ' HA ' ' A' ' 79' ' ' LEU . 23.1 pttp -108.97 132.0 54.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.081 0.467 . . . . 71.14 109.843 176.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.831 HG13 ' HA ' ' A' ' 77' ' ' VAL . 33.7 m -129.79 162.51 37.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.696 -0.684 . . . . 72.35 110.495 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.431 ' HB3' HD12 ' A' ' 78' ' ' LEU . 39.0 ttmt -115.6 143.86 44.73 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.281 -0.872 . . . . 73.21 109.231 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.806 ' HA ' HG11 ' A' ' 75' ' ' VAL . 53.8 t -73.53 95.87 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.855 -0.611 . . . . 72.14 109.947 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.4 mm -64.84 -40.98 90.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.247 -0.888 . . . . 72.14 109.891 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.97 -178.36 44.77 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.466 -0.873 . . . . 74.53 112.334 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.695 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 48.9 mt -128.34 159.3 39.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.364 -0.976 . . . . 70.21 108.364 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -100.1 90.81 1.44 Allowed Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.864 0.364 . . . . 55.24 110.157 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.695 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 17.5 Cg_exo -65.23 -178.56 0.86 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.335 2.69 . . . . 73.11 112.903 -173.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 61.97 25.52 15.32 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.816 0.817 . . . . 64.41 109.77 -173.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.839 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 10.8 t -115.02 150.66 35.5 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.59 -1.186 . . . . 72.42 109.64 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 3.8 mppt? -81.63 -32.73 31.81 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.597 -0.52 . . . . 73.05 109.597 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 31' ' ' ILE . 27.2 m -79.22 -19.95 12.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 64.22 110.652 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.839 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 5.7 tmm_? -52.28 -43.37 64.39 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.076 0.465 . . . . 74.45 109.826 172.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -59.41 -47.35 85.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.459 -0.792 . . . . 64.5 110.42 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 34' ' ' MET . 87.0 tttt -57.39 -47.19 82.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.209 -0.905 . . . . 71.45 111.028 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.492 HG23 ' HB ' ' A' ' 36' ' ' ILE . 75.9 mt -58.18 -44.77 88.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.566 -0.743 . . . . 73.44 111.409 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 55.2 mtt -71.59 -28.76 64.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.466 -0.334 . . . . 75.44 111.179 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.2 -31.96 72.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.237 0.541 . . . . 75.14 110.003 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 97.6 mmm -73.64 -9.18 58.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.462 -0.79 . . . . 74.22 111.057 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.5 -3.38 46.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.771 -0.728 . . . . 54.11 112.508 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.648 HG23 HG21 ' A' ' 18' ' ' VAL . 58.7 mt -88.06 129.72 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.911 0.386 . . . . 65.11 110.403 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.722 HG22 ' H ' ' A' ' 38' ' ' ARG . 1.0 OUTLIER -144.21 -75.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.837 -0.62 . . . . 75.24 111.437 -178.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.722 ' H ' HG22 ' A' ' 37' ' ' VAL . 24.7 ttt180 -150.86 140.18 21.34 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.602 -0.518 . . . . 73.11 109.602 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.06 19.25 69.82 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.776 -0.726 . . . . 54.3 112.106 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 m -85.28 146.72 26.91 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.948 -0.39 . . . . 65.22 109.948 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -90.99 127.8 36.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.866 0.365 . . . . 74.14 111.067 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.8 mm -126.22 114.87 40.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.44 -0.8 . . . . 75.25 109.609 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.806 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 39.3 t80 -106.3 119.34 38.99 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.559 -0.534 . . . . 75.12 109.559 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.427 HD12 HD12 ' A' ' 56' ' ' LEU . 14.6 mm -82.01 99.18 4.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.297 -0.41 . . . . 74.22 110.029 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -82.95 -22.58 33.73 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.154 -0.618 . . . . 73.42 110.364 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.79 -173.93 34.47 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.81 -0.71 . . . . 74.33 112.139 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.757 ' HG2' HG23 ' A' ' 54' ' ' ILE . 53.1 mtpt -126.8 160.3 31.28 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.442 -0.577 . . . . 53.32 109.442 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.18 151.23 94.24 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.712 -0.477 . . . . 51.44 109.712 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -51.4 -30.81 35.91 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.965 2.443 . . . . 61.43 113.215 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.0 tpt -76.09 -19.85 58.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.121 0.486 . . . . 65.01 111.223 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.58 -7.6 57.95 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.213 -0.755 . . . . 42.42 111.213 -174.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -152.42 132.61 7.35 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 108.9 -0.778 . . . . 74.24 108.9 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.71 -172.52 10.31 Favored 'Cis proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.567 -1.431 . . . . 53.44 112.98 0.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.757 HG23 ' HG2' ' A' ' 47' ' ' LYS . 53.5 mt -109.02 141.85 23.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.764 -0.653 . . . . 73.22 109.325 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.12 106.2 18.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.962 0.41 . . . . 70.42 110.998 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -105.72 135.77 46.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.132 -0.486 . . . . 71.12 110.059 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.806 ' HB3' ' HB3' ' A' ' 43' ' ' TYR . 2.3 tmt_? -86.56 114.37 23.24 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.794 -0.817 . . . . 72.4 108.794 175.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.6 tp -136.57 146.82 46.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.726 -0.67 . . . . 74.21 110.271 -175.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 71.05 -56.75 0.62 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.487 0.715 . . . . 65.0 110.762 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.51 -36.94 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.41 -0.676 . . . . 51.44 111.41 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.434 ' HE2' HD22 ' A' ' 63' ' ' LEU . 29.6 p90 -124.34 176.59 6.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.759 0.314 . . . . 74.23 110.4 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.801 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -93.11 140.81 29.11 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.491 0.552 . . . . 63.44 112.491 -175.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.434 HD22 ' HE2' ' A' ' 61' ' ' TYR . 75.6 mt -137.04 148.12 46.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.267 -0.879 . . . . 73.12 109.28 174.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 5.7 p -88.52 128.68 35.56 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.291 0.567 . . . . 72.31 111.829 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -121.5 157.76 29.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.253 -1.017 . . . . 73.42 108.253 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -80.22 156.34 26.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.56 0.695 . . . . 73.11 112.159 -169.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.708 ' HZ3' ' HB3' ' A' ' 67' ' ' LYS . 6.6 ttpm? -57.46 -28.19 63.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.669 -1.151 . . . . 71.24 110.975 174.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.1 m -61.25 -51.82 67.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.858 -0.61 . . . . 75.44 110.395 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' O ' HG13 ' A' ' 73' ' ' ILE . 1.7 mp0 -63.52 -30.54 71.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.94 -0.573 . . . . 72.21 111.111 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.16 -21.79 62.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.335 -0.393 . . . . 70.52 111.69 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.08 -42.45 38.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.398 0.618 . . . . 72.43 109.642 177.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.09 -10.37 53.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.392 -0.822 . . . . 71.43 112.018 -170.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.505 HG21 HG13 ' A' ' 75' ' ' VAL . 74.2 mt -90.27 113.09 25.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.923 -0.399 . . . . 74.03 109.923 174.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.5 mt -97.01 112.07 24.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.243 0.545 . . . . 71.33 110.484 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.806 HG11 ' HA ' ' A' ' 18' ' ' VAL . 29.4 m -132.34 167.7 25.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.758 -0.655 . . . . 72.4 110.203 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -140.23 145.96 38.04 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.123 -0.695 . . . . 74.4 109.123 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.831 ' HA ' HG13 ' A' ' 16' ' ' VAL . 47.9 t -67.88 103.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.019 -0.537 . . . . 63.25 110.415 -177.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.431 HD12 ' HB3' ' A' ' 17' ' ' LYS . 26.6 mt -102.39 5.42 39.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.759 -0.655 . . . . 71.04 111.184 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.464 ' HA ' ' HZ2' ' A' ' 15' ' ' LYS . 4.7 tt -58.82 112.79 1.77 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.556 -1.276 . . . . 72.5 107.556 167.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -33.88 95.46 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 124.689 1.243 . . . . 71.25 113.74 -169.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -130.23 78.53 1.85 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.527 -1.215 . . . . 75.44 108.284 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.433 ' O ' ' HB3' ' A' ' 83' ' ' HIS . 33.3 t60 -66.14 130.0 41.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.31 -0.859 . . . . 74.04 109.821 -175.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.433 ' HB3' ' O ' ' A' ' 82' ' ' HIS . 18.9 t-80 70.22 97.25 0.07 Allowed 'General case' 0 CA--C 1.535 0.377 0 O-C-N 123.829 0.706 . . . . 74.3 109.11 -174.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -49.29 -56.31 9.85 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.293 -0.867 . . . . 63.34 113.024 -169.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -132.19 137.69 47.7 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.751 -0.379 . . . . 63.15 110.372 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.312 -0.852 . . . . 73.03 110.419 175.919 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptp . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.608 0.242 . . . . 73.44 111.22 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.2 p -79.79 75.44 6.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.418 0.628 . . . . 75.12 111.783 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -142.86 98.73 3.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.231 -0.895 . . . . 74.11 109.934 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.43 123.15 2.82 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.505 -0.77 . . . . 71.42 111.441 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.7 pt -107.88 163.07 5.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 110.176 -0.305 . . . . 73.24 110.176 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.26 157.83 53.51 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.732 -0.747 . . . . 61.01 111.755 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.492 HD23 HD12 ' A' ' 56' ' ' LEU . 52.4 tp -61.52 -23.47 65.95 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.938 0.399 . . . . 74.3 111.195 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -87.15 -7.12 58.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.562 -0.29 . . . . 65.44 111.192 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -95.97 0.14 51.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.913 0.387 . . . . 71.15 110.67 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.606 HG13 HG11 ' A' ' 16' ' ' VAL . 12.1 t -90.0 163.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 74.22 110.812 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.437 ' N ' HG12 ' A' ' 10' ' ' VAL . 30.4 tt0 -83.53 165.12 19.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.259 -0.428 . . . . 62.31 109.988 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.439 HG13 ' HZ3' ' A' ' 13' ' ' LYS . 19.7 pt -85.93 163.18 2.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.076 -0.511 . . . . 54.1 110.826 -177.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.439 ' HZ3' HG13 ' A' ' 12' ' ' ILE . 37.6 mtmm 59.45 25.21 13.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.005 0.431 . . . . 73.31 111.301 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.7 m -108.87 159.95 16.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.182 -0.463 . . . . 71.4 110.511 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.566 ' H ' HD11 ' A' ' 79' ' ' LEU . 42.2 tttm -116.48 119.23 34.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.716 -0.846 . . . . 74.05 108.716 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.606 HG11 HG13 ' A' ' 10' ' ' VAL . 28.8 m -125.19 155.86 34.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.038 0.447 . . . . 64.41 112.011 -170.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -117.4 142.63 46.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.478 -0.783 . . . . 73.41 110.27 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.795 ' HA ' HG13 ' A' ' 75' ' ' VAL . 68.0 t -83.06 97.68 4.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.735 -0.666 . . . . 63.11 110.617 -176.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.4 mt -58.09 -54.38 33.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.2 -0.909 . . . . 71.54 110.358 173.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.36 165.66 34.46 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.375 -0.917 . . . . 37.46 113.076 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 22' ' ' VAL . 58.6 mt -119.75 158.8 21.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.879 -0.786 . . . . 70.15 108.879 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 25' ' ' SER . 62.0 t -99.96 91.75 1.75 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.018 0.437 . . . . 74.01 110.028 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.685 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 37.6 Cg_endo -62.53 171.23 5.81 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.211 2.607 . . . . 37.46 113.308 -173.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 66.1 -15.73 0.12 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.004 0.922 . . . . 74.3 112.486 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -66.72 154.3 41.05 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 110.116 -0.327 . . . . 74.24 110.116 175.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 26' ' ' LYS . 72.1 mmtt -69.01 -30.51 68.92 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 111.942 0.349 . . . . 74.04 111.942 -175.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.687 HG21 ' HA ' ' A' ' 69' ' ' GLU . 20.5 m -83.39 -13.41 11.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.886 -0.326 . . . . 74.34 111.336 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.685 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 1.3 tmt_? -58.03 -48.41 80.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.379 -0.373 . . . . 74.14 111.085 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -62.48 -36.34 82.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.094 0.473 . . . . 73.24 110.79 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 34' ' ' MET . 61.5 tttm -66.29 -50.2 64.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.469 -0.787 . . . . 75.33 110.683 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.685 HD12 HD12 ' A' ' 73' ' ' ILE . 70.7 mt -66.37 -42.05 89.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.757 -0.656 . . . . 74.3 111.478 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.477 ' HE1' HG13 ' A' ' 37' ' ' VAL . 83.8 mtp -70.44 -28.75 65.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.633 0.254 . . . . 75.11 111.17 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -67.59 -28.21 67.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.199 0.523 . . . . 73.23 109.891 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 91.7 mmm -73.82 -16.44 61.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.524 -0.762 . . . . 74.44 111.062 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.3 -13.94 21.05 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.592 -0.813 . . . . 63.43 112.865 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.0 mt -78.64 129.33 37.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.71 0.291 . . . . 44.4 110.418 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.767 HG22 ' H ' ' A' ' 38' ' ' ARG . 2.1 m -139.21 -77.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.992 -0.549 . . . . 74.52 111.972 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.767 ' H ' HG22 ' A' ' 37' ' ' VAL . 1.4 tmm_? -149.44 125.44 10.62 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.048 -0.723 . . . . 71.32 109.048 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.33 -14.33 59.69 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.713 -0.756 . . . . 75.33 111.988 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.12 138.31 58.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.32 -0.622 . . . . 71.15 109.32 176.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -123.34 147.45 47.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.359 0.6 . . . . 54.53 111.258 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.77 HG23 ' HB3' ' A' ' 56' ' ' LEU . 44.3 mt -136.35 152.66 30.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.116 -0.947 . . . . 73.24 110.046 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -99.65 137.7 37.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.76 -0.459 . . . . 74.23 109.76 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.4 mm -87.76 103.12 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.431 -0.35 . . . . 71.34 110.585 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -71.67 -39.06 70.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.123 -0.489 . . . . 71.44 110.423 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.73 -175.95 34.92 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.93 -0.652 . . . . 51.14 111.927 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -127.65 152.28 47.87 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.001 -0.37 . . . . 73.53 110.001 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.593 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . . . -65.28 165.55 17.1 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.157 -0.474 . . . . 74.43 110.444 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 48' ' ' ALA . 9.5 Cg_endo -51.53 -32.59 44.33 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.903 2.402 . . . . 64.03 113.014 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.5 mtt -89.52 -4.15 58.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.978 0.418 . . . . 74.21 110.991 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.32 5.83 89.55 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.219 -0.752 . . . . 74.45 111.219 -173.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 52.9 t0 -148.39 121.15 4.56 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.9 -0.778 . . . . 70.1 108.9 -176.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.522 ' HB3' ' HD2' ' A' ' 66' ' ' ARG . 91.5 Cg_endo -86.41 -169.9 6.28 Favored 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.537 -1.443 . . . . 72.21 113.311 1.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.406 HD11 ' N ' ' A' ' 54' ' ' ILE . 4.4 mp -112.63 145.61 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.424 -0.807 . . . . 74.24 109.504 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.45 108.15 20.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.873 0.368 . . . . 75.04 110.798 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.77 ' HB3' HG23 ' A' ' 42' ' ' ILE . 2.2 mm? -102.06 146.14 28.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.464 -0.569 . . . . 64.24 109.464 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 21.8 ttt180 -116.79 114.17 23.57 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.478 -0.489 . . . . 70.34 110.442 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 60' ' ' GLY . 6.0 tt -149.23 156.02 41.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.895 -0.78 . . . . 72.44 108.895 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' A' ' 58' ' ' LEU . 79.6 ttt180 74.64 -21.84 0.28 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.309 0.576 . . . . 74.21 110.412 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 146.88 -40.92 0.99 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.719 -0.673 . . . . 73.41 111.6 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -116.57 168.55 10.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.143 0.497 . . . . 73.42 111.201 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.2 m -85.74 139.03 31.68 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.395 -0.82 . . . . 64.35 111.556 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 76.4 mt -134.49 158.75 43.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.669 -0.696 . . . . 60.43 109.309 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.1 m -100.85 138.48 37.84 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.072 0.463 . . . . 70.53 111.305 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.4 mt -127.76 134.64 49.51 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.357 -0.838 . . . . 63.42 108.909 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.522 ' HD2' ' HB3' ' A' ' 53' ' ' PRO . 25.3 mmm180 -64.9 153.5 40.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.686 -0.233 . . . . 74.31 110.655 -176.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -33.86 67.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.782 0.325 . . . . 65.31 110.192 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.4 m -57.66 -45.8 85.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.932 -0.577 . . . . 44.32 110.711 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.687 ' HA ' HG21 ' A' ' 27' ' ' VAL . 32.6 mt-10 -66.29 -44.54 83.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.227 0.537 . . . . 73.23 109.856 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.33 -22.31 66.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.486 -0.779 . . . . 74.44 111.614 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -81.31 -24.53 37.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.134 0.493 . . . . 74.23 110.608 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -95.25 12.81 27.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.255 0.55 . . . . 65.12 110.599 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.685 HD12 HD12 ' A' ' 31' ' ' ILE . 65.2 mt -121.6 119.57 59.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.65 -0.705 . . . . 71.22 109.669 176.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.7 mt -102.64 122.35 44.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.7 -0.482 . . . . 73.11 109.7 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.795 HG13 ' HA ' ' A' ' 18' ' ' VAL . 31.0 m -132.97 173.13 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.276 0.56 . . . . 74.03 112.3 -172.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.68 160.46 38.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.153 -0.93 . . . . 71.24 109.449 174.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.548 HG22 ' H ' ' A' ' 79' ' ' LEU . 13.3 p -99.61 134.06 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.13 0.49 . . . . 74.51 111.534 -174.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.509 HD12 ' HG2' ' A' ' 15' ' ' LYS . 81.6 mt -82.01 -18.73 42.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.842 -0.617 . . . . 74.01 110.978 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.566 HD11 ' H ' ' A' ' 15' ' ' LYS . 11.2 mp -68.65 114.68 7.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.327 -0.851 . . . . 74.35 110.173 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -81.36 74.6 8.35 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.647 0.737 . . . . 75.04 110.506 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -136.58 99.75 4.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.815 -1.084 . . . . 64.32 108.287 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -75.01 63.55 1.24 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.046 0.758 . . . . 71.54 113.046 -172.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -83.22 97.06 8.66 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.92 -0.77 . . . . 64.12 108.92 172.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -76.03 105.05 6.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.631 -0.713 . . . . 73.51 111.755 -170.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 32.9 t60 63.06 13.62 6.92 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.647 -0.706 . . . . 65.14 111.364 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.181 -0.914 . . . . 73.23 109.441 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 110.151 -0.314 . . . . 62.33 110.151 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 23.7 p -80.6 -60.39 2.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.604 -0.271 . . . . 75.43 110.589 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 3' ' ' LYS . 31.2 mtpt 68.74 169.16 0.28 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.897 0.748 . . . . 73.3 112.52 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 60.94 -164.52 17.33 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.026 -0.988 . . . . 75.21 113.892 173.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 pt -137.03 176.33 8.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.055 -1.091 . . . . 71.32 108.055 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.77 148.71 42.07 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.7 -1.238 . . . . 75.5 111.054 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.625 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 2.0 tm? -57.24 -29.82 64.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.504 0.668 . . . . 73.42 109.799 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.635 HD21 ' HA ' ' A' ' 71' ' ' LYS . 8.7 p30 -71.36 -14.11 62.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.482 -0.781 . . . . 61.13 111.364 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -101.59 3.99 40.5 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.417 -0.356 . . . . 70.34 111.06 -174.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.9 t -83.74 155.45 3.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.112 0.482 . . . . 75.11 110.236 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.565 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 17.3 tt0 -95.02 175.09 6.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.798 -0.637 . . . . 74.42 110.452 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.565 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 23.7 pt -75.09 145.69 10.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.236 -0.438 . . . . 62.34 111.69 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 59.12 24.42 12.76 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.433 -0.803 . . . . 72.23 112.17 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 m -108.45 147.54 31.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.082 -0.508 . . . . 62.2 109.831 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -109.66 149.83 29.15 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.954 -0.387 . . . . 74.24 109.954 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.901 HG12 ' HA ' ' A' ' 77' ' ' VAL . 28.4 m -140.25 178.3 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.14 0.495 . . . . 75.42 110.987 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.675 ' HB2' HD13 ' A' ' 78' ' ' LEU . 7.1 ttpm? -133.06 140.4 47.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.545 -0.752 . . . . 72.32 110.138 176.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.66 ' HA ' HG11 ' A' ' 75' ' ' VAL . 47.6 t -73.14 97.67 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.605 -0.725 . . . . 63.11 110.073 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.7 mm -79.75 -49.34 19.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.693 -0.685 . . . . 73.43 110.951 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -152.55 168.08 31.54 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.818 -1.182 . . . . 72.1 113.646 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.636 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 50.0 mm -124.39 157.42 31.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.023 -1.103 . . . . 64.34 108.023 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 t -102.62 90.32 2.18 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 120.849 0.357 . . . . 73.24 110.218 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.636 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 74.2 Cg_exo -49.71 159.33 1.54 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.774 2.983 . . . . 73.21 113.875 -171.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 64.84 69.86 0.49 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.308 -0.86 . . . . 70.4 110.945 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 9.3 t -149.57 162.98 39.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.366 -0.834 . . . . 73.25 109.137 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -73.27 -45.13 57.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.358 0.599 . . . . 74.25 109.55 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.427 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 27.8 m -78.71 -20.54 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.488 -0.778 . . . . 63.11 111.573 -176.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.646 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 2.1 tmt_? -50.87 -43.98 59.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.257 0.551 . . . . 70.23 109.654 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 29' ' ' ARG . 8.5 tpt180 -71.8 -44.21 64.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.591 -0.731 . . . . 71.52 110.614 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -60.59 -45.96 92.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.429 -0.805 . . . . 63.15 111.926 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 34' ' ' MET . 65.8 mt -68.68 -41.19 82.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.062 -0.517 . . . . 72.23 111.181 -177.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.1 ttt -72.26 -28.47 63.15 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.66 -0.416 . . . . 75.5 110.371 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.8 -38.94 87.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.131 0.491 . . . . 40.32 109.944 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 6.9 mmt -56.81 -29.42 62.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.262 -0.881 . . . . 71.23 111.363 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.51 13.31 22.82 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.763 -0.732 . . . . 52.04 111.975 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -90.51 134.17 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.925 -0.398 . . . . 75.33 109.925 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 m -137.48 -177.86 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.081 -0.509 . . . . 72.34 110.547 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -64.52 131.46 47.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.366 -0.379 . . . . 74.11 110.119 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.61 -21.58 36.35 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.556 -0.831 . . . . 74.4 112.56 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.1 m -68.2 146.49 53.33 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.896 0.379 . . . . 72.5 110.342 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -95.88 132.06 41.56 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.472 0.653 . . . . 53.42 110.916 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.58 HD12 ' HB3' ' A' ' 58' ' ' LEU . 48.7 mm -121.11 122.49 67.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.059 -0.973 . . . . 74.13 109.458 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.662 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 14.9 t80 -102.47 118.35 36.67 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.702 -0.481 . . . . 74.45 109.702 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 mm -85.19 100.16 8.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.487 -0.561 . . . . 73.31 109.487 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.38 -42.0 65.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.207 -0.664 . . . . 73.42 109.207 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.486 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 170.27 -169.44 42.25 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.243 -0.743 . . . . 64.41 111.243 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.727 ' HG3' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -146.1 162.92 36.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.395 -0.594 . . . . 64.3 109.395 175.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.501 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . . . -61.28 160.83 20.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 O-C-N 123.486 0.491 . . . . 42.44 110.315 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 48' ' ' ALA . 9.3 Cg_endo -52.81 -26.54 31.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.151 2.567 . . . . 73.53 113.47 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.8 ttt -93.45 -7.64 43.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.087 0.47 . . . . 75.34 110.877 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.727 ' HA2' ' HG3' ' A' ' 47' ' ' LYS . . . 89.05 -1.54 83.09 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.923 -0.656 . . . . 41.13 112.092 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -145.71 125.86 7.09 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.216 -0.661 . . . . 74.51 109.216 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.93 178.56 31.54 Favored 'Cis proline' 0 C--O 1.236 0.382 0 C-N-CA 123.029 -1.655 . . . . 64.03 112.842 -0.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.685 HG21 ' HB3' ' A' ' 47' ' ' LYS . 19.8 mt -114.92 141.83 30.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 72.24 109.813 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.59 109.73 21.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.995 0.426 . . . . 62.43 110.322 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.6 mt -120.58 135.58 55.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.293 -0.412 . . . . 71.33 110.945 -173.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.662 ' HB3' ' HB3' ' A' ' 43' ' ' TYR . 4.2 tmt_? -92.34 100.83 13.33 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.986 -1.116 . . . . 75.34 107.986 172.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.58 ' HB3' HD12 ' A' ' 42' ' ' ILE . 2.0 pp -138.78 156.59 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.643 -0.708 . . . . 73.2 110.811 -174.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? 71.34 -44.76 0.6 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.909 0.756 . . . . 75.33 110.707 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.69 -19.13 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 116.23 -0.441 . . . . 54.44 112.02 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -137.96 168.9 18.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.988 0.423 . . . . 74.1 111.436 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.659 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.2 m -85.27 126.71 33.92 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.627 -0.715 . . . . 74.0 110.534 175.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 52.9 tp -145.23 148.87 33.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.657 -0.702 . . . . 74.15 109.224 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 21.8 t -95.01 125.96 40.02 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.181 0.515 . . . . 70.45 110.99 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.12 168.18 11.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.266 -0.879 . . . . 73.21 109.397 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.472 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 30.4 mmt180 -77.53 153.48 33.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.157 0.503 . . . . 73.31 111.673 -177.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -60.08 -34.78 73.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.525 -0.761 . . . . 75.35 109.986 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.4 m -61.66 -36.26 80.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.302 -0.863 . . . . 73.04 110.91 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.472 ' HG3' ' HB2' ' A' ' 66' ' ' ARG . 40.7 mt-10 -69.97 -41.89 73.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.458 0.647 . . . . 75.52 110.079 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.77 -21.52 66.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.212 -0.904 . . . . 75.22 111.497 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.635 ' HA ' HD21 ' A' ' 8' ' ' ASN . 61.2 tttm -71.32 -25.21 62.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.792 0.33 . . . . 74.44 111.226 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.61 -4.47 57.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.074 0.464 . . . . 74.45 111.194 -174.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' A' ' 7' ' ' LEU . 21.1 mt -104.54 125.4 59.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.15 -0.477 . . . . 74.42 110.655 -178.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.1 mt -102.99 115.77 31.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.52 -0.548 . . . . 62.52 109.52 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.66 HG11 ' HA ' ' A' ' 18' ' ' VAL . 19.7 m -130.65 150.1 34.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.142 -0.481 . . . . 74.13 111.461 -174.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -99.49 139.87 34.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.453 -0.573 . . . . 55.02 109.453 171.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.901 ' HA ' HG12 ' A' ' 16' ' ' VAL . 40.9 t -73.95 113.63 12.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.033 0.444 . . . . 73.22 110.583 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.675 HD13 ' HB2' ' A' ' 17' ' ' LYS . 47.5 mt -85.78 -6.51 59.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.964 -0.562 . . . . 75.12 110.939 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.8 tp -76.94 86.89 3.48 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.268 -1.382 . . . . 72.11 107.268 166.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -68.91 100.53 1.21 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.181 -0.918 . . . . 71.33 112.52 -166.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -123.97 130.22 52.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.058 -0.974 . . . . 73.33 108.839 172.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -82.77 54.0 2.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.293 0.568 . . . . 75.31 111.163 -172.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -146.68 114.45 6.46 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.161 -0.681 . . . . 63.21 109.161 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -88.61 129.86 35.4 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.332 0.493 . . . . 71.33 112.332 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -88.91 -42.92 11.54 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.369 -0.974 . . . . 72.51 108.369 169.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.1 t60 . . . . . 0 C--O 1.245 0.847 0 CA-C-N 114.605 -1.179 . . . . 72.32 108.519 177.394 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 120.981 0.42 . . . . 54.33 110.63 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.4 m -143.38 91.43 2.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.689 -0.687 . . . . 71.01 109.205 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -106.91 -155.61 0.55 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.365 -0.834 . . . . 73.2 109.966 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.69 109.3 0.4 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 119.913 -1.137 . . . . 61.32 113.271 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.4 pt -97.91 167.34 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.499 -0.926 . . . . 74.51 108.499 172.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.46 143.46 29.37 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 119.276 -1.44 . . . . 41.33 111.482 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 7' ' ' LEU . 8.2 tt -61.73 -26.84 68.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.32 0.581 . . . . 65.11 109.935 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.573 HD21 ' HA ' ' A' ' 71' ' ' LYS . 6.8 p30 -67.76 -14.63 63.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 73.45 110.7 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.97 -2.95 39.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.115 -0.493 . . . . 74.43 111.309 -176.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 11' ' ' GLU . 34.1 t -78.09 159.69 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.956 0.408 . . . . 73.13 110.459 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.449 ' N ' HG12 ' A' ' 10' ' ' VAL . 28.0 tt0 -102.61 173.77 6.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.873 -0.603 . . . . 73.13 110.169 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.576 HG22 ' HA2' ' A' ' 46' ' ' GLY . 33.9 pt -76.42 149.8 6.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.35 0.5 . . . . 72.24 112.35 -173.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 53.8 31.02 12.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.174 -0.921 . . . . 75.4 112.142 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.7 m -121.2 145.86 47.39 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.261 -0.644 . . . . 75.15 109.261 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -110.45 137.97 47.46 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.343 0.592 . . . . 74.41 111.727 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.738 HG13 ' HA ' ' A' ' 77' ' ' VAL . 16.2 m -137.5 163.63 30.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.167 -0.924 . . . . 74.24 109.247 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 41' ' ' GLU . 38.4 ttpt -118.96 141.55 48.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.059 0.457 . . . . 74.22 111.241 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.466 ' HA ' HG11 ' A' ' 75' ' ' VAL . 47.0 t -73.91 93.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.995 -1.002 . . . . 75.3 110.121 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.1 -38.85 56.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.538 -0.755 . . . . 54.44 110.445 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.42 153.27 24.59 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.087 -1.054 . . . . 74.23 113.441 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.0 mt -114.7 158.25 15.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.177 -1.046 . . . . 73.43 108.177 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 22' ' ' VAL . 7.5 p -100.18 91.84 1.86 Allowed Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 121.761 0.791 . . . . 62.02 110.243 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.913 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 29.3 Cg_endo -60.01 166.67 8.41 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.907 2.404 . . . . 74.1 112.544 -174.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 66.52 11.9 8.38 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.388 -0.824 . . . . 73.1 111.226 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.835 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 34.7 t -85.51 157.45 20.42 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.429 -0.582 . . . . 62.53 109.429 174.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -69.0 -43.83 74.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.162 -0.681 . . . . 71.31 109.162 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.3 m -77.94 -15.68 14.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.353 -0.84 . . . . 75.1 110.969 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.913 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -52.46 -43.17 64.78 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.592 -0.276 . . . . 55.32 110.311 176.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -71.06 -41.64 70.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.413 . . . . 65.42 110.956 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -54.1 -45.12 71.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.315 0.579 . . . . 75.43 110.945 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.749 HD12 HD12 ' A' ' 73' ' ' ILE . 86.9 mt -65.8 -46.85 87.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.042 -0.981 . . . . 64.11 112.054 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 51.1 mtt -73.33 -29.37 62.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.726 0.298 . . . . 73.44 111.121 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.89 -28.69 69.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.266 0.555 . . . . 73.41 110.109 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 20.8 ttm -76.87 -20.78 55.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.597 -0.729 . . . . 75.02 110.69 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.7 15.23 15.57 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.659 -0.781 . . . . 50.41 112.901 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.511 ' HB ' HG22 ' A' ' 31' ' ' ILE . 25.8 mt -96.3 129.25 46.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.849 0.357 . . . . 74.35 110.298 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.6 m -134.28 -177.96 2.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.932 -0.576 . . . . 74.25 110.592 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -67.78 139.6 56.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.263 -0.273 . . . . 73.2 110.263 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.35 -2.17 87.46 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.035 -0.603 . . . . 39.02 112.789 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m -75.44 133.88 41.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.166 -0.679 . . . . 74.31 109.166 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 17' ' ' LYS . 5.1 pt-20 -104.57 129.07 52.69 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.28 0.562 . . . . 70.13 109.934 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.629 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 63.0 mt -118.17 132.84 66.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.023 -0.989 . . . . 73.24 110.578 -171.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -92.01 104.12 16.56 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.056 -0.72 . . . . 75.12 109.056 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.8 mm -74.21 97.47 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.183 -0.673 . . . . 63.44 109.183 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.427 ' OE2' ' HB2' ' A' ' 57' ' ' ARG . 50.0 mt-10 -66.47 -39.5 88.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.885 0.374 . . . . 74.3 110.618 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.576 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 170.19 172.69 36.89 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.355 -0.926 . . . . 73.31 112.215 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.639 ' HG2' HG12 ' A' ' 54' ' ' ILE . 46.1 mtmt -110.0 165.05 12.03 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.331 -0.618 . . . . 75.23 109.331 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.474 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -66.79 164.54 32.96 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.844 -0.428 . . . . 74.11 109.844 174.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 84.9 Cg_exo -42.79 -49.16 6.91 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.223 2.616 . . . . 74.41 113.704 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.3 ttt -84.96 -10.86 56.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.893 0.378 . . . . 74.21 111.028 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.98 2.92 39.39 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.917 -0.659 . . . . 73.24 112.774 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -151.68 128.51 5.43 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 110.074 -0.343 . . . . 64.31 110.074 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -82.72 -165.85 4.54 Favored 'Cis proline' 0 CA--C 1.532 0.392 0 C-N-CA 123.414 -1.494 . . . . 72.14 113.088 2.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.639 HG12 ' HG2' ' A' ' 47' ' ' LYS . 52.7 mt -120.51 147.46 24.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.448 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -103.11 111.23 23.49 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.836 0.351 . . . . 61.12 110.351 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.629 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 2.2 mp -117.07 129.99 56.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.184 -0.462 . . . . 74.43 110.006 -176.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.754 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 23.8 ttm180 -101.43 115.28 30.14 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.647 -0.421 . . . . 71.41 110.402 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.574 ' HG ' HG12 ' A' ' 42' ' ' ILE . 5.5 mp -116.76 145.88 43.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.868 -0.605 . . . . 63.3 109.748 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 64.2 -77.97 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.729 0.643 . . . . 75.33 110.852 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.13 9.57 0.35 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.348 -0.453 . . . . 71.31 112.068 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -147.28 154.97 41.61 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.298 0.57 . . . . 74.44 111.137 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.754 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 21.8 t -93.7 144.32 25.51 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.508 -0.769 . . . . 63.04 111.855 -175.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.4 154.74 44.65 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.488 -1.233 . . . . 60.44 108.767 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -116.12 114.53 24.63 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 120.972 0.415 . . . . 74.44 111.916 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.548 ' HG ' HD12 ' A' ' 56' ' ' LEU . 3.6 pp -122.25 167.23 13.48 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.484 -0.562 . . . . 73.53 109.484 174.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 -86.34 163.93 17.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.518 0.675 . . . . 73.41 112.27 -174.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.457 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 1.4 tmtp? -64.5 -20.94 66.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.953 -1.021 . . . . 72.23 110.277 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 m -69.1 -50.92 43.84 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.12 -0.491 . . . . 71.21 110.652 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.76 -36.46 78.99 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.3 0.571 . . . . 54.13 109.956 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.94 -21.68 66.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.336 -0.847 . . . . 75.51 111.862 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.573 ' HA ' HD21 ' A' ' 8' ' ' ASN . 88.8 tttt -84.28 -22.9 30.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.152 0.501 . . . . 74.34 110.526 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.487 ' HB3' HG12 ' A' ' 22' ' ' VAL . 4.6 m-20 -87.09 -14.18 42.14 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.875 -0.602 . . . . 72.1 110.919 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.749 HD12 HD12 ' A' ' 31' ' ' ILE . 40.1 mm -95.92 122.61 47.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.128 -0.487 . . . . 62.24 110.546 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.2 mt -100.61 114.96 29.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.053 -0.521 . . . . 60.04 109.871 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.549 HG13 HG22 ' A' ' 73' ' ' ILE . 24.9 m -118.71 161.12 17.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.087 -0.506 . . . . 73.1 111.241 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -118.75 145.56 45.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.713 -0.676 . . . . 65.33 109.305 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.738 ' HA ' HG13 ' A' ' 16' ' ' VAL . 39.3 t -72.34 123.01 26.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.76 -0.654 . . . . 64.42 110.545 -176.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.1 mt -85.12 -0.86 55.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 75.23 111.593 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.525 ' H ' HG13 ' A' ' 77' ' ' VAL . 10.9 mp -71.21 175.97 4.89 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.92 -0.582 . . . . 54.14 111.383 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.7 16.06 18.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.825 -0.625 . . . . 64.44 111.708 -174.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -75.01 102.85 4.97 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.879 -0.415 . . . . 75.2 109.879 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -86.34 -10.33 54.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.144 -0.48 . . . . 71.32 110.284 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -84.73 70.69 10.84 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.554 -0.906 . . . . 74.52 108.554 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -85.56 66.16 9.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.828 -0.624 . . . . 71.02 110.214 -174.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.3 t60 70.04 -77.03 0.06 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.383 -0.826 . . . . 63.22 110.995 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.004 -0.998 . . . . 73.14 109.612 -176.446 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.9 mtt . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.013 -0.366 . . . . 73.44 110.013 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.7 p -111.11 134.51 52.65 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.066 0.46 . . . . 74.44 111.082 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -79.74 -2.0 41.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.7 0.762 . . . . 72.24 109.546 175.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.52 179.65 52.84 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 114.989 -1.005 . . . . 72.33 112.687 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.5 pt -122.77 179.22 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.89 -0.781 . . . . 63.21 108.89 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 73' ' ' ILE . . . -77.45 151.7 38.49 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 119.805 -1.188 . . . . 52.12 111.884 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 7' ' ' LEU . 2.9 tm? -60.09 -32.62 71.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.297 0.57 . . . . 71.34 109.483 177.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.576 HD21 ' HA ' ' A' ' 71' ' ' LYS . 8.6 p30 -70.27 -15.59 62.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.461 -0.79 . . . . 74.32 111.094 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -92.58 -3.9 54.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.074 0.464 . . . . 74.13 110.658 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.4 t -91.33 158.79 2.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.98 -0.748 . . . . 63.3 108.98 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.58 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 24.8 tt0 -108.01 175.52 5.45 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.239 -0.282 . . . . 71.54 110.239 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.58 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 32.5 pt -68.83 153.59 8.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.24 -0.436 . . . . 64.23 111.691 -175.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 60.64 41.21 15.57 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.301 -0.863 . . . . 73.22 110.914 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 m -128.56 149.77 50.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.149 -0.932 . . . . 75.43 109.638 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HG2' HD11 ' A' ' 78' ' ' LEU . 85.8 tttt -115.37 132.4 56.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.043 -0.354 . . . . 53.15 110.043 177.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.798 HG12 ' HA ' ' A' ' 77' ' ' VAL . 26.6 m -133.04 162.62 39.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.254 0.55 . . . . 74.22 111.226 -176.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.579 ' HB2' HD21 ' A' ' 78' ' ' LEU . 19.8 ttmm -112.22 138.75 48.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.415 -0.811 . . . . 75.32 109.435 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.725 ' HA ' HG13 ' A' ' 75' ' ' VAL . 60.7 t -75.65 95.96 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.619 -0.719 . . . . 72.23 110.038 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.6 mm -61.05 -40.44 85.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.678 -0.692 . . . . 60.31 109.823 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.75 168.65 39.74 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.416 -0.897 . . . . 70.44 112.32 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.712 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 43.9 mt -105.28 159.38 5.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 108.606 -0.886 . . . . 74.42 108.606 176.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 25' ' ' SER . 58.4 t -99.22 92.36 1.71 Allowed Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.106 0.479 . . . . 74.32 110.471 -177.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.712 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 27.8 Cg_exo -60.53 178.31 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.561 2.841 . . . . 72.5 112.816 -174.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 66.73 -32.2 0.18 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.461 0.705 . . . . 63.13 112.026 -173.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 23' ' ' PRO . 1.3 m -63.24 153.36 34.88 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 120.97 0.414 . . . . 37.91 110.86 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -71.92 -49.25 39.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.789 -0.641 . . . . 64.54 110.493 -174.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.567 HG11 ' HG2' ' A' ' 69' ' ' GLU . 11.5 m -72.99 -15.44 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.39 -0.368 . . . . 74.2 110.831 -174.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.645 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -53.8 -45.87 70.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.907 -0.588 . . . . 63.45 111.003 178.149 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -72.25 -33.01 67.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.369 0.604 . . . . 64.44 110.17 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -63.8 -41.85 97.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.378 -0.828 . . . . 65.53 110.508 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.624 ' HA ' ' HE2' ' A' ' 34' ' ' MET . 82.9 mt -64.39 -36.42 77.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.713 -0.676 . . . . 74.54 110.9 177.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 67.7 mtt -67.67 -32.61 73.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 73.45 110.629 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -63.34 -31.89 73.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.946 -0.57 . . . . 54.13 110.492 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.624 ' HE2' ' HA ' ' A' ' 31' ' ' ILE . 65.9 mtm -76.53 -23.98 53.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.962 -0.563 . . . . 62.04 111.169 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.02 36.68 2.12 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.297 -0.954 . . . . 71.32 113.358 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.489 ' HB ' HG23 ' A' ' 31' ' ' ILE . 63.7 mt -122.14 136.1 60.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.468 -0.568 . . . . 73.34 109.468 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.742 HG22 ' H ' ' A' ' 38' ' ' ARG . 1.6 m -135.67 -84.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.321 0.489 . . . . 63.4 112.321 -176.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.742 ' H ' HG22 ' A' ' 37' ' ' VAL . 43.5 ttp180 -156.56 141.12 16.83 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.362 -0.607 . . . . 75.15 109.362 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.71 -0.29 65.89 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 111.429 -0.669 . . . . 73.32 111.429 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.453 HG23 HD22 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -72.6 142.67 48.39 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.387 -0.598 . . . . 73.31 109.387 178.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.49 130.98 52.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.167 0.508 . . . . 73.43 111.606 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.537 HG22 HD23 ' A' ' 56' ' ' LEU . 25.6 mm -120.24 128.16 75.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.34 -0.845 . . . . 71.51 110.898 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -101.12 120.67 40.56 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.447 -0.575 . . . . 75.44 109.447 171.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 44' ' ' ILE . 3.9 mp -85.45 101.62 10.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.226 -0.657 . . . . 72.22 109.226 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.84 -53.29 27.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.275 0.56 . . . . 74.15 110.383 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.26 -177.37 41.01 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.673 -0.694 . . . . 52.51 111.773 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.446 ' HG2' HG22 ' A' ' 54' ' ' ILE . 52.0 mtpt -133.26 152.0 51.92 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.136 -0.69 . . . . 62.52 109.136 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.49 156.34 71.16 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.575 -0.528 . . . . 71.55 109.575 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.35 -30.14 19.42 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.77 2.313 . . . . 60.24 113.176 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.801 ' HA ' ' HE3' ' A' ' 50' ' ' MET . 23.2 mmt -91.29 0.98 57.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.489 -0.323 . . . . 71.51 111.697 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.01 -9.14 73.55 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.892 -0.67 . . . . 64.03 111.999 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -144.01 130.54 10.19 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.685 -0.487 . . . . 74.53 109.685 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.541 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . 91.6 Cg_endo -84.11 -169.26 6.65 Favored 'Cis proline' 0 CA--C 1.533 0.44 0 C-N-CA 123.474 -1.469 . . . . 71.14 112.918 0.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.446 HG22 ' HG2' ' A' ' 47' ' ' LYS . 60.7 mt -119.3 143.2 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.896 -0.593 . . . . 71.31 110.284 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.09 111.83 24.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.896 0.379 . . . . 73.4 110.808 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.537 HD23 HG22 ' A' ' 42' ' ' ILE . 5.9 mp -105.68 171.92 7.08 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.136 -0.69 . . . . 71.12 109.136 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 23.7 ttt180 -151.18 128.79 11.48 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.242 -0.651 . . . . 75.22 109.242 176.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.596 HD21 ' HG3' ' A' ' 59' ' ' ARG . 1.2 tt -131.93 137.41 47.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.01 -0.541 . . . . 74.51 109.83 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.596 ' HG3' HD21 ' A' ' 58' ' ' LEU . 55.8 mtt180 61.15 -80.25 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.795 -1.093 . . . . 53.21 111.667 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -147.78 14.75 1.37 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.016 -0.611 . . . . 74.25 111.759 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -140.01 145.96 38.46 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.677 0.751 . . . . 75.45 111.899 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 33.5 t -74.22 155.22 38.54 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.396 -1.275 . . . . 72.51 110.667 176.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.8 mt -139.7 140.21 36.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.783 -0.644 . . . . 71.13 109.424 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.8 t -118.99 130.2 55.55 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.811 0.339 . . . . 62.44 110.735 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 pp -144.65 164.64 30.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.76 -0.655 . . . . 72.55 110.386 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.541 ' HD3' ' HB3' ' A' ' 53' ' ' PRO . 25.9 mmt180 -83.73 158.68 21.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.37 0.605 . . . . 63.41 111.616 -176.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -39.47 70.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.95 -1.023 . . . . 72.44 111.117 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -65.38 -34.45 78.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.302 -0.408 . . . . 74.32 111.233 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.567 ' HG2' HG11 ' A' ' 27' ' ' VAL . 33.9 mt-10 -74.38 -32.76 62.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.297 0.57 . . . . 74.4 109.86 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.99 -21.1 65.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.452 -0.795 . . . . 75.45 111.19 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.576 ' HA ' HD21 ' A' ' 8' ' ' ASN . 22.1 ttmm -74.32 -34.17 63.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.494 . . . . 74.22 110.392 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -85.51 14.59 5.38 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.196 -0.456 . . . . 60.25 111.574 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.473 HG22 HG12 ' A' ' 75' ' ' VAL . 60.4 mt -118.96 124.23 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.381 . . . . 74.42 110.222 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 99.0 mt -103.47 120.73 41.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 75.55 110.243 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.725 HG13 ' HA ' ' A' ' 18' ' ' VAL . 22.4 m -133.95 157.51 41.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.207 0.527 . . . . 71.22 111.791 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -117.82 143.32 46.38 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.958 -0.756 . . . . 70.43 108.958 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.798 ' HA ' HG12 ' A' ' 16' ' ' VAL . 38.5 t -70.94 125.55 29.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.128 -0.487 . . . . 62.32 110.595 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' A' ' 17' ' ' LYS . 56.3 mt -82.64 -9.56 59.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 75.42 111.008 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.528 ' H ' HG13 ' A' ' 77' ' ' VAL . 91.6 mt -72.1 147.04 47.1 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.843 -0.617 . . . . 74.3 109.472 174.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -86.82 3.5 45.02 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.083 0.468 . . . . 64.51 110.748 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -90.77 83.18 5.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.812 -0.631 . . . . 74.53 110.248 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -83.19 91.74 7.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.288 0.566 . . . . 74.31 110.317 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -87.99 103.89 16.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.595 0.712 . . . . 73.12 110.361 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -86.51 133.03 33.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.838 -0.619 . . . . 71.31 109.852 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 69.3 -76.75 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.552 -0.749 . . . . 73.0 110.206 -173.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.125 -0.94 . . . . 73.44 109.006 -176.041 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' H2 ' ' CD ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.84 0.352 . . . . 64.43 110.506 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.7 p -114.99 113.08 23.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.144 -0.48 . . . . 62.52 110.648 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 61.14 43.69 10.85 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.427 0.454 . . . . 65.01 110.997 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.42 128.09 34.7 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.551 -0.749 . . . . 71.43 112.757 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.8 pt -110.11 171.44 2.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.689 0.281 . . . . 73.33 110.304 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 73' ' ' ILE . . . -76.91 153.11 41.51 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 120.47 -0.871 . . . . 43.42 111.22 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.49 HD21 ' CD1' ' A' ' 56' ' ' LEU . 50.1 tp -59.21 -28.01 66.26 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.185 0.517 . . . . 75.4 110.684 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.439 ' ND2' ' HG3' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -75.38 -4.53 39.92 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.86 -0.609 . . . . 73.33 111.831 178.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.439 ' HG3' ' ND2' ' A' ' 8' ' ' ASN . 44.5 mt-10 -102.1 5.87 40.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.931 0.396 . . . . 72.2 110.801 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 t -97.03 157.32 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.064 -0.517 . . . . 71.32 109.967 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -99.64 164.89 11.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.62 0.247 . . . . 71.24 110.341 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.7 pt -69.39 151.03 10.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.444 . . . . 71.55 111.048 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt 60.26 51.45 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.948 0.88 . . . . 62.15 110.536 -177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 m -132.37 153.08 51.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.142 -0.935 . . . . 73.42 109.759 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -113.44 119.09 36.39 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.803 -0.443 . . . . 65.35 109.803 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.763 HG13 ' HA ' ' A' ' 77' ' ' VAL . 29.1 m -130.76 179.56 4.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.11 -0.495 . . . . 65.41 110.503 -178.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.721 ' HB2' HD11 ' A' ' 78' ' ' LEU . 39.3 ttpt -143.04 144.53 32.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.876 0.37 . . . . 75.03 111.064 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.639 ' HA ' HG11 ' A' ' 75' ' ' VAL . 45.8 t -76.9 95.66 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.598 -0.728 . . . . 74.31 110.673 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.896 HD11 ' HB2' ' A' ' 76' ' ' GLU . 50.1 mt -57.33 -49.33 80.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 70.52 109.988 173.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.59 149.16 7.22 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.54 -0.755 . . . . 74.11 112.258 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.627 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 56.9 mt -83.95 159.68 3.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.516 -0.55 . . . . 75.13 109.516 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 25' ' ' SER . 48.3 t -99.17 93.71 2.29 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 122.757 0.423 . . . . 73.41 110.03 -177.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.994 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 77.6 Cg_exo -49.27 164.26 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.911 3.074 . . . . 72.32 114.271 -173.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 67.28 -11.96 0.27 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.116 0.967 . . . . 75.5 112.92 -175.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 1.2 m -63.72 155.1 31.12 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 120.926 0.393 . . . . 73.22 110.822 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -69.46 -17.29 63.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.16 -0.473 . . . . 75.43 112.164 -173.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 31' ' ' ILE . 30.9 m -112.47 6.32 8.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.664 -0.244 . . . . 74.14 111.43 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.994 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 5.2 tmm_? -58.76 -57.18 14.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.877 0.37 . . . . 74.3 110.771 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -71.5 -36.1 70.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.041 -0.527 . . . . 75.24 110.123 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -58.77 -46.39 87.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.266 -0.879 . . . . 75.33 111.276 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.609 HD13 HD13 ' A' ' 73' ' ' ILE . 99.4 mt -66.51 -42.34 89.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.048 0.452 . . . . 75.12 111.278 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 63.7 mtt -67.53 -36.67 81.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.336 -0.393 . . . . 63.43 110.781 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.01 -30.14 68.46 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 54.22 110.445 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.404 ' HE1' HD22 ' A' ' 63' ' ' LEU . 7.3 ttt -63.04 -34.6 77.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.615 -0.721 . . . . 55.14 110.859 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.67 20.26 1.74 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.307 -0.949 . . . . 51.1 113.178 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.514 HD12 HG21 ' A' ' 31' ' ' ILE . 61.1 mt -105.51 134.84 45.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.719 -0.475 . . . . 53.45 109.719 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.73 177.56 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.389 -0.369 . . . . 72.32 110.835 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -78.7 128.97 34.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.079 0.466 . . . . 63.42 110.26 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.75 5.61 66.38 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.802 -0.713 . . . . 44.01 112.235 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.5 m -68.8 138.65 54.97 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.501 -0.555 . . . . 75.32 109.501 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -96.14 125.45 40.68 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.855 -0.611 . . . . 71.54 109.449 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.2 mt -107.36 120.57 58.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.347 -0.842 . . . . 72.23 110.969 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.556 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 74.4 t80 -93.52 106.88 18.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.821 -0.807 . . . . 72.32 108.821 173.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.438 HD13 HD23 ' A' ' 56' ' ' LEU . 18.6 mm -70.04 104.01 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.183 -0.673 . . . . 74.25 109.183 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -76.38 -61.51 1.93 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.832 0.349 . . . . 72.24 110.401 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.21 158.55 29.13 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.227 -0.987 . . . . 61.42 112.356 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.608 ' HG2' HG12 ' A' ' 54' ' ' ILE . 54.2 mtpt -97.55 151.83 19.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.258 -0.645 . . . . 74.13 109.258 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.53 156.35 32.6 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 110.131 -0.322 . . . . 65.11 110.131 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.0 -32.51 18.32 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.246 2.63 . . . . 61.43 113.752 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.8 ttm -89.42 -11.35 43.38 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.936 0.398 . . . . 73.44 111.172 -177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.45 -14.7 32.81 Favored Glycine 0 C--N 1.328 0.115 0 C-N-CA 120.909 -0.662 . . . . 50.54 112.513 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -149.41 138.96 12.93 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.44 -0.578 . . . . 75.04 109.44 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.8 -164.73 3.94 Favored 'Cis proline' 0 C--N 1.346 0.429 0 C-N-CA 124.15 -1.188 . . . . 73.1 112.636 -0.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.608 HG12 ' HG2' ' A' ' 47' ' ' LYS . 38.2 mt -123.97 134.98 65.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 74.03 110.416 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -91.44 118.93 30.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.372 -0.376 . . . . 70.52 110.255 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.49 ' CD1' HD21 ' A' ' 7' ' ' LEU . 23.1 mt -121.22 137.02 54.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.213 -0.449 . . . . 73.11 110.747 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.609 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 3.9 tmt_? -101.45 109.36 21.18 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.73 -0.841 . . . . 70.4 108.73 175.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 pp -144.64 152.12 40.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.318 -0.401 . . . . 73.02 110.96 -175.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 72.51 -45.29 0.62 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.931 0.77 . . . . 75.5 111.379 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.58 -21.84 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.064 -0.588 . . . . 72.11 112.355 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -145.0 172.4 13.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.01 0.433 . . . . 72.33 111.188 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -84.91 140.88 30.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.539 -0.755 . . . . 71.41 111.208 175.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.404 HD22 ' HE1' ' A' ' 34' ' ' MET . 24.2 tp -143.5 154.66 43.86 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.452 -0.573 . . . . 71.14 109.452 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 p -91.81 121.24 33.25 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.923 0.392 . . . . 74.14 111.767 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.41 HD23 HD12 ' A' ' 56' ' ' LEU . 3.9 mm? -118.59 141.98 48.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.144 -0.48 . . . . 73.22 109.851 175.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.45 162.15 15.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.767 0.318 . . . . 74.33 110.722 -177.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -55.85 -33.0 64.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.643 -0.708 . . . . 72.25 110.999 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.1 m -59.48 -56.57 20.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 64.5 110.739 177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.412 ' HA ' HG21 ' A' ' 27' ' ' VAL . 2.5 mp0 -64.94 -36.79 85.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.081 0.467 . . . . 74.11 110.713 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.2 66.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.648 -0.706 . . . . 74.01 111.813 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -83.01 -32.21 27.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.684 0.278 . . . . 74.5 110.9 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.38 -2.05 56.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.26 -0.427 . . . . 38.71 111.706 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.609 HD13 HD13 ' A' ' 31' ' ' ILE . 68.8 mt -106.42 122.7 60.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.572 -0.285 . . . . 73.01 110.582 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.5 mt -95.03 122.25 37.49 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.913 0.387 . . . . 73.41 110.216 176.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.639 HG11 ' HA ' ' A' ' 18' ' ' VAL . 28.3 m -129.74 167.45 24.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.944 -0.571 . . . . 71.02 111.142 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.896 ' HB2' HD11 ' A' ' 19' ' ' ILE . 41.9 tt0 -129.07 146.01 51.13 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.227 -0.657 . . . . 53.34 109.227 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.763 ' HA ' HG13 ' A' ' 16' ' ' VAL . 10.3 p -76.14 129.5 37.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.275 0.56 . . . . 75.44 110.682 -178.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.721 HD11 ' HB2' ' A' ' 17' ' ' LYS . 86.2 mt -96.64 -14.14 22.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.879 -0.6 . . . . 75.2 109.997 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 tt -59.49 104.74 0.29 Allowed 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.787 -1.097 . . . . 73.43 108.926 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 67.24 105.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.207 -0.906 . . . . 75.31 110.338 -172.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.473 ' O ' ' HD2' ' A' ' 83' ' ' HIS . 51.7 t-80 -71.02 -9.39 57.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.501 -0.772 . . . . 63.14 111.477 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -77.12 99.97 5.56 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.771 0.32 . . . . 75.33 110.639 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.473 ' HD2' ' O ' ' A' ' 81' ' ' HIS . 5.4 p80 -135.24 149.79 49.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.012 -0.366 . . . . 74.4 110.012 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -107.44 129.57 54.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.123 -0.325 . . . . 71.45 110.123 -173.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.04 44.12 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.263 0.554 . . . . 73.32 111.599 -176.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 66.9 t-80 . . . . . 0 C--O 1.241 0.642 0 CA-C-N 115.76 -0.655 . . . . 74.15 109.467 175.302 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 121.044 0.449 . . . . 62.04 110.747 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.401 HG21 ' HB2' ' A' ' 76' ' ' GLU . 9.0 t -120.43 10.14 11.11 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.071 -0.393 . . . . 70.1 110.541 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.74 89.67 0.09 Allowed 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 115.896 -0.593 . . . . 62.33 109.877 -174.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.45 123.1 28.55 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.554 -0.748 . . . . 54.11 112.507 -177.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.0 pt -107.19 174.32 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.789 -0.448 . . . . 75.41 109.789 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.62 156.66 35.2 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.107 -1.044 . . . . 63.34 111.654 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.55 HD12 HG22 ' A' ' 16' ' ' VAL . 61.6 tp -61.62 -26.25 67.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.237 0.542 . . . . 64.13 110.635 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -72.83 -10.87 60.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.666 . . . . 65.22 111.217 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -98.16 0.34 45.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.92 0.39 . . . . 75.14 110.885 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.483 HG21 HG11 ' A' ' 16' ' ' VAL . 6.1 t -103.18 158.1 4.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.393 -0.595 . . . . 63.32 109.393 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -106.1 170.58 7.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.103 0.478 . . . . 65.03 111.241 -176.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 31.7 pt -64.02 157.82 4.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.427 -0.806 . . . . 70.31 113.154 -171.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 60.69 32.1 20.23 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.34 -0.845 . . . . 70.14 111.918 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.4 m -124.36 151.49 44.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.957 -0.565 . . . . 74.24 109.784 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HB2' ' CD2' ' A' ' 43' ' ' TYR . 36.5 ttmt -103.44 130.18 50.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.956 0.407 . . . . 71.52 110.287 176.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.55 HG22 HD12 ' A' ' 7' ' ' LEU . 33.1 m -119.01 165.79 13.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.864 -0.607 . . . . 73.34 110.628 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.62 ' HB2' HD13 ' A' ' 78' ' ' LEU . 69.2 tttt -123.07 135.65 54.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.638 -0.71 . . . . 64.4 110.205 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.77 95.38 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.309 -0.859 . . . . 62.12 110.7 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.816 HD11 ' HB3' ' A' ' 76' ' ' GLU . 28.7 mt -65.64 -49.06 80.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.766 -0.652 . . . . 70.24 109.75 174.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.52 176.31 44.77 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.601 -0.809 . . . . 75.5 112.74 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.661 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 54.6 mt -120.48 159.24 22.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.275 -1.009 . . . . 71.4 108.275 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.553 ' HB ' ' OD2' ' A' ' 72' ' ' ASP . 48.8 t -100.41 90.14 1.34 Allowed Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 121.363 0.602 . . . . 74.21 109.618 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.661 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 34.8 Cg_exo -56.57 163.33 7.03 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.6 2.866 . . . . 72.53 113.698 -170.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 65.96 16.62 10.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.624 -1.171 . . . . 73.12 111.24 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.545 ' O ' ' HB3' ' A' ' 28' ' ' ARG . 1.3 m -88.65 151.8 22.23 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.397 -0.594 . . . . 63.41 109.397 171.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -75.38 -38.96 59.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.895 0.379 . . . . 74.13 110.145 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 31' ' ' ILE . 33.9 m -67.25 -19.6 25.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 72.2 110.771 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.545 ' HB3' ' O ' ' A' ' 25' ' ' SER . 3.1 tmm_? -58.29 -32.49 68.47 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.689 -0.687 . . . . 73.41 110.25 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -64.8 -47.39 78.23 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.385 -0.598 . . . . 71.44 109.385 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -60.47 -50.01 75.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.492 -0.776 . . . . 64.51 110.637 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 27' ' ' VAL . 86.5 mt -53.34 -52.79 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.545 -0.752 . . . . 73.02 111.917 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 64.5 mtt -70.62 -33.01 70.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.557 -0.292 . . . . 54.43 111.305 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.03 -22.44 61.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.408 0.623 . . . . 62.45 110.135 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.8 tpt -78.29 -22.35 48.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.434 -0.803 . . . . 64.23 110.563 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.55 5.49 20.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.758 -0.734 . . . . 73.15 112.831 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.419 HG12 ' HG ' ' A' ' 58' ' ' LEU . 41.2 mt -93.56 129.47 43.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.821 -0.437 . . . . 72.1 109.821 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.728 HG21 ' H ' ' A' ' 38' ' ' ARG . 2.8 m -133.05 -74.83 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.623 0.601 . . . . 72.43 112.623 -176.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.728 ' H ' HG21 ' A' ' 37' ' ' VAL . 61.6 ttt180 -165.28 128.62 2.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.955 -0.387 . . . . 74.15 109.955 -174.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.29 5.97 73.68 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.961 -0.638 . . . . 74.11 112.006 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.5 m -74.04 144.92 44.87 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.987 -0.375 . . . . 72.12 109.987 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -94.27 129.8 40.78 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.053 0.454 . . . . 73.23 110.282 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.74 HG12 HD23 ' A' ' 58' ' ' LEU . 73.8 mt -119.83 116.37 50.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.523 -0.762 . . . . 71.04 109.899 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.407 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 9.0 t80 -100.92 119.44 38.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.175 -0.676 . . . . 72.22 109.175 177.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.5 mt -77.03 125.02 36.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 120.703 0.287 . . . . 64.22 110.233 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -85.65 -59.54 2.28 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.839 0.352 . . . . 64.22 110.346 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.67 171.92 42.34 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.813 -0.708 . . . . 74.12 112.109 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -123.56 145.1 49.14 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.012 -0.366 . . . . 72.12 110.012 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -69.29 163.66 56.01 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.188 -0.46 . . . . 54.15 109.778 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 8.1 Cg_endo -50.66 -38.51 55.8 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 123.027 2.485 . . . . 73.23 113.468 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.657 ' HE3' ' HB3' ' A' ' 52' ' ' ASP . 50.7 ttp -86.14 -10.74 54.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.216 0.532 . . . . 73.13 110.659 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.87 -2.95 73.27 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.564 -0.614 . . . . 63.5 111.564 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.657 ' HB3' ' HE3' ' A' ' 50' ' ' MET . 11.8 t70 -141.36 132.12 13.25 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 108.889 -0.782 . . . . 73.14 108.889 177.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.57 -179.96 27.11 Favored 'Cis proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.036 -1.652 . . . . 72.52 112.391 -0.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.7 mt -113.48 145.37 19.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.167 -0.47 . . . . 71.14 110.03 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.29 119.39 38.68 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.036 -0.357 . . . . 72.32 110.036 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.541 HD22 HD21 ' A' ' 7' ' ' LEU . 5.4 mp -118.11 167.59 11.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.141 -0.481 . . . . 72.12 109.895 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.643 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 33.0 ttt-85 -125.59 105.7 9.21 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.893 -1.151 . . . . 72.54 107.893 167.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.74 HD23 HG12 ' A' ' 42' ' ' ILE . 3.2 tm? -122.84 145.57 48.32 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.674 -0.693 . . . . 73.12 109.967 -170.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.607 ' HB2' HD12 ' A' ' 58' ' ' LEU . 2.4 tmt_? 70.51 -69.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.214 -0.903 . . . . 71.42 110.021 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.69 2.08 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.905 -0.664 . . . . 63.22 112.52 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -148.49 165.26 31.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.859 0.361 . . . . 74.41 110.799 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.643 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 32.1 t -75.78 145.08 41.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.511 0.672 . . . . 74.31 111.347 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.5 mt -146.2 157.04 43.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.696 -1.138 . . . . 73.34 108.598 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 t -120.62 125.27 47.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.299 0.571 . . . . 64.14 110.721 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.27 175.85 5.93 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.314 -0.857 . . . . 74.44 109.312 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.625 ' HB2' ' OE1' ' A' ' 69' ' ' GLU . 41.7 mmt180 -90.75 167.09 12.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.103 0.478 . . . . 74.23 110.31 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.43 -22.59 67.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.582 -0.735 . . . . 73.12 109.604 174.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.7 m -64.1 -52.32 59.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.242 -0.89 . . . . 65.54 110.97 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.625 ' OE1' ' HB2' ' A' ' 66' ' ' ARG . 1.9 mp0 -60.16 -41.95 93.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.153 0.502 . . . . 53.31 110.675 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.77 -22.5 67.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.56 -0.745 . . . . 74.24 111.504 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -75.2 -34.92 61.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.409 -0.36 . . . . 64.42 111.114 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.553 ' OD2' ' HB ' ' A' ' 22' ' ' VAL . 14.5 t70 -80.26 -44.69 19.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 73.25 111.421 -174.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.456 HG22 HG12 ' A' ' 75' ' ' VAL . 48.3 mt -61.42 118.5 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.97 -0.559 . . . . 73.22 111.44 -176.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.2 mt -91.24 119.4 31.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 73.24 109.871 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.535 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 23.7 m -129.08 158.17 41.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.927 0.394 . . . . 73.03 111.964 -174.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.816 ' HB3' HD11 ' A' ' 19' ' ' ILE . 19.3 pt-20 -115.11 151.72 33.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.831 -0.622 . . . . 72.31 109.632 173.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.2 t -80.26 115.84 23.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.988 0.423 . . . . 62.22 111.109 -174.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.62 HD13 ' HB2' ' A' ' 17' ' ' LYS . 40.2 mt -89.81 -1.48 58.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.898 -0.592 . . . . 71.52 111.53 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.0 mt -57.22 115.6 2.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.039 -0.528 . . . . 74.1 110.467 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -73.74 123.56 24.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.519 -0.764 . . . . 74.2 111.34 -175.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -161.96 148.46 13.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.013 -0.539 . . . . 65.55 110.19 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -74.88 134.53 41.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.805 -0.443 . . . . 64.22 109.805 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -141.96 91.45 2.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.051 0.453 . . . . 65.54 111.199 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -137.09 119.39 15.69 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.652 -0.87 . . . . 73.33 108.652 170.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -66.74 122.16 17.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.217 -0.447 . . . . 64.45 109.953 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.8 p80 . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.667 -0.682 . . . . 72.23 109.828 -179.64 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 121.169 0.509 . . . . 72.31 110.574 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.1 m -140.92 130.17 23.58 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.635 -0.712 . . . . 60.22 109.869 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -128.88 112.26 13.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.8 0.334 . . . . 74.1 110.254 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.04 102.96 1.5 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.649 -0.786 . . . . 50.21 112.092 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.6 pt -96.04 163.29 2.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.752 -0.462 . . . . 74.21 109.752 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.23 137.58 45.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.466 -0.873 . . . . 70.42 112.209 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.491 HD12 HG21 ' A' ' 75' ' ' VAL . 44.7 tp -60.25 -25.02 65.35 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 122.986 0.515 . . . . 55.51 112.022 -175.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 9.1 p30 -78.46 -9.81 59.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.721 0.296 . . . . 74.25 110.857 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -99.31 -7.44 26.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.277 -0.42 . . . . 75.35 111.071 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.715 HG12 HG12 ' A' ' 16' ' ' VAL . 14.4 t -77.72 160.3 4.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.93 -0.577 . . . . 72.31 110.293 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.429 ' N ' HG11 ' A' ' 10' ' ' VAL . 31.7 tt0 -80.41 168.44 18.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 62.12 110.448 -177.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.4 ' HA ' ' CG2' ' A' ' 44' ' ' ILE . 33.5 pt -93.5 161.08 2.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.005 -0.543 . . . . 75.34 110.954 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 69.3 5.07 4.92 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.164 0.586 . . . . 70.1 111.611 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -107.12 156.89 18.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.851 0.358 . . . . 54.2 110.993 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HB2' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -107.91 130.97 54.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.008 -0.542 . . . . 74.25 110.341 178.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.738 HG11 ' HA ' ' A' ' 77' ' ' VAL . 27.2 m -127.6 161.31 35.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.739 -0.664 . . . . 73.22 110.911 -177.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.727 ' HD3' ' HG2' ' A' ' 41' ' ' GLU . 9.7 tptm -113.26 138.53 49.87 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.596 -0.729 . . . . 64.4 109.922 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.918 ' HA ' HG12 ' A' ' 75' ' ' VAL . 60.1 t -80.58 94.24 2.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.517 -0.765 . . . . 73.11 109.902 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.36 -52.69 34.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.013 -0.994 . . . . 73.14 110.106 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.23 133.95 4.0 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 119.966 -1.111 . . . . 74.15 113.245 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.428 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 68.3 mt -80.64 158.19 4.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 107.598 -1.26 . . . . 74.34 107.598 169.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 25' ' ' SER . 49.8 t -100.27 91.13 1.59 Allowed Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 121.015 0.436 . . . . 61.11 110.086 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.524 ' C ' ' H ' ' A' ' 25' ' ' SER . 35.8 Cg_endo -62.57 178.51 0.92 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.397 2.732 . . . . 73.14 113.061 -173.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 67.02 -16.19 0.14 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.436 -0.802 . . . . 72.21 111.741 -174.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -73.13 161.87 30.1 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.938 0.399 . . . . 72.33 110.926 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -78.84 -46.24 19.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.991 -0.55 . . . . 65.31 110.61 -176.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.674 HG21 ' HA ' ' A' ' 69' ' ' GLU . 23.3 m -68.13 -18.0 22.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.908 -0.587 . . . . 73.22 110.648 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.454 ' HE ' ' HB3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -53.7 -34.33 58.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.35 -0.841 . . . . 74.0 111.296 178.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -68.37 -42.07 79.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.45 -0.341 . . . . 54.22 111.06 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 34' ' ' MET . 34.0 tttp -73.56 -33.31 64.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.459 -0.337 . . . . 71.21 110.399 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 27' ' ' VAL . 88.5 mt -59.62 -48.31 87.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.174 -0.466 . . . . 53.42 110.719 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 64.9 mtt -68.79 -28.6 66.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 63.32 110.626 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.51 -40.57 76.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 71.32 110.429 176.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.452 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 65.6 mtt -61.93 -34.05 75.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.594 -0.73 . . . . 74.25 110.588 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.69 17.99 5.82 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.818 -0.706 . . . . 62.5 112.248 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.823 HD13 HD22 ' A' ' 58' ' ' LEU . 47.8 mt -101.03 127.46 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.197 0.523 . . . . 73.52 110.386 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.27 -176.53 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.273 -0.876 . . . . 63.34 110.084 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -70.6 109.45 4.88 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.867 -0.419 . . . . 73.24 109.867 175.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.411 ' O ' ' HE3' ' A' ' 17' ' ' LYS . . . 120.8 -9.24 10.58 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 121.042 -0.599 . . . . 53.33 111.739 -176.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.4 m -73.63 149.57 41.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.663 -0.495 . . . . 74.2 109.663 174.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.727 ' HG2' ' HD3' ' A' ' 17' ' ' LYS . 55.5 mt-10 -115.69 134.85 54.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.215 -0.448 . . . . 70.35 110.102 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.577 HG23 HD23 ' A' ' 56' ' ' LEU . 48.2 mm -118.66 126.02 74.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.468 -0.787 . . . . 70.05 110.757 -173.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -104.57 115.79 30.96 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.796 -0.816 . . . . 75.13 108.796 173.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.4 ' CG2' ' HA ' ' A' ' 12' ' ' ILE . 44.5 mm -73.35 106.39 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.92 0.391 . . . . 71.14 110.702 -176.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -75.73 -36.65 59.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.181 -0.674 . . . . 73.0 109.181 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.63 -179.47 39.33 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.783 -0.723 . . . . 61.33 112.371 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -126.59 150.64 48.76 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.442 -0.577 . . . . 72.12 109.442 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.28 165.48 17.4 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.412 -0.358 . . . . 73.44 111.453 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.0 -31.85 83.8 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.571 2.181 . . . . 74.33 112.094 175.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -86.11 -5.31 59.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.207 0.527 . . . . 71.21 110.262 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.48 -34.45 5.65 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.212 -0.755 . . . . 44.14 111.212 -174.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.556 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 4.2 p-10 -137.97 152.31 71.86 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 108.959 -0.756 . . . . 75.03 108.959 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 73.0 Cg_endo -72.26 173.3 53.47 Favored 'Cis proline' 0 C--O 1.234 0.288 0 C-N-CA 123.457 -1.476 . . . . 73.53 113.158 4.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.629 ' HB ' HD12 ' A' ' 56' ' ' LEU . 16.3 mm -97.04 147.32 6.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.514 -0.766 . . . . 73.43 109.304 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.51 111.24 23.88 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.314 -0.624 . . . . 61.51 109.314 174.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.629 HD12 ' HB ' ' A' ' 54' ' ' ILE . 2.3 mp -121.88 144.92 48.56 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.516 -0.311 . . . . 73.43 110.292 -175.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 54.9 mtt180 -100.1 108.14 20.22 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.344 -0.984 . . . . 63.43 108.344 166.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.823 HD22 HD13 ' A' ' 36' ' ' ILE . 2.4 pp -121.78 134.3 54.92 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.602 -0.727 . . . . 73.55 110.858 -173.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.468 ' HD3' ' OH ' ' A' ' 61' ' ' TYR . 50.3 ttt180 65.02 6.06 3.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.283 -0.872 . . . . 74.41 110.839 178.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.58 -19.58 9.72 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 116.019 -0.537 . . . . 64.34 112.794 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.468 ' OH ' ' HD3' ' A' ' 59' ' ' ARG . 4.4 p90 -127.67 148.97 50.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.359 0.599 . . . . 71.12 112.213 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 1.3 m -70.8 137.68 49.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.186 -0.915 . . . . 65.41 111.989 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.692 ' HB3' HD23 ' A' ' 58' ' ' LEU . 9.4 tt -150.99 148.86 28.89 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.689 -0.856 . . . . 65.02 108.689 176.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.1 t -115.07 132.14 56.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.179 0.514 . . . . 72.44 111.566 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.04 165.49 24.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.351 -0.841 . . . . 62.14 109.391 174.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -84.45 169.33 14.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.453 0.644 . . . . 73.31 112.384 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.556 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 37.0 ttmt -54.49 -35.09 62.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.751 -1.113 . . . . 73.31 111.704 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.1 t -66.15 -46.24 78.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.58 -0.282 . . . . 65.23 110.647 -176.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.674 ' HA ' HG21 ' A' ' 27' ' ' VAL . 1.9 mp0 -63.33 -43.92 96.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.942 0.401 . . . . 74.01 110.347 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 8' ' ' ASN . . . -66.49 -22.03 66.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 62.44 111.27 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -74.69 -29.04 61.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.102 -0.499 . . . . 71.45 110.883 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -93.46 19.72 8.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.946 0.403 . . . . 73.02 111.109 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.5 mt -126.04 117.6 49.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.602 -0.518 . . . . 72.15 109.602 174.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.7 mt -103.15 121.41 42.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.745 0.307 . . . . 74.13 110.205 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.918 HG12 ' HA ' ' A' ' 18' ' ' VAL . 35.6 m -137.09 172.58 14.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.968 0.414 . . . . 74.4 111.78 -174.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -143.37 156.68 44.74 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.427 -0.953 . . . . 75.42 108.427 171.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.738 ' HA ' HG11 ' A' ' 16' ' ' VAL . 11.8 p -64.71 147.92 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.003 0.43 . . . . 54.03 111.548 -175.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 17' ' ' LYS . 23.5 mt -75.4 3.8 8.47 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.038 -0.528 . . . . 63.44 112.394 -177.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.406 ' HG ' HG22 ' A' ' 77' ' ' VAL . 88.5 mt -67.28 96.0 0.46 Allowed 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.822 -0.436 . . . . 64.32 109.822 175.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -56.4 -51.62 67.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.005 -0.543 . . . . 62.32 111.656 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -87.38 86.9 7.29 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.55 -0.537 . . . . 75.54 109.55 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -130.59 142.98 50.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.11 -0.496 . . . . 60.31 110.453 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -100.46 128.41 46.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.85 -0.614 . . . . 74.23 110.468 -177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -81.29 107.93 14.49 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.058 -1.09 . . . . 73.33 108.058 172.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -78.2 121.52 24.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.487 0.661 . . . . 65.44 112.425 -165.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 C--O 1.251 1.143 0 CA-C-N 114.859 -1.064 . . . . 53.34 109.329 172.05 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.231 -0.285 . . . . 72.33 110.231 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.7 m -72.01 -53.18 13.77 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.267 -1.012 . . . . 52.21 108.267 167.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.616 ' HG2' HG21 ' A' ' 19' ' ' ILE . 26.4 ttmt 59.18 98.59 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 114.86 -1.064 . . . . 73.15 111.426 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.03 109.46 1.35 Allowed Glycine 0 N--CA 1.437 -1.233 0 CA-C-N 115.078 -0.964 . . . . 55.25 111.605 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.2 pt -85.03 167.76 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.688 -0.856 . . . . 73.13 108.688 175.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.75 146.83 40.79 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 119.429 -1.367 . . . . 52.15 111.076 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.4 tp -65.28 -17.79 64.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.309 0.576 . . . . 64.51 110.173 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -76.56 -20.54 56.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.749 -0.659 . . . . 74.52 110.358 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -89.09 -10.68 46.46 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.173 -0.467 . . . . 70.44 110.532 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 11' ' ' GLU . 17.1 t -84.45 160.43 3.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.906 -0.588 . . . . 72.31 110.087 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.818 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 28.5 tt0 -122.44 -173.58 2.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.668 0.27 . . . . 63.22 110.409 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.818 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 40.8 pt -68.93 154.04 8.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 113.322 0.86 . . . . 73.44 113.322 -170.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.4 mttt 59.86 22.14 11.09 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.57 -1.196 . . . . 74.55 113.256 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.64 ' HA ' HD12 ' A' ' 79' ' ' LEU . 16.5 m -104.74 155.4 18.92 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.428 -0.582 . . . . 54.32 109.428 174.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -115.06 136.7 52.83 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.488 -0.485 . . . . 72.04 110.0 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.814 HG12 ' HA ' ' A' ' 77' ' ' VAL . 29.9 m -140.17 -179.57 2.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.698 -0.683 . . . . 74.31 110.167 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -148.99 146.17 27.67 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.832 -0.432 . . . . 73.45 109.832 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.503 ' HA ' HG11 ' A' ' 75' ' ' VAL . 26.1 t -74.01 93.14 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.238 0.542 . . . . 71.14 110.146 -178.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.616 HG21 ' HG2' ' A' ' 3' ' ' LYS . 38.4 mm -81.64 -38.94 16.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.341 -0.845 . . . . 75.54 110.283 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.4 169.6 25.82 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.569 -0.824 . . . . 64.53 112.881 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.64 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 69.7 mt -136.9 155.26 32.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.613 -0.884 . . . . 73.21 108.613 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.0 t -103.26 91.37 3.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.872 0.368 . . . . 74.31 110.584 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.64 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 35.9 Cg_exo -59.06 172.99 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.375 2.717 . . . . 73.31 113.03 -175.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 60.18 26.3 15.71 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.715 -0.675 . . . . 72.01 111.328 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.767 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 15.6 t -104.15 142.77 33.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.228 -0.442 . . . . 72.13 110.412 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -79.04 -27.03 43.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.874 0.368 . . . . 75.44 110.222 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.6 m -84.97 -19.93 8.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 65.42 110.62 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.767 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 2.0 tmt_? -54.21 -35.15 62.08 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.426 -0.352 . . . . 75.32 110.641 174.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -57.03 -56.64 19.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.992 -0.549 . . . . 74.51 110.444 174.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -54.6 -46.82 73.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.475 -0.784 . . . . 71.41 111.135 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.467 HG23 ' HB ' ' A' ' 36' ' ' ILE . 96.1 mt -57.54 -53.45 44.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.331 -0.849 . . . . 74.04 111.806 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.447 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 77.1 mtp -75.04 -28.45 60.44 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.769 -0.372 . . . . 75.43 111.093 -176.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.54 -32.16 73.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.329 0.585 . . . . 75.42 109.932 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.2 mtt -78.23 -3.81 44.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.359 -0.837 . . . . 65.22 111.774 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.65 4.7 45.86 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.635 -0.793 . . . . 64.01 112.947 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.467 ' HB ' HG23 ' A' ' 31' ' ' ILE . 30.1 mt -89.08 124.04 41.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.975 0.417 . . . . 73.32 110.395 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.421 HG11 ' HE3' ' A' ' 32' ' ' MET . 28.1 m -143.81 168.81 11.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.581 -0.736 . . . . 74.34 110.055 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -66.96 108.39 2.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.052 0.453 . . . . 75.53 110.232 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.5 -18.69 4.6 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.823 -0.704 . . . . 63.51 111.855 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.2 m -75.27 143.87 42.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.927 0.394 . . . . 75.35 110.47 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -102.76 142.52 33.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.995 -0.548 . . . . 71.21 109.736 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.794 HG12 HD11 ' A' ' 58' ' ' LEU . 65.1 mt -123.96 126.1 71.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.817 -0.629 . . . . 74.25 110.939 -173.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -106.58 117.11 33.2 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.038 -0.727 . . . . 75.41 109.038 174.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.7 mm -76.47 114.95 17.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.842 0.353 . . . . 71.44 110.432 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -76.97 -46.51 23.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.251 0.548 . . . . 74.13 109.936 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.659 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 170.82 -170.94 43.56 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.606 -0.725 . . . . 71.43 111.668 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.605 ' HG2' HG22 ' A' ' 54' ' ' ILE . 51.7 mtpt -132.83 137.17 46.65 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.026 -0.731 . . . . 73.52 109.026 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . . . -58.87 158.48 16.32 Favored Pre-proline 0 C--N 1.328 -0.359 0 O-C-N 123.422 0.451 . . . . 75.13 110.943 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 48' ' ' ALA . 9.2 Cg_endo -52.91 -30.96 50.34 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.349 2.699 . . . . 71.23 113.625 -177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.9 ttt -94.48 4.62 53.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.425 0.631 . . . . 70.23 110.433 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.28 3.65 90.61 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 116.035 -0.53 . . . . 75.14 112.38 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -154.04 132.73 6.88 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.288 -0.634 . . . . 64.34 109.288 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.77 -178.03 21.59 Favored 'Cis proline' 0 C--O 1.235 0.373 0 C-N-CA 123.076 -1.635 . . . . 71.24 112.59 0.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.605 HG22 ' HG2' ' A' ' 47' ' ' LYS . 52.6 mt -104.24 126.46 58.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.576 -0.527 . . . . 73.21 109.576 177.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.51 102.84 9.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.183 0.516 . . . . 62.11 110.249 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 62' ' ' SER . 32.5 mt -112.81 146.05 39.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.781 -0.645 . . . . 55.32 110.399 -177.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 45.3 ttt180 -114.21 102.92 10.59 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.581 -0.896 . . . . 71.32 108.581 169.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.794 HD11 HG12 ' A' ' 42' ' ' ILE . 8.3 tt -123.7 147.01 47.84 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.35 -0.841 . . . . 74.55 110.351 -173.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.484 ' HB2' HD23 ' A' ' 58' ' ' LEU . 3.2 tmt_? 71.03 -51.68 0.68 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.306 -0.861 . . . . 64.55 110.907 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.67 -18.23 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.178 -0.534 . . . . 70.13 112.141 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -131.43 166.19 21.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.279 0.561 . . . . 75.03 110.974 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 41.9 t -82.79 144.61 30.03 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.16 -0.927 . . . . 75.34 110.401 177.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.6 tp -148.77 147.97 29.43 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.177 -0.92 . . . . 73.02 109.369 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -93.69 112.27 24.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.456 0.646 . . . . 71.3 110.805 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.441 HD22 HD13 ' A' ' 56' ' ' LEU . 4.0 mm? -111.06 144.1 40.73 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.153 -0.93 . . . . 63.41 109.218 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -87.86 170.09 11.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.123 0.487 . . . . 73.34 111.123 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -58.26 -33.07 68.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.31 -0.859 . . . . 72.45 110.571 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.453 ' HB2' ' OE1' ' A' ' 69' ' ' GLU . 10.3 m -57.62 -55.33 36.2 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.614 -0.721 . . . . 72.2 110.905 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' OE1' ' HB2' ' A' ' 68' ' ' SER . 1.9 mp0 -65.74 -40.1 91.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 73.32 110.749 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.57 -30.66 69.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.926 -0.579 . . . . 65.15 111.292 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -66.15 -38.58 88.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.008 0.433 . . . . 73.14 111.098 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.17 9.06 29.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.933 -0.576 . . . . 74.53 112.122 -173.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.585 HG23 HG13 ' A' ' 75' ' ' VAL . 66.8 mt -112.41 117.0 54.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.893 -0.41 . . . . 74.11 109.893 175.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.7 mt -97.82 111.7 23.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.039 0.447 . . . . 74.14 110.171 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.585 HG13 HG23 ' A' ' 73' ' ' ILE . 29.4 m -126.88 146.15 33.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.155 -0.475 . . . . 73.35 111.268 -176.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -107.18 139.8 41.04 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.398 -0.593 . . . . 63.43 109.398 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.814 ' HA ' HG12 ' A' ' 16' ' ' VAL . 40.8 t -71.22 104.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.093 -0.503 . . . . 73.2 110.369 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.8 mt -93.31 5.71 50.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.989 -0.551 . . . . 72.4 111.375 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.64 HD12 ' HA ' ' A' ' 14' ' ' SER . 4.3 tt -56.18 107.88 0.41 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.736 -0.838 . . . . 72.23 108.736 173.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.18 -178.05 6.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.971 -0.558 . . . . 74.0 111.745 -173.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 42.6 m80 65.54 -145.72 0.21 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.428 -0.806 . . . . 63.43 109.436 -173.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -167.25 -172.96 2.13 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.115 -0.698 . . . . 62.4 109.115 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -64.91 107.21 1.41 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.925 -0.769 . . . . 74.31 108.925 175.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -88.41 23.77 2.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.998 0.428 . . . . 74.32 110.972 -174.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -169.15 166.9 10.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.58 -0.896 . . . . 75.24 108.58 176.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.4 p80 . . . . . 0 C--O 1.245 0.827 0 CA-C-O 119.319 -0.372 . . . . 71.23 110.298 175.744 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.797 0.332 . . . . 74.24 110.221 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.9 m -83.78 100.04 10.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.023 0.439 . . . . 65.34 110.009 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -126.23 -4.84 6.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.826 -0.625 . . . . 62.0 110.26 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.73 129.8 30.52 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.205 -0.907 . . . . 37.41 112.884 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.8 pt -100.84 167.09 2.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.404 -0.591 . . . . 73.55 109.404 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 73' ' ' ILE . . . -69.61 145.84 42.72 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.19 -1.005 . . . . 73.24 111.704 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.489 HD23 HD11 ' A' ' 44' ' ' ILE . 2.2 tm? -54.95 -38.19 67.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.335 0.588 . . . . 74.04 109.909 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.465 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 34.9 t30 -61.54 -18.92 61.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.498 -0.774 . . . . 73.14 111.499 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -105.52 5.86 31.82 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.283 -0.417 . . . . 75.22 111.775 -171.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.429 HG11 ' N ' ' A' ' 11' ' ' GLU . 21.5 t -86.2 159.52 3.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.42 -0.355 . . . . 75.13 110.103 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.513 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 25.2 tt0 -85.42 171.75 11.57 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.626 -0.509 . . . . 73.2 109.626 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.513 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 35.7 pt -86.83 150.63 3.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.942 0.401 . . . . 75.14 111.72 -173.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 56.55 66.17 1.25 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.138 -0.937 . . . . 64.43 111.596 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.475 ' HA ' HD13 ' A' ' 79' ' ' LEU . 67.5 m -152.02 158.32 42.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.662 -1.154 . . . . 74.42 109.339 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HG2' ' HD1' ' A' ' 43' ' ' TYR . 65.6 mttp -105.76 131.25 53.34 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.843 0.354 . . . . 74.34 110.183 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.646 HG13 ' HA ' ' A' ' 77' ' ' VAL . 30.9 m -128.03 155.59 39.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.033 -0.53 . . . . 70.41 110.691 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -119.59 141.44 49.28 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.819 -0.628 . . . . 73.45 109.961 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.637 ' HA ' HG13 ' A' ' 75' ' ' VAL . 42.0 t -74.63 97.05 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.454 -0.794 . . . . 72.3 110.428 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.807 HD11 ' HB2' ' A' ' 76' ' ' GLU . 27.9 mt -62.67 -41.8 93.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.476 -0.784 . . . . 73.34 109.991 173.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.92 166.01 38.0 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.528 -0.844 . . . . 70.11 112.662 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.693 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 54.5 mt -107.62 160.32 6.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.595 -0.891 . . . . 73.22 108.595 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.11 90.8 1.19 Allowed Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.594 -0.521 . . . . 64.52 109.594 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.693 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 34.3 Cg_exo -56.59 167.01 3.1 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.882 3.055 . . . . 73.34 113.564 -170.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 65.17 15.26 9.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.186 -0.915 . . . . 72.53 110.208 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.939 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 37.0 t -67.6 152.87 44.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.075 -0.966 . . . . 75.53 109.732 176.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -87.74 -16.44 34.22 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.171 -0.678 . . . . 75.14 109.171 177.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.12 3.15 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.615 -0.721 . . . . 73.55 111.71 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.939 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 4.7 tmt_? -52.04 -40.85 61.71 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 110.11 -0.33 . . . . 64.1 110.11 173.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -58.41 -44.07 88.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.503 . . . . 73.31 110.611 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.447 ' HD3' ' HG2' ' A' ' 69' ' ' GLU . 88.8 tttt -62.86 -46.49 87.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.256 0.55 . . . . 71.24 110.258 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.534 HG22 HD13 ' A' ' 36' ' ' ILE . 82.6 mt -62.23 -46.14 97.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.298 -0.865 . . . . 74.55 111.262 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -39.84 93.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.055 -0.52 . . . . 73.24 110.553 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.82 -39.86 95.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.805 -0.634 . . . . 74.23 110.945 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.538 ' SD ' HD13 ' A' ' 65' ' ' LEU . 52.9 mtt -69.84 -13.23 62.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.181 -0.463 . . . . 74.34 111.557 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.78 36.9 5.4 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.626 -0.797 . . . . 71.24 112.89 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.534 HD13 HG22 ' A' ' 31' ' ' ILE . 40.4 mt -110.03 124.75 67.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.868 0.366 . . . . 73.33 110.333 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -145.09 177.38 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.606 -0.724 . . . . 74.32 109.693 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.442 ' C ' ' HD3' ' A' ' 38' ' ' ARG . 4.2 tmt_? -64.53 130.28 43.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.856 0.36 . . . . 74.21 110.145 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.01 -15.93 60.02 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.96 -0.638 . . . . 71.32 112.612 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.7 m -79.37 148.74 31.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.962 -0.385 . . . . 74.3 109.962 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -104.08 148.36 26.34 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.164 0.507 . . . . 74.23 110.734 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.412 HG12 ' HB3' ' A' ' 58' ' ' LEU . 79.6 mt -127.91 123.9 61.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.265 -0.88 . . . . 74.41 109.423 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.746 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 50.8 t80 -88.78 114.36 25.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.97 0.414 . . . . 65.53 110.378 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.489 HD11 HD23 ' A' ' 7' ' ' LEU . 21.1 mm -81.34 107.03 13.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.803 -0.635 . . . . 75.51 109.302 176.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -83.16 -53.26 5.91 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.776 -0.824 . . . . 64.14 108.776 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.76 147.43 6.56 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.311 -0.947 . . . . 64.42 112.607 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.565 ' HG2' HG21 ' A' ' 54' ' ' ILE . 51.6 mtpt -88.67 149.14 23.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.353 -0.98 . . . . 73.3 108.353 173.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.77 156.42 24.86 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 110.491 -0.189 . . . . 72.42 110.491 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.88 -16.84 27.57 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.681 2.254 . . . . 75.15 111.94 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.1 ttm -92.43 -12.55 31.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.65 -0.704 . . . . 75.03 110.275 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.75 -29.38 11.44 Favored Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 115.846 -0.616 . . . . 54.33 111.869 -177.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -142.17 147.56 44.49 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 108.923 -0.769 . . . . 73.55 108.923 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -79.71 -179.27 25.71 Favored 'Cis proline' 0 C--O 1.236 0.381 0 C-N-CA 123.317 -1.535 . . . . 74.1 112.472 -0.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.565 HG21 ' HG2' ' A' ' 47' ' ' LYS . 33.3 mt -113.23 124.75 70.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.92 -0.4 . . . . 65.44 109.92 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.08 106.78 11.36 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.908 0.385 . . . . 73.11 110.61 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 62' ' ' SER . 63.8 mt -119.64 142.26 48.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.098 -0.501 . . . . 75.21 110.808 -175.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.746 ' HB3' ' HB3' ' A' ' 43' ' ' TYR . 36.1 ttt180 -110.97 100.97 9.58 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.67 -0.863 . . . . 73.41 108.67 171.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.426 HD21 HD11 ' A' ' 36' ' ' ILE . 3.2 pp -131.41 151.21 51.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.81 -0.632 . . . . 75.31 110.616 -173.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? 71.66 -39.39 0.45 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.37 0.668 . . . . 73.04 111.174 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 170.64 -27.35 0.11 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.152 -0.547 . . . . 74.44 112.262 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -124.46 169.15 12.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.971 0.415 . . . . 75.34 111.346 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 46.5 t -99.48 146.8 25.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.583 -0.735 . . . . 71.31 110.894 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -164.6 161.3 20.92 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.282 -0.872 . . . . 75.01 109.425 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.94 116.89 31.07 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.07 0.462 . . . . 75.15 111.625 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.538 HD13 ' SD ' ' A' ' 34' ' ' MET . 4.1 mm? -98.15 158.84 15.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.757 -0.656 . . . . 63.4 110.881 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -81.87 156.19 24.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.15 -0.477 . . . . 63.53 111.383 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -53.83 -45.21 70.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.728 -0.669 . . . . 70.31 110.982 173.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.2 m -57.77 -50.39 73.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.592 -0.731 . . . . 53.35 111.958 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.447 ' HG2' ' HD3' ' A' ' 30' ' ' LYS . 2.2 mp0 -71.79 -31.06 66.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 74.25 111.536 -175.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 8' ' ' ASN . . . -68.69 -23.11 64.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.25 0.463 . . . . 73.41 112.25 -173.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -87.19 -11.28 50.31 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.957 -0.697 . . . . 62.12 110.682 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.56 0.93 35.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.179 -0.464 . . . . 74.21 111.021 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.477 ' O ' ' HA2' ' A' ' 6' ' ' GLY . 59.5 mt -118.52 126.48 75.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.951 -0.568 . . . . 64.31 109.984 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.2 mt -103.15 122.32 44.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.072 -0.344 . . . . 75.34 110.072 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.637 HG13 ' HA ' ' A' ' 18' ' ' VAL . 29.8 m -131.38 164.3 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.714 0.635 . . . . 75.34 112.714 -172.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.807 ' HB2' HD11 ' A' ' 19' ' ' ILE . 3.7 tp10 -111.21 136.9 49.61 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.916 -1.038 . . . . 73.11 109.477 173.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.646 ' HA ' HG13 ' A' ' 16' ' ' VAL . 46.8 t -82.66 104.67 11.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.534 -0.543 . . . . 42.13 109.534 178.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.8 mt -74.79 -25.18 58.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.224 0.535 . . . . 44.13 110.938 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.475 HD13 ' HA ' ' A' ' 14' ' ' SER . 38.8 mt -92.04 84.66 5.34 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.593 -0.73 . . . . 74.44 111.292 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -94.56 13.08 25.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.476 -0.564 . . . . 65.31 109.476 174.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 69.34 159.04 0.17 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.833 -1.076 . . . . 63.04 111.319 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.419 ' HD2' ' CD2' ' A' ' 83' ' ' HIS . 7.9 t60 -79.43 -33.72 42.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.102 -0.499 . . . . 62.54 109.986 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.419 ' CD2' ' HD2' ' A' ' 82' ' ' HIS . 11.2 m-70 -125.09 145.66 49.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.065 -0.516 . . . . 64.45 109.757 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -74.59 94.91 2.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.88 0.848 . . . . 72.12 110.564 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -94.27 143.99 25.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.2 -0.909 . . . . 63.25 110.509 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.6 t60 . . . . . 0 C--O 1.244 0.804 0 CA-C-O 118.325 -0.845 . . . . 65.23 109.579 176.355 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.903 0.382 . . . . 72.11 110.712 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.4 m -87.79 106.47 18.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.896 0.379 . . . . 62.51 110.943 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.69 147.58 42.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.178 -0.465 . . . . 62.23 110.118 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.02 146.21 16.04 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.753 -0.737 . . . . 74.02 112.097 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.2 pt -134.02 173.64 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.685 0.279 . . . . 74.15 110.318 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.65 157.85 38.48 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.59 -0.814 . . . . 70.3 111.099 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 7' ' ' LEU . 2.0 tm? -54.65 -35.22 63.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.089 0.471 . . . . 73.32 110.67 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -71.58 -11.95 61.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.126 -0.488 . . . . 73.25 111.871 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -99.26 -5.6 29.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.765 0.317 . . . . 72.53 111.259 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 11' ' ' GLU . 15.5 t -77.21 162.57 4.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.259 -0.428 . . . . 72.04 110.564 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.414 ' N ' HG12 ' A' ' 10' ' ' VAL . 23.4 tt0 -96.74 170.27 9.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.627 -0.508 . . . . 73.22 109.627 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.1 pt -76.65 146.63 8.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.835 0.35 . . . . 73.43 111.533 -174.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 61.16 25.65 15.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.378 -0.828 . . . . 73.44 111.925 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.5 m -105.13 148.1 27.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.928 -0.578 . . . . 63.41 109.592 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.516 ' HG2' HD12 ' A' ' 78' ' ' LEU . 45.5 tttm -105.43 126.1 51.73 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.78 -0.452 . . . . 72.33 109.78 -177.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.535 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 17.6 m -131.71 162.87 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.3 0.571 . . . . 72.0 111.634 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.681 ' HE3' ' HA2' ' A' ' 39' ' ' GLY . 2.1 tmtp? -122.36 145.19 48.49 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.5 -0.773 . . . . 72.13 110.094 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.5 t -73.4 97.49 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.094 -0.503 . . . . 71.23 110.872 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.526 HD12 ' HB2' ' A' ' 76' ' ' GLU . 45.6 mt -54.51 -46.96 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 115.619 -0.718 . . . . 71.52 109.616 170.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.46 173.42 39.72 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.328 -0.851 . . . . 71.34 112.451 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.1 mt -96.94 157.9 3.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.36 -0.608 . . . . 72.23 109.36 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.2 91.76 1.83 Allowed Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.764 -0.458 . . . . 53.2 109.764 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.09 165.48 0.88 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 124.055 3.17 . . . . 71.14 113.783 -171.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.468 ' H ' ' NH1' ' A' ' 28' ' ' ARG . 0.5 OUTLIER 64.88 24.06 12.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.093 -0.958 . . . . 74.53 111.486 -177.355 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.541 ' OG ' HG22 ' A' ' 27' ' ' VAL . 40.7 t -93.14 150.97 20.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.653 -0.703 . . . . 72.25 109.778 173.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -82.39 -18.17 42.95 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.933 -0.395 . . . . 73.11 109.933 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.562 HG23 ' HA ' ' A' ' 69' ' ' GLU . 11.2 m -94.75 -9.44 9.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.34 -0.391 . . . . 55.23 110.343 176.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.468 ' NH1' ' H ' ' A' ' 24' ' ' GLU . 52.2 ttp180 -50.6 -49.09 57.39 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.272 0.558 . . . . 70.21 110.121 170.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -62.06 -37.44 84.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.205 -0.907 . . . . 75.14 110.499 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -62.36 -44.99 95.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.726 -0.67 . . . . 74.14 110.824 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.449 HG13 HD11 ' A' ' 73' ' ' ILE . 47.5 mm -63.91 -48.32 86.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.761 -0.654 . . . . 73.24 111.247 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.9 mmt -64.84 -33.41 75.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 75.42 110.732 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.38 -28.14 68.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.871 -0.604 . . . . 73.14 110.361 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 82.6 mmm -81.58 -8.82 59.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.762 -0.654 . . . . 74.43 110.95 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.07 24.79 47.14 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.747 -0.74 . . . . 75.42 112.534 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mt -102.09 134.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.733 -0.469 . . . . 74.13 109.733 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.14 169.99 20.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.18 0.514 . . . . 62.41 111.598 -175.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.423 ' C ' ' HD3' ' A' ' 38' ' ' ARG . 4.1 tmt_? -68.28 110.49 4.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.783 -0.644 . . . . 61.43 109.541 175.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.681 ' HA2' ' HE3' ' A' ' 17' ' ' LYS . . . 132.32 -16.7 4.87 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.763 -0.732 . . . . 74.42 111.952 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 m -71.12 148.9 46.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.877 0.37 . . . . 74.41 110.547 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.431 ' C ' HD13 ' A' ' 42' ' ' ILE . 40.3 mt-10 -100.04 132.35 45.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.962 -0.563 . . . . 74.14 110.361 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.629 HG13 ' HB3' ' A' ' 58' ' ' LEU . 2.0 mp -118.98 122.12 68.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.31 0.576 . . . . 71.31 110.179 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.691 ' HB3' ' HB2' ' A' ' 57' ' ' ARG . 82.3 t80 -96.13 116.78 29.51 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.654 -0.869 . . . . 75.51 108.654 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.2 mm -71.7 101.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.683 -0.488 . . . . 74.11 109.683 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.34 -33.58 69.73 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.365 -0.605 . . . . 74.23 109.365 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.32 150.54 5.6 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.652 -0.785 . . . . 75.34 112.563 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -88.93 154.42 20.25 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.474 -0.936 . . . . 72.45 108.474 173.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.88 151.98 51.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.593 -0.521 . . . . 73.55 109.593 175.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.79 -23.91 61.0 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.49 2.127 . . . . 74.1 111.81 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ttt -86.0 -17.84 34.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.761 -0.654 . . . . 74.14 110.213 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.05 -23.64 20.72 Favored Glycine 0 C--N 1.33 0.2 0 CA-C-N 116.06 -0.518 . . . . 74.34 112.795 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.43 ' OD1' ' HA ' ' A' ' 53' ' ' PRO . 28.9 t70 -145.91 137.0 12.6 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.233 -0.654 . . . . 74.41 109.233 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.43 ' HA ' ' OD1' ' A' ' 52' ' ' ASP . 4.2 Cg_exo -81.53 -168.84 6.95 Favored 'Cis proline' 0 CA--C 1.534 0.49 0 C-N-CA 124.157 -1.185 . . . . 64.21 113.194 0.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 64' ' ' SER . 57.8 mt -121.17 142.86 35.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 73.12 110.138 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.34 112.95 25.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.928 0.394 . . . . 74.33 110.652 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.624 ' O ' ' HA ' ' A' ' 62' ' ' SER . 4.0 mp -107.7 132.32 53.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 73.52 110.741 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.691 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 27.7 mmt180 -90.33 100.48 13.31 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.27 -0.641 . . . . 65.14 109.27 173.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.629 ' HB3' HG13 ' A' ' 42' ' ' ILE . 2.8 pp -137.66 142.6 41.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.984 -0.553 . . . . 74.4 110.016 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 70.63 -4.12 1.75 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.332 0.587 . . . . 71.14 110.42 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 133.26 -41.22 1.5 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.959 -0.564 . . . . 37.36 112.303 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -113.26 159.53 19.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.46 0.648 . . . . 71.45 111.985 -175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 36.1 t -82.25 148.09 28.57 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.879 -1.055 . . . . 72.12 110.289 173.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 42.1 tp -151.08 146.38 26.13 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.554 -0.748 . . . . 64.13 109.793 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -89.01 113.99 25.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.199 0.524 . . . . 75.05 111.64 -178.404 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.492 HD21 HD12 ' A' ' 56' ' ' LEU . 3.6 mm? -112.89 157.16 21.78 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.067 -0.716 . . . . 73.3 109.067 174.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -84.3 160.8 20.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.864 0.364 . . . . 64.31 111.131 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.459 ' HA ' ' HB1' ' A' ' 70' ' ' ALA . 1.6 tmtp? -55.39 -28.44 54.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.627 -0.715 . . . . 52.44 110.667 175.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.8 m -56.6 -56.87 15.94 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.365 -0.38 . . . . 72.53 110.494 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.562 ' HA ' HG23 ' A' ' 27' ' ' VAL . 1.8 mp0 -63.61 -40.19 96.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.095 0.474 . . . . 70.15 110.353 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 67' ' ' LYS . . . -62.86 -20.97 65.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.572 -0.74 . . . . 74.21 111.648 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.477 ' C ' ' HD2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -79.22 -39.05 34.2 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.058 -0.349 . . . . 70.52 110.058 177.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -89.76 8.44 31.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.196 -0.457 . . . . 75.12 112.2 -171.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.449 HD11 HG13 ' A' ' 31' ' ' ILE . 47.1 mm -115.07 113.02 42.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.872 -0.418 . . . . 73.02 109.872 175.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.7 mt -93.45 126.44 38.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.776 -0.453 . . . . 60.45 109.776 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.535 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 18.6 m -128.14 153.27 37.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.277 0.561 . . . . 73.12 112.124 -174.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.526 ' HB2' HD12 ' A' ' 19' ' ' ILE . 42.2 tt0 -119.6 144.33 47.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.004 -0.998 . . . . 73.3 108.812 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.49 HG21 ' HG ' ' A' ' 79' ' ' LEU . 9.3 p -70.38 136.66 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.071 0.462 . . . . 75.15 111.076 -176.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.551 HD21 ' HB2' ' A' ' 17' ' ' LYS . 40.8 mt -95.74 6.34 49.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.284 0.476 . . . . 64.13 112.284 -176.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.49 ' HG ' HG21 ' A' ' 77' ' ' VAL . 94.6 mt -58.19 108.52 0.62 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.829 0.347 . . . . 72.22 110.376 176.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -83.74 78.36 9.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.771 0.796 . . . . 73.45 110.911 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -148.39 130.67 15.57 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.774 -1.103 . . . . 65.51 108.968 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -88.23 -25.5 22.84 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.97 0.414 . . . . 74.52 110.5 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -106.06 85.22 2.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.098 -0.501 . . . . 74.04 109.974 175.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -168.73 131.99 1.41 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.722 -0.672 . . . . 74.33 110.205 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -100.37 -93.46 0.28 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.559 -0.534 . . . . 70.25 109.559 174.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.5 p80 . . . . . 0 C--O 1.247 0.924 0 CA-C-O 119.03 -0.509 . . . . 73.35 110.117 176.011 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 tmm? . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 109.496 -0.557 . . . . 64.22 109.496 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.688 HG21 ' H ' ' A' ' 4' ' ' GLY . 87.9 m -144.22 124.02 13.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.331 -0.395 . . . . 74.24 110.013 175.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -82.5 8.39 11.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 74.31 110.654 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.688 ' H ' HG21 ' A' ' 2' ' ' THR . . . 76.09 -154.53 44.84 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.495 -0.775 . . . . 61.43 111.912 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.8 pt -125.24 168.12 18.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.948 -0.76 . . . . 73.23 108.948 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.24 149.1 50.77 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.027 -1.082 . . . . 72.21 111.033 177.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.672 HD21 HD11 ' A' ' 44' ' ' ILE . 2.7 tm? -54.43 -33.18 58.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.389 0.614 . . . . 73.52 109.89 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' A' ' 71' ' ' LYS . 8.7 p30 -70.62 -19.46 62.82 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.574 -0.739 . . . . 72.4 111.307 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -92.23 -8.12 46.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.903 0.382 . . . . 74.04 110.789 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.1 t -80.28 157.62 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.112 -0.495 . . . . 74.55 110.029 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.59 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 21.1 tt0 -94.81 176.81 6.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.793 -0.447 . . . . 75.12 109.793 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.59 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 39.9 pt -84.73 160.5 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 112.23 0.455 . . . . 71.32 112.23 -173.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 60.59 46.92 8.89 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.121 -0.945 . . . . 64.53 111.998 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.7 m -145.53 154.06 41.79 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.583 -0.735 . . . . 73.34 109.636 174.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.781 ' HE2' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -109.22 130.89 55.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.34 0.59 . . . . 72.44 110.802 178.674 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.564 HG13 ' HA ' ' A' ' 77' ' ' VAL . 27.1 m -132.28 163.73 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.133 -0.94 . . . . 63.51 110.343 -177.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.431 ' HB2' HD21 ' A' ' 78' ' ' LEU . 29.8 ttpt -115.48 143.48 45.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.992 -0.549 . . . . 75.21 110.656 -177.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.556 ' HA ' HG13 ' A' ' 75' ' ' VAL . 52.8 t -77.61 98.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.509 -0.768 . . . . 72.43 110.048 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.789 HD13 ' HB3' ' A' ' 76' ' ' GLU . 39.8 mt -57.41 -54.69 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.638 -0.71 . . . . 72.45 110.453 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -161.6 178.01 37.65 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.158 -0.928 . . . . 73.34 111.34 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 53.6 mt -113.2 155.84 14.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.963 -0.384 . . . . 70.03 109.963 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.8 t -101.82 91.27 2.26 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.213 -0.662 . . . . 75.41 109.213 175.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.691 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 25.7 Cg_endo -59.22 -168.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.844 3.029 . . . . 61.33 113.773 -172.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 68.3 -43.86 0.49 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.571 -0.741 . . . . 74.43 112.371 -173.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.576 ' OG ' HG23 ' A' ' 27' ' ' VAL . 8.6 t -55.57 145.19 23.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.219 0.533 . . . . 72.1 111.725 -176.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.842 ' HD3' ' H ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -71.73 -29.68 64.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.567 -0.742 . . . . 62.43 109.805 173.071 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.669 HG21 ' HA ' ' A' ' 69' ' ' GLU . 11.4 m -79.84 -17.37 12.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.948 0.404 . . . . 75.35 110.049 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.691 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 2.8 tmm_? -55.18 -36.93 66.4 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.064 -0.516 . . . . 70.45 109.999 169.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -71.48 -40.07 70.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.292 0.568 . . . . 73.41 109.805 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.628 ' HG2' ' OE2' ' A' ' 69' ' ' GLU . 23.5 tptm -53.05 -48.04 67.96 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 114.988 -1.005 . . . . 74.54 111.021 177.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 27' ' ' VAL . 61.5 mt -50.99 -53.29 14.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.566 -0.743 . . . . 73.31 111.386 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 59.3 mtt -66.76 -35.39 79.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 73.42 111.371 -178.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.83 -38.58 89.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.943 0.401 . . . . 61.44 110.022 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.6 tpt -65.75 -25.57 67.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.472 -0.786 . . . . 75.32 110.961 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.87 8.09 11.09 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.756 -0.735 . . . . 41.23 112.744 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.417 ' HB ' ' CG2' ' A' ' 31' ' ' ILE . 37.4 mt -104.61 133.28 49.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.711 -0.477 . . . . 71.33 109.711 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.653 HG23 ' H ' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -129.78 -85.89 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 112.092 0.404 . . . . 70.24 112.092 -177.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.653 ' H ' HG23 ' A' ' 37' ' ' VAL . 45.4 ttm180 -153.99 117.56 4.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.964 0.412 . . . . 64.44 110.263 -177.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.43 -1.05 68.89 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.492 -0.861 . . . . 74.55 111.534 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.0 m -66.65 140.85 57.94 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.675 -0.491 . . . . 74.34 109.675 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.504 ' HG2' HD11 ' A' ' 78' ' ' LEU . 35.5 mt-10 -107.07 128.15 54.11 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.803 -0.635 . . . . 71.45 110.029 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.679 HG23 HD23 ' A' ' 56' ' ' LEU . 77.5 mt -121.48 136.28 58.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.317 -0.856 . . . . 73.12 110.535 -172.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.647 ' HD1' ' HB3' ' A' ' 15' ' ' LYS . 37.4 t80 -100.87 105.88 17.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.262 -0.426 . . . . 72.43 109.869 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.672 HD11 HD21 ' A' ' 7' ' ' LEU . 50.4 mm -70.54 120.92 19.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.941 -0.392 . . . . 73.42 109.941 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -89.96 -65.82 0.98 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.09 -0.504 . . . . 65.45 110.516 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.403 ' HA2' ' CG2' ' A' ' 12' ' ' ILE . . . -159.06 173.44 35.92 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.687 -0.768 . . . . 74.41 112.027 -177.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HG2' HG22 ' A' ' 54' ' ' ILE . 58.3 mtpt -129.52 146.98 51.28 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.32 -0.622 . . . . 75.33 109.32 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.67 157.13 68.42 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.497 -0.557 . . . . 64.12 109.497 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -52.3 -29.74 39.76 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.82 2.347 . . . . 73.24 113.196 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -82.43 -7.95 59.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 74.03 110.821 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.11 -8.34 78.62 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.012 -0.835 . . . . 74.54 111.012 -173.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.769 ' HB2' ' HB2' ' A' ' 67' ' ' LYS . 5.9 t70 -139.29 128.98 14.26 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.014 -0.593 . . . . 73.54 109.797 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -87.0 -174.32 9.8 Favored 'Cis proline' 0 C--O 1.237 0.459 0 C-N-CA 123.374 -1.511 . . . . 74.12 113.05 0.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.473 HG22 ' HG2' ' A' ' 47' ' ' LYS . 4.6 mp -112.86 140.78 30.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.791 -0.641 . . . . 55.25 109.31 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.65 106.76 19.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.025 0.441 . . . . 61.33 110.839 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.679 HD23 HG23 ' A' ' 42' ' ' ILE . 3.1 mp -105.51 134.27 48.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.836 -0.62 . . . . 74.13 109.381 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 39.6 mtt180 -98.19 119.98 37.81 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.982 0.42 . . . . 72.43 110.114 175.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.42 ' HG ' HD21 ' A' ' 63' ' ' LEU . 3.4 pp -139.43 140.58 37.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.431 -0.804 . . . . 75.03 109.999 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 46.7 ttm-85 65.9 -0.25 1.38 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.31 -0.859 . . . . 71.4 111.993 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.05 -52.02 0.56 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.468 -0.872 . . . . 55.25 113.585 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -120.87 177.33 5.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.871 0.367 . . . . 73.51 111.722 -173.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.439 ' C ' HD22 ' A' ' 63' ' ' LEU . 30.2 t -88.18 142.9 27.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.596 0.712 . . . . 74.53 112.226 -175.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.439 HD22 ' C ' ' A' ' 62' ' ' SER . 3.2 mm? -134.68 143.54 47.29 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.342 -1.299 . . . . 54.33 108.928 176.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 p -99.33 119.91 38.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.078 0.466 . . . . 62.34 111.695 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.505 HD12 HD12 ' A' ' 56' ' ' LEU . 9.0 mp -114.72 151.42 33.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.86 -0.609 . . . . 70.51 109.423 175.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.489 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 46.8 mmm-85 -75.61 159.81 30.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.32 0.581 . . . . 75.22 111.745 -174.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.769 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -61.94 -33.58 74.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.246 -0.888 . . . . 60.34 110.611 179.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 41.7 m -73.3 -35.47 66.13 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.978 -0.555 . . . . 73.23 111.204 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.669 ' HA ' HG21 ' A' ' 27' ' ' VAL . 39.4 mt-10 -70.11 -43.01 71.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.351 0.596 . . . . 65.52 109.401 176.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.71 -21.25 65.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.386 -0.825 . . . . 65.22 111.072 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.443 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 1.8 ttpm? -70.74 -35.64 72.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.076 -0.511 . . . . 64.35 110.517 176.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -84.46 14.44 4.51 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.586 -0.734 . . . . 73.44 111.204 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.405 HG12 HD13 ' A' ' 31' ' ' ILE . 54.7 mt -125.8 120.47 57.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.897 -0.592 . . . . 65.05 109.909 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.1 mt -104.01 126.1 50.88 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.955 -0.387 . . . . 75.53 109.955 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.556 HG13 ' HA ' ' A' ' 18' ' ' VAL . 23.9 m -129.51 157.44 42.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.318 0.58 . . . . 74.43 112.372 -174.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.789 ' HB3' HD13 ' A' ' 19' ' ' ILE . 14.0 pt-20 -119.22 153.35 35.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.265 -0.88 . . . . 73.03 109.681 176.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.564 ' HA ' HG13 ' A' ' 16' ' ' VAL . 13.1 p -77.92 133.09 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.988 0.423 . . . . 61.42 111.024 -177.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.504 HD11 ' HG2' ' A' ' 41' ' ' GLU . 96.9 mt -93.86 -9.63 36.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.362 0.601 . . . . 61.53 110.826 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.781 HD23 ' HE2' ' A' ' 15' ' ' LYS . 86.9 mt -90.04 132.54 35.33 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.259 -0.882 . . . . 75.1 111.553 -177.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.472 ' HG2' ' H ' ' A' ' 81' ' ' HIS . 25.2 tt0 71.56 170.08 0.32 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 124.186 0.929 . . . . 74.0 111.183 175.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.472 ' H ' ' HG2' ' A' ' 80' ' ' GLU . 79.3 m80 -88.41 -8.09 55.56 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.102 -0.703 . . . . 73.1 109.102 171.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.437 ' H ' ' HG2' ' A' ' 80' ' ' GLU . 12.0 t-160 62.56 87.16 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.614 -1.176 . . . . 75.35 110.735 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -65.49 119.32 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.835 -0.62 . . . . 73.33 111.013 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 53.4 t60 70.6 116.92 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.842 -1.072 . . . . 72.42 111.618 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -81.33 115.85 20.89 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.431 -0.804 . . . . 63.44 109.49 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.029 -0.986 . . . . 65.32 110.726 179.731 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.438 ' O ' ' HB ' ' A' ' 2' ' ' THR . 97.7 mmm . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 109.903 -0.406 . . . . 52.21 109.903 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 1' ' ' MET . 88.8 m 75.21 114.23 0.06 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.87 0.731 . . . . 62.33 110.254 -175.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt 66.25 24.53 10.68 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.466 -0.788 . . . . 71.02 110.098 -173.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.97 178.35 33.35 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.349 -0.841 . . . . 53.51 112.6 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 pt -115.37 173.07 3.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.808 -0.812 . . . . 73.5 108.808 176.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.45 143.2 29.08 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 119.865 -1.16 . . . . 61.43 111.72 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.467 HD12 HD12 ' A' ' 44' ' ' ILE . 39.5 tp -63.61 -24.71 67.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.2 0.524 . . . . 73.34 110.548 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -76.52 -14.39 60.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.853 -0.612 . . . . 74.51 110.604 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.85 -4.63 56.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.339 0.59 . . . . 74.33 110.012 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.5 t -98.26 162.28 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.505 -0.771 . . . . 62.15 109.399 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.776 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 24.8 tt0 -124.77 -172.0 2.47 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.98 -0.288 . . . . 72.44 110.79 -177.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.776 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 31.6 pt -63.35 154.13 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 113.445 0.906 . . . . 73.02 113.445 -170.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 63.02 27.1 15.77 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.965 -1.016 . . . . 62.15 111.962 173.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.801 ' HA ' HD12 ' A' ' 79' ' ' LEU . 19.6 m -102.42 152.66 20.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.259 -0.428 . . . . 65.1 110.53 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -124.17 110.92 15.28 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.235 -0.654 . . . . 71.43 109.235 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.494 HG11 ' HA ' ' A' ' 77' ' ' VAL . 30.4 m -128.32 174.17 12.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.534 -0.757 . . . . 70.01 110.687 -174.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 37.5 ttmt -129.18 140.98 51.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.154 -0.475 . . . . 75.23 110.595 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.545 HG12 HG21 ' A' ' 73' ' ' ILE . 48.7 t -73.36 96.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.319 -0.855 . . . . 64.24 110.619 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.8 mm -63.29 -44.9 99.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.76 -0.655 . . . . 65.32 109.908 174.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.93 172.08 44.51 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.233 -0.984 . . . . 74.33 112.671 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.593 ' HB ' ' NH1' ' A' ' 28' ' ' ARG . 49.4 mt -127.77 158.98 39.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 108.068 -1.086 . . . . 73.2 108.068 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.425 ' O ' ' HB2' ' A' ' 25' ' ' SER . 38.2 t -101.19 91.3 1.96 Allowed Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.058 0.456 . . . . 75.51 111.254 -175.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.622 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 24.4 Cg_endo -59.94 171.55 2.86 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.696 2.264 . . . . 64.42 112.35 -177.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 68.93 -5.28 1.05 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.682 -0.69 . . . . 74.33 111.488 -175.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 1.2 m -78.74 156.77 28.72 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.955 -0.387 . . . . 73.3 109.955 173.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -75.33 -31.43 60.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.894 0.378 . . . . 75.22 110.599 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.511 ' HB ' ' HG3' ' A' ' 69' ' ' GLU . 29.6 m -81.47 -21.61 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 70.34 110.77 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.622 ' HG2' ' HA ' ' A' ' 23' ' ' PRO . 17.7 tpt180 -53.02 -43.78 66.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.94 -0.573 . . . . 61.12 110.465 175.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -59.43 -44.65 92.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.587 -0.733 . . . . 64.33 110.771 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 34' ' ' MET . 88.6 tttt -63.85 -48.93 74.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.818 -0.628 . . . . 75.51 110.931 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 27' ' ' VAL . 82.1 mt -57.33 -45.81 85.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.822 -0.627 . . . . 71.01 111.392 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 95.4 mmm -68.57 -35.5 77.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.795 0.331 . . . . 71.31 110.593 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -66.32 -39.96 89.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.99 -0.55 . . . . 74.42 110.255 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.484 ' HE1' HD12 ' A' ' 63' ' ' LEU . 91.0 mmm -60.52 -34.73 74.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.818 -0.628 . . . . 74.22 110.735 176.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.58 13.82 9.29 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.64 -0.791 . . . . 73.45 112.894 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.7 mt -89.64 127.1 42.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.86 0.362 . . . . 74.32 110.052 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.36 173.13 14.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.722 -0.672 . . . . 64.03 110.675 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.59 135.27 57.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.185 -0.461 . . . . 75.0 110.619 178.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.24 -12.09 66.89 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.908 -0.587 . . . . 73.12 112.662 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.3 m -73.29 142.24 47.17 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.859 -0.423 . . . . 71.12 109.859 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -94.39 136.14 35.02 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.065 0.459 . . . . 65.22 109.785 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.2 mm -116.74 117.82 56.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.643 -0.708 . . . . 75.1 110.463 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 63.4 t80 -95.52 119.48 34.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.854 -0.612 . . . . 74.54 109.436 174.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.467 HD12 HD12 ' A' ' 7' ' ' LEU . 26.3 mm -76.3 101.88 2.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.612 -0.514 . . . . 51.13 109.612 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -70.35 -42.83 71.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.934 -0.575 . . . . 71.11 109.601 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 169.75 177.78 40.42 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.889 -0.672 . . . . 75.34 111.956 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -117.97 143.09 46.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.132 -0.692 . . . . 72.54 109.132 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.64 158.46 31.13 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.605 -0.271 . . . . 63.55 110.394 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -45.41 -41.73 17.8 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.201 2.6 . . . . 72.21 113.419 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.7 ttt -71.22 -21.97 62.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 74.35 111.382 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.59 -7.22 42.31 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.728 -0.949 . . . . 71.01 110.728 -172.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.5 ' OD1' ' HA ' ' A' ' 53' ' ' PRO . 21.8 t70 -155.54 139.25 11.2 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.838 -0.801 . . . . 74.15 108.838 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.5 ' HA ' ' OD1' ' A' ' 52' ' ' ASP . 4.1 Cg_exo -79.45 -170.19 8.51 Favored 'Cis proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.829 -1.321 . . . . 75.24 113.05 2.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.5 mt -116.39 137.5 49.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.713 -0.676 . . . . 74.23 109.904 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.03 111.65 20.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.291 -0.413 . . . . 60.24 110.287 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.6 mt -114.04 135.96 53.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.967 -0.561 . . . . 75.23 109.903 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.706 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 44.4 ttt180 -94.83 107.4 19.41 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.698 -0.482 . . . . 73.22 109.698 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -132.69 153.63 50.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.271 -0.422 . . . . 73.24 110.288 -177.539 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.537 ' HB2' HD23 ' A' ' 58' ' ' LEU . 0.2 OUTLIER 70.62 -55.63 0.63 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.773 0.671 . . . . 70.31 110.631 -178.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.53 -33.03 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 116.116 -0.493 . . . . 74.31 111.956 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -125.85 165.58 18.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.822 0.344 . . . . 75.4 110.938 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.706 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 47.7 t -86.28 145.82 26.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.243 0.544 . . . . 75.1 110.973 -178.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.484 HD12 ' HE1' ' A' ' 34' ' ' MET . 91.1 mt -145.31 161.22 40.14 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.052 -0.976 . . . . 75.45 109.483 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -97.17 121.18 38.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.044 0.449 . . . . 65.34 110.741 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.42 143.31 49.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.355 -0.839 . . . . 75.52 109.389 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.479 ' HA ' ' HB3' ' A' ' 53' ' ' PRO . 37.4 mmt180 -71.82 155.14 40.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.073 0.463 . . . . 72.23 110.898 -177.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -56.27 -30.9 63.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.381 -0.827 . . . . 72.05 111.045 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.9 p -63.81 -37.87 89.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 44.41 111.607 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.511 ' HG3' ' HB ' ' A' ' 27' ' ' VAL . 1.6 mp0 -73.87 -39.39 63.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.003 0.43 . . . . 74.21 110.554 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.16 -23.64 66.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.202 0.525 . . . . 72.35 110.734 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -62.99 -33.9 76.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.79 -0.641 . . . . 74.14 111.74 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -88.65 -5.24 58.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.128 0.49 . . . . 72.14 111.78 -168.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.545 HG21 HG12 ' A' ' 18' ' ' VAL . 65.6 mt -105.13 115.58 47.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.192 -0.458 . . . . 64.1 110.899 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.485 ' N ' HD21 ' A' ' 74' ' ' LEU . 2.7 mm? -86.67 126.87 34.83 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.633 -0.506 . . . . 70.24 109.633 174.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.49 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 24.2 m -130.15 153.72 39.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.877 0.37 . . . . 72.11 111.574 -176.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -102.52 148.49 25.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.283 -0.636 . . . . 75.52 109.283 173.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.494 ' HA ' HG11 ' A' ' 16' ' ' VAL . 53.6 t -89.3 114.51 27.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.864 0.364 . . . . 65.41 110.187 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.2 mt -94.23 0.23 55.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.192 0.52 . . . . 64.43 111.343 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.801 HD12 ' HA ' ' A' ' 14' ' ' SER . 87.3 mt -82.17 169.9 16.07 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.797 -0.638 . . . . 62.04 111.512 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -76.08 -164.03 0.34 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.183 -0.917 . . . . 70.13 110.341 174.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -66.4 140.81 58.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.802 0.334 . . . . 73.42 110.218 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -116.72 113.58 22.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.232 0.539 . . . . 74.31 111.299 -173.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -163.81 159.7 21.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.935 -0.575 . . . . 71.14 110.106 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.3 t60 59.78 34.3 21.91 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.605 0.717 . . . . 64.44 109.923 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -115.74 103.3 10.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.779 -0.646 . . . . 73.04 111.106 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.1 t60 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.205 -0.902 . . . . 53.03 109.322 177.862 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.965 0.412 . . . . 62.51 110.778 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.59 96.83 8.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.998 -0.546 . . . . 71.22 110.808 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -99.73 -177.84 3.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.182 -0.463 . . . . 75.31 110.542 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.99 116.69 6.95 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.74 -0.743 . . . . 61.03 112.07 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.6 pt -115.74 168.19 7.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.987 -0.375 . . . . 74.04 109.987 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.07 143.65 41.73 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.311 -0.947 . . . . 73.52 111.924 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 7' ' ' LEU . 2.6 tm? -58.3 -34.31 70.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.214 0.53 . . . . 74.42 109.841 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -69.78 -14.36 62.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.73 -0.668 . . . . 70.04 111.387 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -96.12 -2.86 45.66 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.809 0.338 . . . . 73.24 111.122 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 11' ' ' GLU . 16.5 t -90.76 159.21 2.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.234 -0.439 . . . . 51.01 110.208 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.412 ' N ' HG12 ' A' ' 10' ' ' VAL . 27.9 tt0 -89.98 166.0 13.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.155 -0.475 . . . . 74.31 110.266 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.9 pt -77.48 162.87 4.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.185 -0.462 . . . . 71.1 110.599 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt 60.55 30.09 19.49 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.192 0.597 . . . . 74.14 111.014 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.6 m -120.88 151.67 39.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.68 -0.691 . . . . 74.21 110.3 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -109.59 127.4 54.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.097 -0.501 . . . . 73.2 109.698 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.434 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 22.5 m -128.97 173.54 13.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.261 -0.427 . . . . 72.04 111.099 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.804 ' HE3' HD21 ' A' ' 78' ' ' LEU . 29.9 ttmt -126.5 140.29 52.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.907 -0.588 . . . . 65.21 110.689 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.88 96.85 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.604 -0.726 . . . . 74.12 110.345 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.1 mm -92.36 -52.77 9.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.405 -0.816 . . . . 73.02 110.894 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.81 160.55 22.83 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.207 -0.997 . . . . 72.11 112.945 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.711 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 71.8 mt -142.4 158.12 19.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.801 -1.185 . . . . 72.21 107.801 -178.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.0 t -100.62 91.42 1.81 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.65 0.262 . . . . 74.12 110.65 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.711 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 31.4 Cg_exo -57.57 159.06 17.63 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.26 2.64 . . . . 75.25 112.732 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 62.62 74.5 0.43 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.521 -0.763 . . . . 75.43 110.155 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.454 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 28.9 t -159.26 153.52 23.81 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.134 -0.939 . . . . 62.42 109.599 -176.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -68.97 -22.6 64.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.833 0.349 . . . . 72.15 110.344 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 31' ' ' ILE . 25.2 m -95.77 -20.34 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.495 -0.32 . . . . 72.24 110.684 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.603 ' CD ' ' HA ' ' A' ' 23' ' ' PRO . 2.0 tpm_? -50.33 -54.45 21.41 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.184 -0.462 . . . . 74.13 111.074 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -65.61 -37.07 85.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.971 -0.559 . . . . 64.3 110.992 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -66.32 -45.05 81.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.327 -0.397 . . . . 72.23 111.23 -174.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.473 ' HA ' ' HE3' ' A' ' 34' ' ' MET . 79.2 mt -59.71 -45.83 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.347 -0.388 . . . . 75.12 110.834 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.574 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 2.2 ttt -71.98 -33.16 67.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.328 -0.397 . . . . 71.42 110.675 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -68.27 -24.66 64.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.031 -0.531 . . . . 63.13 110.079 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.473 ' HE3' ' HA ' ' A' ' 31' ' ' ILE . 63.0 mtm -79.64 2.32 22.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.786 -0.643 . . . . 63.44 111.441 178.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.63 -8.06 59.81 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.696 -0.764 . . . . 37.66 112.763 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 32' ' ' MET . 63.2 mt -81.5 137.42 21.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.864 0.364 . . . . 74.2 110.371 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.756 HG22 ' H ' ' A' ' 38' ' ' ARG . 1.9 m -133.78 -85.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.201 -0.454 . . . . 74.02 111.152 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.756 ' H ' HG22 ' A' ' 37' ' ' VAL . 17.8 ttm180 -153.37 140.68 19.59 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.985 -0.746 . . . . 73.21 108.985 175.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.58 -9.81 69.66 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.634 -0.793 . . . . 74.32 111.278 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -64.82 147.09 53.89 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.755 -0.461 . . . . 72.43 109.755 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -97.28 147.4 24.18 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.234 0.54 . . . . 63.22 111.541 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.587 HG12 ' HB3' ' A' ' 58' ' ' LEU . 64.5 mt -130.81 118.23 41.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.027 -0.988 . . . . 71.22 109.479 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.6 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 64.0 t80 -105.0 106.18 16.56 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.317 -0.401 . . . . 74.22 109.985 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.555 HG12 HD21 ' A' ' 56' ' ' LEU . 52.6 mt -75.31 102.35 2.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.235 -0.654 . . . . 74.51 109.235 177.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -85.54 -24.62 27.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.968 0.413 . . . . 71.52 110.906 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.12 -172.09 40.66 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.844 -0.693 . . . . 65.44 112.265 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.654 ' HG2' HG21 ' A' ' 54' ' ' ILE . 54.5 mtpt -123.49 159.08 29.85 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.737 -0.838 . . . . 74.43 108.737 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.82 152.14 87.44 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.64 -0.504 . . . . 75.34 109.64 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.91 -9.66 12.53 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.816 2.344 . . . . 37.66 112.999 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 55.7 ttp -97.29 -4.62 38.39 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.325 0.583 . . . . 74.5 110.318 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.67 -12.74 67.67 Favored Glycine 0 N--CA 1.454 -0.128 0 CA-C-N 115.988 -0.551 . . . . 72.54 111.958 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.543 ' OD2' ' HB2' ' A' ' 67' ' ' LYS . 11.4 t70 -152.32 136.51 10.22 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.344 -0.984 . . . . 70.11 108.344 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.455 ' HB3' ' HA ' ' A' ' 66' ' ' ARG . 3.5 Cg_exo -81.25 -167.96 6.31 Favored 'Cis proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.817 -1.326 . . . . 75.14 112.401 -1.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.654 HG21 ' HG2' ' A' ' 47' ' ' LYS . 46.8 mt -109.98 134.1 53.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.991 -0.55 . . . . 75.01 110.091 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.51 107.29 18.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.021 0.439 . . . . 65.0 110.167 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.555 HD21 HG12 ' A' ' 44' ' ' ILE . 28.8 mt -120.21 131.97 55.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.041 -0.527 . . . . 61.54 110.295 -177.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.779 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 27.9 ttt-85 -93.29 99.97 12.41 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.765 -0.828 . . . . 64.22 108.765 171.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.587 ' HB3' HG12 ' A' ' 42' ' ' ILE . 1.1 pp -119.13 146.0 45.49 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.084 -0.507 . . . . 74.11 110.461 -176.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 73.01 -45.87 0.63 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.895 0.747 . . . . 73.34 111.069 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.47 -26.42 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.293 -0.479 . . . . 74.45 112.152 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -121.45 157.74 29.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.855 0.36 . . . . 75.14 111.147 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.779 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -89.61 133.41 34.64 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.891 -0.595 . . . . 71.34 111.361 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.4 mt -141.98 152.02 43.06 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.552 -0.749 . . . . 71.22 109.475 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -88.86 110.81 21.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.203 0.525 . . . . 75.22 110.886 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.83 145.8 28.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.501 -0.772 . . . . 74.21 108.963 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.455 ' HA ' ' HB3' ' A' ' 53' ' ' PRO . 10.3 mpt_? -80.68 163.34 23.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.977 0.418 . . . . 75.51 110.338 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.72 ' HB2' ' HZ1' ' A' ' 67' ' ' LYS . 4.5 ttmp? -47.76 -38.39 15.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.349 -0.841 . . . . 71.41 111.917 176.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.5 m -59.46 -50.78 72.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.251 -0.432 . . . . 74.32 111.766 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.42 ' O ' HG13 ' A' ' 73' ' ' ILE . 1.8 mp0 -63.66 -49.0 74.91 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.29 0.369 . . . . 74.22 110.795 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.55 -22.55 65.26 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.157 0.503 . . . . 65.53 111.481 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.884 ' HZ1' ' HB3' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -78.95 -23.2 44.75 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.0 -0.546 . . . . 55.43 110.705 -179.169 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -102.48 12.86 35.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 74.12 111.736 -175.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.432 HG21 HG13 ' A' ' 75' ' ' VAL . 61.9 mt -113.57 127.26 71.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.293 -0.412 . . . . 71.4 110.212 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.71 123.27 49.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.044 0.45 . . . . 73.24 109.923 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.434 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 28.2 m -129.56 160.04 40.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 112.324 0.49 . . . . 61.23 112.324 -170.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -106.28 159.02 16.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.591 -0.731 . . . . 63.4 109.305 172.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -83.75 124.61 39.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.775 0.322 . . . . 74.43 110.668 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.804 HD21 ' HE3' ' A' ' 17' ' ' LYS . 46.3 mt -94.87 -4.19 47.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.923 0.392 . . . . 65.5 111.01 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.4 mt -68.97 90.89 0.45 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.676 -0.693 . . . . 74.24 110.89 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -101.74 155.17 18.29 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.956 -0.757 . . . . 61.31 108.956 176.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 72.2 108.59 0.07 Allowed 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.896 0.747 . . . . 72.25 109.229 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 77.15 125.74 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 O-C-N 124.163 0.915 . . . . 75.25 109.579 -171.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -80.94 161.17 24.43 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.926 -0.579 . . . . 71.0 110.543 -173.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -148.12 96.65 2.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.089 0.471 . . . . 70.1 111.318 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -150.43 128.75 12.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.547 -0.751 . . . . 73.21 109.815 175.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.8 p80 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.58 -0.724 . . . . 71.2 109.805 178.325 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.749 0.309 . . . . 70.23 110.485 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.9 m -96.13 -84.82 0.35 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.39 -0.368 . . . . 72.11 110.856 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -146.18 172.33 13.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.634 0.254 . . . . 74.13 110.442 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.53 160.77 13.11 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.507 -0.854 . . . . 42.25 112.95 -176.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.2 pt -125.97 179.33 3.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.185 -0.672 . . . . 74.24 109.185 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.93 145.49 31.18 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.024 -1.084 . . . . 70.31 110.942 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.939 HD23 HD22 ' A' ' 56' ' ' LEU . 51.7 tp -57.55 -30.85 65.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.982 0.42 . . . . 75.02 111.587 -176.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.529 ' ND2' ' HG3' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -71.25 -6.51 40.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.408 -0.36 . . . . 54.45 111.97 179.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.529 ' HG3' ' ND2' ' A' ' 8' ' ' ASN . 44.1 mt-10 -103.55 2.22 33.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.619 0.247 . . . . 53.24 111.145 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.8 t -88.08 157.55 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.877 0.37 . . . . 71.41 110.797 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.52 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 32.1 tt0 -99.27 176.02 5.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.957 -0.565 . . . . 65.43 110.12 -178.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.52 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 40.9 pt -79.95 159.31 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.854 0.359 . . . . 72.31 111.943 -175.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 59.55 35.79 22.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.379 -0.828 . . . . 74.2 111.15 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -130.94 151.27 51.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.269 -0.423 . . . . 70.02 110.809 -177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.759 ' HG2' ' HD1' ' A' ' 43' ' ' TYR . 32.6 mtmt -109.07 130.18 55.48 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.238 0.542 . . . . 62.01 110.563 176.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.674 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 7.0 m -129.4 142.9 42.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.198 -0.91 . . . . 62.3 109.617 176.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HB2' HD11 ' A' ' 78' ' ' LEU . 30.5 ttpt -104.5 142.62 34.3 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.059 0.457 . . . . 64.41 110.486 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.477 ' HA ' HG13 ' A' ' 75' ' ' VAL . 37.0 t -74.75 96.6 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.524 -0.762 . . . . 74.24 110.769 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.696 HD12 ' HB3' ' A' ' 76' ' ' GLU . 16.9 mt -58.72 -42.92 86.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.7 0.762 . . . . 72.15 108.951 171.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.29 170.66 39.95 Favored Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 114.55 -1.205 . . . . 72.22 111.911 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.736 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 14.5 mt -114.23 161.92 12.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.399 -1.334 . . . . 75.03 107.399 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.53 91.84 1.15 Allowed Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.252 0.548 . . . . 74.41 110.377 -174.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.736 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 31.6 Cg_exo -57.26 169.83 1.95 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.812 3.008 . . . . 73.42 113.414 -170.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 65.89 13.61 9.12 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.18 -0.918 . . . . 54.53 110.113 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.501 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 14.7 t -98.89 134.9 41.1 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.566 -0.743 . . . . 61.32 109.354 174.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -68.13 -15.61 63.66 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.334 -0.394 . . . . 75.14 111.295 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 31' ' ' ILE . 27.8 m -94.96 -28.14 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.557 -0.457 . . . . 74.51 110.736 174.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.501 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 3.8 tmt_? -54.1 -47.0 72.26 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.263 0.554 . . . . 75.21 109.845 174.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.9 ttt-85 -55.77 -47.33 77.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.187 -0.915 . . . . 65.24 110.433 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.58 -44.76 95.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.308 -0.86 . . . . 72.22 111.408 -177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.477 HD13 ' CG1' ' A' ' 73' ' ' ILE . 60.3 mt -64.74 -47.62 87.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.516 -0.766 . . . . 61.31 111.411 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 2.3 ttt -68.48 -32.87 73.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.089 0.471 . . . . 64.31 110.545 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.07 -23.62 64.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.815 -0.63 . . . . 64.15 110.612 177.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 22.2 ttm -75.62 -19.62 59.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.835 -0.621 . . . . 75.42 110.65 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.4 -5.06 13.31 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.418 -0.896 . . . . 72.5 112.825 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 32' ' ' MET . 44.6 mt -84.79 125.12 40.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.086 0.469 . . . . 73.12 110.298 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.05 -178.0 2.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.687 -0.688 . . . . 74.32 110.91 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -68.51 116.45 9.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.077 -0.51 . . . . 74.45 110.897 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.14 -2.47 44.01 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.887 -0.597 . . . . 63.53 113.018 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.9 m -75.72 148.34 38.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.858 0.329 . . . . 73.24 110.126 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -95.81 125.22 40.22 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.087 -0.506 . . . . 73.2 110.193 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.7 mt -100.66 114.83 40.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.475 -0.784 . . . . 72.41 109.748 176.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.759 ' HD1' ' HG2' ' A' ' 15' ' ' LYS . 37.1 t80 -91.26 105.09 17.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.121 -0.491 . . . . 74.32 110.105 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.62 HD12 HD11 ' A' ' 7' ' ' LEU . 47.8 mm -80.53 96.37 2.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.071 -0.714 . . . . 75.11 109.071 175.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.05 -26.89 33.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.983 0.421 . . . . 72.42 110.708 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.05 176.84 47.72 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.32 -0.943 . . . . 64.24 112.57 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.747 ' HG2' HG22 ' A' ' 54' ' ' ILE . 56.2 mtpt -133.62 158.22 43.76 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.756 -0.831 . . . . 73.02 108.756 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.85 156.84 63.97 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.501 -0.185 . . . . 62.11 110.501 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.98 -33.74 73.98 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.809 2.339 . . . . 72.4 112.729 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.1 ttm -87.68 -7.65 57.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.134 0.492 . . . . 72.33 110.875 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.89 -15.3 60.88 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 121.13 -0.557 . . . . 71.32 112.075 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -140.3 131.54 14.15 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.38 -0.6 . . . . 73.22 109.38 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.06 -170.08 7.94 Favored 'Cis proline' 0 CA--C 1.531 0.33 0 C-N-CA 124.124 -1.199 . . . . 71.35 113.217 1.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.747 HG22 ' HG2' ' A' ' 47' ' ' LYS . 41.1 mt -110.07 145.08 17.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.766 -0.652 . . . . 61.43 110.005 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.89 104.16 15.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.197 0.523 . . . . 61.05 110.706 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.939 HD22 HD23 ' A' ' 7' ' ' LEU . 7.9 mp -99.93 164.01 12.2 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.477 -0.783 . . . . 71.51 110.27 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.595 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 27.8 ttm180 -142.35 111.73 6.59 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.703 -0.851 . . . . 74.21 108.703 171.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -136.5 149.48 48.19 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.793 0.33 . . . . 73.2 110.823 -177.336 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 62.89 2.72 1.04 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.581 -0.736 . . . . 71.4 111.676 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.67 -14.2 11.69 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.803 -0.713 . . . . 61.31 112.861 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.415 ' HD1' HD22 ' A' ' 63' ' ' LEU . 7.5 p90 -128.01 150.73 49.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.447 0.642 . . . . 75.01 112.385 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 47.9 t -84.46 144.63 28.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.093 -0.958 . . . . 73.15 111.969 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.477 HD21 ' C ' ' A' ' 62' ' ' SER . 3.4 mm? -135.11 144.37 47.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.897 -1.047 . . . . 73.44 109.757 177.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.47 110.01 21.41 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.349 -0.387 . . . . 74.21 110.194 175.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.588 HD22 HD21 ' A' ' 56' ' ' LEU . 2.9 pp -124.55 160.77 27.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.76 0.314 . . . . 71.3 110.46 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 6.1 mpt_? -80.17 161.98 24.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.564 0.697 . . . . 73.12 112.214 -169.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -57.89 -54.85 42.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.725 -1.125 . . . . 71.44 111.459 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.0 m -75.4 -11.71 60.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.033 0.444 . . . . 74.32 111.175 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 66' ' ' ARG . 20.8 tt0 -79.76 -42.45 24.5 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.835 -0.802 . . . . 73.54 108.835 176.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 7' ' ' LEU . . . -69.71 -21.15 63.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.817 -1.083 . . . . 64.34 111.157 174.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -59.01 -26.61 64.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.86 -0.609 . . . . 72.4 112.017 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.4 -3.19 57.31 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.331 0.586 . . . . 54.41 110.622 -177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.496 HG21 HG12 ' A' ' 75' ' ' VAL . 51.7 mt -101.83 128.58 54.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.104 -0.498 . . . . 64.53 110.722 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.0 mt -106.7 118.01 35.55 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.847 -0.427 . . . . 75.11 109.847 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.674 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 15.3 m -129.15 146.13 34.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.935 0.398 . . . . 72.53 111.957 -174.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.696 ' HB3' HD12 ' A' ' 19' ' ' ILE . 9.7 pt-20 -100.67 139.06 36.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.852 -0.613 . . . . 73.15 110.164 176.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.624 ' HA ' HG12 ' A' ' 16' ' ' VAL . 39.5 t -75.12 112.11 12.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.149 -0.478 . . . . 50.25 110.572 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 17' ' ' LYS . 90.6 mt -77.6 -17.97 57.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.249 0.547 . . . . 73.22 110.918 -177.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.3 mt -91.78 19.42 6.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.615 -0.72 . . . . 74.21 111.994 -176.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 61.01 -154.72 0.36 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.168 -0.469 . . . . 65.0 111.761 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.3 t60 80.1 -21.15 0.34 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.066 0.946 . . . . 72.21 111.905 173.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.9 p80 35.37 82.68 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.11 0.964 . . . . 72.31 112.814 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -74.21 141.76 45.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.186 -0.916 . . . . 73.3 111.435 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -117.14 153.44 32.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.913 -0.585 . . . . 70.4 110.399 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -79.79 -62.35 1.71 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.899 -0.778 . . . . 73.12 108.899 172.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 52.5 m80 . . . . . 0 C--O 1.246 0.875 0 CA-C-N 115.291 -0.868 . . . . 72.21 109.29 174.575 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.419 ' HA3' HD12 ' A' ' 19' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 121.09 0.272 . . . . 64.439999999999998 113.672 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.1 pt -106.8 174.77 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.448 -0.945 . . . . 65.019999999999996 108.448 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.75 147.73 28.23 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 119.811 -1.185 . . . . 74.5 111.267 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.482 HD21 HD21 ' A' ' 56' ' ' LEU . 44.0 tp -62.65 -17.97 61.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.369 0.604 . . . . 74.430000000000007 110.94 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.538 ' OD1' ' HA ' ' A' ' 71' ' ' LYS . 4.1 p-10 -75.44 -10.99 59.94 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.572 -0.74 . . . . 70.540000000000006 110.895 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -101.81 9.53 40.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.044 -0.525 . . . . 73.430000000000007 110.747 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.1 t -103.19 160.27 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.01 -0.541 . . . . 72.540000000000006 109.602 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.473 ' CG ' ' H ' ' A' ' 12' ' ' ILE . 12.6 tt0 -112.13 -176.85 3.02 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.226 -0.287 . . . . 73.329999999999998 110.226 -177.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.473 ' H ' ' CG ' ' A' ' 11' ' ' GLU . 40.8 pt -66.85 150.38 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.709 0.633 . . . . 73.019999999999996 112.709 -171.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 68.3 mttm 51.93 48.99 21.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.078 -0.965 . . . . 60.340000000000003 112.343 174.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.7 m -127.37 153.7 45.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.705 -0.68 . . . . 64.420000000000002 109.6 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -112.45 129.23 56.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.237 0.541 . . . . 60.25 111.023 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 77' ' ' VAL . 15.4 m -137.47 152.65 27.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.114 -0.948 . . . . 65.319999999999993 109.795 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.741 ' HB2' HD11 ' A' ' 78' ' ' LEU . 1.9 tmtp? -105.94 140.85 38.32 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.112 -0.495 . . . . 74.420000000000002 110.27 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -77.75 95.16 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.314 -0.857 . . . . 74.5 110.207 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.869 HD11 ' HB3' ' A' ' 76' ' ' GLU . 17.3 mt -63.49 -55.95 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.595 -0.729 . . . . 63.310000000000002 110.004 175.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.22 -177.19 33.1 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.398 -0.905 . . . . 51.409999999999997 112.91 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.496 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 22.4 mt -129.08 161.52 38.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.392 -0.966 . . . . 55.109999999999999 108.392 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.44 90.56 1.03 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.683 0.754 . . . . 71.349999999999994 109.582 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.878 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 36.6 Cg_endo -61.43 162.45 20.61 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.412 2.741 . . . . 64.450000000000003 113.864 -167.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 65.38 5.68 3.28 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.903 -1.044 . . . . 75.140000000000001 112.193 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.538 ' HB3' HG22 ' A' ' 27' ' ' VAL . 1.0 OUTLIER -77.15 -4.67 45.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.69 0.281 . . . . 64.219999999999999 111.503 179.076 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 88.6 tttt 71.24 -45.66 0.62 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.494 0.718 . . . . 71.140000000000001 110.941 -174.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 25' ' ' SER . 31.5 m -66.72 -16.73 21.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.069 0.461 . . . . 74.200000000000003 109.92 173.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.878 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 4.4 tmt_? -57.87 -37.96 74.89 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.115 -0.698 . . . . 75.209999999999994 109.115 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 6.3 tpp180 -64.82 -46.22 82.89 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 115.62 -0.718 . . . . 72.400000000000006 109.969 174.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -55.41 -48.74 73.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.609 -0.723 . . . . 71.030000000000001 110.834 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.498 HD11 ' HB3' ' A' ' 72' ' ' ASP . 78.3 mt -59.89 -48.65 86.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.957 -0.565 . . . . 74.340000000000003 111.139 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -38.17 90.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 64.310000000000002 110.837 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.86 -32.9 74.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.788 -0.642 . . . . 74.5 111.048 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -17.74 64.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.046 -0.525 . . . . 62.539999999999999 111.09 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.25 12.51 29.05 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.513 -0.851 . . . . 71.310000000000002 112.558 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.1 mt -91.51 126.71 44.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.079 0.466 . . . . 74.049999999999997 110.035 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.11 169.79 21.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.671 -0.695 . . . . 75.420000000000002 111.014 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -61.33 109.12 1.05 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.825 -0.625 . . . . 73.349999999999994 110.562 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.677 ' HA2' ' HE3' ' A' ' 17' ' ' LYS . . . 119.64 -9.85 11.53 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.761 -0.733 . . . . 63.119999999999997 113.092 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 m -71.48 149.24 46.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.02 0.438 . . . . 75.519999999999996 110.737 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -98.08 132.77 43.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.726 -0.67 . . . . 74.129999999999995 110.147 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.455 ' HB ' HG23 ' A' ' 16' ' ' VAL . 45.0 mm -108.93 121.66 62.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.461 -0.791 . . . . 73.129999999999995 110.343 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -111.31 112.15 23.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.329 -0.619 . . . . 74.450000000000003 109.329 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 7' ' ' LEU . 51.3 mm -75.59 121.22 26.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.351 -0.611 . . . . 75.200000000000003 109.351 176.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.56 -53.25 6.42 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.847 -0.798 . . . . 52.43 108.847 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.452 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . -172.77 179.05 44.5 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.731 -0.947 . . . . 73.400000000000006 110.731 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -118.37 156.96 28.03 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.166 -0.679 . . . . 73.129999999999995 109.166 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.27 157.37 77.76 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 110.038 -0.356 . . . . 53.420000000000002 110.038 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -59.18 -12.38 15.84 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.734 2.289 . . . . 74.129999999999995 112.77 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.5 mmt -99.89 -2.35 35.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.48 . . . . 71.329999999999998 110.486 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.01 -16.06 56.42 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.197 -0.525 . . . . 73.329999999999998 111.894 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -150.52 137.76 11.68 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 108.64 -0.874 . . . . 60.240000000000002 108.64 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.04 -164.95 4.02 Favored 'Cis proline' 0 CA--C 1.531 0.36 0 C-N-CA 123.734 -1.361 . . . . 71.099999999999994 113.25 1.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.4 mt -119.03 147.34 22.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.862 -0.608 . . . . 64.239999999999995 109.975 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.89 119.45 36.52 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.089 -0.337 . . . . 53.219999999999999 110.089 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.482 HD21 HD21 ' A' ' 7' ' ' LEU . 5.9 mp -117.04 154.65 30.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.816 0.341 . . . . 62.310000000000002 110.731 -176.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -128.28 105.13 8.13 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.337 -0.616 . . . . 74.230000000000004 109.337 170.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -142.6 160.33 40.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.197 -0.911 . . . . 74.239999999999995 109.871 -175.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? 75.15 -56.91 0.61 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.973 0.795 . . . . 72.109999999999999 109.574 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 173.91 -1.01 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.71 -0.677 . . . . 74.120000000000005 111.901 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -142.46 155.09 45.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.236 0.541 . . . . 75.340000000000003 111.956 -173.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 m -86.81 135.8 33.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.312 -0.858 . . . . 73.299999999999997 111.011 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.445 HD13 ' CD2' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -160.36 158.38 29.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.324 -0.398 . . . . 52.43 110.197 175.661 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.8 t -102.76 123.77 47.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.452 0.644 . . . . 73.420000000000002 111.62 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.445 ' CD2' HD13 ' A' ' 63' ' ' LEU . 4.1 mm? -112.64 158.0 20.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.924 -1.035 . . . . 73.349999999999994 108.812 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -86.51 159.35 19.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.057 0.455 . . . . 73.450000000000003 110.521 -175.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.52 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 0.9 OUTLIER -58.95 -28.74 66.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.682 -0.69 . . . . 74.200000000000003 110.026 176.441 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.5 m -59.2 -46.73 87.66 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.126 -0.488 . . . . 60.009999999999998 111.248 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -68.43 -41.99 79.56 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.186 0.517 . . . . 74.140000000000001 110.241 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.64 -21.55 64.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.661 -0.699 . . . . 65.340000000000003 111.304 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.538 ' HA ' ' OD1' ' A' ' 8' ' ' ASN . 54.2 tttm -79.4 -18.43 52.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.348 -0.387 . . . . 73.420000000000002 110.9 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.498 ' HB3' HD11 ' A' ' 31' ' ' ILE . 4.1 t70 -97.25 -9.8 27.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.246 0.546 . . . . 74.409999999999997 110.582 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.413 HG12 HD13 ' A' ' 31' ' ' ILE . 58.4 mt -96.78 121.99 47.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.982 -0.554 . . . . 74.239999999999995 110.481 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.8 mt -99.34 118.65 36.45 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.865 -0.42 . . . . 61.450000000000003 109.865 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.551 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 24.1 m -124.26 159.14 30.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.423 0.63 . . . . 65.400000000000006 112.474 -173.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.869 ' HB3' HD11 ' A' ' 19' ' ' ILE . 9.3 pt-20 -111.89 138.54 48.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.215 -0.902 . . . . 61.399999999999999 110.147 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.553 ' HA ' HG12 ' A' ' 16' ' ' VAL . 43.2 t -75.06 121.49 26.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.404 -0.362 . . . . 72.25 110.267 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.741 HD11 ' HB2' ' A' ' 17' ' ' LYS . 82.2 mt . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 121.313 0.578 . . . . 71.340000000000003 111.313 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.893 0 N-CA-C 112.453 -0.259 . . . . 73.439999999999998 112.453 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 pt -105.45 171.77 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.451 -0.574 . . . . 64.219999999999999 109.451 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.02 156.35 35.96 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 119.974 -1.108 . . . . 60.399999999999999 111.717 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.589 HD23 HG11 ' A' ' 75' ' ' VAL . 3.0 tm? -59.88 -26.52 65.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.508 0.67 . . . . 73.329999999999998 109.718 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.56 ' HB2' ' HG2' ' A' ' 67' ' ' LYS . 9.2 p30 -73.23 -8.94 57.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.499 -0.773 . . . . 65.310000000000002 111.417 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -103.47 1.0 31.84 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.496 -0.32 . . . . 73.409999999999997 111.612 -174.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 11' ' ' GLU . 20.9 t -81.54 157.31 4.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 61.119999999999997 111.501 -174.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.408 ' N ' HG12 ' A' ' 10' ' ' VAL . 8.0 tp10 -80.59 164.77 22.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.25 -0.886 . . . . 73.439999999999998 110.127 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.0 pt -79.25 138.09 20.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.102 -0.499 . . . . 71.239999999999995 111.116 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt 59.69 44.17 14.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.534 -0.757 . . . . 73.540000000000006 111.422 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.8 t -113.67 171.13 7.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.406 -0.815 . . . . 72.230000000000004 109.692 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -129.02 113.31 15.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.207 -0.451 . . . . 65.540000000000006 109.886 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 77' ' ' VAL . 18.4 m -123.01 160.35 25.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.449 0.642 . . . . 64.219999999999999 112.252 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -106.75 144.09 33.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.747 -1.115 . . . . 74.109999999999999 110.303 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.5 t -86.12 104.05 13.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.049 -0.523 . . . . 71.519999999999996 109.731 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.6 mt -59.37 -49.46 83.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.541 -0.754 . . . . 74.209999999999994 110.33 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.24 175.34 43.52 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.777 -0.725 . . . . 54.229999999999997 112.438 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.663 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 22.0 mt -97.6 159.79 3.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.307 -0.627 . . . . 64.219999999999999 109.307 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.42 90.84 1.27 Allowed Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 109.555 -0.535 . . . . 73.409999999999997 109.555 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.945 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 33.1 Cg_exo -58.19 167.25 4.79 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.932 3.088 . . . . 75.450000000000003 114.165 -170.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 64.59 15.99 10.02 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.79 -1.096 . . . . 71.400000000000006 110.828 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.584 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 23.3 t -87.5 165.12 15.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.607 -0.724 . . . . 73.430000000000007 110.067 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -21.83 46.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.944 -0.391 . . . . 63.340000000000003 109.944 175.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 31' ' ' ILE . 35.2 m -104.74 -3.69 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.285 -0.416 . . . . 71.400000000000006 111.554 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.945 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 3.6 tmm_? -50.73 -51.6 48.35 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.093 0.245 . . . . 61.520000000000003 110.929 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -63.85 -45.63 88.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.59 -0.277 . . . . 74.030000000000001 110.535 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -50.45 -53.48 29.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 52.43 111.129 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.553 HD12 HD11 ' A' ' 73' ' ' ILE . 46.7 mm -58.68 -47.81 87.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.631 -0.713 . . . . 74.510000000000005 111.752 -177.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.607 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 4.6 ppp? -73.86 -28.17 61.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.916 0.388 . . . . 61.420000000000002 111.072 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.89 -28.65 64.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.276 0.56 . . . . 75.219999999999999 109.883 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 81.0 mtp -81.49 1.03 35.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.294 -0.866 . . . . 75.439999999999998 111.44 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.66 -7.53 53.53 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.616 -0.802 . . . . 71.329999999999998 113.132 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 32' ' ' MET . 21.6 mt -84.08 130.36 36.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.772 0.32 . . . . 61.039999999999999 110.232 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.612 HG23 ' H ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -148.05 -85.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.182 -0.463 . . . . 61.140000000000001 111.473 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.612 ' H ' HG23 ' A' ' 37' ' ' VAL . 17.9 mtp180 -145.44 131.23 19.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.232 -0.44 . . . . 75.319999999999993 109.922 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.03 -4.08 86.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.567 -0.825 . . . . 60.25 112.156 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 m -64.29 144.07 57.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.607 -0.516 . . . . 41.100000000000001 109.607 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -117.47 133.93 55.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.968 0.413 . . . . 74.209999999999994 110.94 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.854 HG12 HD13 ' A' ' 58' ' ' LEU . 74.4 mt -119.68 136.06 58.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.599 -0.728 . . . . 73.049999999999997 111.312 -174.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -98.12 116.43 30.32 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.727 -0.471 . . . . 52.140000000000001 109.727 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.532 HD11 HD21 ' A' ' 7' ' ' LEU . 50.5 mm -82.64 104.61 11.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.623 -0.51 . . . . 62.409999999999997 109.623 177.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -76.85 -34.03 57.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.91 0.386 . . . . 74.140000000000001 110.724 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.35 171.56 31.72 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.564 -0.827 . . . . 64.230000000000004 112.196 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.609 ' HG2' HG23 ' A' ' 54' ' ' ILE . 40.6 mtmt -124.39 148.63 47.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.012 -0.736 . . . . 75.409999999999997 109.012 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.47 156.94 49.59 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.093 -0.336 . . . . 74.219999999999999 110.093 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.65 -14.17 25.04 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.525 2.15 . . . . 63.009999999999998 112.456 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.9 mtt -93.76 -6.17 46.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 73.400000000000006 110.205 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.67 -10.37 59.84 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.378 -0.689 . . . . 55.5 111.378 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -145.43 133.01 10.33 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 108.981 -0.748 . . . . 60.340000000000003 108.981 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -84.7 -172.32 9.18 Favored 'Cis proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.341 -1.524 . . . . 52.219999999999999 112.866 -0.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.609 HG23 ' HG2' ' A' ' 47' ' ' LYS . 59.4 mt -114.21 142.07 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.232 -0.44 . . . . 72.129999999999995 110.11 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.07 115.55 30.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.071 0.462 . . . . 75.519999999999996 110.415 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.644 HD23 HG21 ' A' ' 42' ' ' ILE . 5.7 mp -113.13 156.42 23.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.968 -0.56 . . . . 71.519999999999996 110.327 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 16.4 ttm180 -119.08 106.73 12.69 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.18 -1.044 . . . . 64.230000000000004 108.18 167.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.854 HD13 HG12 ' A' ' 42' ' ' ILE . 41.8 tp -137.36 146.75 44.9 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.579 -0.737 . . . . 73.310000000000002 110.219 -173.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.443 ' HD3' ' OH ' ' A' ' 61' ' ' TYR . 53.1 ttt180 65.67 12.48 8.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.37 -0.832 . . . . 71.239999999999995 110.646 176.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.5 -12.12 36.04 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 121.009 -0.615 . . . . 61.030000000000001 113.116 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.443 ' OH ' ' HD3' ' A' ' 59' ' ' ARG . 27.4 p90 -134.52 155.85 49.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.635 0.731 . . . . 53.140000000000001 112.448 -177.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -79.96 143.26 34.32 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.933 -1.03 . . . . 74.5 110.974 175.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -157.57 151.31 24.09 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.255 -0.646 . . . . 72.129999999999995 109.255 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -113.95 134.15 55.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.07 0.462 . . . . 65.230000000000004 110.952 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 pp -133.13 167.09 20.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.671 -0.695 . . . . 75.140000000000001 109.697 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -77.71 148.53 34.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.202 0.525 . . . . 71.319999999999993 111.766 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.56 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 14.8 tmtt? -62.31 -35.52 79.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.197 -0.911 . . . . 64.019999999999996 111.355 -176.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 60.2 m -67.86 -30.77 70.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.689 0.255 . . . . 73.049999999999997 111.689 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.25 -31.82 55.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.153 0.502 . . . . 61.539999999999999 109.809 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' A' ' 7' ' ' LEU . . . -65.51 -21.53 66.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.758 -0.656 . . . . 72.040000000000006 110.712 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.47 ' HE3' ' HB3' ' A' ' 71' ' ' LYS . 0.9 OUTLIER -69.55 -30.87 68.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.853 -0.612 . . . . 73.230000000000004 110.44 176.584 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.8 2.63 22.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.046 -0.525 . . . . 73.239999999999995 111.399 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.553 HD11 HD12 ' A' ' 31' ' ' ILE . 59.5 mt -115.98 114.96 47.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.99 -0.55 . . . . 74.5 109.81 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.0 mt -94.71 121.9 36.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.338 -0.392 . . . . 71.310000000000002 110.079 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.589 HG11 HD23 ' A' ' 7' ' ' LEU . 30.3 m -120.98 158.89 23.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.78 0.8 . . . . 63.399999999999999 112.424 -173.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.94 126.58 47.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.444 -1.253 . . . . 73.140000000000001 109.206 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.502 ' HA ' HG12 ' A' ' 16' ' ' VAL . 11.0 p -74.59 127.07 36.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.902 -0.59 . . . . 74.200000000000003 110.51 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.341 0.591 . . . . 71.239999999999995 110.898 -178.723 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.444 -0.807 0 N-CA-C 111.956 -0.458 . . . . 74.040000000000006 111.956 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.3 pt -133.03 179.49 4.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.782 -0.451 . . . . 74.25 109.782 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.17 151.01 48.2 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.263 -0.97 . . . . 40.119999999999997 111.008 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.58 HD11 HD21 ' A' ' 56' ' ' LEU . 3.1 tm? -57.06 -33.15 66.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 42.409999999999997 110.461 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -77.13 -10.15 59.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.33 -0.396 . . . . 71.329999999999998 111.762 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.37 -9.81 37.47 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.975 0.417 . . . . 64.230000000000004 110.953 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.6 t -77.94 159.42 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.973 -0.558 . . . . 75.140000000000001 110.406 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 29.9 tt0 -103.42 173.97 6.07 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.146 -0.316 . . . . 73.510000000000005 110.146 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.585 HG22 ' HA2' ' A' ' 46' ' ' GLY . 40.2 pt -72.99 153.78 7.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 112.21 0.448 . . . . 71.25 112.21 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 51.4 49.24 21.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.194 -0.912 . . . . 72.439999999999998 111.998 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.9 m -134.06 152.8 52.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.282 -0.872 . . . . 73.519999999999996 109.001 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -109.34 140.85 42.5 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.318 -0.553 . . . . 74.540000000000006 110.254 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 77' ' ' VAL . 29.3 m -132.57 174.86 12.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.793 -0.639 . . . . 61.109999999999999 110.677 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.405 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 84.3 tttt -134.34 139.11 45.42 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.0 -0.546 . . . . 73.140000000000001 110.324 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.688 ' HA ' HG12 ' A' ' 75' ' ' VAL . 35.0 t -75.54 93.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.428 -0.805 . . . . 72.340000000000003 110.257 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.531 HD11 ' OE2' ' A' ' 76' ' ' GLU . 47.9 mm -80.94 -56.8 5.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.553 -0.749 . . . . 73.409999999999997 111.312 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.86 158.97 22.84 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.23 -0.986 . . . . 42.43 112.908 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.651 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 68.7 mt -127.43 156.34 39.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.757 -0.831 . . . . 73.519999999999996 108.757 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.5 t -103.14 90.21 2.36 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 120.748 0.309 . . . . 74.25 110.33 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.651 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 29.2 Cg_exo -61.18 171.51 3.95 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.147 2.565 . . . . 63.109999999999999 112.441 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 63.81 21.14 12.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.873 -0.603 . . . . 63.329999999999998 111.007 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.795 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 22.6 t -88.54 153.39 21.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.907 -0.588 . . . . 70.340000000000003 109.702 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -93.28 -3.1 54.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.901 0.382 . . . . 73.219999999999999 110.069 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.509 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 32.8 m -113.5 -2.42 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 116.145 -0.479 . . . . 73.209999999999994 110.537 174.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.795 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 15.0 ttp180 -54.09 -42.4 69.33 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.927 0.394 . . . . 73.329999999999998 110.285 175.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.52 -38.96 92.0 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 115.98 -0.555 . . . . 64.439999999999998 110.958 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.667 ' HG2' ' OE2' ' A' ' 69' ' ' GLU . 21.1 tptm -55.41 -54.02 48.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.294 0.568 . . . . 71.129999999999995 110.363 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.696 HG23 HD12 ' A' ' 36' ' ' ILE . 65.3 mt -62.78 -40.98 90.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.055 -0.975 . . . . 74.519999999999996 110.939 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ttt -67.65 -32.4 73.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.968 -0.56 . . . . 75.530000000000001 110.985 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -73.12 -26.29 61.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.083 -0.508 . . . . 73.150000000000006 110.114 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 60.9 mtt -69.12 -27.66 65.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.4 0.619 . . . . 61.450000000000003 110.167 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.08 18.82 11.51 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.641 -0.709 . . . . 54.509999999999998 112.12 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.696 HD12 HG23 ' A' ' 31' ' ' ILE . 39.5 mt -88.93 124.27 41.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.162 0.506 . . . . 54.520000000000003 110.118 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.01 161.12 41.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.349 -0.841 . . . . 75.129999999999995 109.438 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -64.23 121.57 14.58 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.201 -0.296 . . . . 44.43 110.201 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.97 -20.32 11.63 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.866 -0.683 . . . . 74.319999999999993 111.929 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.4 m -72.92 147.97 44.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.199 -0.297 . . . . 72.400000000000006 110.199 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -105.85 144.86 31.98 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.786 -0.45 . . . . 53.530000000000001 109.786 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.658 HG21 HD23 ' A' ' 56' ' ' LEU . 73.0 mt -129.89 128.53 65.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.209 -0.45 . . . . 63.25 111.213 -174.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.547 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 69.4 t80 -96.69 108.08 20.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.145 -0.48 . . . . 71.209999999999994 109.866 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.469 HD11 HD21 ' A' ' 7' ' ' LEU . 46.3 mm -75.68 111.75 12.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.92 -0.4 . . . . 44.210000000000001 109.92 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -73.59 -53.25 10.93 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.636 -0.505 . . . . 62.520000000000003 109.636 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.585 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 179.23 177.54 47.74 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.396 -0.82 . . . . 70.310000000000002 111.772 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -123.02 143.22 50.09 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.283 -0.636 . . . . 74.329999999999998 109.283 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.402 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -59.99 156.59 36.06 Favored Pre-proline 0 C--N 1.326 -0.421 0 O-C-N 123.186 0.304 . . . . 73.239999999999995 110.206 177.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.402 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 10.6 Cg_endo -54.41 -24.85 37.07 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.096 2.53 . . . . 70.209999999999994 113.105 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.5 mtt -84.41 -13.33 52.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.117 0.484 . . . . 72.299999999999997 110.796 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.82 -2.68 80.26 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.338 -0.705 . . . . 43.450000000000003 111.338 -173.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.753 ' HB2' ' HB2' ' A' ' 67' ' ' LYS . 5.4 t70 -151.15 135.17 9.46 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.267 -0.642 . . . . 74.310000000000002 109.267 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -82.67 179.91 25.14 Favored 'Cis proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.564 -1.432 . . . . 74.409999999999997 112.436 -1.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 54' ' ' ILE . 4.5 mp -109.02 141.71 23.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.327 -0.62 . . . . 55.420000000000002 109.327 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.84 113.38 26.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.985 0.421 . . . . 63.0 110.834 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.658 HD23 HG21 ' A' ' 42' ' ' ILE . 2.2 mp -117.43 133.85 55.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.04 -0.527 . . . . 72.219999999999999 110.201 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.704 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 46.3 ttt180 -97.47 105.48 17.63 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.887 -0.782 . . . . 72.349999999999994 108.887 173.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.557 ' HB3' HG12 ' A' ' 42' ' ' ILE . 3.3 pp -139.86 151.71 45.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.279 -0.419 . . . . 73.329999999999998 110.75 -174.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 71.44 -19.93 0.24 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.065 0.546 . . . . 73.109999999999999 111.703 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 150.58 -26.65 1.07 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.27 -0.49 . . . . 51.109999999999999 112.212 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -140.85 166.86 23.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.001 0.429 . . . . 74.5 111.182 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.704 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.3 m -85.58 138.45 32.17 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.107 -0.497 . . . . 61.43 111.871 -176.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.9 mt -134.54 159.06 42.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.558 -0.746 . . . . 75.25 109.471 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p -104.73 122.2 45.2 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.154 0.502 . . . . 74.099999999999994 111.361 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.9 tp -109.19 145.47 35.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.861 -0.609 . . . . 62.539999999999999 109.504 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -77.53 149.3 34.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.601 0.239 . . . . 75.140000000000001 110.541 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.753 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 13.3 tmtt? -57.81 -36.96 72.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 62.43 110.646 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.3 m -62.84 -48.1 80.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.97 -0.559 . . . . 51.200000000000003 110.49 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.667 ' OE2' ' HG2' ' A' ' 30' ' ' LYS . 36.9 mt-10 -67.13 -30.96 71.1 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.788 -0.642 . . . . 73.409999999999997 110.551 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.68 -21.26 62.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.316 -0.856 . . . . 62.140000000000001 111.876 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -81.31 -23.73 37.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.926 0.394 . . . . 75.219999999999999 110.532 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.34 -5.45 47.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.073 -0.512 . . . . 52.240000000000002 111.445 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.534 HG22 HG13 ' A' ' 75' ' ' VAL . 43.8 mm -122.22 126.22 73.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.516 -0.311 . . . . 71.219999999999999 110.772 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.1 mt -108.15 120.79 43.36 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.052 -0.522 . . . . 72.540000000000006 109.969 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 18' ' ' VAL . 22.0 m -126.47 151.26 32.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.127 -0.488 . . . . 71.439999999999998 111.531 -173.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.531 ' OE2' HD11 ' A' ' 19' ' ' ILE . 14.6 pt-20 -91.39 138.78 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.437 -0.579 . . . . 73.530000000000001 109.437 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.663 ' HA ' HG12 ' A' ' 16' ' ' VAL . 24.3 t -87.64 109.9 20.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 120.916 0.388 . . . . 63.450000000000003 110.454 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 121.318 0.58 . . . . 45.539999999999999 110.695 -178.525 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.482 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.506 0 CA-C-O 120.824 0.124 . . . . 64.129999999999995 112.812 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.4 pt -101.67 160.83 3.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.614 -0.513 . . . . 63.210000000000001 109.614 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.01 147.53 30.59 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.142 -1.028 . . . . 54.310000000000002 111.283 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.726 HD11 HD11 ' A' ' 44' ' ' ILE . 36.9 tp -60.01 -26.81 66.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.017 0.437 . . . . 73.219999999999999 110.853 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -78.14 -9.8 59.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.148 -0.478 . . . . 73.010000000000005 111.011 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -90.34 -13.96 34.08 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.16 0.505 . . . . 75.420000000000002 109.932 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.5 t -77.86 154.88 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.613 -0.721 . . . . 71.140000000000001 110.49 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -103.76 170.87 7.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.741 -0.663 . . . . 73.409999999999997 110.278 -175.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.3 pt -71.72 146.91 11.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.012 -0.54 . . . . 72.439999999999998 111.116 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 13' ' ' LYS . 33.7 ttmt 59.04 63.96 1.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.8 0.81 . . . . 75.519999999999996 110.333 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 m -136.0 151.2 49.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.034 -0.985 . . . . 63.420000000000002 109.836 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -118.14 110.88 18.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.136 0.493 . . . . 72.519999999999996 110.017 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 77' ' ' VAL . 27.0 m -123.69 167.38 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.719 -0.673 . . . . 70.010000000000005 111.801 -173.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.619 ' HB2' HD21 ' A' ' 78' ' ' LEU . 81.0 tttt -117.96 145.83 44.42 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.094 -0.957 . . . . 61.329999999999998 110.126 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.594 ' HA ' HG12 ' A' ' 75' ' ' VAL . 45.9 t -82.15 97.96 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.131 -0.486 . . . . 65.099999999999994 110.266 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.872 HD11 ' HB2' ' A' ' 76' ' ' GLU . 42.6 mt -61.03 -48.59 88.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.816 -0.629 . . . . 70.439999999999998 109.991 175.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.68 160.73 31.03 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.489 -0.778 . . . . 62.030000000000001 112.31 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.701 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 58.5 mt -98.04 157.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.164 -0.68 . . . . 73.150000000000006 109.164 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.9 t -102.45 89.71 1.85 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 120.982 0.42 . . . . 72.340000000000003 110.144 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.932 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 21.1 Cg_exo -64.93 170.05 10.86 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.026 2.484 . . . . 71.510000000000005 112.367 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 64.25 7.55 3.59 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.638 -0.71 . . . . 75.239999999999995 111.879 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 28' ' ' ARG . 1.3 m -91.7 154.19 19.15 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.648 -0.871 . . . . 75.140000000000001 108.648 170.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -69.61 -45.59 68.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.702 0.287 . . . . 62.329999999999998 111.065 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.544 ' HB ' ' HG3' ' A' ' 69' ' ' GLU . 24.5 m -78.03 -6.79 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.065 0.46 . . . . 62.439999999999998 110.815 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.932 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -57.07 -36.7 70.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.682 -0.69 . . . . 65.049999999999997 111.373 178.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -67.23 -39.27 86.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.117 0.484 . . . . 51.539999999999999 110.007 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 34' ' ' MET . 85.3 tttt -63.12 -46.67 86.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.384 -0.826 . . . . 72.239999999999995 110.107 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 27' ' ' VAL . 68.9 mt -57.55 -48.2 83.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.603 -0.726 . . . . 71.319999999999993 111.445 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.61 -37.19 85.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.958 0.409 . . . . 60.310000000000002 110.81 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.26 -30.99 69.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 61.409999999999997 110.562 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 62.0 mtt -58.6 -32.29 68.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.047 -0.524 . . . . 71.230000000000004 110.887 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.41 1.82 7.71 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.617 -0.802 . . . . 64.530000000000001 112.208 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.456 HG23 HG21 ' A' ' 18' ' ' VAL . 63.1 mt -84.65 133.1 30.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.873 0.368 . . . . 64.319999999999993 110.31 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.748 HG23 ' H ' ' A' ' 38' ' ' ARG . 1.4 m -129.04 -74.86 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.911 -0.586 . . . . 74.109999999999999 111.03 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.748 ' H ' HG23 ' A' ' 37' ' ' VAL . 49.2 ttp180 -169.12 138.29 2.09 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.22 -0.659 . . . . 73.299999999999997 109.22 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.04 17.22 77.0 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.578 -0.82 . . . . 42.109999999999999 111.671 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 m -81.44 151.03 28.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.936 -0.394 . . . . 72.519999999999996 109.936 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -95.62 133.32 39.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.898 0.38 . . . . 63.350000000000001 110.728 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.4 mt -123.55 116.06 47.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.803 -0.635 . . . . 62.310000000000002 110.381 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.528 ' HE2' ' HG2' ' A' ' 45' ' ' GLU . 44.5 t80 -95.15 108.06 20.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.007 -0.542 . . . . 73.430000000000007 109.569 174.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.726 HD11 HD11 ' A' ' 7' ' ' LEU . 49.1 mm -75.3 105.87 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.119 -0.697 . . . . 71.349999999999994 109.119 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.528 ' HG2' ' HE2' ' A' ' 43' ' ' TYR . 0.4 OUTLIER -73.83 -61.14 1.95 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.123 -0.695 . . . . 72.239999999999995 109.123 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.01 162.56 35.9 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.649 -0.786 . . . . 70.239999999999995 112.203 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -125.52 153.0 44.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.202 -0.666 . . . . 70.349999999999994 109.202 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.72 156.42 89.12 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.589 -0.522 . . . . 72.340000000000003 109.589 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.68 -35.39 57.37 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.701 2.267 . . . . 75.109999999999999 112.574 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 tpt -65.43 -22.85 66.81 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.182 0.515 . . . . 71.519999999999996 111.264 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.27 -2.98 63.67 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 111.024 -0.831 . . . . 40.5 111.024 -174.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -143.32 132.75 11.71 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.996 -0.742 . . . . 72.019999999999996 108.996 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -89.56 176.63 20.01 Favored 'Cis proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.704 -1.373 . . . . 74.019999999999996 113.023 0.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 64' ' ' SER . 4.6 mp -105.75 130.97 56.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.728 -0.669 . . . . 65.430000000000007 109.804 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.66 113.6 26.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.501 -0.318 . . . . 74.239999999999995 110.248 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.635 HD21 HD21 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -129.49 172.15 11.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.459 -0.337 . . . . 74.420000000000002 110.938 -178.029 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.677 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 35.4 ttm180 -129.23 117.24 20.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.841 -0.429 . . . . 71.540000000000006 109.841 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.547 ' H ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -135.95 148.7 48.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.54 -0.3 . . . . 71.319999999999993 110.58 -177.892 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.6 tpt85 69.09 -19.59 0.17 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.22 0.608 . . . . 72.219999999999999 111.997 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 143.34 -24.27 2.2 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.606 -0.598 . . . . 41.240000000000002 111.606 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -115.49 156.76 25.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.098 0.475 . . . . 71.530000000000001 111.401 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 46.7 t -93.8 146.81 23.61 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.751 -0.659 . . . . 61.43 110.477 176.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.3 mt -144.82 160.25 41.57 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.284 -0.871 . . . . 61.32 109.571 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 35.8 t -118.89 128.04 54.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.679 -0.489 . . . . 54.439999999999998 109.679 176.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.635 HD21 HD21 ' A' ' 56' ' ' LEU . 2.0 pp -125.94 166.91 16.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.251 -0.432 . . . . 72.019999999999996 111.268 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.58 163.11 24.9 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.562 -0.745 . . . . 73.010000000000005 111.191 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.81 -22.39 64.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.404 -0.816 . . . . 62.119999999999997 109.998 174.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.2 m -66.14 -50.97 62.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.815 -0.629 . . . . 75.209999999999994 110.99 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.544 ' HG3' ' HB ' ' A' ' 27' ' ' VAL . 1.6 mp0 -58.26 -40.73 82.59 Favored 'General case' 0 N--CA 1.46 0.066 0 CA-C-O 121.075 0.464 . . . . 71.439999999999998 110.359 175.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HA ' ' HB3' ' A' ' 7' ' ' LEU . . . -62.03 -21.66 65.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.85 -0.614 . . . . 61.210000000000001 111.511 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' A' ' 71' ' ' LYS . 1.2 tmmt? -83.25 -32.29 26.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.285 -0.416 . . . . 65.299999999999997 110.633 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -96.95 9.33 42.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.285 0.476 . . . . 73.030000000000001 112.285 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.52 HG22 HG13 ' A' ' 75' ' ' VAL . 79.9 mt -113.24 120.85 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.22 -0.289 . . . . 72.329999999999998 110.22 174.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.0 mt -105.56 121.37 43.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.251 -0.431 . . . . 70.409999999999997 109.95 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.594 HG12 ' HA ' ' A' ' 18' ' ' VAL . 23.6 m -132.54 174.59 13.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.027 -0.533 . . . . 73.129999999999995 111.643 -174.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.872 ' HB2' HD11 ' A' ' 19' ' ' ILE . 35.4 tt0 -143.14 145.08 32.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.271 -0.877 . . . . 52.409999999999997 108.891 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.579 ' HA ' HG12 ' A' ' 16' ' ' VAL . 11.1 p -71.92 141.01 17.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.0 0.429 . . . . 71.340000000000003 110.661 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' A' ' 17' ' ' LYS . 68.1 mt . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.116 -0.493 . . . . 73.239999999999995 111.527 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.752 0 N-CA-C 112.154 -0.379 . . . . 74.340000000000003 112.154 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.1 pt -109.84 169.91 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.757 -0.46 . . . . 72.230000000000004 109.757 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.95 158.21 46.14 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.11 -1.043 . . . . 65.230000000000004 111.294 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.3 tp -65.81 -18.39 65.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.761 0.315 . . . . 61.130000000000003 111.214 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 33.8 p30 -92.63 0.16 57.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.797 0.332 . . . . 53.210000000000001 111.311 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.48 5.98 31.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.926 0.393 . . . . 65.420000000000002 110.684 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 t -88.72 157.34 3.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.01 0.433 . . . . 54.130000000000003 110.951 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -101.74 164.55 11.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.663 -0.698 . . . . 71.109999999999999 110.166 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.439 HG22 ' HA2' ' A' ' 46' ' ' GLY . 36.2 pt -75.87 166.53 2.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.951 -0.568 . . . . 63.109999999999999 111.16 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.3 mttm 65.91 9.42 6.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.783 -0.644 . . . . 74.5 111.41 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 m -111.7 148.23 33.88 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.226 -0.443 . . . . 71.019999999999996 110.811 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 41' ' ' GLU . 81.9 tttt -105.73 123.93 48.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.812 -0.631 . . . . 74.129999999999995 109.496 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 77' ' ' VAL . 21.5 m -119.17 167.81 12.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.132 -0.485 . . . . 72.329999999999998 110.57 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.578 ' HB2' HD21 ' A' ' 78' ' ' LEU . 84.3 tttt -133.58 141.12 47.54 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.768 -0.651 . . . . 73.420000000000002 109.982 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.591 ' HA ' HG12 ' A' ' 75' ' ' VAL . 43.4 t -76.52 95.74 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.377 -0.829 . . . . 73.310000000000002 110.2 -177.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.79 HD11 ' HB2' ' A' ' 76' ' ' GLU . 36.2 mt -57.46 -49.83 79.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.569 -0.741 . . . . 62.340000000000003 109.639 174.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.594 ' HA2' ' HG2' ' A' ' 38' ' ' ARG . . . -173.26 164.57 36.44 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.659 -0.781 . . . . 62.229999999999997 112.622 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.701 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 37.9 mt -85.38 158.97 3.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.733 -0.84 . . . . 74.519999999999996 108.733 176.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.3 91.71 1.84 Allowed Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.679 -0.489 . . . . 61.420000000000002 109.679 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.701 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 72.1 Cg_exo -49.62 169.08 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 124.226 3.284 . . . . 70.409999999999997 114.073 -173.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 66.27 19.93 11.04 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.953 -1.021 . . . . 73.430000000000007 109.302 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 1.032 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 42.1 t -84.03 152.06 24.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.489 -1.232 . . . . 61.140000000000001 110.248 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.598 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 11.1 mptt -98.11 -23.56 15.68 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.159 -0.682 . . . . 65.200000000000003 109.159 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -97.25 -7.81 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.559 -0.746 . . . . 62.420000000000002 111.039 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 1.032 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 8.4 tmm_? -46.77 -47.92 20.71 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.079 0.4 . . . . 75.209999999999994 112.079 176.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -70.27 -28.47 65.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.962 0.41 . . . . 64.329999999999998 110.455 -177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -73.46 -48.26 34.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.726 -0.67 . . . . 50.399999999999999 110.364 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.54 HD13 HD11 ' A' ' 73' ' ' ILE . 85.7 mt -60.5 -42.1 90.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.525 -0.761 . . . . 53.100000000000001 111.182 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ttt -65.9 -30.1 70.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 60.329999999999998 110.579 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.75 -32.88 70.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.889 -0.596 . . . . 54.119999999999997 110.146 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.8 mtt -63.24 -29.07 70.48 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.934 -0.576 . . . . 72.109999999999999 110.43 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.5 5.1 12.92 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.79 -0.641 . . . . 74.439999999999998 112.365 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.507 ' HB ' HG22 ' A' ' 31' ' ' ILE . 43.3 mt -90.42 126.59 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.992 0.425 . . . . 72.150000000000006 110.436 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.1 m -141.1 -177.67 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.489 -0.778 . . . . 65.319999999999993 110.268 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.594 ' HG2' ' HA2' ' A' ' 20' ' ' GLY . 46.0 mtt85 -69.78 114.75 8.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 72.420000000000002 110.313 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.39 -8.67 22.5 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.534 -0.841 . . . . 63.140000000000001 112.812 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 m -70.41 142.69 52.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.041 0.448 . . . . 72.420000000000002 110.412 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.402 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 47.0 mt-10 -106.45 137.47 44.37 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.61 -0.723 . . . . 72.129999999999995 110.218 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.763 HG12 ' HB3' ' A' ' 58' ' ' LEU . 66.1 mt -129.5 131.41 67.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.71 -0.677 . . . . 71.25 111.293 -172.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.536 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 53.3 t80 -96.95 125.9 41.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.696 -0.483 . . . . 64.109999999999999 109.696 171.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.6 mm -87.24 99.48 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.574 -0.528 . . . . 73.230000000000004 109.574 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.15 -41.94 24.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.653 -0.703 . . . . 65.019999999999996 110.497 -176.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.439 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 172.74 -172.91 45.32 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.432 -0.667 . . . . 34.009999999999998 111.432 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.881 ' HE2' ' HA2' ' A' ' 51' ' ' GLY . 13.9 ptmt -151.0 165.89 32.36 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.246 -0.65 . . . . 73.030000000000001 109.246 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.47 156.42 82.23 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.771 -0.455 . . . . 64.010000000000005 109.771 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.49 -32.14 51.71 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.797 2.331 . . . . 74.540000000000006 113.086 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 45.5 ttm -86.6 -8.67 57.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.426 0.631 . . . . 75.140000000000001 110.367 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.881 ' HA2' ' HE2' ' A' ' 47' ' ' LYS . . . 95.71 -11.27 68.35 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.618 -0.719 . . . . 52.43 112.477 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -131.87 127.53 21.26 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-O 120.841 0.353 . . . . 71.140000000000001 110.271 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -83.61 170.33 53.17 Favored 'Cis proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.918 -1.701 . . . . 60.43 112.718 -1.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.52 HG23 ' HB3' ' A' ' 47' ' ' LYS . 41.0 mt -98.57 141.99 15.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.849 -0.797 . . . . 75.420000000000002 108.849 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.99 102.9 14.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.033 0.444 . . . . 74.340000000000003 110.313 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.721 HD23 HG21 ' A' ' 42' ' ' ILE . 4.5 mp -108.4 162.01 14.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.0 -0.545 . . . . 65.0 109.941 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.696 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 75.3 ttt180 -132.51 100.66 5.04 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.878 -0.786 . . . . 63.140000000000001 108.878 173.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.763 ' HB3' HG12 ' A' ' 42' ' ' ILE . 2.9 pp -127.36 149.76 49.91 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.827 -0.624 . . . . 73.109999999999999 110.856 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.464 ' HD3' ' OH ' ' A' ' 61' ' ' TYR . 52.4 ttt180 70.26 -22.44 0.17 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.532 0.52 . . . . 72.420000000000002 112.13 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 141.52 -3.58 2.13 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.927 -0.654 . . . . 61.43 112.141 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.464 ' OH ' ' HD3' ' A' ' 59' ' ' ARG . 16.9 p90 -138.28 158.33 44.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.162 0.506 . . . . 72.409999999999997 111.328 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 34.8 t -87.14 147.15 25.75 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.532 -0.758 . . . . 73.430000000000007 110.126 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 54.1 tp -155.52 147.73 23.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.579 -0.737 . . . . 71.109999999999999 109.775 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 4.1 m -97.48 133.55 41.91 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.07 0.462 . . . . 63.310000000000002 110.71 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.702 HD23 HD13 ' A' ' 56' ' ' LEU . 3.8 mm? -123.09 150.12 43.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.609 -0.723 . . . . 70.430000000000007 110.178 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 66' ' ' ARG . 22.9 mmt180 -81.87 161.44 23.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.141 0.496 . . . . 63.439999999999998 111.222 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.39 -36.89 85.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 71.400000000000006 110.898 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.9 m -70.33 -43.27 70.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.442 . . . . 50.420000000000002 111.005 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.15 -35.07 79.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.261 0.553 . . . . 60.200000000000003 110.482 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 8' ' ' ASN . . . -68.03 -22.19 64.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.525 -0.761 . . . . 61.420000000000002 111.358 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -76.36 -29.23 57.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.168 0.508 . . . . 73.219999999999999 110.267 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.11 9.18 5.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.751 -0.659 . . . . 62.32 111.629 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.54 HD11 HD13 ' A' ' 31' ' ' ILE . 62.5 mt -128.23 131.27 69.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.327 -0.397 . . . . 64.230000000000004 110.55 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.2 mt -107.23 125.71 51.47 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.275 -0.421 . . . . 72.230000000000004 109.87 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 18' ' ' VAL . 27.4 m -129.81 160.31 40.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.307 0.575 . . . . 62.039999999999999 111.948 -175.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.79 ' HB2' HD11 ' A' ' 19' ' ' ILE . 6.5 tp10 -120.76 146.6 46.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.956 -1.02 . . . . 72.310000000000002 109.104 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.419 ' HA ' HG12 ' A' ' 16' ' ' VAL . 10.0 p -91.09 133.63 32.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.911 0.386 . . . . 74.519999999999996 110.094 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 17' ' ' LYS . 4.0 mm? . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 121.09 0.471 . . . . 74.049999999999997 111.342 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.629 0 N-CA-C 112.046 -0.422 . . . . 74.120000000000005 112.046 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 pt -124.89 179.41 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.389 -0.597 . . . . 75.129999999999995 109.389 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.42 154.13 41.91 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.464 -1.35 . . . . 61.439999999999998 111.598 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.9 tp -60.67 -27.56 67.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.964 0.411 . . . . 70.140000000000001 110.796 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -71.86 -15.16 62.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 53.409999999999997 111.533 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.26 -3.9 54.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.877 0.37 . . . . 74.120000000000005 110.823 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.7 t -90.36 159.39 2.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.345 -0.389 . . . . 64.439999999999998 110.375 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.609 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 22.1 tt0 -98.29 171.97 7.86 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.502 -0.555 . . . . 75.140000000000001 109.502 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.609 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 38.4 pt -79.83 177.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.457 -0.338 . . . . 61.539999999999999 110.474 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 pttm 52.79 21.16 1.83 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.414 1.085 . . . . 41.310000000000002 112.423 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.2 m -121.53 153.03 38.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.8 0.334 . . . . 62.509999999999998 110.726 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -108.97 132.0 54.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.081 0.467 . . . . 71.140000000000001 109.843 176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.853 HG12 ' HA ' ' A' ' 77' ' ' VAL . 33.7 m -129.79 162.51 37.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.696 -0.684 . . . . 72.349999999999994 110.495 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.478 ' HB3' HD12 ' A' ' 78' ' ' LEU . 39.0 ttmt -115.6 143.86 44.73 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.281 -0.872 . . . . 65.420000000000002 109.231 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.822 ' HA ' HG12 ' A' ' 75' ' ' VAL . 53.8 t -73.53 95.87 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.855 -0.611 . . . . 71.129999999999995 109.947 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.4 mm -64.84 -40.98 90.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.247 -0.888 . . . . 72.140000000000001 109.891 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.97 -178.36 44.77 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.466 -0.873 . . . . 74.530000000000001 112.334 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.697 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 48.9 mt -128.34 159.3 39.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.364 -0.976 . . . . 70.209999999999994 108.364 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -100.1 90.81 1.44 Allowed Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.864 0.364 . . . . 52.5 110.157 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.697 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 17.5 Cg_exo -65.23 -178.56 0.86 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.335 2.69 . . . . 73.109999999999999 112.903 -173.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 61.97 25.52 15.32 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.816 0.817 . . . . 64.409999999999997 109.77 -173.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.866 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 10.8 t -115.02 150.66 35.5 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.59 -1.186 . . . . 72.420000000000002 109.64 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 3.8 mppt? -81.63 -32.73 31.81 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.597 -0.52 . . . . 73.049999999999997 109.597 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 31' ' ' ILE . 27.2 m -79.22 -19.95 12.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 64.219999999999999 110.652 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.866 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 5.7 tmm_? -52.28 -43.37 64.39 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.076 0.465 . . . . 74.450000000000003 109.826 172.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -59.41 -47.35 85.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.459 -0.792 . . . . 64.340000000000003 110.42 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 34' ' ' MET . 87.0 tttt -57.39 -47.19 82.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.209 -0.905 . . . . 71.450000000000003 111.028 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.489 HG22 ' HB ' ' A' ' 36' ' ' ILE . 75.9 mt -58.18 -44.77 88.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.566 -0.743 . . . . 34.340000000000003 111.409 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 55.2 mtt -71.59 -28.76 64.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.466 -0.334 . . . . 75.439999999999998 111.179 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.2 -31.96 72.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.237 0.541 . . . . 75.140000000000001 110.003 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 97.6 mmm -73.64 -9.18 58.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.462 -0.79 . . . . 74.219999999999999 111.057 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.5 -3.38 46.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.771 -0.728 . . . . 54.109999999999999 112.508 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.663 HG23 HG21 ' A' ' 18' ' ' VAL . 58.7 mt -88.06 129.72 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.911 0.386 . . . . 65.109999999999999 110.403 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.741 HG23 ' H ' ' A' ' 38' ' ' ARG . 1.0 OUTLIER -144.21 -75.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.837 -0.62 . . . . 75.239999999999995 111.437 -178.634 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.741 ' H ' HG23 ' A' ' 37' ' ' VAL . 24.7 ttt180 -150.86 140.18 21.34 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.602 -0.518 . . . . 73.109999999999999 109.602 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.06 19.25 69.82 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.776 -0.726 . . . . 54.299999999999997 112.106 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 m -85.28 146.72 26.91 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.948 -0.39 . . . . 62.340000000000003 109.948 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -90.99 127.8 36.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.866 0.365 . . . . 74.140000000000001 111.067 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.8 mm -126.22 114.87 40.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.44 -0.8 . . . . 75.25 109.609 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.825 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 39.3 t80 -106.3 119.34 38.99 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.559 -0.534 . . . . 75.120000000000005 109.559 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.434 HD13 HD12 ' A' ' 56' ' ' LEU . 14.6 mm -82.01 99.18 4.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.297 -0.41 . . . . 74.219999999999999 110.029 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -82.95 -22.58 33.73 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.154 -0.618 . . . . 73.420000000000002 110.364 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.79 -173.93 34.47 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.81 -0.71 . . . . 74.329999999999998 112.139 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.783 ' HG2' HG23 ' A' ' 54' ' ' ILE . 53.1 mtpt -126.8 160.3 31.28 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.442 -0.577 . . . . 53.32 109.442 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.18 151.23 94.24 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.712 -0.477 . . . . 51.439999999999998 109.712 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -51.4 -30.81 35.91 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.965 2.443 . . . . 61.43 113.215 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.0 tpt -76.09 -19.85 58.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.121 0.486 . . . . 65.010000000000005 111.223 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.58 -7.6 57.95 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.213 -0.755 . . . . 41.340000000000003 111.213 -174.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -152.42 132.61 7.35 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 108.9 -0.778 . . . . 74.239999999999995 108.9 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.71 -172.52 10.31 Favored 'Cis proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.567 -1.431 . . . . 53.439999999999998 112.98 0.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.783 HG23 ' HG2' ' A' ' 47' ' ' LYS . 53.5 mt -109.02 141.85 23.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.764 -0.653 . . . . 73.219999999999999 109.325 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.12 106.2 18.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.962 0.41 . . . . 70.420000000000002 110.998 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -105.72 135.77 46.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.132 -0.486 . . . . 61.229999999999997 110.059 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.825 ' HB3' ' HB3' ' A' ' 43' ' ' TYR . 2.3 tmt_? -86.56 114.37 23.24 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.794 -0.817 . . . . 72.400000000000006 108.794 175.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.6 tp -136.57 146.82 46.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.726 -0.67 . . . . 74.209999999999994 110.271 -175.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 71.05 -56.75 0.62 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.487 0.715 . . . . 65.0 110.762 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.51 -36.94 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.41 -0.676 . . . . 51.439999999999998 111.41 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.42 ' HE2' HD21 ' A' ' 63' ' ' LEU . 29.6 p90 -124.34 176.59 6.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.759 0.314 . . . . 74.230000000000004 110.4 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.784 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -93.11 140.81 29.11 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.491 0.552 . . . . 63.439999999999998 112.491 -175.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.42 HD21 ' HE2' ' A' ' 61' ' ' TYR . 75.6 mt -137.04 148.12 46.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.267 -0.879 . . . . 64.25 109.28 174.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 5.7 p -88.52 128.68 35.56 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.291 0.567 . . . . 64.140000000000001 111.829 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -121.5 157.76 29.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.253 -1.017 . . . . 73.420000000000002 108.253 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -80.22 156.34 26.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.56 0.695 . . . . 73.109999999999999 112.159 -169.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.435 ' HB3' ' NZ ' ' A' ' 67' ' ' LYS . 6.6 ttpm? -57.46 -28.19 63.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.669 -1.151 . . . . 71.239999999999995 110.975 174.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.1 m -61.25 -51.82 67.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.858 -0.61 . . . . 63.310000000000002 110.395 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' O ' HG13 ' A' ' 73' ' ' ILE . 1.7 mp0 -63.52 -30.54 71.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.94 -0.573 . . . . 72.209999999999994 111.111 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.16 -21.79 62.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.335 -0.393 . . . . 63.420000000000002 111.69 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.08 -42.45 38.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.398 0.618 . . . . 72.430000000000007 109.642 177.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.09 -10.37 53.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.392 -0.822 . . . . 54.420000000000002 112.018 -170.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.531 HG22 HG13 ' A' ' 75' ' ' VAL . 74.2 mt -90.27 113.09 25.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.923 -0.399 . . . . 74.030000000000001 109.923 174.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.5 mt -97.01 112.07 24.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.243 0.545 . . . . 52.030000000000001 110.484 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.822 HG12 ' HA ' ' A' ' 18' ' ' VAL . 29.4 m -132.34 167.7 25.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.758 -0.655 . . . . 72.400000000000006 110.203 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -140.23 145.96 38.04 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.123 -0.695 . . . . 74.400000000000006 109.123 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.853 ' HA ' HG12 ' A' ' 16' ' ' VAL . 47.9 t -67.88 103.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.019 -0.537 . . . . 63.25 110.415 -177.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 17' ' ' LYS . 26.6 mt . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 115.759 -0.655 . . . . 71.040000000000006 111.184 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.79 0 N-CA-C 111.441 -0.664 . . . . 42.240000000000002 111.441 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.7 pt -107.88 163.07 5.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 110.176 -0.305 . . . . 73.239999999999995 110.176 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.26 157.83 53.51 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.732 -0.747 . . . . 61.009999999999998 111.755 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.559 HD21 HD11 ' A' ' 56' ' ' LEU . 52.4 tp -61.52 -23.47 65.95 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.938 0.399 . . . . 73.319999999999993 111.195 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -87.15 -7.12 58.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.562 -0.29 . . . . 52.439999999999998 111.192 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -95.97 0.14 51.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.913 0.387 . . . . 71.150000000000006 110.67 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.624 HG11 HG11 ' A' ' 16' ' ' VAL . 12.1 t -90.0 163.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 65.349999999999994 110.812 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.437 ' N ' HG12 ' A' ' 10' ' ' VAL . 30.4 tt0 -83.53 165.12 19.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.259 -0.428 . . . . 62.310000000000002 109.988 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.7 pt -85.93 163.18 2.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.076 -0.511 . . . . 54.100000000000001 110.826 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm 59.45 25.21 13.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.005 0.431 . . . . 73.310000000000002 111.301 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.7 m -108.87 159.95 16.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.182 -0.463 . . . . 45.200000000000003 110.511 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.52 ' HG2' HD12 ' A' ' 78' ' ' LEU . 42.2 tttm -116.48 119.23 34.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.716 -0.846 . . . . 74.049999999999997 108.716 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.624 HG11 HG11 ' A' ' 10' ' ' VAL . 28.8 m -125.19 155.86 34.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.038 0.447 . . . . 64.409999999999997 112.011 -170.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -117.4 142.63 46.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.478 -0.783 . . . . 73.409999999999997 110.27 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.825 ' HA ' HG12 ' A' ' 75' ' ' VAL . 68.0 t -83.06 97.68 4.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.735 -0.666 . . . . 63.109999999999999 110.617 -176.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.4 mt -58.09 -54.38 33.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.2 -0.909 . . . . 63.5 110.358 173.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.36 165.66 34.46 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.375 -0.917 . . . . 33.409999999999997 113.076 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.42 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 58.6 mt -119.75 158.8 21.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.879 -0.786 . . . . 70.150000000000006 108.879 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 25' ' ' SER . 62.0 t -99.96 91.75 1.75 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.018 0.437 . . . . 74.010000000000005 110.028 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.692 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 37.6 Cg_endo -62.53 171.23 5.81 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.211 2.607 . . . . 34.299999999999997 113.308 -173.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 66.1 -15.73 0.12 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.004 0.922 . . . . 74.299999999999997 112.486 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -66.72 154.3 41.05 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 110.116 -0.327 . . . . 74.239999999999995 110.116 175.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 26' ' ' LYS . 72.1 mmtt -69.01 -30.51 68.92 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 111.942 0.349 . . . . 74.040000000000006 111.942 -175.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.712 HG21 ' HA ' ' A' ' 69' ' ' GLU . 20.5 m -83.39 -13.41 11.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.886 -0.326 . . . . 74.340000000000003 111.336 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.692 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 1.3 tmt_? -58.03 -48.41 80.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.379 -0.373 . . . . 74.140000000000001 111.085 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -62.48 -36.34 82.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.094 0.473 . . . . 73.239999999999995 110.79 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 34' ' ' MET . 61.5 tttm -66.29 -50.2 64.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.469 -0.787 . . . . 75.329999999999998 110.683 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.703 HD13 HD11 ' A' ' 73' ' ' ILE . 70.7 mt -66.37 -42.05 89.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.757 -0.656 . . . . 74.299999999999997 111.478 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 83.8 mtp -70.44 -28.75 65.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.633 0.254 . . . . 65.439999999999998 111.17 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -67.59 -28.21 67.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.199 0.523 . . . . 71.109999999999999 109.891 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.521 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 91.7 mmm -73.82 -16.44 61.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.524 -0.762 . . . . 74.439999999999998 111.062 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.3 -13.94 21.05 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.592 -0.813 . . . . 63.43 112.865 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.401 ' HB ' HG22 ' A' ' 31' ' ' ILE . 40.0 mt -78.64 129.33 37.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.71 0.291 . . . . 44.399999999999999 110.418 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.777 HG23 ' H ' ' A' ' 38' ' ' ARG . 2.1 m -139.21 -77.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.992 -0.549 . . . . 63.450000000000003 111.972 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.777 ' H ' HG23 ' A' ' 37' ' ' VAL . 1.4 tmm_? -149.44 125.44 10.62 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.048 -0.723 . . . . 71.319999999999993 109.048 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.33 -14.33 59.69 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.713 -0.756 . . . . 75.329999999999998 111.988 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.12 138.31 58.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.32 -0.622 . . . . 71.150000000000006 109.32 176.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -123.34 147.45 47.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.359 0.6 . . . . 54.530000000000001 111.258 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.782 HG21 ' HB3' ' A' ' 56' ' ' LEU . 44.3 mt -136.35 152.66 30.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.116 -0.947 . . . . 73.239999999999995 110.046 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -99.65 137.7 37.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.76 -0.459 . . . . 65.540000000000006 109.76 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.4 mm -87.76 103.12 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.431 -0.35 . . . . 71.340000000000003 110.585 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 57' ' ' ARG . 17.9 mm-40 -71.67 -39.06 70.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.123 -0.489 . . . . 71.439999999999998 110.423 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.73 -175.95 34.92 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.93 -0.652 . . . . 51.140000000000001 111.927 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -127.65 152.28 47.87 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.001 -0.37 . . . . 73.530000000000001 110.001 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -65.28 165.55 17.1 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.157 -0.474 . . . . 62.240000000000002 110.444 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 9.5 Cg_endo -51.53 -32.59 44.33 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.903 2.402 . . . . 64.030000000000001 113.014 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.5 mtt -89.52 -4.15 58.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.978 0.418 . . . . 74.209999999999994 110.991 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.32 5.83 89.55 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.219 -0.752 . . . . 74.450000000000003 111.219 -173.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 52.9 t0 -148.39 121.15 4.56 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.9 -0.778 . . . . 70.099999999999994 108.9 -176.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HB3' ' HD2' ' A' ' 66' ' ' ARG . 91.5 Cg_endo -86.41 -169.9 6.28 Favored 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.537 -1.443 . . . . 64.219999999999999 113.311 1.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 54' ' ' ILE . 4.4 mp -112.63 145.61 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.424 -0.807 . . . . 72.030000000000001 109.504 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.45 108.15 20.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.873 0.368 . . . . 75.040000000000006 110.798 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.782 ' HB3' HG21 ' A' ' 42' ' ' ILE . 2.2 mm? -102.06 146.14 28.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.464 -0.569 . . . . 64.239999999999995 109.464 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 21.8 ttt180 -116.79 114.17 23.57 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.478 -0.489 . . . . 70.340000000000003 110.442 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 60' ' ' GLY . 6.0 tt -149.23 156.02 41.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.895 -0.78 . . . . 71.010000000000005 108.895 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 58' ' ' LEU . 79.6 ttt180 74.64 -21.84 0.28 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.309 0.576 . . . . 74.209999999999994 110.412 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 146.88 -40.92 0.99 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.719 -0.673 . . . . 73.409999999999997 111.6 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.4 ' HE2' HD21 ' A' ' 63' ' ' LEU . 23.9 p90 -116.57 168.55 10.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.143 0.497 . . . . 73.420000000000002 111.201 -175.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.2 m -85.74 139.03 31.68 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.395 -0.82 . . . . 64.349999999999994 111.556 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.4 HD21 ' HE2' ' A' ' 61' ' ' TYR . 76.4 mt -134.49 158.75 43.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.669 -0.696 . . . . 60.43 109.309 175.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.1 m -100.85 138.48 37.84 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.072 0.463 . . . . 64.010000000000005 111.305 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.4 mt -127.76 134.64 49.51 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.357 -0.838 . . . . 52.009999999999998 108.909 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.536 ' HD2' ' HB3' ' A' ' 53' ' ' PRO . 25.3 mmm180 -64.9 153.5 40.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.686 -0.233 . . . . 71.040000000000006 110.655 -176.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -33.86 67.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.782 0.325 . . . . 65.310000000000002 110.192 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.4 m -57.66 -45.8 85.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.932 -0.577 . . . . 43.210000000000001 110.711 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.712 ' HA ' HG21 ' A' ' 27' ' ' VAL . 32.6 mt-10 -66.29 -44.54 83.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.227 0.537 . . . . 73.230000000000004 109.856 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.33 -22.31 66.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.486 -0.779 . . . . 62.119999999999997 111.614 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -81.31 -24.53 37.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.134 0.493 . . . . 74.230000000000004 110.608 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -95.25 12.81 27.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.255 0.55 . . . . 65.120000000000005 110.599 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.703 HD11 HD13 ' A' ' 31' ' ' ILE . 65.2 mt -121.6 119.57 59.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.65 -0.705 . . . . 71.219999999999999 109.669 176.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.7 mt -102.64 122.35 44.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.7 -0.482 . . . . 65.439999999999998 109.7 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.825 HG12 ' HA ' ' A' ' 18' ' ' VAL . 31.0 m -132.97 173.13 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.276 0.56 . . . . 74.030000000000001 112.3 -172.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.68 160.46 38.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.153 -0.93 . . . . 64.219999999999999 109.449 174.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.61 134.06 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.13 0.49 . . . . 74.510000000000005 111.534 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.52 HD12 ' HG2' ' A' ' 15' ' ' LYS . 81.6 mt . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 115.842 -0.617 . . . . 74.010000000000005 110.978 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 121.409 0.449 . . . . 51.140000000000001 113.892 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 pt -137.03 176.33 8.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.055 -1.091 . . . . 71.319999999999993 108.055 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.77 148.71 42.07 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.7 -1.238 . . . . 75.5 111.054 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.642 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 2.0 tm? -57.24 -29.82 64.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.504 0.668 . . . . 73.420000000000002 109.799 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.46 ' OD1' ' HA ' ' A' ' 71' ' ' LYS . 3.6 p-10 -71.36 -14.11 62.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.482 -0.781 . . . . 61.130000000000003 111.364 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -101.59 3.99 40.5 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.417 -0.356 . . . . 70.340000000000003 111.06 -174.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.9 t -83.74 155.45 3.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.112 0.482 . . . . 72.329999999999998 110.236 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.548 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 17.3 tt0 -95.02 175.09 6.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.798 -0.637 . . . . 74.420000000000002 110.452 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.548 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 23.7 pt -75.09 145.69 10.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.236 -0.438 . . . . 62.340000000000003 111.69 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 59.12 24.42 12.76 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.433 -0.803 . . . . 72.230000000000004 112.17 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 m -108.45 147.54 31.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.082 -0.508 . . . . 62.200000000000003 109.831 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -109.66 149.83 29.15 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.954 -0.387 . . . . 74.239999999999995 109.954 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.942 HG12 ' HA ' ' A' ' 77' ' ' VAL . 28.4 m -140.25 178.3 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.14 0.495 . . . . 75.420000000000002 110.987 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.672 ' HB2' HD11 ' A' ' 78' ' ' LEU . 7.1 ttpm? -133.06 140.4 47.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.545 -0.752 . . . . 72.319999999999993 110.138 176.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.682 ' HA ' HG12 ' A' ' 75' ' ' VAL . 47.6 t -73.14 97.67 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.605 -0.725 . . . . 63.109999999999999 110.073 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.7 mm -79.75 -49.34 19.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.693 -0.685 . . . . 73.430000000000007 110.951 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -152.55 168.08 31.54 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.818 -1.182 . . . . 53.329999999999998 113.646 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.65 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 50.0 mm -124.39 157.42 31.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.023 -1.103 . . . . 64.340000000000003 108.023 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 t -102.62 90.32 2.18 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 120.849 0.357 . . . . 73.239999999999995 110.218 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.65 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 74.2 Cg_exo -49.71 159.33 1.54 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.774 2.983 . . . . 73.209999999999994 113.875 -171.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 64.84 69.86 0.49 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.308 -0.86 . . . . 70.400000000000006 110.945 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.69 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 9.3 t -149.57 162.98 39.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.366 -0.834 . . . . 73.25 109.137 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -73.27 -45.13 57.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.358 0.599 . . . . 74.25 109.55 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.457 HG11 ' HG2' ' A' ' 69' ' ' GLU . 27.8 m -78.71 -20.54 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.488 -0.778 . . . . 63.109999999999999 111.573 -176.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.69 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 2.1 tmt_? -50.87 -43.98 59.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.257 0.551 . . . . 70.230000000000004 109.654 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.45 HH11 ' HD3' ' A' ' 29' ' ' ARG . 8.5 tpt180 -71.8 -44.21 64.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.591 -0.731 . . . . 71.519999999999996 110.614 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -60.59 -45.96 92.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.429 -0.805 . . . . 63.149999999999999 111.926 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 34' ' ' MET . 65.8 mt -68.68 -41.19 82.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.062 -0.517 . . . . 72.230000000000004 111.181 -177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.1 ttt -72.26 -28.47 63.15 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.66 -0.416 . . . . 75.5 110.371 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.8 -38.94 87.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.131 0.491 . . . . 40.32 109.944 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 6.9 mmt -56.81 -29.42 62.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.262 -0.881 . . . . 55.509999999999998 111.363 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.51 13.31 22.82 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.763 -0.732 . . . . 52.039999999999999 111.975 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -90.51 134.17 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.925 -0.398 . . . . 75.329999999999998 109.925 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 m -137.48 -177.86 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.081 -0.509 . . . . 72.340000000000003 110.547 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 54.8 ttp180 -64.52 131.46 47.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.366 -0.379 . . . . 74.109999999999999 110.119 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.61 -21.58 36.35 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.556 -0.831 . . . . 74.400000000000006 112.56 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.1 m -68.2 146.49 53.33 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.896 0.379 . . . . 72.5 110.342 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -95.88 132.06 41.56 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.472 0.653 . . . . 53.420000000000002 110.916 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.599 HD12 ' HB3' ' A' ' 58' ' ' LEU . 48.7 mm -121.11 122.49 67.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.059 -0.973 . . . . 74.129999999999995 109.458 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.693 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 14.9 t80 -102.47 118.35 36.67 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.702 -0.481 . . . . 73.430000000000007 109.702 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 mm -85.19 100.16 8.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.487 -0.561 . . . . 73.310000000000002 109.487 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.38 -42.0 65.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.207 -0.664 . . . . 73.420000000000002 109.207 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.52 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 170.27 -169.44 42.25 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.243 -0.743 . . . . 64.409999999999997 111.243 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.749 ' HG3' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -146.1 162.92 36.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.395 -0.594 . . . . 64.299999999999997 109.395 175.581 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -61.28 160.83 20.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 O-C-N 123.486 0.491 . . . . 42.439999999999998 110.315 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 9.3 Cg_endo -52.81 -26.54 31.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.151 2.567 . . . . 73.530000000000001 113.47 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.8 ttt -93.45 -7.64 43.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.087 0.47 . . . . 62.009999999999998 110.877 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.749 ' HA2' ' HG3' ' A' ' 47' ' ' LYS . . . 89.05 -1.54 83.09 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.923 -0.656 . . . . 41.130000000000003 112.092 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -145.71 125.86 7.09 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.216 -0.661 . . . . 61.049999999999997 109.216 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.93 178.56 31.54 Favored 'Cis proline' 0 C--O 1.236 0.382 0 C-N-CA 123.029 -1.655 . . . . 64.030000000000001 112.842 -0.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.712 HG23 ' HB3' ' A' ' 47' ' ' LYS . 19.8 mt -114.92 141.83 30.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 72.239999999999995 109.813 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.59 109.73 21.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.995 0.426 . . . . 62.43 110.322 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.6 mt -120.58 135.58 55.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.293 -0.412 . . . . 52.130000000000003 110.945 -173.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.693 ' HB3' ' HB3' ' A' ' 43' ' ' TYR . 4.2 tmt_? -92.34 100.83 13.33 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.986 -1.116 . . . . 71.340000000000003 107.986 172.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.599 ' HB3' HD12 ' A' ' 42' ' ' ILE . 2.0 pp -138.78 156.59 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.643 -0.708 . . . . 73.200000000000003 110.811 -174.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? 71.34 -44.76 0.6 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.909 0.756 . . . . 75.329999999999998 110.707 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.69 -19.13 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 116.23 -0.441 . . . . 54.439999999999998 112.02 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -137.96 168.9 18.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.988 0.423 . . . . 74.099999999999994 111.436 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.652 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.2 m -85.27 126.71 33.92 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.627 -0.715 . . . . 74.0 110.534 175.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 52.9 tp -145.23 148.87 33.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.657 -0.702 . . . . 74.150000000000006 109.224 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 21.8 t -95.01 125.96 40.02 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.181 0.515 . . . . 70.450000000000003 110.99 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.12 168.18 11.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.266 -0.879 . . . . 73.209999999999994 109.397 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.48 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 30.4 mmt180 -77.53 153.48 33.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.157 0.503 . . . . 71.310000000000002 111.673 -177.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -60.08 -34.78 73.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.525 -0.761 . . . . 75.349999999999994 109.986 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.4 m -61.66 -36.26 80.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.302 -0.863 . . . . 73.040000000000006 110.91 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.48 ' HG3' ' HB2' ' A' ' 66' ' ' ARG . 40.7 mt-10 -69.97 -41.89 73.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.458 0.647 . . . . 75.519999999999996 110.079 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.77 -21.52 66.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.212 -0.904 . . . . 75.219999999999999 111.497 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.46 ' HA ' ' OD1' ' A' ' 8' ' ' ASN . 61.2 tttm -71.32 -25.21 62.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.792 0.33 . . . . 61.140000000000001 111.226 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.61 -4.47 57.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.074 0.464 . . . . 74.450000000000003 111.194 -174.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.642 ' HB ' ' HB2' ' A' ' 7' ' ' LEU . 21.1 mt -104.54 125.4 59.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.15 -0.477 . . . . 72.219999999999999 110.655 -178.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.1 mt -102.99 115.77 31.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.52 -0.548 . . . . 62.520000000000003 109.52 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.682 HG12 ' HA ' ' A' ' 18' ' ' VAL . 19.7 m -130.65 150.1 34.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.142 -0.481 . . . . 72.349999999999994 111.461 -174.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -99.49 139.87 34.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.453 -0.573 . . . . 55.020000000000003 109.453 171.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.942 ' HA ' HG12 ' A' ' 16' ' ' VAL . 40.9 t -73.95 113.63 12.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.033 0.444 . . . . 73.219999999999999 110.583 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' A' ' 17' ' ' LYS . 47.5 mt . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.964 -0.562 . . . . 75.120000000000005 110.939 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.691 0 CA-C-O 120.933 0.185 . . . . 53.329999999999998 113.271 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.4 pt -97.91 167.34 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.499 -0.926 . . . . 74.510000000000005 108.499 172.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.46 143.46 29.37 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 119.276 -1.44 . . . . 41.329999999999998 111.482 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 7' ' ' LEU . 8.2 tt -61.73 -26.84 68.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.32 0.581 . . . . 65.109999999999999 109.935 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.496 ' HB2' ' HG2' ' A' ' 67' ' ' LYS . 2.7 p-10 -67.76 -14.63 63.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 73.450000000000003 110.7 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.97 -2.95 39.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.115 -0.493 . . . . 74.430000000000007 111.309 -176.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.451 HG21 HG21 ' A' ' 16' ' ' VAL . 34.1 t -78.09 159.69 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.956 0.408 . . . . 73.129999999999995 110.459 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.452 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 28.0 tt0 -102.61 173.77 6.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.873 -0.603 . . . . 73.129999999999995 110.169 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.59 HG22 ' HA2' ' A' ' 46' ' ' GLY . 33.9 pt -76.42 149.8 6.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.35 0.5 . . . . 71.040000000000006 112.35 -173.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 53.8 31.02 12.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.174 -0.921 . . . . 75.400000000000006 112.142 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.7 m -121.2 145.86 47.39 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.261 -0.644 . . . . 70.209999999999994 109.261 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -110.45 137.97 47.46 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.343 0.592 . . . . 74.409999999999997 111.727 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' A' ' 77' ' ' VAL . 16.2 m -137.5 163.63 30.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.167 -0.924 . . . . 74.239999999999995 109.247 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 41' ' ' GLU . 38.4 ttpt -118.96 141.55 48.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.059 0.457 . . . . 74.219999999999999 111.241 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.512 ' HA ' HG12 ' A' ' 75' ' ' VAL . 47.0 t -73.91 93.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.995 -1.002 . . . . 75.299999999999997 110.121 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.1 -38.85 56.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.538 -0.755 . . . . 54.439999999999998 110.445 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.42 153.27 24.59 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.087 -1.054 . . . . 74.230000000000004 113.441 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.0 mt -114.7 158.25 15.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.177 -1.046 . . . . 73.430000000000007 108.177 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 22' ' ' VAL . 7.5 p -100.18 91.84 1.86 Allowed Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 121.761 0.791 . . . . 62.020000000000003 110.243 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.945 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 29.3 Cg_endo -60.01 166.67 8.41 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.907 2.404 . . . . 74.099999999999994 112.544 -174.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 66.52 11.9 8.38 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.388 -0.824 . . . . 73.099999999999994 111.226 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.859 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 34.7 t -85.51 157.45 20.42 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.429 -0.582 . . . . 62.530000000000001 109.429 174.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -69.0 -43.83 74.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.162 -0.681 . . . . 71.310000000000002 109.162 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.3 m -77.94 -15.68 14.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.353 -0.84 . . . . 75.099999999999994 110.969 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.945 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -52.46 -43.17 64.78 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.592 -0.276 . . . . 55.32 110.311 176.418 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -71.06 -41.64 70.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.413 . . . . 65.420000000000002 110.956 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -54.1 -45.12 71.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.315 0.579 . . . . 75.329999999999998 110.945 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.776 HD13 HD11 ' A' ' 73' ' ' ILE . 86.9 mt -65.8 -46.85 87.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.042 -0.981 . . . . 64.109999999999999 112.054 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 51.1 mtt -73.33 -29.37 62.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.726 0.298 . . . . 73.439999999999998 111.121 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.89 -28.69 69.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.266 0.555 . . . . 73.409999999999997 110.109 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 20.8 ttm -76.87 -20.78 55.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.597 -0.729 . . . . 75.019999999999996 110.69 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.7 15.23 15.57 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.659 -0.781 . . . . 50.409999999999997 112.901 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.519 ' HB ' HG22 ' A' ' 31' ' ' ILE . 25.8 mt -96.3 129.25 46.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.849 0.357 . . . . 74.349999999999994 110.298 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.6 m -134.28 -177.96 2.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.932 -0.576 . . . . 61.25 110.592 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -67.78 139.6 56.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.263 -0.273 . . . . 70.120000000000005 110.263 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.35 -2.17 87.46 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.035 -0.603 . . . . 34.240000000000002 112.789 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m -75.44 133.88 41.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.166 -0.679 . . . . 71.219999999999999 109.166 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 17' ' ' LYS . 5.1 pt-20 -104.57 129.07 52.69 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.28 0.562 . . . . 70.129999999999995 109.934 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.638 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 63.0 mt -118.17 132.84 66.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.023 -0.989 . . . . 54.25 110.578 -171.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -92.01 104.12 16.56 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.056 -0.72 . . . . 75.120000000000005 109.056 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.8 mm -74.21 97.47 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.183 -0.673 . . . . 63.439999999999998 109.183 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.436 ' OE2' ' HB2' ' A' ' 57' ' ' ARG . 50.0 mt-10 -66.47 -39.5 88.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.885 0.374 . . . . 74.299999999999997 110.618 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.59 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 170.19 172.69 36.89 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.355 -0.926 . . . . 73.310000000000002 112.215 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.639 ' HG2' HG12 ' A' ' 54' ' ' ILE . 46.1 mtmt -110.0 165.05 12.03 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.331 -0.618 . . . . 71.439999999999998 109.331 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -66.79 164.54 32.96 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.844 -0.428 . . . . 74.109999999999999 109.844 174.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.502 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 84.9 Cg_exo -42.79 -49.16 6.91 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.223 2.616 . . . . 74.409999999999997 113.704 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.3 ttt -84.96 -10.86 56.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.893 0.378 . . . . 74.209999999999994 111.028 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.98 2.92 39.39 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.917 -0.659 . . . . 73.239999999999995 112.774 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -151.68 128.51 5.43 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 110.074 -0.343 . . . . 61.030000000000001 110.074 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -82.72 -165.85 4.54 Favored 'Cis proline' 0 CA--C 1.532 0.392 0 C-N-CA 123.414 -1.494 . . . . 72.140000000000001 113.088 2.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.639 HG12 ' HG2' ' A' ' 47' ' ' LYS . 52.7 mt -120.51 147.46 24.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.168 -0.469 . . . . 73.310000000000002 110.448 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -103.11 111.23 23.49 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.836 0.351 . . . . 51.310000000000002 110.351 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.638 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 2.2 mp -117.07 129.99 56.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 110.006 -176.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.764 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 23.8 ttm180 -101.43 115.28 30.14 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.647 -0.421 . . . . 60.450000000000003 110.402 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.566 ' HG ' HG12 ' A' ' 42' ' ' ILE . 5.5 mp -116.76 145.88 43.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.868 -0.605 . . . . 63.299999999999997 109.748 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 64.2 -77.97 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.729 0.643 . . . . 75.329999999999998 110.852 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.13 9.57 0.35 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.348 -0.453 . . . . 71.310000000000002 112.068 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -147.28 154.97 41.61 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.298 0.57 . . . . 63.409999999999997 111.137 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.764 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 21.8 t -93.7 144.32 25.51 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.508 -0.769 . . . . 63.039999999999999 111.855 -175.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.4 154.74 44.65 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.488 -1.233 . . . . 60.439999999999998 108.767 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -116.12 114.53 24.63 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 120.972 0.415 . . . . 74.439999999999998 111.916 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.543 ' HG ' HD13 ' A' ' 56' ' ' LEU . 3.6 pp -122.25 167.23 13.48 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.484 -0.562 . . . . 64.010000000000005 109.484 174.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 -86.34 163.93 17.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.518 0.675 . . . . 72.230000000000004 112.27 -174.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.496 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 1.4 tmtp? -64.5 -20.94 66.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.953 -1.021 . . . . 72.230000000000004 110.277 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 m -69.1 -50.92 43.84 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.12 -0.491 . . . . 63.020000000000003 110.652 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.76 -36.46 78.99 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.3 0.571 . . . . 54.130000000000003 109.956 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.94 -21.68 66.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.336 -0.847 . . . . 75.510000000000005 111.862 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -84.28 -22.9 30.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.152 0.501 . . . . 74.340000000000003 110.526 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.478 ' HB3' HG12 ' A' ' 22' ' ' VAL . 4.6 m-20 -87.09 -14.18 42.14 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.875 -0.602 . . . . 72.099999999999994 110.919 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.776 HD11 HD13 ' A' ' 31' ' ' ILE . 40.1 mm -95.92 122.61 47.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.128 -0.487 . . . . 62.240000000000002 110.546 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.2 mt -100.61 114.96 29.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.053 -0.521 . . . . 60.039999999999999 109.871 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.568 HG13 HG22 ' A' ' 73' ' ' ILE . 24.9 m -118.71 161.12 17.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.087 -0.506 . . . . 73.099999999999994 111.241 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -118.75 145.56 45.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.713 -0.676 . . . . 65.329999999999998 109.305 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.756 ' HA ' HG12 ' A' ' 16' ' ' VAL . 39.3 t -72.34 123.01 26.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.76 -0.654 . . . . 64.040000000000006 110.545 -176.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 75.230000000000004 111.593 -177.889 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.668 0 CA-C-O 121.072 0.262 . . . . 72.329999999999998 112.687 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.5 pt -122.77 179.22 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.89 -0.781 . . . . 63.210000000000001 108.89 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 73' ' ' ILE . . . -77.45 151.7 38.49 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 119.805 -1.188 . . . . 52.119999999999997 111.884 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.438 ' O ' HD13 ' A' ' 7' ' ' LEU . 2.9 tm? -60.09 -32.62 71.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.297 0.57 . . . . 71.340000000000003 109.483 177.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.429 ' OD1' ' HA ' ' A' ' 71' ' ' LYS . 2.6 p-10 -70.27 -15.59 62.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.461 -0.79 . . . . 74.319999999999993 111.094 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -92.58 -3.9 54.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.074 0.464 . . . . 74.129999999999995 110.658 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.4 t -91.33 158.79 2.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.98 -0.748 . . . . 63.299999999999997 108.98 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.588 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 24.8 tt0 -108.01 175.52 5.45 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.239 -0.282 . . . . 71.540000000000006 110.239 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.588 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 32.5 pt -68.83 153.59 8.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.24 -0.436 . . . . 64.230000000000004 111.691 -175.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 60.64 41.21 15.57 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.301 -0.863 . . . . 72.310000000000002 110.914 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 m -128.56 149.77 50.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.149 -0.932 . . . . 75.430000000000007 109.638 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.475 ' HG2' HD12 ' A' ' 78' ' ' LEU . 85.8 tttt -115.37 132.4 56.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.043 -0.354 . . . . 50.450000000000003 110.043 177.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.813 HG12 ' HA ' ' A' ' 77' ' ' VAL . 26.6 m -133.04 162.62 39.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.254 0.55 . . . . 74.219999999999999 111.226 -176.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.614 ' HB2' HD21 ' A' ' 78' ' ' LEU . 19.8 ttmm -112.22 138.75 48.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.415 -0.811 . . . . 75.319999999999993 109.435 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.76 ' HA ' HG12 ' A' ' 75' ' ' VAL . 60.7 t -75.65 95.96 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.619 -0.719 . . . . 72.230000000000004 110.038 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.6 mm -61.05 -40.44 85.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.678 -0.692 . . . . 54.340000000000003 109.823 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.75 168.65 39.74 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.416 -0.897 . . . . 70.439999999999998 112.32 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.713 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 43.9 mt -105.28 159.38 5.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 108.606 -0.886 . . . . 74.420000000000002 108.606 176.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 25' ' ' SER . 58.4 t -99.22 92.36 1.71 Allowed Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.106 0.479 . . . . 73.109999999999999 110.471 -177.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.713 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 27.8 Cg_exo -60.53 178.31 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.561 2.841 . . . . 72.5 112.816 -174.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 66.73 -32.2 0.18 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.461 0.705 . . . . 63.130000000000003 112.026 -173.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.487 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 1.3 m -63.24 153.36 34.88 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 120.97 0.414 . . . . 32.130000000000003 110.86 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -71.92 -49.25 39.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.789 -0.641 . . . . 64.540000000000006 110.493 -174.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.564 HG11 ' HG2' ' A' ' 69' ' ' GLU . 11.5 m -72.99 -15.44 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.39 -0.368 . . . . 74.200000000000003 110.831 -174.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.655 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -53.8 -45.87 70.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.907 -0.588 . . . . 63.450000000000003 111.003 178.149 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -72.25 -33.01 67.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.369 0.604 . . . . 64.030000000000001 110.17 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -63.8 -41.85 97.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.378 -0.828 . . . . 65.530000000000001 110.508 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.511 HG22 ' HB ' ' A' ' 36' ' ' ILE . 82.9 mt -64.39 -36.42 77.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.713 -0.676 . . . . 74.540000000000006 110.9 177.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 67.7 mtt -67.67 -32.61 73.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 73.450000000000003 110.629 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -63.34 -31.89 73.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.946 -0.57 . . . . 54.130000000000003 110.492 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.9 mtm -76.53 -23.98 53.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.962 -0.563 . . . . 61.119999999999997 111.169 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.02 36.68 2.12 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.297 -0.954 . . . . 71.319999999999993 113.358 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.511 ' HB ' HG22 ' A' ' 31' ' ' ILE . 63.7 mt -122.14 136.1 60.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.468 -0.568 . . . . 73.340000000000003 109.468 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.745 HG23 ' H ' ' A' ' 38' ' ' ARG . 1.6 m -135.67 -84.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.321 0.489 . . . . 63.399999999999999 112.321 -176.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.745 ' H ' HG23 ' A' ' 37' ' ' VAL . 43.5 ttp180 -156.56 141.12 16.83 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.362 -0.607 . . . . 74.099999999999994 109.362 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.71 -0.29 65.89 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 111.429 -0.669 . . . . 73.319999999999993 111.429 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.472 HG22 HD21 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -72.6 142.67 48.39 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.387 -0.598 . . . . 73.310000000000002 109.387 178.275 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.49 130.98 52.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.167 0.508 . . . . 73.430000000000007 111.606 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.563 HG21 HD23 ' A' ' 56' ' ' LEU . 25.6 mm -120.24 128.16 75.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.34 -0.845 . . . . 71.510000000000005 110.898 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -101.12 120.67 40.56 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.447 -0.575 . . . . 75.439999999999998 109.447 171.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 44' ' ' ILE . 3.9 mp -85.45 101.62 10.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.226 -0.657 . . . . 64.420000000000002 109.226 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.84 -53.29 27.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.275 0.56 . . . . 74.150000000000006 110.383 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.26 -177.37 41.01 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.673 -0.694 . . . . 52.509999999999998 111.773 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HG2' HG23 ' A' ' 54' ' ' ILE . 52.0 mtpt -133.26 152.0 51.92 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.136 -0.69 . . . . 62.520000000000003 109.136 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.49 156.34 71.16 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.575 -0.528 . . . . 51.329999999999998 109.575 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.35 -30.14 19.42 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.77 2.313 . . . . 60.240000000000002 113.176 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.429 ' HA ' ' CE ' ' A' ' 50' ' ' MET . 23.2 mmt -91.29 0.98 57.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.489 -0.323 . . . . 71.510000000000005 111.697 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.01 -9.14 73.55 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.892 -0.67 . . . . 64.030000000000001 111.999 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 22.7 t70 -144.01 130.54 10.19 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.685 -0.487 . . . . 74.530000000000001 109.685 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.553 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . 91.6 Cg_endo -84.11 -169.26 6.65 Favored 'Cis proline' 0 CA--C 1.533 0.44 0 C-N-CA 123.474 -1.469 . . . . 64.129999999999995 112.918 0.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.461 HG23 ' HG2' ' A' ' 47' ' ' LYS . 60.7 mt -119.3 143.2 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.896 -0.593 . . . . 71.310000000000002 110.284 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.09 111.83 24.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.896 0.379 . . . . 73.400000000000006 110.808 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.563 HD23 HG21 ' A' ' 42' ' ' ILE . 5.9 mp -105.68 171.92 7.08 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.136 -0.69 . . . . 71.120000000000005 109.136 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 23.7 ttt180 -151.18 128.79 11.48 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.242 -0.651 . . . . 75.219999999999999 109.242 176.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.597 HD22 ' HG3' ' A' ' 59' ' ' ARG . 1.2 tt -131.93 137.41 47.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.01 -0.541 . . . . 74.510000000000005 109.83 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.597 ' HG3' HD22 ' A' ' 58' ' ' LEU . 55.8 mtt180 61.15 -80.25 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.795 -1.093 . . . . 53.210000000000001 111.667 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -147.78 14.75 1.37 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.016 -0.611 . . . . 74.25 111.759 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -140.01 145.96 38.46 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.677 0.751 . . . . 73.430000000000007 111.899 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 33.5 t -74.22 155.22 38.54 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.396 -1.275 . . . . 72.510000000000005 110.667 176.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.8 mt -139.7 140.21 36.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.783 -0.644 . . . . 71.129999999999995 109.424 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.8 t -118.99 130.2 55.55 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.811 0.339 . . . . 62.439999999999998 110.735 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 pp -144.65 164.64 30.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.76 -0.655 . . . . 72.549999999999997 110.386 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.553 ' HD3' ' HB3' ' A' ' 53' ' ' PRO . 25.9 mmt180 -83.73 158.68 21.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.37 0.605 . . . . 61.020000000000003 111.616 -176.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -39.47 70.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.95 -1.023 . . . . 72.439999999999998 111.117 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -65.38 -34.45 78.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.302 -0.408 . . . . 74.319999999999993 111.233 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.564 ' HG2' HG11 ' A' ' 27' ' ' VAL . 33.9 mt-10 -74.38 -32.76 62.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.297 0.57 . . . . 74.400000000000006 109.86 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.99 -21.1 65.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.452 -0.795 . . . . 75.450000000000003 111.19 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.429 ' HA ' ' OD1' ' A' ' 8' ' ' ASN . 22.1 ttmm -74.32 -34.17 63.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.494 . . . . 72.510000000000005 110.392 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -85.51 14.59 5.38 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.196 -0.456 . . . . 60.25 111.574 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.491 HG22 HG13 ' A' ' 75' ' ' VAL . 60.4 mt -118.96 124.23 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.381 . . . . 72.420000000000002 110.222 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 99.0 mt -103.47 120.73 41.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 75.549999999999997 110.243 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.76 HG12 ' HA ' ' A' ' 18' ' ' VAL . 22.4 m -133.95 157.51 41.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.207 0.527 . . . . 71.219999999999999 111.791 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -117.82 143.32 46.38 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.958 -0.756 . . . . 70.430000000000007 108.958 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.813 ' HA ' HG12 ' A' ' 16' ' ' VAL . 38.5 t -70.94 125.55 29.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.128 -0.487 . . . . 61.149999999999999 110.595 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 17' ' ' LYS . 56.3 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 75.420000000000002 111.008 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.757 -0.137 . . . . 71.430000000000007 112.757 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.8 pt -110.11 171.44 2.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.689 0.281 . . . . 62.140000000000001 110.304 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 73' ' ' ILE . . . -76.91 153.11 41.51 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 120.47 -0.871 . . . . 43.420000000000002 111.22 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' A' ' 56' ' ' LEU . 50.1 tp -59.21 -28.01 66.26 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.185 0.517 . . . . 75.400000000000006 110.684 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -75.38 -4.53 39.92 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.86 -0.609 . . . . 73.329999999999998 111.831 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -102.1 5.87 40.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.931 0.396 . . . . 72.200000000000003 110.801 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 t -97.03 157.32 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.064 -0.517 . . . . 61.130000000000003 109.967 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -99.64 164.89 11.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.62 0.247 . . . . 71.239999999999995 110.341 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.7 pt -69.39 151.03 10.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.444 . . . . 71.549999999999997 111.048 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt 60.26 51.45 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.948 0.88 . . . . 62.149999999999999 110.536 -177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 m -132.37 153.08 51.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.142 -0.935 . . . . 70.140000000000001 109.759 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -113.44 119.09 36.39 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.803 -0.443 . . . . 65.349999999999994 109.803 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.772 HG12 ' HA ' ' A' ' 77' ' ' VAL . 29.1 m -130.76 179.56 4.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.11 -0.495 . . . . 65.409999999999997 110.503 -178.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.75 ' HB2' HD11 ' A' ' 78' ' ' LEU . 39.3 ttpt -143.04 144.53 32.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.876 0.37 . . . . 75.030000000000001 111.064 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.67 ' HA ' HG12 ' A' ' 75' ' ' VAL . 45.8 t -76.9 95.66 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.598 -0.728 . . . . 74.310000000000002 110.673 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.927 HD11 ' HB2' ' A' ' 76' ' ' GLU . 50.1 mt -57.33 -49.33 80.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 64.310000000000002 109.988 173.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.59 149.16 7.22 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.54 -0.755 . . . . 74.109999999999999 112.258 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.643 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 56.9 mt -83.95 159.68 3.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.516 -0.55 . . . . 75.129999999999995 109.516 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 25' ' ' SER . 48.3 t -99.17 93.71 2.29 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 122.757 0.423 . . . . 73.030000000000001 110.03 -177.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 1.022 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 77.6 Cg_exo -49.27 164.26 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.911 3.074 . . . . 72.319999999999993 114.271 -173.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 67.28 -11.96 0.27 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.116 0.967 . . . . 75.5 112.92 -175.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 1.2 m -63.72 155.1 31.12 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 120.926 0.393 . . . . 73.219999999999999 110.822 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -69.46 -17.29 63.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.16 -0.473 . . . . 75.430000000000007 112.164 -173.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.443 HG21 ' HA ' ' A' ' 69' ' ' GLU . 30.9 m -112.47 6.32 8.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.664 -0.244 . . . . 74.140000000000001 111.43 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 1.022 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 5.2 tmm_? -58.76 -57.18 14.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.877 0.37 . . . . 74.299999999999997 110.771 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 29' ' ' ARG . 42.0 ttm180 -71.5 -36.1 70.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.041 -0.527 . . . . 75.239999999999995 110.123 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -58.77 -46.39 87.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.266 -0.879 . . . . 73.329999999999998 111.276 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.622 HD13 HD11 ' A' ' 73' ' ' ILE . 99.4 mt -66.51 -42.34 89.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.048 0.452 . . . . 75.120000000000005 111.278 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 63.7 mtt -67.53 -36.67 81.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.336 -0.393 . . . . 63.43 110.781 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.01 -30.14 68.46 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 54.219999999999999 110.445 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.3 ttt -63.04 -34.6 77.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.615 -0.721 . . . . 54.420000000000002 110.859 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.67 20.26 1.74 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.307 -0.949 . . . . 51.100000000000001 113.178 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.525 HD12 HG23 ' A' ' 31' ' ' ILE . 61.1 mt -105.51 134.84 45.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.719 -0.475 . . . . 53.450000000000003 109.719 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.73 177.56 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.389 -0.369 . . . . 72.319999999999993 110.835 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -78.7 128.97 34.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.079 0.466 . . . . 43.399999999999999 110.26 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.75 5.61 66.38 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.802 -0.713 . . . . 44.009999999999998 112.235 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.5 m -68.8 138.65 54.97 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.501 -0.555 . . . . 64.349999999999994 109.501 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -96.14 125.45 40.68 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.855 -0.611 . . . . 71.540000000000006 109.449 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.2 mt -107.36 120.57 58.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.347 -0.842 . . . . 65.230000000000004 110.969 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.566 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 74.4 t80 -93.52 106.88 18.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.821 -0.807 . . . . 64.409999999999997 108.821 173.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.441 HD13 HD22 ' A' ' 56' ' ' LEU . 18.6 mm -70.04 104.01 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.183 -0.673 . . . . 72.450000000000003 109.183 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -76.38 -61.51 1.93 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.832 0.349 . . . . 72.239999999999995 110.401 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.21 158.55 29.13 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.227 -0.987 . . . . 61.420000000000002 112.356 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.603 ' HG2' HG12 ' A' ' 54' ' ' ILE . 54.2 mtpt -97.55 151.83 19.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.258 -0.645 . . . . 74.129999999999995 109.258 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.53 156.35 32.6 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 110.131 -0.322 . . . . 65.109999999999999 110.131 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.0 -32.51 18.32 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.246 2.63 . . . . 52.219999999999999 113.752 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.8 ttm -89.42 -11.35 43.38 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.936 0.398 . . . . 73.439999999999998 111.172 -177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.45 -14.7 32.81 Favored Glycine 0 C--N 1.328 0.115 0 C-N-CA 120.909 -0.662 . . . . 50.539999999999999 112.513 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -149.41 138.96 12.93 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.44 -0.578 . . . . 71.25 109.44 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.8 -164.73 3.94 Favored 'Cis proline' 0 C--N 1.346 0.429 0 C-N-CA 124.15 -1.188 . . . . 73.099999999999994 112.636 -0.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.603 HG12 ' HG2' ' A' ' 47' ' ' LYS . 38.2 mt -123.97 134.98 65.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 74.030000000000001 110.416 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -91.44 118.93 30.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.372 -0.376 . . . . 34.140000000000001 110.255 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.506 ' CD1' HD21 ' A' ' 7' ' ' LEU . 23.1 mt -121.22 137.02 54.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.213 -0.449 . . . . 63.509999999999998 110.747 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.603 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 3.9 tmt_? -101.45 109.36 21.18 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.73 -0.841 . . . . 62.100000000000001 108.73 175.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 pp -144.64 152.12 40.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.318 -0.401 . . . . 73.019999999999996 110.96 -175.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 72.51 -45.29 0.62 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.931 0.77 . . . . 75.5 111.379 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.58 -21.84 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.064 -0.588 . . . . 72.109999999999999 112.355 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -145.0 172.4 13.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.01 0.433 . . . . 72.329999999999998 111.188 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -84.91 140.88 30.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.539 -0.755 . . . . 65.140000000000001 111.208 175.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.2 tp -143.5 154.66 43.86 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.452 -0.573 . . . . 71.140000000000001 109.452 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 p -91.81 121.24 33.25 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.923 0.392 . . . . 74.140000000000001 111.767 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.418 HD23 HD12 ' A' ' 56' ' ' LEU . 3.9 mm? -118.59 141.98 48.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.144 -0.48 . . . . 72.400000000000006 109.851 175.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.45 162.15 15.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.767 0.318 . . . . 74.329999999999998 110.722 -177.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -55.85 -33.0 64.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.643 -0.708 . . . . 72.25 110.999 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.1 m -59.48 -56.57 20.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 64.5 110.739 177.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.443 ' HA ' HG21 ' A' ' 27' ' ' VAL . 2.5 mp0 -64.94 -36.79 85.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.081 0.467 . . . . 63.140000000000001 110.713 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.2 66.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.648 -0.706 . . . . 61.100000000000001 111.813 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -83.01 -32.21 27.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.684 0.278 . . . . 74.5 110.9 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.38 -2.05 56.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.26 -0.427 . . . . 34.240000000000002 111.706 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.622 HD11 HD13 ' A' ' 31' ' ' ILE . 68.8 mt -106.42 122.7 60.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.572 -0.285 . . . . 73.010000000000005 110.582 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.5 mt -95.03 122.25 37.49 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.913 0.387 . . . . 55.32 110.216 176.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 18' ' ' VAL . 28.3 m -129.74 167.45 24.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.944 -0.571 . . . . 62.149999999999999 111.142 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.927 ' HB2' HD11 ' A' ' 19' ' ' ILE . 41.9 tt0 -129.07 146.01 51.13 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.227 -0.657 . . . . 53.340000000000003 109.227 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.772 ' HA ' HG12 ' A' ' 16' ' ' VAL . 10.3 p -76.14 129.5 37.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.275 0.56 . . . . 31.350000000000001 110.682 -178.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' A' ' 17' ' ' LYS . 86.2 mt . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.879 -0.6 . . . . 75.200000000000003 109.997 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 112.507 -0.237 . . . . 54.109999999999999 112.507 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.0 pt -107.19 174.32 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.789 -0.448 . . . . 75.409999999999997 109.789 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.62 156.66 35.2 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.107 -1.044 . . . . 63.340000000000003 111.654 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.556 HD13 HG21 ' A' ' 16' ' ' VAL . 61.6 tp -61.62 -26.25 67.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.237 0.542 . . . . 64.129999999999995 110.635 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -72.83 -10.87 60.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.666 . . . . 65.219999999999999 111.217 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -98.16 0.34 45.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.92 0.39 . . . . 75.140000000000001 110.885 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.513 HG21 HG11 ' A' ' 16' ' ' VAL . 6.1 t -103.18 158.1 4.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.393 -0.595 . . . . 63.32 109.393 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -106.1 170.58 7.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.103 0.478 . . . . 42.409999999999997 111.241 -176.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 31.7 pt -64.02 157.82 4.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.427 -0.806 . . . . 70.310000000000002 113.154 -171.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 60.69 32.1 20.23 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.34 -0.845 . . . . 70.140000000000001 111.918 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.4 m -124.36 151.49 44.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.957 -0.565 . . . . 74.120000000000005 109.784 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HB2' ' CD2' ' A' ' 43' ' ' TYR . 36.5 ttmt -103.44 130.18 50.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.956 0.407 . . . . 71.519999999999996 110.287 176.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.556 HG21 HD13 ' A' ' 7' ' ' LEU . 33.1 m -119.01 165.79 13.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.864 -0.607 . . . . 73.340000000000003 110.628 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.634 ' HB2' HD11 ' A' ' 78' ' ' LEU . 69.2 tttt -123.07 135.65 54.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.638 -0.71 . . . . 64.400000000000006 110.205 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.77 95.38 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.309 -0.859 . . . . 53.409999999999997 110.7 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.832 HD11 ' HB3' ' A' ' 76' ' ' GLU . 28.7 mt -65.64 -49.06 80.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.766 -0.652 . . . . 70.239999999999995 109.75 174.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.52 176.31 44.77 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.601 -0.809 . . . . 75.5 112.74 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.673 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 54.6 mt -120.48 159.24 22.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.275 -1.009 . . . . 70.010000000000005 108.275 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.564 ' HB ' ' OD2' ' A' ' 72' ' ' ASP . 48.8 t -100.41 90.14 1.34 Allowed Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 121.363 0.602 . . . . 74.209999999999994 109.618 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.673 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 34.8 Cg_exo -56.57 163.33 7.03 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.6 2.866 . . . . 72.530000000000001 113.698 -170.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 65.96 16.62 10.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.624 -1.171 . . . . 53.200000000000003 111.24 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 28' ' ' ARG . 1.3 m -88.65 151.8 22.23 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.397 -0.594 . . . . 52.240000000000002 109.397 171.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -75.38 -38.96 59.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.895 0.379 . . . . 74.129999999999995 110.145 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 31' ' ' ILE . 33.9 m -67.25 -19.6 25.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 72.200000000000003 110.771 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 25' ' ' SER . 3.1 tmm_? -58.29 -32.49 68.47 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.689 -0.687 . . . . 73.409999999999997 110.25 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -64.8 -47.39 78.23 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.385 -0.598 . . . . 71.439999999999998 109.385 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -60.47 -50.01 75.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.492 -0.776 . . . . 64.510000000000005 110.637 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 27' ' ' VAL . 86.5 mt -53.34 -52.79 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.545 -0.752 . . . . 73.019999999999996 111.917 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 64.5 mtt -70.62 -33.01 70.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.557 -0.292 . . . . 54.43 111.305 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.03 -22.44 61.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.408 0.623 . . . . 62.450000000000003 110.135 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.8 tpt -78.29 -22.35 48.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.434 -0.803 . . . . 64.230000000000004 110.563 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.55 5.49 20.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.758 -0.734 . . . . 73.150000000000006 112.831 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.419 HG12 ' HG ' ' A' ' 58' ' ' LEU . 41.2 mt -93.56 129.47 43.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.821 -0.437 . . . . 54.109999999999999 109.821 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.737 HG23 ' H ' ' A' ' 38' ' ' ARG . 2.8 m -133.05 -74.83 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.623 0.601 . . . . 72.430000000000007 112.623 -176.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.737 ' H ' HG23 ' A' ' 37' ' ' VAL . 61.6 ttt180 -165.28 128.62 2.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.955 -0.387 . . . . 74.150000000000006 109.955 -174.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.29 5.97 73.68 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.961 -0.638 . . . . 74.109999999999999 112.006 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.5 m -74.04 144.92 44.87 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.987 -0.375 . . . . 72.120000000000005 109.987 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -94.27 129.8 40.78 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.053 0.454 . . . . 73.230000000000004 110.282 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.773 HG12 HD23 ' A' ' 58' ' ' LEU . 73.8 mt -119.83 116.37 50.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.523 -0.762 . . . . 71.040000000000006 109.899 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.416 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 9.0 t80 -100.92 119.44 38.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.175 -0.676 . . . . 62.420000000000002 109.175 177.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.5 mt -77.03 125.02 36.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 120.703 0.287 . . . . 64.219999999999999 110.233 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -85.65 -59.54 2.28 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.839 0.352 . . . . 64.219999999999999 110.346 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.67 171.92 42.34 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.813 -0.708 . . . . 74.120000000000005 112.109 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -123.56 145.1 49.14 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.012 -0.366 . . . . 72.120000000000005 110.012 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.561 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -69.29 163.66 56.01 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.188 -0.46 . . . . 54.149999999999999 109.778 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.561 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 8.1 Cg_endo -50.66 -38.51 55.8 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 123.027 2.485 . . . . 73.230000000000004 113.468 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.426 ' HE2' ' HB3' ' A' ' 52' ' ' ASP . 50.7 ttp -86.14 -10.74 54.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.216 0.532 . . . . 73.129999999999995 110.659 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.87 -2.95 73.27 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.564 -0.614 . . . . 41.240000000000002 111.564 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.426 ' HB3' ' HE2' ' A' ' 50' ' ' MET . 11.8 t70 -141.36 132.12 13.25 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 108.889 -0.782 . . . . 73.140000000000001 108.889 177.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.57 -179.96 27.11 Favored 'Cis proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.036 -1.652 . . . . 72.519999999999996 112.391 -0.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.7 mt -113.48 145.37 19.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.167 -0.47 . . . . 71.140000000000001 110.03 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.29 119.39 38.68 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.036 -0.357 . . . . 72.319999999999993 110.036 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.539 HD21 HD21 ' A' ' 7' ' ' LEU . 5.4 mp -118.11 167.59 11.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.141 -0.481 . . . . 63.140000000000001 109.895 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.661 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 33.0 ttt-85 -125.59 105.7 9.21 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.893 -1.151 . . . . 72.540000000000006 107.893 167.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.773 HD23 HG12 ' A' ' 42' ' ' ILE . 3.2 tm? -122.84 145.57 48.32 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.674 -0.693 . . . . 73.120000000000005 109.967 -170.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.612 ' HB2' HD13 ' A' ' 58' ' ' LEU . 2.4 tmt_? 70.51 -69.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.214 -0.903 . . . . 71.420000000000002 110.021 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.69 2.08 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.905 -0.664 . . . . 63.219999999999999 112.52 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -148.49 165.26 31.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.859 0.361 . . . . 74.409999999999997 110.799 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.661 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 32.1 t -75.78 145.08 41.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.511 0.672 . . . . 74.310000000000002 111.347 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.5 mt -146.2 157.04 43.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.696 -1.138 . . . . 73.340000000000003 108.598 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 t -120.62 125.27 47.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.299 0.571 . . . . 64.140000000000001 110.721 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.27 175.85 5.93 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.314 -0.857 . . . . 74.439999999999998 109.312 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.634 ' HB2' ' OE1' ' A' ' 69' ' ' GLU . 41.7 mmt180 -90.75 167.09 12.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.103 0.478 . . . . 73.420000000000002 110.31 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.43 -22.59 67.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.582 -0.735 . . . . 73.120000000000005 109.604 174.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.7 m -64.1 -52.32 59.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.242 -0.89 . . . . 65.540000000000006 110.97 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.634 ' OE1' ' HB2' ' A' ' 66' ' ' ARG . 1.9 mp0 -60.16 -41.95 93.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.153 0.502 . . . . 53.310000000000002 110.675 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.77 -22.5 67.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.56 -0.745 . . . . 73.420000000000002 111.504 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -75.2 -34.92 61.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.409 -0.36 . . . . 64.420000000000002 111.114 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.564 ' OD2' ' HB ' ' A' ' 22' ' ' VAL . 14.5 t70 -80.26 -44.69 19.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 73.25 111.421 -174.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.472 HG22 HG13 ' A' ' 75' ' ' VAL . 48.3 mt -61.42 118.5 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.97 -0.559 . . . . 73.219999999999999 111.44 -176.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.2 mt -91.24 119.4 31.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 73.239999999999995 109.871 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.547 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 23.7 m -129.08 158.17 41.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.927 0.394 . . . . 70.319999999999993 111.964 -174.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.832 ' HB3' HD11 ' A' ' 19' ' ' ILE . 19.3 pt-20 -115.11 151.72 33.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.831 -0.622 . . . . 72.310000000000002 109.632 173.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.2 t -80.26 115.84 23.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.988 0.423 . . . . 62.219999999999999 111.109 -174.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' A' ' 17' ' ' LYS . 40.2 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.898 -0.592 . . . . 71.519999999999996 111.53 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.763 0 N-CA-C 112.092 -0.403 . . . . 44.450000000000003 112.092 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.6 pt -96.04 163.29 2.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.752 -0.462 . . . . 74.209999999999994 109.752 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.23 137.58 45.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.466 -0.873 . . . . 70.420000000000002 112.209 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 75' ' ' VAL . 44.7 tp -60.25 -25.02 65.35 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 122.986 0.515 . . . . 52.140000000000001 112.022 -175.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -78.46 -9.81 59.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.721 0.296 . . . . 74.25 110.857 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -99.31 -7.44 26.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.277 -0.42 . . . . 75.349999999999994 111.071 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.723 HG11 HG11 ' A' ' 16' ' ' VAL . 14.4 t -77.72 160.3 4.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.93 -0.577 . . . . 61.030000000000001 110.293 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.418 ' N ' HG12 ' A' ' 10' ' ' VAL . 31.7 tt0 -80.41 168.44 18.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 62.119999999999997 110.448 -177.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.408 ' HA ' ' CG2' ' A' ' 44' ' ' ILE . 33.5 pt -93.5 161.08 2.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.005 -0.543 . . . . 75.340000000000003 110.954 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 69.3 5.07 4.92 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.164 0.586 . . . . 63.25 111.611 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -107.12 156.89 18.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.851 0.358 . . . . 54.200000000000003 110.993 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.521 ' HB2' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -107.91 130.97 54.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.008 -0.542 . . . . 61.409999999999997 110.341 178.312 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' A' ' 77' ' ' VAL . 27.2 m -127.6 161.31 35.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.739 -0.664 . . . . 73.219999999999999 110.911 -177.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.761 ' HD3' ' HG2' ' A' ' 41' ' ' GLU . 9.7 tptm -113.26 138.53 49.87 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.596 -0.729 . . . . 64.400000000000006 109.922 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.946 ' HA ' HG12 ' A' ' 75' ' ' VAL . 60.1 t -80.58 94.24 2.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.517 -0.765 . . . . 73.109999999999999 109.902 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.36 -52.69 34.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.013 -0.994 . . . . 73.140000000000001 110.106 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 38' ' ' ARG . . . -155.23 133.95 4.0 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 119.966 -1.111 . . . . 74.150000000000006 113.245 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.454 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 68.3 mt -80.64 158.19 4.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 107.598 -1.26 . . . . 74.340000000000003 107.598 169.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 25' ' ' SER . 49.8 t -100.27 91.13 1.59 Allowed Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 121.015 0.436 . . . . 50.329999999999998 110.086 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 25' ' ' SER . 35.8 Cg_endo -62.57 178.51 0.92 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.397 2.732 . . . . 51.299999999999997 113.061 -173.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 67.02 -16.19 0.14 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.436 -0.802 . . . . 72.209999999999994 111.741 -174.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -73.13 161.87 30.1 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.938 0.399 . . . . 72.329999999999998 110.926 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -78.84 -46.24 19.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.991 -0.55 . . . . 65.310000000000002 110.61 -176.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.688 HG21 ' HA ' ' A' ' 69' ' ' GLU . 23.3 m -68.13 -18.0 22.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.908 -0.587 . . . . 73.219999999999999 110.648 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.454 ' HE ' ' HB3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -53.7 -34.33 58.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.35 -0.841 . . . . 74.0 111.296 178.631 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -68.37 -42.07 79.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.45 -0.341 . . . . 54.219999999999999 111.06 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.447 ' O ' ' HG3' ' A' ' 34' ' ' MET . 34.0 tttp -73.56 -33.31 64.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.459 -0.337 . . . . 71.209999999999994 110.399 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 27' ' ' VAL . 88.5 mt -59.62 -48.31 87.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.174 -0.466 . . . . 51.210000000000001 110.719 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 64.9 mtt -68.79 -28.6 66.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 63.32 110.626 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.51 -40.57 76.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 71.319999999999993 110.429 176.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.447 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 65.6 mtt -61.93 -34.05 75.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.594 -0.73 . . . . 74.25 110.588 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.69 17.99 5.82 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.818 -0.706 . . . . 62.5 112.248 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.825 HD11 HD22 ' A' ' 58' ' ' LEU . 47.8 mt -101.03 127.46 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.197 0.523 . . . . 65.519999999999996 110.386 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.27 -176.53 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.273 -0.876 . . . . 53.229999999999997 110.084 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HG2' ' HA2' ' A' ' 20' ' ' GLY . 84.8 mtm180 -70.6 109.45 4.88 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.867 -0.419 . . . . 73.239999999999995 109.867 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.424 ' O ' ' HE3' ' A' ' 17' ' ' LYS . . . 120.8 -9.24 10.58 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 121.042 -0.599 . . . . 53.329999999999998 111.739 -176.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.4 m -73.63 149.57 41.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.663 -0.495 . . . . 74.200000000000003 109.663 174.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.761 ' HG2' ' HD3' ' A' ' 17' ' ' LYS . 55.5 mt-10 -115.69 134.85 54.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.215 -0.448 . . . . 70.349999999999994 110.102 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.575 HG21 HD23 ' A' ' 56' ' ' LEU . 48.2 mm -118.66 126.02 74.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.468 -0.787 . . . . 70.049999999999997 110.757 -173.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 57' ' ' ARG . 9.8 t80 -104.57 115.79 30.96 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.796 -0.816 . . . . 74.010000000000005 108.796 173.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.408 ' CG2' ' HA ' ' A' ' 12' ' ' ILE . 44.5 mm -73.35 106.39 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.92 0.391 . . . . 71.140000000000001 110.702 -176.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -75.73 -36.65 59.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.181 -0.674 . . . . 73.0 109.181 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.63 -179.47 39.33 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.783 -0.723 . . . . 61.329999999999998 112.371 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -126.59 150.64 48.76 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.442 -0.577 . . . . 72.120000000000005 109.442 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.28 165.48 17.4 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.412 -0.358 . . . . 73.439999999999998 111.453 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.0 -31.85 83.8 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.571 2.181 . . . . 74.329999999999998 112.094 175.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -86.11 -5.31 59.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.207 0.527 . . . . 71.209999999999994 110.262 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.48 -34.45 5.65 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.212 -0.755 . . . . 34.109999999999999 111.212 -174.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 4.2 p-10 -137.97 152.31 71.86 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 108.959 -0.756 . . . . 75.030000000000001 108.959 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 73.0 Cg_endo -72.26 173.3 53.47 Favored 'Cis proline' 0 C--O 1.234 0.288 0 C-N-CA 123.457 -1.476 . . . . 73.530000000000001 113.158 4.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.655 ' HB ' HD11 ' A' ' 56' ' ' LEU . 16.3 mm -97.04 147.32 6.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.514 -0.766 . . . . 73.430000000000007 109.304 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.51 111.24 23.88 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.314 -0.624 . . . . 61.509999999999998 109.314 174.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.655 HD11 ' HB ' ' A' ' 54' ' ' ILE . 2.3 mp -121.88 144.92 48.56 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.516 -0.311 . . . . 65.349999999999994 110.292 -175.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 54.9 mtt180 -100.1 108.14 20.22 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.344 -0.984 . . . . 63.43 108.344 166.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.825 HD22 HD11 ' A' ' 36' ' ' ILE . 2.4 pp -121.78 134.3 54.92 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.602 -0.727 . . . . 73.549999999999997 110.858 -173.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.485 ' HD3' ' OH ' ' A' ' 61' ' ' TYR . 50.3 ttt180 65.02 6.06 3.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.283 -0.872 . . . . 74.409999999999997 110.839 178.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.58 -19.58 9.72 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 116.019 -0.537 . . . . 64.340000000000003 112.794 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.485 ' OH ' ' HD3' ' A' ' 59' ' ' ARG . 4.4 p90 -127.67 148.97 50.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.359 0.599 . . . . 71.120000000000005 112.213 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.3 m -70.8 137.68 49.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.186 -0.915 . . . . 50.520000000000003 111.989 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.702 ' HB3' HD21 ' A' ' 58' ' ' LEU . 9.4 tt -150.99 148.86 28.89 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.689 -0.856 . . . . 65.019999999999996 108.689 176.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.1 t -115.07 132.14 56.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.179 0.514 . . . . 72.439999999999998 111.566 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.403 ' CD2' HD13 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -134.04 165.49 24.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.351 -0.841 . . . . 62.140000000000001 109.391 174.581 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -84.45 169.33 14.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.453 0.644 . . . . 72.120000000000005 112.384 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 37.0 ttmt -54.49 -35.09 62.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.751 -1.113 . . . . 73.310000000000002 111.704 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.1 t -66.15 -46.24 78.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.58 -0.282 . . . . 63.43 110.647 -176.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.688 ' HA ' HG21 ' A' ' 27' ' ' VAL . 1.9 mp0 -63.33 -43.92 96.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.942 0.401 . . . . 74.010000000000005 110.347 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.49 -22.03 66.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 62.109999999999999 111.27 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -74.69 -29.04 61.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.102 -0.499 . . . . 71.450000000000003 110.883 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -93.46 19.72 8.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.946 0.403 . . . . 73.019999999999996 111.109 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.428 HG22 HG13 ' A' ' 75' ' ' VAL . 69.5 mt -126.04 117.6 49.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.602 -0.518 . . . . 63.130000000000003 109.602 174.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.7 mt -103.15 121.41 42.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.745 0.307 . . . . 73.409999999999997 110.205 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.946 HG12 ' HA ' ' A' ' 18' ' ' VAL . 35.6 m -137.09 172.58 14.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.968 0.414 . . . . 72.010000000000005 111.78 -174.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -143.37 156.68 44.74 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.427 -0.953 . . . . 75.420000000000002 108.427 171.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.756 ' HA ' HG12 ' A' ' 16' ' ' VAL . 11.8 p -64.71 147.92 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.003 0.43 . . . . 54.030000000000001 111.548 -175.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.615 HD21 ' HB2' ' A' ' 17' ' ' LYS . 23.5 mt . . . . . 0 C--O 1.233 0.22 0 CA-C-N 116.038 -0.528 . . . . 63.439999999999998 112.394 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.233 0 N-CA-C 111.605 -0.598 . . . . 55.25 111.605 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.2 pt -85.03 167.76 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.688 -0.856 . . . . 73.129999999999995 108.688 175.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.75 146.83 40.79 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 119.429 -1.367 . . . . 52.149999999999999 111.076 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.413 HD21 HD13 ' A' ' 56' ' ' LEU . 27.4 tp -65.28 -17.79 64.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.309 0.576 . . . . 64.510000000000005 110.173 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -76.56 -20.54 56.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.749 -0.659 . . . . 74.519999999999996 110.358 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -89.09 -10.68 46.46 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.173 -0.467 . . . . 70.439999999999998 110.532 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.1 t -84.45 160.43 3.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.906 -0.588 . . . . 72.310000000000002 110.087 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.842 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 28.5 tt0 -122.44 -173.58 2.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.668 0.27 . . . . 63.219999999999999 110.409 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.842 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 40.8 pt -68.93 154.04 8.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 113.322 0.86 . . . . 73.439999999999998 113.322 -170.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.4 mttt 59.86 22.14 11.09 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.57 -1.196 . . . . 74.549999999999997 113.256 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 m -104.74 155.4 18.92 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.428 -0.582 . . . . 54.32 109.428 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -115.06 136.7 52.83 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.488 -0.485 . . . . 72.040000000000006 110.0 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.839 HG12 ' HA ' ' A' ' 77' ' ' VAL . 29.9 m -140.17 -179.57 2.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.698 -0.683 . . . . 72.450000000000003 110.167 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -148.99 146.17 27.67 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.832 -0.432 . . . . 73.450000000000003 109.832 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.539 ' HA ' HG12 ' A' ' 75' ' ' VAL . 26.1 t -74.01 93.14 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.238 0.542 . . . . 71.140000000000001 110.146 -178.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.4 mm -81.64 -38.94 16.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.341 -0.845 . . . . 75.540000000000006 110.283 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.4 169.6 25.82 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.569 -0.824 . . . . 64.530000000000001 112.881 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.657 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 69.7 mt -136.9 155.26 32.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.613 -0.884 . . . . 73.209999999999994 108.613 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.0 t -103.26 91.37 3.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.872 0.368 . . . . 52.210000000000001 110.584 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.657 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 35.9 Cg_exo -59.06 172.99 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.375 2.717 . . . . 73.310000000000002 113.03 -175.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 60.18 26.3 15.71 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.715 -0.675 . . . . 72.010000000000005 111.328 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.801 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 15.6 t -104.15 142.77 33.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.228 -0.442 . . . . 72.129999999999995 110.412 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -79.04 -27.03 43.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.874 0.368 . . . . 64.329999999999998 110.222 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.6 m -84.97 -19.93 8.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 65.420000000000002 110.62 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.801 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 2.0 tmt_? -54.21 -35.15 62.08 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.426 -0.352 . . . . 75.319999999999993 110.641 174.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -57.03 -56.64 19.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.992 -0.549 . . . . 74.510000000000005 110.444 174.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -54.6 -46.82 73.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.475 -0.784 . . . . 71.409999999999997 111.135 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.497 HG22 ' HB ' ' A' ' 36' ' ' ILE . 96.1 mt -57.54 -53.45 44.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.331 -0.849 . . . . 74.019999999999996 111.806 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.455 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 77.1 mtp -75.04 -28.45 60.44 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.769 -0.372 . . . . 75.430000000000007 111.093 -176.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.54 -32.16 73.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.329 0.585 . . . . 75.420000000000002 109.932 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.2 mtt -78.23 -3.81 44.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.359 -0.837 . . . . 65.219999999999999 111.774 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.65 4.7 45.86 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.635 -0.793 . . . . 64.010000000000005 112.947 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.497 ' HB ' HG22 ' A' ' 31' ' ' ILE . 30.1 mt -89.08 124.04 41.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.975 0.417 . . . . 64.340000000000003 110.395 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.1 m -143.81 168.81 11.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.581 -0.736 . . . . 74.140000000000001 110.055 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -66.96 108.39 2.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.052 0.453 . . . . 75.530000000000001 110.232 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.5 -18.69 4.6 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.823 -0.704 . . . . 63.509999999999998 111.855 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.2 m -75.27 143.87 42.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.927 0.394 . . . . 75.349999999999994 110.47 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -102.76 142.52 33.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.995 -0.548 . . . . 71.209999999999994 109.736 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.812 HG12 HD12 ' A' ' 58' ' ' LEU . 65.1 mt -123.96 126.1 71.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.817 -0.629 . . . . 74.25 110.939 -173.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -106.58 117.11 33.2 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.038 -0.727 . . . . 75.409999999999997 109.038 174.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.7 mm -76.47 114.95 17.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.842 0.353 . . . . 71.439999999999998 110.432 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -76.97 -46.51 23.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.251 0.548 . . . . 74.129999999999995 109.936 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.652 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 170.82 -170.94 43.56 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.606 -0.725 . . . . 71.430000000000007 111.668 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.633 ' HG2' HG23 ' A' ' 54' ' ' ILE . 51.7 mtpt -132.83 137.17 46.65 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.026 -0.731 . . . . 72.239999999999995 109.026 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -58.87 158.48 16.32 Favored Pre-proline 0 C--N 1.328 -0.359 0 O-C-N 123.422 0.451 . . . . 75.129999999999995 110.943 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 9.2 Cg_endo -52.91 -30.96 50.34 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.349 2.699 . . . . 71.230000000000004 113.625 -177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.9 ttt -94.48 4.62 53.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.425 0.631 . . . . 70.230000000000004 110.433 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.28 3.65 90.61 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 116.035 -0.53 . . . . 75.140000000000001 112.38 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -154.04 132.73 6.88 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.288 -0.634 . . . . 54.130000000000003 109.288 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.77 -178.03 21.59 Favored 'Cis proline' 0 C--O 1.235 0.373 0 C-N-CA 123.076 -1.635 . . . . 71.239999999999995 112.59 0.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.633 HG23 ' HG2' ' A' ' 47' ' ' LYS . 52.6 mt -104.24 126.46 58.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.576 -0.527 . . . . 73.209999999999994 109.576 177.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.51 102.84 9.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.183 0.516 . . . . 62.109999999999999 110.249 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 62' ' ' SER . 32.5 mt -112.81 146.05 39.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.781 -0.645 . . . . 55.32 110.399 -177.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 45.3 ttt180 -114.21 102.92 10.59 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.581 -0.896 . . . . 71.319999999999993 108.581 169.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.812 HD12 HG12 ' A' ' 42' ' ' ILE . 8.3 tt -123.7 147.01 47.84 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.35 -0.841 . . . . 74.549999999999997 110.351 -173.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.521 ' HB2' HD23 ' A' ' 58' ' ' LEU . 3.2 tmt_? 71.03 -51.68 0.68 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.306 -0.861 . . . . 64.549999999999997 110.907 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.67 -18.23 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.178 -0.534 . . . . 70.129999999999995 112.141 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -131.43 166.19 21.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.279 0.561 . . . . 75.030000000000001 110.974 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 41.9 t -82.79 144.61 30.03 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.16 -0.927 . . . . 75.340000000000003 110.401 177.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.6 tp -148.77 147.97 29.43 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.177 -0.92 . . . . 73.019999999999996 109.369 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -93.69 112.27 24.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.456 0.646 . . . . 71.299999999999997 110.805 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.465 HD23 HD12 ' A' ' 56' ' ' LEU . 4.0 mm? -111.06 144.1 40.73 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.153 -0.93 . . . . 61.409999999999997 109.218 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -87.86 170.09 11.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.123 0.487 . . . . 62.549999999999997 111.123 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -58.26 -33.07 68.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.31 -0.859 . . . . 72.450000000000003 110.571 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.46 ' HB2' ' OE1' ' A' ' 69' ' ' GLU . 10.3 m -57.62 -55.33 36.2 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.614 -0.721 . . . . 72.200000000000003 110.905 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.46 ' OE1' ' HB2' ' A' ' 68' ' ' SER . 1.9 mp0 -65.74 -40.1 91.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 73.319999999999993 110.749 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.57 -30.66 69.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.926 -0.579 . . . . 65.150000000000006 111.292 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -66.15 -38.58 88.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.008 0.433 . . . . 73.140000000000001 111.098 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.17 9.06 29.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.933 -0.576 . . . . 74.530000000000001 112.122 -173.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.598 HG22 HG13 ' A' ' 75' ' ' VAL . 66.8 mt -112.41 117.0 54.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.893 -0.41 . . . . 74.109999999999999 109.893 175.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.7 mt -97.82 111.7 23.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.039 0.447 . . . . 71.329999999999998 110.171 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.598 HG13 HG22 ' A' ' 73' ' ' ILE . 29.4 m -126.88 146.15 33.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.155 -0.475 . . . . 73.349999999999994 111.268 -176.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -107.18 139.8 41.04 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.398 -0.593 . . . . 63.43 109.398 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.839 ' HA ' HG12 ' A' ' 16' ' ' VAL . 40.8 t -71.22 104.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.093 -0.503 . . . . 73.200000000000003 110.369 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 78' ' ' LEU . 28.8 mt . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 115.989 -0.551 . . . . 72.400000000000006 111.375 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.593 0 CA-C-O 120.961 0.201 . . . . 23.100000000000001 112.884 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.8 pt -100.84 167.09 2.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.404 -0.591 . . . . 73.549999999999997 109.404 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 73' ' ' ILE . . . -69.61 145.84 42.72 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.19 -1.005 . . . . 73.239999999999995 111.704 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.511 HD21 HD11 ' A' ' 44' ' ' ILE . 2.2 tm? -54.95 -38.19 67.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.335 0.588 . . . . 74.040000000000006 109.909 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 34.9 t30 -61.54 -18.92 61.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.498 -0.774 . . . . 73.140000000000001 111.499 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -105.52 5.86 31.82 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.283 -0.417 . . . . 75.219999999999999 111.775 -171.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 11' ' ' GLU . 21.5 t -86.2 159.52 3.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.42 -0.355 . . . . 71.310000000000002 110.103 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.502 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 25.2 tt0 -85.42 171.75 11.57 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.626 -0.509 . . . . 73.200000000000003 109.626 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.502 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 35.7 pt -86.83 150.63 3.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.942 0.401 . . . . 75.140000000000001 111.72 -173.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 56.55 66.17 1.25 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.138 -0.937 . . . . 64.430000000000007 111.596 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -152.02 158.32 42.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.662 -1.154 . . . . 74.420000000000002 109.339 174.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HG2' ' HD1' ' A' ' 43' ' ' TYR . 65.6 mttp -105.76 131.25 53.34 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.843 0.354 . . . . 74.340000000000003 110.183 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.672 HG12 ' HA ' ' A' ' 77' ' ' VAL . 30.9 m -128.03 155.59 39.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.033 -0.53 . . . . 70.409999999999997 110.691 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -119.59 141.44 49.28 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.819 -0.628 . . . . 73.450000000000003 109.961 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.66 ' HA ' HG12 ' A' ' 75' ' ' VAL . 42.0 t -74.63 97.05 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.454 -0.794 . . . . 72.299999999999997 110.428 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.83 HD11 ' HB2' ' A' ' 76' ' ' GLU . 27.9 mt -62.67 -41.8 93.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.476 -0.784 . . . . 73.230000000000004 109.991 173.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.92 166.01 38.0 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.528 -0.844 . . . . 70.109999999999999 112.662 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.692 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 54.5 mt -107.62 160.32 6.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.595 -0.891 . . . . 73.219999999999999 108.595 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.11 90.8 1.19 Allowed Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.594 -0.521 . . . . 64.519999999999996 109.594 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 34.3 Cg_exo -56.59 167.01 3.1 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.882 3.055 . . . . 73.340000000000003 113.564 -170.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 65.17 15.26 9.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.186 -0.915 . . . . 72.530000000000001 110.208 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.952 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 37.0 t -67.6 152.87 44.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.075 -0.966 . . . . 75.530000000000001 109.732 176.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 26' ' ' LYS . 20.4 tptp -87.74 -16.44 34.22 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.171 -0.678 . . . . 54.439999999999998 109.171 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.12 3.15 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.615 -0.721 . . . . 73.549999999999997 111.71 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.952 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 4.7 tmt_? -52.04 -40.85 61.71 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 110.11 -0.33 . . . . 64.099999999999994 110.11 173.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -58.41 -44.07 88.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.503 . . . . 63.140000000000001 110.611 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.464 ' HD3' ' HG2' ' A' ' 69' ' ' GLU . 88.8 tttt -62.86 -46.49 87.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.256 0.55 . . . . 71.0 110.258 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.541 HG23 HD12 ' A' ' 36' ' ' ILE . 82.6 mt -62.23 -46.14 97.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.298 -0.865 . . . . 74.549999999999997 111.262 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -39.84 93.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.055 -0.52 . . . . 73.239999999999995 110.553 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.82 -39.86 95.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.805 -0.634 . . . . 72.010000000000005 110.945 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.547 ' SD ' HD11 ' A' ' 65' ' ' LEU . 52.9 mtt -69.84 -13.23 62.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 111.557 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.412 ' HA3' ' HG3' ' A' ' 59' ' ' ARG . . . 94.78 36.9 5.4 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.626 -0.797 . . . . 50.340000000000003 112.89 174.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.541 HD12 HG23 ' A' ' 31' ' ' ILE . 40.4 mt -110.03 124.75 67.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.868 0.366 . . . . 73.329999999999998 110.333 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -145.09 177.38 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.606 -0.724 . . . . 74.319999999999993 109.693 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.444 ' HD3' ' C ' ' A' ' 38' ' ' ARG . 4.2 tmt_? -64.53 130.28 43.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.856 0.36 . . . . 74.209999999999994 110.145 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.01 -15.93 60.02 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.96 -0.638 . . . . 71.319999999999993 112.612 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.7 m -79.37 148.74 31.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.962 -0.385 . . . . 65.400000000000006 109.962 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -104.08 148.36 26.34 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.164 0.507 . . . . 74.230000000000004 110.734 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.43 HG12 ' HB3' ' A' ' 58' ' ' LEU . 79.6 mt -127.91 123.9 61.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.265 -0.88 . . . . 74.409999999999997 109.423 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.767 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 50.8 t80 -88.78 114.36 25.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.97 0.414 . . . . 55.229999999999997 110.378 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.511 HD11 HD21 ' A' ' 7' ' ' LEU . 21.1 mm -81.34 107.03 13.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.803 -0.635 . . . . 75.510000000000005 109.302 176.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -83.16 -53.26 5.91 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.776 -0.824 . . . . 64.140000000000001 108.776 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.76 147.43 6.56 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.311 -0.947 . . . . 33.109999999999999 112.607 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.586 ' HG2' HG23 ' A' ' 54' ' ' ILE . 51.6 mtpt -88.67 149.14 23.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.353 -0.98 . . . . 73.299999999999997 108.353 173.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.77 156.42 24.86 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 110.491 -0.189 . . . . 72.420000000000002 110.491 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.88 -16.84 27.57 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.681 2.254 . . . . 75.150000000000006 111.94 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.1 ttm -92.43 -12.55 31.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.65 -0.704 . . . . 75.030000000000001 110.275 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.75 -29.38 11.44 Favored Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 115.846 -0.616 . . . . 54.329999999999998 111.869 -177.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -142.17 147.56 44.49 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 108.923 -0.769 . . . . 73.549999999999997 108.923 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -79.71 -179.27 25.71 Favored 'Cis proline' 0 C--O 1.236 0.381 0 C-N-CA 123.317 -1.535 . . . . 74.099999999999994 112.472 -0.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.586 HG23 ' HG2' ' A' ' 47' ' ' LYS . 33.3 mt -113.23 124.75 70.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.92 -0.4 . . . . 65.439999999999998 109.92 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.08 106.78 11.36 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.908 0.385 . . . . 73.109999999999999 110.61 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 62' ' ' SER . 63.8 mt -119.64 142.26 48.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.098 -0.501 . . . . 74.120000000000005 110.808 -175.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.767 ' HB3' ' HB3' ' A' ' 43' ' ' TYR . 36.1 ttt180 -110.97 100.97 9.58 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.67 -0.863 . . . . 73.409999999999997 108.67 171.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.43 ' HB3' HG12 ' A' ' 42' ' ' ILE . 3.2 pp -131.41 151.21 51.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.81 -0.632 . . . . 63.020000000000003 110.616 -173.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.412 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 3.2 tmt_? 71.66 -39.39 0.45 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.37 0.668 . . . . 73.040000000000006 111.174 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.64 -27.35 0.11 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.152 -0.547 . . . . 74.439999999999998 112.262 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -124.46 169.15 12.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.971 0.415 . . . . 75.030000000000001 111.346 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.64 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 46.5 t -99.48 146.8 25.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.583 -0.735 . . . . 30.539999999999999 110.894 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 63' ' ' LEU . 2.4 pt? -164.6 161.3 20.92 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.282 -0.872 . . . . 75.010000000000005 109.425 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.94 116.89 31.07 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.07 0.462 . . . . 64.209999999999994 111.625 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.547 HD11 ' SD ' ' A' ' 34' ' ' MET . 4.1 mm? -98.15 158.84 15.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.757 -0.656 . . . . 63.399999999999999 110.881 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -81.87 156.19 24.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.15 -0.477 . . . . 63.530000000000001 111.383 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -53.83 -45.21 70.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.728 -0.669 . . . . 70.310000000000002 110.982 173.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.2 m -57.77 -50.39 73.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.592 -0.731 . . . . 51.299999999999997 111.958 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.464 ' HG2' ' HD3' ' A' ' 30' ' ' LYS . 2.2 mp0 -71.79 -31.06 66.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 74.25 111.536 -175.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 8' ' ' ASN . . . -68.69 -23.11 64.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.25 0.463 . . . . 70.420000000000002 112.25 -173.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -87.19 -11.28 50.31 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.957 -0.697 . . . . 35.329999999999998 110.682 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.56 0.93 35.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.179 -0.464 . . . . 72.319999999999993 111.021 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.481 ' O ' ' HA2' ' A' ' 6' ' ' GLY . 59.5 mt -118.52 126.48 75.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.951 -0.568 . . . . 64.310000000000002 109.984 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.2 mt -103.15 122.32 44.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.072 -0.344 . . . . 75.340000000000003 110.072 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.66 HG12 ' HA ' ' A' ' 18' ' ' VAL . 29.8 m -131.38 164.3 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.714 0.635 . . . . 75.340000000000003 112.714 -172.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.83 ' HB2' HD11 ' A' ' 19' ' ' ILE . 3.7 tp10 -111.21 136.9 49.61 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.916 -1.038 . . . . 73.109999999999999 109.477 173.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.672 ' HA ' HG12 ' A' ' 16' ' ' VAL . 46.8 t -82.66 104.67 11.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.534 -0.543 . . . . 42.130000000000003 109.534 178.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.8 mt . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 121.224 0.535 . . . . 44.130000000000003 110.938 -175.671 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.687 0 N-CA-C 112.097 -0.401 . . . . 74.019999999999996 112.097 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.2 pt -134.02 173.64 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.685 0.279 . . . . 71.140000000000001 110.318 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.65 157.85 38.48 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.59 -0.814 . . . . 64.030000000000001 111.099 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.514 ' O ' HD13 ' A' ' 7' ' ' LEU . 2.0 tm? -54.65 -35.22 63.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.089 0.471 . . . . 73.319999999999993 110.67 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -71.58 -11.95 61.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.126 -0.488 . . . . 73.25 111.871 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -99.26 -5.6 29.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.765 0.317 . . . . 72.530000000000001 111.259 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 11' ' ' GLU . 15.5 t -77.21 162.57 4.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.259 -0.428 . . . . 72.040000000000006 110.564 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.428 ' N ' HG12 ' A' ' 10' ' ' VAL . 23.4 tt0 -96.74 170.27 9.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.627 -0.508 . . . . 73.219999999999999 109.627 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.1 pt -76.65 146.63 8.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.835 0.35 . . . . 54.43 111.533 -174.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 61.16 25.65 15.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.378 -0.828 . . . . 73.439999999999998 111.925 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.5 m -105.13 148.1 27.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.928 -0.578 . . . . 63.409999999999997 109.592 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.531 ' HG2' HD12 ' A' ' 78' ' ' LEU . 45.5 tttm -105.43 126.1 51.73 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.78 -0.452 . . . . 72.329999999999998 109.78 -177.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 17.6 m -131.71 162.87 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.3 0.571 . . . . 70.219999999999999 111.634 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.695 ' HE3' ' HA2' ' A' ' 39' ' ' GLY . 2.1 tmtp? -122.36 145.19 48.49 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.5 -0.773 . . . . 72.129999999999995 110.094 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.5 t -73.4 97.49 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.094 -0.503 . . . . 71.230000000000004 110.872 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.545 HD11 ' HB2' ' A' ' 76' ' ' GLU . 45.6 mt -54.51 -46.96 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 115.619 -0.718 . . . . 62.229999999999997 109.616 170.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.46 173.42 39.72 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.328 -0.851 . . . . 71.340000000000003 112.451 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.1 mt -96.94 157.9 3.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.36 -0.608 . . . . 51.5 109.36 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.2 91.76 1.83 Allowed Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.764 -0.458 . . . . 44.329999999999998 109.764 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.09 165.48 0.88 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 124.055 3.17 . . . . 64.25 113.783 -171.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.529 ' H ' ' NH1' ' A' ' 28' ' ' ARG . 0.5 OUTLIER 64.88 24.06 12.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.093 -0.958 . . . . 74.530000000000001 111.486 -177.355 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.552 ' OG ' HG22 ' A' ' 27' ' ' VAL . 40.7 t -93.14 150.97 20.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.653 -0.703 . . . . 72.25 109.778 173.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -82.39 -18.17 42.95 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.933 -0.395 . . . . 73.109999999999999 109.933 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.586 HG21 ' HA ' ' A' ' 69' ' ' GLU . 11.2 m -94.75 -9.44 9.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.34 -0.391 . . . . 55.229999999999997 110.343 176.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.529 ' NH1' ' H ' ' A' ' 24' ' ' GLU . 52.2 ttp180 -50.6 -49.09 57.39 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.272 0.558 . . . . 65.150000000000006 110.121 170.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -62.06 -37.44 84.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.205 -0.907 . . . . 75.140000000000001 110.499 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -62.36 -44.99 95.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.726 -0.67 . . . . 74.140000000000001 110.824 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.453 HG13 HD11 ' A' ' 73' ' ' ILE . 47.5 mm -63.91 -48.32 86.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.761 -0.654 . . . . 73.239999999999995 111.247 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.9 mmt -64.84 -33.41 75.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 75.420000000000002 110.732 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.38 -28.14 68.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.871 -0.604 . . . . 61.009999999999998 110.361 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 82.6 mmm -81.58 -8.82 59.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.762 -0.654 . . . . 74.430000000000007 110.95 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.07 24.79 47.14 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.747 -0.74 . . . . 75.409999999999997 112.534 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mt -102.09 134.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.733 -0.469 . . . . 74.129999999999995 109.733 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.14 169.99 20.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.18 0.514 . . . . 62.409999999999997 111.598 -175.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.421 ' HD3' ' C ' ' A' ' 38' ' ' ARG . 4.1 tmt_? -68.28 110.49 4.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.783 -0.644 . . . . 53.109999999999999 109.541 175.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.695 ' HA2' ' HE3' ' A' ' 17' ' ' LYS . . . 132.32 -16.7 4.87 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.763 -0.732 . . . . 74.420000000000002 111.952 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 m -71.12 148.9 46.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.877 0.37 . . . . 74.409999999999997 110.547 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.437 ' C ' HD12 ' A' ' 42' ' ' ILE . 40.3 mt-10 -100.04 132.35 45.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.962 -0.563 . . . . 74.140000000000001 110.361 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.64 HG13 ' HB3' ' A' ' 58' ' ' LEU . 2.0 mp -118.98 122.12 68.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.31 0.576 . . . . 71.310000000000002 110.179 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.725 ' HB3' ' HB2' ' A' ' 57' ' ' ARG . 82.3 t80 -96.13 116.78 29.51 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.654 -0.869 . . . . 75.510000000000005 108.654 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.2 mm -71.7 101.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.683 -0.488 . . . . 74.109999999999999 109.683 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.34 -33.58 69.73 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.365 -0.605 . . . . 74.230000000000004 109.365 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.32 150.54 5.6 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.652 -0.785 . . . . 75.340000000000003 112.563 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -88.93 154.42 20.25 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.474 -0.936 . . . . 72.450000000000003 108.474 173.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.88 151.98 51.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.593 -0.521 . . . . 73.540000000000006 109.593 175.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.79 -23.91 61.0 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.49 2.127 . . . . 74.099999999999994 111.81 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ttt -86.0 -17.84 34.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.761 -0.654 . . . . 74.140000000000001 110.213 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.05 -23.64 20.72 Favored Glycine 0 C--N 1.33 0.2 0 CA-C-N 116.06 -0.518 . . . . 74.340000000000003 112.795 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.406 ' OD1' ' HA ' ' A' ' 53' ' ' PRO . 28.9 t70 -145.91 137.0 12.6 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.233 -0.654 . . . . 74.409999999999997 109.233 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HA ' ' OD1' ' A' ' 52' ' ' ASP . 4.2 Cg_exo -81.53 -168.84 6.95 Favored 'Cis proline' 0 CA--C 1.534 0.49 0 C-N-CA 124.157 -1.185 . . . . 64.209999999999994 113.194 0.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 64' ' ' SER . 57.8 mt -121.17 142.86 35.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 73.120000000000005 110.138 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.34 112.95 25.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.928 0.394 . . . . 74.329999999999998 110.652 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.639 ' O ' ' HA ' ' A' ' 62' ' ' SER . 4.0 mp -107.7 132.32 53.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 61.420000000000002 110.741 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.725 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 27.7 mmt180 -90.33 100.48 13.31 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.27 -0.641 . . . . 65.140000000000001 109.27 173.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.64 ' HB3' HG13 ' A' ' 42' ' ' ILE . 2.8 pp -137.66 142.6 41.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.984 -0.553 . . . . 74.400000000000006 110.016 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 70.63 -4.12 1.75 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.332 0.587 . . . . 71.140000000000001 110.42 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.26 -41.22 1.5 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.959 -0.564 . . . . 35.509999999999998 112.303 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -113.26 159.53 19.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.46 0.648 . . . . 71.450000000000003 111.985 -175.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 36.1 t -82.25 148.09 28.57 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.879 -1.055 . . . . 72.120000000000005 110.289 173.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 42.1 tp -151.08 146.38 26.13 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.554 -0.748 . . . . 64.129999999999995 109.793 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -89.01 113.99 25.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.199 0.524 . . . . 74.299999999999997 111.64 -178.404 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.503 HD23 HD13 ' A' ' 56' ' ' LEU . 3.6 mm? -112.89 157.16 21.78 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.067 -0.716 . . . . 73.299999999999997 109.067 174.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -84.3 160.8 20.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.864 0.364 . . . . 64.310000000000002 111.131 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.492 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 1.6 tmtp? -55.39 -28.44 54.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.627 -0.715 . . . . 43.520000000000003 110.667 175.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.8 m -56.6 -56.87 15.94 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.365 -0.38 . . . . 71.109999999999999 110.494 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.586 ' HA ' HG21 ' A' ' 27' ' ' VAL . 1.8 mp0 -63.61 -40.19 96.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.095 0.474 . . . . 70.150000000000006 110.353 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . . . -62.86 -20.97 65.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.572 -0.74 . . . . 74.209999999999994 111.648 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.474 ' HD2' ' C ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -79.22 -39.05 34.2 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.058 -0.349 . . . . 70.519999999999996 110.058 177.564 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -89.76 8.44 31.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.196 -0.457 . . . . 75.120000000000005 112.2 -171.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.453 HD11 HG13 ' A' ' 31' ' ' ILE . 47.1 mm -115.07 113.02 42.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.872 -0.418 . . . . 71.340000000000003 109.872 175.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.7 mt -93.45 126.44 38.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.776 -0.453 . . . . 55.020000000000003 109.776 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 18.6 m -128.14 153.27 37.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.277 0.561 . . . . 72.409999999999997 112.124 -174.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.545 ' HB2' HD11 ' A' ' 19' ' ' ILE . 42.2 tt0 -119.6 144.33 47.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.004 -0.998 . . . . 73.299999999999997 108.812 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.456 ' HA ' HG12 ' A' ' 16' ' ' VAL . 9.3 p -70.38 136.66 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.071 0.462 . . . . 75.150000000000006 111.076 -176.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' A' ' 17' ' ' LYS . 40.8 mt . . . . . 0 C--N 1.327 -0.374 0 N-CA-C 112.284 0.476 . . . . 64.129999999999995 112.284 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.004 0 N-CA-C 111.912 -0.475 . . . . 61.43 111.912 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.8 pt -125.24 168.12 18.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.948 -0.76 . . . . 62.240000000000002 108.948 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.24 149.1 50.77 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.027 -1.082 . . . . 55.109999999999999 111.033 177.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.688 HD21 HD11 ' A' ' 44' ' ' ILE . 2.7 tm? -54.43 -33.18 58.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.389 0.614 . . . . 73.519999999999996 109.89 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -70.62 -19.46 62.82 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.574 -0.739 . . . . 72.400000000000006 111.307 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -92.23 -8.12 46.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.903 0.382 . . . . 74.040000000000006 110.789 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.1 t -80.28 157.62 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.112 -0.495 . . . . 74.549999999999997 110.029 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.584 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 21.1 tt0 -94.81 176.81 6.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.793 -0.447 . . . . 75.120000000000005 109.793 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.584 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 39.9 pt -84.73 160.5 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 112.23 0.455 . . . . 61.140000000000001 112.23 -173.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 60.59 46.92 8.89 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.121 -0.945 . . . . 64.530000000000001 111.998 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.7 m -145.53 154.06 41.79 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.583 -0.735 . . . . 73.340000000000003 109.636 174.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.657 ' HB3' ' HD1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -109.22 130.89 55.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.34 0.59 . . . . 72.439999999999998 110.802 178.674 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 77' ' ' VAL . 27.1 m -132.28 163.73 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.133 -0.94 . . . . 63.509999999999998 110.343 -177.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.48 ' HB2' HD21 ' A' ' 78' ' ' LEU . 29.8 ttpt -115.48 143.48 45.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.992 -0.549 . . . . 75.209999999999994 110.656 -177.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.566 ' HA ' HG12 ' A' ' 75' ' ' VAL . 52.8 t -77.61 98.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.509 -0.768 . . . . 72.430000000000007 110.048 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.8 HD11 ' HB3' ' A' ' 76' ' ' GLU . 39.8 mt -57.41 -54.69 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.638 -0.71 . . . . 72.450000000000003 110.453 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -161.6 178.01 37.65 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.158 -0.928 . . . . 73.340000000000003 111.34 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 53.6 mt -113.2 155.84 14.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.963 -0.384 . . . . 70.030000000000001 109.963 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.407 ' HA ' ' HD2' ' A' ' 23' ' ' PRO . 51.8 t -101.82 91.27 2.26 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.213 -0.662 . . . . 75.409999999999997 109.213 175.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.717 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 25.7 Cg_endo -59.22 -168.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.844 3.029 . . . . 61.329999999999998 113.773 -172.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 68.3 -43.86 0.49 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.571 -0.741 . . . . 74.430000000000007 112.371 -173.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.581 ' OG ' HG22 ' A' ' 27' ' ' VAL . 8.6 t -55.57 145.19 23.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.219 0.533 . . . . 71.239999999999995 111.725 -176.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.922 ' HD3' ' H ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -71.73 -29.68 64.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.567 -0.742 . . . . 62.43 109.805 173.071 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.691 HG21 ' HA ' ' A' ' 69' ' ' GLU . 11.4 m -79.84 -17.37 12.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.948 0.404 . . . . 75.349999999999994 110.049 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.717 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 2.8 tmm_? -55.18 -36.93 66.4 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.064 -0.516 . . . . 70.450000000000003 109.999 169.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -71.48 -40.07 70.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.292 0.568 . . . . 73.409999999999997 109.805 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.638 ' HG2' ' OE2' ' A' ' 69' ' ' GLU . 23.5 tptm -53.05 -48.04 67.96 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 114.988 -1.005 . . . . 62.119999999999997 111.021 177.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 27' ' ' VAL . 61.5 mt -50.99 -53.29 14.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.566 -0.743 . . . . 73.310000000000002 111.386 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 59.3 mtt -66.76 -35.39 79.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 73.420000000000002 111.371 -178.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.83 -38.58 89.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.943 0.401 . . . . 61.130000000000003 110.022 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.6 tpt -65.75 -25.57 67.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.472 -0.786 . . . . 75.319999999999993 110.961 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.87 8.09 11.09 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.756 -0.735 . . . . 41.229999999999997 112.744 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.425 ' HB ' ' CG2' ' A' ' 31' ' ' ILE . 37.4 mt -104.61 133.28 49.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.711 -0.477 . . . . 71.329999999999998 109.711 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.656 HG23 ' H ' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -129.78 -85.89 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 112.092 0.404 . . . . 70.239999999999995 112.092 -177.603 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.656 ' H ' HG23 ' A' ' 37' ' ' VAL . 45.4 ttm180 -153.99 117.56 4.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.964 0.412 . . . . 64.439999999999998 110.263 -177.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.43 -1.05 68.89 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.492 -0.861 . . . . 74.549999999999997 111.534 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.0 m -66.65 140.85 57.94 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.675 -0.491 . . . . 74.340000000000003 109.675 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.512 ' HG2' HD11 ' A' ' 78' ' ' LEU . 35.5 mt-10 -107.07 128.15 54.11 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.803 -0.635 . . . . 71.450000000000003 110.029 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.682 HG21 HD23 ' A' ' 56' ' ' LEU . 77.5 mt -121.48 136.28 58.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.317 -0.856 . . . . 73.120000000000005 110.535 -172.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.657 ' HD1' ' HB3' ' A' ' 15' ' ' LYS . 37.4 t80 -100.87 105.88 17.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.262 -0.426 . . . . 72.430000000000007 109.869 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.688 HD11 HD21 ' A' ' 7' ' ' LEU . 50.4 mm -70.54 120.92 19.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.941 -0.392 . . . . 73.420000000000002 109.941 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -89.96 -65.82 0.98 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.09 -0.504 . . . . 65.450000000000003 110.516 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' A' ' 12' ' ' ILE . . . -159.06 173.44 35.92 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.687 -0.768 . . . . 52.149999999999999 112.027 -177.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.496 ' HG2' HG23 ' A' ' 54' ' ' ILE . 58.3 mtpt -129.52 146.98 51.28 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.32 -0.622 . . . . 75.329999999999998 109.32 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.67 157.13 68.42 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.497 -0.557 . . . . 64.120000000000005 109.497 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -52.3 -29.74 39.76 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.82 2.347 . . . . 73.239999999999995 113.196 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -82.43 -7.95 59.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 74.030000000000001 110.821 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.11 -8.34 78.62 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.012 -0.835 . . . . 74.540000000000006 111.012 -173.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.776 ' HB2' ' HB2' ' A' ' 67' ' ' LYS . 5.9 t70 -139.29 128.98 14.26 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.014 -0.593 . . . . 73.409999999999997 109.797 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 97.3 Cg_endo -87.0 -174.32 9.8 Favored 'Cis proline' 0 C--O 1.237 0.459 0 C-N-CA 123.374 -1.511 . . . . 74.120000000000005 113.05 0.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.496 HG23 ' HG2' ' A' ' 47' ' ' LYS . 4.6 mp -112.86 140.78 30.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.791 -0.641 . . . . 44.43 109.31 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.65 106.76 19.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.025 0.441 . . . . 61.329999999999998 110.839 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.682 HD23 HG21 ' A' ' 42' ' ' ILE . 3.1 mp -105.51 134.27 48.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.836 -0.62 . . . . 74.129999999999995 109.381 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 39.6 mtt180 -98.19 119.98 37.81 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.982 0.42 . . . . 72.430000000000007 110.114 175.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.432 ' HG ' HD23 ' A' ' 63' ' ' LEU . 3.4 pp -139.43 140.58 37.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.431 -0.804 . . . . 65.519999999999996 109.999 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 46.7 ttm-85 65.9 -0.25 1.38 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.31 -0.859 . . . . 63.420000000000002 111.993 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.05 -52.02 0.56 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.468 -0.872 . . . . 55.25 113.585 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -120.87 177.33 5.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.871 0.367 . . . . 63.340000000000003 111.722 -173.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 30.2 t -88.18 142.9 27.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.596 0.712 . . . . 71.120000000000005 112.226 -175.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 62' ' ' SER . 3.2 mm? -134.68 143.54 47.29 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.342 -1.299 . . . . 54.329999999999998 108.928 176.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 p -99.33 119.91 38.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.078 0.466 . . . . 52.030000000000001 111.695 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.526 HD13 HD13 ' A' ' 56' ' ' LEU . 9.0 mp -114.72 151.42 33.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.86 -0.609 . . . . 70.510000000000005 109.423 175.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.492 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 46.8 mmm-85 -75.61 159.81 30.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.32 0.581 . . . . 75.219999999999999 111.745 -174.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.776 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -61.94 -33.58 74.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.246 -0.888 . . . . 60.340000000000003 110.611 179.691 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 41.7 m -73.3 -35.47 66.13 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.978 -0.555 . . . . 73.230000000000004 111.204 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.691 ' HA ' HG21 ' A' ' 27' ' ' VAL . 39.4 mt-10 -70.11 -43.01 71.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.351 0.596 . . . . 65.519999999999996 109.401 176.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.71 -21.25 65.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.386 -0.825 . . . . 63.450000000000003 111.072 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 68' ' ' SER . 1.8 ttpm? -70.74 -35.64 72.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.076 -0.511 . . . . 64.349999999999994 110.517 176.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -84.46 14.44 4.51 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.586 -0.734 . . . . 73.439999999999998 111.204 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.418 HG12 HD13 ' A' ' 31' ' ' ILE . 54.7 mt -125.8 120.47 57.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.897 -0.592 . . . . 65.049999999999997 109.909 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.1 mt -104.01 126.1 50.88 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.955 -0.387 . . . . 75.530000000000001 109.955 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 18' ' ' VAL . 23.9 m -129.51 157.44 42.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.318 0.58 . . . . 74.430000000000007 112.372 -174.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.8 ' HB3' HD11 ' A' ' 19' ' ' ILE . 14.0 pt-20 -119.22 153.35 35.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.265 -0.88 . . . . 73.030000000000001 109.681 176.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.578 ' HA ' HG12 ' A' ' 16' ' ' VAL . 13.1 p -77.92 133.09 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.988 0.423 . . . . 54.229999999999997 111.024 -177.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.512 HD11 ' HG2' ' A' ' 41' ' ' GLU . 96.9 mt . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 121.362 0.601 . . . . 61.530000000000001 110.826 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.728 0 CA-C-O 121.03 0.239 . . . . 52.530000000000001 112.6 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 pt -115.37 173.07 3.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.808 -0.812 . . . . 71.150000000000006 108.808 176.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.45 143.2 29.08 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 119.865 -1.16 . . . . 61.43 111.72 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.507 HD11 HD11 ' A' ' 44' ' ' ILE . 39.5 tp -63.61 -24.71 67.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.2 0.524 . . . . 73.340000000000003 110.548 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -76.52 -14.39 60.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.853 -0.612 . . . . 74.510000000000005 110.604 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.85 -4.63 56.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.339 0.59 . . . . 74.329999999999998 110.012 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.5 t -98.26 162.28 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.505 -0.771 . . . . 62.149999999999999 109.399 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.791 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 24.8 tt0 -124.77 -172.0 2.47 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.98 -0.288 . . . . 72.439999999999998 110.79 -177.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.791 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 31.6 pt -63.35 154.13 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 113.445 0.906 . . . . 73.019999999999996 113.445 -170.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 63.02 27.1 15.77 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.965 -1.016 . . . . 62.149999999999999 111.962 173.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.422 ' H ' ' HB ' ' A' ' 44' ' ' ILE . 19.6 m -102.42 152.66 20.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.259 -0.428 . . . . 65.099999999999994 110.53 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -124.17 110.92 15.28 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.235 -0.654 . . . . 71.430000000000007 109.235 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 77' ' ' VAL . 30.4 m -128.32 174.17 12.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.534 -0.757 . . . . 70.010000000000005 110.687 -174.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 37.5 ttmt -129.18 140.98 51.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.154 -0.475 . . . . 75.230000000000004 110.595 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.55 HG13 HG23 ' A' ' 73' ' ' ILE . 48.7 t -73.36 96.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.319 -0.855 . . . . 64.239999999999995 110.619 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.8 mm -63.29 -44.9 99.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.76 -0.655 . . . . 65.319999999999993 109.908 174.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.93 172.08 44.51 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.233 -0.984 . . . . 74.329999999999998 112.671 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.605 ' HB ' ' NH1' ' A' ' 28' ' ' ARG . 49.4 mt -127.77 158.98 39.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 108.068 -1.086 . . . . 73.200000000000003 108.068 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 25' ' ' SER . 38.2 t -101.19 91.3 1.96 Allowed Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.058 0.456 . . . . 65.420000000000002 111.254 -175.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.612 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 24.4 Cg_endo -59.94 171.55 2.86 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.696 2.264 . . . . 64.420000000000002 112.35 -177.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 68.93 -5.28 1.05 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.682 -0.69 . . . . 74.329999999999998 111.488 -175.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 1.2 m -78.74 156.77 28.72 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.955 -0.387 . . . . 54.039999999999999 109.955 173.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -75.33 -31.43 60.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.894 0.378 . . . . 75.219999999999999 110.599 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.525 ' HB ' ' HG3' ' A' ' 69' ' ' GLU . 29.6 m -81.47 -21.61 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 70.340000000000003 110.77 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.612 ' HG2' ' HA ' ' A' ' 23' ' ' PRO . 17.7 tpt180 -53.02 -43.78 66.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.94 -0.573 . . . . 54.329999999999998 110.465 175.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -59.43 -44.65 92.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.587 -0.733 . . . . 64.329999999999998 110.771 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 34' ' ' MET . 88.6 tttt -63.85 -48.93 74.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.818 -0.628 . . . . 62.229999999999997 110.931 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 27' ' ' VAL . 82.1 mt -57.33 -45.81 85.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.822 -0.627 . . . . 71.010000000000005 111.392 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 95.4 mmm -68.57 -35.5 77.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.795 0.331 . . . . 71.310000000000002 110.593 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -66.32 -39.96 89.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.99 -0.55 . . . . 74.420000000000002 110.255 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 91.0 mmm -60.52 -34.73 74.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.818 -0.628 . . . . 74.219999999999999 110.735 176.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.58 13.82 9.29 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.64 -0.791 . . . . 73.450000000000003 112.894 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.7 mt -89.64 127.1 42.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.86 0.362 . . . . 74.319999999999993 110.052 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.36 173.13 14.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.722 -0.672 . . . . 60.520000000000003 110.675 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.59 135.27 57.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.185 -0.461 . . . . 74.519999999999996 110.619 178.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.24 -12.09 66.89 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.908 -0.587 . . . . 71.120000000000005 112.662 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.3 m -73.29 142.24 47.17 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.859 -0.423 . . . . 71.120000000000005 109.859 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -94.39 136.14 35.02 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.065 0.459 . . . . 61.229999999999997 109.785 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.2 mm -116.74 117.82 56.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.643 -0.708 . . . . 75.099999999999994 110.463 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 63.4 t80 -95.52 119.48 34.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.854 -0.612 . . . . 74.540000000000006 109.436 174.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.507 HD11 HD11 ' A' ' 7' ' ' LEU . 26.3 mm -76.3 101.88 2.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.612 -0.514 . . . . 51.130000000000003 109.612 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -70.35 -42.83 71.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.934 -0.575 . . . . 71.109999999999999 109.601 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 169.75 177.78 40.42 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.889 -0.672 . . . . 75.340000000000003 111.956 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -117.97 143.09 46.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.132 -0.692 . . . . 72.340000000000003 109.132 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.64 158.46 31.13 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.605 -0.271 . . . . 63.549999999999997 110.394 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -45.41 -41.73 17.8 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.201 2.6 . . . . 72.209999999999994 113.419 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.7 ttt -71.22 -21.97 62.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 74.349999999999994 111.382 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.59 -7.22 42.31 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.728 -0.949 . . . . 71.010000000000005 110.728 -172.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.483 ' OD1' ' HA ' ' A' ' 53' ' ' PRO . 21.8 t70 -155.54 139.25 11.2 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.838 -0.801 . . . . 74.150000000000006 108.838 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HB3' ' HA ' ' A' ' 66' ' ' ARG . 4.1 Cg_exo -79.45 -170.19 8.51 Favored 'Cis proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.829 -1.321 . . . . 75.239999999999995 113.05 2.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.5 mt -116.39 137.5 49.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.713 -0.676 . . . . 74.230000000000004 109.904 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.03 111.65 20.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.291 -0.413 . . . . 60.240000000000002 110.287 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.6 mt -114.04 135.96 53.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.967 -0.561 . . . . 71.430000000000007 109.903 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.715 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 44.4 ttt180 -94.83 107.4 19.41 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.698 -0.482 . . . . 73.219999999999999 109.698 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.557 ' H ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -132.69 153.63 50.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.271 -0.422 . . . . 73.239999999999995 110.288 -177.539 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.543 ' HB2' HD22 ' A' ' 58' ' ' LEU . 0.2 OUTLIER 70.62 -55.63 0.63 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.773 0.671 . . . . 51.130000000000003 110.631 -178.897 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.53 -33.03 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 116.116 -0.493 . . . . 64.409999999999997 111.956 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -125.85 165.58 18.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.822 0.344 . . . . 75.400000000000006 110.938 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.715 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 47.7 t -86.28 145.82 26.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.243 0.544 . . . . 72.400000000000006 110.973 -178.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.1 mt -145.31 161.22 40.14 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.052 -0.976 . . . . 62.409999999999997 109.483 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -97.17 121.18 38.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.044 0.449 . . . . 65.340000000000003 110.741 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.42 143.31 49.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.355 -0.839 . . . . 65.430000000000007 109.389 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.485 ' HA ' ' HB3' ' A' ' 53' ' ' PRO . 37.4 mmt180 -71.82 155.14 40.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.073 0.463 . . . . 72.230000000000004 110.898 -177.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -56.27 -30.9 63.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.381 -0.827 . . . . 72.049999999999997 111.045 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 2.9 p -63.81 -37.87 89.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 44.409999999999997 111.607 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.525 ' HG3' ' HB ' ' A' ' 27' ' ' VAL . 1.6 mp0 -73.87 -39.39 63.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.003 0.43 . . . . 74.209999999999994 110.554 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.16 -23.64 66.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.202 0.525 . . . . 65.540000000000006 110.734 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 68' ' ' SER . 7.1 tmtt? -62.99 -33.9 76.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.79 -0.641 . . . . 74.140000000000001 111.74 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -88.65 -5.24 58.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.128 0.49 . . . . 72.140000000000001 111.78 -168.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.55 HG23 HG13 ' A' ' 18' ' ' VAL . 65.6 mt -105.13 115.58 47.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.192 -0.458 . . . . 61.119999999999997 110.899 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 74' ' ' LEU . 2.7 mm? -86.67 126.87 34.83 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.633 -0.506 . . . . 70.239999999999995 109.633 174.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.499 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 24.2 m -130.15 153.72 39.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.877 0.37 . . . . 72.109999999999999 111.574 -176.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -102.52 148.49 25.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.283 -0.636 . . . . 75.519999999999996 109.283 173.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 16' ' ' VAL . 53.6 t -89.3 114.51 27.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.864 0.364 . . . . 65.409999999999997 110.187 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--N 1.324 -0.504 0 CA-C-O 121.192 0.52 . . . . 64.430000000000007 111.343 -177.751 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 112.07 -0.412 . . . . 61.030000000000001 112.07 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.6 pt -115.74 168.19 7.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.987 -0.375 . . . . 74.040000000000006 109.987 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.07 143.65 41.73 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.311 -0.947 . . . . 73.519999999999996 111.924 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.453 ' O ' HD13 ' A' ' 7' ' ' LEU . 2.6 tm? -58.3 -34.31 70.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.214 0.53 . . . . 74.420000000000002 109.841 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -69.78 -14.36 62.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.73 -0.668 . . . . 45.219999999999999 111.387 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -96.12 -2.86 45.66 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.809 0.338 . . . . 73.239999999999995 111.122 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.5 t -90.76 159.21 2.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.234 -0.439 . . . . 51.009999999999998 110.208 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -89.98 166.0 13.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.155 -0.475 . . . . 74.310000000000002 110.266 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.9 pt -77.48 162.87 4.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.185 -0.462 . . . . 64.239999999999995 110.599 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt 60.55 30.09 19.49 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.192 0.597 . . . . 74.140000000000001 111.014 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.6 m -120.88 151.67 39.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.68 -0.691 . . . . 74.209999999999994 110.3 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -109.59 127.4 54.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.097 -0.501 . . . . 73.200000000000003 109.698 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.447 HG23 ' HB ' ' A' ' 42' ' ' ILE . 22.5 m -128.97 173.54 13.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.261 -0.427 . . . . 63.0 111.099 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.821 ' HE3' HD21 ' A' ' 78' ' ' LEU . 29.9 ttmt -126.5 140.29 52.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.907 -0.588 . . . . 63.420000000000002 110.689 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.88 96.85 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.604 -0.726 . . . . 74.120000000000005 110.345 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.439 HD11 ' HD2' ' A' ' 17' ' ' LYS . 38.1 mm -92.36 -52.77 9.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.405 -0.816 . . . . 60.32 110.894 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.81 160.55 22.83 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.207 -0.997 . . . . 72.109999999999999 112.945 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.716 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 71.8 mt -142.4 158.12 19.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.801 -1.185 . . . . 72.209999999999994 107.801 -178.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.0 t -100.62 91.42 1.81 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.65 0.262 . . . . 74.120000000000005 110.65 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.716 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 31.4 Cg_exo -57.57 159.06 17.63 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.26 2.64 . . . . 65.030000000000001 112.732 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 62.62 74.5 0.43 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.521 -0.763 . . . . 75.430000000000007 110.155 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 28.9 t -159.26 153.52 23.81 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.134 -0.939 . . . . 62.340000000000003 109.599 -176.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -68.97 -22.6 64.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.833 0.349 . . . . 72.150000000000006 110.344 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 31' ' ' ILE . 25.2 m -95.77 -20.34 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.495 -0.32 . . . . 72.239999999999995 110.684 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.605 ' CD ' ' HA ' ' A' ' 23' ' ' PRO . 2.0 tpm_? -50.33 -54.45 21.41 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.184 -0.462 . . . . 74.129999999999995 111.074 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -65.61 -37.07 85.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.971 -0.559 . . . . 63.219999999999999 110.992 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -66.32 -45.05 81.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.327 -0.397 . . . . 54.439999999999998 111.23 -174.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.446 ' HA ' ' HE2' ' A' ' 34' ' ' MET . 79.2 mt -59.71 -45.83 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.347 -0.388 . . . . 75.120000000000005 110.834 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.584 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 2.2 ttt -71.98 -33.16 67.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.328 -0.397 . . . . 71.420000000000002 110.675 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -68.27 -24.66 64.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.031 -0.531 . . . . 63.130000000000003 110.079 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.446 ' HE2' ' HA ' ' A' ' 31' ' ' ILE . 63.0 mtm -79.64 2.32 22.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.786 -0.643 . . . . 63.439999999999998 111.441 178.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.63 -8.06 59.81 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.696 -0.764 . . . . 22.129999999999999 112.763 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 32' ' ' MET . 63.2 mt -81.5 137.42 21.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.864 0.364 . . . . 74.200000000000003 110.371 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.763 HG23 ' H ' ' A' ' 38' ' ' ARG . 1.9 m -133.78 -85.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.201 -0.454 . . . . 72.310000000000002 111.152 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.763 ' H ' HG23 ' A' ' 37' ' ' VAL . 17.8 ttm180 -153.37 140.68 19.59 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.985 -0.746 . . . . 73.209999999999994 108.985 175.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.58 -9.81 69.66 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.634 -0.793 . . . . 73.140000000000001 111.278 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -64.82 147.09 53.89 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.755 -0.461 . . . . 72.430000000000007 109.755 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -97.28 147.4 24.18 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.234 0.54 . . . . 61.200000000000003 111.541 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.603 HG12 ' HB3' ' A' ' 58' ' ' LEU . 64.5 mt -130.81 118.23 41.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.027 -0.988 . . . . 70.319999999999993 109.479 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.617 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 64.0 t80 -105.0 106.18 16.56 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.317 -0.401 . . . . 74.219999999999999 109.985 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.573 HG12 HD22 ' A' ' 56' ' ' LEU . 52.6 mt -75.31 102.35 2.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.235 -0.654 . . . . 74.510000000000005 109.235 177.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -85.54 -24.62 27.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.968 0.413 . . . . 71.519999999999996 110.906 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.12 -172.09 40.66 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.844 -0.693 . . . . 65.439999999999998 112.265 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.687 ' HG2' HG23 ' A' ' 54' ' ' ILE . 54.5 mtpt -123.49 159.08 29.85 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.737 -0.838 . . . . 74.430000000000007 108.737 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.82 152.14 87.44 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.64 -0.504 . . . . 75.340000000000003 109.64 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.91 -9.66 12.53 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.816 2.344 . . . . 34.109999999999999 112.999 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 55.7 ttp -97.29 -4.62 38.39 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.325 0.583 . . . . 74.5 110.318 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.67 -12.74 67.67 Favored Glycine 0 N--CA 1.454 -0.128 0 CA-C-N 115.988 -0.551 . . . . 71.25 111.958 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.559 ' OD2' ' HB2' ' A' ' 67' ' ' LYS . 11.4 t70 -152.32 136.51 10.22 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.344 -0.984 . . . . 70.109999999999999 108.344 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.466 ' HB3' ' HA ' ' A' ' 66' ' ' ARG . 3.5 Cg_exo -81.25 -167.96 6.31 Favored 'Cis proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.817 -1.326 . . . . 72.230000000000004 112.401 -1.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.687 HG23 ' HG2' ' A' ' 47' ' ' LYS . 46.8 mt -109.98 134.1 53.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.991 -0.55 . . . . 75.010000000000005 110.091 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.51 107.29 18.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.021 0.439 . . . . 43.240000000000002 110.167 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.573 HD22 HG12 ' A' ' 44' ' ' ILE . 28.8 mt -120.21 131.97 55.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.041 -0.527 . . . . 60.030000000000001 110.295 -177.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.813 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 27.9 ttt-85 -93.29 99.97 12.41 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.765 -0.828 . . . . 64.219999999999999 108.765 171.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.603 ' HB3' HG12 ' A' ' 42' ' ' ILE . 1.1 pp -119.13 146.0 45.49 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.084 -0.507 . . . . 74.109999999999999 110.461 -176.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 73.01 -45.87 0.63 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.895 0.747 . . . . 72.140000000000001 111.069 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.47 -26.42 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.293 -0.479 . . . . 74.450000000000003 112.152 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -121.45 157.74 29.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.855 0.36 . . . . 75.140000000000001 111.147 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.813 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -89.61 133.41 34.64 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.891 -0.595 . . . . 65.299999999999997 111.361 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.4 mt -141.98 152.02 43.06 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.552 -0.749 . . . . 71.219999999999999 109.475 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -88.86 110.81 21.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.203 0.525 . . . . 71.400000000000006 110.886 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.83 145.8 28.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.501 -0.772 . . . . 74.209999999999994 108.963 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.466 ' HA ' ' HB3' ' A' ' 53' ' ' PRO . 10.3 mpt_? -80.68 163.34 23.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.977 0.418 . . . . 75.510000000000005 110.338 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.559 ' HB2' ' OD2' ' A' ' 52' ' ' ASP . 4.5 ttmp? -47.76 -38.39 15.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.349 -0.841 . . . . 71.409999999999997 111.917 176.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.5 m -59.46 -50.78 72.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.251 -0.432 . . . . 74.319999999999993 111.766 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 73' ' ' ILE . 1.8 mp0 -63.66 -49.0 74.91 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.29 0.369 . . . . 74.219999999999999 110.795 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.55 -22.55 65.26 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.157 0.503 . . . . 65.530000000000001 111.481 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.595 ' HZ2' ' HB3' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -78.95 -23.2 44.75 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.0 -0.546 . . . . 55.43 110.705 -179.169 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -102.48 12.86 35.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 74.120000000000005 111.736 -175.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.463 HG22 HG13 ' A' ' 75' ' ' VAL . 61.9 mt -113.57 127.26 71.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.293 -0.412 . . . . 71.400000000000006 110.212 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.71 123.27 49.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.044 0.45 . . . . 73.239999999999995 109.923 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.463 HG13 HG22 ' A' ' 73' ' ' ILE . 28.2 m -129.56 160.04 40.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 112.324 0.49 . . . . 61.229999999999997 112.324 -170.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -106.28 159.02 16.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.591 -0.731 . . . . 63.399999999999999 109.305 172.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -83.75 124.61 39.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.775 0.322 . . . . 74.430000000000007 110.668 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.821 HD21 ' HE3' ' A' ' 17' ' ' LYS . 46.3 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.923 0.392 . . . . 45.43 111.01 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.85 0 CA-C-O 121.052 0.251 . . . . 42.25 112.95 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.2 pt -125.97 179.33 3.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.185 -0.672 . . . . 74.239999999999995 109.185 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.93 145.49 31.18 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.024 -1.084 . . . . 70.310000000000002 110.942 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.944 HD21 HD21 ' A' ' 56' ' ' LEU . 51.7 tp -57.55 -30.85 65.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.982 0.42 . . . . 75.019999999999996 111.587 -176.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -71.25 -6.51 40.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.408 -0.36 . . . . 54.450000000000003 111.97 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -103.55 2.22 33.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.619 0.247 . . . . 53.240000000000002 111.145 -177.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.8 t -88.08 157.55 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.877 0.37 . . . . 71.409999999999997 110.797 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.522 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 32.1 tt0 -99.27 176.02 5.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.957 -0.565 . . . . 65.430000000000007 110.12 -178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.522 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 40.9 pt -79.95 159.31 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.854 0.359 . . . . 72.310000000000002 111.943 -175.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 59.55 35.79 22.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.379 -0.828 . . . . 74.200000000000003 111.15 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -130.94 151.27 51.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.269 -0.423 . . . . 70.019999999999996 110.809 -177.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.777 ' HG2' ' HD1' ' A' ' 43' ' ' TYR . 32.6 mtmt -109.07 130.18 55.48 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.238 0.542 . . . . 62.009999999999998 110.563 176.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 7.0 m -129.4 142.9 42.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.198 -0.91 . . . . 61.219999999999999 109.617 176.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.534 ' HB2' HD11 ' A' ' 78' ' ' LEU . 30.5 ttpt -104.5 142.62 34.3 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.059 0.457 . . . . 64.409999999999997 110.486 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.514 ' HA ' HG12 ' A' ' 75' ' ' VAL . 37.0 t -74.75 96.6 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.524 -0.762 . . . . 74.239999999999995 110.769 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.695 HD11 ' HB3' ' A' ' 76' ' ' GLU . 16.9 mt -58.72 -42.92 86.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.7 0.762 . . . . 72.129999999999995 108.951 171.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.29 170.66 39.95 Favored Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 114.55 -1.205 . . . . 72.219999999999999 111.911 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.734 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 14.5 mt -114.23 161.92 12.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.399 -1.334 . . . . 70.099999999999994 107.399 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.53 91.84 1.15 Allowed Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.252 0.548 . . . . 74.409999999999997 110.377 -174.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.734 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 31.6 Cg_exo -57.26 169.83 1.95 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.812 3.008 . . . . 73.420000000000002 113.414 -170.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 65.89 13.61 9.12 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.18 -0.918 . . . . 54.530000000000001 110.113 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 14.7 t -98.89 134.9 41.1 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.566 -0.743 . . . . 55.119999999999997 109.354 174.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' A' ' 26' ' ' LYS . 17.4 pttp -68.13 -15.61 63.66 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.334 -0.394 . . . . 75.140000000000001 111.295 178.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 31' ' ' ILE . 27.8 m -94.96 -28.14 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.557 -0.457 . . . . 74.510000000000005 110.736 174.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 3.8 tmt_? -54.1 -47.0 72.26 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.263 0.554 . . . . 75.209999999999994 109.845 174.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.9 ttt-85 -55.77 -47.33 77.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.187 -0.915 . . . . 65.239999999999995 110.433 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.58 -44.76 95.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.308 -0.86 . . . . 72.219999999999999 111.408 -177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.489 HD13 ' CG1' ' A' ' 73' ' ' ILE . 60.3 mt -64.74 -47.62 87.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.516 -0.766 . . . . 61.310000000000002 111.411 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.434 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 2.3 ttt -68.48 -32.87 73.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.089 0.471 . . . . 64.310000000000002 110.545 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.07 -23.62 64.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.815 -0.63 . . . . 54.240000000000002 110.612 177.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 22.2 ttm -75.62 -19.62 59.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.835 -0.621 . . . . 75.420000000000002 110.65 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.4 -5.06 13.31 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.418 -0.896 . . . . 72.5 112.825 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 32' ' ' MET . 44.6 mt -84.79 125.12 40.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.086 0.469 . . . . 73.120000000000005 110.298 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.05 -178.0 2.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.687 -0.688 . . . . 62.340000000000003 110.91 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -68.51 116.45 9.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.077 -0.51 . . . . 74.450000000000003 110.897 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.14 -2.47 44.01 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.887 -0.597 . . . . 61.020000000000003 113.018 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.9 m -75.72 148.34 38.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.858 0.329 . . . . 54.030000000000001 110.126 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -95.81 125.22 40.22 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.087 -0.506 . . . . 73.200000000000003 110.193 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.7 mt -100.66 114.83 40.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.475 -0.784 . . . . 72.409999999999997 109.748 176.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.777 ' HD1' ' HG2' ' A' ' 15' ' ' LYS . 37.1 t80 -91.26 105.09 17.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.121 -0.491 . . . . 74.319999999999993 110.105 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.652 HD11 HD11 ' A' ' 7' ' ' LEU . 47.8 mm -80.53 96.37 2.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.071 -0.714 . . . . 75.109999999999999 109.071 175.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.05 -26.89 33.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.983 0.421 . . . . 72.420000000000002 110.708 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.05 176.84 47.72 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.32 -0.943 . . . . 61.0 112.57 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.772 ' HG2' HG23 ' A' ' 54' ' ' ILE . 56.2 mtpt -133.62 158.22 43.76 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.756 -0.831 . . . . 73.019999999999996 108.756 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.85 156.84 63.97 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.501 -0.185 . . . . 52.310000000000002 110.501 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.98 -33.74 73.98 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.809 2.339 . . . . 72.400000000000006 112.729 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.1 ttm -87.68 -7.65 57.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.134 0.492 . . . . 72.329999999999998 110.875 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.89 -15.3 60.88 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 121.13 -0.557 . . . . 71.319999999999993 112.075 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -140.3 131.54 14.15 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.38 -0.6 . . . . 73.219999999999999 109.38 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.06 -170.08 7.94 Favored 'Cis proline' 0 CA--C 1.531 0.33 0 C-N-CA 124.124 -1.199 . . . . 64.430000000000007 113.217 1.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.772 HG23 ' HG2' ' A' ' 47' ' ' LYS . 41.1 mt -110.07 145.08 17.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.766 -0.652 . . . . 60.340000000000003 110.005 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.89 104.16 15.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.197 0.523 . . . . 61.049999999999997 110.706 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.944 HD21 HD21 ' A' ' 7' ' ' LEU . 7.9 mp -99.93 164.01 12.2 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.477 -0.783 . . . . 71.510000000000005 110.27 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 27.8 ttm180 -142.35 111.73 6.59 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.703 -0.851 . . . . 74.209999999999994 108.703 171.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.531 HD13 ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -136.5 149.48 48.19 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.793 0.33 . . . . 71.239999999999995 110.823 -177.336 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 62.89 2.72 1.04 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.581 -0.736 . . . . 64.230000000000004 111.676 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.67 -14.2 11.69 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.803 -0.713 . . . . 61.310000000000002 112.861 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.414 ' CD1' HD21 ' A' ' 63' ' ' LEU . 7.5 p90 -128.01 150.73 49.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.447 0.642 . . . . 62.039999999999999 112.385 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 47.9 t -84.46 144.63 28.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.093 -0.958 . . . . 54.039999999999999 111.969 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.476 HD22 ' C ' ' A' ' 62' ' ' SER . 3.4 mm? -135.11 144.37 47.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.897 -1.047 . . . . 73.439999999999998 109.757 177.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.47 110.01 21.41 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.349 -0.387 . . . . 74.209999999999994 110.194 175.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.58 HD21 HD22 ' A' ' 56' ' ' LEU . 2.9 pp -124.55 160.77 27.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.76 0.314 . . . . 63.509999999999998 110.46 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 6.1 mpt_? -80.17 161.98 24.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.564 0.697 . . . . 73.120000000000005 112.214 -169.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -57.89 -54.85 42.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.725 -1.125 . . . . 71.439999999999998 111.459 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.0 m -75.4 -11.71 60.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.033 0.444 . . . . 73.450000000000003 111.175 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 66' ' ' ARG . 20.8 tt0 -79.76 -42.45 24.5 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.835 -0.802 . . . . 73.540000000000006 108.835 176.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 7' ' ' LEU . . . -69.71 -21.15 63.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.817 -1.083 . . . . 64.340000000000003 111.157 174.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -59.01 -26.61 64.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.86 -0.609 . . . . 72.400000000000006 112.017 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.4 -3.19 57.31 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.331 0.586 . . . . 54.409999999999997 110.622 -177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.504 HG22 HG13 ' A' ' 75' ' ' VAL . 51.7 mt -101.83 128.58 54.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.104 -0.498 . . . . 33.0 110.722 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.0 mt -106.7 118.01 35.55 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.847 -0.427 . . . . 75.109999999999999 109.847 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 15.3 m -129.15 146.13 34.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.935 0.398 . . . . 72.530000000000001 111.957 -174.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.695 ' HB3' HD11 ' A' ' 19' ' ' ILE . 9.7 pt-20 -100.67 139.06 36.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.852 -0.613 . . . . 73.150000000000006 110.164 176.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.651 ' HA ' HG12 ' A' ' 16' ' ' VAL . 39.5 t -75.12 112.11 12.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.149 -0.478 . . . . 50.25 110.572 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 17' ' ' LYS . 90.6 mt . . . . . 0 C--N 1.327 -0.375 0 CA-C-O 121.249 0.547 . . . . 73.219999999999999 110.918 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.8 mtt . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.073 0.463 . . . . 74.329999999999998 110.903 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.9 p -148.7 -178.33 6.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.58 -0.736 . . . . 74.099999999999994 109.314 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.01 111.13 2.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.088 -0.708 . . . . 64.439999999999998 109.088 171.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.419 ' HA3' HD12 ' A' ' 19' ' ' ILE . . . -71.3 141.75 33.01 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.551 -0.749 . . . . 64.439999999999998 113.672 -170.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.1 pt -106.8 174.77 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.448 -0.945 . . . . 65.019999999999996 108.448 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.75 147.73 28.23 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 119.811 -1.185 . . . . 74.5 111.267 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.482 HD21 HD21 ' A' ' 56' ' ' LEU . 44.0 tp -62.65 -17.97 61.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.369 0.604 . . . . 74.430000000000007 110.94 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.538 ' OD1' ' HA ' ' A' ' 71' ' ' LYS . 4.1 p-10 -75.44 -10.99 59.94 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.572 -0.74 . . . . 70.540000000000006 110.895 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -101.81 9.53 40.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.044 -0.525 . . . . 73.430000000000007 110.747 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.1 t -103.19 160.27 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.01 -0.541 . . . . 72.540000000000006 109.602 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.473 ' CG ' ' H ' ' A' ' 12' ' ' ILE . 12.6 tt0 -112.13 -176.85 3.02 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.226 -0.287 . . . . 73.329999999999998 110.226 -177.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.473 ' H ' ' CG ' ' A' ' 11' ' ' GLU . 40.8 pt -66.85 150.38 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.709 0.633 . . . . 73.019999999999996 112.709 -171.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 68.3 mttm 51.93 48.99 21.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.078 -0.965 . . . . 60.340000000000003 112.343 174.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.7 m -127.37 153.7 45.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.705 -0.68 . . . . 64.420000000000002 109.6 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' H ' HD12 ' A' ' 79' ' ' LEU . 91.1 mttt -112.45 129.23 56.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.237 0.541 . . . . 60.25 111.023 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 77' ' ' VAL . 15.4 m -137.47 152.65 27.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.114 -0.948 . . . . 65.319999999999993 109.795 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.741 ' HB2' HD11 ' A' ' 78' ' ' LEU . 1.9 tmtp? -105.94 140.85 38.32 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.112 -0.495 . . . . 74.420000000000002 110.27 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -77.75 95.16 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.314 -0.857 . . . . 74.5 110.207 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.869 HD11 ' HB3' ' A' ' 76' ' ' GLU . 17.3 mt -63.49 -55.95 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.595 -0.729 . . . . 63.310000000000002 110.004 175.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.22 -177.19 33.1 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.398 -0.905 . . . . 51.409999999999997 112.91 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.496 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 22.4 mt -129.08 161.52 38.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.392 -0.966 . . . . 55.109999999999999 108.392 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.44 90.56 1.03 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.683 0.754 . . . . 71.349999999999994 109.582 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.878 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 36.6 Cg_endo -61.43 162.45 20.61 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.412 2.741 . . . . 64.450000000000003 113.864 -167.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 65.38 5.68 3.28 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.903 -1.044 . . . . 75.140000000000001 112.193 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.538 ' HB3' HG22 ' A' ' 27' ' ' VAL . 1.0 OUTLIER -77.15 -4.67 45.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.69 0.281 . . . . 64.219999999999999 111.503 179.076 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 88.6 tttt 71.24 -45.66 0.62 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.494 0.718 . . . . 71.140000000000001 110.941 -174.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 25' ' ' SER . 31.5 m -66.72 -16.73 21.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.069 0.461 . . . . 74.200000000000003 109.92 173.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.878 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 4.4 tmt_? -57.87 -37.96 74.89 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.115 -0.698 . . . . 75.209999999999994 109.115 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 6.3 tpp180 -64.82 -46.22 82.89 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 115.62 -0.718 . . . . 72.400000000000006 109.969 174.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -55.41 -48.74 73.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.609 -0.723 . . . . 71.030000000000001 110.834 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.498 HD11 ' HB3' ' A' ' 72' ' ' ASP . 78.3 mt -59.89 -48.65 86.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.957 -0.565 . . . . 74.340000000000003 111.139 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -38.17 90.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 64.310000000000002 110.837 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.86 -32.9 74.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.788 -0.642 . . . . 74.5 111.048 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -17.74 64.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.046 -0.525 . . . . 62.539999999999999 111.09 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.25 12.51 29.05 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.513 -0.851 . . . . 71.310000000000002 112.558 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.1 mt -91.51 126.71 44.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.079 0.466 . . . . 74.049999999999997 110.035 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.11 169.79 21.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.671 -0.695 . . . . 75.420000000000002 111.014 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -61.33 109.12 1.05 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.825 -0.625 . . . . 73.349999999999994 110.562 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.677 ' HA2' ' HE3' ' A' ' 17' ' ' LYS . . . 119.64 -9.85 11.53 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.761 -0.733 . . . . 63.119999999999997 113.092 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 m -71.48 149.24 46.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.02 0.438 . . . . 75.519999999999996 110.737 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -98.08 132.77 43.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.726 -0.67 . . . . 74.129999999999995 110.147 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.455 ' HB ' HG23 ' A' ' 16' ' ' VAL . 45.0 mm -108.93 121.66 62.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.461 -0.791 . . . . 73.129999999999995 110.343 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -111.31 112.15 23.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.329 -0.619 . . . . 74.450000000000003 109.329 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 7' ' ' LEU . 51.3 mm -75.59 121.22 26.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.351 -0.611 . . . . 75.200000000000003 109.351 176.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.56 -53.25 6.42 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.847 -0.798 . . . . 52.43 108.847 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.452 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . -172.77 179.05 44.5 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.731 -0.947 . . . . 73.400000000000006 110.731 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -118.37 156.96 28.03 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.166 -0.679 . . . . 73.129999999999995 109.166 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.27 157.37 77.76 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 110.038 -0.356 . . . . 53.420000000000002 110.038 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -59.18 -12.38 15.84 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.734 2.289 . . . . 74.129999999999995 112.77 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.5 mmt -99.89 -2.35 35.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.48 . . . . 71.329999999999998 110.486 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.01 -16.06 56.42 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.197 -0.525 . . . . 73.329999999999998 111.894 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -150.52 137.76 11.68 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 108.64 -0.874 . . . . 60.240000000000002 108.64 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.04 -164.95 4.02 Favored 'Cis proline' 0 CA--C 1.531 0.36 0 C-N-CA 123.734 -1.361 . . . . 71.099999999999994 113.25 1.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.4 mt -119.03 147.34 22.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.862 -0.608 . . . . 64.239999999999995 109.975 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.89 119.45 36.52 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.089 -0.337 . . . . 53.219999999999999 110.089 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.482 HD21 HD21 ' A' ' 7' ' ' LEU . 5.9 mp -117.04 154.65 30.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.816 0.341 . . . . 62.310000000000002 110.731 -176.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -128.28 105.13 8.13 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.337 -0.616 . . . . 74.230000000000004 109.337 170.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -142.6 160.33 40.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.197 -0.911 . . . . 74.239999999999995 109.871 -175.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? 75.15 -56.91 0.61 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.973 0.795 . . . . 72.109999999999999 109.574 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 173.91 -1.01 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.71 -0.677 . . . . 74.120000000000005 111.901 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -142.46 155.09 45.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.236 0.541 . . . . 75.340000000000003 111.956 -173.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 m -86.81 135.8 33.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.312 -0.858 . . . . 73.299999999999997 111.011 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.445 HD13 ' CD2' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -160.36 158.38 29.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.324 -0.398 . . . . 52.43 110.197 175.661 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.8 t -102.76 123.77 47.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.452 0.644 . . . . 73.420000000000002 111.62 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.445 ' CD2' HD13 ' A' ' 63' ' ' LEU . 4.1 mm? -112.64 158.0 20.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.924 -1.035 . . . . 73.349999999999994 108.812 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -86.51 159.35 19.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.057 0.455 . . . . 73.450000000000003 110.521 -175.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.52 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 0.9 OUTLIER -58.95 -28.74 66.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.682 -0.69 . . . . 74.200000000000003 110.026 176.441 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.5 m -59.2 -46.73 87.66 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.126 -0.488 . . . . 60.009999999999998 111.248 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -68.43 -41.99 79.56 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.186 0.517 . . . . 74.140000000000001 110.241 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.64 -21.55 64.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.661 -0.699 . . . . 65.340000000000003 111.304 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.538 ' HA ' ' OD1' ' A' ' 8' ' ' ASN . 54.2 tttm -79.4 -18.43 52.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.348 -0.387 . . . . 73.420000000000002 110.9 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.498 ' HB3' HD11 ' A' ' 31' ' ' ILE . 4.1 t70 -97.25 -9.8 27.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.246 0.546 . . . . 74.409999999999997 110.582 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.413 HG12 HD13 ' A' ' 31' ' ' ILE . 58.4 mt -96.78 121.99 47.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.982 -0.554 . . . . 74.239999999999995 110.481 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.8 mt -99.34 118.65 36.45 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.865 -0.42 . . . . 61.450000000000003 109.865 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.551 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 24.1 m -124.26 159.14 30.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.423 0.63 . . . . 65.400000000000006 112.474 -173.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.869 ' HB3' HD11 ' A' ' 19' ' ' ILE . 9.3 pt-20 -111.89 138.54 48.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.215 -0.902 . . . . 61.399999999999999 110.147 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.553 ' HA ' HG12 ' A' ' 16' ' ' VAL . 43.2 t -75.06 121.49 26.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.404 -0.362 . . . . 72.25 110.267 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.741 HD11 ' HB2' ' A' ' 17' ' ' LYS . 82.2 mt -99.37 -25.07 14.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.313 0.578 . . . . 71.340000000000003 111.313 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.418 HD12 ' H ' ' A' ' 15' ' ' LYS . 37.6 mt -96.29 113.93 25.57 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.595 -0.73 . . . . 65.430000000000007 112.405 -174.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -142.83 115.11 8.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.59 -0.732 . . . . 73.219999999999999 109.247 168.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -149.23 -75.64 0.16 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.621 -0.511 . . . . 71.329999999999998 109.621 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -173.16 83.86 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.801 -0.814 . . . . 64.530000000000001 108.801 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -54.4 134.1 45.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.25 -0.886 . . . . 71.340000000000003 112.339 -170.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.81 121.12 18.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.26 -0.882 . . . . 74.150000000000006 109.962 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -92.52 -7.87 46.08 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.702 -0.399 . . . . 73.349999999999994 110.653 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.9 m170 . . . . . 0 C--O 1.246 0.919 0 CA-C-O 118.577 -0.725 . . . . 74.109999999999999 109.229 171.908 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.795 0.331 . . . . 61.350000000000001 110.576 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.681 HG21 HG12 ' A' ' 77' ' ' VAL . 25.7 m -66.26 137.86 57.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.347 -0.388 . . . . 64.099999999999994 110.226 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.3 148.86 29.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.295 -0.411 . . . . 75.019999999999996 110.635 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.21 112.02 3.43 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.869 -0.681 . . . . 73.439999999999998 112.453 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 pt -105.45 171.77 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.451 -0.574 . . . . 64.219999999999999 109.451 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.02 156.35 35.96 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 119.974 -1.108 . . . . 60.399999999999999 111.717 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.589 HD23 HG11 ' A' ' 75' ' ' VAL . 3.0 tm? -59.88 -26.52 65.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.508 0.67 . . . . 73.329999999999998 109.718 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.56 ' HB2' ' HG2' ' A' ' 67' ' ' LYS . 9.2 p30 -73.23 -8.94 57.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.499 -0.773 . . . . 65.310000000000002 111.417 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -103.47 1.0 31.84 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.496 -0.32 . . . . 73.409999999999997 111.612 -174.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 11' ' ' GLU . 20.9 t -81.54 157.31 4.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 61.119999999999997 111.501 -174.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.408 ' N ' HG12 ' A' ' 10' ' ' VAL . 8.0 tp10 -80.59 164.77 22.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.25 -0.886 . . . . 73.439999999999998 110.127 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.0 pt -79.25 138.09 20.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.102 -0.499 . . . . 71.239999999999995 111.116 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt 59.69 44.17 14.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.534 -0.757 . . . . 73.540000000000006 111.422 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.8 t -113.67 171.13 7.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.406 -0.815 . . . . 72.230000000000004 109.692 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -129.02 113.31 15.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.207 -0.451 . . . . 65.540000000000006 109.886 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 77' ' ' VAL . 18.4 m -123.01 160.35 25.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.449 0.642 . . . . 64.219999999999999 112.252 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -106.75 144.09 33.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.747 -1.115 . . . . 74.109999999999999 110.303 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.5 t -86.12 104.05 13.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.049 -0.523 . . . . 71.519999999999996 109.731 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.6 mt -59.37 -49.46 83.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.541 -0.754 . . . . 74.209999999999994 110.33 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.24 175.34 43.52 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.777 -0.725 . . . . 54.229999999999997 112.438 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.663 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 22.0 mt -97.6 159.79 3.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.307 -0.627 . . . . 64.219999999999999 109.307 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.42 90.84 1.27 Allowed Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 109.555 -0.535 . . . . 73.409999999999997 109.555 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.945 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 33.1 Cg_exo -58.19 167.25 4.79 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.932 3.088 . . . . 75.450000000000003 114.165 -170.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 64.59 15.99 10.02 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.79 -1.096 . . . . 71.400000000000006 110.828 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.584 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 23.3 t -87.5 165.12 15.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.607 -0.724 . . . . 73.430000000000007 110.067 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -21.83 46.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.944 -0.391 . . . . 63.340000000000003 109.944 175.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 31' ' ' ILE . 35.2 m -104.74 -3.69 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.285 -0.416 . . . . 71.400000000000006 111.554 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.945 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 3.6 tmm_? -50.73 -51.6 48.35 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.093 0.245 . . . . 61.520000000000003 110.929 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -63.85 -45.63 88.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.59 -0.277 . . . . 74.030000000000001 110.535 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -50.45 -53.48 29.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 52.43 111.129 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.553 HD12 HD11 ' A' ' 73' ' ' ILE . 46.7 mm -58.68 -47.81 87.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.631 -0.713 . . . . 74.510000000000005 111.752 -177.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.607 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 4.6 ppp? -73.86 -28.17 61.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.916 0.388 . . . . 61.420000000000002 111.072 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.89 -28.65 64.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.276 0.56 . . . . 75.219999999999999 109.883 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 81.0 mtp -81.49 1.03 35.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.294 -0.866 . . . . 75.439999999999998 111.44 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.66 -7.53 53.53 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.616 -0.802 . . . . 71.329999999999998 113.132 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 32' ' ' MET . 21.6 mt -84.08 130.36 36.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.772 0.32 . . . . 61.039999999999999 110.232 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.612 HG23 ' H ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -148.05 -85.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.182 -0.463 . . . . 61.140000000000001 111.473 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.612 ' H ' HG23 ' A' ' 37' ' ' VAL . 17.9 mtp180 -145.44 131.23 19.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.232 -0.44 . . . . 75.319999999999993 109.922 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.03 -4.08 86.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.567 -0.825 . . . . 60.25 112.156 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 m -64.29 144.07 57.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.607 -0.516 . . . . 41.100000000000001 109.607 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -117.47 133.93 55.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.968 0.413 . . . . 74.209999999999994 110.94 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.854 HG12 HD13 ' A' ' 58' ' ' LEU . 74.4 mt -119.68 136.06 58.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.599 -0.728 . . . . 73.049999999999997 111.312 -174.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -98.12 116.43 30.32 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.727 -0.471 . . . . 52.140000000000001 109.727 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.532 HD11 HD21 ' A' ' 7' ' ' LEU . 50.5 mm -82.64 104.61 11.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.623 -0.51 . . . . 62.409999999999997 109.623 177.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -76.85 -34.03 57.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.91 0.386 . . . . 74.140000000000001 110.724 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.35 171.56 31.72 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.564 -0.827 . . . . 64.230000000000004 112.196 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.609 ' HG2' HG23 ' A' ' 54' ' ' ILE . 40.6 mtmt -124.39 148.63 47.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.012 -0.736 . . . . 75.409999999999997 109.012 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.47 156.94 49.59 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.093 -0.336 . . . . 74.219999999999999 110.093 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.65 -14.17 25.04 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.525 2.15 . . . . 63.009999999999998 112.456 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.9 mtt -93.76 -6.17 46.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 73.400000000000006 110.205 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.67 -10.37 59.84 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.378 -0.689 . . . . 55.5 111.378 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -145.43 133.01 10.33 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 108.981 -0.748 . . . . 60.340000000000003 108.981 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -84.7 -172.32 9.18 Favored 'Cis proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.341 -1.524 . . . . 52.219999999999999 112.866 -0.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.609 HG23 ' HG2' ' A' ' 47' ' ' LYS . 59.4 mt -114.21 142.07 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.232 -0.44 . . . . 72.129999999999995 110.11 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.07 115.55 30.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.071 0.462 . . . . 75.519999999999996 110.415 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.644 HD23 HG21 ' A' ' 42' ' ' ILE . 5.7 mp -113.13 156.42 23.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.968 -0.56 . . . . 71.519999999999996 110.327 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 16.4 ttm180 -119.08 106.73 12.69 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.18 -1.044 . . . . 64.230000000000004 108.18 167.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.854 HD13 HG12 ' A' ' 42' ' ' ILE . 41.8 tp -137.36 146.75 44.9 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.579 -0.737 . . . . 73.310000000000002 110.219 -173.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.443 ' HD3' ' OH ' ' A' ' 61' ' ' TYR . 53.1 ttt180 65.67 12.48 8.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.37 -0.832 . . . . 71.239999999999995 110.646 176.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.5 -12.12 36.04 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 121.009 -0.615 . . . . 61.030000000000001 113.116 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.443 ' OH ' ' HD3' ' A' ' 59' ' ' ARG . 27.4 p90 -134.52 155.85 49.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.635 0.731 . . . . 53.140000000000001 112.448 -177.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -79.96 143.26 34.32 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.933 -1.03 . . . . 74.5 110.974 175.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -157.57 151.31 24.09 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.255 -0.646 . . . . 72.129999999999995 109.255 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -113.95 134.15 55.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.07 0.462 . . . . 65.230000000000004 110.952 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 pp -133.13 167.09 20.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.671 -0.695 . . . . 75.140000000000001 109.697 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -77.71 148.53 34.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.202 0.525 . . . . 71.319999999999993 111.766 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.56 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 14.8 tmtt? -62.31 -35.52 79.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.197 -0.911 . . . . 64.019999999999996 111.355 -176.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 60.2 m -67.86 -30.77 70.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.689 0.255 . . . . 73.049999999999997 111.689 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.25 -31.82 55.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.153 0.502 . . . . 61.539999999999999 109.809 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' A' ' 7' ' ' LEU . . . -65.51 -21.53 66.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.758 -0.656 . . . . 72.040000000000006 110.712 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.47 ' HE3' ' HB3' ' A' ' 71' ' ' LYS . 0.9 OUTLIER -69.55 -30.87 68.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.853 -0.612 . . . . 73.230000000000004 110.44 176.584 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.8 2.63 22.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.046 -0.525 . . . . 73.239999999999995 111.399 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.553 HD11 HD12 ' A' ' 31' ' ' ILE . 59.5 mt -115.98 114.96 47.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.99 -0.55 . . . . 74.5 109.81 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.0 mt -94.71 121.9 36.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.338 -0.392 . . . . 71.310000000000002 110.079 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.589 HG11 HD23 ' A' ' 7' ' ' LEU . 30.3 m -120.98 158.89 23.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.78 0.8 . . . . 63.399999999999999 112.424 -173.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.94 126.58 47.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.444 -1.253 . . . . 73.140000000000001 109.206 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.681 HG12 HG21 ' A' ' 2' ' ' THR . 11.0 p -74.59 127.07 36.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.902 -0.59 . . . . 74.200000000000003 110.51 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.2 mt -92.71 -11.23 34.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.341 0.591 . . . . 71.239999999999995 110.898 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.1 tt -81.48 79.54 8.06 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.697 -0.683 . . . . 54.43 109.24 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.84 82.16 2.37 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.363 -0.835 . . . . 74.329999999999998 109.718 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -84.7 -47.71 10.19 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.413 -1.329 . . . . 72.340000000000003 107.413 172.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -155.79 130.66 9.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.218 -1.355 . . . . 73.409999999999997 108.148 167.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -58.27 -22.24 51.78 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.215 0.322 . . . . 72.219999999999999 110.914 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 t60 67.89 89.27 0.1 Allowed 'General case' 0 C--O 1.23 0.071 0 CA-C-N 115.842 -0.617 . . . . 74.019999999999996 111.679 166.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -86.69 -39.08 16.38 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.55 -0.537 . . . . 74.120000000000005 109.55 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.0 m170 . . . . . 0 C--O 1.244 0.799 0 CA-C-N 115.379 -0.828 . . . . 61.009999999999998 109.536 175.585 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 110.069 -0.345 . . . . 70.120000000000005 110.069 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.2 p -75.6 82.54 2.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.668 0.747 . . . . 61.149999999999999 111.411 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -112.89 78.71 1.15 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.337 -0.847 . . . . 71.549999999999997 109.609 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 76' ' ' GLU . . . -120.12 125.83 6.44 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.034 -0.984 . . . . 74.040000000000006 111.956 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.3 pt -133.03 179.49 4.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.782 -0.451 . . . . 74.25 109.782 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.17 151.01 48.2 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.263 -0.97 . . . . 40.119999999999997 111.008 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.58 HD11 HD21 ' A' ' 56' ' ' LEU . 3.1 tm? -57.06 -33.15 66.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 42.409999999999997 110.461 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -77.13 -10.15 59.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.33 -0.396 . . . . 71.329999999999998 111.762 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.37 -9.81 37.47 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.975 0.417 . . . . 64.230000000000004 110.953 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.6 t -77.94 159.42 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.973 -0.558 . . . . 75.140000000000001 110.406 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 29.9 tt0 -103.42 173.97 6.07 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.146 -0.316 . . . . 73.510000000000005 110.146 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.585 HG22 ' HA2' ' A' ' 46' ' ' GLY . 40.2 pt -72.99 153.78 7.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 112.21 0.448 . . . . 71.25 112.21 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 51.4 49.24 21.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.194 -0.912 . . . . 72.439999999999998 111.998 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.473 ' HA ' HD12 ' A' ' 79' ' ' LEU . 17.9 m -134.06 152.8 52.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.282 -0.872 . . . . 73.519999999999996 109.001 174.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -109.34 140.85 42.5 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.318 -0.553 . . . . 74.540000000000006 110.254 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 77' ' ' VAL . 29.3 m -132.57 174.86 12.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.793 -0.639 . . . . 61.109999999999999 110.677 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.405 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 84.3 tttt -134.34 139.11 45.42 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.0 -0.546 . . . . 73.140000000000001 110.324 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.688 ' HA ' HG12 ' A' ' 75' ' ' VAL . 35.0 t -75.54 93.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.428 -0.805 . . . . 72.340000000000003 110.257 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.531 HD11 ' OE2' ' A' ' 76' ' ' GLU . 47.9 mm -80.94 -56.8 5.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.553 -0.749 . . . . 73.409999999999997 111.312 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.86 158.97 22.84 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.23 -0.986 . . . . 42.43 112.908 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.651 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 68.7 mt -127.43 156.34 39.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.757 -0.831 . . . . 73.519999999999996 108.757 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.5 t -103.14 90.21 2.36 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 120.748 0.309 . . . . 74.25 110.33 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.651 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 29.2 Cg_exo -61.18 171.51 3.95 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.147 2.565 . . . . 63.109999999999999 112.441 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 63.81 21.14 12.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.873 -0.603 . . . . 63.329999999999998 111.007 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.795 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 22.6 t -88.54 153.39 21.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.907 -0.588 . . . . 70.340000000000003 109.702 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -93.28 -3.1 54.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.901 0.382 . . . . 73.219999999999999 110.069 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.509 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 32.8 m -113.5 -2.42 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 116.145 -0.479 . . . . 73.209999999999994 110.537 174.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.795 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 15.0 ttp180 -54.09 -42.4 69.33 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.927 0.394 . . . . 73.329999999999998 110.285 175.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.52 -38.96 92.0 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 115.98 -0.555 . . . . 64.439999999999998 110.958 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.667 ' HG2' ' OE2' ' A' ' 69' ' ' GLU . 21.1 tptm -55.41 -54.02 48.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.294 0.568 . . . . 71.129999999999995 110.363 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.696 HG23 HD12 ' A' ' 36' ' ' ILE . 65.3 mt -62.78 -40.98 90.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.055 -0.975 . . . . 74.519999999999996 110.939 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ttt -67.65 -32.4 73.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.968 -0.56 . . . . 75.530000000000001 110.985 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -73.12 -26.29 61.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.083 -0.508 . . . . 73.150000000000006 110.114 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 60.9 mtt -69.12 -27.66 65.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.4 0.619 . . . . 61.450000000000003 110.167 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.08 18.82 11.51 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.641 -0.709 . . . . 54.509999999999998 112.12 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.696 HD12 HG23 ' A' ' 31' ' ' ILE . 39.5 mt -88.93 124.27 41.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.162 0.506 . . . . 54.520000000000003 110.118 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.01 161.12 41.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.349 -0.841 . . . . 75.129999999999995 109.438 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -64.23 121.57 14.58 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.201 -0.296 . . . . 44.43 110.201 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.97 -20.32 11.63 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.866 -0.683 . . . . 74.319999999999993 111.929 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.4 m -72.92 147.97 44.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.199 -0.297 . . . . 72.400000000000006 110.199 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -105.85 144.86 31.98 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.786 -0.45 . . . . 53.530000000000001 109.786 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.658 HG21 HD23 ' A' ' 56' ' ' LEU . 73.0 mt -129.89 128.53 65.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.209 -0.45 . . . . 63.25 111.213 -174.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.547 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 69.4 t80 -96.69 108.08 20.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.145 -0.48 . . . . 71.209999999999994 109.866 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.469 HD11 HD21 ' A' ' 7' ' ' LEU . 46.3 mm -75.68 111.75 12.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.92 -0.4 . . . . 44.210000000000001 109.92 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -73.59 -53.25 10.93 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.636 -0.505 . . . . 62.520000000000003 109.636 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.585 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 179.23 177.54 47.74 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.396 -0.82 . . . . 70.310000000000002 111.772 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -123.02 143.22 50.09 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.283 -0.636 . . . . 74.329999999999998 109.283 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.402 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -59.99 156.59 36.06 Favored Pre-proline 0 C--N 1.326 -0.421 0 O-C-N 123.186 0.304 . . . . 73.239999999999995 110.206 177.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.402 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 10.6 Cg_endo -54.41 -24.85 37.07 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.096 2.53 . . . . 70.209999999999994 113.105 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.5 mtt -84.41 -13.33 52.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.117 0.484 . . . . 72.299999999999997 110.796 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.82 -2.68 80.26 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.338 -0.705 . . . . 43.450000000000003 111.338 -173.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.753 ' HB2' ' HB2' ' A' ' 67' ' ' LYS . 5.4 t70 -151.15 135.17 9.46 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.267 -0.642 . . . . 74.310000000000002 109.267 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -82.67 179.91 25.14 Favored 'Cis proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.564 -1.432 . . . . 74.409999999999997 112.436 -1.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 54' ' ' ILE . 4.5 mp -109.02 141.71 23.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.327 -0.62 . . . . 55.420000000000002 109.327 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.84 113.38 26.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.985 0.421 . . . . 63.0 110.834 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.658 HD23 HG21 ' A' ' 42' ' ' ILE . 2.2 mp -117.43 133.85 55.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.04 -0.527 . . . . 72.219999999999999 110.201 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.704 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 46.3 ttt180 -97.47 105.48 17.63 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.887 -0.782 . . . . 72.349999999999994 108.887 173.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.557 ' HB3' HG12 ' A' ' 42' ' ' ILE . 3.3 pp -139.86 151.71 45.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.279 -0.419 . . . . 73.329999999999998 110.75 -174.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 71.44 -19.93 0.24 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.065 0.546 . . . . 73.109999999999999 111.703 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 150.58 -26.65 1.07 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.27 -0.49 . . . . 51.109999999999999 112.212 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -140.85 166.86 23.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.001 0.429 . . . . 74.5 111.182 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.704 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.3 m -85.58 138.45 32.17 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.107 -0.497 . . . . 61.43 111.871 -176.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.9 mt -134.54 159.06 42.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.558 -0.746 . . . . 75.25 109.471 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p -104.73 122.2 45.2 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.154 0.502 . . . . 74.099999999999994 111.361 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.9 tp -109.19 145.47 35.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.861 -0.609 . . . . 62.539999999999999 109.504 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -77.53 149.3 34.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.601 0.239 . . . . 75.140000000000001 110.541 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.753 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 13.3 tmtt? -57.81 -36.96 72.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 62.43 110.646 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.3 m -62.84 -48.1 80.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.97 -0.559 . . . . 51.200000000000003 110.49 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.667 ' OE2' ' HG2' ' A' ' 30' ' ' LYS . 36.9 mt-10 -67.13 -30.96 71.1 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.788 -0.642 . . . . 73.409999999999997 110.551 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.68 -21.26 62.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.316 -0.856 . . . . 62.140000000000001 111.876 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -81.31 -23.73 37.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.926 0.394 . . . . 75.219999999999999 110.532 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.34 -5.45 47.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.073 -0.512 . . . . 52.240000000000002 111.445 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.534 HG22 HG13 ' A' ' 75' ' ' VAL . 43.8 mm -122.22 126.22 73.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.516 -0.311 . . . . 71.219999999999999 110.772 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.1 mt -108.15 120.79 43.36 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.052 -0.522 . . . . 72.540000000000006 109.969 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 18' ' ' VAL . 22.0 m -126.47 151.26 32.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.127 -0.488 . . . . 71.439999999999998 111.531 -173.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.531 ' OE2' HD11 ' A' ' 19' ' ' ILE . 14.6 pt-20 -91.39 138.78 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.437 -0.579 . . . . 73.530000000000001 109.437 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.663 ' HA ' HG12 ' A' ' 16' ' ' VAL . 24.3 t -87.64 109.9 20.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 120.916 0.388 . . . . 63.450000000000003 110.454 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.3 mt -78.56 -25.59 45.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.318 0.58 . . . . 45.539999999999999 110.695 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 14' ' ' SER . 62.4 mt -111.51 83.94 1.86 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.543 -0.753 . . . . 52.310000000000002 110.993 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -136.3 130.94 33.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.685 -0.689 . . . . 75.140000000000001 109.389 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -134.29 89.18 2.53 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.692 -0.855 . . . . 65.540000000000006 108.692 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -49.14 109.82 0.3 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.069 -0.969 . . . . 72.209999999999994 113.601 -169.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -135.74 -80.66 0.42 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.07 -0.968 . . . . 75.319999999999993 109.605 169.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -102.16 58.94 0.82 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.371 -0.603 . . . . 63.530000000000001 109.371 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -164.64 102.01 0.81 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.572 -0.74 . . . . 74.329999999999998 110.443 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.3 p80 . . . . . 0 C--O 1.245 0.862 0 CA-C-O 118.122 -0.942 . . . . 62.130000000000003 109.867 175.915 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.0 ttp . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.854 -0.424 . . . . 60.119999999999997 109.854 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.5 m -96.64 132.07 42.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.615 -0.513 . . . . 62.409999999999997 109.615 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -126.82 98.12 5.24 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.849 -0.426 . . . . 72.120000000000005 109.849 -176.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.482 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . -67.03 108.71 2.55 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.787 -0.642 . . . . 64.129999999999995 112.812 -177.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.4 pt -101.67 160.83 3.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.614 -0.513 . . . . 63.210000000000001 109.614 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.01 147.53 30.59 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.142 -1.028 . . . . 54.310000000000002 111.283 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.726 HD11 HD11 ' A' ' 44' ' ' ILE . 36.9 tp -60.01 -26.81 66.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.017 0.437 . . . . 73.219999999999999 110.853 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -78.14 -9.8 59.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.148 -0.478 . . . . 73.010000000000005 111.011 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -90.34 -13.96 34.08 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.16 0.505 . . . . 75.420000000000002 109.932 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.5 t -77.86 154.88 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.613 -0.721 . . . . 71.140000000000001 110.49 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -103.76 170.87 7.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.741 -0.663 . . . . 73.409999999999997 110.278 -175.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.3 pt -71.72 146.91 11.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.012 -0.54 . . . . 72.439999999999998 111.116 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 13' ' ' LYS . 33.7 ttmt 59.04 63.96 1.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.8 0.81 . . . . 75.519999999999996 110.333 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 m -136.0 151.2 49.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.034 -0.985 . . . . 63.420000000000002 109.836 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -118.14 110.88 18.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.136 0.493 . . . . 72.519999999999996 110.017 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 77' ' ' VAL . 27.0 m -123.69 167.38 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.719 -0.673 . . . . 70.010000000000005 111.801 -173.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.619 ' HB2' HD21 ' A' ' 78' ' ' LEU . 81.0 tttt -117.96 145.83 44.42 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.094 -0.957 . . . . 61.329999999999998 110.126 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.594 ' HA ' HG12 ' A' ' 75' ' ' VAL . 45.9 t -82.15 97.96 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.131 -0.486 . . . . 65.099999999999994 110.266 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.872 HD11 ' HB2' ' A' ' 76' ' ' GLU . 42.6 mt -61.03 -48.59 88.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.816 -0.629 . . . . 70.439999999999998 109.991 175.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.68 160.73 31.03 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.489 -0.778 . . . . 62.030000000000001 112.31 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.701 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 58.5 mt -98.04 157.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.164 -0.68 . . . . 73.150000000000006 109.164 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.9 t -102.45 89.71 1.85 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 120.982 0.42 . . . . 72.340000000000003 110.144 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.932 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 21.1 Cg_exo -64.93 170.05 10.86 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.026 2.484 . . . . 71.510000000000005 112.367 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 64.25 7.55 3.59 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.638 -0.71 . . . . 75.239999999999995 111.879 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 28' ' ' ARG . 1.3 m -91.7 154.19 19.15 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.648 -0.871 . . . . 75.140000000000001 108.648 170.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -69.61 -45.59 68.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.702 0.287 . . . . 62.329999999999998 111.065 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.544 ' HB ' ' HG3' ' A' ' 69' ' ' GLU . 24.5 m -78.03 -6.79 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.065 0.46 . . . . 62.439999999999998 110.815 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.932 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -57.07 -36.7 70.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.682 -0.69 . . . . 65.049999999999997 111.373 178.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -67.23 -39.27 86.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.117 0.484 . . . . 51.539999999999999 110.007 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 34' ' ' MET . 85.3 tttt -63.12 -46.67 86.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.384 -0.826 . . . . 72.239999999999995 110.107 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 27' ' ' VAL . 68.9 mt -57.55 -48.2 83.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.603 -0.726 . . . . 71.319999999999993 111.445 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.61 -37.19 85.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.958 0.409 . . . . 60.310000000000002 110.81 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.26 -30.99 69.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 61.409999999999997 110.562 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 62.0 mtt -58.6 -32.29 68.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.047 -0.524 . . . . 71.230000000000004 110.887 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.41 1.82 7.71 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.617 -0.802 . . . . 64.530000000000001 112.208 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.456 HG23 HG21 ' A' ' 18' ' ' VAL . 63.1 mt -84.65 133.1 30.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.873 0.368 . . . . 64.319999999999993 110.31 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.748 HG23 ' H ' ' A' ' 38' ' ' ARG . 1.4 m -129.04 -74.86 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.911 -0.586 . . . . 74.109999999999999 111.03 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.748 ' H ' HG23 ' A' ' 37' ' ' VAL . 49.2 ttp180 -169.12 138.29 2.09 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.22 -0.659 . . . . 73.299999999999997 109.22 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.04 17.22 77.0 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.578 -0.82 . . . . 42.109999999999999 111.671 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 m -81.44 151.03 28.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.936 -0.394 . . . . 72.519999999999996 109.936 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -95.62 133.32 39.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.898 0.38 . . . . 63.350000000000001 110.728 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.4 mt -123.55 116.06 47.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.803 -0.635 . . . . 62.310000000000002 110.381 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.528 ' HE2' ' HG2' ' A' ' 45' ' ' GLU . 44.5 t80 -95.15 108.06 20.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.007 -0.542 . . . . 73.430000000000007 109.569 174.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.726 HD11 HD11 ' A' ' 7' ' ' LEU . 49.1 mm -75.3 105.87 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.119 -0.697 . . . . 71.349999999999994 109.119 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.528 ' HG2' ' HE2' ' A' ' 43' ' ' TYR . 0.4 OUTLIER -73.83 -61.14 1.95 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.123 -0.695 . . . . 72.239999999999995 109.123 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.01 162.56 35.9 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.649 -0.786 . . . . 70.239999999999995 112.203 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -125.52 153.0 44.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.202 -0.666 . . . . 70.349999999999994 109.202 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.72 156.42 89.12 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.589 -0.522 . . . . 72.340000000000003 109.589 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.68 -35.39 57.37 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.701 2.267 . . . . 75.109999999999999 112.574 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 tpt -65.43 -22.85 66.81 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.182 0.515 . . . . 71.519999999999996 111.264 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.27 -2.98 63.67 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 111.024 -0.831 . . . . 40.5 111.024 -174.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -143.32 132.75 11.71 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.996 -0.742 . . . . 72.019999999999996 108.996 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -89.56 176.63 20.01 Favored 'Cis proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.704 -1.373 . . . . 74.019999999999996 113.023 0.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 64' ' ' SER . 4.6 mp -105.75 130.97 56.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.728 -0.669 . . . . 65.430000000000007 109.804 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.66 113.6 26.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.501 -0.318 . . . . 74.239999999999995 110.248 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.635 HD21 HD21 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -129.49 172.15 11.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.459 -0.337 . . . . 74.420000000000002 110.938 -178.029 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.677 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 35.4 ttm180 -129.23 117.24 20.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.841 -0.429 . . . . 71.540000000000006 109.841 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.547 ' H ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -135.95 148.7 48.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.54 -0.3 . . . . 71.319999999999993 110.58 -177.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.6 tpt85 69.09 -19.59 0.17 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.22 0.608 . . . . 72.219999999999999 111.997 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 143.34 -24.27 2.2 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.606 -0.598 . . . . 41.240000000000002 111.606 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -115.49 156.76 25.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.098 0.475 . . . . 71.530000000000001 111.401 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 46.7 t -93.8 146.81 23.61 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.751 -0.659 . . . . 61.43 110.477 176.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.3 mt -144.82 160.25 41.57 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.284 -0.871 . . . . 61.32 109.571 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 35.8 t -118.89 128.04 54.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.679 -0.489 . . . . 54.439999999999998 109.679 176.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.635 HD21 HD21 ' A' ' 56' ' ' LEU . 2.0 pp -125.94 166.91 16.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.251 -0.432 . . . . 72.019999999999996 111.268 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.58 163.11 24.9 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.562 -0.745 . . . . 73.010000000000005 111.191 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.81 -22.39 64.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.404 -0.816 . . . . 62.119999999999997 109.998 174.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.2 m -66.14 -50.97 62.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.815 -0.629 . . . . 75.209999999999994 110.99 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.544 ' HG3' ' HB ' ' A' ' 27' ' ' VAL . 1.6 mp0 -58.26 -40.73 82.59 Favored 'General case' 0 N--CA 1.46 0.066 0 CA-C-O 121.075 0.464 . . . . 71.439999999999998 110.359 175.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HA ' ' HB3' ' A' ' 7' ' ' LEU . . . -62.03 -21.66 65.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.85 -0.614 . . . . 61.210000000000001 111.511 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' A' ' 71' ' ' LYS . 1.2 tmmt? -83.25 -32.29 26.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.285 -0.416 . . . . 65.299999999999997 110.633 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -96.95 9.33 42.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.285 0.476 . . . . 73.030000000000001 112.285 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.52 HG22 HG13 ' A' ' 75' ' ' VAL . 79.9 mt -113.24 120.85 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.22 -0.289 . . . . 72.329999999999998 110.22 174.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.0 mt -105.56 121.37 43.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.251 -0.431 . . . . 70.409999999999997 109.95 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.594 HG12 ' HA ' ' A' ' 18' ' ' VAL . 23.6 m -132.54 174.59 13.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.027 -0.533 . . . . 73.129999999999995 111.643 -174.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.872 ' HB2' HD11 ' A' ' 19' ' ' ILE . 35.4 tt0 -143.14 145.08 32.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.271 -0.877 . . . . 52.409999999999997 108.891 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.687 HG22 ' H ' ' A' ' 79' ' ' LEU . 11.1 p -71.92 141.01 17.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.0 0.429 . . . . 71.340000000000003 110.661 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' A' ' 17' ' ' LYS . 68.1 mt -85.75 -0.18 54.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.116 -0.493 . . . . 73.239999999999995 111.527 -178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.687 ' H ' HG22 ' A' ' 77' ' ' VAL . 3.9 tt -72.46 90.24 1.3 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.702 -0.681 . . . . 75.209999999999994 110.147 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 68.51 120.25 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 O-C-N 124.126 0.891 . . . . 74.549999999999997 111.153 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -83.66 35.34 0.51 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.043 -0.526 . . . . 73.349999999999994 110.89 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -136.25 121.99 19.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.239 -0.652 . . . . 72.439999999999998 109.239 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -88.84 104.29 16.79 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.37 0.605 . . . . 63.539999999999999 111.726 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -87.62 75.64 9.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.37 -0.832 . . . . 64.239999999999995 109.19 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -79.09 -3.19 44.15 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.681 -0.69 . . . . 74.430000000000007 112.148 -173.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.267 -0.873 . . . . 75.310000000000002 109.696 173.188 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.496 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.767 -0.457 . . . . 64.310000000000002 109.767 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.8 m -79.33 105.58 10.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.914 0.388 . . . . 75.409999999999997 111.207 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -138.63 120.44 15.34 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.627 -0.508 . . . . 74.420000000000002 109.627 174.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.92 145.49 16.19 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.445 -0.883 . . . . 74.340000000000003 112.154 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.1 pt -109.84 169.91 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.757 -0.46 . . . . 72.230000000000004 109.757 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.95 158.21 46.14 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.11 -1.043 . . . . 65.230000000000004 111.294 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.3 tp -65.81 -18.39 65.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.761 0.315 . . . . 61.130000000000003 111.214 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 33.8 p30 -92.63 0.16 57.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.797 0.332 . . . . 53.210000000000001 111.311 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.48 5.98 31.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.926 0.393 . . . . 65.420000000000002 110.684 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 t -88.72 157.34 3.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.01 0.433 . . . . 54.130000000000003 110.951 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -101.74 164.55 11.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.663 -0.698 . . . . 71.109999999999999 110.166 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.439 HG22 ' HA2' ' A' ' 46' ' ' GLY . 36.2 pt -75.87 166.53 2.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.951 -0.568 . . . . 63.109999999999999 111.16 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.3 mttm 65.91 9.42 6.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.783 -0.644 . . . . 74.5 111.41 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 m -111.7 148.23 33.88 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.226 -0.443 . . . . 71.019999999999996 110.811 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 41' ' ' GLU . 81.9 tttt -105.73 123.93 48.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.812 -0.631 . . . . 74.129999999999995 109.496 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 77' ' ' VAL . 21.5 m -119.17 167.81 12.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.132 -0.485 . . . . 72.329999999999998 110.57 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.578 ' HB2' HD21 ' A' ' 78' ' ' LEU . 84.3 tttt -133.58 141.12 47.54 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.768 -0.651 . . . . 73.420000000000002 109.982 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.591 ' HA ' HG12 ' A' ' 75' ' ' VAL . 43.4 t -76.52 95.74 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.377 -0.829 . . . . 73.310000000000002 110.2 -177.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.79 HD11 ' HB2' ' A' ' 76' ' ' GLU . 36.2 mt -57.46 -49.83 79.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.569 -0.741 . . . . 62.340000000000003 109.639 174.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.594 ' HA2' ' HG2' ' A' ' 38' ' ' ARG . . . -173.26 164.57 36.44 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.659 -0.781 . . . . 62.229999999999997 112.622 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.701 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 37.9 mt -85.38 158.97 3.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.733 -0.84 . . . . 74.519999999999996 108.733 176.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.3 91.71 1.84 Allowed Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.679 -0.489 . . . . 61.420000000000002 109.679 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.701 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 72.1 Cg_exo -49.62 169.08 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 124.226 3.284 . . . . 70.409999999999997 114.073 -173.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 66.27 19.93 11.04 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.953 -1.021 . . . . 73.430000000000007 109.302 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 1.032 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 42.1 t -84.03 152.06 24.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.489 -1.232 . . . . 61.140000000000001 110.248 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.598 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 11.1 mptt -98.11 -23.56 15.68 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.159 -0.682 . . . . 65.200000000000003 109.159 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -97.25 -7.81 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.559 -0.746 . . . . 62.420000000000002 111.039 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 1.032 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 8.4 tmm_? -46.77 -47.92 20.71 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.079 0.4 . . . . 75.209999999999994 112.079 176.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -70.27 -28.47 65.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.962 0.41 . . . . 64.329999999999998 110.455 -177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -73.46 -48.26 34.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.726 -0.67 . . . . 50.399999999999999 110.364 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.54 HD13 HD11 ' A' ' 73' ' ' ILE . 85.7 mt -60.5 -42.1 90.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.525 -0.761 . . . . 53.100000000000001 111.182 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ttt -65.9 -30.1 70.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 60.329999999999998 110.579 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.75 -32.88 70.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.889 -0.596 . . . . 54.119999999999997 110.146 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.8 mtt -63.24 -29.07 70.48 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.934 -0.576 . . . . 72.109999999999999 110.43 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.5 5.1 12.92 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.79 -0.641 . . . . 74.439999999999998 112.365 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.507 ' HB ' HG22 ' A' ' 31' ' ' ILE . 43.3 mt -90.42 126.59 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.992 0.425 . . . . 72.150000000000006 110.436 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.1 m -141.1 -177.67 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.489 -0.778 . . . . 65.319999999999993 110.268 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.594 ' HG2' ' HA2' ' A' ' 20' ' ' GLY . 46.0 mtt85 -69.78 114.75 8.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 72.420000000000002 110.313 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.39 -8.67 22.5 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.534 -0.841 . . . . 63.140000000000001 112.812 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 m -70.41 142.69 52.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.041 0.448 . . . . 72.420000000000002 110.412 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.402 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 47.0 mt-10 -106.45 137.47 44.37 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.61 -0.723 . . . . 72.129999999999995 110.218 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.763 HG12 ' HB3' ' A' ' 58' ' ' LEU . 66.1 mt -129.5 131.41 67.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.71 -0.677 . . . . 71.25 111.293 -172.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.536 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 53.3 t80 -96.95 125.9 41.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.696 -0.483 . . . . 64.109999999999999 109.696 171.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.6 mm -87.24 99.48 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.574 -0.528 . . . . 73.230000000000004 109.574 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.15 -41.94 24.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.653 -0.703 . . . . 65.019999999999996 110.497 -176.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.439 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 172.74 -172.91 45.32 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.432 -0.667 . . . . 34.009999999999998 111.432 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.881 ' HE2' ' HA2' ' A' ' 51' ' ' GLY . 13.9 ptmt -151.0 165.89 32.36 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.246 -0.65 . . . . 73.030000000000001 109.246 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.47 156.42 82.23 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.771 -0.455 . . . . 64.010000000000005 109.771 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.49 -32.14 51.71 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.797 2.331 . . . . 74.540000000000006 113.086 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 45.5 ttm -86.6 -8.67 57.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.426 0.631 . . . . 75.140000000000001 110.367 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.881 ' HA2' ' HE2' ' A' ' 47' ' ' LYS . . . 95.71 -11.27 68.35 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.618 -0.719 . . . . 52.43 112.477 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -131.87 127.53 21.26 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-O 120.841 0.353 . . . . 71.140000000000001 110.271 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -83.61 170.33 53.17 Favored 'Cis proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.918 -1.701 . . . . 60.43 112.718 -1.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.52 HG23 ' HB3' ' A' ' 47' ' ' LYS . 41.0 mt -98.57 141.99 15.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.849 -0.797 . . . . 75.420000000000002 108.849 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.99 102.9 14.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.033 0.444 . . . . 74.340000000000003 110.313 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.721 HD23 HG21 ' A' ' 42' ' ' ILE . 4.5 mp -108.4 162.01 14.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.0 -0.545 . . . . 65.0 109.941 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.696 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 75.3 ttt180 -132.51 100.66 5.04 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.878 -0.786 . . . . 63.140000000000001 108.878 173.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.763 ' HB3' HG12 ' A' ' 42' ' ' ILE . 2.9 pp -127.36 149.76 49.91 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.827 -0.624 . . . . 73.109999999999999 110.856 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.464 ' HD3' ' OH ' ' A' ' 61' ' ' TYR . 52.4 ttt180 70.26 -22.44 0.17 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.532 0.52 . . . . 72.420000000000002 112.13 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 141.52 -3.58 2.13 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.927 -0.654 . . . . 61.43 112.141 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.464 ' OH ' ' HD3' ' A' ' 59' ' ' ARG . 16.9 p90 -138.28 158.33 44.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.162 0.506 . . . . 72.409999999999997 111.328 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 34.8 t -87.14 147.15 25.75 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.532 -0.758 . . . . 73.430000000000007 110.126 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 54.1 tp -155.52 147.73 23.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.579 -0.737 . . . . 71.109999999999999 109.775 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 4.1 m -97.48 133.55 41.91 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.07 0.462 . . . . 63.310000000000002 110.71 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.702 HD23 HD13 ' A' ' 56' ' ' LEU . 3.8 mm? -123.09 150.12 43.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.609 -0.723 . . . . 70.430000000000007 110.178 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 66' ' ' ARG . 22.9 mmt180 -81.87 161.44 23.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.141 0.496 . . . . 63.439999999999998 111.222 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.39 -36.89 85.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 71.400000000000006 110.898 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.9 m -70.33 -43.27 70.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.442 . . . . 50.420000000000002 111.005 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.15 -35.07 79.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.261 0.553 . . . . 60.200000000000003 110.482 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 8' ' ' ASN . . . -68.03 -22.19 64.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.525 -0.761 . . . . 61.420000000000002 111.358 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -76.36 -29.23 57.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.168 0.508 . . . . 73.219999999999999 110.267 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.11 9.18 5.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.751 -0.659 . . . . 62.32 111.629 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.54 HD11 HD13 ' A' ' 31' ' ' ILE . 62.5 mt -128.23 131.27 69.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.327 -0.397 . . . . 64.230000000000004 110.55 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.2 mt -107.23 125.71 51.47 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.275 -0.421 . . . . 72.230000000000004 109.87 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 18' ' ' VAL . 27.4 m -129.81 160.31 40.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.307 0.575 . . . . 62.039999999999999 111.948 -175.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.79 ' HB2' HD11 ' A' ' 19' ' ' ILE . 6.5 tp10 -120.76 146.6 46.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.956 -1.02 . . . . 72.310000000000002 109.104 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.622 HG22 ' H ' ' A' ' 79' ' ' LEU . 10.0 p -91.09 133.63 32.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.911 0.386 . . . . 74.519999999999996 110.094 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 17' ' ' LYS . 4.0 mm? -78.01 -18.22 56.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.09 0.471 . . . . 74.049999999999997 111.342 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.622 ' H ' HG22 ' A' ' 77' ' ' VAL . 89.1 mt -72.6 149.0 44.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.587 -0.733 . . . . 75.230000000000004 109.776 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.403 ' C ' ' H ' ' A' ' 82' ' ' HIS . 2.6 mp0 -52.06 136.07 30.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.542 0.527 . . . . 71.340000000000003 110.564 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -77.58 38.49 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.163 0.506 . . . . 75.019999999999996 111.69 -175.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.403 ' H ' ' C ' ' A' ' 80' ' ' GLU . 61.8 t60 -151.45 -25.58 0.2 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.29 -0.868 . . . . 74.230000000000004 108.743 174.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -66.66 -29.64 69.71 Favored 'General case' 0 N--CA 1.46 0.033 0 CA-C-N 115.605 -0.725 . . . . 74.340000000000003 109.152 173.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.3 99.66 8.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.939 -0.763 . . . . 73.129999999999995 108.939 174.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 86' ' ' HIS . 42.3 t-80 -107.07 -40.73 5.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.668 -0.697 . . . . 75.310000000000002 112.246 -169.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 85' ' ' HIS . 19.3 m-70 . . . . . 0 C--O 1.246 0.872 0 N-CA-C 109.079 -0.712 . . . . 71.239999999999995 109.079 -167.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.9 mtt . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 110.02 -0.363 . . . . 74.530000000000001 110.02 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.5 m -73.37 104.58 4.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.295 -0.411 . . . . 74.319999999999993 111.203 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -132.89 158.65 42.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.797 -0.446 . . . . 62.310000000000002 109.797 173.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.61 153.99 26.14 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.844 -0.693 . . . . 74.120000000000005 112.046 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 pt -124.89 179.41 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.389 -0.597 . . . . 75.129999999999995 109.389 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.42 154.13 41.91 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.464 -1.35 . . . . 61.439999999999998 111.598 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.9 tp -60.67 -27.56 67.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.964 0.411 . . . . 70.140000000000001 110.796 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -71.86 -15.16 62.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 53.409999999999997 111.533 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.26 -3.9 54.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.877 0.37 . . . . 74.120000000000005 110.823 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.7 t -90.36 159.39 2.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.345 -0.389 . . . . 64.439999999999998 110.375 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.609 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 22.1 tt0 -98.29 171.97 7.86 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.502 -0.555 . . . . 75.140000000000001 109.502 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.609 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 38.4 pt -79.83 177.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.457 -0.338 . . . . 61.539999999999999 110.474 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 pttm 52.79 21.16 1.83 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.414 1.085 . . . . 41.310000000000002 112.423 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.41 ' HA ' HD12 ' A' ' 79' ' ' LEU . 16.2 m -121.53 153.03 38.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.8 0.334 . . . . 62.509999999999998 110.726 -178.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -108.97 132.0 54.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.081 0.467 . . . . 71.140000000000001 109.843 176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.853 HG12 ' HA ' ' A' ' 77' ' ' VAL . 33.7 m -129.79 162.51 37.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.696 -0.684 . . . . 72.349999999999994 110.495 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.478 ' HB3' HD12 ' A' ' 78' ' ' LEU . 39.0 ttmt -115.6 143.86 44.73 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.281 -0.872 . . . . 65.420000000000002 109.231 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.822 ' HA ' HG12 ' A' ' 75' ' ' VAL . 53.8 t -73.53 95.87 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.855 -0.611 . . . . 71.129999999999995 109.947 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.4 mm -64.84 -40.98 90.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.247 -0.888 . . . . 72.140000000000001 109.891 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.97 -178.36 44.77 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.466 -0.873 . . . . 74.530000000000001 112.334 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.697 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 48.9 mt -128.34 159.3 39.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.364 -0.976 . . . . 70.209999999999994 108.364 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -100.1 90.81 1.44 Allowed Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.864 0.364 . . . . 52.5 110.157 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.697 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 17.5 Cg_exo -65.23 -178.56 0.86 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.335 2.69 . . . . 73.109999999999999 112.903 -173.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 61.97 25.52 15.32 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.816 0.817 . . . . 64.409999999999997 109.77 -173.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.866 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 10.8 t -115.02 150.66 35.5 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.59 -1.186 . . . . 72.420000000000002 109.64 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 3.8 mppt? -81.63 -32.73 31.81 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.597 -0.52 . . . . 73.049999999999997 109.597 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 31' ' ' ILE . 27.2 m -79.22 -19.95 12.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 64.219999999999999 110.652 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.866 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 5.7 tmm_? -52.28 -43.37 64.39 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.076 0.465 . . . . 74.450000000000003 109.826 172.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -59.41 -47.35 85.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.459 -0.792 . . . . 64.340000000000003 110.42 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 34' ' ' MET . 87.0 tttt -57.39 -47.19 82.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.209 -0.905 . . . . 71.450000000000003 111.028 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.489 HG22 ' HB ' ' A' ' 36' ' ' ILE . 75.9 mt -58.18 -44.77 88.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.566 -0.743 . . . . 34.340000000000003 111.409 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 55.2 mtt -71.59 -28.76 64.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.466 -0.334 . . . . 75.439999999999998 111.179 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.2 -31.96 72.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.237 0.541 . . . . 75.140000000000001 110.003 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 97.6 mmm -73.64 -9.18 58.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.462 -0.79 . . . . 74.219999999999999 111.057 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.5 -3.38 46.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.771 -0.728 . . . . 54.109999999999999 112.508 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.663 HG23 HG21 ' A' ' 18' ' ' VAL . 58.7 mt -88.06 129.72 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.911 0.386 . . . . 65.109999999999999 110.403 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.741 HG23 ' H ' ' A' ' 38' ' ' ARG . 1.0 OUTLIER -144.21 -75.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.837 -0.62 . . . . 75.239999999999995 111.437 -178.634 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.741 ' H ' HG23 ' A' ' 37' ' ' VAL . 24.7 ttt180 -150.86 140.18 21.34 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.602 -0.518 . . . . 73.109999999999999 109.602 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.06 19.25 69.82 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.776 -0.726 . . . . 54.299999999999997 112.106 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 m -85.28 146.72 26.91 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.948 -0.39 . . . . 62.340000000000003 109.948 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -90.99 127.8 36.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.866 0.365 . . . . 74.140000000000001 111.067 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.8 mm -126.22 114.87 40.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.44 -0.8 . . . . 75.25 109.609 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.825 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 39.3 t80 -106.3 119.34 38.99 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.559 -0.534 . . . . 75.120000000000005 109.559 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.434 HD13 HD12 ' A' ' 56' ' ' LEU . 14.6 mm -82.01 99.18 4.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.297 -0.41 . . . . 74.219999999999999 110.029 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -82.95 -22.58 33.73 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.154 -0.618 . . . . 73.420000000000002 110.364 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.79 -173.93 34.47 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.81 -0.71 . . . . 74.329999999999998 112.139 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.783 ' HG2' HG23 ' A' ' 54' ' ' ILE . 53.1 mtpt -126.8 160.3 31.28 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.442 -0.577 . . . . 53.32 109.442 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.18 151.23 94.24 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.712 -0.477 . . . . 51.439999999999998 109.712 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -51.4 -30.81 35.91 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.965 2.443 . . . . 61.43 113.215 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.0 tpt -76.09 -19.85 58.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.121 0.486 . . . . 65.010000000000005 111.223 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.58 -7.6 57.95 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.213 -0.755 . . . . 41.340000000000003 111.213 -174.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -152.42 132.61 7.35 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 108.9 -0.778 . . . . 74.239999999999995 108.9 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.71 -172.52 10.31 Favored 'Cis proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.567 -1.431 . . . . 53.439999999999998 112.98 0.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.783 HG23 ' HG2' ' A' ' 47' ' ' LYS . 53.5 mt -109.02 141.85 23.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.764 -0.653 . . . . 73.219999999999999 109.325 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.12 106.2 18.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.962 0.41 . . . . 70.420000000000002 110.998 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -105.72 135.77 46.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.132 -0.486 . . . . 61.229999999999997 110.059 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.825 ' HB3' ' HB3' ' A' ' 43' ' ' TYR . 2.3 tmt_? -86.56 114.37 23.24 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.794 -0.817 . . . . 72.400000000000006 108.794 175.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.6 tp -136.57 146.82 46.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.726 -0.67 . . . . 74.209999999999994 110.271 -175.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 71.05 -56.75 0.62 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.487 0.715 . . . . 65.0 110.762 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.51 -36.94 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.41 -0.676 . . . . 51.439999999999998 111.41 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.42 ' HE2' HD21 ' A' ' 63' ' ' LEU . 29.6 p90 -124.34 176.59 6.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.759 0.314 . . . . 74.230000000000004 110.4 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.784 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -93.11 140.81 29.11 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.491 0.552 . . . . 63.439999999999998 112.491 -175.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.42 HD21 ' HE2' ' A' ' 61' ' ' TYR . 75.6 mt -137.04 148.12 46.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.267 -0.879 . . . . 64.25 109.28 174.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 5.7 p -88.52 128.68 35.56 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.291 0.567 . . . . 64.140000000000001 111.829 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -121.5 157.76 29.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.253 -1.017 . . . . 73.420000000000002 108.253 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -80.22 156.34 26.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.56 0.695 . . . . 73.109999999999999 112.159 -169.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.435 ' HB3' ' NZ ' ' A' ' 67' ' ' LYS . 6.6 ttpm? -57.46 -28.19 63.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.669 -1.151 . . . . 71.239999999999995 110.975 174.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.1 m -61.25 -51.82 67.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.858 -0.61 . . . . 63.310000000000002 110.395 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' O ' HG13 ' A' ' 73' ' ' ILE . 1.7 mp0 -63.52 -30.54 71.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.94 -0.573 . . . . 72.209999999999994 111.111 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.16 -21.79 62.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.335 -0.393 . . . . 63.420000000000002 111.69 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.08 -42.45 38.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.398 0.618 . . . . 72.430000000000007 109.642 177.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.09 -10.37 53.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.392 -0.822 . . . . 54.420000000000002 112.018 -170.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.531 HG22 HG13 ' A' ' 75' ' ' VAL . 74.2 mt -90.27 113.09 25.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.923 -0.399 . . . . 74.030000000000001 109.923 174.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.5 mt -97.01 112.07 24.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.243 0.545 . . . . 52.030000000000001 110.484 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.822 HG12 ' HA ' ' A' ' 18' ' ' VAL . 29.4 m -132.34 167.7 25.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.758 -0.655 . . . . 72.400000000000006 110.203 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -140.23 145.96 38.04 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.123 -0.695 . . . . 74.400000000000006 109.123 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.853 ' HA ' HG12 ' A' ' 16' ' ' VAL . 47.9 t -67.88 103.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.019 -0.537 . . . . 63.25 110.415 -177.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 17' ' ' LYS . 26.6 mt -102.39 5.42 39.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.759 -0.655 . . . . 71.040000000000006 111.184 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 14' ' ' SER . 4.7 tt -58.82 112.79 1.77 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.556 -1.276 . . . . 62.119999999999997 107.556 167.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -33.88 95.46 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 124.689 1.243 . . . . 71.25 113.74 -169.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -130.23 78.53 1.85 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.527 -1.215 . . . . 74.530000000000001 108.284 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.447 ' O ' ' HB3' ' A' ' 83' ' ' HIS . 33.3 t60 -66.14 130.0 41.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.31 -0.859 . . . . 51.409999999999997 109.821 -175.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.447 ' HB3' ' O ' ' A' ' 82' ' ' HIS . 74.4 t60 70.22 97.25 0.07 Allowed 'General case' 0 CA--C 1.535 0.377 0 O-C-N 123.829 0.706 . . . . 74.299999999999997 109.11 -174.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -49.29 -56.31 9.85 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.293 -0.867 . . . . 62.020000000000003 113.024 -169.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -132.19 137.69 47.7 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.751 -0.379 . . . . 63.149999999999999 110.372 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.312 -0.852 . . . . 73.030000000000001 110.419 175.919 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptp . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.608 0.242 . . . . 73.439999999999998 111.22 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.2 p -79.79 75.44 6.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.418 0.628 . . . . 74.150000000000006 111.783 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -142.86 98.73 3.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.231 -0.895 . . . . 74.109999999999999 109.934 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.43 123.15 2.82 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.505 -0.77 . . . . 42.240000000000002 111.441 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.7 pt -107.88 163.07 5.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 110.176 -0.305 . . . . 73.239999999999995 110.176 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.26 157.83 53.51 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.732 -0.747 . . . . 61.009999999999998 111.755 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.559 HD21 HD11 ' A' ' 56' ' ' LEU . 52.4 tp -61.52 -23.47 65.95 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.938 0.399 . . . . 73.319999999999993 111.195 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -87.15 -7.12 58.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.562 -0.29 . . . . 52.439999999999998 111.192 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -95.97 0.14 51.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.913 0.387 . . . . 71.150000000000006 110.67 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.624 HG11 HG11 ' A' ' 16' ' ' VAL . 12.1 t -90.0 163.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 65.349999999999994 110.812 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.437 ' N ' HG12 ' A' ' 10' ' ' VAL . 30.4 tt0 -83.53 165.12 19.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.259 -0.428 . . . . 62.310000000000002 109.988 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.7 pt -85.93 163.18 2.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.076 -0.511 . . . . 54.100000000000001 110.826 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm 59.45 25.21 13.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.005 0.431 . . . . 73.310000000000002 111.301 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.7 m -108.87 159.95 16.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.182 -0.463 . . . . 45.200000000000003 110.511 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.605 ' H ' HD13 ' A' ' 79' ' ' LEU . 42.2 tttm -116.48 119.23 34.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.716 -0.846 . . . . 74.049999999999997 108.716 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.624 HG11 HG11 ' A' ' 10' ' ' VAL . 28.8 m -125.19 155.86 34.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.038 0.447 . . . . 64.409999999999997 112.011 -170.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -117.4 142.63 46.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.478 -0.783 . . . . 73.409999999999997 110.27 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.825 ' HA ' HG12 ' A' ' 75' ' ' VAL . 68.0 t -83.06 97.68 4.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.735 -0.666 . . . . 63.109999999999999 110.617 -176.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.4 mt -58.09 -54.38 33.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.2 -0.909 . . . . 63.5 110.358 173.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.36 165.66 34.46 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.375 -0.917 . . . . 33.409999999999997 113.076 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.42 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 58.6 mt -119.75 158.8 21.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.879 -0.786 . . . . 70.150000000000006 108.879 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 25' ' ' SER . 62.0 t -99.96 91.75 1.75 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.018 0.437 . . . . 74.010000000000005 110.028 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.692 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 37.6 Cg_endo -62.53 171.23 5.81 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.211 2.607 . . . . 34.299999999999997 113.308 -173.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 66.1 -15.73 0.12 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.004 0.922 . . . . 74.299999999999997 112.486 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -66.72 154.3 41.05 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 110.116 -0.327 . . . . 74.239999999999995 110.116 175.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 26' ' ' LYS . 72.1 mmtt -69.01 -30.51 68.92 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 111.942 0.349 . . . . 74.040000000000006 111.942 -175.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.712 HG21 ' HA ' ' A' ' 69' ' ' GLU . 20.5 m -83.39 -13.41 11.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.886 -0.326 . . . . 74.340000000000003 111.336 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.692 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 1.3 tmt_? -58.03 -48.41 80.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.379 -0.373 . . . . 74.140000000000001 111.085 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -62.48 -36.34 82.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.094 0.473 . . . . 73.239999999999995 110.79 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 34' ' ' MET . 61.5 tttm -66.29 -50.2 64.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.469 -0.787 . . . . 75.329999999999998 110.683 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.703 HD13 HD11 ' A' ' 73' ' ' ILE . 70.7 mt -66.37 -42.05 89.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.757 -0.656 . . . . 74.299999999999997 111.478 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 83.8 mtp -70.44 -28.75 65.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.633 0.254 . . . . 65.439999999999998 111.17 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -67.59 -28.21 67.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.199 0.523 . . . . 71.109999999999999 109.891 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.521 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 91.7 mmm -73.82 -16.44 61.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.524 -0.762 . . . . 74.439999999999998 111.062 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.3 -13.94 21.05 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.592 -0.813 . . . . 63.43 112.865 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.401 ' HB ' HG22 ' A' ' 31' ' ' ILE . 40.0 mt -78.64 129.33 37.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.71 0.291 . . . . 44.399999999999999 110.418 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.777 HG23 ' H ' ' A' ' 38' ' ' ARG . 2.1 m -139.21 -77.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.992 -0.549 . . . . 63.450000000000003 111.972 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.777 ' H ' HG23 ' A' ' 37' ' ' VAL . 1.4 tmm_? -149.44 125.44 10.62 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.048 -0.723 . . . . 71.319999999999993 109.048 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.33 -14.33 59.69 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.713 -0.756 . . . . 75.329999999999998 111.988 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.12 138.31 58.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.32 -0.622 . . . . 71.150000000000006 109.32 176.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -123.34 147.45 47.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.359 0.6 . . . . 54.530000000000001 111.258 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.782 HG21 ' HB3' ' A' ' 56' ' ' LEU . 44.3 mt -136.35 152.66 30.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.116 -0.947 . . . . 73.239999999999995 110.046 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -99.65 137.7 37.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.76 -0.459 . . . . 65.540000000000006 109.76 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.4 mm -87.76 103.12 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.431 -0.35 . . . . 71.340000000000003 110.585 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 57' ' ' ARG . 17.9 mm-40 -71.67 -39.06 70.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.123 -0.489 . . . . 71.439999999999998 110.423 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.73 -175.95 34.92 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.93 -0.652 . . . . 51.140000000000001 111.927 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -127.65 152.28 47.87 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.001 -0.37 . . . . 73.530000000000001 110.001 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -65.28 165.55 17.1 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.157 -0.474 . . . . 62.240000000000002 110.444 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 9.5 Cg_endo -51.53 -32.59 44.33 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.903 2.402 . . . . 64.030000000000001 113.014 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.5 mtt -89.52 -4.15 58.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.978 0.418 . . . . 74.209999999999994 110.991 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.32 5.83 89.55 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.219 -0.752 . . . . 74.450000000000003 111.219 -173.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 52.9 t0 -148.39 121.15 4.56 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.9 -0.778 . . . . 70.099999999999994 108.9 -176.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HB3' ' HD2' ' A' ' 66' ' ' ARG . 91.5 Cg_endo -86.41 -169.9 6.28 Favored 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.537 -1.443 . . . . 64.219999999999999 113.311 1.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 54' ' ' ILE . 4.4 mp -112.63 145.61 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.424 -0.807 . . . . 72.030000000000001 109.504 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.45 108.15 20.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.873 0.368 . . . . 75.040000000000006 110.798 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.782 ' HB3' HG21 ' A' ' 42' ' ' ILE . 2.2 mm? -102.06 146.14 28.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.464 -0.569 . . . . 64.239999999999995 109.464 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 21.8 ttt180 -116.79 114.17 23.57 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.478 -0.489 . . . . 70.340000000000003 110.442 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 60' ' ' GLY . 6.0 tt -149.23 156.02 41.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.895 -0.78 . . . . 71.010000000000005 108.895 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 58' ' ' LEU . 79.6 ttt180 74.64 -21.84 0.28 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.309 0.576 . . . . 74.209999999999994 110.412 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 146.88 -40.92 0.99 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.719 -0.673 . . . . 73.409999999999997 111.6 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.4 ' HE2' HD21 ' A' ' 63' ' ' LEU . 23.9 p90 -116.57 168.55 10.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.143 0.497 . . . . 73.420000000000002 111.201 -175.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.2 m -85.74 139.03 31.68 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.395 -0.82 . . . . 64.349999999999994 111.556 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.4 HD21 ' HE2' ' A' ' 61' ' ' TYR . 76.4 mt -134.49 158.75 43.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.669 -0.696 . . . . 60.43 109.309 175.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.1 m -100.85 138.48 37.84 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.072 0.463 . . . . 64.010000000000005 111.305 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.4 mt -127.76 134.64 49.51 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.357 -0.838 . . . . 52.009999999999998 108.909 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.536 ' HD2' ' HB3' ' A' ' 53' ' ' PRO . 25.3 mmm180 -64.9 153.5 40.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.686 -0.233 . . . . 71.040000000000006 110.655 -176.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -33.86 67.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.782 0.325 . . . . 65.310000000000002 110.192 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.4 m -57.66 -45.8 85.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.932 -0.577 . . . . 43.210000000000001 110.711 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.712 ' HA ' HG21 ' A' ' 27' ' ' VAL . 32.6 mt-10 -66.29 -44.54 83.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.227 0.537 . . . . 73.230000000000004 109.856 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.33 -22.31 66.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.486 -0.779 . . . . 62.119999999999997 111.614 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -81.31 -24.53 37.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.134 0.493 . . . . 74.230000000000004 110.608 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -95.25 12.81 27.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.255 0.55 . . . . 65.120000000000005 110.599 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.703 HD11 HD13 ' A' ' 31' ' ' ILE . 65.2 mt -121.6 119.57 59.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.65 -0.705 . . . . 71.219999999999999 109.669 176.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.7 mt -102.64 122.35 44.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.7 -0.482 . . . . 65.439999999999998 109.7 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.825 HG12 ' HA ' ' A' ' 18' ' ' VAL . 31.0 m -132.97 173.13 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.276 0.56 . . . . 74.030000000000001 112.3 -172.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.68 160.46 38.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.153 -0.93 . . . . 64.219999999999999 109.449 174.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.613 HG22 ' H ' ' A' ' 79' ' ' LEU . 13.3 p -99.61 134.06 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.13 0.49 . . . . 74.510000000000005 111.534 -174.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.52 HD12 ' HG2' ' A' ' 15' ' ' LYS . 81.6 mt -82.01 -18.73 42.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.842 -0.617 . . . . 74.010000000000005 110.978 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.613 ' H ' HG22 ' A' ' 77' ' ' VAL . 11.2 mp -68.65 114.68 7.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.327 -0.851 . . . . 74.349999999999994 110.173 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -81.36 74.6 8.35 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.647 0.737 . . . . 73.219999999999999 110.506 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -136.58 99.75 4.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.815 -1.084 . . . . 64.319999999999993 108.287 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -75.01 63.55 1.24 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.046 0.758 . . . . 71.319999999999993 113.046 -172.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -83.22 97.06 8.66 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.92 -0.77 . . . . 64.120000000000005 108.92 172.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -76.03 105.05 6.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.631 -0.713 . . . . 73.510000000000005 111.755 -170.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 32.9 t60 63.06 13.62 6.92 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.647 -0.706 . . . . 65.140000000000001 111.364 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.181 -0.914 . . . . 73.230000000000004 109.441 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 110.151 -0.314 . . . . 62.329999999999998 110.151 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 23.7 p -80.6 -60.39 2.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.604 -0.271 . . . . 75.430000000000007 110.589 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 3' ' ' LYS . 31.2 mtpt 68.74 169.16 0.28 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.897 0.748 . . . . 73.299999999999997 112.52 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 60.94 -164.52 17.33 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.026 -0.988 . . . . 51.140000000000001 113.892 173.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 pt -137.03 176.33 8.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.055 -1.091 . . . . 71.319999999999993 108.055 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.77 148.71 42.07 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.7 -1.238 . . . . 75.5 111.054 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.642 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 2.0 tm? -57.24 -29.82 64.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.504 0.668 . . . . 73.420000000000002 109.799 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.46 ' OD1' ' HA ' ' A' ' 71' ' ' LYS . 3.6 p-10 -71.36 -14.11 62.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.482 -0.781 . . . . 61.130000000000003 111.364 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -101.59 3.99 40.5 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.417 -0.356 . . . . 70.340000000000003 111.06 -174.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.9 t -83.74 155.45 3.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.112 0.482 . . . . 72.329999999999998 110.236 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.548 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 17.3 tt0 -95.02 175.09 6.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.798 -0.637 . . . . 74.420000000000002 110.452 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.548 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 23.7 pt -75.09 145.69 10.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.236 -0.438 . . . . 62.340000000000003 111.69 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 59.12 24.42 12.76 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.433 -0.803 . . . . 72.230000000000004 112.17 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 m -108.45 147.54 31.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.082 -0.508 . . . . 62.200000000000003 109.831 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -109.66 149.83 29.15 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.954 -0.387 . . . . 74.239999999999995 109.954 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.942 HG12 ' HA ' ' A' ' 77' ' ' VAL . 28.4 m -140.25 178.3 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.14 0.495 . . . . 75.420000000000002 110.987 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.672 ' HB2' HD11 ' A' ' 78' ' ' LEU . 7.1 ttpm? -133.06 140.4 47.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.545 -0.752 . . . . 72.319999999999993 110.138 176.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.682 ' HA ' HG12 ' A' ' 75' ' ' VAL . 47.6 t -73.14 97.67 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.605 -0.725 . . . . 63.109999999999999 110.073 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.7 mm -79.75 -49.34 19.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.693 -0.685 . . . . 73.430000000000007 110.951 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -152.55 168.08 31.54 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.818 -1.182 . . . . 53.329999999999998 113.646 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.65 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 50.0 mm -124.39 157.42 31.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.023 -1.103 . . . . 64.340000000000003 108.023 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 t -102.62 90.32 2.18 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 120.849 0.357 . . . . 73.239999999999995 110.218 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.65 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 74.2 Cg_exo -49.71 159.33 1.54 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.774 2.983 . . . . 73.209999999999994 113.875 -171.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 64.84 69.86 0.49 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.308 -0.86 . . . . 70.400000000000006 110.945 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.69 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 9.3 t -149.57 162.98 39.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.366 -0.834 . . . . 73.25 109.137 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -73.27 -45.13 57.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.358 0.599 . . . . 74.25 109.55 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.457 HG11 ' HG2' ' A' ' 69' ' ' GLU . 27.8 m -78.71 -20.54 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.488 -0.778 . . . . 63.109999999999999 111.573 -176.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.69 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 2.1 tmt_? -50.87 -43.98 59.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.257 0.551 . . . . 70.230000000000004 109.654 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.45 HH11 ' HD3' ' A' ' 29' ' ' ARG . 8.5 tpt180 -71.8 -44.21 64.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.591 -0.731 . . . . 71.519999999999996 110.614 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -60.59 -45.96 92.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.429 -0.805 . . . . 63.149999999999999 111.926 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 34' ' ' MET . 65.8 mt -68.68 -41.19 82.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.062 -0.517 . . . . 72.230000000000004 111.181 -177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.1 ttt -72.26 -28.47 63.15 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.66 -0.416 . . . . 75.5 110.371 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.8 -38.94 87.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.131 0.491 . . . . 40.32 109.944 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 6.9 mmt -56.81 -29.42 62.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.262 -0.881 . . . . 55.509999999999998 111.363 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.51 13.31 22.82 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.763 -0.732 . . . . 52.039999999999999 111.975 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -90.51 134.17 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.925 -0.398 . . . . 75.329999999999998 109.925 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 m -137.48 -177.86 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.081 -0.509 . . . . 72.340000000000003 110.547 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 54.8 ttp180 -64.52 131.46 47.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.366 -0.379 . . . . 74.109999999999999 110.119 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.61 -21.58 36.35 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.556 -0.831 . . . . 74.400000000000006 112.56 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.1 m -68.2 146.49 53.33 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.896 0.379 . . . . 72.5 110.342 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -95.88 132.06 41.56 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.472 0.653 . . . . 53.420000000000002 110.916 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.599 HD12 ' HB3' ' A' ' 58' ' ' LEU . 48.7 mm -121.11 122.49 67.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.059 -0.973 . . . . 74.129999999999995 109.458 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.693 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 14.9 t80 -102.47 118.35 36.67 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.702 -0.481 . . . . 73.430000000000007 109.702 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 mm -85.19 100.16 8.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.487 -0.561 . . . . 73.310000000000002 109.487 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.38 -42.0 65.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.207 -0.664 . . . . 73.420000000000002 109.207 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.52 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 170.27 -169.44 42.25 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.243 -0.743 . . . . 64.409999999999997 111.243 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.749 ' HG3' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -146.1 162.92 36.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.395 -0.594 . . . . 64.299999999999997 109.395 175.581 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -61.28 160.83 20.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 O-C-N 123.486 0.491 . . . . 42.439999999999998 110.315 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 9.3 Cg_endo -52.81 -26.54 31.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.151 2.567 . . . . 73.530000000000001 113.47 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.8 ttt -93.45 -7.64 43.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.087 0.47 . . . . 62.009999999999998 110.877 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.749 ' HA2' ' HG3' ' A' ' 47' ' ' LYS . . . 89.05 -1.54 83.09 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.923 -0.656 . . . . 41.130000000000003 112.092 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -145.71 125.86 7.09 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.216 -0.661 . . . . 61.049999999999997 109.216 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.93 178.56 31.54 Favored 'Cis proline' 0 C--O 1.236 0.382 0 C-N-CA 123.029 -1.655 . . . . 64.030000000000001 112.842 -0.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.712 HG23 ' HB3' ' A' ' 47' ' ' LYS . 19.8 mt -114.92 141.83 30.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 72.239999999999995 109.813 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.59 109.73 21.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.995 0.426 . . . . 62.43 110.322 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.6 mt -120.58 135.58 55.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.293 -0.412 . . . . 52.130000000000003 110.945 -173.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.693 ' HB3' ' HB3' ' A' ' 43' ' ' TYR . 4.2 tmt_? -92.34 100.83 13.33 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.986 -1.116 . . . . 71.340000000000003 107.986 172.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.599 ' HB3' HD12 ' A' ' 42' ' ' ILE . 2.0 pp -138.78 156.59 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.643 -0.708 . . . . 73.200000000000003 110.811 -174.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? 71.34 -44.76 0.6 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.909 0.756 . . . . 75.329999999999998 110.707 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.69 -19.13 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 116.23 -0.441 . . . . 54.439999999999998 112.02 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -137.96 168.9 18.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.988 0.423 . . . . 74.099999999999994 111.436 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.652 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.2 m -85.27 126.71 33.92 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.627 -0.715 . . . . 74.0 110.534 175.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 52.9 tp -145.23 148.87 33.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.657 -0.702 . . . . 74.150000000000006 109.224 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 21.8 t -95.01 125.96 40.02 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.181 0.515 . . . . 70.450000000000003 110.99 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.12 168.18 11.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.266 -0.879 . . . . 73.209999999999994 109.397 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.48 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 30.4 mmt180 -77.53 153.48 33.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.157 0.503 . . . . 71.310000000000002 111.673 -177.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -60.08 -34.78 73.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.525 -0.761 . . . . 75.349999999999994 109.986 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.4 m -61.66 -36.26 80.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.302 -0.863 . . . . 73.040000000000006 110.91 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.48 ' HG3' ' HB2' ' A' ' 66' ' ' ARG . 40.7 mt-10 -69.97 -41.89 73.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.458 0.647 . . . . 75.519999999999996 110.079 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.77 -21.52 66.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.212 -0.904 . . . . 75.219999999999999 111.497 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.46 ' HA ' ' OD1' ' A' ' 8' ' ' ASN . 61.2 tttm -71.32 -25.21 62.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.792 0.33 . . . . 61.140000000000001 111.226 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.61 -4.47 57.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.074 0.464 . . . . 74.450000000000003 111.194 -174.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.642 ' HB ' ' HB2' ' A' ' 7' ' ' LEU . 21.1 mt -104.54 125.4 59.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.15 -0.477 . . . . 72.219999999999999 110.655 -178.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.1 mt -102.99 115.77 31.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.52 -0.548 . . . . 62.520000000000003 109.52 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.682 HG12 ' HA ' ' A' ' 18' ' ' VAL . 19.7 m -130.65 150.1 34.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.142 -0.481 . . . . 72.349999999999994 111.461 -174.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -99.49 139.87 34.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.453 -0.573 . . . . 55.020000000000003 109.453 171.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.942 ' HA ' HG12 ' A' ' 16' ' ' VAL . 40.9 t -73.95 113.63 12.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.033 0.444 . . . . 73.219999999999999 110.583 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' A' ' 17' ' ' LYS . 47.5 mt -85.78 -6.51 59.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.964 -0.562 . . . . 75.120000000000005 110.939 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.8 tp -76.94 86.89 3.48 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.268 -1.382 . . . . 72.109999999999999 107.268 166.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -68.91 100.53 1.21 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.181 -0.918 . . . . 71.329999999999998 112.52 -166.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -123.97 130.22 52.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.058 -0.974 . . . . 73.329999999999998 108.839 172.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -82.77 54.0 2.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.293 0.568 . . . . 75.310000000000002 111.163 -172.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -146.68 114.45 6.46 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.161 -0.681 . . . . 63.210000000000001 109.161 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -88.61 129.86 35.4 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.332 0.493 . . . . 71.329999999999998 112.332 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -88.91 -42.92 11.54 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.369 -0.974 . . . . 72.510000000000005 108.369 169.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.1 t60 . . . . . 0 C--O 1.245 0.847 0 CA-C-N 114.605 -1.179 . . . . 70.299999999999997 108.519 177.394 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 120.981 0.42 . . . . 54.329999999999998 110.63 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.4 m -143.38 91.43 2.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.689 -0.687 . . . . 71.010000000000005 109.205 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -106.91 -155.61 0.55 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.365 -0.834 . . . . 73.200000000000003 109.966 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.69 109.3 0.4 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 119.913 -1.137 . . . . 53.329999999999998 113.271 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.4 pt -97.91 167.34 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.499 -0.926 . . . . 74.510000000000005 108.499 172.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.46 143.46 29.37 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 119.276 -1.44 . . . . 41.329999999999998 111.482 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 7' ' ' LEU . 8.2 tt -61.73 -26.84 68.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.32 0.581 . . . . 65.109999999999999 109.935 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.496 ' HB2' ' HG2' ' A' ' 67' ' ' LYS . 2.7 p-10 -67.76 -14.63 63.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 73.450000000000003 110.7 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.97 -2.95 39.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.115 -0.493 . . . . 74.430000000000007 111.309 -176.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.451 HG21 HG21 ' A' ' 16' ' ' VAL . 34.1 t -78.09 159.69 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.956 0.408 . . . . 73.129999999999995 110.459 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.452 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 28.0 tt0 -102.61 173.77 6.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.873 -0.603 . . . . 73.129999999999995 110.169 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.59 HG22 ' HA2' ' A' ' 46' ' ' GLY . 33.9 pt -76.42 149.8 6.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.35 0.5 . . . . 71.040000000000006 112.35 -173.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 53.8 31.02 12.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.174 -0.921 . . . . 75.400000000000006 112.142 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.7 m -121.2 145.86 47.39 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.261 -0.644 . . . . 70.209999999999994 109.261 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -110.45 137.97 47.46 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.343 0.592 . . . . 74.409999999999997 111.727 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' A' ' 77' ' ' VAL . 16.2 m -137.5 163.63 30.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.167 -0.924 . . . . 74.239999999999995 109.247 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 41' ' ' GLU . 38.4 ttpt -118.96 141.55 48.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.059 0.457 . . . . 74.219999999999999 111.241 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.512 ' HA ' HG12 ' A' ' 75' ' ' VAL . 47.0 t -73.91 93.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.995 -1.002 . . . . 75.299999999999997 110.121 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.1 -38.85 56.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.538 -0.755 . . . . 54.439999999999998 110.445 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.42 153.27 24.59 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.087 -1.054 . . . . 74.230000000000004 113.441 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.0 mt -114.7 158.25 15.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.177 -1.046 . . . . 73.430000000000007 108.177 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 22' ' ' VAL . 7.5 p -100.18 91.84 1.86 Allowed Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 121.761 0.791 . . . . 62.020000000000003 110.243 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.945 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 29.3 Cg_endo -60.01 166.67 8.41 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.907 2.404 . . . . 74.099999999999994 112.544 -174.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 66.52 11.9 8.38 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.388 -0.824 . . . . 73.099999999999994 111.226 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.859 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 34.7 t -85.51 157.45 20.42 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.429 -0.582 . . . . 62.530000000000001 109.429 174.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -69.0 -43.83 74.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.162 -0.681 . . . . 71.310000000000002 109.162 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.3 m -77.94 -15.68 14.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.353 -0.84 . . . . 75.099999999999994 110.969 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.945 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -52.46 -43.17 64.78 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.592 -0.276 . . . . 55.32 110.311 176.418 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -71.06 -41.64 70.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.413 . . . . 65.420000000000002 110.956 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -54.1 -45.12 71.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.315 0.579 . . . . 75.329999999999998 110.945 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.776 HD13 HD11 ' A' ' 73' ' ' ILE . 86.9 mt -65.8 -46.85 87.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.042 -0.981 . . . . 64.109999999999999 112.054 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 51.1 mtt -73.33 -29.37 62.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.726 0.298 . . . . 73.439999999999998 111.121 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.89 -28.69 69.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.266 0.555 . . . . 73.409999999999997 110.109 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 20.8 ttm -76.87 -20.78 55.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.597 -0.729 . . . . 75.019999999999996 110.69 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.7 15.23 15.57 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.659 -0.781 . . . . 50.409999999999997 112.901 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.519 ' HB ' HG22 ' A' ' 31' ' ' ILE . 25.8 mt -96.3 129.25 46.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.849 0.357 . . . . 74.349999999999994 110.298 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.6 m -134.28 -177.96 2.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.932 -0.576 . . . . 61.25 110.592 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -67.78 139.6 56.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.263 -0.273 . . . . 70.120000000000005 110.263 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.35 -2.17 87.46 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.035 -0.603 . . . . 34.240000000000002 112.789 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m -75.44 133.88 41.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.166 -0.679 . . . . 71.219999999999999 109.166 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 17' ' ' LYS . 5.1 pt-20 -104.57 129.07 52.69 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.28 0.562 . . . . 70.129999999999995 109.934 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.638 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 63.0 mt -118.17 132.84 66.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.023 -0.989 . . . . 54.25 110.578 -171.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -92.01 104.12 16.56 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.056 -0.72 . . . . 75.120000000000005 109.056 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.8 mm -74.21 97.47 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.183 -0.673 . . . . 63.439999999999998 109.183 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.436 ' OE2' ' HB2' ' A' ' 57' ' ' ARG . 50.0 mt-10 -66.47 -39.5 88.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.885 0.374 . . . . 74.299999999999997 110.618 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.59 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 170.19 172.69 36.89 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.355 -0.926 . . . . 73.310000000000002 112.215 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.639 ' HG2' HG12 ' A' ' 54' ' ' ILE . 46.1 mtmt -110.0 165.05 12.03 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.331 -0.618 . . . . 71.439999999999998 109.331 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -66.79 164.54 32.96 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.844 -0.428 . . . . 74.109999999999999 109.844 174.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.502 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 84.9 Cg_exo -42.79 -49.16 6.91 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.223 2.616 . . . . 74.409999999999997 113.704 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.3 ttt -84.96 -10.86 56.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.893 0.378 . . . . 74.209999999999994 111.028 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.98 2.92 39.39 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.917 -0.659 . . . . 73.239999999999995 112.774 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -151.68 128.51 5.43 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 110.074 -0.343 . . . . 61.030000000000001 110.074 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -82.72 -165.85 4.54 Favored 'Cis proline' 0 CA--C 1.532 0.392 0 C-N-CA 123.414 -1.494 . . . . 72.140000000000001 113.088 2.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.639 HG12 ' HG2' ' A' ' 47' ' ' LYS . 52.7 mt -120.51 147.46 24.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.168 -0.469 . . . . 73.310000000000002 110.448 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -103.11 111.23 23.49 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.836 0.351 . . . . 51.310000000000002 110.351 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.638 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 2.2 mp -117.07 129.99 56.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 110.006 -176.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.764 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 23.8 ttm180 -101.43 115.28 30.14 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.647 -0.421 . . . . 60.450000000000003 110.402 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.566 ' HG ' HG12 ' A' ' 42' ' ' ILE . 5.5 mp -116.76 145.88 43.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.868 -0.605 . . . . 63.299999999999997 109.748 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 64.2 -77.97 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.729 0.643 . . . . 75.329999999999998 110.852 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.13 9.57 0.35 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.348 -0.453 . . . . 71.310000000000002 112.068 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -147.28 154.97 41.61 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.298 0.57 . . . . 63.409999999999997 111.137 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.764 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 21.8 t -93.7 144.32 25.51 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.508 -0.769 . . . . 63.039999999999999 111.855 -175.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.4 154.74 44.65 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.488 -1.233 . . . . 60.439999999999998 108.767 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -116.12 114.53 24.63 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 120.972 0.415 . . . . 74.439999999999998 111.916 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.543 ' HG ' HD13 ' A' ' 56' ' ' LEU . 3.6 pp -122.25 167.23 13.48 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.484 -0.562 . . . . 64.010000000000005 109.484 174.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 -86.34 163.93 17.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.518 0.675 . . . . 72.230000000000004 112.27 -174.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.496 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 1.4 tmtp? -64.5 -20.94 66.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.953 -1.021 . . . . 72.230000000000004 110.277 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 m -69.1 -50.92 43.84 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.12 -0.491 . . . . 63.020000000000003 110.652 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.76 -36.46 78.99 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.3 0.571 . . . . 54.130000000000003 109.956 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.94 -21.68 66.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.336 -0.847 . . . . 75.510000000000005 111.862 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -84.28 -22.9 30.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.152 0.501 . . . . 74.340000000000003 110.526 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.478 ' HB3' HG12 ' A' ' 22' ' ' VAL . 4.6 m-20 -87.09 -14.18 42.14 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.875 -0.602 . . . . 72.099999999999994 110.919 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.776 HD11 HD13 ' A' ' 31' ' ' ILE . 40.1 mm -95.92 122.61 47.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.128 -0.487 . . . . 62.240000000000002 110.546 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.2 mt -100.61 114.96 29.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.053 -0.521 . . . . 60.039999999999999 109.871 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.568 HG13 HG22 ' A' ' 73' ' ' ILE . 24.9 m -118.71 161.12 17.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.087 -0.506 . . . . 73.099999999999994 111.241 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -118.75 145.56 45.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.713 -0.676 . . . . 65.329999999999998 109.305 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.756 ' HA ' HG12 ' A' ' 16' ' ' VAL . 39.3 t -72.34 123.01 26.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.76 -0.654 . . . . 64.040000000000006 110.545 -176.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.1 mt -85.12 -0.86 55.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 75.230000000000004 111.593 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.61 ' H ' HG12 ' A' ' 77' ' ' VAL . 10.9 mp -71.21 175.97 4.89 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.92 -0.582 . . . . 54.140000000000001 111.383 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.7 16.06 18.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.825 -0.625 . . . . 64.439999999999998 111.708 -174.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -75.01 102.85 4.97 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.879 -0.415 . . . . 75.200000000000003 109.879 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -86.34 -10.33 54.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.144 -0.48 . . . . 64.219999999999999 110.284 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -84.73 70.69 10.84 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.554 -0.906 . . . . 74.519999999999996 108.554 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -85.56 66.16 9.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.828 -0.624 . . . . 71.019999999999996 110.214 -174.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.3 t60 70.04 -77.03 0.06 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.383 -0.826 . . . . 63.219999999999999 110.995 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.004 -0.998 . . . . 73.140000000000001 109.612 -176.446 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.9 mtt . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.013 -0.366 . . . . 72.129999999999995 110.013 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.7 p -111.11 134.51 52.65 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.066 0.46 . . . . 74.439999999999998 111.082 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -79.74 -2.0 41.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.7 0.762 . . . . 70.510000000000005 109.546 175.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.52 179.65 52.84 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 114.989 -1.005 . . . . 72.329999999999998 112.687 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.5 pt -122.77 179.22 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.89 -0.781 . . . . 63.210000000000001 108.89 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 73' ' ' ILE . . . -77.45 151.7 38.49 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 119.805 -1.188 . . . . 52.119999999999997 111.884 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.438 ' O ' HD13 ' A' ' 7' ' ' LEU . 2.9 tm? -60.09 -32.62 71.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.297 0.57 . . . . 71.340000000000003 109.483 177.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.429 ' OD1' ' HA ' ' A' ' 71' ' ' LYS . 2.6 p-10 -70.27 -15.59 62.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.461 -0.79 . . . . 74.319999999999993 111.094 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -92.58 -3.9 54.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.074 0.464 . . . . 74.129999999999995 110.658 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.4 t -91.33 158.79 2.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.98 -0.748 . . . . 63.299999999999997 108.98 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.588 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 24.8 tt0 -108.01 175.52 5.45 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.239 -0.282 . . . . 71.540000000000006 110.239 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.588 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 32.5 pt -68.83 153.59 8.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.24 -0.436 . . . . 64.230000000000004 111.691 -175.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 60.64 41.21 15.57 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.301 -0.863 . . . . 72.310000000000002 110.914 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 m -128.56 149.77 50.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.149 -0.932 . . . . 75.430000000000007 109.638 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.475 ' HG2' HD12 ' A' ' 78' ' ' LEU . 85.8 tttt -115.37 132.4 56.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.043 -0.354 . . . . 50.450000000000003 110.043 177.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.813 HG12 ' HA ' ' A' ' 77' ' ' VAL . 26.6 m -133.04 162.62 39.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.254 0.55 . . . . 74.219999999999999 111.226 -176.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.614 ' HB2' HD21 ' A' ' 78' ' ' LEU . 19.8 ttmm -112.22 138.75 48.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.415 -0.811 . . . . 75.319999999999993 109.435 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.76 ' HA ' HG12 ' A' ' 75' ' ' VAL . 60.7 t -75.65 95.96 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.619 -0.719 . . . . 72.230000000000004 110.038 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.6 mm -61.05 -40.44 85.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.678 -0.692 . . . . 54.340000000000003 109.823 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.75 168.65 39.74 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.416 -0.897 . . . . 70.439999999999998 112.32 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.713 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 43.9 mt -105.28 159.38 5.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 108.606 -0.886 . . . . 74.420000000000002 108.606 176.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 25' ' ' SER . 58.4 t -99.22 92.36 1.71 Allowed Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.106 0.479 . . . . 73.109999999999999 110.471 -177.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.713 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 27.8 Cg_exo -60.53 178.31 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.561 2.841 . . . . 72.5 112.816 -174.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 66.73 -32.2 0.18 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.461 0.705 . . . . 63.130000000000003 112.026 -173.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.487 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 1.3 m -63.24 153.36 34.88 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 120.97 0.414 . . . . 32.130000000000003 110.86 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -71.92 -49.25 39.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.789 -0.641 . . . . 64.540000000000006 110.493 -174.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.564 HG11 ' HG2' ' A' ' 69' ' ' GLU . 11.5 m -72.99 -15.44 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.39 -0.368 . . . . 74.200000000000003 110.831 -174.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.655 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -53.8 -45.87 70.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.907 -0.588 . . . . 63.450000000000003 111.003 178.149 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -72.25 -33.01 67.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.369 0.604 . . . . 64.030000000000001 110.17 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -63.8 -41.85 97.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.378 -0.828 . . . . 65.530000000000001 110.508 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.511 HG22 ' HB ' ' A' ' 36' ' ' ILE . 82.9 mt -64.39 -36.42 77.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.713 -0.676 . . . . 74.540000000000006 110.9 177.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 67.7 mtt -67.67 -32.61 73.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 73.450000000000003 110.629 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -63.34 -31.89 73.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.946 -0.57 . . . . 54.130000000000003 110.492 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.9 mtm -76.53 -23.98 53.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.962 -0.563 . . . . 61.119999999999997 111.169 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.02 36.68 2.12 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.297 -0.954 . . . . 71.319999999999993 113.358 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.511 ' HB ' HG22 ' A' ' 31' ' ' ILE . 63.7 mt -122.14 136.1 60.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.468 -0.568 . . . . 73.340000000000003 109.468 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.745 HG23 ' H ' ' A' ' 38' ' ' ARG . 1.6 m -135.67 -84.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.321 0.489 . . . . 63.399999999999999 112.321 -176.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.745 ' H ' HG23 ' A' ' 37' ' ' VAL . 43.5 ttp180 -156.56 141.12 16.83 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.362 -0.607 . . . . 74.099999999999994 109.362 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.71 -0.29 65.89 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 111.429 -0.669 . . . . 73.319999999999993 111.429 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.472 HG22 HD21 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -72.6 142.67 48.39 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.387 -0.598 . . . . 73.310000000000002 109.387 178.275 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.49 130.98 52.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.167 0.508 . . . . 73.430000000000007 111.606 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.563 HG21 HD23 ' A' ' 56' ' ' LEU . 25.6 mm -120.24 128.16 75.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.34 -0.845 . . . . 71.510000000000005 110.898 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -101.12 120.67 40.56 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.447 -0.575 . . . . 75.439999999999998 109.447 171.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 44' ' ' ILE . 3.9 mp -85.45 101.62 10.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.226 -0.657 . . . . 64.420000000000002 109.226 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.84 -53.29 27.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.275 0.56 . . . . 74.150000000000006 110.383 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.26 -177.37 41.01 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.673 -0.694 . . . . 52.509999999999998 111.773 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HG2' HG23 ' A' ' 54' ' ' ILE . 52.0 mtpt -133.26 152.0 51.92 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.136 -0.69 . . . . 62.520000000000003 109.136 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.49 156.34 71.16 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.575 -0.528 . . . . 51.329999999999998 109.575 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.35 -30.14 19.42 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.77 2.313 . . . . 60.240000000000002 113.176 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.429 ' HA ' ' CE ' ' A' ' 50' ' ' MET . 23.2 mmt -91.29 0.98 57.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.489 -0.323 . . . . 71.510000000000005 111.697 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.01 -9.14 73.55 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.892 -0.67 . . . . 64.030000000000001 111.999 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 22.7 t70 -144.01 130.54 10.19 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.685 -0.487 . . . . 74.530000000000001 109.685 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.553 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . 91.6 Cg_endo -84.11 -169.26 6.65 Favored 'Cis proline' 0 CA--C 1.533 0.44 0 C-N-CA 123.474 -1.469 . . . . 64.129999999999995 112.918 0.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.461 HG23 ' HG2' ' A' ' 47' ' ' LYS . 60.7 mt -119.3 143.2 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.896 -0.593 . . . . 71.310000000000002 110.284 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.09 111.83 24.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.896 0.379 . . . . 73.400000000000006 110.808 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.563 HD23 HG21 ' A' ' 42' ' ' ILE . 5.9 mp -105.68 171.92 7.08 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.136 -0.69 . . . . 71.120000000000005 109.136 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 23.7 ttt180 -151.18 128.79 11.48 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.242 -0.651 . . . . 75.219999999999999 109.242 176.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.597 HD22 ' HG3' ' A' ' 59' ' ' ARG . 1.2 tt -131.93 137.41 47.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.01 -0.541 . . . . 74.510000000000005 109.83 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.597 ' HG3' HD22 ' A' ' 58' ' ' LEU . 55.8 mtt180 61.15 -80.25 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.795 -1.093 . . . . 53.210000000000001 111.667 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -147.78 14.75 1.37 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.016 -0.611 . . . . 74.25 111.759 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -140.01 145.96 38.46 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.677 0.751 . . . . 73.430000000000007 111.899 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 33.5 t -74.22 155.22 38.54 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.396 -1.275 . . . . 72.510000000000005 110.667 176.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.8 mt -139.7 140.21 36.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.783 -0.644 . . . . 71.129999999999995 109.424 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.8 t -118.99 130.2 55.55 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.811 0.339 . . . . 62.439999999999998 110.735 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 pp -144.65 164.64 30.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.76 -0.655 . . . . 72.549999999999997 110.386 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.553 ' HD3' ' HB3' ' A' ' 53' ' ' PRO . 25.9 mmt180 -83.73 158.68 21.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.37 0.605 . . . . 61.020000000000003 111.616 -176.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -39.47 70.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.95 -1.023 . . . . 72.439999999999998 111.117 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -65.38 -34.45 78.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.302 -0.408 . . . . 74.319999999999993 111.233 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.564 ' HG2' HG11 ' A' ' 27' ' ' VAL . 33.9 mt-10 -74.38 -32.76 62.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.297 0.57 . . . . 74.400000000000006 109.86 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.99 -21.1 65.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.452 -0.795 . . . . 75.450000000000003 111.19 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.429 ' HA ' ' OD1' ' A' ' 8' ' ' ASN . 22.1 ttmm -74.32 -34.17 63.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.494 . . . . 72.510000000000005 110.392 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -85.51 14.59 5.38 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.196 -0.456 . . . . 60.25 111.574 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.491 HG22 HG13 ' A' ' 75' ' ' VAL . 60.4 mt -118.96 124.23 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.381 . . . . 72.420000000000002 110.222 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 99.0 mt -103.47 120.73 41.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 75.549999999999997 110.243 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.76 HG12 ' HA ' ' A' ' 18' ' ' VAL . 22.4 m -133.95 157.51 41.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.207 0.527 . . . . 71.219999999999999 111.791 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -117.82 143.32 46.38 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.958 -0.756 . . . . 70.430000000000007 108.958 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.813 ' HA ' HG12 ' A' ' 16' ' ' VAL . 38.5 t -70.94 125.55 29.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.128 -0.487 . . . . 61.149999999999999 110.595 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 17' ' ' LYS . 56.3 mt -82.64 -9.56 59.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 75.420000000000002 111.008 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.588 ' H ' HG12 ' A' ' 77' ' ' VAL . 91.6 mt -72.1 147.04 47.1 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.843 -0.617 . . . . 74.299999999999997 109.472 174.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -86.82 3.5 45.02 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.083 0.468 . . . . 64.510000000000005 110.748 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -90.77 83.18 5.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.812 -0.631 . . . . 74.530000000000001 110.248 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -83.19 91.74 7.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.288 0.566 . . . . 74.310000000000002 110.317 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -87.99 103.89 16.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.595 0.712 . . . . 73.120000000000005 110.361 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -86.51 133.03 33.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.838 -0.619 . . . . 71.310000000000002 109.852 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 69.3 -76.75 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.552 -0.749 . . . . 73.0 110.206 -173.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.125 -0.94 . . . . 73.439999999999998 109.006 -176.041 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.84 0.352 . . . . 64.430000000000007 110.506 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.7 p -114.99 113.08 23.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.144 -0.48 . . . . 61.030000000000001 110.648 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 61.14 43.69 10.85 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.427 0.454 . . . . 65.010000000000005 110.997 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.42 128.09 34.7 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.551 -0.749 . . . . 71.430000000000007 112.757 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.8 pt -110.11 171.44 2.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.689 0.281 . . . . 62.140000000000001 110.304 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 73' ' ' ILE . . . -76.91 153.11 41.51 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 120.47 -0.871 . . . . 43.420000000000002 111.22 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' A' ' 56' ' ' LEU . 50.1 tp -59.21 -28.01 66.26 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.185 0.517 . . . . 75.400000000000006 110.684 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -75.38 -4.53 39.92 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.86 -0.609 . . . . 73.329999999999998 111.831 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -102.1 5.87 40.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.931 0.396 . . . . 72.200000000000003 110.801 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 t -97.03 157.32 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.064 -0.517 . . . . 61.130000000000003 109.967 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -99.64 164.89 11.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.62 0.247 . . . . 71.239999999999995 110.341 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.7 pt -69.39 151.03 10.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.444 . . . . 71.549999999999997 111.048 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt 60.26 51.45 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.948 0.88 . . . . 62.149999999999999 110.536 -177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 m -132.37 153.08 51.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.142 -0.935 . . . . 70.140000000000001 109.759 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -113.44 119.09 36.39 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.803 -0.443 . . . . 65.349999999999994 109.803 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.772 HG12 ' HA ' ' A' ' 77' ' ' VAL . 29.1 m -130.76 179.56 4.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.11 -0.495 . . . . 65.409999999999997 110.503 -178.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.75 ' HB2' HD11 ' A' ' 78' ' ' LEU . 39.3 ttpt -143.04 144.53 32.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.876 0.37 . . . . 75.030000000000001 111.064 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.67 ' HA ' HG12 ' A' ' 75' ' ' VAL . 45.8 t -76.9 95.66 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.598 -0.728 . . . . 74.310000000000002 110.673 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.927 HD11 ' HB2' ' A' ' 76' ' ' GLU . 50.1 mt -57.33 -49.33 80.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 64.310000000000002 109.988 173.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.59 149.16 7.22 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.54 -0.755 . . . . 74.109999999999999 112.258 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.643 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 56.9 mt -83.95 159.68 3.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.516 -0.55 . . . . 75.129999999999995 109.516 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 25' ' ' SER . 48.3 t -99.17 93.71 2.29 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 122.757 0.423 . . . . 73.030000000000001 110.03 -177.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 1.022 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 77.6 Cg_exo -49.27 164.26 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.911 3.074 . . . . 72.319999999999993 114.271 -173.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 67.28 -11.96 0.27 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.116 0.967 . . . . 75.5 112.92 -175.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 1.2 m -63.72 155.1 31.12 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 120.926 0.393 . . . . 73.219999999999999 110.822 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -69.46 -17.29 63.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.16 -0.473 . . . . 75.430000000000007 112.164 -173.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.443 HG21 ' HA ' ' A' ' 69' ' ' GLU . 30.9 m -112.47 6.32 8.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.664 -0.244 . . . . 74.140000000000001 111.43 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 1.022 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 5.2 tmm_? -58.76 -57.18 14.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.877 0.37 . . . . 74.299999999999997 110.771 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 29' ' ' ARG . 42.0 ttm180 -71.5 -36.1 70.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.041 -0.527 . . . . 75.239999999999995 110.123 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -58.77 -46.39 87.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.266 -0.879 . . . . 73.329999999999998 111.276 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.622 HD13 HD11 ' A' ' 73' ' ' ILE . 99.4 mt -66.51 -42.34 89.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.048 0.452 . . . . 75.120000000000005 111.278 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 63.7 mtt -67.53 -36.67 81.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.336 -0.393 . . . . 63.43 110.781 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.01 -30.14 68.46 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 54.219999999999999 110.445 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.3 ttt -63.04 -34.6 77.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.615 -0.721 . . . . 54.420000000000002 110.859 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.67 20.26 1.74 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.307 -0.949 . . . . 51.100000000000001 113.178 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.525 HD12 HG23 ' A' ' 31' ' ' ILE . 61.1 mt -105.51 134.84 45.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.719 -0.475 . . . . 53.450000000000003 109.719 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.73 177.56 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.389 -0.369 . . . . 72.319999999999993 110.835 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -78.7 128.97 34.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.079 0.466 . . . . 43.399999999999999 110.26 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.75 5.61 66.38 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.802 -0.713 . . . . 44.009999999999998 112.235 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.5 m -68.8 138.65 54.97 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.501 -0.555 . . . . 64.349999999999994 109.501 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -96.14 125.45 40.68 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.855 -0.611 . . . . 71.540000000000006 109.449 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.2 mt -107.36 120.57 58.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.347 -0.842 . . . . 65.230000000000004 110.969 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.566 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 74.4 t80 -93.52 106.88 18.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.821 -0.807 . . . . 64.409999999999997 108.821 173.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.441 HD13 HD22 ' A' ' 56' ' ' LEU . 18.6 mm -70.04 104.01 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.183 -0.673 . . . . 72.450000000000003 109.183 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -76.38 -61.51 1.93 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.832 0.349 . . . . 72.239999999999995 110.401 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.21 158.55 29.13 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.227 -0.987 . . . . 61.420000000000002 112.356 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.603 ' HG2' HG12 ' A' ' 54' ' ' ILE . 54.2 mtpt -97.55 151.83 19.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.258 -0.645 . . . . 74.129999999999995 109.258 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.53 156.35 32.6 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 110.131 -0.322 . . . . 65.109999999999999 110.131 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.0 -32.51 18.32 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.246 2.63 . . . . 52.219999999999999 113.752 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.8 ttm -89.42 -11.35 43.38 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.936 0.398 . . . . 73.439999999999998 111.172 -177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.45 -14.7 32.81 Favored Glycine 0 C--N 1.328 0.115 0 C-N-CA 120.909 -0.662 . . . . 50.539999999999999 112.513 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -149.41 138.96 12.93 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.44 -0.578 . . . . 71.25 109.44 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.8 -164.73 3.94 Favored 'Cis proline' 0 C--N 1.346 0.429 0 C-N-CA 124.15 -1.188 . . . . 73.099999999999994 112.636 -0.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.603 HG12 ' HG2' ' A' ' 47' ' ' LYS . 38.2 mt -123.97 134.98 65.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 74.030000000000001 110.416 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -91.44 118.93 30.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.372 -0.376 . . . . 34.140000000000001 110.255 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.506 ' CD1' HD21 ' A' ' 7' ' ' LEU . 23.1 mt -121.22 137.02 54.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.213 -0.449 . . . . 63.509999999999998 110.747 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.603 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 3.9 tmt_? -101.45 109.36 21.18 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.73 -0.841 . . . . 62.100000000000001 108.73 175.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 pp -144.64 152.12 40.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.318 -0.401 . . . . 73.019999999999996 110.96 -175.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 72.51 -45.29 0.62 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.931 0.77 . . . . 75.5 111.379 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.58 -21.84 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.064 -0.588 . . . . 72.109999999999999 112.355 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -145.0 172.4 13.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.01 0.433 . . . . 72.329999999999998 111.188 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -84.91 140.88 30.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.539 -0.755 . . . . 65.140000000000001 111.208 175.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.2 tp -143.5 154.66 43.86 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.452 -0.573 . . . . 71.140000000000001 109.452 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 p -91.81 121.24 33.25 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.923 0.392 . . . . 74.140000000000001 111.767 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.418 HD23 HD12 ' A' ' 56' ' ' LEU . 3.9 mm? -118.59 141.98 48.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.144 -0.48 . . . . 72.400000000000006 109.851 175.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.45 162.15 15.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.767 0.318 . . . . 74.329999999999998 110.722 -177.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -55.85 -33.0 64.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.643 -0.708 . . . . 72.25 110.999 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.1 m -59.48 -56.57 20.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 64.5 110.739 177.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.443 ' HA ' HG21 ' A' ' 27' ' ' VAL . 2.5 mp0 -64.94 -36.79 85.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.081 0.467 . . . . 63.140000000000001 110.713 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.2 66.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.648 -0.706 . . . . 61.100000000000001 111.813 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -83.01 -32.21 27.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.684 0.278 . . . . 74.5 110.9 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.38 -2.05 56.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.26 -0.427 . . . . 34.240000000000002 111.706 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.622 HD11 HD13 ' A' ' 31' ' ' ILE . 68.8 mt -106.42 122.7 60.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.572 -0.285 . . . . 73.010000000000005 110.582 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.5 mt -95.03 122.25 37.49 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.913 0.387 . . . . 55.32 110.216 176.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 18' ' ' VAL . 28.3 m -129.74 167.45 24.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.944 -0.571 . . . . 62.149999999999999 111.142 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.927 ' HB2' HD11 ' A' ' 19' ' ' ILE . 41.9 tt0 -129.07 146.01 51.13 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.227 -0.657 . . . . 53.340000000000003 109.227 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.772 ' HA ' HG12 ' A' ' 16' ' ' VAL . 10.3 p -76.14 129.5 37.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.275 0.56 . . . . 31.350000000000001 110.682 -178.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' A' ' 17' ' ' LYS . 86.2 mt -96.64 -14.14 22.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.879 -0.6 . . . . 75.200000000000003 109.997 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 tt -59.49 104.74 0.29 Allowed 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.787 -1.097 . . . . 73.430000000000007 108.926 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 67.24 105.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.207 -0.906 . . . . 75.310000000000002 110.338 -172.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.471 ' O ' ' HD2' ' A' ' 83' ' ' HIS . 51.7 t-80 -71.02 -9.39 57.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.501 -0.772 . . . . 63.140000000000001 111.477 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -77.12 99.97 5.56 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.771 0.32 . . . . 65.400000000000006 110.639 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.471 ' HD2' ' O ' ' A' ' 81' ' ' HIS . 5.4 p80 -135.24 149.79 49.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.012 -0.366 . . . . 74.400000000000006 110.012 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -107.44 129.57 54.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.123 -0.325 . . . . 71.450000000000003 110.123 -173.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.04 44.12 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.263 0.554 . . . . 73.319999999999993 111.599 -176.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 66.9 t-80 . . . . . 0 C--O 1.241 0.642 0 CA-C-N 115.76 -0.655 . . . . 74.150000000000006 109.467 175.302 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 121.044 0.449 . . . . 62.039999999999999 110.747 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.428 HG21 ' HB2' ' A' ' 76' ' ' GLU . 9.0 t -120.43 10.14 11.11 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.071 -0.393 . . . . 54.420000000000002 110.541 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.74 89.67 0.09 Allowed 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 115.896 -0.593 . . . . 62.329999999999998 109.877 -174.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.45 123.1 28.55 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.554 -0.748 . . . . 54.109999999999999 112.507 -177.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.0 pt -107.19 174.32 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.789 -0.448 . . . . 75.409999999999997 109.789 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.62 156.66 35.2 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.107 -1.044 . . . . 63.340000000000003 111.654 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.556 HD13 HG21 ' A' ' 16' ' ' VAL . 61.6 tp -61.62 -26.25 67.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.237 0.542 . . . . 64.129999999999995 110.635 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -72.83 -10.87 60.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.666 . . . . 65.219999999999999 111.217 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -98.16 0.34 45.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.92 0.39 . . . . 75.140000000000001 110.885 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.513 HG21 HG11 ' A' ' 16' ' ' VAL . 6.1 t -103.18 158.1 4.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.393 -0.595 . . . . 63.32 109.393 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -106.1 170.58 7.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.103 0.478 . . . . 42.409999999999997 111.241 -176.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 31.7 pt -64.02 157.82 4.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.427 -0.806 . . . . 70.310000000000002 113.154 -171.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 60.69 32.1 20.23 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.34 -0.845 . . . . 70.140000000000001 111.918 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.4 m -124.36 151.49 44.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.957 -0.565 . . . . 74.120000000000005 109.784 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HB2' ' CD2' ' A' ' 43' ' ' TYR . 36.5 ttmt -103.44 130.18 50.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.956 0.407 . . . . 71.519999999999996 110.287 176.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.556 HG21 HD13 ' A' ' 7' ' ' LEU . 33.1 m -119.01 165.79 13.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.864 -0.607 . . . . 73.340000000000003 110.628 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.634 ' HB2' HD11 ' A' ' 78' ' ' LEU . 69.2 tttt -123.07 135.65 54.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.638 -0.71 . . . . 64.400000000000006 110.205 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.77 95.38 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.309 -0.859 . . . . 53.409999999999997 110.7 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.832 HD11 ' HB3' ' A' ' 76' ' ' GLU . 28.7 mt -65.64 -49.06 80.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.766 -0.652 . . . . 70.239999999999995 109.75 174.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.52 176.31 44.77 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.601 -0.809 . . . . 75.5 112.74 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.673 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 54.6 mt -120.48 159.24 22.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.275 -1.009 . . . . 70.010000000000005 108.275 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.564 ' HB ' ' OD2' ' A' ' 72' ' ' ASP . 48.8 t -100.41 90.14 1.34 Allowed Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 121.363 0.602 . . . . 74.209999999999994 109.618 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.673 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 34.8 Cg_exo -56.57 163.33 7.03 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.6 2.866 . . . . 72.530000000000001 113.698 -170.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 65.96 16.62 10.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.624 -1.171 . . . . 53.200000000000003 111.24 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 28' ' ' ARG . 1.3 m -88.65 151.8 22.23 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.397 -0.594 . . . . 52.240000000000002 109.397 171.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -75.38 -38.96 59.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.895 0.379 . . . . 74.129999999999995 110.145 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 31' ' ' ILE . 33.9 m -67.25 -19.6 25.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 72.200000000000003 110.771 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 25' ' ' SER . 3.1 tmm_? -58.29 -32.49 68.47 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.689 -0.687 . . . . 73.409999999999997 110.25 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -64.8 -47.39 78.23 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.385 -0.598 . . . . 71.439999999999998 109.385 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -60.47 -50.01 75.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.492 -0.776 . . . . 64.510000000000005 110.637 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 27' ' ' VAL . 86.5 mt -53.34 -52.79 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.545 -0.752 . . . . 73.019999999999996 111.917 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 64.5 mtt -70.62 -33.01 70.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.557 -0.292 . . . . 54.43 111.305 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.03 -22.44 61.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.408 0.623 . . . . 62.450000000000003 110.135 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.8 tpt -78.29 -22.35 48.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.434 -0.803 . . . . 64.230000000000004 110.563 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.55 5.49 20.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.758 -0.734 . . . . 73.150000000000006 112.831 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.419 HG12 ' HG ' ' A' ' 58' ' ' LEU . 41.2 mt -93.56 129.47 43.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.821 -0.437 . . . . 54.109999999999999 109.821 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.737 HG23 ' H ' ' A' ' 38' ' ' ARG . 2.8 m -133.05 -74.83 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.623 0.601 . . . . 72.430000000000007 112.623 -176.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.737 ' H ' HG23 ' A' ' 37' ' ' VAL . 61.6 ttt180 -165.28 128.62 2.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.955 -0.387 . . . . 74.150000000000006 109.955 -174.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.29 5.97 73.68 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.961 -0.638 . . . . 74.109999999999999 112.006 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.5 m -74.04 144.92 44.87 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.987 -0.375 . . . . 72.120000000000005 109.987 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -94.27 129.8 40.78 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.053 0.454 . . . . 73.230000000000004 110.282 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.773 HG12 HD23 ' A' ' 58' ' ' LEU . 73.8 mt -119.83 116.37 50.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.523 -0.762 . . . . 71.040000000000006 109.899 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.416 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 9.0 t80 -100.92 119.44 38.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.175 -0.676 . . . . 62.420000000000002 109.175 177.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.5 mt -77.03 125.02 36.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 120.703 0.287 . . . . 64.219999999999999 110.233 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -85.65 -59.54 2.28 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.839 0.352 . . . . 64.219999999999999 110.346 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.67 171.92 42.34 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.813 -0.708 . . . . 74.120000000000005 112.109 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -123.56 145.1 49.14 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.012 -0.366 . . . . 72.120000000000005 110.012 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.561 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -69.29 163.66 56.01 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.188 -0.46 . . . . 54.149999999999999 109.778 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.561 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 8.1 Cg_endo -50.66 -38.51 55.8 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 123.027 2.485 . . . . 73.230000000000004 113.468 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.426 ' HE2' ' HB3' ' A' ' 52' ' ' ASP . 50.7 ttp -86.14 -10.74 54.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.216 0.532 . . . . 73.129999999999995 110.659 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.87 -2.95 73.27 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.564 -0.614 . . . . 41.240000000000002 111.564 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.426 ' HB3' ' HE2' ' A' ' 50' ' ' MET . 11.8 t70 -141.36 132.12 13.25 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 108.889 -0.782 . . . . 73.140000000000001 108.889 177.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.57 -179.96 27.11 Favored 'Cis proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.036 -1.652 . . . . 72.519999999999996 112.391 -0.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.7 mt -113.48 145.37 19.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.167 -0.47 . . . . 71.140000000000001 110.03 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.29 119.39 38.68 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.036 -0.357 . . . . 72.319999999999993 110.036 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.539 HD21 HD21 ' A' ' 7' ' ' LEU . 5.4 mp -118.11 167.59 11.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.141 -0.481 . . . . 63.140000000000001 109.895 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.661 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 33.0 ttt-85 -125.59 105.7 9.21 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.893 -1.151 . . . . 72.540000000000006 107.893 167.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.773 HD23 HG12 ' A' ' 42' ' ' ILE . 3.2 tm? -122.84 145.57 48.32 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.674 -0.693 . . . . 73.120000000000005 109.967 -170.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.612 ' HB2' HD13 ' A' ' 58' ' ' LEU . 2.4 tmt_? 70.51 -69.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.214 -0.903 . . . . 71.420000000000002 110.021 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.69 2.08 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.905 -0.664 . . . . 63.219999999999999 112.52 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -148.49 165.26 31.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.859 0.361 . . . . 74.409999999999997 110.799 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.661 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 32.1 t -75.78 145.08 41.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.511 0.672 . . . . 74.310000000000002 111.347 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.5 mt -146.2 157.04 43.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.696 -1.138 . . . . 73.340000000000003 108.598 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 t -120.62 125.27 47.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.299 0.571 . . . . 64.140000000000001 110.721 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.27 175.85 5.93 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.314 -0.857 . . . . 74.439999999999998 109.312 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.634 ' HB2' ' OE1' ' A' ' 69' ' ' GLU . 41.7 mmt180 -90.75 167.09 12.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.103 0.478 . . . . 73.420000000000002 110.31 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.43 -22.59 67.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.582 -0.735 . . . . 73.120000000000005 109.604 174.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.7 m -64.1 -52.32 59.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.242 -0.89 . . . . 65.540000000000006 110.97 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.634 ' OE1' ' HB2' ' A' ' 66' ' ' ARG . 1.9 mp0 -60.16 -41.95 93.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.153 0.502 . . . . 53.310000000000002 110.675 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.77 -22.5 67.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.56 -0.745 . . . . 73.420000000000002 111.504 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -75.2 -34.92 61.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.409 -0.36 . . . . 64.420000000000002 111.114 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.564 ' OD2' ' HB ' ' A' ' 22' ' ' VAL . 14.5 t70 -80.26 -44.69 19.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 73.25 111.421 -174.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.472 HG22 HG13 ' A' ' 75' ' ' VAL . 48.3 mt -61.42 118.5 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.97 -0.559 . . . . 73.219999999999999 111.44 -176.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.2 mt -91.24 119.4 31.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 73.239999999999995 109.871 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.547 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 23.7 m -129.08 158.17 41.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.927 0.394 . . . . 70.319999999999993 111.964 -174.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.832 ' HB3' HD11 ' A' ' 19' ' ' ILE . 19.3 pt-20 -115.11 151.72 33.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.831 -0.622 . . . . 72.310000000000002 109.632 173.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.2 t -80.26 115.84 23.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.988 0.423 . . . . 62.219999999999999 111.109 -174.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' A' ' 17' ' ' LYS . 40.2 mt -89.81 -1.48 58.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.898 -0.592 . . . . 71.519999999999996 111.53 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.0 mt -57.22 115.6 2.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.039 -0.528 . . . . 73.420000000000002 110.467 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -73.74 123.56 24.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.519 -0.764 . . . . 74.200000000000003 111.34 -175.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -161.96 148.46 13.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.013 -0.539 . . . . 65.549999999999997 110.19 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -74.88 134.53 41.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.805 -0.443 . . . . 61.109999999999999 109.805 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -141.96 91.45 2.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.051 0.453 . . . . 65.540000000000006 111.199 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -137.09 119.39 15.69 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.652 -0.87 . . . . 63.520000000000003 108.652 170.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -66.74 122.16 17.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.217 -0.447 . . . . 64.450000000000003 109.953 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.8 p80 . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.667 -0.682 . . . . 71.310000000000002 109.828 -179.64 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 121.169 0.509 . . . . 55.25 110.574 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.1 m -140.92 130.17 23.58 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.635 -0.712 . . . . 53.25 109.869 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -128.88 112.26 13.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.8 0.334 . . . . 74.099999999999994 110.254 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.04 102.96 1.5 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.649 -0.786 . . . . 44.450000000000003 112.092 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.6 pt -96.04 163.29 2.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.752 -0.462 . . . . 74.209999999999994 109.752 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.23 137.58 45.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.466 -0.873 . . . . 70.420000000000002 112.209 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 75' ' ' VAL . 44.7 tp -60.25 -25.02 65.35 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 122.986 0.515 . . . . 52.140000000000001 112.022 -175.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -78.46 -9.81 59.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.721 0.296 . . . . 74.25 110.857 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -99.31 -7.44 26.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.277 -0.42 . . . . 75.349999999999994 111.071 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.723 HG11 HG11 ' A' ' 16' ' ' VAL . 14.4 t -77.72 160.3 4.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.93 -0.577 . . . . 61.030000000000001 110.293 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.418 ' N ' HG12 ' A' ' 10' ' ' VAL . 31.7 tt0 -80.41 168.44 18.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 62.119999999999997 110.448 -177.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.408 ' HA ' ' CG2' ' A' ' 44' ' ' ILE . 33.5 pt -93.5 161.08 2.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.005 -0.543 . . . . 75.340000000000003 110.954 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 69.3 5.07 4.92 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.164 0.586 . . . . 63.25 111.611 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -107.12 156.89 18.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.851 0.358 . . . . 54.200000000000003 110.993 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.521 ' HB2' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -107.91 130.97 54.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.008 -0.542 . . . . 61.409999999999997 110.341 178.312 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' A' ' 77' ' ' VAL . 27.2 m -127.6 161.31 35.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.739 -0.664 . . . . 73.219999999999999 110.911 -177.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.761 ' HD3' ' HG2' ' A' ' 41' ' ' GLU . 9.7 tptm -113.26 138.53 49.87 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.596 -0.729 . . . . 64.400000000000006 109.922 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.946 ' HA ' HG12 ' A' ' 75' ' ' VAL . 60.1 t -80.58 94.24 2.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.517 -0.765 . . . . 73.109999999999999 109.902 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.36 -52.69 34.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.013 -0.994 . . . . 73.140000000000001 110.106 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 38' ' ' ARG . . . -155.23 133.95 4.0 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 119.966 -1.111 . . . . 74.150000000000006 113.245 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.454 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 68.3 mt -80.64 158.19 4.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 107.598 -1.26 . . . . 74.340000000000003 107.598 169.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 25' ' ' SER . 49.8 t -100.27 91.13 1.59 Allowed Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 121.015 0.436 . . . . 50.329999999999998 110.086 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 25' ' ' SER . 35.8 Cg_endo -62.57 178.51 0.92 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.397 2.732 . . . . 51.299999999999997 113.061 -173.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 67.02 -16.19 0.14 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.436 -0.802 . . . . 72.209999999999994 111.741 -174.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -73.13 161.87 30.1 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.938 0.399 . . . . 72.329999999999998 110.926 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -78.84 -46.24 19.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.991 -0.55 . . . . 65.310000000000002 110.61 -176.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.688 HG21 ' HA ' ' A' ' 69' ' ' GLU . 23.3 m -68.13 -18.0 22.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.908 -0.587 . . . . 73.219999999999999 110.648 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.454 ' HE ' ' HB3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -53.7 -34.33 58.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.35 -0.841 . . . . 74.0 111.296 178.631 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -68.37 -42.07 79.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.45 -0.341 . . . . 54.219999999999999 111.06 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.447 ' O ' ' HG3' ' A' ' 34' ' ' MET . 34.0 tttp -73.56 -33.31 64.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.459 -0.337 . . . . 71.209999999999994 110.399 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 27' ' ' VAL . 88.5 mt -59.62 -48.31 87.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.174 -0.466 . . . . 51.210000000000001 110.719 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 64.9 mtt -68.79 -28.6 66.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 63.32 110.626 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.51 -40.57 76.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 71.319999999999993 110.429 176.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.447 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 65.6 mtt -61.93 -34.05 75.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.594 -0.73 . . . . 74.25 110.588 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.69 17.99 5.82 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.818 -0.706 . . . . 62.5 112.248 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.825 HD11 HD22 ' A' ' 58' ' ' LEU . 47.8 mt -101.03 127.46 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.197 0.523 . . . . 65.519999999999996 110.386 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.27 -176.53 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.273 -0.876 . . . . 53.229999999999997 110.084 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HG2' ' HA2' ' A' ' 20' ' ' GLY . 84.8 mtm180 -70.6 109.45 4.88 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.867 -0.419 . . . . 73.239999999999995 109.867 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.424 ' O ' ' HE3' ' A' ' 17' ' ' LYS . . . 120.8 -9.24 10.58 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 121.042 -0.599 . . . . 53.329999999999998 111.739 -176.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.4 m -73.63 149.57 41.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.663 -0.495 . . . . 74.200000000000003 109.663 174.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.761 ' HG2' ' HD3' ' A' ' 17' ' ' LYS . 55.5 mt-10 -115.69 134.85 54.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.215 -0.448 . . . . 70.349999999999994 110.102 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.575 HG21 HD23 ' A' ' 56' ' ' LEU . 48.2 mm -118.66 126.02 74.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.468 -0.787 . . . . 70.049999999999997 110.757 -173.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 57' ' ' ARG . 9.8 t80 -104.57 115.79 30.96 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.796 -0.816 . . . . 74.010000000000005 108.796 173.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.408 ' CG2' ' HA ' ' A' ' 12' ' ' ILE . 44.5 mm -73.35 106.39 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.92 0.391 . . . . 71.140000000000001 110.702 -176.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -75.73 -36.65 59.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.181 -0.674 . . . . 73.0 109.181 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.63 -179.47 39.33 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.783 -0.723 . . . . 61.329999999999998 112.371 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -126.59 150.64 48.76 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.442 -0.577 . . . . 72.120000000000005 109.442 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.28 165.48 17.4 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.412 -0.358 . . . . 73.439999999999998 111.453 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.0 -31.85 83.8 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.571 2.181 . . . . 74.329999999999998 112.094 175.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -86.11 -5.31 59.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.207 0.527 . . . . 71.209999999999994 110.262 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.48 -34.45 5.65 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.212 -0.755 . . . . 34.109999999999999 111.212 -174.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 4.2 p-10 -137.97 152.31 71.86 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 108.959 -0.756 . . . . 75.030000000000001 108.959 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 73.0 Cg_endo -72.26 173.3 53.47 Favored 'Cis proline' 0 C--O 1.234 0.288 0 C-N-CA 123.457 -1.476 . . . . 73.530000000000001 113.158 4.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.655 ' HB ' HD11 ' A' ' 56' ' ' LEU . 16.3 mm -97.04 147.32 6.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.514 -0.766 . . . . 73.430000000000007 109.304 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.51 111.24 23.88 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.314 -0.624 . . . . 61.509999999999998 109.314 174.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.655 HD11 ' HB ' ' A' ' 54' ' ' ILE . 2.3 mp -121.88 144.92 48.56 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.516 -0.311 . . . . 65.349999999999994 110.292 -175.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 54.9 mtt180 -100.1 108.14 20.22 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.344 -0.984 . . . . 63.43 108.344 166.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.825 HD22 HD11 ' A' ' 36' ' ' ILE . 2.4 pp -121.78 134.3 54.92 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.602 -0.727 . . . . 73.549999999999997 110.858 -173.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.485 ' HD3' ' OH ' ' A' ' 61' ' ' TYR . 50.3 ttt180 65.02 6.06 3.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.283 -0.872 . . . . 74.409999999999997 110.839 178.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.58 -19.58 9.72 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 116.019 -0.537 . . . . 64.340000000000003 112.794 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.485 ' OH ' ' HD3' ' A' ' 59' ' ' ARG . 4.4 p90 -127.67 148.97 50.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.359 0.599 . . . . 71.120000000000005 112.213 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.3 m -70.8 137.68 49.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.186 -0.915 . . . . 50.520000000000003 111.989 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.702 ' HB3' HD21 ' A' ' 58' ' ' LEU . 9.4 tt -150.99 148.86 28.89 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.689 -0.856 . . . . 65.019999999999996 108.689 176.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.1 t -115.07 132.14 56.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.179 0.514 . . . . 72.439999999999998 111.566 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.403 ' CD2' HD13 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -134.04 165.49 24.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.351 -0.841 . . . . 62.140000000000001 109.391 174.581 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -84.45 169.33 14.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.453 0.644 . . . . 72.120000000000005 112.384 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 37.0 ttmt -54.49 -35.09 62.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.751 -1.113 . . . . 73.310000000000002 111.704 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.1 t -66.15 -46.24 78.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.58 -0.282 . . . . 63.43 110.647 -176.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.688 ' HA ' HG21 ' A' ' 27' ' ' VAL . 1.9 mp0 -63.33 -43.92 96.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.942 0.401 . . . . 74.010000000000005 110.347 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.49 -22.03 66.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 62.109999999999999 111.27 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -74.69 -29.04 61.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.102 -0.499 . . . . 71.450000000000003 110.883 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -93.46 19.72 8.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.946 0.403 . . . . 73.019999999999996 111.109 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.428 HG22 HG13 ' A' ' 75' ' ' VAL . 69.5 mt -126.04 117.6 49.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.602 -0.518 . . . . 63.130000000000003 109.602 174.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.7 mt -103.15 121.41 42.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.745 0.307 . . . . 73.409999999999997 110.205 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.946 HG12 ' HA ' ' A' ' 18' ' ' VAL . 35.6 m -137.09 172.58 14.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.968 0.414 . . . . 72.010000000000005 111.78 -174.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -143.37 156.68 44.74 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.427 -0.953 . . . . 75.420000000000002 108.427 171.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.756 ' HA ' HG12 ' A' ' 16' ' ' VAL . 11.8 p -64.71 147.92 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.003 0.43 . . . . 54.030000000000001 111.548 -175.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.615 HD21 ' HB2' ' A' ' 17' ' ' LYS . 23.5 mt -75.4 3.8 8.47 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.038 -0.528 . . . . 63.439999999999998 112.394 -177.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.407 ' HG ' HG22 ' A' ' 77' ' ' VAL . 88.5 mt -67.28 96.0 0.46 Allowed 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.822 -0.436 . . . . 64.319999999999993 109.822 175.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -56.4 -51.62 67.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.005 -0.543 . . . . 62.32 111.656 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -87.38 86.9 7.29 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.55 -0.537 . . . . 75.540000000000006 109.55 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -130.59 142.98 50.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.11 -0.496 . . . . 54.420000000000002 110.453 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -100.46 128.41 46.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.85 -0.614 . . . . 55.420000000000002 110.468 -177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -81.29 107.93 14.49 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.058 -1.09 . . . . 73.329999999999998 108.058 172.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -78.2 121.52 24.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.487 0.661 . . . . 65.209999999999994 112.425 -165.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 C--O 1.251 1.143 0 CA-C-N 114.859 -1.064 . . . . 50.240000000000002 109.329 172.05 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.231 -0.285 . . . . 72.329999999999998 110.231 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.7 m -72.01 -53.18 13.77 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.267 -1.012 . . . . 52.210000000000001 108.267 167.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.632 ' HG2' HG21 ' A' ' 19' ' ' ILE . 26.4 ttmt 59.18 98.59 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 114.86 -1.064 . . . . 73.150000000000006 111.426 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.03 109.46 1.35 Allowed Glycine 0 N--CA 1.437 -1.233 0 CA-C-N 115.078 -0.964 . . . . 55.25 111.605 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.2 pt -85.03 167.76 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.688 -0.856 . . . . 73.129999999999995 108.688 175.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.75 146.83 40.79 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 119.429 -1.367 . . . . 52.149999999999999 111.076 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.413 HD21 HD13 ' A' ' 56' ' ' LEU . 27.4 tp -65.28 -17.79 64.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.309 0.576 . . . . 64.510000000000005 110.173 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -76.56 -20.54 56.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.749 -0.659 . . . . 74.519999999999996 110.358 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -89.09 -10.68 46.46 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.173 -0.467 . . . . 70.439999999999998 110.532 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.1 t -84.45 160.43 3.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.906 -0.588 . . . . 72.310000000000002 110.087 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.842 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 28.5 tt0 -122.44 -173.58 2.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.668 0.27 . . . . 63.219999999999999 110.409 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.842 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 40.8 pt -68.93 154.04 8.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 113.322 0.86 . . . . 73.439999999999998 113.322 -170.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.4 mttt 59.86 22.14 11.09 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.57 -1.196 . . . . 74.549999999999997 113.256 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.663 ' HA ' HD12 ' A' ' 79' ' ' LEU . 16.5 m -104.74 155.4 18.92 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.428 -0.582 . . . . 54.32 109.428 174.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -115.06 136.7 52.83 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.488 -0.485 . . . . 72.040000000000006 110.0 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.839 HG12 ' HA ' ' A' ' 77' ' ' VAL . 29.9 m -140.17 -179.57 2.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.698 -0.683 . . . . 72.450000000000003 110.167 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -148.99 146.17 27.67 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.832 -0.432 . . . . 73.450000000000003 109.832 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.539 ' HA ' HG12 ' A' ' 75' ' ' VAL . 26.1 t -74.01 93.14 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.238 0.542 . . . . 71.140000000000001 110.146 -178.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.632 HG21 ' HG2' ' A' ' 3' ' ' LYS . 38.4 mm -81.64 -38.94 16.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.341 -0.845 . . . . 75.540000000000006 110.283 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.4 169.6 25.82 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.569 -0.824 . . . . 64.530000000000001 112.881 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.657 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 69.7 mt -136.9 155.26 32.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.613 -0.884 . . . . 73.209999999999994 108.613 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.0 t -103.26 91.37 3.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.872 0.368 . . . . 52.210000000000001 110.584 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.657 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 35.9 Cg_exo -59.06 172.99 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.375 2.717 . . . . 73.310000000000002 113.03 -175.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 60.18 26.3 15.71 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.715 -0.675 . . . . 72.010000000000005 111.328 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.801 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 15.6 t -104.15 142.77 33.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.228 -0.442 . . . . 72.129999999999995 110.412 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -79.04 -27.03 43.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.874 0.368 . . . . 64.329999999999998 110.222 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.6 m -84.97 -19.93 8.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 65.420000000000002 110.62 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.801 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 2.0 tmt_? -54.21 -35.15 62.08 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.426 -0.352 . . . . 75.319999999999993 110.641 174.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -57.03 -56.64 19.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.992 -0.549 . . . . 74.510000000000005 110.444 174.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -54.6 -46.82 73.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.475 -0.784 . . . . 71.409999999999997 111.135 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.497 HG22 ' HB ' ' A' ' 36' ' ' ILE . 96.1 mt -57.54 -53.45 44.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.331 -0.849 . . . . 74.019999999999996 111.806 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.455 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 77.1 mtp -75.04 -28.45 60.44 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.769 -0.372 . . . . 75.430000000000007 111.093 -176.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.54 -32.16 73.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.329 0.585 . . . . 75.420000000000002 109.932 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.2 mtt -78.23 -3.81 44.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.359 -0.837 . . . . 65.219999999999999 111.774 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.65 4.7 45.86 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.635 -0.793 . . . . 64.010000000000005 112.947 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.497 ' HB ' HG22 ' A' ' 31' ' ' ILE . 30.1 mt -89.08 124.04 41.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.975 0.417 . . . . 64.340000000000003 110.395 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.1 m -143.81 168.81 11.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.581 -0.736 . . . . 74.140000000000001 110.055 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -66.96 108.39 2.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.052 0.453 . . . . 75.530000000000001 110.232 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.5 -18.69 4.6 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.823 -0.704 . . . . 63.509999999999998 111.855 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.2 m -75.27 143.87 42.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.927 0.394 . . . . 75.349999999999994 110.47 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -102.76 142.52 33.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.995 -0.548 . . . . 71.209999999999994 109.736 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.812 HG12 HD12 ' A' ' 58' ' ' LEU . 65.1 mt -123.96 126.1 71.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.817 -0.629 . . . . 74.25 110.939 -173.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -106.58 117.11 33.2 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.038 -0.727 . . . . 75.409999999999997 109.038 174.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.7 mm -76.47 114.95 17.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.842 0.353 . . . . 71.439999999999998 110.432 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -76.97 -46.51 23.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.251 0.548 . . . . 74.129999999999995 109.936 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.652 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 170.82 -170.94 43.56 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.606 -0.725 . . . . 71.430000000000007 111.668 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.633 ' HG2' HG23 ' A' ' 54' ' ' ILE . 51.7 mtpt -132.83 137.17 46.65 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.026 -0.731 . . . . 72.239999999999995 109.026 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -58.87 158.48 16.32 Favored Pre-proline 0 C--N 1.328 -0.359 0 O-C-N 123.422 0.451 . . . . 75.129999999999995 110.943 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 9.2 Cg_endo -52.91 -30.96 50.34 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.349 2.699 . . . . 71.230000000000004 113.625 -177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.9 ttt -94.48 4.62 53.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.425 0.631 . . . . 70.230000000000004 110.433 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.28 3.65 90.61 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 116.035 -0.53 . . . . 75.140000000000001 112.38 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -154.04 132.73 6.88 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.288 -0.634 . . . . 54.130000000000003 109.288 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.77 -178.03 21.59 Favored 'Cis proline' 0 C--O 1.235 0.373 0 C-N-CA 123.076 -1.635 . . . . 71.239999999999995 112.59 0.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.633 HG23 ' HG2' ' A' ' 47' ' ' LYS . 52.6 mt -104.24 126.46 58.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.576 -0.527 . . . . 73.209999999999994 109.576 177.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.51 102.84 9.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.183 0.516 . . . . 62.109999999999999 110.249 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 62' ' ' SER . 32.5 mt -112.81 146.05 39.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.781 -0.645 . . . . 55.32 110.399 -177.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 45.3 ttt180 -114.21 102.92 10.59 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.581 -0.896 . . . . 71.319999999999993 108.581 169.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.812 HD12 HG12 ' A' ' 42' ' ' ILE . 8.3 tt -123.7 147.01 47.84 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.35 -0.841 . . . . 74.549999999999997 110.351 -173.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.521 ' HB2' HD23 ' A' ' 58' ' ' LEU . 3.2 tmt_? 71.03 -51.68 0.68 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.306 -0.861 . . . . 64.549999999999997 110.907 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.67 -18.23 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.178 -0.534 . . . . 70.129999999999995 112.141 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -131.43 166.19 21.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.279 0.561 . . . . 75.030000000000001 110.974 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 41.9 t -82.79 144.61 30.03 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.16 -0.927 . . . . 75.340000000000003 110.401 177.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.6 tp -148.77 147.97 29.43 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.177 -0.92 . . . . 73.019999999999996 109.369 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -93.69 112.27 24.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.456 0.646 . . . . 71.299999999999997 110.805 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.465 HD23 HD12 ' A' ' 56' ' ' LEU . 4.0 mm? -111.06 144.1 40.73 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.153 -0.93 . . . . 61.409999999999997 109.218 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -87.86 170.09 11.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.123 0.487 . . . . 62.549999999999997 111.123 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -58.26 -33.07 68.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.31 -0.859 . . . . 72.450000000000003 110.571 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.46 ' HB2' ' OE1' ' A' ' 69' ' ' GLU . 10.3 m -57.62 -55.33 36.2 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.614 -0.721 . . . . 72.200000000000003 110.905 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.46 ' OE1' ' HB2' ' A' ' 68' ' ' SER . 1.9 mp0 -65.74 -40.1 91.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 73.319999999999993 110.749 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.57 -30.66 69.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.926 -0.579 . . . . 65.150000000000006 111.292 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -66.15 -38.58 88.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.008 0.433 . . . . 73.140000000000001 111.098 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.17 9.06 29.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.933 -0.576 . . . . 74.530000000000001 112.122 -173.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.598 HG22 HG13 ' A' ' 75' ' ' VAL . 66.8 mt -112.41 117.0 54.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.893 -0.41 . . . . 74.109999999999999 109.893 175.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.7 mt -97.82 111.7 23.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.039 0.447 . . . . 71.329999999999998 110.171 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.598 HG13 HG22 ' A' ' 73' ' ' ILE . 29.4 m -126.88 146.15 33.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.155 -0.475 . . . . 73.349999999999994 111.268 -176.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -107.18 139.8 41.04 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.398 -0.593 . . . . 63.43 109.398 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.839 ' HA ' HG12 ' A' ' 16' ' ' VAL . 40.8 t -71.22 104.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.093 -0.503 . . . . 73.200000000000003 110.369 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 78' ' ' LEU . 28.8 mt -93.31 5.71 50.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.989 -0.551 . . . . 72.400000000000006 111.375 -177.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.663 HD12 ' HA ' ' A' ' 14' ' ' SER . 4.3 tt -56.18 107.88 0.41 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.736 -0.838 . . . . 72.230000000000004 108.736 173.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.18 -178.05 6.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.971 -0.558 . . . . 74.0 111.745 -173.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 42.6 m80 65.54 -145.72 0.21 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.428 -0.806 . . . . 63.43 109.436 -173.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -167.25 -172.96 2.13 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.115 -0.698 . . . . 62.399999999999999 109.115 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -64.91 107.21 1.41 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.925 -0.769 . . . . 74.310000000000002 108.925 175.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -88.41 23.77 2.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.998 0.428 . . . . 74.319999999999993 110.972 -174.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -169.15 166.9 10.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.58 -0.896 . . . . 75.239999999999995 108.58 176.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.4 p80 . . . . . 0 C--O 1.245 0.827 0 CA-C-O 119.319 -0.372 . . . . 71.230000000000004 110.298 175.744 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.797 0.332 . . . . 74.239999999999995 110.221 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.9 m -83.78 100.04 10.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.023 0.439 . . . . 65.340000000000003 110.009 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -126.23 -4.84 6.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.826 -0.625 . . . . 62.0 110.26 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.73 129.8 30.52 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.205 -0.907 . . . . 23.100000000000001 112.884 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.8 pt -100.84 167.09 2.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.404 -0.591 . . . . 73.549999999999997 109.404 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 73' ' ' ILE . . . -69.61 145.84 42.72 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.19 -1.005 . . . . 73.239999999999995 111.704 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.511 HD21 HD11 ' A' ' 44' ' ' ILE . 2.2 tm? -54.95 -38.19 67.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.335 0.588 . . . . 74.040000000000006 109.909 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 34.9 t30 -61.54 -18.92 61.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.498 -0.774 . . . . 73.140000000000001 111.499 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -105.52 5.86 31.82 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.283 -0.417 . . . . 75.219999999999999 111.775 -171.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 11' ' ' GLU . 21.5 t -86.2 159.52 3.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.42 -0.355 . . . . 71.310000000000002 110.103 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.502 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 25.2 tt0 -85.42 171.75 11.57 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.626 -0.509 . . . . 73.200000000000003 109.626 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.502 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 35.7 pt -86.83 150.63 3.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.942 0.401 . . . . 75.140000000000001 111.72 -173.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 56.55 66.17 1.25 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.138 -0.937 . . . . 64.430000000000007 111.596 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.503 ' HA ' HD12 ' A' ' 79' ' ' LEU . 67.5 m -152.02 158.32 42.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.662 -1.154 . . . . 74.420000000000002 109.339 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HG2' ' HD1' ' A' ' 43' ' ' TYR . 65.6 mttp -105.76 131.25 53.34 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.843 0.354 . . . . 74.340000000000003 110.183 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.672 HG12 ' HA ' ' A' ' 77' ' ' VAL . 30.9 m -128.03 155.59 39.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.033 -0.53 . . . . 70.409999999999997 110.691 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -119.59 141.44 49.28 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.819 -0.628 . . . . 73.450000000000003 109.961 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.66 ' HA ' HG12 ' A' ' 75' ' ' VAL . 42.0 t -74.63 97.05 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.454 -0.794 . . . . 72.299999999999997 110.428 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.83 HD11 ' HB2' ' A' ' 76' ' ' GLU . 27.9 mt -62.67 -41.8 93.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.476 -0.784 . . . . 73.230000000000004 109.991 173.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.92 166.01 38.0 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.528 -0.844 . . . . 70.109999999999999 112.662 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.692 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 54.5 mt -107.62 160.32 6.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.595 -0.891 . . . . 73.219999999999999 108.595 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.11 90.8 1.19 Allowed Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.594 -0.521 . . . . 64.519999999999996 109.594 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 34.3 Cg_exo -56.59 167.01 3.1 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.882 3.055 . . . . 73.340000000000003 113.564 -170.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 65.17 15.26 9.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.186 -0.915 . . . . 72.530000000000001 110.208 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.952 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 37.0 t -67.6 152.87 44.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.075 -0.966 . . . . 75.530000000000001 109.732 176.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 26' ' ' LYS . 20.4 tptp -87.74 -16.44 34.22 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.171 -0.678 . . . . 54.439999999999998 109.171 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.12 3.15 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.615 -0.721 . . . . 73.549999999999997 111.71 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.952 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 4.7 tmt_? -52.04 -40.85 61.71 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 110.11 -0.33 . . . . 64.099999999999994 110.11 173.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -58.41 -44.07 88.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.503 . . . . 63.140000000000001 110.611 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.464 ' HD3' ' HG2' ' A' ' 69' ' ' GLU . 88.8 tttt -62.86 -46.49 87.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.256 0.55 . . . . 71.0 110.258 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.541 HG23 HD12 ' A' ' 36' ' ' ILE . 82.6 mt -62.23 -46.14 97.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.298 -0.865 . . . . 74.549999999999997 111.262 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -39.84 93.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.055 -0.52 . . . . 73.239999999999995 110.553 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.82 -39.86 95.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.805 -0.634 . . . . 72.010000000000005 110.945 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.547 ' SD ' HD11 ' A' ' 65' ' ' LEU . 52.9 mtt -69.84 -13.23 62.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 111.557 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.412 ' HA3' ' HG3' ' A' ' 59' ' ' ARG . . . 94.78 36.9 5.4 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.626 -0.797 . . . . 50.340000000000003 112.89 174.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.541 HD12 HG23 ' A' ' 31' ' ' ILE . 40.4 mt -110.03 124.75 67.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.868 0.366 . . . . 73.329999999999998 110.333 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -145.09 177.38 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.606 -0.724 . . . . 74.319999999999993 109.693 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.444 ' HD3' ' C ' ' A' ' 38' ' ' ARG . 4.2 tmt_? -64.53 130.28 43.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.856 0.36 . . . . 74.209999999999994 110.145 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.01 -15.93 60.02 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.96 -0.638 . . . . 71.319999999999993 112.612 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.7 m -79.37 148.74 31.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.962 -0.385 . . . . 65.400000000000006 109.962 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -104.08 148.36 26.34 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.164 0.507 . . . . 74.230000000000004 110.734 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.43 HG12 ' HB3' ' A' ' 58' ' ' LEU . 79.6 mt -127.91 123.9 61.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.265 -0.88 . . . . 74.409999999999997 109.423 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.767 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 50.8 t80 -88.78 114.36 25.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.97 0.414 . . . . 55.229999999999997 110.378 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.511 HD11 HD21 ' A' ' 7' ' ' LEU . 21.1 mm -81.34 107.03 13.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.803 -0.635 . . . . 75.510000000000005 109.302 176.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -83.16 -53.26 5.91 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.776 -0.824 . . . . 64.140000000000001 108.776 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.76 147.43 6.56 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.311 -0.947 . . . . 33.109999999999999 112.607 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.586 ' HG2' HG23 ' A' ' 54' ' ' ILE . 51.6 mtpt -88.67 149.14 23.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.353 -0.98 . . . . 73.299999999999997 108.353 173.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.77 156.42 24.86 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 110.491 -0.189 . . . . 72.420000000000002 110.491 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.88 -16.84 27.57 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.681 2.254 . . . . 75.150000000000006 111.94 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.1 ttm -92.43 -12.55 31.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.65 -0.704 . . . . 75.030000000000001 110.275 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.75 -29.38 11.44 Favored Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 115.846 -0.616 . . . . 54.329999999999998 111.869 -177.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -142.17 147.56 44.49 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 108.923 -0.769 . . . . 73.549999999999997 108.923 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -79.71 -179.27 25.71 Favored 'Cis proline' 0 C--O 1.236 0.381 0 C-N-CA 123.317 -1.535 . . . . 74.099999999999994 112.472 -0.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.586 HG23 ' HG2' ' A' ' 47' ' ' LYS . 33.3 mt -113.23 124.75 70.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.92 -0.4 . . . . 65.439999999999998 109.92 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.08 106.78 11.36 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.908 0.385 . . . . 73.109999999999999 110.61 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 62' ' ' SER . 63.8 mt -119.64 142.26 48.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.098 -0.501 . . . . 74.120000000000005 110.808 -175.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.767 ' HB3' ' HB3' ' A' ' 43' ' ' TYR . 36.1 ttt180 -110.97 100.97 9.58 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.67 -0.863 . . . . 73.409999999999997 108.67 171.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.43 ' HB3' HG12 ' A' ' 42' ' ' ILE . 3.2 pp -131.41 151.21 51.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.81 -0.632 . . . . 63.020000000000003 110.616 -173.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.412 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 3.2 tmt_? 71.66 -39.39 0.45 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.37 0.668 . . . . 73.040000000000006 111.174 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.64 -27.35 0.11 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.152 -0.547 . . . . 74.439999999999998 112.262 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -124.46 169.15 12.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.971 0.415 . . . . 75.030000000000001 111.346 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.64 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 46.5 t -99.48 146.8 25.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.583 -0.735 . . . . 30.539999999999999 110.894 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 63' ' ' LEU . 2.4 pt? -164.6 161.3 20.92 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.282 -0.872 . . . . 75.010000000000005 109.425 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.94 116.89 31.07 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.07 0.462 . . . . 64.209999999999994 111.625 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.547 HD11 ' SD ' ' A' ' 34' ' ' MET . 4.1 mm? -98.15 158.84 15.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.757 -0.656 . . . . 63.399999999999999 110.881 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -81.87 156.19 24.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.15 -0.477 . . . . 63.530000000000001 111.383 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -53.83 -45.21 70.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.728 -0.669 . . . . 70.310000000000002 110.982 173.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.2 m -57.77 -50.39 73.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.592 -0.731 . . . . 51.299999999999997 111.958 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.464 ' HG2' ' HD3' ' A' ' 30' ' ' LYS . 2.2 mp0 -71.79 -31.06 66.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 74.25 111.536 -175.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 8' ' ' ASN . . . -68.69 -23.11 64.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.25 0.463 . . . . 70.420000000000002 112.25 -173.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -87.19 -11.28 50.31 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.957 -0.697 . . . . 35.329999999999998 110.682 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.56 0.93 35.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.179 -0.464 . . . . 72.319999999999993 111.021 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.481 ' O ' ' HA2' ' A' ' 6' ' ' GLY . 59.5 mt -118.52 126.48 75.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.951 -0.568 . . . . 64.310000000000002 109.984 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.2 mt -103.15 122.32 44.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.072 -0.344 . . . . 75.340000000000003 110.072 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.66 HG12 ' HA ' ' A' ' 18' ' ' VAL . 29.8 m -131.38 164.3 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.714 0.635 . . . . 75.340000000000003 112.714 -172.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.83 ' HB2' HD11 ' A' ' 19' ' ' ILE . 3.7 tp10 -111.21 136.9 49.61 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.916 -1.038 . . . . 73.109999999999999 109.477 173.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.672 ' HA ' HG12 ' A' ' 16' ' ' VAL . 46.8 t -82.66 104.67 11.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.534 -0.543 . . . . 42.130000000000003 109.534 178.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.8 mt -74.79 -25.18 58.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.224 0.535 . . . . 44.130000000000003 110.938 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 14' ' ' SER . 38.8 mt -92.04 84.66 5.34 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.593 -0.73 . . . . 64.540000000000006 111.292 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -94.56 13.08 25.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.476 -0.564 . . . . 65.310000000000002 109.476 174.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 69.34 159.04 0.17 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.833 -1.076 . . . . 55.109999999999999 111.319 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -79.43 -33.72 42.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.102 -0.499 . . . . 55.140000000000001 109.986 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -125.09 145.66 49.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.065 -0.516 . . . . 64.450000000000003 109.757 176.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -74.59 94.91 2.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.88 0.848 . . . . 72.120000000000005 110.564 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -94.27 143.99 25.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.2 -0.909 . . . . 63.25 110.509 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.6 t60 . . . . . 0 C--O 1.244 0.804 0 CA-C-O 118.325 -0.845 . . . . 65.230000000000004 109.579 176.355 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.903 0.382 . . . . 72.109999999999999 110.712 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.4 m -87.79 106.47 18.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.896 0.379 . . . . 62.509999999999998 110.943 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.69 147.58 42.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.178 -0.465 . . . . 62.229999999999997 110.118 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.02 146.21 16.04 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.753 -0.737 . . . . 74.019999999999996 112.097 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.2 pt -134.02 173.64 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.685 0.279 . . . . 71.140000000000001 110.318 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.65 157.85 38.48 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.59 -0.814 . . . . 64.030000000000001 111.099 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.514 ' O ' HD13 ' A' ' 7' ' ' LEU . 2.0 tm? -54.65 -35.22 63.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.089 0.471 . . . . 73.319999999999993 110.67 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -71.58 -11.95 61.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.126 -0.488 . . . . 73.25 111.871 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -99.26 -5.6 29.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.765 0.317 . . . . 72.530000000000001 111.259 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 11' ' ' GLU . 15.5 t -77.21 162.57 4.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.259 -0.428 . . . . 72.040000000000006 110.564 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.428 ' N ' HG12 ' A' ' 10' ' ' VAL . 23.4 tt0 -96.74 170.27 9.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.627 -0.508 . . . . 73.219999999999999 109.627 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.1 pt -76.65 146.63 8.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.835 0.35 . . . . 54.43 111.533 -174.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 61.16 25.65 15.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.378 -0.828 . . . . 73.439999999999998 111.925 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.5 m -105.13 148.1 27.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.928 -0.578 . . . . 63.409999999999997 109.592 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.531 ' HG2' HD12 ' A' ' 78' ' ' LEU . 45.5 tttm -105.43 126.1 51.73 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.78 -0.452 . . . . 72.329999999999998 109.78 -177.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 17.6 m -131.71 162.87 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.3 0.571 . . . . 70.219999999999999 111.634 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.695 ' HE3' ' HA2' ' A' ' 39' ' ' GLY . 2.1 tmtp? -122.36 145.19 48.49 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.5 -0.773 . . . . 72.129999999999995 110.094 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.5 t -73.4 97.49 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.094 -0.503 . . . . 71.230000000000004 110.872 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.545 HD11 ' HB2' ' A' ' 76' ' ' GLU . 45.6 mt -54.51 -46.96 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 115.619 -0.718 . . . . 62.229999999999997 109.616 170.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.46 173.42 39.72 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.328 -0.851 . . . . 71.340000000000003 112.451 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.1 mt -96.94 157.9 3.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.36 -0.608 . . . . 51.5 109.36 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.2 91.76 1.83 Allowed Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.764 -0.458 . . . . 44.329999999999998 109.764 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.09 165.48 0.88 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 124.055 3.17 . . . . 64.25 113.783 -171.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.529 ' H ' ' NH1' ' A' ' 28' ' ' ARG . 0.5 OUTLIER 64.88 24.06 12.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.093 -0.958 . . . . 74.530000000000001 111.486 -177.355 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.552 ' OG ' HG22 ' A' ' 27' ' ' VAL . 40.7 t -93.14 150.97 20.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.653 -0.703 . . . . 72.25 109.778 173.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -82.39 -18.17 42.95 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.933 -0.395 . . . . 73.109999999999999 109.933 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.586 HG21 ' HA ' ' A' ' 69' ' ' GLU . 11.2 m -94.75 -9.44 9.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.34 -0.391 . . . . 55.229999999999997 110.343 176.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.529 ' NH1' ' H ' ' A' ' 24' ' ' GLU . 52.2 ttp180 -50.6 -49.09 57.39 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.272 0.558 . . . . 65.150000000000006 110.121 170.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -62.06 -37.44 84.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.205 -0.907 . . . . 75.140000000000001 110.499 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -62.36 -44.99 95.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.726 -0.67 . . . . 74.140000000000001 110.824 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.453 HG13 HD11 ' A' ' 73' ' ' ILE . 47.5 mm -63.91 -48.32 86.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.761 -0.654 . . . . 73.239999999999995 111.247 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.9 mmt -64.84 -33.41 75.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 75.420000000000002 110.732 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.38 -28.14 68.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.871 -0.604 . . . . 61.009999999999998 110.361 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 82.6 mmm -81.58 -8.82 59.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.762 -0.654 . . . . 74.430000000000007 110.95 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.07 24.79 47.14 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.747 -0.74 . . . . 75.409999999999997 112.534 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mt -102.09 134.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.733 -0.469 . . . . 74.129999999999995 109.733 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.14 169.99 20.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.18 0.514 . . . . 62.409999999999997 111.598 -175.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.421 ' HD3' ' C ' ' A' ' 38' ' ' ARG . 4.1 tmt_? -68.28 110.49 4.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.783 -0.644 . . . . 53.109999999999999 109.541 175.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.695 ' HA2' ' HE3' ' A' ' 17' ' ' LYS . . . 132.32 -16.7 4.87 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.763 -0.732 . . . . 74.420000000000002 111.952 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 m -71.12 148.9 46.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.877 0.37 . . . . 74.409999999999997 110.547 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.437 ' C ' HD12 ' A' ' 42' ' ' ILE . 40.3 mt-10 -100.04 132.35 45.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.962 -0.563 . . . . 74.140000000000001 110.361 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.64 HG13 ' HB3' ' A' ' 58' ' ' LEU . 2.0 mp -118.98 122.12 68.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.31 0.576 . . . . 71.310000000000002 110.179 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.725 ' HB3' ' HB2' ' A' ' 57' ' ' ARG . 82.3 t80 -96.13 116.78 29.51 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.654 -0.869 . . . . 75.510000000000005 108.654 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.2 mm -71.7 101.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.683 -0.488 . . . . 74.109999999999999 109.683 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.34 -33.58 69.73 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.365 -0.605 . . . . 74.230000000000004 109.365 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.32 150.54 5.6 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.652 -0.785 . . . . 75.340000000000003 112.563 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -88.93 154.42 20.25 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.474 -0.936 . . . . 72.450000000000003 108.474 173.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.88 151.98 51.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.593 -0.521 . . . . 73.540000000000006 109.593 175.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.79 -23.91 61.0 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.49 2.127 . . . . 74.099999999999994 111.81 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ttt -86.0 -17.84 34.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.761 -0.654 . . . . 74.140000000000001 110.213 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.05 -23.64 20.72 Favored Glycine 0 C--N 1.33 0.2 0 CA-C-N 116.06 -0.518 . . . . 74.340000000000003 112.795 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.406 ' OD1' ' HA ' ' A' ' 53' ' ' PRO . 28.9 t70 -145.91 137.0 12.6 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.233 -0.654 . . . . 74.409999999999997 109.233 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HA ' ' OD1' ' A' ' 52' ' ' ASP . 4.2 Cg_exo -81.53 -168.84 6.95 Favored 'Cis proline' 0 CA--C 1.534 0.49 0 C-N-CA 124.157 -1.185 . . . . 64.209999999999994 113.194 0.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 64' ' ' SER . 57.8 mt -121.17 142.86 35.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 73.120000000000005 110.138 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.34 112.95 25.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.928 0.394 . . . . 74.329999999999998 110.652 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.639 ' O ' ' HA ' ' A' ' 62' ' ' SER . 4.0 mp -107.7 132.32 53.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 61.420000000000002 110.741 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.725 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 27.7 mmt180 -90.33 100.48 13.31 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.27 -0.641 . . . . 65.140000000000001 109.27 173.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.64 ' HB3' HG13 ' A' ' 42' ' ' ILE . 2.8 pp -137.66 142.6 41.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.984 -0.553 . . . . 74.400000000000006 110.016 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 70.63 -4.12 1.75 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.332 0.587 . . . . 71.140000000000001 110.42 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.26 -41.22 1.5 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.959 -0.564 . . . . 35.509999999999998 112.303 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -113.26 159.53 19.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.46 0.648 . . . . 71.450000000000003 111.985 -175.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 36.1 t -82.25 148.09 28.57 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.879 -1.055 . . . . 72.120000000000005 110.289 173.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 42.1 tp -151.08 146.38 26.13 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.554 -0.748 . . . . 64.129999999999995 109.793 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -89.01 113.99 25.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.199 0.524 . . . . 74.299999999999997 111.64 -178.404 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.503 HD23 HD13 ' A' ' 56' ' ' LEU . 3.6 mm? -112.89 157.16 21.78 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.067 -0.716 . . . . 73.299999999999997 109.067 174.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -84.3 160.8 20.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.864 0.364 . . . . 64.310000000000002 111.131 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.492 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 1.6 tmtp? -55.39 -28.44 54.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.627 -0.715 . . . . 43.520000000000003 110.667 175.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.8 m -56.6 -56.87 15.94 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.365 -0.38 . . . . 71.109999999999999 110.494 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.586 ' HA ' HG21 ' A' ' 27' ' ' VAL . 1.8 mp0 -63.61 -40.19 96.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.095 0.474 . . . . 70.150000000000006 110.353 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . . . -62.86 -20.97 65.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.572 -0.74 . . . . 74.209999999999994 111.648 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.474 ' HD2' ' C ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -79.22 -39.05 34.2 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.058 -0.349 . . . . 70.519999999999996 110.058 177.564 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -89.76 8.44 31.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.196 -0.457 . . . . 75.120000000000005 112.2 -171.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.453 HD11 HG13 ' A' ' 31' ' ' ILE . 47.1 mm -115.07 113.02 42.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.872 -0.418 . . . . 71.340000000000003 109.872 175.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.7 mt -93.45 126.44 38.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.776 -0.453 . . . . 55.020000000000003 109.776 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 18.6 m -128.14 153.27 37.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.277 0.561 . . . . 72.409999999999997 112.124 -174.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.545 ' HB2' HD11 ' A' ' 19' ' ' ILE . 42.2 tt0 -119.6 144.33 47.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.004 -0.998 . . . . 73.299999999999997 108.812 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.576 HG22 ' H ' ' A' ' 79' ' ' LEU . 9.3 p -70.38 136.66 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.071 0.462 . . . . 75.150000000000006 111.076 -176.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' A' ' 17' ' ' LYS . 40.8 mt -95.74 6.34 49.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.284 0.476 . . . . 64.129999999999995 112.284 -176.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.576 ' H ' HG22 ' A' ' 77' ' ' VAL . 94.6 mt -58.19 108.52 0.62 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.829 0.347 . . . . 62.109999999999999 110.376 176.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -83.74 78.36 9.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.771 0.796 . . . . 73.450000000000003 110.911 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -148.39 130.67 15.57 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.774 -1.103 . . . . 65.510000000000005 108.968 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -88.23 -25.5 22.84 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.97 0.414 . . . . 73.099999999999994 110.5 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -106.06 85.22 2.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.098 -0.501 . . . . 74.040000000000006 109.974 175.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -168.73 131.99 1.41 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.722 -0.672 . . . . 74.329999999999998 110.205 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -100.37 -93.46 0.28 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.559 -0.534 . . . . 70.25 109.559 174.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.5 p80 . . . . . 0 C--O 1.247 0.924 0 CA-C-O 119.03 -0.509 . . . . 71.420000000000002 110.117 176.011 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 tmm? . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 109.496 -0.557 . . . . 64.219999999999999 109.496 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.771 HG22 ' H ' ' A' ' 4' ' ' GLY . 87.9 m -144.22 124.02 13.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.331 -0.395 . . . . 70.209999999999994 110.013 175.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -82.5 8.39 11.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 74.310000000000002 110.654 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.771 ' H ' HG22 ' A' ' 2' ' ' THR . . . 76.09 -154.53 44.84 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.495 -0.775 . . . . 61.43 111.912 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.8 pt -125.24 168.12 18.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.948 -0.76 . . . . 62.240000000000002 108.948 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.24 149.1 50.77 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.027 -1.082 . . . . 55.109999999999999 111.033 177.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.688 HD21 HD11 ' A' ' 44' ' ' ILE . 2.7 tm? -54.43 -33.18 58.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.389 0.614 . . . . 73.519999999999996 109.89 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -70.62 -19.46 62.82 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.574 -0.739 . . . . 72.400000000000006 111.307 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -92.23 -8.12 46.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.903 0.382 . . . . 74.040000000000006 110.789 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.1 t -80.28 157.62 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.112 -0.495 . . . . 74.549999999999997 110.029 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.584 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 21.1 tt0 -94.81 176.81 6.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.793 -0.447 . . . . 75.120000000000005 109.793 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.584 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 39.9 pt -84.73 160.5 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 112.23 0.455 . . . . 61.140000000000001 112.23 -173.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 60.59 46.92 8.89 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.121 -0.945 . . . . 64.530000000000001 111.998 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.7 m -145.53 154.06 41.79 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.583 -0.735 . . . . 73.340000000000003 109.636 174.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.786 ' HE2' HD21 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -109.22 130.89 55.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.34 0.59 . . . . 72.439999999999998 110.802 178.674 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 77' ' ' VAL . 27.1 m -132.28 163.73 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.133 -0.94 . . . . 63.509999999999998 110.343 -177.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.48 ' HB2' HD21 ' A' ' 78' ' ' LEU . 29.8 ttpt -115.48 143.48 45.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.992 -0.549 . . . . 75.209999999999994 110.656 -177.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.566 ' HA ' HG12 ' A' ' 75' ' ' VAL . 52.8 t -77.61 98.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.509 -0.768 . . . . 72.430000000000007 110.048 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.8 HD11 ' HB3' ' A' ' 76' ' ' GLU . 39.8 mt -57.41 -54.69 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.638 -0.71 . . . . 72.450000000000003 110.453 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -161.6 178.01 37.65 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.158 -0.928 . . . . 73.340000000000003 111.34 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 53.6 mt -113.2 155.84 14.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.963 -0.384 . . . . 70.030000000000001 109.963 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.407 ' HA ' ' HD2' ' A' ' 23' ' ' PRO . 51.8 t -101.82 91.27 2.26 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.213 -0.662 . . . . 75.409999999999997 109.213 175.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.717 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 25.7 Cg_endo -59.22 -168.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.844 3.029 . . . . 61.329999999999998 113.773 -172.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 68.3 -43.86 0.49 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.571 -0.741 . . . . 74.430000000000007 112.371 -173.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.581 ' OG ' HG22 ' A' ' 27' ' ' VAL . 8.6 t -55.57 145.19 23.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.219 0.533 . . . . 71.239999999999995 111.725 -176.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.922 ' HD3' ' H ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -71.73 -29.68 64.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.567 -0.742 . . . . 62.43 109.805 173.071 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.691 HG21 ' HA ' ' A' ' 69' ' ' GLU . 11.4 m -79.84 -17.37 12.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.948 0.404 . . . . 75.349999999999994 110.049 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.717 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 2.8 tmm_? -55.18 -36.93 66.4 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.064 -0.516 . . . . 70.450000000000003 109.999 169.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -71.48 -40.07 70.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.292 0.568 . . . . 73.409999999999997 109.805 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.638 ' HG2' ' OE2' ' A' ' 69' ' ' GLU . 23.5 tptm -53.05 -48.04 67.96 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 114.988 -1.005 . . . . 62.119999999999997 111.021 177.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 27' ' ' VAL . 61.5 mt -50.99 -53.29 14.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.566 -0.743 . . . . 73.310000000000002 111.386 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 59.3 mtt -66.76 -35.39 79.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 73.420000000000002 111.371 -178.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.83 -38.58 89.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.943 0.401 . . . . 61.130000000000003 110.022 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.6 tpt -65.75 -25.57 67.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.472 -0.786 . . . . 75.319999999999993 110.961 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.87 8.09 11.09 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.756 -0.735 . . . . 41.229999999999997 112.744 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.425 ' HB ' ' CG2' ' A' ' 31' ' ' ILE . 37.4 mt -104.61 133.28 49.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.711 -0.477 . . . . 71.329999999999998 109.711 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.656 HG23 ' H ' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -129.78 -85.89 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 112.092 0.404 . . . . 70.239999999999995 112.092 -177.603 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.656 ' H ' HG23 ' A' ' 37' ' ' VAL . 45.4 ttm180 -153.99 117.56 4.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.964 0.412 . . . . 64.439999999999998 110.263 -177.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.43 -1.05 68.89 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.492 -0.861 . . . . 74.549999999999997 111.534 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.0 m -66.65 140.85 57.94 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.675 -0.491 . . . . 74.340000000000003 109.675 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.512 ' HG2' HD11 ' A' ' 78' ' ' LEU . 35.5 mt-10 -107.07 128.15 54.11 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.803 -0.635 . . . . 71.450000000000003 110.029 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.682 HG21 HD23 ' A' ' 56' ' ' LEU . 77.5 mt -121.48 136.28 58.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.317 -0.856 . . . . 73.120000000000005 110.535 -172.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.657 ' HD1' ' HB3' ' A' ' 15' ' ' LYS . 37.4 t80 -100.87 105.88 17.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.262 -0.426 . . . . 72.430000000000007 109.869 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.688 HD11 HD21 ' A' ' 7' ' ' LEU . 50.4 mm -70.54 120.92 19.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.941 -0.392 . . . . 73.420000000000002 109.941 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -89.96 -65.82 0.98 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.09 -0.504 . . . . 65.450000000000003 110.516 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' A' ' 12' ' ' ILE . . . -159.06 173.44 35.92 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.687 -0.768 . . . . 52.149999999999999 112.027 -177.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.496 ' HG2' HG23 ' A' ' 54' ' ' ILE . 58.3 mtpt -129.52 146.98 51.28 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.32 -0.622 . . . . 75.329999999999998 109.32 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.67 157.13 68.42 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.497 -0.557 . . . . 64.120000000000005 109.497 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -52.3 -29.74 39.76 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.82 2.347 . . . . 73.239999999999995 113.196 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -82.43 -7.95 59.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 74.030000000000001 110.821 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.11 -8.34 78.62 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.012 -0.835 . . . . 74.540000000000006 111.012 -173.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.776 ' HB2' ' HB2' ' A' ' 67' ' ' LYS . 5.9 t70 -139.29 128.98 14.26 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.014 -0.593 . . . . 73.409999999999997 109.797 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 97.3 Cg_endo -87.0 -174.32 9.8 Favored 'Cis proline' 0 C--O 1.237 0.459 0 C-N-CA 123.374 -1.511 . . . . 74.120000000000005 113.05 0.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.496 HG23 ' HG2' ' A' ' 47' ' ' LYS . 4.6 mp -112.86 140.78 30.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.791 -0.641 . . . . 44.43 109.31 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.65 106.76 19.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.025 0.441 . . . . 61.329999999999998 110.839 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.682 HD23 HG21 ' A' ' 42' ' ' ILE . 3.1 mp -105.51 134.27 48.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.836 -0.62 . . . . 74.129999999999995 109.381 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 39.6 mtt180 -98.19 119.98 37.81 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.982 0.42 . . . . 72.430000000000007 110.114 175.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.432 ' HG ' HD23 ' A' ' 63' ' ' LEU . 3.4 pp -139.43 140.58 37.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.431 -0.804 . . . . 65.519999999999996 109.999 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 46.7 ttm-85 65.9 -0.25 1.38 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.31 -0.859 . . . . 63.420000000000002 111.993 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.05 -52.02 0.56 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.468 -0.872 . . . . 55.25 113.585 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -120.87 177.33 5.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.871 0.367 . . . . 63.340000000000003 111.722 -173.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 30.2 t -88.18 142.9 27.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.596 0.712 . . . . 71.120000000000005 112.226 -175.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 62' ' ' SER . 3.2 mm? -134.68 143.54 47.29 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.342 -1.299 . . . . 54.329999999999998 108.928 176.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 p -99.33 119.91 38.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.078 0.466 . . . . 52.030000000000001 111.695 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.526 HD13 HD13 ' A' ' 56' ' ' LEU . 9.0 mp -114.72 151.42 33.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.86 -0.609 . . . . 70.510000000000005 109.423 175.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.492 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 46.8 mmm-85 -75.61 159.81 30.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.32 0.581 . . . . 75.219999999999999 111.745 -174.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.776 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -61.94 -33.58 74.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.246 -0.888 . . . . 60.340000000000003 110.611 179.691 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 41.7 m -73.3 -35.47 66.13 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.978 -0.555 . . . . 73.230000000000004 111.204 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.691 ' HA ' HG21 ' A' ' 27' ' ' VAL . 39.4 mt-10 -70.11 -43.01 71.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.351 0.596 . . . . 65.519999999999996 109.401 176.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.71 -21.25 65.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.386 -0.825 . . . . 63.450000000000003 111.072 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 68' ' ' SER . 1.8 ttpm? -70.74 -35.64 72.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.076 -0.511 . . . . 64.349999999999994 110.517 176.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -84.46 14.44 4.51 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.586 -0.734 . . . . 73.439999999999998 111.204 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.418 HG12 HD13 ' A' ' 31' ' ' ILE . 54.7 mt -125.8 120.47 57.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.897 -0.592 . . . . 65.049999999999997 109.909 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.1 mt -104.01 126.1 50.88 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.955 -0.387 . . . . 75.530000000000001 109.955 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 18' ' ' VAL . 23.9 m -129.51 157.44 42.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.318 0.58 . . . . 74.430000000000007 112.372 -174.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.8 ' HB3' HD11 ' A' ' 19' ' ' ILE . 14.0 pt-20 -119.22 153.35 35.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.265 -0.88 . . . . 73.030000000000001 109.681 176.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.655 HG22 ' H ' ' A' ' 79' ' ' LEU . 13.1 p -77.92 133.09 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.988 0.423 . . . . 54.229999999999997 111.024 -177.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.512 HD11 ' HG2' ' A' ' 41' ' ' GLU . 96.9 mt -93.86 -9.63 36.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.362 0.601 . . . . 61.530000000000001 110.826 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.786 HD21 ' HE2' ' A' ' 15' ' ' LYS . 86.9 mt -90.04 132.54 35.33 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.259 -0.882 . . . . 75.099999999999994 111.553 -177.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.477 ' HG2' ' H ' ' A' ' 81' ' ' HIS . 25.2 tt0 71.56 170.08 0.32 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 124.186 0.929 . . . . 74.0 111.183 175.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.477 ' H ' ' HG2' ' A' ' 80' ' ' GLU . 79.3 m80 -88.41 -8.09 55.56 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.102 -0.703 . . . . 73.099999999999994 109.102 171.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.436 ' H ' ' HG2' ' A' ' 80' ' ' GLU . 12.0 t-160 62.56 87.16 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.614 -1.176 . . . . 73.140000000000001 110.735 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -65.49 119.32 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.835 -0.62 . . . . 62.399999999999999 111.013 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 53.4 t60 70.6 116.92 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.842 -1.072 . . . . 72.420000000000002 111.618 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -81.33 115.85 20.89 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.431 -0.804 . . . . 61.130000000000003 109.49 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.029 -0.986 . . . . 65.319999999999993 110.726 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' HB ' ' A' ' 2' ' ' THR . 97.7 mmm . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 109.903 -0.406 . . . . 52.210000000000001 109.903 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 1' ' ' MET . 88.8 m 75.21 114.23 0.06 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.87 0.731 . . . . 62.329999999999998 110.254 -175.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt 66.25 24.53 10.68 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.466 -0.788 . . . . 71.019999999999996 110.098 -173.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.97 178.35 33.35 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.349 -0.841 . . . . 52.530000000000001 112.6 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 pt -115.37 173.07 3.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.808 -0.812 . . . . 71.150000000000006 108.808 176.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.45 143.2 29.08 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 119.865 -1.16 . . . . 61.43 111.72 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.507 HD11 HD11 ' A' ' 44' ' ' ILE . 39.5 tp -63.61 -24.71 67.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.2 0.524 . . . . 73.340000000000003 110.548 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -76.52 -14.39 60.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.853 -0.612 . . . . 74.510000000000005 110.604 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.85 -4.63 56.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.339 0.59 . . . . 74.329999999999998 110.012 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.5 t -98.26 162.28 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.505 -0.771 . . . . 62.149999999999999 109.399 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.791 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 24.8 tt0 -124.77 -172.0 2.47 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.98 -0.288 . . . . 72.439999999999998 110.79 -177.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.791 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 31.6 pt -63.35 154.13 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 113.445 0.906 . . . . 73.019999999999996 113.445 -170.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 63.02 27.1 15.77 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.965 -1.016 . . . . 62.149999999999999 111.962 173.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.843 ' HA ' HD11 ' A' ' 79' ' ' LEU . 19.6 m -102.42 152.66 20.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.259 -0.428 . . . . 65.099999999999994 110.53 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -124.17 110.92 15.28 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.235 -0.654 . . . . 71.430000000000007 109.235 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 77' ' ' VAL . 30.4 m -128.32 174.17 12.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.534 -0.757 . . . . 70.010000000000005 110.687 -174.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 37.5 ttmt -129.18 140.98 51.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.154 -0.475 . . . . 75.230000000000004 110.595 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.55 HG13 HG23 ' A' ' 73' ' ' ILE . 48.7 t -73.36 96.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.319 -0.855 . . . . 64.239999999999995 110.619 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.8 mm -63.29 -44.9 99.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.76 -0.655 . . . . 65.319999999999993 109.908 174.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.93 172.08 44.51 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.233 -0.984 . . . . 74.329999999999998 112.671 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.605 ' HB ' ' NH1' ' A' ' 28' ' ' ARG . 49.4 mt -127.77 158.98 39.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 108.068 -1.086 . . . . 73.200000000000003 108.068 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 25' ' ' SER . 38.2 t -101.19 91.3 1.96 Allowed Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.058 0.456 . . . . 65.420000000000002 111.254 -175.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.612 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 24.4 Cg_endo -59.94 171.55 2.86 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.696 2.264 . . . . 64.420000000000002 112.35 -177.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 68.93 -5.28 1.05 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.682 -0.69 . . . . 74.329999999999998 111.488 -175.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 1.2 m -78.74 156.77 28.72 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.955 -0.387 . . . . 54.039999999999999 109.955 173.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -75.33 -31.43 60.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.894 0.378 . . . . 75.219999999999999 110.599 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.525 ' HB ' ' HG3' ' A' ' 69' ' ' GLU . 29.6 m -81.47 -21.61 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 70.340000000000003 110.77 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.612 ' HG2' ' HA ' ' A' ' 23' ' ' PRO . 17.7 tpt180 -53.02 -43.78 66.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.94 -0.573 . . . . 54.329999999999998 110.465 175.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -59.43 -44.65 92.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.587 -0.733 . . . . 64.329999999999998 110.771 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 34' ' ' MET . 88.6 tttt -63.85 -48.93 74.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.818 -0.628 . . . . 62.229999999999997 110.931 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 27' ' ' VAL . 82.1 mt -57.33 -45.81 85.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.822 -0.627 . . . . 71.010000000000005 111.392 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 95.4 mmm -68.57 -35.5 77.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.795 0.331 . . . . 71.310000000000002 110.593 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -66.32 -39.96 89.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.99 -0.55 . . . . 74.420000000000002 110.255 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 91.0 mmm -60.52 -34.73 74.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.818 -0.628 . . . . 74.219999999999999 110.735 176.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.58 13.82 9.29 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.64 -0.791 . . . . 73.450000000000003 112.894 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.7 mt -89.64 127.1 42.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.86 0.362 . . . . 74.319999999999993 110.052 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.36 173.13 14.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.722 -0.672 . . . . 60.520000000000003 110.675 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.59 135.27 57.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.185 -0.461 . . . . 74.519999999999996 110.619 178.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.24 -12.09 66.89 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.908 -0.587 . . . . 71.120000000000005 112.662 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.3 m -73.29 142.24 47.17 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.859 -0.423 . . . . 71.120000000000005 109.859 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -94.39 136.14 35.02 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.065 0.459 . . . . 61.229999999999997 109.785 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.2 mm -116.74 117.82 56.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.643 -0.708 . . . . 75.099999999999994 110.463 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 63.4 t80 -95.52 119.48 34.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.854 -0.612 . . . . 74.540000000000006 109.436 174.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.507 HD11 HD11 ' A' ' 7' ' ' LEU . 26.3 mm -76.3 101.88 2.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.612 -0.514 . . . . 51.130000000000003 109.612 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -70.35 -42.83 71.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.934 -0.575 . . . . 71.109999999999999 109.601 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 169.75 177.78 40.42 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.889 -0.672 . . . . 75.340000000000003 111.956 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -117.97 143.09 46.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.132 -0.692 . . . . 72.340000000000003 109.132 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.64 158.46 31.13 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.605 -0.271 . . . . 63.549999999999997 110.394 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -45.41 -41.73 17.8 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.201 2.6 . . . . 72.209999999999994 113.419 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.7 ttt -71.22 -21.97 62.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 74.349999999999994 111.382 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.59 -7.22 42.31 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.728 -0.949 . . . . 71.010000000000005 110.728 -172.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.483 ' OD1' ' HA ' ' A' ' 53' ' ' PRO . 21.8 t70 -155.54 139.25 11.2 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.838 -0.801 . . . . 74.150000000000006 108.838 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HB3' ' HA ' ' A' ' 66' ' ' ARG . 4.1 Cg_exo -79.45 -170.19 8.51 Favored 'Cis proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.829 -1.321 . . . . 75.239999999999995 113.05 2.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.5 mt -116.39 137.5 49.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.713 -0.676 . . . . 74.230000000000004 109.904 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.03 111.65 20.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.291 -0.413 . . . . 60.240000000000002 110.287 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.6 mt -114.04 135.96 53.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.967 -0.561 . . . . 71.430000000000007 109.903 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.715 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 44.4 ttt180 -94.83 107.4 19.41 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.698 -0.482 . . . . 73.219999999999999 109.698 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.557 ' H ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -132.69 153.63 50.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.271 -0.422 . . . . 73.239999999999995 110.288 -177.539 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.543 ' HB2' HD22 ' A' ' 58' ' ' LEU . 0.2 OUTLIER 70.62 -55.63 0.63 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.773 0.671 . . . . 51.130000000000003 110.631 -178.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.53 -33.03 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 116.116 -0.493 . . . . 64.409999999999997 111.956 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -125.85 165.58 18.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.822 0.344 . . . . 75.400000000000006 110.938 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.715 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 47.7 t -86.28 145.82 26.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.243 0.544 . . . . 72.400000000000006 110.973 -178.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.1 mt -145.31 161.22 40.14 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.052 -0.976 . . . . 62.409999999999997 109.483 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -97.17 121.18 38.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.044 0.449 . . . . 65.340000000000003 110.741 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.42 143.31 49.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.355 -0.839 . . . . 65.430000000000007 109.389 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.485 ' HA ' ' HB3' ' A' ' 53' ' ' PRO . 37.4 mmt180 -71.82 155.14 40.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.073 0.463 . . . . 72.230000000000004 110.898 -177.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -56.27 -30.9 63.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.381 -0.827 . . . . 72.049999999999997 111.045 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 2.9 p -63.81 -37.87 89.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 44.409999999999997 111.607 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.525 ' HG3' ' HB ' ' A' ' 27' ' ' VAL . 1.6 mp0 -73.87 -39.39 63.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.003 0.43 . . . . 74.209999999999994 110.554 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.16 -23.64 66.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.202 0.525 . . . . 65.540000000000006 110.734 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 68' ' ' SER . 7.1 tmtt? -62.99 -33.9 76.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.79 -0.641 . . . . 74.140000000000001 111.74 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -88.65 -5.24 58.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.128 0.49 . . . . 72.140000000000001 111.78 -168.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.55 HG23 HG13 ' A' ' 18' ' ' VAL . 65.6 mt -105.13 115.58 47.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.192 -0.458 . . . . 61.119999999999997 110.899 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 74' ' ' LEU . 2.7 mm? -86.67 126.87 34.83 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.633 -0.506 . . . . 70.239999999999995 109.633 174.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.499 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 24.2 m -130.15 153.72 39.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.877 0.37 . . . . 72.109999999999999 111.574 -176.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -102.52 148.49 25.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.283 -0.636 . . . . 75.519999999999996 109.283 173.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 16' ' ' VAL . 53.6 t -89.3 114.51 27.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.864 0.364 . . . . 65.409999999999997 110.187 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.2 mt -94.23 0.23 55.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.192 0.52 . . . . 64.430000000000007 111.343 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.843 HD11 ' HA ' ' A' ' 14' ' ' SER . 87.3 mt -82.17 169.9 16.07 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.797 -0.638 . . . . 62.030000000000001 111.512 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -76.08 -164.03 0.34 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.183 -0.917 . . . . 70.129999999999995 110.341 174.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -66.4 140.81 58.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.802 0.334 . . . . 73.420000000000002 110.218 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -116.72 113.58 22.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.232 0.539 . . . . 74.310000000000002 111.299 -173.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -163.81 159.7 21.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.935 -0.575 . . . . 71.140000000000001 110.106 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.3 t60 59.78 34.3 21.91 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.605 0.717 . . . . 62.520000000000003 109.923 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -115.74 103.3 10.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.779 -0.646 . . . . 71.340000000000003 111.106 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.1 t60 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.205 -0.902 . . . . 53.030000000000001 109.322 177.862 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.965 0.412 . . . . 62.509999999999998 110.778 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.59 96.83 8.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.998 -0.546 . . . . 71.219999999999999 110.808 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -99.73 -177.84 3.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.182 -0.463 . . . . 73.510000000000005 110.542 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.99 116.69 6.95 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.74 -0.743 . . . . 61.030000000000001 112.07 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.6 pt -115.74 168.19 7.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.987 -0.375 . . . . 74.040000000000006 109.987 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.07 143.65 41.73 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.311 -0.947 . . . . 73.519999999999996 111.924 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.453 ' O ' HD13 ' A' ' 7' ' ' LEU . 2.6 tm? -58.3 -34.31 70.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.214 0.53 . . . . 74.420000000000002 109.841 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -69.78 -14.36 62.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.73 -0.668 . . . . 45.219999999999999 111.387 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -96.12 -2.86 45.66 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.809 0.338 . . . . 73.239999999999995 111.122 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.5 t -90.76 159.21 2.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.234 -0.439 . . . . 51.009999999999998 110.208 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -89.98 166.0 13.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.155 -0.475 . . . . 74.310000000000002 110.266 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.9 pt -77.48 162.87 4.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.185 -0.462 . . . . 64.239999999999995 110.599 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt 60.55 30.09 19.49 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.192 0.597 . . . . 74.140000000000001 111.014 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.6 m -120.88 151.67 39.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.68 -0.691 . . . . 74.209999999999994 110.3 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -109.59 127.4 54.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.097 -0.501 . . . . 73.200000000000003 109.698 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.447 HG23 ' HB ' ' A' ' 42' ' ' ILE . 22.5 m -128.97 173.54 13.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.261 -0.427 . . . . 63.0 111.099 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.821 ' HE3' HD21 ' A' ' 78' ' ' LEU . 29.9 ttmt -126.5 140.29 52.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.907 -0.588 . . . . 63.420000000000002 110.689 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.88 96.85 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.604 -0.726 . . . . 74.120000000000005 110.345 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.439 HD11 ' HD2' ' A' ' 17' ' ' LYS . 38.1 mm -92.36 -52.77 9.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.405 -0.816 . . . . 60.32 110.894 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.81 160.55 22.83 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.207 -0.997 . . . . 72.109999999999999 112.945 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.716 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 71.8 mt -142.4 158.12 19.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.801 -1.185 . . . . 72.209999999999994 107.801 -178.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.0 t -100.62 91.42 1.81 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.65 0.262 . . . . 74.120000000000005 110.65 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.716 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 31.4 Cg_exo -57.57 159.06 17.63 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.26 2.64 . . . . 65.030000000000001 112.732 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 62.62 74.5 0.43 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.521 -0.763 . . . . 75.430000000000007 110.155 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 28.9 t -159.26 153.52 23.81 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.134 -0.939 . . . . 62.340000000000003 109.599 -176.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -68.97 -22.6 64.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.833 0.349 . . . . 72.150000000000006 110.344 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 31' ' ' ILE . 25.2 m -95.77 -20.34 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.495 -0.32 . . . . 72.239999999999995 110.684 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.605 ' CD ' ' HA ' ' A' ' 23' ' ' PRO . 2.0 tpm_? -50.33 -54.45 21.41 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.184 -0.462 . . . . 74.129999999999995 111.074 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -65.61 -37.07 85.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.971 -0.559 . . . . 63.219999999999999 110.992 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -66.32 -45.05 81.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.327 -0.397 . . . . 54.439999999999998 111.23 -174.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.446 ' HA ' ' HE2' ' A' ' 34' ' ' MET . 79.2 mt -59.71 -45.83 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.347 -0.388 . . . . 75.120000000000005 110.834 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.584 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 2.2 ttt -71.98 -33.16 67.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.328 -0.397 . . . . 71.420000000000002 110.675 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -68.27 -24.66 64.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.031 -0.531 . . . . 63.130000000000003 110.079 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.446 ' HE2' ' HA ' ' A' ' 31' ' ' ILE . 63.0 mtm -79.64 2.32 22.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.786 -0.643 . . . . 63.439999999999998 111.441 178.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.63 -8.06 59.81 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.696 -0.764 . . . . 22.129999999999999 112.763 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 32' ' ' MET . 63.2 mt -81.5 137.42 21.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.864 0.364 . . . . 74.200000000000003 110.371 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.763 HG23 ' H ' ' A' ' 38' ' ' ARG . 1.9 m -133.78 -85.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.201 -0.454 . . . . 72.310000000000002 111.152 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.763 ' H ' HG23 ' A' ' 37' ' ' VAL . 17.8 ttm180 -153.37 140.68 19.59 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.985 -0.746 . . . . 73.209999999999994 108.985 175.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.58 -9.81 69.66 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.634 -0.793 . . . . 73.140000000000001 111.278 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -64.82 147.09 53.89 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.755 -0.461 . . . . 72.430000000000007 109.755 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -97.28 147.4 24.18 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.234 0.54 . . . . 61.200000000000003 111.541 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.603 HG12 ' HB3' ' A' ' 58' ' ' LEU . 64.5 mt -130.81 118.23 41.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.027 -0.988 . . . . 70.319999999999993 109.479 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.617 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 64.0 t80 -105.0 106.18 16.56 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.317 -0.401 . . . . 74.219999999999999 109.985 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.573 HG12 HD22 ' A' ' 56' ' ' LEU . 52.6 mt -75.31 102.35 2.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.235 -0.654 . . . . 74.510000000000005 109.235 177.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -85.54 -24.62 27.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.968 0.413 . . . . 71.519999999999996 110.906 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.12 -172.09 40.66 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.844 -0.693 . . . . 65.439999999999998 112.265 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.687 ' HG2' HG23 ' A' ' 54' ' ' ILE . 54.5 mtpt -123.49 159.08 29.85 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.737 -0.838 . . . . 74.430000000000007 108.737 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.82 152.14 87.44 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.64 -0.504 . . . . 75.340000000000003 109.64 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.91 -9.66 12.53 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.816 2.344 . . . . 34.109999999999999 112.999 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 55.7 ttp -97.29 -4.62 38.39 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.325 0.583 . . . . 74.5 110.318 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.67 -12.74 67.67 Favored Glycine 0 N--CA 1.454 -0.128 0 CA-C-N 115.988 -0.551 . . . . 71.25 111.958 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.559 ' OD2' ' HB2' ' A' ' 67' ' ' LYS . 11.4 t70 -152.32 136.51 10.22 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.344 -0.984 . . . . 70.109999999999999 108.344 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.466 ' HB3' ' HA ' ' A' ' 66' ' ' ARG . 3.5 Cg_exo -81.25 -167.96 6.31 Favored 'Cis proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.817 -1.326 . . . . 72.230000000000004 112.401 -1.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.687 HG23 ' HG2' ' A' ' 47' ' ' LYS . 46.8 mt -109.98 134.1 53.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.991 -0.55 . . . . 75.010000000000005 110.091 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.51 107.29 18.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.021 0.439 . . . . 43.240000000000002 110.167 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.573 HD22 HG12 ' A' ' 44' ' ' ILE . 28.8 mt -120.21 131.97 55.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.041 -0.527 . . . . 60.030000000000001 110.295 -177.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.813 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 27.9 ttt-85 -93.29 99.97 12.41 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.765 -0.828 . . . . 64.219999999999999 108.765 171.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.603 ' HB3' HG12 ' A' ' 42' ' ' ILE . 1.1 pp -119.13 146.0 45.49 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.084 -0.507 . . . . 74.109999999999999 110.461 -176.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 73.01 -45.87 0.63 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.895 0.747 . . . . 72.140000000000001 111.069 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.47 -26.42 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.293 -0.479 . . . . 74.450000000000003 112.152 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -121.45 157.74 29.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.855 0.36 . . . . 75.140000000000001 111.147 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.813 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -89.61 133.41 34.64 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.891 -0.595 . . . . 65.299999999999997 111.361 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.4 mt -141.98 152.02 43.06 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.552 -0.749 . . . . 71.219999999999999 109.475 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -88.86 110.81 21.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.203 0.525 . . . . 71.400000000000006 110.886 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.83 145.8 28.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.501 -0.772 . . . . 74.209999999999994 108.963 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.466 ' HA ' ' HB3' ' A' ' 53' ' ' PRO . 10.3 mpt_? -80.68 163.34 23.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.977 0.418 . . . . 75.510000000000005 110.338 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.559 ' HB2' ' OD2' ' A' ' 52' ' ' ASP . 4.5 ttmp? -47.76 -38.39 15.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.349 -0.841 . . . . 71.409999999999997 111.917 176.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.5 m -59.46 -50.78 72.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.251 -0.432 . . . . 74.319999999999993 111.766 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 73' ' ' ILE . 1.8 mp0 -63.66 -49.0 74.91 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.29 0.369 . . . . 74.219999999999999 110.795 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.55 -22.55 65.26 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.157 0.503 . . . . 65.530000000000001 111.481 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.595 ' HZ2' ' HB3' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -78.95 -23.2 44.75 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.0 -0.546 . . . . 55.43 110.705 -179.169 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -102.48 12.86 35.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 74.120000000000005 111.736 -175.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.463 HG22 HG13 ' A' ' 75' ' ' VAL . 61.9 mt -113.57 127.26 71.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.293 -0.412 . . . . 71.400000000000006 110.212 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.71 123.27 49.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.044 0.45 . . . . 73.239999999999995 109.923 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.463 HG13 HG22 ' A' ' 73' ' ' ILE . 28.2 m -129.56 160.04 40.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 112.324 0.49 . . . . 61.229999999999997 112.324 -170.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -106.28 159.02 16.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.591 -0.731 . . . . 63.399999999999999 109.305 172.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 79' ' ' LEU . 48.2 t -83.75 124.61 39.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.775 0.322 . . . . 74.430000000000007 110.668 -177.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.821 HD21 ' HE3' ' A' ' 17' ' ' LYS . 46.3 mt -94.87 -4.19 47.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.923 0.392 . . . . 45.43 111.01 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.418 ' H ' HG12 ' A' ' 77' ' ' VAL . 87.4 mt -68.97 90.89 0.45 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.676 -0.693 . . . . 74.239999999999995 110.89 178.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -101.74 155.17 18.29 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.956 -0.757 . . . . 61.310000000000002 108.956 176.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 72.2 108.59 0.07 Allowed 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.896 0.747 . . . . 72.25 109.229 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 77.15 125.74 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 O-C-N 124.163 0.915 . . . . 75.25 109.579 -171.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -80.94 161.17 24.43 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.926 -0.579 . . . . 44.439999999999998 110.543 -173.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -148.12 96.65 2.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.089 0.471 . . . . 70.099999999999994 111.318 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -150.43 128.75 12.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.547 -0.751 . . . . 73.209999999999994 109.815 175.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.8 p80 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.58 -0.724 . . . . 55.5 109.805 178.325 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.749 0.309 . . . . 70.230000000000004 110.485 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.9 m -96.13 -84.82 0.35 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.39 -0.368 . . . . 63.439999999999998 110.856 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -146.18 172.33 13.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.634 0.254 . . . . 74.129999999999995 110.442 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.53 160.77 13.11 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.507 -0.854 . . . . 42.25 112.95 -176.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.2 pt -125.97 179.33 3.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.185 -0.672 . . . . 74.239999999999995 109.185 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.93 145.49 31.18 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.024 -1.084 . . . . 70.310000000000002 110.942 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.944 HD21 HD21 ' A' ' 56' ' ' LEU . 51.7 tp -57.55 -30.85 65.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.982 0.42 . . . . 75.019999999999996 111.587 -176.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -71.25 -6.51 40.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.408 -0.36 . . . . 54.450000000000003 111.97 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -103.55 2.22 33.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.619 0.247 . . . . 53.240000000000002 111.145 -177.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.8 t -88.08 157.55 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.877 0.37 . . . . 71.409999999999997 110.797 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.522 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 32.1 tt0 -99.27 176.02 5.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.957 -0.565 . . . . 65.430000000000007 110.12 -178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.522 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 40.9 pt -79.95 159.31 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.854 0.359 . . . . 72.310000000000002 111.943 -175.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 59.55 35.79 22.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.379 -0.828 . . . . 74.200000000000003 111.15 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -130.94 151.27 51.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.269 -0.423 . . . . 70.019999999999996 110.809 -177.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.777 ' HG2' ' HD1' ' A' ' 43' ' ' TYR . 32.6 mtmt -109.07 130.18 55.48 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.238 0.542 . . . . 62.009999999999998 110.563 176.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 7.0 m -129.4 142.9 42.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.198 -0.91 . . . . 61.219999999999999 109.617 176.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.534 ' HB2' HD11 ' A' ' 78' ' ' LEU . 30.5 ttpt -104.5 142.62 34.3 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.059 0.457 . . . . 64.409999999999997 110.486 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.514 ' HA ' HG12 ' A' ' 75' ' ' VAL . 37.0 t -74.75 96.6 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.524 -0.762 . . . . 74.239999999999995 110.769 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.695 HD11 ' HB3' ' A' ' 76' ' ' GLU . 16.9 mt -58.72 -42.92 86.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.7 0.762 . . . . 72.129999999999995 108.951 171.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.29 170.66 39.95 Favored Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 114.55 -1.205 . . . . 72.219999999999999 111.911 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.734 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 14.5 mt -114.23 161.92 12.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.399 -1.334 . . . . 70.099999999999994 107.399 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.53 91.84 1.15 Allowed Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.252 0.548 . . . . 74.409999999999997 110.377 -174.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.734 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 31.6 Cg_exo -57.26 169.83 1.95 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.812 3.008 . . . . 73.420000000000002 113.414 -170.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 65.89 13.61 9.12 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.18 -0.918 . . . . 54.530000000000001 110.113 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 14.7 t -98.89 134.9 41.1 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.566 -0.743 . . . . 55.119999999999997 109.354 174.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' A' ' 26' ' ' LYS . 17.4 pttp -68.13 -15.61 63.66 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.334 -0.394 . . . . 75.140000000000001 111.295 178.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 31' ' ' ILE . 27.8 m -94.96 -28.14 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.557 -0.457 . . . . 74.510000000000005 110.736 174.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 3.8 tmt_? -54.1 -47.0 72.26 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.263 0.554 . . . . 75.209999999999994 109.845 174.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.9 ttt-85 -55.77 -47.33 77.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.187 -0.915 . . . . 65.239999999999995 110.433 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.58 -44.76 95.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.308 -0.86 . . . . 72.219999999999999 111.408 -177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.489 HD13 ' CG1' ' A' ' 73' ' ' ILE . 60.3 mt -64.74 -47.62 87.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.516 -0.766 . . . . 61.310000000000002 111.411 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.434 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 2.3 ttt -68.48 -32.87 73.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.089 0.471 . . . . 64.310000000000002 110.545 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.07 -23.62 64.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.815 -0.63 . . . . 54.240000000000002 110.612 177.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 22.2 ttm -75.62 -19.62 59.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.835 -0.621 . . . . 75.420000000000002 110.65 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.4 -5.06 13.31 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.418 -0.896 . . . . 72.5 112.825 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 32' ' ' MET . 44.6 mt -84.79 125.12 40.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.086 0.469 . . . . 73.120000000000005 110.298 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.05 -178.0 2.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.687 -0.688 . . . . 62.340000000000003 110.91 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -68.51 116.45 9.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.077 -0.51 . . . . 74.450000000000003 110.897 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.14 -2.47 44.01 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.887 -0.597 . . . . 61.020000000000003 113.018 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.9 m -75.72 148.34 38.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.858 0.329 . . . . 54.030000000000001 110.126 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -95.81 125.22 40.22 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.087 -0.506 . . . . 73.200000000000003 110.193 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.7 mt -100.66 114.83 40.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.475 -0.784 . . . . 72.409999999999997 109.748 176.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.777 ' HD1' ' HG2' ' A' ' 15' ' ' LYS . 37.1 t80 -91.26 105.09 17.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.121 -0.491 . . . . 74.319999999999993 110.105 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.652 HD11 HD11 ' A' ' 7' ' ' LEU . 47.8 mm -80.53 96.37 2.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.071 -0.714 . . . . 75.109999999999999 109.071 175.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.05 -26.89 33.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.983 0.421 . . . . 72.420000000000002 110.708 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.05 176.84 47.72 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.32 -0.943 . . . . 61.0 112.57 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.772 ' HG2' HG23 ' A' ' 54' ' ' ILE . 56.2 mtpt -133.62 158.22 43.76 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.756 -0.831 . . . . 73.019999999999996 108.756 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.85 156.84 63.97 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.501 -0.185 . . . . 52.310000000000002 110.501 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.98 -33.74 73.98 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.809 2.339 . . . . 72.400000000000006 112.729 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.1 ttm -87.68 -7.65 57.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.134 0.492 . . . . 72.329999999999998 110.875 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.89 -15.3 60.88 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 121.13 -0.557 . . . . 71.319999999999993 112.075 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -140.3 131.54 14.15 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.38 -0.6 . . . . 73.219999999999999 109.38 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.06 -170.08 7.94 Favored 'Cis proline' 0 CA--C 1.531 0.33 0 C-N-CA 124.124 -1.199 . . . . 64.430000000000007 113.217 1.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.772 HG23 ' HG2' ' A' ' 47' ' ' LYS . 41.1 mt -110.07 145.08 17.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.766 -0.652 . . . . 60.340000000000003 110.005 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.89 104.16 15.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.197 0.523 . . . . 61.049999999999997 110.706 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.944 HD21 HD21 ' A' ' 7' ' ' LEU . 7.9 mp -99.93 164.01 12.2 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.477 -0.783 . . . . 71.510000000000005 110.27 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 27.8 ttm180 -142.35 111.73 6.59 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.703 -0.851 . . . . 74.209999999999994 108.703 171.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.531 HD13 ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -136.5 149.48 48.19 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.793 0.33 . . . . 71.239999999999995 110.823 -177.336 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 62.89 2.72 1.04 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.581 -0.736 . . . . 64.230000000000004 111.676 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.67 -14.2 11.69 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.803 -0.713 . . . . 61.310000000000002 112.861 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.414 ' CD1' HD21 ' A' ' 63' ' ' LEU . 7.5 p90 -128.01 150.73 49.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.447 0.642 . . . . 62.039999999999999 112.385 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 47.9 t -84.46 144.63 28.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.093 -0.958 . . . . 54.039999999999999 111.969 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.476 HD22 ' C ' ' A' ' 62' ' ' SER . 3.4 mm? -135.11 144.37 47.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.897 -1.047 . . . . 73.439999999999998 109.757 177.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.47 110.01 21.41 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.349 -0.387 . . . . 74.209999999999994 110.194 175.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.58 HD21 HD22 ' A' ' 56' ' ' LEU . 2.9 pp -124.55 160.77 27.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.76 0.314 . . . . 63.509999999999998 110.46 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 6.1 mpt_? -80.17 161.98 24.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.564 0.697 . . . . 73.120000000000005 112.214 -169.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -57.89 -54.85 42.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.725 -1.125 . . . . 71.439999999999998 111.459 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.0 m -75.4 -11.71 60.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.033 0.444 . . . . 73.450000000000003 111.175 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 66' ' ' ARG . 20.8 tt0 -79.76 -42.45 24.5 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.835 -0.802 . . . . 73.540000000000006 108.835 176.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 7' ' ' LEU . . . -69.71 -21.15 63.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.817 -1.083 . . . . 64.340000000000003 111.157 174.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -59.01 -26.61 64.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.86 -0.609 . . . . 72.400000000000006 112.017 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.4 -3.19 57.31 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.331 0.586 . . . . 54.409999999999997 110.622 -177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.504 HG22 HG13 ' A' ' 75' ' ' VAL . 51.7 mt -101.83 128.58 54.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.104 -0.498 . . . . 33.0 110.722 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.0 mt -106.7 118.01 35.55 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.847 -0.427 . . . . 75.109999999999999 109.847 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 15.3 m -129.15 146.13 34.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.935 0.398 . . . . 72.530000000000001 111.957 -174.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.695 ' HB3' HD11 ' A' ' 19' ' ' ILE . 9.7 pt-20 -100.67 139.06 36.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.852 -0.613 . . . . 73.150000000000006 110.164 176.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.651 ' HA ' HG12 ' A' ' 16' ' ' VAL . 39.5 t -75.12 112.11 12.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.149 -0.478 . . . . 50.25 110.572 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 17' ' ' LYS . 90.6 mt -77.6 -17.97 57.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.249 0.547 . . . . 73.219999999999999 110.918 -177.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.3 mt -91.78 19.42 6.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.615 -0.72 . . . . 74.209999999999994 111.994 -176.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 61.01 -154.72 0.36 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.168 -0.469 . . . . 65.0 111.761 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.3 t60 80.1 -21.15 0.34 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.066 0.946 . . . . 72.209999999999994 111.905 173.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 35.37 82.68 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.11 0.964 . . . . 72.310000000000002 112.814 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -74.21 141.76 45.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.186 -0.916 . . . . 73.299999999999997 111.435 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -117.14 153.44 32.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.913 -0.585 . . . . 70.400000000000006 110.399 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -79.79 -62.35 1.71 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.899 -0.778 . . . . 73.120000000000005 108.899 172.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 52.5 m80 . . . . . 0 C--O 1.246 0.875 0 CA-C-N 115.291 -0.868 . . . . 72.209999999999994 109.29 174.575 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.419 ' HA3' HD12 ' A' ' 19' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 121.09 0.272 . . . . 64.44 113.672 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.1 pt -106.8 174.77 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.448 -0.945 . . . . 65.02 108.448 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.75 147.73 28.23 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 119.811 -1.185 . . . . 74.5 111.267 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.482 HD21 HD21 ' A' ' 56' ' ' LEU . 44.0 tp -62.65 -17.97 61.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.369 0.604 . . . . 74.43 110.94 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.706 HD22 ' HA ' ' A' ' 71' ' ' LYS . 7.8 p30 -75.44 -10.99 59.94 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.572 -0.74 . . . . 70.54 110.895 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -101.81 9.53 40.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.044 -0.525 . . . . 73.43 110.747 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.1 t -103.19 160.27 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.01 -0.541 . . . . 72.54 109.602 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.473 ' CG ' ' H ' ' A' ' 12' ' ' ILE . 12.6 tt0 -112.13 -176.85 3.02 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.226 -0.287 . . . . 73.33 110.226 -177.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.473 ' H ' ' CG ' ' A' ' 11' ' ' GLU . 40.8 pt -66.85 150.38 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.709 0.633 . . . . 73.02 112.709 -171.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 68.3 mttm 51.93 48.99 21.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.078 -0.965 . . . . 60.34 112.343 174.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.7 m -127.37 153.7 45.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.705 -0.68 . . . . 64.42 109.6 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -112.45 129.23 56.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.237 0.541 . . . . 60.25 111.023 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 77' ' ' VAL . 15.4 m -137.47 152.65 27.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.114 -0.948 . . . . 65.32 109.795 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.741 ' HB2' HD11 ' A' ' 78' ' ' LEU . 1.9 tmtp? -105.94 140.85 38.32 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.112 -0.495 . . . . 74.42 110.27 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -77.75 95.16 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.314 -0.857 . . . . 74.5 110.207 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.869 HD11 ' HB3' ' A' ' 76' ' ' GLU . 17.3 mt -63.49 -55.95 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.595 -0.729 . . . . 63.31 110.004 175.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.22 -177.19 33.1 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.398 -0.905 . . . . 51.41 112.91 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.496 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 22.4 mt -129.08 161.52 38.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.392 -0.966 . . . . 55.11 108.392 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.44 90.56 1.03 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.683 0.754 . . . . 71.35 109.582 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.878 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 36.6 Cg_endo -61.43 162.45 20.61 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.412 2.741 . . . . 64.45 113.864 -167.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 65.38 5.68 3.28 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.903 -1.044 . . . . 75.14 112.193 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.538 ' HB3' HG22 ' A' ' 27' ' ' VAL . 1.0 OUTLIER -77.15 -4.67 45.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.69 0.281 . . . . 64.22 111.503 179.076 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 88.6 tttt 71.24 -45.66 0.62 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.494 0.718 . . . . 71.14 110.941 -174.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 25' ' ' SER . 31.5 m -66.72 -16.73 21.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.069 0.461 . . . . 74.2 109.92 173.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.878 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 4.4 tmt_? -57.87 -37.96 74.89 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.115 -0.698 . . . . 75.21 109.115 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 6.3 tpp180 -64.82 -46.22 82.89 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 115.62 -0.718 . . . . 72.4 109.969 174.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -55.41 -48.74 73.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.609 -0.723 . . . . 71.03 110.834 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.498 HD11 ' HB3' ' A' ' 72' ' ' ASP . 78.3 mt -59.89 -48.65 86.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.957 -0.565 . . . . 74.34 111.139 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -38.17 90.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 64.31 110.837 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.86 -32.9 74.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.788 -0.642 . . . . 74.5 111.048 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -17.74 64.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.046 -0.525 . . . . 62.54 111.09 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.25 12.51 29.05 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.513 -0.851 . . . . 71.31 112.558 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.1 mt -91.51 126.71 44.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.079 0.466 . . . . 74.05 110.035 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.11 169.79 21.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.671 -0.695 . . . . 75.42 111.014 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -61.33 109.12 1.05 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.825 -0.625 . . . . 73.35 110.562 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.677 ' HA2' ' HE3' ' A' ' 17' ' ' LYS . . . 119.64 -9.85 11.53 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.761 -0.733 . . . . 63.12 113.092 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 m -71.48 149.24 46.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.02 0.438 . . . . 75.52 110.737 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -98.08 132.77 43.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.726 -0.67 . . . . 74.13 110.147 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.455 ' HB ' HG23 ' A' ' 16' ' ' VAL . 45.0 mm -108.93 121.66 62.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.461 -0.791 . . . . 73.13 110.343 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -111.31 112.15 23.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.329 -0.619 . . . . 74.45 109.329 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 7' ' ' LEU . 51.3 mm -75.59 121.22 26.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.351 -0.611 . . . . 75.2 109.351 176.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.56 -53.25 6.42 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.847 -0.798 . . . . 52.43 108.847 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.452 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . -172.77 179.05 44.5 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.731 -0.947 . . . . 73.4 110.731 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -118.37 156.96 28.03 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.166 -0.679 . . . . 73.13 109.166 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.27 157.37 77.76 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 110.038 -0.356 . . . . 53.42 110.038 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -59.18 -12.38 15.84 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.734 2.289 . . . . 74.13 112.77 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.5 mmt -99.89 -2.35 35.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.48 . . . . 71.33 110.486 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.01 -16.06 56.42 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.197 -0.525 . . . . 73.33 111.894 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -150.52 137.76 11.68 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 108.64 -0.874 . . . . 60.24 108.64 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.04 -164.95 4.02 Favored 'Cis proline' 0 CA--C 1.531 0.36 0 C-N-CA 123.734 -1.361 . . . . 71.1 113.25 1.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.4 mt -119.03 147.34 22.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.862 -0.608 . . . . 64.24 109.975 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.89 119.45 36.52 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.089 -0.337 . . . . 53.22 110.089 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.482 HD21 HD21 ' A' ' 7' ' ' LEU . 5.9 mp -117.04 154.65 30.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.816 0.341 . . . . 62.31 110.731 -176.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -128.28 105.13 8.13 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.337 -0.616 . . . . 74.23 109.337 170.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.462 ' N ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -142.6 160.33 40.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.197 -0.911 . . . . 74.24 109.871 -175.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? 75.15 -56.91 0.61 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.973 0.795 . . . . 72.11 109.574 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 173.91 -1.01 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.71 -0.677 . . . . 74.12 111.901 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -142.46 155.09 45.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.236 0.541 . . . . 75.34 111.956 -173.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 m -86.81 135.8 33.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.312 -0.858 . . . . 73.3 111.011 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.445 HD13 ' CD2' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -160.36 158.38 29.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.324 -0.398 . . . . 52.43 110.197 175.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.8 t -102.76 123.77 47.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.452 0.644 . . . . 73.42 111.62 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.445 ' CD2' HD13 ' A' ' 63' ' ' LEU . 4.1 mm? -112.64 158.0 20.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.924 -1.035 . . . . 73.35 108.812 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -86.51 159.35 19.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.057 0.455 . . . . 73.45 110.521 -175.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.52 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 0.9 OUTLIER -58.95 -28.74 66.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.682 -0.69 . . . . 74.2 110.026 176.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.5 m -59.2 -46.73 87.66 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.126 -0.488 . . . . 60.01 111.248 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -68.43 -41.99 79.56 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.186 0.517 . . . . 74.14 110.241 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.64 -21.55 64.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.661 -0.699 . . . . 65.34 111.304 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.706 ' HA ' HD22 ' A' ' 8' ' ' ASN . 54.2 tttm -79.4 -18.43 52.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.348 -0.387 . . . . 73.42 110.9 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.498 ' HB3' HD11 ' A' ' 31' ' ' ILE . 4.1 t70 -97.25 -9.8 27.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.246 0.546 . . . . 74.41 110.582 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.413 HG12 HD13 ' A' ' 31' ' ' ILE . 58.4 mt -96.78 121.99 47.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.982 -0.554 . . . . 74.24 110.481 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.8 mt -99.34 118.65 36.45 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.865 -0.42 . . . . 61.45 109.865 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.551 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 24.1 m -124.26 159.14 30.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.423 0.63 . . . . 65.4 112.474 -173.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.869 ' HB3' HD11 ' A' ' 19' ' ' ILE . 9.3 pt-20 -111.89 138.54 48.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.215 -0.902 . . . . 61.4 110.147 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.553 ' HA ' HG12 ' A' ' 16' ' ' VAL . 43.2 t -75.06 121.49 26.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.404 -0.362 . . . . 72.25 110.267 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.741 HD11 ' HB2' ' A' ' 17' ' ' LYS . 82.2 mt . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 121.313 0.578 . . . . 71.34 111.313 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.893 0 N-CA-C 112.453 -0.259 . . . . 73.44 112.453 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 pt -105.45 171.77 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.451 -0.574 . . . . 64.22 109.451 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.02 156.35 35.96 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 119.974 -1.108 . . . . 60.4 111.717 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.589 HD23 HG11 ' A' ' 75' ' ' VAL . 3.0 tm? -59.88 -26.52 65.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.508 0.67 . . . . 73.33 109.718 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.56 ' HB2' ' HG2' ' A' ' 67' ' ' LYS . 9.2 p30 -73.23 -8.94 57.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.499 -0.773 . . . . 65.31 111.417 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -103.47 1.0 31.84 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.496 -0.32 . . . . 73.41 111.612 -174.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 11' ' ' GLU . 20.9 t -81.54 157.31 4.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 61.12 111.501 -174.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.408 ' N ' HG12 ' A' ' 10' ' ' VAL . 8.0 tp10 -80.59 164.77 22.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.25 -0.886 . . . . 73.44 110.127 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.0 pt -79.25 138.09 20.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.102 -0.499 . . . . 71.24 111.116 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt 59.69 44.17 14.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.534 -0.757 . . . . 73.54 111.422 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.8 t -113.67 171.13 7.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.406 -0.815 . . . . 72.23 109.692 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -129.02 113.31 15.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.207 -0.451 . . . . 65.54 109.886 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 77' ' ' VAL . 18.4 m -123.01 160.35 25.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.449 0.642 . . . . 64.22 112.252 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -106.75 144.09 33.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.747 -1.115 . . . . 74.11 110.303 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.5 t -86.12 104.05 13.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.049 -0.523 . . . . 71.52 109.731 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.6 mt -59.37 -49.46 83.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.541 -0.754 . . . . 74.21 110.33 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.24 175.34 43.52 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.777 -0.725 . . . . 54.23 112.438 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.663 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 22.0 mt -97.6 159.79 3.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.307 -0.627 . . . . 64.22 109.307 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.42 90.84 1.27 Allowed Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 109.555 -0.535 . . . . 73.41 109.555 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.945 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 33.1 Cg_exo -58.19 167.25 4.79 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.932 3.088 . . . . 75.45 114.165 -170.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 64.59 15.99 10.02 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.79 -1.096 . . . . 71.4 110.828 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.584 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 23.3 t -87.5 165.12 15.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.607 -0.724 . . . . 73.43 110.067 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -21.83 46.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.944 -0.391 . . . . 63.34 109.944 175.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 31' ' ' ILE . 35.2 m -104.74 -3.69 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.285 -0.416 . . . . 71.4 111.554 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.945 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 3.6 tmm_? -50.73 -51.6 48.35 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.093 0.245 . . . . 61.52 110.929 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -63.85 -45.63 88.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.59 -0.277 . . . . 74.03 110.535 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -50.45 -53.48 29.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 52.43 111.129 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.553 HD12 HD11 ' A' ' 73' ' ' ILE . 46.7 mm -58.68 -47.81 87.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.631 -0.713 . . . . 74.51 111.752 -177.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.607 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 4.6 ppp? -73.86 -28.17 61.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.916 0.388 . . . . 61.42 111.072 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.89 -28.65 64.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.276 0.56 . . . . 75.22 109.883 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 81.0 mtp -81.49 1.03 35.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.294 -0.866 . . . . 75.44 111.44 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.66 -7.53 53.53 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.616 -0.802 . . . . 71.33 113.132 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 32' ' ' MET . 21.6 mt -84.08 130.36 36.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.772 0.32 . . . . 61.04 110.232 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.612 HG23 ' H ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -148.05 -85.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.182 -0.463 . . . . 61.14 111.473 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.612 ' H ' HG23 ' A' ' 37' ' ' VAL . 17.9 mtp180 -145.44 131.23 19.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.232 -0.44 . . . . 75.32 109.922 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.03 -4.08 86.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.567 -0.825 . . . . 60.25 112.156 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 m -64.29 144.07 57.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.607 -0.516 . . . . 41.1 109.607 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -117.47 133.93 55.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.968 0.413 . . . . 74.21 110.94 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.854 HG12 HD13 ' A' ' 58' ' ' LEU . 74.4 mt -119.68 136.06 58.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.599 -0.728 . . . . 73.05 111.312 -174.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -98.12 116.43 30.32 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.727 -0.471 . . . . 52.14 109.727 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.532 HD11 HD21 ' A' ' 7' ' ' LEU . 50.5 mm -82.64 104.61 11.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.623 -0.51 . . . . 62.41 109.623 177.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -76.85 -34.03 57.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.91 0.386 . . . . 74.14 110.724 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.35 171.56 31.72 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.564 -0.827 . . . . 64.23 112.196 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.609 ' HG2' HG23 ' A' ' 54' ' ' ILE . 40.6 mtmt -124.39 148.63 47.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.012 -0.736 . . . . 75.41 109.012 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.47 156.94 49.59 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.093 -0.336 . . . . 74.22 110.093 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.65 -14.17 25.04 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.525 2.15 . . . . 63.01 112.456 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.9 mtt -93.76 -6.17 46.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 73.4 110.205 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.67 -10.37 59.84 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.378 -0.689 . . . . 55.5 111.378 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -145.43 133.01 10.33 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 108.981 -0.748 . . . . 60.34 108.981 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -84.7 -172.32 9.18 Favored 'Cis proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.341 -1.524 . . . . 52.22 112.866 -0.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.609 HG23 ' HG2' ' A' ' 47' ' ' LYS . 59.4 mt -114.21 142.07 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.232 -0.44 . . . . 72.13 110.11 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.07 115.55 30.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.071 0.462 . . . . 75.52 110.415 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.644 HD23 HG21 ' A' ' 42' ' ' ILE . 5.7 mp -113.13 156.42 23.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.968 -0.56 . . . . 71.52 110.327 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 16.4 ttm180 -119.08 106.73 12.69 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.18 -1.044 . . . . 64.23 108.18 167.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.854 HD13 HG12 ' A' ' 42' ' ' ILE . 41.8 tp -137.36 146.75 44.9 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.579 -0.737 . . . . 73.31 110.219 -173.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.443 ' HD3' ' OH ' ' A' ' 61' ' ' TYR . 53.1 ttt180 65.67 12.48 8.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.37 -0.832 . . . . 71.24 110.646 176.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.5 -12.12 36.04 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 121.009 -0.615 . . . . 61.03 113.116 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.443 ' OH ' ' HD3' ' A' ' 59' ' ' ARG . 27.4 p90 -134.52 155.85 49.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.635 0.731 . . . . 53.14 112.448 -177.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -79.96 143.26 34.32 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.933 -1.03 . . . . 74.5 110.974 175.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -157.57 151.31 24.09 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.255 -0.646 . . . . 72.13 109.255 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -113.95 134.15 55.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.07 0.462 . . . . 65.23 110.952 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 pp -133.13 167.09 20.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.671 -0.695 . . . . 75.14 109.697 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -77.71 148.53 34.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.202 0.525 . . . . 71.32 111.766 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.56 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 14.8 tmtt? -62.31 -35.52 79.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.197 -0.911 . . . . 64.02 111.355 -176.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 60.2 m -67.86 -30.77 70.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.689 0.255 . . . . 73.05 111.689 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.25 -31.82 55.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.153 0.502 . . . . 61.54 109.809 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' A' ' 7' ' ' LEU . . . -65.51 -21.53 66.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.758 -0.656 . . . . 72.04 110.712 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.47 ' HE3' ' HB3' ' A' ' 71' ' ' LYS . 0.9 OUTLIER -69.55 -30.87 68.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.853 -0.612 . . . . 73.23 110.44 176.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.8 2.63 22.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.046 -0.525 . . . . 73.24 111.399 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.553 HD11 HD12 ' A' ' 31' ' ' ILE . 59.5 mt -115.98 114.96 47.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.99 -0.55 . . . . 74.5 109.81 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.0 mt -94.71 121.9 36.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.338 -0.392 . . . . 71.31 110.079 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.589 HG11 HD23 ' A' ' 7' ' ' LEU . 30.3 m -120.98 158.89 23.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.78 0.8 . . . . 63.4 112.424 -173.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.94 126.58 47.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.444 -1.253 . . . . 73.14 109.206 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.502 ' HA ' HG12 ' A' ' 16' ' ' VAL . 11.0 p -74.59 127.07 36.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.902 -0.59 . . . . 74.2 110.51 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.341 0.591 . . . . 71.24 110.898 -178.723 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.444 -0.807 0 N-CA-C 111.956 -0.458 . . . . 74.04 111.956 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.3 pt -133.03 179.49 4.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.782 -0.451 . . . . 74.25 109.782 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.17 151.01 48.2 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.263 -0.97 . . . . 40.12 111.008 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.58 HD11 HD21 ' A' ' 56' ' ' LEU . 3.1 tm? -57.06 -33.15 66.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 42.41 110.461 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -77.13 -10.15 59.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.33 -0.396 . . . . 71.33 111.762 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.37 -9.81 37.47 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.975 0.417 . . . . 64.23 110.953 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.6 t -77.94 159.42 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.973 -0.558 . . . . 75.14 110.406 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 29.9 tt0 -103.42 173.97 6.07 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.146 -0.316 . . . . 73.51 110.146 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.585 HG22 ' HA2' ' A' ' 46' ' ' GLY . 40.2 pt -72.99 153.78 7.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 112.21 0.448 . . . . 71.25 112.21 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 51.4 49.24 21.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.194 -0.912 . . . . 72.44 111.998 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.9 m -134.06 152.8 52.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.282 -0.872 . . . . 73.52 109.001 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -109.34 140.85 42.5 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.318 -0.553 . . . . 74.54 110.254 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 77' ' ' VAL . 29.3 m -132.57 174.86 12.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.793 -0.639 . . . . 61.11 110.677 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.405 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 84.3 tttt -134.34 139.11 45.42 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.0 -0.546 . . . . 73.14 110.324 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.688 ' HA ' HG12 ' A' ' 75' ' ' VAL . 35.0 t -75.54 93.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.428 -0.805 . . . . 72.34 110.257 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.531 HD11 ' OE2' ' A' ' 76' ' ' GLU . 47.9 mm -80.94 -56.8 5.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.553 -0.749 . . . . 73.41 111.312 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.86 158.97 22.84 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.23 -0.986 . . . . 42.43 112.908 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.651 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 68.7 mt -127.43 156.34 39.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.757 -0.831 . . . . 73.52 108.757 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.5 t -103.14 90.21 2.36 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 120.748 0.309 . . . . 74.25 110.33 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.651 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 29.2 Cg_exo -61.18 171.51 3.95 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.147 2.565 . . . . 63.11 112.441 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 63.81 21.14 12.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.873 -0.603 . . . . 63.33 111.007 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.795 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 22.6 t -88.54 153.39 21.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.907 -0.588 . . . . 70.34 109.702 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -93.28 -3.1 54.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.901 0.382 . . . . 73.22 110.069 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.509 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 32.8 m -113.5 -2.42 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 116.145 -0.479 . . . . 73.21 110.537 174.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.795 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 15.0 ttp180 -54.09 -42.4 69.33 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.927 0.394 . . . . 73.33 110.285 175.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.52 -38.96 92.0 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 115.98 -0.555 . . . . 64.44 110.958 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.667 ' HG2' ' OE2' ' A' ' 69' ' ' GLU . 21.1 tptm -55.41 -54.02 48.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.294 0.568 . . . . 71.13 110.363 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.696 HG23 HD12 ' A' ' 36' ' ' ILE . 65.3 mt -62.78 -40.98 90.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.055 -0.975 . . . . 74.52 110.939 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ttt -67.65 -32.4 73.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.968 -0.56 . . . . 75.53 110.985 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -73.12 -26.29 61.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.083 -0.508 . . . . 73.15 110.114 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 60.9 mtt -69.12 -27.66 65.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.4 0.619 . . . . 61.45 110.167 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.08 18.82 11.51 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.641 -0.709 . . . . 54.51 112.12 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.696 HD12 HG23 ' A' ' 31' ' ' ILE . 39.5 mt -88.93 124.27 41.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.162 0.506 . . . . 54.52 110.118 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.01 161.12 41.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.349 -0.841 . . . . 75.13 109.438 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -64.23 121.57 14.58 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.201 -0.296 . . . . 44.43 110.201 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.97 -20.32 11.63 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.866 -0.683 . . . . 74.32 111.929 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.4 m -72.92 147.97 44.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.199 -0.297 . . . . 72.4 110.199 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -105.85 144.86 31.98 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.786 -0.45 . . . . 53.53 109.786 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.658 HG21 HD23 ' A' ' 56' ' ' LEU . 73.0 mt -129.89 128.53 65.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.209 -0.45 . . . . 63.25 111.213 -174.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.547 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 69.4 t80 -96.69 108.08 20.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.145 -0.48 . . . . 71.21 109.866 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.469 HD11 HD21 ' A' ' 7' ' ' LEU . 46.3 mm -75.68 111.75 12.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.92 -0.4 . . . . 44.21 109.92 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -73.59 -53.25 10.93 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.636 -0.505 . . . . 62.52 109.636 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.585 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 179.23 177.54 47.74 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.396 -0.82 . . . . 70.31 111.772 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -123.02 143.22 50.09 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.283 -0.636 . . . . 74.33 109.283 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.402 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -59.99 156.59 36.06 Favored Pre-proline 0 C--N 1.326 -0.421 0 O-C-N 123.186 0.304 . . . . 73.24 110.206 177.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.402 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 10.6 Cg_endo -54.41 -24.85 37.07 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.096 2.53 . . . . 70.21 113.105 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.5 mtt -84.41 -13.33 52.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.117 0.484 . . . . 72.3 110.796 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.82 -2.68 80.26 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.338 -0.705 . . . . 43.45 111.338 -173.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.753 ' HB2' ' HB2' ' A' ' 67' ' ' LYS . 5.4 t70 -151.15 135.17 9.46 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.267 -0.642 . . . . 74.31 109.267 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -82.67 179.91 25.14 Favored 'Cis proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.564 -1.432 . . . . 74.41 112.436 -1.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 54' ' ' ILE . 4.5 mp -109.02 141.71 23.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.327 -0.62 . . . . 55.42 109.327 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.84 113.38 26.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.985 0.421 . . . . 63.0 110.834 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.658 HD23 HG21 ' A' ' 42' ' ' ILE . 2.2 mp -117.43 133.85 55.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.04 -0.527 . . . . 72.22 110.201 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.704 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 46.3 ttt180 -97.47 105.48 17.63 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.887 -0.782 . . . . 72.35 108.887 173.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.557 ' HB3' HG12 ' A' ' 42' ' ' ILE . 3.3 pp -139.86 151.71 45.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.279 -0.419 . . . . 73.33 110.75 -174.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 71.44 -19.93 0.24 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.065 0.546 . . . . 73.11 111.703 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 150.58 -26.65 1.07 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.27 -0.49 . . . . 51.11 112.212 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -140.85 166.86 23.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.001 0.429 . . . . 74.5 111.182 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.704 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.3 m -85.58 138.45 32.17 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.107 -0.497 . . . . 61.43 111.871 -176.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.9 mt -134.54 159.06 42.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.558 -0.746 . . . . 75.25 109.471 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p -104.73 122.2 45.2 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.154 0.502 . . . . 74.1 111.361 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.9 tp -109.19 145.47 35.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.861 -0.609 . . . . 62.54 109.504 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -77.53 149.3 34.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.601 0.239 . . . . 75.14 110.541 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.753 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 13.3 tmtt? -57.81 -36.96 72.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 62.43 110.646 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.3 m -62.84 -48.1 80.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.97 -0.559 . . . . 51.2 110.49 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.667 ' OE2' ' HG2' ' A' ' 30' ' ' LYS . 36.9 mt-10 -67.13 -30.96 71.1 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.788 -0.642 . . . . 73.41 110.551 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.68 -21.26 62.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.316 -0.856 . . . . 62.14 111.876 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -81.31 -23.73 37.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.926 0.394 . . . . 75.22 110.532 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.34 -5.45 47.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.073 -0.512 . . . . 52.24 111.445 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.534 HG22 HG13 ' A' ' 75' ' ' VAL . 43.8 mm -122.22 126.22 73.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.516 -0.311 . . . . 71.22 110.772 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.1 mt -108.15 120.79 43.36 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.052 -0.522 . . . . 72.54 109.969 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 18' ' ' VAL . 22.0 m -126.47 151.26 32.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.127 -0.488 . . . . 71.44 111.531 -173.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.531 ' OE2' HD11 ' A' ' 19' ' ' ILE . 14.6 pt-20 -91.39 138.78 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.437 -0.579 . . . . 73.53 109.437 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.663 ' HA ' HG12 ' A' ' 16' ' ' VAL . 24.3 t -87.64 109.9 20.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 120.916 0.388 . . . . 63.45 110.454 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 121.318 0.58 . . . . 45.54 110.695 -178.525 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.482 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.506 0 CA-C-O 120.824 0.124 . . . . 64.13 112.812 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.4 pt -101.67 160.83 3.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.614 -0.513 . . . . 63.21 109.614 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.01 147.53 30.59 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.142 -1.028 . . . . 54.31 111.283 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.726 HD11 HD11 ' A' ' 44' ' ' ILE . 36.9 tp -60.01 -26.81 66.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.017 0.437 . . . . 73.22 110.853 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.435 HD22 ' HA ' ' A' ' 71' ' ' LYS . 9.2 p30 -78.14 -9.8 59.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.148 -0.478 . . . . 73.01 111.011 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -90.34 -13.96 34.08 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.16 0.505 . . . . 75.42 109.932 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.5 t -77.86 154.88 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.613 -0.721 . . . . 71.14 110.49 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -103.76 170.87 7.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.741 -0.663 . . . . 73.41 110.278 -175.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.3 pt -71.72 146.91 11.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.012 -0.54 . . . . 72.44 111.116 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 13' ' ' LYS . 33.7 ttmt 59.04 63.96 1.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.8 0.81 . . . . 75.52 110.333 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 m -136.0 151.2 49.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.034 -0.985 . . . . 63.42 109.836 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -118.14 110.88 18.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.136 0.493 . . . . 72.52 110.017 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 77' ' ' VAL . 27.0 m -123.69 167.38 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.719 -0.673 . . . . 70.01 111.801 -173.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.619 ' HB2' HD21 ' A' ' 78' ' ' LEU . 81.0 tttt -117.96 145.83 44.42 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.094 -0.957 . . . . 61.33 110.126 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.594 ' HA ' HG12 ' A' ' 75' ' ' VAL . 45.9 t -82.15 97.96 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.131 -0.486 . . . . 65.1 110.266 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.872 HD11 ' HB2' ' A' ' 76' ' ' GLU . 42.6 mt -61.03 -48.59 88.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.816 -0.629 . . . . 70.44 109.991 175.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.68 160.73 31.03 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.489 -0.778 . . . . 62.03 112.31 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.701 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 58.5 mt -98.04 157.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.164 -0.68 . . . . 73.15 109.164 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.9 t -102.45 89.71 1.85 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 120.982 0.42 . . . . 72.34 110.144 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.932 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 21.1 Cg_exo -64.93 170.05 10.86 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.026 2.484 . . . . 71.51 112.367 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 64.25 7.55 3.59 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.638 -0.71 . . . . 75.24 111.879 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 28' ' ' ARG . 1.3 m -91.7 154.19 19.15 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.648 -0.871 . . . . 75.14 108.648 170.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -69.61 -45.59 68.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.702 0.287 . . . . 62.33 111.065 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.544 ' HB ' ' HG3' ' A' ' 69' ' ' GLU . 24.5 m -78.03 -6.79 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.065 0.46 . . . . 62.44 110.815 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.932 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -57.07 -36.7 70.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.682 -0.69 . . . . 65.05 111.373 178.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -67.23 -39.27 86.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.117 0.484 . . . . 51.54 110.007 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 34' ' ' MET . 85.3 tttt -63.12 -46.67 86.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.384 -0.826 . . . . 72.24 110.107 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 27' ' ' VAL . 68.9 mt -57.55 -48.2 83.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.603 -0.726 . . . . 71.32 111.445 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.61 -37.19 85.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.958 0.409 . . . . 60.31 110.81 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.26 -30.99 69.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 61.41 110.562 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 62.0 mtt -58.6 -32.29 68.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.047 -0.524 . . . . 71.23 110.887 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.41 1.82 7.71 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.617 -0.802 . . . . 64.53 112.208 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.456 HG23 HG21 ' A' ' 18' ' ' VAL . 63.1 mt -84.65 133.1 30.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.873 0.368 . . . . 64.32 110.31 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.748 HG23 ' H ' ' A' ' 38' ' ' ARG . 1.4 m -129.04 -74.86 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.911 -0.586 . . . . 74.11 111.03 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.748 ' H ' HG23 ' A' ' 37' ' ' VAL . 49.2 ttp180 -169.12 138.29 2.09 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.22 -0.659 . . . . 73.3 109.22 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.04 17.22 77.0 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.578 -0.82 . . . . 42.11 111.671 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 m -81.44 151.03 28.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.936 -0.394 . . . . 72.52 109.936 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -95.62 133.32 39.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.898 0.38 . . . . 63.35 110.728 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.4 mt -123.55 116.06 47.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.803 -0.635 . . . . 62.31 110.381 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.528 ' HE2' ' HG2' ' A' ' 45' ' ' GLU . 44.5 t80 -95.15 108.06 20.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.007 -0.542 . . . . 73.43 109.569 174.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.726 HD11 HD11 ' A' ' 7' ' ' LEU . 49.1 mm -75.3 105.87 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.119 -0.697 . . . . 71.35 109.119 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.528 ' HG2' ' HE2' ' A' ' 43' ' ' TYR . 0.4 OUTLIER -73.83 -61.14 1.95 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.123 -0.695 . . . . 72.24 109.123 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.01 162.56 35.9 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.649 -0.786 . . . . 70.24 112.203 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -125.52 153.0 44.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.202 -0.666 . . . . 70.35 109.202 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.72 156.42 89.12 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.589 -0.522 . . . . 72.34 109.589 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.68 -35.39 57.37 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.701 2.267 . . . . 75.11 112.574 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 tpt -65.43 -22.85 66.81 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.182 0.515 . . . . 71.52 111.264 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.27 -2.98 63.67 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 111.024 -0.831 . . . . 40.5 111.024 -174.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -143.32 132.75 11.71 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.996 -0.742 . . . . 72.02 108.996 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -89.56 176.63 20.01 Favored 'Cis proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.704 -1.373 . . . . 74.02 113.023 0.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 64' ' ' SER . 4.6 mp -105.75 130.97 56.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.728 -0.669 . . . . 65.43 109.804 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.66 113.6 26.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.501 -0.318 . . . . 74.24 110.248 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.635 HD21 HD21 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -129.49 172.15 11.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.459 -0.337 . . . . 74.42 110.938 -178.029 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.677 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 35.4 ttm180 -129.23 117.24 20.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.841 -0.429 . . . . 71.54 109.841 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.547 HD13 ' H ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -135.95 148.7 48.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.54 -0.3 . . . . 71.32 110.58 -177.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.6 tpt85 69.09 -19.59 0.17 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.22 0.608 . . . . 72.22 111.997 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 143.34 -24.27 2.2 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.606 -0.598 . . . . 41.24 111.606 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -115.49 156.76 25.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.098 0.475 . . . . 71.53 111.401 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 46.7 t -93.8 146.81 23.61 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.751 -0.659 . . . . 61.43 110.477 176.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.3 mt -144.82 160.25 41.57 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.284 -0.871 . . . . 61.32 109.571 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 35.8 t -118.89 128.04 54.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.679 -0.489 . . . . 54.44 109.679 176.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.635 HD21 HD21 ' A' ' 56' ' ' LEU . 2.0 pp -125.94 166.91 16.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.251 -0.432 . . . . 72.02 111.268 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.58 163.11 24.9 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.562 -0.745 . . . . 73.01 111.191 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.81 -22.39 64.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.404 -0.816 . . . . 62.12 109.998 174.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.2 m -66.14 -50.97 62.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.815 -0.629 . . . . 75.21 110.99 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.544 ' HG3' ' HB ' ' A' ' 27' ' ' VAL . 1.6 mp0 -58.26 -40.73 82.59 Favored 'General case' 0 N--CA 1.46 0.066 0 CA-C-O 121.075 0.464 . . . . 71.44 110.359 175.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HA ' ' HB3' ' A' ' 7' ' ' LEU . . . -62.03 -21.66 65.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.85 -0.614 . . . . 61.21 111.511 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.435 ' HA ' HD22 ' A' ' 8' ' ' ASN . 1.2 tmmt? -83.25 -32.29 26.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.285 -0.416 . . . . 65.3 110.633 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -96.95 9.33 42.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.285 0.476 . . . . 73.03 112.285 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.52 HG22 HG13 ' A' ' 75' ' ' VAL . 79.9 mt -113.24 120.85 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.22 -0.289 . . . . 72.33 110.22 174.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.0 mt -105.56 121.37 43.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.251 -0.431 . . . . 70.41 109.95 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.594 HG12 ' HA ' ' A' ' 18' ' ' VAL . 23.6 m -132.54 174.59 13.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.027 -0.533 . . . . 73.13 111.643 -174.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.872 ' HB2' HD11 ' A' ' 19' ' ' ILE . 35.4 tt0 -143.14 145.08 32.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.271 -0.877 . . . . 52.41 108.891 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.579 ' HA ' HG12 ' A' ' 16' ' ' VAL . 11.1 p -71.92 141.01 17.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.0 0.429 . . . . 71.34 110.661 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' A' ' 17' ' ' LYS . 68.1 mt . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.116 -0.493 . . . . 73.24 111.527 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.752 0 N-CA-C 112.154 -0.379 . . . . 74.34 112.154 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.1 pt -109.84 169.91 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.757 -0.46 . . . . 72.23 109.757 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.95 158.21 46.14 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.11 -1.043 . . . . 65.23 111.294 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.3 tp -65.81 -18.39 65.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.761 0.315 . . . . 61.13 111.214 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 33.8 p30 -92.63 0.16 57.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.797 0.332 . . . . 53.21 111.311 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.48 5.98 31.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.926 0.393 . . . . 65.42 110.684 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 t -88.72 157.34 3.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.01 0.433 . . . . 54.13 110.951 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -101.74 164.55 11.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.663 -0.698 . . . . 71.11 110.166 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.439 HG22 ' HA2' ' A' ' 46' ' ' GLY . 36.2 pt -75.87 166.53 2.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.951 -0.568 . . . . 63.11 111.16 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.3 mttm 65.91 9.42 6.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.783 -0.644 . . . . 74.5 111.41 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 m -111.7 148.23 33.88 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.226 -0.443 . . . . 71.02 110.811 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 41' ' ' GLU . 81.9 tttt -105.73 123.93 48.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.812 -0.631 . . . . 74.13 109.496 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 77' ' ' VAL . 21.5 m -119.17 167.81 12.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.132 -0.485 . . . . 72.33 110.57 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.578 ' HB2' HD21 ' A' ' 78' ' ' LEU . 84.3 tttt -133.58 141.12 47.54 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.768 -0.651 . . . . 73.42 109.982 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.591 ' HA ' HG12 ' A' ' 75' ' ' VAL . 43.4 t -76.52 95.74 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.377 -0.829 . . . . 73.31 110.2 -177.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.79 HD11 ' HB2' ' A' ' 76' ' ' GLU . 36.2 mt -57.46 -49.83 79.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.569 -0.741 . . . . 62.34 109.639 174.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.594 ' HA2' ' HG2' ' A' ' 38' ' ' ARG . . . -173.26 164.57 36.44 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.659 -0.781 . . . . 62.23 112.622 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.701 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 37.9 mt -85.38 158.97 3.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.733 -0.84 . . . . 74.52 108.733 176.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.3 91.71 1.84 Allowed Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.679 -0.489 . . . . 61.42 109.679 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.701 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 72.1 Cg_exo -49.62 169.08 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 124.226 3.284 . . . . 70.41 114.073 -173.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 66.27 19.93 11.04 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.953 -1.021 . . . . 73.43 109.302 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 1.032 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 42.1 t -84.03 152.06 24.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.489 -1.232 . . . . 61.14 110.248 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 11.1 mptt -98.11 -23.56 15.68 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.159 -0.682 . . . . 65.2 109.159 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -97.25 -7.81 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.559 -0.746 . . . . 62.42 111.039 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 1.032 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 8.4 tmm_? -46.77 -47.92 20.71 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.079 0.4 . . . . 75.21 112.079 176.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -70.27 -28.47 65.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.962 0.41 . . . . 64.33 110.455 -177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -73.46 -48.26 34.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.726 -0.67 . . . . 50.4 110.364 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.54 HD13 HD11 ' A' ' 73' ' ' ILE . 85.7 mt -60.5 -42.1 90.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.525 -0.761 . . . . 53.1 111.182 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ttt -65.9 -30.1 70.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 60.33 110.579 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.75 -32.88 70.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.889 -0.596 . . . . 54.12 110.146 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.8 mtt -63.24 -29.07 70.48 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.934 -0.576 . . . . 72.11 110.43 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.5 5.1 12.92 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.79 -0.641 . . . . 74.44 112.365 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.507 ' HB ' HG22 ' A' ' 31' ' ' ILE . 43.3 mt -90.42 126.59 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.992 0.425 . . . . 72.15 110.436 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.1 m -141.1 -177.67 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.489 -0.778 . . . . 65.32 110.268 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.594 ' HG2' ' HA2' ' A' ' 20' ' ' GLY . 46.0 mtt85 -69.78 114.75 8.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 72.42 110.313 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.39 -8.67 22.5 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.534 -0.841 . . . . 63.14 112.812 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 m -70.41 142.69 52.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.041 0.448 . . . . 72.42 110.412 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.402 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 47.0 mt-10 -106.45 137.47 44.37 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.61 -0.723 . . . . 72.13 110.218 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.763 HG12 ' HB3' ' A' ' 58' ' ' LEU . 66.1 mt -129.5 131.41 67.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.71 -0.677 . . . . 71.25 111.293 -172.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.536 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 53.3 t80 -96.95 125.9 41.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.696 -0.483 . . . . 64.11 109.696 171.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.6 mm -87.24 99.48 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.574 -0.528 . . . . 73.23 109.574 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.15 -41.94 24.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.653 -0.703 . . . . 65.02 110.497 -176.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.439 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 172.74 -172.91 45.32 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.432 -0.667 . . . . 34.01 111.432 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.881 ' HE2' ' HA2' ' A' ' 51' ' ' GLY . 13.9 ptmt -151.0 165.89 32.36 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.246 -0.65 . . . . 73.03 109.246 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.47 156.42 82.23 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.771 -0.455 . . . . 64.01 109.771 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.49 -32.14 51.71 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.797 2.331 . . . . 74.54 113.086 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 45.5 ttm -86.6 -8.67 57.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.426 0.631 . . . . 75.14 110.367 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.881 ' HA2' ' HE2' ' A' ' 47' ' ' LYS . . . 95.71 -11.27 68.35 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.618 -0.719 . . . . 52.43 112.477 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -131.87 127.53 21.26 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-O 120.841 0.353 . . . . 71.14 110.271 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -83.61 170.33 53.17 Favored 'Cis proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.918 -1.701 . . . . 60.43 112.718 -1.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.52 HG23 ' HB3' ' A' ' 47' ' ' LYS . 41.0 mt -98.57 141.99 15.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.849 -0.797 . . . . 75.42 108.849 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.99 102.9 14.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.033 0.444 . . . . 74.34 110.313 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.721 HD23 HG21 ' A' ' 42' ' ' ILE . 4.5 mp -108.4 162.01 14.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.0 -0.545 . . . . 65.0 109.941 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.696 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 75.3 ttt180 -132.51 100.66 5.04 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.878 -0.786 . . . . 63.14 108.878 173.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.763 ' HB3' HG12 ' A' ' 42' ' ' ILE . 2.9 pp -127.36 149.76 49.91 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.827 -0.624 . . . . 73.11 110.856 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.464 ' HD3' ' OH ' ' A' ' 61' ' ' TYR . 52.4 ttt180 70.26 -22.44 0.17 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.532 0.52 . . . . 72.42 112.13 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 141.52 -3.58 2.13 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.927 -0.654 . . . . 61.43 112.141 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.464 ' OH ' ' HD3' ' A' ' 59' ' ' ARG . 16.9 p90 -138.28 158.33 44.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.162 0.506 . . . . 72.41 111.328 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 34.8 t -87.14 147.15 25.75 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.532 -0.758 . . . . 73.43 110.126 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 54.1 tp -155.52 147.73 23.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.579 -0.737 . . . . 71.11 109.775 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 4.1 m -97.48 133.55 41.91 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.07 0.462 . . . . 63.31 110.71 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.702 HD23 HD13 ' A' ' 56' ' ' LEU . 3.8 mm? -123.09 150.12 43.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.609 -0.723 . . . . 70.43 110.178 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 66' ' ' ARG . 22.9 mmt180 -81.87 161.44 23.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.141 0.496 . . . . 63.44 111.222 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.39 -36.89 85.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 71.4 110.898 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.9 m -70.33 -43.27 70.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.442 . . . . 50.42 111.005 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.15 -35.07 79.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.261 0.553 . . . . 60.2 110.482 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 8' ' ' ASN . . . -68.03 -22.19 64.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.525 -0.761 . . . . 61.42 111.358 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -76.36 -29.23 57.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.168 0.508 . . . . 73.22 110.267 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.11 9.18 5.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.751 -0.659 . . . . 62.32 111.629 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.54 HD11 HD13 ' A' ' 31' ' ' ILE . 62.5 mt -128.23 131.27 69.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.327 -0.397 . . . . 64.23 110.55 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.2 mt -107.23 125.71 51.47 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.275 -0.421 . . . . 72.23 109.87 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 18' ' ' VAL . 27.4 m -129.81 160.31 40.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.307 0.575 . . . . 62.04 111.948 -175.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.79 ' HB2' HD11 ' A' ' 19' ' ' ILE . 6.5 tp10 -120.76 146.6 46.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.956 -1.02 . . . . 72.31 109.104 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.419 ' HA ' HG12 ' A' ' 16' ' ' VAL . 10.0 p -91.09 133.63 32.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.911 0.386 . . . . 74.52 110.094 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 17' ' ' LYS . 4.0 mm? . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 121.09 0.471 . . . . 74.05 111.342 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.629 0 N-CA-C 112.046 -0.422 . . . . 74.12 112.046 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 pt -124.89 179.41 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.389 -0.597 . . . . 75.13 109.389 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.42 154.13 41.91 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.464 -1.35 . . . . 61.44 111.598 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.9 tp -60.67 -27.56 67.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.964 0.411 . . . . 70.14 110.796 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -71.86 -15.16 62.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 53.41 111.533 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.26 -3.9 54.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.877 0.37 . . . . 74.12 110.823 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.7 t -90.36 159.39 2.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.345 -0.389 . . . . 64.44 110.375 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.609 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 22.1 tt0 -98.29 171.97 7.86 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.502 -0.555 . . . . 75.14 109.502 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.609 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 38.4 pt -79.83 177.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.457 -0.338 . . . . 61.54 110.474 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 pttm 52.79 21.16 1.83 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.414 1.085 . . . . 41.31 112.423 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.2 m -121.53 153.03 38.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.8 0.334 . . . . 62.51 110.726 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -108.97 132.0 54.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.081 0.467 . . . . 71.14 109.843 176.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.853 HG12 ' HA ' ' A' ' 77' ' ' VAL . 33.7 m -129.79 162.51 37.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.696 -0.684 . . . . 72.35 110.495 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.478 ' HB3' HD12 ' A' ' 78' ' ' LEU . 39.0 ttmt -115.6 143.86 44.73 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.281 -0.872 . . . . 65.42 109.231 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.822 ' HA ' HG12 ' A' ' 75' ' ' VAL . 53.8 t -73.53 95.87 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.855 -0.611 . . . . 71.13 109.947 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.4 mm -64.84 -40.98 90.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.247 -0.888 . . . . 72.14 109.891 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.97 -178.36 44.77 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.466 -0.873 . . . . 74.53 112.334 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.697 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 48.9 mt -128.34 159.3 39.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.364 -0.976 . . . . 70.21 108.364 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -100.1 90.81 1.44 Allowed Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.864 0.364 . . . . 52.5 110.157 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.697 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 17.5 Cg_exo -65.23 -178.56 0.86 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.335 2.69 . . . . 73.11 112.903 -173.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 61.97 25.52 15.32 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.816 0.817 . . . . 64.41 109.77 -173.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.866 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 10.8 t -115.02 150.66 35.5 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.59 -1.186 . . . . 72.42 109.64 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 3.8 mppt? -81.63 -32.73 31.81 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.597 -0.52 . . . . 73.05 109.597 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 31' ' ' ILE . 27.2 m -79.22 -19.95 12.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 64.22 110.652 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.866 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 5.7 tmm_? -52.28 -43.37 64.39 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.076 0.465 . . . . 74.45 109.826 172.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -59.41 -47.35 85.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.459 -0.792 . . . . 64.34 110.42 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 34' ' ' MET . 87.0 tttt -57.39 -47.19 82.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.209 -0.905 . . . . 71.45 111.028 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.489 HG22 ' HB ' ' A' ' 36' ' ' ILE . 75.9 mt -58.18 -44.77 88.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.566 -0.743 . . . . 34.34 111.409 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 55.2 mtt -71.59 -28.76 64.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.466 -0.334 . . . . 75.44 111.179 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.2 -31.96 72.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.237 0.541 . . . . 75.14 110.003 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 97.6 mmm -73.64 -9.18 58.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.462 -0.79 . . . . 74.22 111.057 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.5 -3.38 46.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.771 -0.728 . . . . 54.11 112.508 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.663 HG23 HG21 ' A' ' 18' ' ' VAL . 58.7 mt -88.06 129.72 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.911 0.386 . . . . 65.11 110.403 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.741 HG23 ' H ' ' A' ' 38' ' ' ARG . 1.0 OUTLIER -144.21 -75.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.837 -0.62 . . . . 75.24 111.437 -178.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.741 ' H ' HG23 ' A' ' 37' ' ' VAL . 24.7 ttt180 -150.86 140.18 21.34 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.602 -0.518 . . . . 73.11 109.602 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.06 19.25 69.82 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.776 -0.726 . . . . 54.3 112.106 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 m -85.28 146.72 26.91 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.948 -0.39 . . . . 62.34 109.948 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -90.99 127.8 36.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.866 0.365 . . . . 74.14 111.067 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.8 mm -126.22 114.87 40.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.44 -0.8 . . . . 75.25 109.609 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.825 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 39.3 t80 -106.3 119.34 38.99 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.559 -0.534 . . . . 75.12 109.559 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.434 HD13 HD12 ' A' ' 56' ' ' LEU . 14.6 mm -82.01 99.18 4.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.297 -0.41 . . . . 74.22 110.029 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -82.95 -22.58 33.73 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.154 -0.618 . . . . 73.42 110.364 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.79 -173.93 34.47 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.81 -0.71 . . . . 74.33 112.139 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.783 ' HG2' HG23 ' A' ' 54' ' ' ILE . 53.1 mtpt -126.8 160.3 31.28 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.442 -0.577 . . . . 53.32 109.442 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.18 151.23 94.24 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.712 -0.477 . . . . 51.44 109.712 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -51.4 -30.81 35.91 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.965 2.443 . . . . 61.43 113.215 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.0 tpt -76.09 -19.85 58.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.121 0.486 . . . . 65.01 111.223 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.58 -7.6 57.95 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.213 -0.755 . . . . 41.34 111.213 -174.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -152.42 132.61 7.35 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 108.9 -0.778 . . . . 74.24 108.9 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.71 -172.52 10.31 Favored 'Cis proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.567 -1.431 . . . . 53.44 112.98 0.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.783 HG23 ' HG2' ' A' ' 47' ' ' LYS . 53.5 mt -109.02 141.85 23.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.764 -0.653 . . . . 73.22 109.325 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.12 106.2 18.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.962 0.41 . . . . 70.42 110.998 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.447 ' N ' HD22 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -105.72 135.77 46.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.132 -0.486 . . . . 61.23 110.059 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.825 ' HB3' ' HB3' ' A' ' 43' ' ' TYR . 2.3 tmt_? -86.56 114.37 23.24 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.794 -0.817 . . . . 72.4 108.794 175.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.6 tp -136.57 146.82 46.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.726 -0.67 . . . . 74.21 110.271 -175.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 71.05 -56.75 0.62 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.487 0.715 . . . . 65.0 110.762 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.51 -36.94 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.41 -0.676 . . . . 51.44 111.41 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.42 ' HE2' HD21 ' A' ' 63' ' ' LEU . 29.6 p90 -124.34 176.59 6.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.759 0.314 . . . . 74.23 110.4 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.784 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -93.11 140.81 29.11 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.491 0.552 . . . . 63.44 112.491 -175.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.42 HD21 ' HE2' ' A' ' 61' ' ' TYR . 75.6 mt -137.04 148.12 46.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.267 -0.879 . . . . 64.25 109.28 174.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 5.7 p -88.52 128.68 35.56 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.291 0.567 . . . . 64.14 111.829 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -121.5 157.76 29.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.253 -1.017 . . . . 73.42 108.253 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -80.22 156.34 26.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.56 0.695 . . . . 73.11 112.159 -169.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 67' ' ' LYS . 6.6 ttpm? -57.46 -28.19 63.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.669 -1.151 . . . . 71.24 110.975 174.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.1 m -61.25 -51.82 67.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.858 -0.61 . . . . 63.31 110.395 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' O ' HG13 ' A' ' 73' ' ' ILE . 1.7 mp0 -63.52 -30.54 71.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.94 -0.573 . . . . 72.21 111.111 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.16 -21.79 62.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.335 -0.393 . . . . 63.42 111.69 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.08 -42.45 38.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.398 0.618 . . . . 72.43 109.642 177.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.09 -10.37 53.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.392 -0.822 . . . . 54.42 112.018 -170.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.531 HG22 HG13 ' A' ' 75' ' ' VAL . 74.2 mt -90.27 113.09 25.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.923 -0.399 . . . . 74.03 109.923 174.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.5 mt -97.01 112.07 24.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.243 0.545 . . . . 52.03 110.484 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.822 HG12 ' HA ' ' A' ' 18' ' ' VAL . 29.4 m -132.34 167.7 25.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.758 -0.655 . . . . 72.4 110.203 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -140.23 145.96 38.04 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.123 -0.695 . . . . 74.4 109.123 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.853 ' HA ' HG12 ' A' ' 16' ' ' VAL . 47.9 t -67.88 103.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.019 -0.537 . . . . 63.25 110.415 -177.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 17' ' ' LYS . 26.6 mt . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 115.759 -0.655 . . . . 71.04 111.184 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.79 0 N-CA-C 111.441 -0.664 . . . . 42.24 111.441 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.7 pt -107.88 163.07 5.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 110.176 -0.305 . . . . 73.24 110.176 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.26 157.83 53.51 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.732 -0.747 . . . . 61.01 111.755 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.559 HD21 HD11 ' A' ' 56' ' ' LEU . 52.4 tp -61.52 -23.47 65.95 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.938 0.399 . . . . 73.32 111.195 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -87.15 -7.12 58.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.562 -0.29 . . . . 52.44 111.192 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -95.97 0.14 51.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.913 0.387 . . . . 71.15 110.67 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.624 HG11 HG11 ' A' ' 16' ' ' VAL . 12.1 t -90.0 163.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 65.35 110.812 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.437 ' N ' HG12 ' A' ' 10' ' ' VAL . 30.4 tt0 -83.53 165.12 19.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.259 -0.428 . . . . 62.31 109.988 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.7 pt -85.93 163.18 2.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.076 -0.511 . . . . 54.1 110.826 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm 59.45 25.21 13.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.005 0.431 . . . . 73.31 111.301 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.7 m -108.87 159.95 16.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.182 -0.463 . . . . 45.2 110.511 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.52 ' HG2' HD12 ' A' ' 78' ' ' LEU . 42.2 tttm -116.48 119.23 34.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.716 -0.846 . . . . 74.05 108.716 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.624 HG11 HG11 ' A' ' 10' ' ' VAL . 28.8 m -125.19 155.86 34.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.038 0.447 . . . . 64.41 112.011 -170.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -117.4 142.63 46.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.478 -0.783 . . . . 73.41 110.27 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.825 ' HA ' HG12 ' A' ' 75' ' ' VAL . 68.0 t -83.06 97.68 4.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.735 -0.666 . . . . 63.11 110.617 -176.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.4 mt -58.09 -54.38 33.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.2 -0.909 . . . . 63.5 110.358 173.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.36 165.66 34.46 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.375 -0.917 . . . . 33.41 113.076 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.42 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 58.6 mt -119.75 158.8 21.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.879 -0.786 . . . . 70.15 108.879 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 25' ' ' SER . 62.0 t -99.96 91.75 1.75 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.018 0.437 . . . . 74.01 110.028 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.692 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 37.6 Cg_endo -62.53 171.23 5.81 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.211 2.607 . . . . 34.3 113.308 -173.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 66.1 -15.73 0.12 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.004 0.922 . . . . 74.3 112.486 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -66.72 154.3 41.05 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 110.116 -0.327 . . . . 74.24 110.116 175.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 26' ' ' LYS . 72.1 mmtt -69.01 -30.51 68.92 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 111.942 0.349 . . . . 74.04 111.942 -175.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.712 HG21 ' HA ' ' A' ' 69' ' ' GLU . 20.5 m -83.39 -13.41 11.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.886 -0.326 . . . . 74.34 111.336 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.692 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 1.3 tmt_? -58.03 -48.41 80.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.379 -0.373 . . . . 74.14 111.085 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -62.48 -36.34 82.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.094 0.473 . . . . 73.24 110.79 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 34' ' ' MET . 61.5 tttm -66.29 -50.2 64.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.469 -0.787 . . . . 75.33 110.683 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.703 HD13 HD11 ' A' ' 73' ' ' ILE . 70.7 mt -66.37 -42.05 89.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.757 -0.656 . . . . 74.3 111.478 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 83.8 mtp -70.44 -28.75 65.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.633 0.254 . . . . 65.44 111.17 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -67.59 -28.21 67.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.199 0.523 . . . . 71.11 109.891 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.521 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 91.7 mmm -73.82 -16.44 61.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.524 -0.762 . . . . 74.44 111.062 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.3 -13.94 21.05 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.592 -0.813 . . . . 63.43 112.865 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.401 ' HB ' HG22 ' A' ' 31' ' ' ILE . 40.0 mt -78.64 129.33 37.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.71 0.291 . . . . 44.4 110.418 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.777 HG23 ' H ' ' A' ' 38' ' ' ARG . 2.1 m -139.21 -77.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.992 -0.549 . . . . 63.45 111.972 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.777 ' H ' HG23 ' A' ' 37' ' ' VAL . 1.4 tmm_? -149.44 125.44 10.62 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.048 -0.723 . . . . 71.32 109.048 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.33 -14.33 59.69 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.713 -0.756 . . . . 75.33 111.988 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.12 138.31 58.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.32 -0.622 . . . . 71.15 109.32 176.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -123.34 147.45 47.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.359 0.6 . . . . 54.53 111.258 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.782 HG21 ' HB3' ' A' ' 56' ' ' LEU . 44.3 mt -136.35 152.66 30.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.116 -0.947 . . . . 73.24 110.046 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -99.65 137.7 37.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.76 -0.459 . . . . 65.54 109.76 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.4 mm -87.76 103.12 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.431 -0.35 . . . . 71.34 110.585 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 57' ' ' ARG . 17.9 mm-40 -71.67 -39.06 70.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.123 -0.489 . . . . 71.44 110.423 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.73 -175.95 34.92 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.93 -0.652 . . . . 51.14 111.927 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -127.65 152.28 47.87 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.001 -0.37 . . . . 73.53 110.001 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -65.28 165.55 17.1 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.157 -0.474 . . . . 62.24 110.444 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 9.5 Cg_endo -51.53 -32.59 44.33 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.903 2.402 . . . . 64.03 113.014 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.5 mtt -89.52 -4.15 58.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.978 0.418 . . . . 74.21 110.991 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.32 5.83 89.55 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.219 -0.752 . . . . 74.45 111.219 -173.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 52.9 t0 -148.39 121.15 4.56 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.9 -0.778 . . . . 70.1 108.9 -176.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HB3' ' HD2' ' A' ' 66' ' ' ARG . 91.5 Cg_endo -86.41 -169.9 6.28 Favored 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.537 -1.443 . . . . 64.22 113.311 1.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 54' ' ' ILE . 4.4 mp -112.63 145.61 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.424 -0.807 . . . . 72.03 109.504 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.45 108.15 20.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.873 0.368 . . . . 75.04 110.798 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.782 ' HB3' HG21 ' A' ' 42' ' ' ILE . 2.2 mm? -102.06 146.14 28.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.464 -0.569 . . . . 64.24 109.464 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 21.8 ttt180 -116.79 114.17 23.57 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.478 -0.489 . . . . 70.34 110.442 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 60' ' ' GLY . 6.0 tt -149.23 156.02 41.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.895 -0.78 . . . . 71.01 108.895 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 58' ' ' LEU . 79.6 ttt180 74.64 -21.84 0.28 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.309 0.576 . . . . 74.21 110.412 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 146.88 -40.92 0.99 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.719 -0.673 . . . . 73.41 111.6 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.4 ' HE2' HD21 ' A' ' 63' ' ' LEU . 23.9 p90 -116.57 168.55 10.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.143 0.497 . . . . 73.42 111.201 -175.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.2 m -85.74 139.03 31.68 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.395 -0.82 . . . . 64.35 111.556 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.4 HD21 ' HE2' ' A' ' 61' ' ' TYR . 76.4 mt -134.49 158.75 43.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.669 -0.696 . . . . 60.43 109.309 175.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.1 m -100.85 138.48 37.84 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.072 0.463 . . . . 64.01 111.305 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.4 mt -127.76 134.64 49.51 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.357 -0.838 . . . . 52.01 108.909 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.536 ' HD2' ' HB3' ' A' ' 53' ' ' PRO . 25.3 mmm180 -64.9 153.5 40.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.686 -0.233 . . . . 71.04 110.655 -176.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -33.86 67.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.782 0.325 . . . . 65.31 110.192 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.4 m -57.66 -45.8 85.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.932 -0.577 . . . . 43.21 110.711 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.712 ' HA ' HG21 ' A' ' 27' ' ' VAL . 32.6 mt-10 -66.29 -44.54 83.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.227 0.537 . . . . 73.23 109.856 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.33 -22.31 66.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.486 -0.779 . . . . 62.12 111.614 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -81.31 -24.53 37.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.134 0.493 . . . . 74.23 110.608 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -95.25 12.81 27.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.255 0.55 . . . . 65.12 110.599 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.703 HD11 HD13 ' A' ' 31' ' ' ILE . 65.2 mt -121.6 119.57 59.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.65 -0.705 . . . . 71.22 109.669 176.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.7 mt -102.64 122.35 44.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.7 -0.482 . . . . 65.44 109.7 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.825 HG12 ' HA ' ' A' ' 18' ' ' VAL . 31.0 m -132.97 173.13 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.276 0.56 . . . . 74.03 112.3 -172.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.68 160.46 38.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.153 -0.93 . . . . 64.22 109.449 174.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.61 134.06 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.13 0.49 . . . . 74.51 111.534 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.52 HD12 ' HG2' ' A' ' 15' ' ' LYS . 81.6 mt . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 115.842 -0.617 . . . . 74.01 110.978 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 121.409 0.449 . . . . 51.14 113.892 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 pt -137.03 176.33 8.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.055 -1.091 . . . . 71.32 108.055 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.77 148.71 42.07 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.7 -1.238 . . . . 75.5 111.054 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.642 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 2.0 tm? -57.24 -29.82 64.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.504 0.668 . . . . 73.42 109.799 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.675 HD22 ' HA ' ' A' ' 71' ' ' LYS . 8.7 p30 -71.36 -14.11 62.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.482 -0.781 . . . . 61.13 111.364 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -101.59 3.99 40.5 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.417 -0.356 . . . . 70.34 111.06 -174.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.9 t -83.74 155.45 3.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.112 0.482 . . . . 72.33 110.236 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.548 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 17.3 tt0 -95.02 175.09 6.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.798 -0.637 . . . . 74.42 110.452 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.548 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 23.7 pt -75.09 145.69 10.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.236 -0.438 . . . . 62.34 111.69 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 59.12 24.42 12.76 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.433 -0.803 . . . . 72.23 112.17 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 m -108.45 147.54 31.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.082 -0.508 . . . . 62.2 109.831 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -109.66 149.83 29.15 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.954 -0.387 . . . . 74.24 109.954 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.942 HG12 ' HA ' ' A' ' 77' ' ' VAL . 28.4 m -140.25 178.3 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.14 0.495 . . . . 75.42 110.987 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.672 ' HB2' HD11 ' A' ' 78' ' ' LEU . 7.1 ttpm? -133.06 140.4 47.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.545 -0.752 . . . . 72.32 110.138 176.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.682 ' HA ' HG12 ' A' ' 75' ' ' VAL . 47.6 t -73.14 97.67 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.605 -0.725 . . . . 63.11 110.073 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.7 mm -79.75 -49.34 19.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.693 -0.685 . . . . 73.43 110.951 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -152.55 168.08 31.54 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.818 -1.182 . . . . 53.33 113.646 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.65 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 50.0 mm -124.39 157.42 31.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.023 -1.103 . . . . 64.34 108.023 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 t -102.62 90.32 2.18 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 120.849 0.357 . . . . 73.24 110.218 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.65 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 74.2 Cg_exo -49.71 159.33 1.54 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.774 2.983 . . . . 73.21 113.875 -171.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 64.84 69.86 0.49 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.308 -0.86 . . . . 70.4 110.945 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.69 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 9.3 t -149.57 162.98 39.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.366 -0.834 . . . . 73.25 109.137 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -73.27 -45.13 57.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.358 0.599 . . . . 74.25 109.55 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.457 HG11 ' HG2' ' A' ' 69' ' ' GLU . 27.8 m -78.71 -20.54 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.488 -0.778 . . . . 63.11 111.573 -176.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.69 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 2.1 tmt_? -50.87 -43.98 59.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.257 0.551 . . . . 70.23 109.654 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.45 HH11 ' HD3' ' A' ' 29' ' ' ARG . 8.5 tpt180 -71.8 -44.21 64.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.591 -0.731 . . . . 71.52 110.614 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -60.59 -45.96 92.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.429 -0.805 . . . . 63.15 111.926 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 34' ' ' MET . 65.8 mt -68.68 -41.19 82.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.062 -0.517 . . . . 72.23 111.181 -177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.1 ttt -72.26 -28.47 63.15 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.66 -0.416 . . . . 75.5 110.371 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.8 -38.94 87.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.131 0.491 . . . . 40.32 109.944 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 6.9 mmt -56.81 -29.42 62.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.262 -0.881 . . . . 55.51 111.363 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.51 13.31 22.82 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.763 -0.732 . . . . 52.04 111.975 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -90.51 134.17 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.925 -0.398 . . . . 75.33 109.925 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 m -137.48 -177.86 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.081 -0.509 . . . . 72.34 110.547 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 54.8 ttp180 -64.52 131.46 47.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.366 -0.379 . . . . 74.11 110.119 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.61 -21.58 36.35 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.556 -0.831 . . . . 74.4 112.56 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.1 m -68.2 146.49 53.33 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.896 0.379 . . . . 72.5 110.342 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -95.88 132.06 41.56 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.472 0.653 . . . . 53.42 110.916 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.599 HD12 ' HB3' ' A' ' 58' ' ' LEU . 48.7 mm -121.11 122.49 67.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.059 -0.973 . . . . 74.13 109.458 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.693 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 14.9 t80 -102.47 118.35 36.67 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.702 -0.481 . . . . 73.43 109.702 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 mm -85.19 100.16 8.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.487 -0.561 . . . . 73.31 109.487 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.38 -42.0 65.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.207 -0.664 . . . . 73.42 109.207 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.52 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 170.27 -169.44 42.25 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.243 -0.743 . . . . 64.41 111.243 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.749 ' HG3' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -146.1 162.92 36.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.395 -0.594 . . . . 64.3 109.395 175.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -61.28 160.83 20.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 O-C-N 123.486 0.491 . . . . 42.44 110.315 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 9.3 Cg_endo -52.81 -26.54 31.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.151 2.567 . . . . 73.53 113.47 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.8 ttt -93.45 -7.64 43.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.087 0.47 . . . . 62.01 110.877 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.749 ' HA2' ' HG3' ' A' ' 47' ' ' LYS . . . 89.05 -1.54 83.09 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.923 -0.656 . . . . 41.13 112.092 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -145.71 125.86 7.09 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.216 -0.661 . . . . 61.05 109.216 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.93 178.56 31.54 Favored 'Cis proline' 0 C--O 1.236 0.382 0 C-N-CA 123.029 -1.655 . . . . 64.03 112.842 -0.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.712 HG23 ' HB3' ' A' ' 47' ' ' LYS . 19.8 mt -114.92 141.83 30.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 72.24 109.813 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.59 109.73 21.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.995 0.426 . . . . 62.43 110.322 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.6 mt -120.58 135.58 55.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.293 -0.412 . . . . 52.13 110.945 -173.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.693 ' HB3' ' HB3' ' A' ' 43' ' ' TYR . 4.2 tmt_? -92.34 100.83 13.33 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.986 -1.116 . . . . 71.34 107.986 172.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.599 ' HB3' HD12 ' A' ' 42' ' ' ILE . 2.0 pp -138.78 156.59 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.643 -0.708 . . . . 73.2 110.811 -174.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? 71.34 -44.76 0.6 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.909 0.756 . . . . 75.33 110.707 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.69 -19.13 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 116.23 -0.441 . . . . 54.44 112.02 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -137.96 168.9 18.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.988 0.423 . . . . 74.1 111.436 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.652 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.2 m -85.27 126.71 33.92 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.627 -0.715 . . . . 74.0 110.534 175.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 52.9 tp -145.23 148.87 33.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.657 -0.702 . . . . 74.15 109.224 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 21.8 t -95.01 125.96 40.02 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.181 0.515 . . . . 70.45 110.99 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.12 168.18 11.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.266 -0.879 . . . . 73.21 109.397 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.48 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 30.4 mmt180 -77.53 153.48 33.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.157 0.503 . . . . 71.31 111.673 -177.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -60.08 -34.78 73.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.525 -0.761 . . . . 75.35 109.986 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.4 m -61.66 -36.26 80.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.302 -0.863 . . . . 73.04 110.91 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.48 ' HG3' ' HB2' ' A' ' 66' ' ' ARG . 40.7 mt-10 -69.97 -41.89 73.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.458 0.647 . . . . 75.52 110.079 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.77 -21.52 66.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.212 -0.904 . . . . 75.22 111.497 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.675 ' HA ' HD22 ' A' ' 8' ' ' ASN . 61.2 tttm -71.32 -25.21 62.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.792 0.33 . . . . 61.14 111.226 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.61 -4.47 57.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.074 0.464 . . . . 74.45 111.194 -174.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.642 ' HB ' ' HB2' ' A' ' 7' ' ' LEU . 21.1 mt -104.54 125.4 59.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.15 -0.477 . . . . 72.22 110.655 -178.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.1 mt -102.99 115.77 31.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.52 -0.548 . . . . 62.52 109.52 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.682 HG12 ' HA ' ' A' ' 18' ' ' VAL . 19.7 m -130.65 150.1 34.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.142 -0.481 . . . . 72.35 111.461 -174.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -99.49 139.87 34.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.453 -0.573 . . . . 55.02 109.453 171.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.942 ' HA ' HG12 ' A' ' 16' ' ' VAL . 40.9 t -73.95 113.63 12.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.033 0.444 . . . . 73.22 110.583 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' A' ' 17' ' ' LYS . 47.5 mt . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.964 -0.562 . . . . 75.12 110.939 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.691 0 CA-C-O 120.933 0.185 . . . . 53.33 113.271 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.4 pt -97.91 167.34 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.499 -0.926 . . . . 74.51 108.499 172.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.46 143.46 29.37 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 119.276 -1.44 . . . . 41.33 111.482 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.414 ' O ' HD23 ' A' ' 7' ' ' LEU . 8.2 tt -61.73 -26.84 68.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.32 0.581 . . . . 65.11 109.935 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.611 HD22 ' HA ' ' A' ' 71' ' ' LYS . 6.8 p30 -67.76 -14.63 63.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 73.45 110.7 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.97 -2.95 39.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.115 -0.493 . . . . 74.43 111.309 -176.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.451 HG21 HG21 ' A' ' 16' ' ' VAL . 34.1 t -78.09 159.69 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.956 0.408 . . . . 73.13 110.459 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.452 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 28.0 tt0 -102.61 173.77 6.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.873 -0.603 . . . . 73.13 110.169 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.59 HG22 ' HA2' ' A' ' 46' ' ' GLY . 33.9 pt -76.42 149.8 6.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.35 0.5 . . . . 71.04 112.35 -173.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 53.8 31.02 12.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.174 -0.921 . . . . 75.4 112.142 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.7 m -121.2 145.86 47.39 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.261 -0.644 . . . . 70.21 109.261 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -110.45 137.97 47.46 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.343 0.592 . . . . 74.41 111.727 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' A' ' 77' ' ' VAL . 16.2 m -137.5 163.63 30.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.167 -0.924 . . . . 74.24 109.247 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 41' ' ' GLU . 38.4 ttpt -118.96 141.55 48.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.059 0.457 . . . . 74.22 111.241 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.512 ' HA ' HG12 ' A' ' 75' ' ' VAL . 47.0 t -73.91 93.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.995 -1.002 . . . . 75.3 110.121 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.1 -38.85 56.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.538 -0.755 . . . . 54.44 110.445 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.42 153.27 24.59 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.087 -1.054 . . . . 74.23 113.441 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.0 mt -114.7 158.25 15.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.177 -1.046 . . . . 73.43 108.177 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 22' ' ' VAL . 7.5 p -100.18 91.84 1.86 Allowed Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 121.761 0.791 . . . . 62.02 110.243 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.945 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 29.3 Cg_endo -60.01 166.67 8.41 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.907 2.404 . . . . 74.1 112.544 -174.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 66.52 11.9 8.38 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.388 -0.824 . . . . 73.1 111.226 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.859 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 34.7 t -85.51 157.45 20.42 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.429 -0.582 . . . . 62.53 109.429 174.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -69.0 -43.83 74.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.162 -0.681 . . . . 71.31 109.162 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.3 m -77.94 -15.68 14.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.353 -0.84 . . . . 75.1 110.969 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.945 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -52.46 -43.17 64.78 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.592 -0.276 . . . . 55.32 110.311 176.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -71.06 -41.64 70.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.413 . . . . 65.42 110.956 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -54.1 -45.12 71.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.315 0.579 . . . . 75.33 110.945 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.776 HD13 HD11 ' A' ' 73' ' ' ILE . 86.9 mt -65.8 -46.85 87.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.042 -0.981 . . . . 64.11 112.054 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 51.1 mtt -73.33 -29.37 62.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.726 0.298 . . . . 73.44 111.121 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.89 -28.69 69.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.266 0.555 . . . . 73.41 110.109 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 20.8 ttm -76.87 -20.78 55.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.597 -0.729 . . . . 75.02 110.69 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.7 15.23 15.57 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.659 -0.781 . . . . 50.41 112.901 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.519 ' HB ' HG22 ' A' ' 31' ' ' ILE . 25.8 mt -96.3 129.25 46.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.849 0.357 . . . . 74.35 110.298 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.6 m -134.28 -177.96 2.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.932 -0.576 . . . . 61.25 110.592 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -67.78 139.6 56.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.263 -0.273 . . . . 70.12 110.263 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.35 -2.17 87.46 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.035 -0.603 . . . . 34.24 112.789 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m -75.44 133.88 41.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.166 -0.679 . . . . 71.22 109.166 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 17' ' ' LYS . 5.1 pt-20 -104.57 129.07 52.69 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.28 0.562 . . . . 70.13 109.934 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.638 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 63.0 mt -118.17 132.84 66.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.023 -0.989 . . . . 54.25 110.578 -171.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -92.01 104.12 16.56 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.056 -0.72 . . . . 75.12 109.056 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.8 mm -74.21 97.47 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.183 -0.673 . . . . 63.44 109.183 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.436 ' OE2' ' HB2' ' A' ' 57' ' ' ARG . 50.0 mt-10 -66.47 -39.5 88.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.885 0.374 . . . . 74.3 110.618 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.59 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 170.19 172.69 36.89 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.355 -0.926 . . . . 73.31 112.215 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.639 ' HG2' HG12 ' A' ' 54' ' ' ILE . 46.1 mtmt -110.0 165.05 12.03 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.331 -0.618 . . . . 71.44 109.331 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -66.79 164.54 32.96 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.844 -0.428 . . . . 74.11 109.844 174.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.502 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 84.9 Cg_exo -42.79 -49.16 6.91 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.223 2.616 . . . . 74.41 113.704 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.3 ttt -84.96 -10.86 56.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.893 0.378 . . . . 74.21 111.028 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.98 2.92 39.39 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.917 -0.659 . . . . 73.24 112.774 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -151.68 128.51 5.43 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 110.074 -0.343 . . . . 61.03 110.074 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -82.72 -165.85 4.54 Favored 'Cis proline' 0 CA--C 1.532 0.392 0 C-N-CA 123.414 -1.494 . . . . 72.14 113.088 2.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.639 HG12 ' HG2' ' A' ' 47' ' ' LYS . 52.7 mt -120.51 147.46 24.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.448 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -103.11 111.23 23.49 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.836 0.351 . . . . 51.31 110.351 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.638 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 2.2 mp -117.07 129.99 56.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.184 -0.462 . . . . 74.43 110.006 -176.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.764 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 23.8 ttm180 -101.43 115.28 30.14 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.647 -0.421 . . . . 60.45 110.402 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.566 ' HG ' HG12 ' A' ' 42' ' ' ILE . 5.5 mp -116.76 145.88 43.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.868 -0.605 . . . . 63.3 109.748 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 64.2 -77.97 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.729 0.643 . . . . 75.33 110.852 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.13 9.57 0.35 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.348 -0.453 . . . . 71.31 112.068 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -147.28 154.97 41.61 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.298 0.57 . . . . 63.41 111.137 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.764 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 21.8 t -93.7 144.32 25.51 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.508 -0.769 . . . . 63.04 111.855 -175.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.4 154.74 44.65 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.488 -1.233 . . . . 60.44 108.767 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -116.12 114.53 24.63 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 120.972 0.415 . . . . 74.44 111.916 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.543 ' HG ' HD13 ' A' ' 56' ' ' LEU . 3.6 pp -122.25 167.23 13.48 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.484 -0.562 . . . . 64.01 109.484 174.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 -86.34 163.93 17.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.518 0.675 . . . . 72.23 112.27 -174.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.496 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 1.4 tmtp? -64.5 -20.94 66.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.953 -1.021 . . . . 72.23 110.277 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 m -69.1 -50.92 43.84 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.12 -0.491 . . . . 63.02 110.652 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.76 -36.46 78.99 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.3 0.571 . . . . 54.13 109.956 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.94 -21.68 66.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.336 -0.847 . . . . 75.51 111.862 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.611 ' HA ' HD22 ' A' ' 8' ' ' ASN . 88.8 tttt -84.28 -22.9 30.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.152 0.501 . . . . 74.34 110.526 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.478 ' HB3' HG12 ' A' ' 22' ' ' VAL . 4.6 m-20 -87.09 -14.18 42.14 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.875 -0.602 . . . . 72.1 110.919 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.776 HD11 HD13 ' A' ' 31' ' ' ILE . 40.1 mm -95.92 122.61 47.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.128 -0.487 . . . . 62.24 110.546 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.2 mt -100.61 114.96 29.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.053 -0.521 . . . . 60.04 109.871 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.568 HG13 HG22 ' A' ' 73' ' ' ILE . 24.9 m -118.71 161.12 17.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.087 -0.506 . . . . 73.1 111.241 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -118.75 145.56 45.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.713 -0.676 . . . . 65.33 109.305 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.756 ' HA ' HG12 ' A' ' 16' ' ' VAL . 39.3 t -72.34 123.01 26.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.76 -0.654 . . . . 64.04 110.545 -176.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 75.23 111.593 -177.889 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.668 0 CA-C-O 121.072 0.262 . . . . 72.33 112.687 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.5 pt -122.77 179.22 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.89 -0.781 . . . . 63.21 108.89 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 73' ' ' ILE . . . -77.45 151.7 38.49 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 119.805 -1.188 . . . . 52.12 111.884 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 7' ' ' LEU . 2.9 tm? -60.09 -32.62 71.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.297 0.57 . . . . 71.34 109.483 177.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.597 HD22 ' HA ' ' A' ' 71' ' ' LYS . 8.6 p30 -70.27 -15.59 62.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.461 -0.79 . . . . 74.32 111.094 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -92.58 -3.9 54.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.074 0.464 . . . . 74.13 110.658 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.4 t -91.33 158.79 2.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.98 -0.748 . . . . 63.3 108.98 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.588 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 24.8 tt0 -108.01 175.52 5.45 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.239 -0.282 . . . . 71.54 110.239 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.588 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 32.5 pt -68.83 153.59 8.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.24 -0.436 . . . . 64.23 111.691 -175.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 60.64 41.21 15.57 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.301 -0.863 . . . . 72.31 110.914 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 m -128.56 149.77 50.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.149 -0.932 . . . . 75.43 109.638 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.475 ' HG2' HD12 ' A' ' 78' ' ' LEU . 85.8 tttt -115.37 132.4 56.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.043 -0.354 . . . . 50.45 110.043 177.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.813 HG12 ' HA ' ' A' ' 77' ' ' VAL . 26.6 m -133.04 162.62 39.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.254 0.55 . . . . 74.22 111.226 -176.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.614 ' HB2' HD21 ' A' ' 78' ' ' LEU . 19.8 ttmm -112.22 138.75 48.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.415 -0.811 . . . . 75.32 109.435 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.76 ' HA ' HG12 ' A' ' 75' ' ' VAL . 60.7 t -75.65 95.96 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.619 -0.719 . . . . 72.23 110.038 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.6 mm -61.05 -40.44 85.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.678 -0.692 . . . . 54.34 109.823 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.75 168.65 39.74 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.416 -0.897 . . . . 70.44 112.32 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.713 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 43.9 mt -105.28 159.38 5.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 108.606 -0.886 . . . . 74.42 108.606 176.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 25' ' ' SER . 58.4 t -99.22 92.36 1.71 Allowed Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.106 0.479 . . . . 73.11 110.471 -177.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.713 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 27.8 Cg_exo -60.53 178.31 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.561 2.841 . . . . 72.5 112.816 -174.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 66.73 -32.2 0.18 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.461 0.705 . . . . 63.13 112.026 -173.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.487 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 1.3 m -63.24 153.36 34.88 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 120.97 0.414 . . . . 32.13 110.86 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -71.92 -49.25 39.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.789 -0.641 . . . . 64.54 110.493 -174.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.564 HG11 ' HG2' ' A' ' 69' ' ' GLU . 11.5 m -72.99 -15.44 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.39 -0.368 . . . . 74.2 110.831 -174.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.655 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -53.8 -45.87 70.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.907 -0.588 . . . . 63.45 111.003 178.149 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -72.25 -33.01 67.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.369 0.604 . . . . 64.03 110.17 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -63.8 -41.85 97.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.378 -0.828 . . . . 65.53 110.508 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.511 HG22 ' HB ' ' A' ' 36' ' ' ILE . 82.9 mt -64.39 -36.42 77.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.713 -0.676 . . . . 74.54 110.9 177.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 67.7 mtt -67.67 -32.61 73.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 73.45 110.629 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -63.34 -31.89 73.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.946 -0.57 . . . . 54.13 110.492 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.9 mtm -76.53 -23.98 53.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.962 -0.563 . . . . 61.12 111.169 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.02 36.68 2.12 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.297 -0.954 . . . . 71.32 113.358 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.511 ' HB ' HG22 ' A' ' 31' ' ' ILE . 63.7 mt -122.14 136.1 60.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.468 -0.568 . . . . 73.34 109.468 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.745 HG23 ' H ' ' A' ' 38' ' ' ARG . 1.6 m -135.67 -84.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.321 0.489 . . . . 63.4 112.321 -176.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.745 ' H ' HG23 ' A' ' 37' ' ' VAL . 43.5 ttp180 -156.56 141.12 16.83 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.362 -0.607 . . . . 74.1 109.362 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.71 -0.29 65.89 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 111.429 -0.669 . . . . 73.32 111.429 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.472 HG22 HD21 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -72.6 142.67 48.39 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.387 -0.598 . . . . 73.31 109.387 178.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.49 130.98 52.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.167 0.508 . . . . 73.43 111.606 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.563 HG21 HD23 ' A' ' 56' ' ' LEU . 25.6 mm -120.24 128.16 75.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.34 -0.845 . . . . 71.51 110.898 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -101.12 120.67 40.56 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.447 -0.575 . . . . 75.44 109.447 171.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 44' ' ' ILE . 3.9 mp -85.45 101.62 10.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.226 -0.657 . . . . 64.42 109.226 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.84 -53.29 27.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.275 0.56 . . . . 74.15 110.383 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.26 -177.37 41.01 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.673 -0.694 . . . . 52.51 111.773 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HG2' HG23 ' A' ' 54' ' ' ILE . 52.0 mtpt -133.26 152.0 51.92 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.136 -0.69 . . . . 62.52 109.136 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.49 156.34 71.16 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.575 -0.528 . . . . 51.33 109.575 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.35 -30.14 19.42 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.77 2.313 . . . . 60.24 113.176 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.429 ' CE ' ' HA ' ' A' ' 50' ' ' MET . 23.2 mmt -91.29 0.98 57.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.489 -0.323 . . . . 71.51 111.697 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.01 -9.14 73.55 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.892 -0.67 . . . . 64.03 111.999 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 22.7 t70 -144.01 130.54 10.19 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.685 -0.487 . . . . 74.53 109.685 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.553 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . 91.6 Cg_endo -84.11 -169.26 6.65 Favored 'Cis proline' 0 CA--C 1.533 0.44 0 C-N-CA 123.474 -1.469 . . . . 64.13 112.918 0.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.461 HG23 ' HG2' ' A' ' 47' ' ' LYS . 60.7 mt -119.3 143.2 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.896 -0.593 . . . . 71.31 110.284 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.09 111.83 24.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.896 0.379 . . . . 73.4 110.808 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.563 HD23 HG21 ' A' ' 42' ' ' ILE . 5.9 mp -105.68 171.92 7.08 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.136 -0.69 . . . . 71.12 109.136 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 23.7 ttt180 -151.18 128.79 11.48 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.242 -0.651 . . . . 75.22 109.242 176.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.597 HD22 ' HG3' ' A' ' 59' ' ' ARG . 1.2 tt -131.93 137.41 47.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.01 -0.541 . . . . 74.51 109.83 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.597 ' HG3' HD22 ' A' ' 58' ' ' LEU . 55.8 mtt180 61.15 -80.25 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.795 -1.093 . . . . 53.21 111.667 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -147.78 14.75 1.37 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.016 -0.611 . . . . 74.25 111.759 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -140.01 145.96 38.46 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.677 0.751 . . . . 73.43 111.899 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 33.5 t -74.22 155.22 38.54 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.396 -1.275 . . . . 72.51 110.667 176.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.8 mt -139.7 140.21 36.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.783 -0.644 . . . . 71.13 109.424 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.8 t -118.99 130.2 55.55 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.811 0.339 . . . . 62.44 110.735 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 pp -144.65 164.64 30.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.76 -0.655 . . . . 72.55 110.386 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.553 ' HD3' ' HB3' ' A' ' 53' ' ' PRO . 25.9 mmt180 -83.73 158.68 21.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.37 0.605 . . . . 61.02 111.616 -176.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -39.47 70.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.95 -1.023 . . . . 72.44 111.117 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -65.38 -34.45 78.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.302 -0.408 . . . . 74.32 111.233 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.564 ' HG2' HG11 ' A' ' 27' ' ' VAL . 33.9 mt-10 -74.38 -32.76 62.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.297 0.57 . . . . 74.4 109.86 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.99 -21.1 65.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.452 -0.795 . . . . 75.45 111.19 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.597 ' HA ' HD22 ' A' ' 8' ' ' ASN . 22.1 ttmm -74.32 -34.17 63.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.494 . . . . 72.51 110.392 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -85.51 14.59 5.38 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.196 -0.456 . . . . 60.25 111.574 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.491 HG22 HG13 ' A' ' 75' ' ' VAL . 60.4 mt -118.96 124.23 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.381 . . . . 72.42 110.222 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 99.0 mt -103.47 120.73 41.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 75.55 110.243 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.76 HG12 ' HA ' ' A' ' 18' ' ' VAL . 22.4 m -133.95 157.51 41.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.207 0.527 . . . . 71.22 111.791 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -117.82 143.32 46.38 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.958 -0.756 . . . . 70.43 108.958 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.813 ' HA ' HG12 ' A' ' 16' ' ' VAL . 38.5 t -70.94 125.55 29.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.128 -0.487 . . . . 61.15 110.595 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 17' ' ' LYS . 56.3 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 75.42 111.008 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.757 -0.137 . . . . 71.43 112.757 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.8 pt -110.11 171.44 2.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.689 0.281 . . . . 62.14 110.304 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 73' ' ' ILE . . . -76.91 153.11 41.51 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 120.47 -0.871 . . . . 43.42 111.22 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' A' ' 56' ' ' LEU . 50.1 tp -59.21 -28.01 66.26 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.185 0.517 . . . . 75.4 110.684 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.452 ' ND2' ' HG3' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -75.38 -4.53 39.92 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.86 -0.609 . . . . 73.33 111.831 178.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.452 ' HG3' ' ND2' ' A' ' 8' ' ' ASN . 44.5 mt-10 -102.1 5.87 40.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.931 0.396 . . . . 72.2 110.801 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 t -97.03 157.32 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.064 -0.517 . . . . 61.13 109.967 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -99.64 164.89 11.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.62 0.247 . . . . 71.24 110.341 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.7 pt -69.39 151.03 10.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.444 . . . . 71.55 111.048 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt 60.26 51.45 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.948 0.88 . . . . 62.15 110.536 -177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 m -132.37 153.08 51.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.142 -0.935 . . . . 70.14 109.759 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -113.44 119.09 36.39 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.803 -0.443 . . . . 65.35 109.803 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.772 HG12 ' HA ' ' A' ' 77' ' ' VAL . 29.1 m -130.76 179.56 4.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.11 -0.495 . . . . 65.41 110.503 -178.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.75 ' HB2' HD11 ' A' ' 78' ' ' LEU . 39.3 ttpt -143.04 144.53 32.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.876 0.37 . . . . 75.03 111.064 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.67 ' HA ' HG12 ' A' ' 75' ' ' VAL . 45.8 t -76.9 95.66 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.598 -0.728 . . . . 74.31 110.673 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.927 HD11 ' HB2' ' A' ' 76' ' ' GLU . 50.1 mt -57.33 -49.33 80.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 64.31 109.988 173.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.59 149.16 7.22 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.54 -0.755 . . . . 74.11 112.258 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.643 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 56.9 mt -83.95 159.68 3.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.516 -0.55 . . . . 75.13 109.516 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 25' ' ' SER . 48.3 t -99.17 93.71 2.29 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 122.757 0.423 . . . . 73.03 110.03 -177.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 1.022 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 77.6 Cg_exo -49.27 164.26 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.911 3.074 . . . . 72.32 114.271 -173.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 67.28 -11.96 0.27 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.116 0.967 . . . . 75.5 112.92 -175.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 1.2 m -63.72 155.1 31.12 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 120.926 0.393 . . . . 73.22 110.822 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -69.46 -17.29 63.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.16 -0.473 . . . . 75.43 112.164 -173.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.443 HG21 ' HA ' ' A' ' 69' ' ' GLU . 30.9 m -112.47 6.32 8.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.664 -0.244 . . . . 74.14 111.43 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 1.022 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 5.2 tmm_? -58.76 -57.18 14.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.877 0.37 . . . . 74.3 110.771 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 29' ' ' ARG . 42.0 ttm180 -71.5 -36.1 70.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.041 -0.527 . . . . 75.24 110.123 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -58.77 -46.39 87.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.266 -0.879 . . . . 73.33 111.276 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.622 HD13 HD11 ' A' ' 73' ' ' ILE . 99.4 mt -66.51 -42.34 89.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.048 0.452 . . . . 75.12 111.278 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 63.7 mtt -67.53 -36.67 81.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.336 -0.393 . . . . 63.43 110.781 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.01 -30.14 68.46 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 54.22 110.445 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.3 ttt -63.04 -34.6 77.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.615 -0.721 . . . . 54.42 110.859 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.67 20.26 1.74 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.307 -0.949 . . . . 51.1 113.178 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.525 HD12 HG23 ' A' ' 31' ' ' ILE . 61.1 mt -105.51 134.84 45.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.719 -0.475 . . . . 53.45 109.719 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.73 177.56 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.389 -0.369 . . . . 72.32 110.835 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -78.7 128.97 34.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.079 0.466 . . . . 43.4 110.26 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.75 5.61 66.38 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.802 -0.713 . . . . 44.01 112.235 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.5 m -68.8 138.65 54.97 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.501 -0.555 . . . . 64.35 109.501 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -96.14 125.45 40.68 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.855 -0.611 . . . . 71.54 109.449 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.2 mt -107.36 120.57 58.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.347 -0.842 . . . . 65.23 110.969 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.566 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 74.4 t80 -93.52 106.88 18.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.821 -0.807 . . . . 64.41 108.821 173.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.441 HD13 HD22 ' A' ' 56' ' ' LEU . 18.6 mm -70.04 104.01 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.183 -0.673 . . . . 72.45 109.183 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -76.38 -61.51 1.93 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.832 0.349 . . . . 72.24 110.401 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.21 158.55 29.13 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.227 -0.987 . . . . 61.42 112.356 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.603 ' HG2' HG12 ' A' ' 54' ' ' ILE . 54.2 mtpt -97.55 151.83 19.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.258 -0.645 . . . . 74.13 109.258 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.53 156.35 32.6 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 110.131 -0.322 . . . . 65.11 110.131 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.0 -32.51 18.32 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.246 2.63 . . . . 52.22 113.752 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.8 ttm -89.42 -11.35 43.38 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.936 0.398 . . . . 73.44 111.172 -177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.45 -14.7 32.81 Favored Glycine 0 C--N 1.328 0.115 0 C-N-CA 120.909 -0.662 . . . . 50.54 112.513 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -149.41 138.96 12.93 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.44 -0.578 . . . . 71.25 109.44 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.8 -164.73 3.94 Favored 'Cis proline' 0 C--N 1.346 0.429 0 C-N-CA 124.15 -1.188 . . . . 73.1 112.636 -0.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.603 HG12 ' HG2' ' A' ' 47' ' ' LYS . 38.2 mt -123.97 134.98 65.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 74.03 110.416 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -91.44 118.93 30.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.372 -0.376 . . . . 34.14 110.255 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.506 ' CD1' HD21 ' A' ' 7' ' ' LEU . 23.1 mt -121.22 137.02 54.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.213 -0.449 . . . . 63.51 110.747 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.603 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 3.9 tmt_? -101.45 109.36 21.18 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.73 -0.841 . . . . 62.1 108.73 175.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 pp -144.64 152.12 40.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.318 -0.401 . . . . 73.02 110.96 -175.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 72.51 -45.29 0.62 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.931 0.77 . . . . 75.5 111.379 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.58 -21.84 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.064 -0.588 . . . . 72.11 112.355 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -145.0 172.4 13.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.01 0.433 . . . . 72.33 111.188 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -84.91 140.88 30.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.539 -0.755 . . . . 65.14 111.208 175.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.2 tp -143.5 154.66 43.86 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.452 -0.573 . . . . 71.14 109.452 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 p -91.81 121.24 33.25 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.923 0.392 . . . . 74.14 111.767 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.418 HD23 HD12 ' A' ' 56' ' ' LEU . 3.9 mm? -118.59 141.98 48.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.144 -0.48 . . . . 72.4 109.851 175.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.45 162.15 15.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.767 0.318 . . . . 74.33 110.722 -177.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -55.85 -33.0 64.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.643 -0.708 . . . . 72.25 110.999 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.1 m -59.48 -56.57 20.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 64.5 110.739 177.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.443 ' HA ' HG21 ' A' ' 27' ' ' VAL . 2.5 mp0 -64.94 -36.79 85.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.081 0.467 . . . . 63.14 110.713 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.2 66.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.648 -0.706 . . . . 61.1 111.813 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -83.01 -32.21 27.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.684 0.278 . . . . 74.5 110.9 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.38 -2.05 56.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.26 -0.427 . . . . 34.24 111.706 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.622 HD11 HD13 ' A' ' 31' ' ' ILE . 68.8 mt -106.42 122.7 60.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.572 -0.285 . . . . 73.01 110.582 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.5 mt -95.03 122.25 37.49 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.913 0.387 . . . . 55.32 110.216 176.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 18' ' ' VAL . 28.3 m -129.74 167.45 24.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.944 -0.571 . . . . 62.15 111.142 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.927 ' HB2' HD11 ' A' ' 19' ' ' ILE . 41.9 tt0 -129.07 146.01 51.13 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.227 -0.657 . . . . 53.34 109.227 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.772 ' HA ' HG12 ' A' ' 16' ' ' VAL . 10.3 p -76.14 129.5 37.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.275 0.56 . . . . 31.35 110.682 -178.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' A' ' 17' ' ' LYS . 86.2 mt . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.879 -0.6 . . . . 75.2 109.997 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 112.507 -0.237 . . . . 54.11 112.507 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.0 pt -107.19 174.32 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.789 -0.448 . . . . 75.41 109.789 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.62 156.66 35.2 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.107 -1.044 . . . . 63.34 111.654 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.556 HD13 HG21 ' A' ' 16' ' ' VAL . 61.6 tp -61.62 -26.25 67.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.237 0.542 . . . . 64.13 110.635 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -72.83 -10.87 60.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.666 . . . . 65.22 111.217 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -98.16 0.34 45.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.92 0.39 . . . . 75.14 110.885 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.513 HG21 HG11 ' A' ' 16' ' ' VAL . 6.1 t -103.18 158.1 4.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.393 -0.595 . . . . 63.32 109.393 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -106.1 170.58 7.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.103 0.478 . . . . 42.41 111.241 -176.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 31.7 pt -64.02 157.82 4.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.427 -0.806 . . . . 70.31 113.154 -171.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 60.69 32.1 20.23 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.34 -0.845 . . . . 70.14 111.918 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.4 m -124.36 151.49 44.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.957 -0.565 . . . . 74.12 109.784 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HB2' ' CD2' ' A' ' 43' ' ' TYR . 36.5 ttmt -103.44 130.18 50.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.956 0.407 . . . . 71.52 110.287 176.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.556 HG21 HD13 ' A' ' 7' ' ' LEU . 33.1 m -119.01 165.79 13.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.864 -0.607 . . . . 73.34 110.628 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.634 ' HB2' HD11 ' A' ' 78' ' ' LEU . 69.2 tttt -123.07 135.65 54.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.638 -0.71 . . . . 64.4 110.205 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.77 95.38 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.309 -0.859 . . . . 53.41 110.7 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.832 HD11 ' HB3' ' A' ' 76' ' ' GLU . 28.7 mt -65.64 -49.06 80.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.766 -0.652 . . . . 70.24 109.75 174.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.52 176.31 44.77 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.601 -0.809 . . . . 75.5 112.74 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.673 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 54.6 mt -120.48 159.24 22.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.275 -1.009 . . . . 70.01 108.275 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.564 ' HB ' ' OD2' ' A' ' 72' ' ' ASP . 48.8 t -100.41 90.14 1.34 Allowed Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 121.363 0.602 . . . . 74.21 109.618 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.673 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 34.8 Cg_exo -56.57 163.33 7.03 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.6 2.866 . . . . 72.53 113.698 -170.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 65.96 16.62 10.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.624 -1.171 . . . . 53.2 111.24 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 28' ' ' ARG . 1.3 m -88.65 151.8 22.23 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.397 -0.594 . . . . 52.24 109.397 171.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -75.38 -38.96 59.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.895 0.379 . . . . 74.13 110.145 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 31' ' ' ILE . 33.9 m -67.25 -19.6 25.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 72.2 110.771 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 25' ' ' SER . 3.1 tmm_? -58.29 -32.49 68.47 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.689 -0.687 . . . . 73.41 110.25 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -64.8 -47.39 78.23 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.385 -0.598 . . . . 71.44 109.385 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -60.47 -50.01 75.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.492 -0.776 . . . . 64.51 110.637 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 27' ' ' VAL . 86.5 mt -53.34 -52.79 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.545 -0.752 . . . . 73.02 111.917 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 64.5 mtt -70.62 -33.01 70.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.557 -0.292 . . . . 54.43 111.305 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.03 -22.44 61.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.408 0.623 . . . . 62.45 110.135 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.8 tpt -78.29 -22.35 48.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.434 -0.803 . . . . 64.23 110.563 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.55 5.49 20.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.758 -0.734 . . . . 73.15 112.831 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.419 HG12 ' HG ' ' A' ' 58' ' ' LEU . 41.2 mt -93.56 129.47 43.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.821 -0.437 . . . . 54.11 109.821 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.737 HG23 ' H ' ' A' ' 38' ' ' ARG . 2.8 m -133.05 -74.83 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.623 0.601 . . . . 72.43 112.623 -176.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.737 ' H ' HG23 ' A' ' 37' ' ' VAL . 61.6 ttt180 -165.28 128.62 2.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.955 -0.387 . . . . 74.15 109.955 -174.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.29 5.97 73.68 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.961 -0.638 . . . . 74.11 112.006 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.5 m -74.04 144.92 44.87 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.987 -0.375 . . . . 72.12 109.987 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -94.27 129.8 40.78 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.053 0.454 . . . . 73.23 110.282 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.773 HG12 HD23 ' A' ' 58' ' ' LEU . 73.8 mt -119.83 116.37 50.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.523 -0.762 . . . . 71.04 109.899 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.416 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 9.0 t80 -100.92 119.44 38.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.175 -0.676 . . . . 62.42 109.175 177.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.5 mt -77.03 125.02 36.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 120.703 0.287 . . . . 64.22 110.233 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -85.65 -59.54 2.28 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.839 0.352 . . . . 64.22 110.346 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.67 171.92 42.34 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.813 -0.708 . . . . 74.12 112.109 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -123.56 145.1 49.14 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.012 -0.366 . . . . 72.12 110.012 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.561 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -69.29 163.66 56.01 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.188 -0.46 . . . . 54.15 109.778 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.561 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 8.1 Cg_endo -50.66 -38.51 55.8 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 123.027 2.485 . . . . 73.23 113.468 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.426 ' HE2' ' HB3' ' A' ' 52' ' ' ASP . 50.7 ttp -86.14 -10.74 54.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.216 0.532 . . . . 73.13 110.659 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.87 -2.95 73.27 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.564 -0.614 . . . . 41.24 111.564 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.426 ' HB3' ' HE2' ' A' ' 50' ' ' MET . 11.8 t70 -141.36 132.12 13.25 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 108.889 -0.782 . . . . 73.14 108.889 177.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.57 -179.96 27.11 Favored 'Cis proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.036 -1.652 . . . . 72.52 112.391 -0.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.7 mt -113.48 145.37 19.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.167 -0.47 . . . . 71.14 110.03 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.29 119.39 38.68 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.036 -0.357 . . . . 72.32 110.036 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.539 HD21 HD21 ' A' ' 7' ' ' LEU . 5.4 mp -118.11 167.59 11.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.141 -0.481 . . . . 63.14 109.895 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.661 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 33.0 ttt-85 -125.59 105.7 9.21 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.893 -1.151 . . . . 72.54 107.893 167.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.773 HD23 HG12 ' A' ' 42' ' ' ILE . 3.2 tm? -122.84 145.57 48.32 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.674 -0.693 . . . . 73.12 109.967 -170.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.612 ' HB2' HD13 ' A' ' 58' ' ' LEU . 2.4 tmt_? 70.51 -69.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.214 -0.903 . . . . 71.42 110.021 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.69 2.08 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.905 -0.664 . . . . 63.22 112.52 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -148.49 165.26 31.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.859 0.361 . . . . 74.41 110.799 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.661 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 32.1 t -75.78 145.08 41.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.511 0.672 . . . . 74.31 111.347 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.5 mt -146.2 157.04 43.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.696 -1.138 . . . . 73.34 108.598 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 t -120.62 125.27 47.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.299 0.571 . . . . 64.14 110.721 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.27 175.85 5.93 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.314 -0.857 . . . . 74.44 109.312 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.634 ' HB2' ' OE1' ' A' ' 69' ' ' GLU . 41.7 mmt180 -90.75 167.09 12.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.103 0.478 . . . . 73.42 110.31 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.43 -22.59 67.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.582 -0.735 . . . . 73.12 109.604 174.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.7 m -64.1 -52.32 59.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.242 -0.89 . . . . 65.54 110.97 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.634 ' OE1' ' HB2' ' A' ' 66' ' ' ARG . 1.9 mp0 -60.16 -41.95 93.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.153 0.502 . . . . 53.31 110.675 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.77 -22.5 67.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.56 -0.745 . . . . 73.42 111.504 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -75.2 -34.92 61.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.409 -0.36 . . . . 64.42 111.114 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.564 ' OD2' ' HB ' ' A' ' 22' ' ' VAL . 14.5 t70 -80.26 -44.69 19.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 73.25 111.421 -174.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.472 HG22 HG13 ' A' ' 75' ' ' VAL . 48.3 mt -61.42 118.5 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.97 -0.559 . . . . 73.22 111.44 -176.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.2 mt -91.24 119.4 31.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 73.24 109.871 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.547 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 23.7 m -129.08 158.17 41.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.927 0.394 . . . . 70.32 111.964 -174.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.832 ' HB3' HD11 ' A' ' 19' ' ' ILE . 19.3 pt-20 -115.11 151.72 33.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.831 -0.622 . . . . 72.31 109.632 173.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.2 t -80.26 115.84 23.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.988 0.423 . . . . 62.22 111.109 -174.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' A' ' 17' ' ' LYS . 40.2 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.898 -0.592 . . . . 71.52 111.53 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.763 0 N-CA-C 112.092 -0.403 . . . . 44.45 112.092 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.6 pt -96.04 163.29 2.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.752 -0.462 . . . . 74.21 109.752 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.23 137.58 45.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.466 -0.873 . . . . 70.42 112.209 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 75' ' ' VAL . 44.7 tp -60.25 -25.02 65.35 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 122.986 0.515 . . . . 52.14 112.022 -175.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -78.46 -9.81 59.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.721 0.296 . . . . 74.25 110.857 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -99.31 -7.44 26.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.277 -0.42 . . . . 75.35 111.071 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.723 HG11 HG11 ' A' ' 16' ' ' VAL . 14.4 t -77.72 160.3 4.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.93 -0.577 . . . . 61.03 110.293 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.418 ' N ' HG12 ' A' ' 10' ' ' VAL . 31.7 tt0 -80.41 168.44 18.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 62.12 110.448 -177.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.408 ' HA ' ' CG2' ' A' ' 44' ' ' ILE . 33.5 pt -93.5 161.08 2.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.005 -0.543 . . . . 75.34 110.954 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 69.3 5.07 4.92 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.164 0.586 . . . . 63.25 111.611 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -107.12 156.89 18.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.851 0.358 . . . . 54.2 110.993 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.521 ' HB2' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -107.91 130.97 54.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.008 -0.542 . . . . 61.41 110.341 178.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' A' ' 77' ' ' VAL . 27.2 m -127.6 161.31 35.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.739 -0.664 . . . . 73.22 110.911 -177.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.761 ' HD3' ' HG2' ' A' ' 41' ' ' GLU . 9.7 tptm -113.26 138.53 49.87 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.596 -0.729 . . . . 64.4 109.922 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.946 ' HA ' HG12 ' A' ' 75' ' ' VAL . 60.1 t -80.58 94.24 2.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.517 -0.765 . . . . 73.11 109.902 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.36 -52.69 34.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.013 -0.994 . . . . 73.14 110.106 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 38' ' ' ARG . . . -155.23 133.95 4.0 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 119.966 -1.111 . . . . 74.15 113.245 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.454 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 68.3 mt -80.64 158.19 4.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 107.598 -1.26 . . . . 74.34 107.598 169.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 25' ' ' SER . 49.8 t -100.27 91.13 1.59 Allowed Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 121.015 0.436 . . . . 50.33 110.086 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 25' ' ' SER . 35.8 Cg_endo -62.57 178.51 0.92 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.397 2.732 . . . . 51.3 113.061 -173.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 67.02 -16.19 0.14 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.436 -0.802 . . . . 72.21 111.741 -174.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -73.13 161.87 30.1 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.938 0.399 . . . . 72.33 110.926 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -78.84 -46.24 19.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.991 -0.55 . . . . 65.31 110.61 -176.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.688 HG21 ' HA ' ' A' ' 69' ' ' GLU . 23.3 m -68.13 -18.0 22.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.908 -0.587 . . . . 73.22 110.648 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.454 ' HE ' ' HB3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -53.7 -34.33 58.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.35 -0.841 . . . . 74.0 111.296 178.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -68.37 -42.07 79.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.45 -0.341 . . . . 54.22 111.06 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.447 ' O ' ' HG3' ' A' ' 34' ' ' MET . 34.0 tttp -73.56 -33.31 64.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.459 -0.337 . . . . 71.21 110.399 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 27' ' ' VAL . 88.5 mt -59.62 -48.31 87.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.174 -0.466 . . . . 51.21 110.719 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 64.9 mtt -68.79 -28.6 66.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 63.32 110.626 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.51 -40.57 76.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 71.32 110.429 176.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.447 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 65.6 mtt -61.93 -34.05 75.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.594 -0.73 . . . . 74.25 110.588 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.69 17.99 5.82 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.818 -0.706 . . . . 62.5 112.248 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.825 HD11 HD22 ' A' ' 58' ' ' LEU . 47.8 mt -101.03 127.46 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.197 0.523 . . . . 65.52 110.386 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.27 -176.53 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.273 -0.876 . . . . 53.23 110.084 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HG2' ' HA2' ' A' ' 20' ' ' GLY . 84.8 mtm180 -70.6 109.45 4.88 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.867 -0.419 . . . . 73.24 109.867 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.424 ' O ' ' HE3' ' A' ' 17' ' ' LYS . . . 120.8 -9.24 10.58 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 121.042 -0.599 . . . . 53.33 111.739 -176.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.4 m -73.63 149.57 41.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.663 -0.495 . . . . 74.2 109.663 174.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.761 ' HG2' ' HD3' ' A' ' 17' ' ' LYS . 55.5 mt-10 -115.69 134.85 54.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.215 -0.448 . . . . 70.35 110.102 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.575 HG21 HD23 ' A' ' 56' ' ' LEU . 48.2 mm -118.66 126.02 74.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.468 -0.787 . . . . 70.05 110.757 -173.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 57' ' ' ARG . 9.8 t80 -104.57 115.79 30.96 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.796 -0.816 . . . . 74.01 108.796 173.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.408 ' CG2' ' HA ' ' A' ' 12' ' ' ILE . 44.5 mm -73.35 106.39 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.92 0.391 . . . . 71.14 110.702 -176.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -75.73 -36.65 59.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.181 -0.674 . . . . 73.0 109.181 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.63 -179.47 39.33 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.783 -0.723 . . . . 61.33 112.371 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -126.59 150.64 48.76 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.442 -0.577 . . . . 72.12 109.442 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.28 165.48 17.4 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.412 -0.358 . . . . 73.44 111.453 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.0 -31.85 83.8 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.571 2.181 . . . . 74.33 112.094 175.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -86.11 -5.31 59.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.207 0.527 . . . . 71.21 110.262 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.48 -34.45 5.65 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.212 -0.755 . . . . 34.11 111.212 -174.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 4.2 p-10 -137.97 152.31 71.86 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 108.959 -0.756 . . . . 75.03 108.959 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 73.0 Cg_endo -72.26 173.3 53.47 Favored 'Cis proline' 0 C--O 1.234 0.288 0 C-N-CA 123.457 -1.476 . . . . 73.53 113.158 4.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.655 ' HB ' HD11 ' A' ' 56' ' ' LEU . 16.3 mm -97.04 147.32 6.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.514 -0.766 . . . . 73.43 109.304 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.51 111.24 23.88 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.314 -0.624 . . . . 61.51 109.314 174.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.655 HD11 ' HB ' ' A' ' 54' ' ' ILE . 2.3 mp -121.88 144.92 48.56 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.516 -0.311 . . . . 65.35 110.292 -175.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 54.9 mtt180 -100.1 108.14 20.22 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.344 -0.984 . . . . 63.43 108.344 166.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.825 HD22 HD11 ' A' ' 36' ' ' ILE . 2.4 pp -121.78 134.3 54.92 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.602 -0.727 . . . . 73.55 110.858 -173.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.485 ' HD3' ' OH ' ' A' ' 61' ' ' TYR . 50.3 ttt180 65.02 6.06 3.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.283 -0.872 . . . . 74.41 110.839 178.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.58 -19.58 9.72 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 116.019 -0.537 . . . . 64.34 112.794 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.485 ' OH ' ' HD3' ' A' ' 59' ' ' ARG . 4.4 p90 -127.67 148.97 50.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.359 0.599 . . . . 71.12 112.213 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.3 m -70.8 137.68 49.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.186 -0.915 . . . . 50.52 111.989 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.702 ' HB3' HD21 ' A' ' 58' ' ' LEU . 9.4 tt -150.99 148.86 28.89 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.689 -0.856 . . . . 65.02 108.689 176.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.1 t -115.07 132.14 56.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.179 0.514 . . . . 72.44 111.566 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.403 ' CD2' HD13 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -134.04 165.49 24.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.351 -0.841 . . . . 62.14 109.391 174.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -84.45 169.33 14.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.453 0.644 . . . . 72.12 112.384 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 37.0 ttmt -54.49 -35.09 62.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.751 -1.113 . . . . 73.31 111.704 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.1 t -66.15 -46.24 78.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.58 -0.282 . . . . 63.43 110.647 -176.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.688 ' HA ' HG21 ' A' ' 27' ' ' VAL . 1.9 mp0 -63.33 -43.92 96.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.942 0.401 . . . . 74.01 110.347 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.49 -22.03 66.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 62.11 111.27 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -74.69 -29.04 61.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.102 -0.499 . . . . 71.45 110.883 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -93.46 19.72 8.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.946 0.403 . . . . 73.02 111.109 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.428 HG22 HG13 ' A' ' 75' ' ' VAL . 69.5 mt -126.04 117.6 49.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.602 -0.518 . . . . 63.13 109.602 174.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.7 mt -103.15 121.41 42.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.745 0.307 . . . . 73.41 110.205 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.946 HG12 ' HA ' ' A' ' 18' ' ' VAL . 35.6 m -137.09 172.58 14.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.968 0.414 . . . . 72.01 111.78 -174.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -143.37 156.68 44.74 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.427 -0.953 . . . . 75.42 108.427 171.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.756 ' HA ' HG12 ' A' ' 16' ' ' VAL . 11.8 p -64.71 147.92 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.003 0.43 . . . . 54.03 111.548 -175.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.615 HD21 ' HB2' ' A' ' 17' ' ' LYS . 23.5 mt . . . . . 0 C--O 1.233 0.22 0 CA-C-N 116.038 -0.528 . . . . 63.44 112.394 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.233 0 N-CA-C 111.605 -0.598 . . . . 55.25 111.605 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.2 pt -85.03 167.76 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.688 -0.856 . . . . 73.13 108.688 175.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.75 146.83 40.79 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 119.429 -1.367 . . . . 52.15 111.076 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.413 HD21 HD13 ' A' ' 56' ' ' LEU . 27.4 tp -65.28 -17.79 64.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.309 0.576 . . . . 64.51 110.173 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -76.56 -20.54 56.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.749 -0.659 . . . . 74.52 110.358 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -89.09 -10.68 46.46 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.173 -0.467 . . . . 70.44 110.532 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.1 t -84.45 160.43 3.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.906 -0.588 . . . . 72.31 110.087 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.842 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 28.5 tt0 -122.44 -173.58 2.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.668 0.27 . . . . 63.22 110.409 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.842 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 40.8 pt -68.93 154.04 8.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 113.322 0.86 . . . . 73.44 113.322 -170.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.4 mttt 59.86 22.14 11.09 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.57 -1.196 . . . . 74.55 113.256 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 m -104.74 155.4 18.92 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.428 -0.582 . . . . 54.32 109.428 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -115.06 136.7 52.83 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.488 -0.485 . . . . 72.04 110.0 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.839 HG12 ' HA ' ' A' ' 77' ' ' VAL . 29.9 m -140.17 -179.57 2.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.698 -0.683 . . . . 72.45 110.167 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -148.99 146.17 27.67 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.832 -0.432 . . . . 73.45 109.832 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.539 ' HA ' HG12 ' A' ' 75' ' ' VAL . 26.1 t -74.01 93.14 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.238 0.542 . . . . 71.14 110.146 -178.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 38.4 mm -81.64 -38.94 16.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.341 -0.845 . . . . 75.54 110.283 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.4 169.6 25.82 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.569 -0.824 . . . . 64.53 112.881 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.657 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 69.7 mt -136.9 155.26 32.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.613 -0.884 . . . . 73.21 108.613 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.0 t -103.26 91.37 3.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.872 0.368 . . . . 52.21 110.584 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.657 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 35.9 Cg_exo -59.06 172.99 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.375 2.717 . . . . 73.31 113.03 -175.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 60.18 26.3 15.71 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.715 -0.675 . . . . 72.01 111.328 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.801 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 15.6 t -104.15 142.77 33.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.228 -0.442 . . . . 72.13 110.412 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -79.04 -27.03 43.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.874 0.368 . . . . 64.33 110.222 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.6 m -84.97 -19.93 8.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 65.42 110.62 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.801 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 2.0 tmt_? -54.21 -35.15 62.08 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.426 -0.352 . . . . 75.32 110.641 174.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -57.03 -56.64 19.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.992 -0.549 . . . . 74.51 110.444 174.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -54.6 -46.82 73.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.475 -0.784 . . . . 71.41 111.135 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.497 HG22 ' HB ' ' A' ' 36' ' ' ILE . 96.1 mt -57.54 -53.45 44.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.331 -0.849 . . . . 74.02 111.806 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.455 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 77.1 mtp -75.04 -28.45 60.44 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.769 -0.372 . . . . 75.43 111.093 -176.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.54 -32.16 73.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.329 0.585 . . . . 75.42 109.932 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.2 mtt -78.23 -3.81 44.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.359 -0.837 . . . . 65.22 111.774 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.65 4.7 45.86 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.635 -0.793 . . . . 64.01 112.947 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.497 ' HB ' HG22 ' A' ' 31' ' ' ILE . 30.1 mt -89.08 124.04 41.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.975 0.417 . . . . 64.34 110.395 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.1 m -143.81 168.81 11.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.581 -0.736 . . . . 74.14 110.055 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -66.96 108.39 2.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.052 0.453 . . . . 75.53 110.232 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.5 -18.69 4.6 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.823 -0.704 . . . . 63.51 111.855 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.2 m -75.27 143.87 42.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.927 0.394 . . . . 75.35 110.47 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -102.76 142.52 33.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.995 -0.548 . . . . 71.21 109.736 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.812 HG12 HD12 ' A' ' 58' ' ' LEU . 65.1 mt -123.96 126.1 71.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.817 -0.629 . . . . 74.25 110.939 -173.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -106.58 117.11 33.2 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.038 -0.727 . . . . 75.41 109.038 174.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.7 mm -76.47 114.95 17.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.842 0.353 . . . . 71.44 110.432 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -76.97 -46.51 23.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.251 0.548 . . . . 74.13 109.936 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.652 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 170.82 -170.94 43.56 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.606 -0.725 . . . . 71.43 111.668 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.633 ' HG2' HG23 ' A' ' 54' ' ' ILE . 51.7 mtpt -132.83 137.17 46.65 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.026 -0.731 . . . . 72.24 109.026 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -58.87 158.48 16.32 Favored Pre-proline 0 C--N 1.328 -0.359 0 O-C-N 123.422 0.451 . . . . 75.13 110.943 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 9.2 Cg_endo -52.91 -30.96 50.34 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.349 2.699 . . . . 71.23 113.625 -177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.9 ttt -94.48 4.62 53.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.425 0.631 . . . . 70.23 110.433 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.28 3.65 90.61 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 116.035 -0.53 . . . . 75.14 112.38 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -154.04 132.73 6.88 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.288 -0.634 . . . . 54.13 109.288 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.77 -178.03 21.59 Favored 'Cis proline' 0 C--O 1.235 0.373 0 C-N-CA 123.076 -1.635 . . . . 71.24 112.59 0.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.633 HG23 ' HG2' ' A' ' 47' ' ' LYS . 52.6 mt -104.24 126.46 58.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.576 -0.527 . . . . 73.21 109.576 177.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.51 102.84 9.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.183 0.516 . . . . 62.11 110.249 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 62' ' ' SER . 32.5 mt -112.81 146.05 39.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.781 -0.645 . . . . 55.32 110.399 -177.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 45.3 ttt180 -114.21 102.92 10.59 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.581 -0.896 . . . . 71.32 108.581 169.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.812 HD12 HG12 ' A' ' 42' ' ' ILE . 8.3 tt -123.7 147.01 47.84 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.35 -0.841 . . . . 74.55 110.351 -173.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.521 ' HB2' HD23 ' A' ' 58' ' ' LEU . 3.2 tmt_? 71.03 -51.68 0.68 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.306 -0.861 . . . . 64.55 110.907 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.67 -18.23 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.178 -0.534 . . . . 70.13 112.141 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -131.43 166.19 21.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.279 0.561 . . . . 75.03 110.974 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 41.9 t -82.79 144.61 30.03 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.16 -0.927 . . . . 75.34 110.401 177.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.6 tp -148.77 147.97 29.43 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.177 -0.92 . . . . 73.02 109.369 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -93.69 112.27 24.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.456 0.646 . . . . 71.3 110.805 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.465 HD23 HD12 ' A' ' 56' ' ' LEU . 4.0 mm? -111.06 144.1 40.73 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.153 -0.93 . . . . 61.41 109.218 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -87.86 170.09 11.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.123 0.487 . . . . 62.55 111.123 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -58.26 -33.07 68.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.31 -0.859 . . . . 72.45 110.571 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.46 ' HB2' ' OE1' ' A' ' 69' ' ' GLU . 10.3 m -57.62 -55.33 36.2 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.614 -0.721 . . . . 72.2 110.905 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.46 ' OE1' ' HB2' ' A' ' 68' ' ' SER . 1.9 mp0 -65.74 -40.1 91.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 73.32 110.749 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.57 -30.66 69.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.926 -0.579 . . . . 65.15 111.292 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -66.15 -38.58 88.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.008 0.433 . . . . 73.14 111.098 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.17 9.06 29.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.933 -0.576 . . . . 74.53 112.122 -173.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.598 HG22 HG13 ' A' ' 75' ' ' VAL . 66.8 mt -112.41 117.0 54.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.893 -0.41 . . . . 74.11 109.893 175.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.7 mt -97.82 111.7 23.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.039 0.447 . . . . 71.33 110.171 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.598 HG13 HG22 ' A' ' 73' ' ' ILE . 29.4 m -126.88 146.15 33.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.155 -0.475 . . . . 73.35 111.268 -176.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -107.18 139.8 41.04 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.398 -0.593 . . . . 63.43 109.398 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.839 ' HA ' HG12 ' A' ' 16' ' ' VAL . 40.8 t -71.22 104.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.093 -0.503 . . . . 73.2 110.369 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 78' ' ' LEU . 28.8 mt . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 115.989 -0.551 . . . . 72.4 111.375 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.593 0 CA-C-O 120.961 0.201 . . . . 23.1 112.884 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.8 pt -100.84 167.09 2.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.404 -0.591 . . . . 73.55 109.404 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 73' ' ' ILE . . . -69.61 145.84 42.72 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.19 -1.005 . . . . 73.24 111.704 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.511 HD21 HD11 ' A' ' 44' ' ' ILE . 2.2 tm? -54.95 -38.19 67.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.335 0.588 . . . . 74.04 109.909 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 34.9 t30 -61.54 -18.92 61.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.498 -0.774 . . . . 73.14 111.499 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -105.52 5.86 31.82 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.283 -0.417 . . . . 75.22 111.775 -171.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 11' ' ' GLU . 21.5 t -86.2 159.52 3.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.42 -0.355 . . . . 71.31 110.103 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.502 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 25.2 tt0 -85.42 171.75 11.57 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.626 -0.509 . . . . 73.2 109.626 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.502 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 35.7 pt -86.83 150.63 3.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.942 0.401 . . . . 75.14 111.72 -173.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 56.55 66.17 1.25 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.138 -0.937 . . . . 64.43 111.596 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.5 m -152.02 158.32 42.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.662 -1.154 . . . . 74.42 109.339 174.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HG2' ' HD1' ' A' ' 43' ' ' TYR . 65.6 mttp -105.76 131.25 53.34 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.843 0.354 . . . . 74.34 110.183 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.672 HG12 ' HA ' ' A' ' 77' ' ' VAL . 30.9 m -128.03 155.59 39.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.033 -0.53 . . . . 70.41 110.691 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -119.59 141.44 49.28 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.819 -0.628 . . . . 73.45 109.961 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.66 ' HA ' HG12 ' A' ' 75' ' ' VAL . 42.0 t -74.63 97.05 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.454 -0.794 . . . . 72.3 110.428 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.83 HD11 ' HB2' ' A' ' 76' ' ' GLU . 27.9 mt -62.67 -41.8 93.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.476 -0.784 . . . . 73.23 109.991 173.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.92 166.01 38.0 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.528 -0.844 . . . . 70.11 112.662 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.692 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 54.5 mt -107.62 160.32 6.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.595 -0.891 . . . . 73.22 108.595 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.11 90.8 1.19 Allowed Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.594 -0.521 . . . . 64.52 109.594 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 34.3 Cg_exo -56.59 167.01 3.1 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.882 3.055 . . . . 73.34 113.564 -170.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 65.17 15.26 9.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.186 -0.915 . . . . 72.53 110.208 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.952 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 37.0 t -67.6 152.87 44.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.075 -0.966 . . . . 75.53 109.732 176.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 26' ' ' LYS . 20.4 tptp -87.74 -16.44 34.22 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.171 -0.678 . . . . 54.44 109.171 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.12 3.15 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.615 -0.721 . . . . 73.55 111.71 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.952 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 4.7 tmt_? -52.04 -40.85 61.71 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 110.11 -0.33 . . . . 64.1 110.11 173.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -58.41 -44.07 88.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.503 . . . . 63.14 110.611 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.464 ' HD3' ' HG2' ' A' ' 69' ' ' GLU . 88.8 tttt -62.86 -46.49 87.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.256 0.55 . . . . 71.0 110.258 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.541 HG23 HD12 ' A' ' 36' ' ' ILE . 82.6 mt -62.23 -46.14 97.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.298 -0.865 . . . . 74.55 111.262 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -39.84 93.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.055 -0.52 . . . . 73.24 110.553 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.82 -39.86 95.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.805 -0.634 . . . . 72.01 110.945 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.547 ' SD ' HD11 ' A' ' 65' ' ' LEU . 52.9 mtt -69.84 -13.23 62.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.181 -0.463 . . . . 74.34 111.557 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.412 ' HA3' ' HG3' ' A' ' 59' ' ' ARG . . . 94.78 36.9 5.4 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.626 -0.797 . . . . 50.34 112.89 174.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.541 HD12 HG23 ' A' ' 31' ' ' ILE . 40.4 mt -110.03 124.75 67.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.868 0.366 . . . . 73.33 110.333 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -145.09 177.38 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.606 -0.724 . . . . 74.32 109.693 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.444 ' C ' ' HD3' ' A' ' 38' ' ' ARG . 4.2 tmt_? -64.53 130.28 43.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.856 0.36 . . . . 74.21 110.145 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.01 -15.93 60.02 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.96 -0.638 . . . . 71.32 112.612 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.7 m -79.37 148.74 31.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.962 -0.385 . . . . 65.4 109.962 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -104.08 148.36 26.34 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.164 0.507 . . . . 74.23 110.734 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.43 HG12 ' HB3' ' A' ' 58' ' ' LEU . 79.6 mt -127.91 123.9 61.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.265 -0.88 . . . . 74.41 109.423 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.767 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 50.8 t80 -88.78 114.36 25.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.97 0.414 . . . . 55.23 110.378 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.511 HD11 HD21 ' A' ' 7' ' ' LEU . 21.1 mm -81.34 107.03 13.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.803 -0.635 . . . . 75.51 109.302 176.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -83.16 -53.26 5.91 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.776 -0.824 . . . . 64.14 108.776 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.76 147.43 6.56 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.311 -0.947 . . . . 33.11 112.607 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.586 ' HG2' HG23 ' A' ' 54' ' ' ILE . 51.6 mtpt -88.67 149.14 23.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.353 -0.98 . . . . 73.3 108.353 173.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.77 156.42 24.86 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 110.491 -0.189 . . . . 72.42 110.491 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.88 -16.84 27.57 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.681 2.254 . . . . 75.15 111.94 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.1 ttm -92.43 -12.55 31.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.65 -0.704 . . . . 75.03 110.275 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.75 -29.38 11.44 Favored Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 115.846 -0.616 . . . . 54.33 111.869 -177.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -142.17 147.56 44.49 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 108.923 -0.769 . . . . 73.55 108.923 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -79.71 -179.27 25.71 Favored 'Cis proline' 0 C--O 1.236 0.381 0 C-N-CA 123.317 -1.535 . . . . 74.1 112.472 -0.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.586 HG23 ' HG2' ' A' ' 47' ' ' LYS . 33.3 mt -113.23 124.75 70.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.92 -0.4 . . . . 65.44 109.92 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.08 106.78 11.36 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.908 0.385 . . . . 73.11 110.61 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 62' ' ' SER . 63.8 mt -119.64 142.26 48.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.098 -0.501 . . . . 74.12 110.808 -175.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.767 ' HB3' ' HB3' ' A' ' 43' ' ' TYR . 36.1 ttt180 -110.97 100.97 9.58 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.67 -0.863 . . . . 73.41 108.67 171.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.43 ' HB3' HG12 ' A' ' 42' ' ' ILE . 3.2 pp -131.41 151.21 51.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.81 -0.632 . . . . 63.02 110.616 -173.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.412 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 3.2 tmt_? 71.66 -39.39 0.45 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.37 0.668 . . . . 73.04 111.174 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.64 -27.35 0.11 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.152 -0.547 . . . . 74.44 112.262 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -124.46 169.15 12.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.971 0.415 . . . . 75.03 111.346 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.64 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 46.5 t -99.48 146.8 25.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.583 -0.735 . . . . 30.54 110.894 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 63' ' ' LEU . 2.4 pt? -164.6 161.3 20.92 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.282 -0.872 . . . . 75.01 109.425 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.94 116.89 31.07 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.07 0.462 . . . . 64.21 111.625 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.547 HD11 ' SD ' ' A' ' 34' ' ' MET . 4.1 mm? -98.15 158.84 15.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.757 -0.656 . . . . 63.4 110.881 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -81.87 156.19 24.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.15 -0.477 . . . . 63.53 111.383 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -53.83 -45.21 70.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.728 -0.669 . . . . 70.31 110.982 173.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.2 m -57.77 -50.39 73.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.592 -0.731 . . . . 51.3 111.958 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.464 ' HG2' ' HD3' ' A' ' 30' ' ' LYS . 2.2 mp0 -71.79 -31.06 66.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 74.25 111.536 -175.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 8' ' ' ASN . . . -68.69 -23.11 64.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.25 0.463 . . . . 70.42 112.25 -173.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -87.19 -11.28 50.31 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.957 -0.697 . . . . 35.33 110.682 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.56 0.93 35.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.179 -0.464 . . . . 72.32 111.021 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.481 ' O ' ' HA2' ' A' ' 6' ' ' GLY . 59.5 mt -118.52 126.48 75.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.951 -0.568 . . . . 64.31 109.984 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.2 mt -103.15 122.32 44.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.072 -0.344 . . . . 75.34 110.072 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.66 HG12 ' HA ' ' A' ' 18' ' ' VAL . 29.8 m -131.38 164.3 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.714 0.635 . . . . 75.34 112.714 -172.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.83 ' HB2' HD11 ' A' ' 19' ' ' ILE . 3.7 tp10 -111.21 136.9 49.61 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.916 -1.038 . . . . 73.11 109.477 173.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.672 ' HA ' HG12 ' A' ' 16' ' ' VAL . 46.8 t -82.66 104.67 11.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.534 -0.543 . . . . 42.13 109.534 178.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.8 mt . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 121.224 0.535 . . . . 44.13 110.938 -175.671 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.687 0 N-CA-C 112.097 -0.401 . . . . 74.02 112.097 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.2 pt -134.02 173.64 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.685 0.279 . . . . 71.14 110.318 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.65 157.85 38.48 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.59 -0.814 . . . . 64.03 111.099 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 7' ' ' LEU . 2.0 tm? -54.65 -35.22 63.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.089 0.471 . . . . 73.32 110.67 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -71.58 -11.95 61.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.126 -0.488 . . . . 73.25 111.871 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -99.26 -5.6 29.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.765 0.317 . . . . 72.53 111.259 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 11' ' ' GLU . 15.5 t -77.21 162.57 4.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.259 -0.428 . . . . 72.04 110.564 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.428 ' N ' HG12 ' A' ' 10' ' ' VAL . 23.4 tt0 -96.74 170.27 9.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.627 -0.508 . . . . 73.22 109.627 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.1 pt -76.65 146.63 8.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.835 0.35 . . . . 54.43 111.533 -174.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 61.16 25.65 15.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.378 -0.828 . . . . 73.44 111.925 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.5 m -105.13 148.1 27.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.928 -0.578 . . . . 63.41 109.592 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.531 ' HG2' HD12 ' A' ' 78' ' ' LEU . 45.5 tttm -105.43 126.1 51.73 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.78 -0.452 . . . . 72.33 109.78 -177.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 17.6 m -131.71 162.87 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.3 0.571 . . . . 70.22 111.634 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.695 ' HE3' ' HA2' ' A' ' 39' ' ' GLY . 2.1 tmtp? -122.36 145.19 48.49 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.5 -0.773 . . . . 72.13 110.094 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.5 t -73.4 97.49 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.094 -0.503 . . . . 71.23 110.872 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.545 HD11 ' HB2' ' A' ' 76' ' ' GLU . 45.6 mt -54.51 -46.96 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 115.619 -0.718 . . . . 62.23 109.616 170.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.46 173.42 39.72 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.328 -0.851 . . . . 71.34 112.451 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.1 mt -96.94 157.9 3.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.36 -0.608 . . . . 51.5 109.36 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.2 91.76 1.83 Allowed Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.764 -0.458 . . . . 44.33 109.764 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.09 165.48 0.88 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 124.055 3.17 . . . . 64.25 113.783 -171.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.529 ' H ' ' NH1' ' A' ' 28' ' ' ARG . 0.5 OUTLIER 64.88 24.06 12.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.093 -0.958 . . . . 74.53 111.486 -177.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.552 ' OG ' HG22 ' A' ' 27' ' ' VAL . 40.7 t -93.14 150.97 20.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.653 -0.703 . . . . 72.25 109.778 173.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -82.39 -18.17 42.95 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.933 -0.395 . . . . 73.11 109.933 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.586 HG21 ' HA ' ' A' ' 69' ' ' GLU . 11.2 m -94.75 -9.44 9.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.34 -0.391 . . . . 55.23 110.343 176.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.529 ' NH1' ' H ' ' A' ' 24' ' ' GLU . 52.2 ttp180 -50.6 -49.09 57.39 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.272 0.558 . . . . 65.15 110.121 170.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -62.06 -37.44 84.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.205 -0.907 . . . . 75.14 110.499 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -62.36 -44.99 95.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.726 -0.67 . . . . 74.14 110.824 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.453 HG13 HD11 ' A' ' 73' ' ' ILE . 47.5 mm -63.91 -48.32 86.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.761 -0.654 . . . . 73.24 111.247 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.9 mmt -64.84 -33.41 75.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 75.42 110.732 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.38 -28.14 68.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.871 -0.604 . . . . 61.01 110.361 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 82.6 mmm -81.58 -8.82 59.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.762 -0.654 . . . . 74.43 110.95 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.07 24.79 47.14 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.747 -0.74 . . . . 75.41 112.534 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mt -102.09 134.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.733 -0.469 . . . . 74.13 109.733 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.14 169.99 20.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.18 0.514 . . . . 62.41 111.598 -175.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.421 ' C ' ' HD3' ' A' ' 38' ' ' ARG . 4.1 tmt_? -68.28 110.49 4.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.783 -0.644 . . . . 53.11 109.541 175.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.695 ' HA2' ' HE3' ' A' ' 17' ' ' LYS . . . 132.32 -16.7 4.87 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.763 -0.732 . . . . 74.42 111.952 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 m -71.12 148.9 46.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.877 0.37 . . . . 74.41 110.547 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.437 ' C ' HD12 ' A' ' 42' ' ' ILE . 40.3 mt-10 -100.04 132.35 45.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.962 -0.563 . . . . 74.14 110.361 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.64 HG13 ' HB3' ' A' ' 58' ' ' LEU . 2.0 mp -118.98 122.12 68.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.31 0.576 . . . . 71.31 110.179 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.725 ' HB3' ' HB2' ' A' ' 57' ' ' ARG . 82.3 t80 -96.13 116.78 29.51 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.654 -0.869 . . . . 75.51 108.654 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.2 mm -71.7 101.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.683 -0.488 . . . . 74.11 109.683 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.34 -33.58 69.73 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.365 -0.605 . . . . 74.23 109.365 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.32 150.54 5.6 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.652 -0.785 . . . . 75.34 112.563 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -88.93 154.42 20.25 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.474 -0.936 . . . . 72.45 108.474 173.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.88 151.98 51.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.593 -0.521 . . . . 73.54 109.593 175.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.79 -23.91 61.0 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.49 2.127 . . . . 74.1 111.81 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ttt -86.0 -17.84 34.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.761 -0.654 . . . . 74.14 110.213 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.05 -23.64 20.72 Favored Glycine 0 C--N 1.33 0.2 0 CA-C-N 116.06 -0.518 . . . . 74.34 112.795 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.406 ' OD1' ' HA ' ' A' ' 53' ' ' PRO . 28.9 t70 -145.91 137.0 12.6 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.233 -0.654 . . . . 74.41 109.233 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HA ' ' OD1' ' A' ' 52' ' ' ASP . 4.2 Cg_exo -81.53 -168.84 6.95 Favored 'Cis proline' 0 CA--C 1.534 0.49 0 C-N-CA 124.157 -1.185 . . . . 64.21 113.194 0.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 64' ' ' SER . 57.8 mt -121.17 142.86 35.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 73.12 110.138 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.34 112.95 25.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.928 0.394 . . . . 74.33 110.652 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.639 ' O ' ' HA ' ' A' ' 62' ' ' SER . 4.0 mp -107.7 132.32 53.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 61.42 110.741 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.725 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 27.7 mmt180 -90.33 100.48 13.31 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.27 -0.641 . . . . 65.14 109.27 173.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.64 ' HB3' HG13 ' A' ' 42' ' ' ILE . 2.8 pp -137.66 142.6 41.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.984 -0.553 . . . . 74.4 110.016 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 70.63 -4.12 1.75 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.332 0.587 . . . . 71.14 110.42 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.26 -41.22 1.5 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.959 -0.564 . . . . 35.51 112.303 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -113.26 159.53 19.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.46 0.648 . . . . 71.45 111.985 -175.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 36.1 t -82.25 148.09 28.57 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.879 -1.055 . . . . 72.12 110.289 173.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 42.1 tp -151.08 146.38 26.13 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.554 -0.748 . . . . 64.13 109.793 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -89.01 113.99 25.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.199 0.524 . . . . 74.3 111.64 -178.404 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.503 HD23 HD13 ' A' ' 56' ' ' LEU . 3.6 mm? -112.89 157.16 21.78 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.067 -0.716 . . . . 73.3 109.067 174.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -84.3 160.8 20.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.864 0.364 . . . . 64.31 111.131 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.492 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 1.6 tmtp? -55.39 -28.44 54.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.627 -0.715 . . . . 43.52 110.667 175.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.8 m -56.6 -56.87 15.94 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.365 -0.38 . . . . 71.11 110.494 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.586 ' HA ' HG21 ' A' ' 27' ' ' VAL . 1.8 mp0 -63.61 -40.19 96.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.095 0.474 . . . . 70.15 110.353 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . . . -62.86 -20.97 65.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.572 -0.74 . . . . 74.21 111.648 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.474 ' C ' ' HD2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -79.22 -39.05 34.2 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.058 -0.349 . . . . 70.52 110.058 177.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -89.76 8.44 31.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.196 -0.457 . . . . 75.12 112.2 -171.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.453 HD11 HG13 ' A' ' 31' ' ' ILE . 47.1 mm -115.07 113.02 42.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.872 -0.418 . . . . 71.34 109.872 175.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.7 mt -93.45 126.44 38.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.776 -0.453 . . . . 55.02 109.776 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 18.6 m -128.14 153.27 37.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.277 0.561 . . . . 72.41 112.124 -174.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.545 ' HB2' HD11 ' A' ' 19' ' ' ILE . 42.2 tt0 -119.6 144.33 47.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.004 -0.998 . . . . 73.3 108.812 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.456 ' HA ' HG12 ' A' ' 16' ' ' VAL . 9.3 p -70.38 136.66 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.071 0.462 . . . . 75.15 111.076 -176.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' A' ' 17' ' ' LYS . 40.8 mt . . . . . 0 C--N 1.327 -0.374 0 N-CA-C 112.284 0.476 . . . . 64.13 112.284 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.004 0 N-CA-C 111.912 -0.475 . . . . 61.43 111.912 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.8 pt -125.24 168.12 18.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.948 -0.76 . . . . 62.24 108.948 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.24 149.1 50.77 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.027 -1.082 . . . . 55.11 111.033 177.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.688 HD21 HD11 ' A' ' 44' ' ' ILE . 2.7 tm? -54.43 -33.18 58.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.389 0.614 . . . . 73.52 109.89 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.456 ' ND2' ' HA ' ' A' ' 71' ' ' LYS . 8.7 p30 -70.62 -19.46 62.82 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.574 -0.739 . . . . 72.4 111.307 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -92.23 -8.12 46.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.903 0.382 . . . . 74.04 110.789 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.1 t -80.28 157.62 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.112 -0.495 . . . . 74.55 110.029 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.584 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 21.1 tt0 -94.81 176.81 6.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.793 -0.447 . . . . 75.12 109.793 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.584 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 39.9 pt -84.73 160.5 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 112.23 0.455 . . . . 61.14 112.23 -173.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 60.59 46.92 8.89 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.121 -0.945 . . . . 64.53 111.998 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.7 m -145.53 154.06 41.79 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.583 -0.735 . . . . 73.34 109.636 174.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.657 ' HB3' ' HD1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -109.22 130.89 55.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.34 0.59 . . . . 72.44 110.802 178.674 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 77' ' ' VAL . 27.1 m -132.28 163.73 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.133 -0.94 . . . . 63.51 110.343 -177.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.48 ' HB2' HD21 ' A' ' 78' ' ' LEU . 29.8 ttpt -115.48 143.48 45.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.992 -0.549 . . . . 75.21 110.656 -177.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.566 ' HA ' HG12 ' A' ' 75' ' ' VAL . 52.8 t -77.61 98.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.509 -0.768 . . . . 72.43 110.048 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.8 HD11 ' HB3' ' A' ' 76' ' ' GLU . 39.8 mt -57.41 -54.69 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.638 -0.71 . . . . 72.45 110.453 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -161.6 178.01 37.65 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.158 -0.928 . . . . 73.34 111.34 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 53.6 mt -113.2 155.84 14.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.963 -0.384 . . . . 70.03 109.963 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.407 ' HA ' ' HD2' ' A' ' 23' ' ' PRO . 51.8 t -101.82 91.27 2.26 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.213 -0.662 . . . . 75.41 109.213 175.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.717 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 25.7 Cg_endo -59.22 -168.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.844 3.029 . . . . 61.33 113.773 -172.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 68.3 -43.86 0.49 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.571 -0.741 . . . . 74.43 112.371 -173.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.581 ' OG ' HG22 ' A' ' 27' ' ' VAL . 8.6 t -55.57 145.19 23.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.219 0.533 . . . . 71.24 111.725 -176.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.922 ' HD3' ' H ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -71.73 -29.68 64.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.567 -0.742 . . . . 62.43 109.805 173.071 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.691 HG21 ' HA ' ' A' ' 69' ' ' GLU . 11.4 m -79.84 -17.37 12.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.948 0.404 . . . . 75.35 110.049 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.717 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 2.8 tmm_? -55.18 -36.93 66.4 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.064 -0.516 . . . . 70.45 109.999 169.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -71.48 -40.07 70.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.292 0.568 . . . . 73.41 109.805 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.638 ' HG2' ' OE2' ' A' ' 69' ' ' GLU . 23.5 tptm -53.05 -48.04 67.96 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 114.988 -1.005 . . . . 62.12 111.021 177.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 27' ' ' VAL . 61.5 mt -50.99 -53.29 14.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.566 -0.743 . . . . 73.31 111.386 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 59.3 mtt -66.76 -35.39 79.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 73.42 111.371 -178.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.83 -38.58 89.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.943 0.401 . . . . 61.13 110.022 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.6 tpt -65.75 -25.57 67.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.472 -0.786 . . . . 75.32 110.961 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.87 8.09 11.09 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.756 -0.735 . . . . 41.23 112.744 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.425 ' HB ' ' CG2' ' A' ' 31' ' ' ILE . 37.4 mt -104.61 133.28 49.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.711 -0.477 . . . . 71.33 109.711 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.656 HG23 ' H ' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -129.78 -85.89 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 112.092 0.404 . . . . 70.24 112.092 -177.603 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.656 ' H ' HG23 ' A' ' 37' ' ' VAL . 45.4 ttm180 -153.99 117.56 4.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.964 0.412 . . . . 64.44 110.263 -177.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.43 -1.05 68.89 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.492 -0.861 . . . . 74.55 111.534 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.0 m -66.65 140.85 57.94 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.675 -0.491 . . . . 74.34 109.675 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.512 ' HG2' HD11 ' A' ' 78' ' ' LEU . 35.5 mt-10 -107.07 128.15 54.11 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.803 -0.635 . . . . 71.45 110.029 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.682 HG21 HD23 ' A' ' 56' ' ' LEU . 77.5 mt -121.48 136.28 58.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.317 -0.856 . . . . 73.12 110.535 -172.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.657 ' HD1' ' HB3' ' A' ' 15' ' ' LYS . 37.4 t80 -100.87 105.88 17.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.262 -0.426 . . . . 72.43 109.869 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.688 HD11 HD21 ' A' ' 7' ' ' LEU . 50.4 mm -70.54 120.92 19.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.941 -0.392 . . . . 73.42 109.941 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -89.96 -65.82 0.98 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.09 -0.504 . . . . 65.45 110.516 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' A' ' 12' ' ' ILE . . . -159.06 173.44 35.92 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.687 -0.768 . . . . 52.15 112.027 -177.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.496 ' HG2' HG23 ' A' ' 54' ' ' ILE . 58.3 mtpt -129.52 146.98 51.28 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.32 -0.622 . . . . 75.33 109.32 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.67 157.13 68.42 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.497 -0.557 . . . . 64.12 109.497 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -52.3 -29.74 39.76 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.82 2.347 . . . . 73.24 113.196 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -82.43 -7.95 59.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 74.03 110.821 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.11 -8.34 78.62 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.012 -0.835 . . . . 74.54 111.012 -173.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.776 ' HB2' ' HB2' ' A' ' 67' ' ' LYS . 5.9 t70 -139.29 128.98 14.26 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.014 -0.593 . . . . 73.41 109.797 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 97.3 Cg_endo -87.0 -174.32 9.8 Favored 'Cis proline' 0 C--O 1.237 0.459 0 C-N-CA 123.374 -1.511 . . . . 74.12 113.05 0.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.496 HG23 ' HG2' ' A' ' 47' ' ' LYS . 4.6 mp -112.86 140.78 30.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.791 -0.641 . . . . 44.43 109.31 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.65 106.76 19.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.025 0.441 . . . . 61.33 110.839 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.682 HD23 HG21 ' A' ' 42' ' ' ILE . 3.1 mp -105.51 134.27 48.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.836 -0.62 . . . . 74.13 109.381 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 39.6 mtt180 -98.19 119.98 37.81 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.982 0.42 . . . . 72.43 110.114 175.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.432 ' HG ' HD23 ' A' ' 63' ' ' LEU . 3.4 pp -139.43 140.58 37.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.431 -0.804 . . . . 65.52 109.999 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 46.7 ttm-85 65.9 -0.25 1.38 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.31 -0.859 . . . . 63.42 111.993 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.05 -52.02 0.56 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.468 -0.872 . . . . 55.25 113.585 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -120.87 177.33 5.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.871 0.367 . . . . 63.34 111.722 -173.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 30.2 t -88.18 142.9 27.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.596 0.712 . . . . 71.12 112.226 -175.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 62' ' ' SER . 3.2 mm? -134.68 143.54 47.29 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.342 -1.299 . . . . 54.33 108.928 176.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 p -99.33 119.91 38.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.078 0.466 . . . . 52.03 111.695 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.526 HD13 HD13 ' A' ' 56' ' ' LEU . 9.0 mp -114.72 151.42 33.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.86 -0.609 . . . . 70.51 109.423 175.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.492 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 46.8 mmm-85 -75.61 159.81 30.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.32 0.581 . . . . 75.22 111.745 -174.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.776 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -61.94 -33.58 74.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.246 -0.888 . . . . 60.34 110.611 179.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 41.7 m -73.3 -35.47 66.13 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.978 -0.555 . . . . 73.23 111.204 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.691 ' HA ' HG21 ' A' ' 27' ' ' VAL . 39.4 mt-10 -70.11 -43.01 71.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.351 0.596 . . . . 65.52 109.401 176.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.71 -21.25 65.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.386 -0.825 . . . . 63.45 111.072 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.456 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 1.8 ttpm? -70.74 -35.64 72.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.076 -0.511 . . . . 64.35 110.517 176.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -84.46 14.44 4.51 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.586 -0.734 . . . . 73.44 111.204 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.418 HG12 HD13 ' A' ' 31' ' ' ILE . 54.7 mt -125.8 120.47 57.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.897 -0.592 . . . . 65.05 109.909 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.1 mt -104.01 126.1 50.88 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.955 -0.387 . . . . 75.53 109.955 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 18' ' ' VAL . 23.9 m -129.51 157.44 42.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.318 0.58 . . . . 74.43 112.372 -174.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.8 ' HB3' HD11 ' A' ' 19' ' ' ILE . 14.0 pt-20 -119.22 153.35 35.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.265 -0.88 . . . . 73.03 109.681 176.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.578 ' HA ' HG12 ' A' ' 16' ' ' VAL . 13.1 p -77.92 133.09 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.988 0.423 . . . . 54.23 111.024 -177.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.512 HD11 ' HG2' ' A' ' 41' ' ' GLU . 96.9 mt . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 121.362 0.601 . . . . 61.53 110.826 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.728 0 CA-C-O 121.03 0.239 . . . . 52.53 112.6 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 pt -115.37 173.07 3.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.808 -0.812 . . . . 71.15 108.808 176.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.45 143.2 29.08 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 119.865 -1.16 . . . . 61.43 111.72 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.507 HD11 HD11 ' A' ' 44' ' ' ILE . 39.5 tp -63.61 -24.71 67.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.2 0.524 . . . . 73.34 110.548 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -76.52 -14.39 60.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.853 -0.612 . . . . 74.51 110.604 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.85 -4.63 56.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.339 0.59 . . . . 74.33 110.012 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.5 t -98.26 162.28 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.505 -0.771 . . . . 62.15 109.399 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.791 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 24.8 tt0 -124.77 -172.0 2.47 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.98 -0.288 . . . . 72.44 110.79 -177.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.791 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 31.6 pt -63.35 154.13 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 113.445 0.906 . . . . 73.02 113.445 -170.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 63.02 27.1 15.77 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.965 -1.016 . . . . 62.15 111.962 173.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.422 ' H ' ' HB ' ' A' ' 44' ' ' ILE . 19.6 m -102.42 152.66 20.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.259 -0.428 . . . . 65.1 110.53 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -124.17 110.92 15.28 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.235 -0.654 . . . . 71.43 109.235 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 77' ' ' VAL . 30.4 m -128.32 174.17 12.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.534 -0.757 . . . . 70.01 110.687 -174.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 37.5 ttmt -129.18 140.98 51.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.154 -0.475 . . . . 75.23 110.595 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.55 HG13 HG23 ' A' ' 73' ' ' ILE . 48.7 t -73.36 96.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.319 -0.855 . . . . 64.24 110.619 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.8 mm -63.29 -44.9 99.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.76 -0.655 . . . . 65.32 109.908 174.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.93 172.08 44.51 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.233 -0.984 . . . . 74.33 112.671 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.605 ' HB ' ' NH1' ' A' ' 28' ' ' ARG . 49.4 mt -127.77 158.98 39.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 108.068 -1.086 . . . . 73.2 108.068 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 25' ' ' SER . 38.2 t -101.19 91.3 1.96 Allowed Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.058 0.456 . . . . 65.42 111.254 -175.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.612 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 24.4 Cg_endo -59.94 171.55 2.86 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.696 2.264 . . . . 64.42 112.35 -177.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 68.93 -5.28 1.05 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.682 -0.69 . . . . 74.33 111.488 -175.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 1.2 m -78.74 156.77 28.72 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.955 -0.387 . . . . 54.04 109.955 173.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -75.33 -31.43 60.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.894 0.378 . . . . 75.22 110.599 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.525 ' HB ' ' HG3' ' A' ' 69' ' ' GLU . 29.6 m -81.47 -21.61 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 70.34 110.77 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.612 ' HG2' ' HA ' ' A' ' 23' ' ' PRO . 17.7 tpt180 -53.02 -43.78 66.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.94 -0.573 . . . . 54.33 110.465 175.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -59.43 -44.65 92.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.587 -0.733 . . . . 64.33 110.771 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 34' ' ' MET . 88.6 tttt -63.85 -48.93 74.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.818 -0.628 . . . . 62.23 110.931 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 27' ' ' VAL . 82.1 mt -57.33 -45.81 85.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.822 -0.627 . . . . 71.01 111.392 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 95.4 mmm -68.57 -35.5 77.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.795 0.331 . . . . 71.31 110.593 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -66.32 -39.96 89.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.99 -0.55 . . . . 74.42 110.255 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 91.0 mmm -60.52 -34.73 74.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.818 -0.628 . . . . 74.22 110.735 176.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.58 13.82 9.29 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.64 -0.791 . . . . 73.45 112.894 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.7 mt -89.64 127.1 42.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.86 0.362 . . . . 74.32 110.052 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.36 173.13 14.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.722 -0.672 . . . . 60.52 110.675 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.59 135.27 57.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.185 -0.461 . . . . 74.52 110.619 178.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.24 -12.09 66.89 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.908 -0.587 . . . . 71.12 112.662 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.3 m -73.29 142.24 47.17 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.859 -0.423 . . . . 71.12 109.859 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -94.39 136.14 35.02 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.065 0.459 . . . . 61.23 109.785 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.2 mm -116.74 117.82 56.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.643 -0.708 . . . . 75.1 110.463 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 63.4 t80 -95.52 119.48 34.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.854 -0.612 . . . . 74.54 109.436 174.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.507 HD11 HD11 ' A' ' 7' ' ' LEU . 26.3 mm -76.3 101.88 2.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.612 -0.514 . . . . 51.13 109.612 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -70.35 -42.83 71.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.934 -0.575 . . . . 71.11 109.601 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 169.75 177.78 40.42 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.889 -0.672 . . . . 75.34 111.956 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -117.97 143.09 46.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.132 -0.692 . . . . 72.34 109.132 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.64 158.46 31.13 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.605 -0.271 . . . . 63.55 110.394 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -45.41 -41.73 17.8 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.201 2.6 . . . . 72.21 113.419 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.7 ttt -71.22 -21.97 62.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 74.35 111.382 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.59 -7.22 42.31 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.728 -0.949 . . . . 71.01 110.728 -172.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.483 ' OD1' ' HA ' ' A' ' 53' ' ' PRO . 21.8 t70 -155.54 139.25 11.2 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.838 -0.801 . . . . 74.15 108.838 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HB3' ' HA ' ' A' ' 66' ' ' ARG . 4.1 Cg_exo -79.45 -170.19 8.51 Favored 'Cis proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.829 -1.321 . . . . 75.24 113.05 2.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.5 mt -116.39 137.5 49.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.713 -0.676 . . . . 74.23 109.904 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.03 111.65 20.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.291 -0.413 . . . . 60.24 110.287 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.6 mt -114.04 135.96 53.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.967 -0.561 . . . . 71.43 109.903 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.715 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 44.4 ttt180 -94.83 107.4 19.41 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.698 -0.482 . . . . 73.22 109.698 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.557 HD13 ' H ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -132.69 153.63 50.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.271 -0.422 . . . . 73.24 110.288 -177.539 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.543 ' HB2' HD22 ' A' ' 58' ' ' LEU . 0.2 OUTLIER 70.62 -55.63 0.63 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.773 0.671 . . . . 51.13 110.631 -178.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.53 -33.03 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 116.116 -0.493 . . . . 64.41 111.956 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -125.85 165.58 18.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.822 0.344 . . . . 75.4 110.938 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.715 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 47.7 t -86.28 145.82 26.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.243 0.544 . . . . 72.4 110.973 -178.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.1 mt -145.31 161.22 40.14 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.052 -0.976 . . . . 62.41 109.483 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -97.17 121.18 38.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.044 0.449 . . . . 65.34 110.741 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.42 143.31 49.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.355 -0.839 . . . . 65.43 109.389 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.485 ' HA ' ' HB3' ' A' ' 53' ' ' PRO . 37.4 mmt180 -71.82 155.14 40.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.073 0.463 . . . . 72.23 110.898 -177.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -56.27 -30.9 63.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.381 -0.827 . . . . 72.05 111.045 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 2.9 p -63.81 -37.87 89.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 44.41 111.607 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.525 ' HG3' ' HB ' ' A' ' 27' ' ' VAL . 1.6 mp0 -73.87 -39.39 63.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.003 0.43 . . . . 74.21 110.554 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.16 -23.64 66.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.202 0.525 . . . . 65.54 110.734 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 68' ' ' SER . 7.1 tmtt? -62.99 -33.9 76.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.79 -0.641 . . . . 74.14 111.74 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -88.65 -5.24 58.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.128 0.49 . . . . 72.14 111.78 -168.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.55 HG23 HG13 ' A' ' 18' ' ' VAL . 65.6 mt -105.13 115.58 47.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.192 -0.458 . . . . 61.12 110.899 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.489 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.7 mm? -86.67 126.87 34.83 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.633 -0.506 . . . . 70.24 109.633 174.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.499 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 24.2 m -130.15 153.72 39.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.877 0.37 . . . . 72.11 111.574 -176.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -102.52 148.49 25.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.283 -0.636 . . . . 75.52 109.283 173.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 16' ' ' VAL . 53.6 t -89.3 114.51 27.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.864 0.364 . . . . 65.41 110.187 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--N 1.324 -0.504 0 CA-C-O 121.192 0.52 . . . . 64.43 111.343 -177.751 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 112.07 -0.412 . . . . 61.03 112.07 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.6 pt -115.74 168.19 7.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.987 -0.375 . . . . 74.04 109.987 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.07 143.65 41.73 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.311 -0.947 . . . . 73.52 111.924 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 7' ' ' LEU . 2.6 tm? -58.3 -34.31 70.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.214 0.53 . . . . 74.42 109.841 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -69.78 -14.36 62.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.73 -0.668 . . . . 45.22 111.387 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -96.12 -2.86 45.66 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.809 0.338 . . . . 73.24 111.122 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.5 t -90.76 159.21 2.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.234 -0.439 . . . . 51.01 110.208 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -89.98 166.0 13.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.155 -0.475 . . . . 74.31 110.266 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.9 pt -77.48 162.87 4.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.185 -0.462 . . . . 64.24 110.599 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt 60.55 30.09 19.49 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.192 0.597 . . . . 74.14 111.014 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.6 m -120.88 151.67 39.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.68 -0.691 . . . . 74.21 110.3 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -109.59 127.4 54.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.097 -0.501 . . . . 73.2 109.698 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.447 HG23 ' HB ' ' A' ' 42' ' ' ILE . 22.5 m -128.97 173.54 13.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.261 -0.427 . . . . 63.0 111.099 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.821 ' HE3' HD21 ' A' ' 78' ' ' LEU . 29.9 ttmt -126.5 140.29 52.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.907 -0.588 . . . . 63.42 110.689 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.88 96.85 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.604 -0.726 . . . . 74.12 110.345 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.439 HD11 ' HD2' ' A' ' 17' ' ' LYS . 38.1 mm -92.36 -52.77 9.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.405 -0.816 . . . . 60.32 110.894 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.81 160.55 22.83 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.207 -0.997 . . . . 72.11 112.945 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.716 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 71.8 mt -142.4 158.12 19.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.801 -1.185 . . . . 72.21 107.801 -178.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.0 t -100.62 91.42 1.81 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.65 0.262 . . . . 74.12 110.65 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.716 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 31.4 Cg_exo -57.57 159.06 17.63 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.26 2.64 . . . . 65.03 112.732 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 62.62 74.5 0.43 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.521 -0.763 . . . . 75.43 110.155 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 28.9 t -159.26 153.52 23.81 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.134 -0.939 . . . . 62.34 109.599 -176.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -68.97 -22.6 64.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.833 0.349 . . . . 72.15 110.344 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 31' ' ' ILE . 25.2 m -95.77 -20.34 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.495 -0.32 . . . . 72.24 110.684 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.605 ' CD ' ' HA ' ' A' ' 23' ' ' PRO . 2.0 tpm_? -50.33 -54.45 21.41 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.184 -0.462 . . . . 74.13 111.074 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -65.61 -37.07 85.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.971 -0.559 . . . . 63.22 110.992 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -66.32 -45.05 81.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.327 -0.397 . . . . 54.44 111.23 -174.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.446 ' HA ' ' HE2' ' A' ' 34' ' ' MET . 79.2 mt -59.71 -45.83 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.347 -0.388 . . . . 75.12 110.834 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.584 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 2.2 ttt -71.98 -33.16 67.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.328 -0.397 . . . . 71.42 110.675 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -68.27 -24.66 64.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.031 -0.531 . . . . 63.13 110.079 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.446 ' HE2' ' HA ' ' A' ' 31' ' ' ILE . 63.0 mtm -79.64 2.32 22.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.786 -0.643 . . . . 63.44 111.441 178.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.63 -8.06 59.81 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.696 -0.764 . . . . 22.13 112.763 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 32' ' ' MET . 63.2 mt -81.5 137.42 21.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.864 0.364 . . . . 74.2 110.371 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.763 HG23 ' H ' ' A' ' 38' ' ' ARG . 1.9 m -133.78 -85.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.201 -0.454 . . . . 72.31 111.152 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.763 ' H ' HG23 ' A' ' 37' ' ' VAL . 17.8 ttm180 -153.37 140.68 19.59 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.985 -0.746 . . . . 73.21 108.985 175.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.58 -9.81 69.66 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.634 -0.793 . . . . 73.14 111.278 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -64.82 147.09 53.89 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.755 -0.461 . . . . 72.43 109.755 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -97.28 147.4 24.18 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.234 0.54 . . . . 61.2 111.541 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.603 HG12 ' HB3' ' A' ' 58' ' ' LEU . 64.5 mt -130.81 118.23 41.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.027 -0.988 . . . . 70.32 109.479 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.617 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 64.0 t80 -105.0 106.18 16.56 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.317 -0.401 . . . . 74.22 109.985 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.573 HG12 HD22 ' A' ' 56' ' ' LEU . 52.6 mt -75.31 102.35 2.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.235 -0.654 . . . . 74.51 109.235 177.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -85.54 -24.62 27.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.968 0.413 . . . . 71.52 110.906 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.12 -172.09 40.66 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.844 -0.693 . . . . 65.44 112.265 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.687 ' HG2' HG23 ' A' ' 54' ' ' ILE . 54.5 mtpt -123.49 159.08 29.85 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.737 -0.838 . . . . 74.43 108.737 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.82 152.14 87.44 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.64 -0.504 . . . . 75.34 109.64 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.91 -9.66 12.53 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.816 2.344 . . . . 34.11 112.999 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 55.7 ttp -97.29 -4.62 38.39 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.325 0.583 . . . . 74.5 110.318 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.67 -12.74 67.67 Favored Glycine 0 N--CA 1.454 -0.128 0 CA-C-N 115.988 -0.551 . . . . 71.25 111.958 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.559 ' OD2' ' HB2' ' A' ' 67' ' ' LYS . 11.4 t70 -152.32 136.51 10.22 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.344 -0.984 . . . . 70.11 108.344 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.466 ' HB3' ' HA ' ' A' ' 66' ' ' ARG . 3.5 Cg_exo -81.25 -167.96 6.31 Favored 'Cis proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.817 -1.326 . . . . 72.23 112.401 -1.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.687 HG23 ' HG2' ' A' ' 47' ' ' LYS . 46.8 mt -109.98 134.1 53.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.991 -0.55 . . . . 75.01 110.091 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.51 107.29 18.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.021 0.439 . . . . 43.24 110.167 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.573 HD22 HG12 ' A' ' 44' ' ' ILE . 28.8 mt -120.21 131.97 55.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.041 -0.527 . . . . 60.03 110.295 -177.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.813 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 27.9 ttt-85 -93.29 99.97 12.41 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.765 -0.828 . . . . 64.22 108.765 171.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.603 ' HB3' HG12 ' A' ' 42' ' ' ILE . 1.1 pp -119.13 146.0 45.49 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.084 -0.507 . . . . 74.11 110.461 -176.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 73.01 -45.87 0.63 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.895 0.747 . . . . 72.14 111.069 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.47 -26.42 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.293 -0.479 . . . . 74.45 112.152 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -121.45 157.74 29.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.855 0.36 . . . . 75.14 111.147 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.813 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -89.61 133.41 34.64 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.891 -0.595 . . . . 65.3 111.361 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.4 mt -141.98 152.02 43.06 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.552 -0.749 . . . . 71.22 109.475 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -88.86 110.81 21.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.203 0.525 . . . . 71.4 110.886 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.83 145.8 28.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.501 -0.772 . . . . 74.21 108.963 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.466 ' HA ' ' HB3' ' A' ' 53' ' ' PRO . 10.3 mpt_? -80.68 163.34 23.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.977 0.418 . . . . 75.51 110.338 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.559 ' HB2' ' OD2' ' A' ' 52' ' ' ASP . 4.5 ttmp? -47.76 -38.39 15.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.349 -0.841 . . . . 71.41 111.917 176.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.5 m -59.46 -50.78 72.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.251 -0.432 . . . . 74.32 111.766 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 73' ' ' ILE . 1.8 mp0 -63.66 -49.0 74.91 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.29 0.369 . . . . 74.22 110.795 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.55 -22.55 65.26 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.157 0.503 . . . . 65.53 111.481 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.595 ' HB3' ' HZ2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -78.95 -23.2 44.75 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.0 -0.546 . . . . 55.43 110.705 -179.169 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -102.48 12.86 35.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 74.12 111.736 -175.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.463 HG22 HG13 ' A' ' 75' ' ' VAL . 61.9 mt -113.57 127.26 71.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.293 -0.412 . . . . 71.4 110.212 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.71 123.27 49.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.044 0.45 . . . . 73.24 109.923 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.463 HG13 HG22 ' A' ' 73' ' ' ILE . 28.2 m -129.56 160.04 40.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 112.324 0.49 . . . . 61.23 112.324 -170.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -106.28 159.02 16.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.591 -0.731 . . . . 63.4 109.305 172.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -83.75 124.61 39.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.775 0.322 . . . . 74.43 110.668 -177.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.821 HD21 ' HE3' ' A' ' 17' ' ' LYS . 46.3 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.923 0.392 . . . . 45.43 111.01 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.85 0 CA-C-O 121.052 0.251 . . . . 42.25 112.95 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.2 pt -125.97 179.33 3.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.185 -0.672 . . . . 74.24 109.185 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.93 145.49 31.18 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.024 -1.084 . . . . 70.31 110.942 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.944 HD21 HD21 ' A' ' 56' ' ' LEU . 51.7 tp -57.55 -30.85 65.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.982 0.42 . . . . 75.02 111.587 -176.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.543 ' ND2' ' HG3' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -71.25 -6.51 40.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.408 -0.36 . . . . 54.45 111.97 179.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.543 ' HG3' ' ND2' ' A' ' 8' ' ' ASN . 44.1 mt-10 -103.55 2.22 33.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.619 0.247 . . . . 53.24 111.145 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.8 t -88.08 157.55 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.877 0.37 . . . . 71.41 110.797 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.522 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 32.1 tt0 -99.27 176.02 5.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.957 -0.565 . . . . 65.43 110.12 -178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.522 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 40.9 pt -79.95 159.31 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.854 0.359 . . . . 72.31 111.943 -175.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 59.55 35.79 22.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.379 -0.828 . . . . 74.2 111.15 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -130.94 151.27 51.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.269 -0.423 . . . . 70.02 110.809 -177.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.777 ' HG2' ' HD1' ' A' ' 43' ' ' TYR . 32.6 mtmt -109.07 130.18 55.48 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.238 0.542 . . . . 62.01 110.563 176.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 7.0 m -129.4 142.9 42.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.198 -0.91 . . . . 61.22 109.617 176.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.534 ' HB2' HD11 ' A' ' 78' ' ' LEU . 30.5 ttpt -104.5 142.62 34.3 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.059 0.457 . . . . 64.41 110.486 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.514 ' HA ' HG12 ' A' ' 75' ' ' VAL . 37.0 t -74.75 96.6 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.524 -0.762 . . . . 74.24 110.769 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.695 HD11 ' HB3' ' A' ' 76' ' ' GLU . 16.9 mt -58.72 -42.92 86.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.7 0.762 . . . . 72.13 108.951 171.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.29 170.66 39.95 Favored Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 114.55 -1.205 . . . . 72.22 111.911 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.734 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 14.5 mt -114.23 161.92 12.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.399 -1.334 . . . . 70.1 107.399 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.53 91.84 1.15 Allowed Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.252 0.548 . . . . 74.41 110.377 -174.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.734 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 31.6 Cg_exo -57.26 169.83 1.95 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.812 3.008 . . . . 73.42 113.414 -170.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 65.89 13.61 9.12 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.18 -0.918 . . . . 54.53 110.113 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 14.7 t -98.89 134.9 41.1 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.566 -0.743 . . . . 55.12 109.354 174.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' A' ' 26' ' ' LYS . 17.4 pttp -68.13 -15.61 63.66 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.334 -0.394 . . . . 75.14 111.295 178.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 31' ' ' ILE . 27.8 m -94.96 -28.14 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.557 -0.457 . . . . 74.51 110.736 174.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 3.8 tmt_? -54.1 -47.0 72.26 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.263 0.554 . . . . 75.21 109.845 174.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.9 ttt-85 -55.77 -47.33 77.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.187 -0.915 . . . . 65.24 110.433 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.58 -44.76 95.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.308 -0.86 . . . . 72.22 111.408 -177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.489 HD13 ' CG1' ' A' ' 73' ' ' ILE . 60.3 mt -64.74 -47.62 87.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.516 -0.766 . . . . 61.31 111.411 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.434 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 2.3 ttt -68.48 -32.87 73.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.089 0.471 . . . . 64.31 110.545 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.07 -23.62 64.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.815 -0.63 . . . . 54.24 110.612 177.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 22.2 ttm -75.62 -19.62 59.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.835 -0.621 . . . . 75.42 110.65 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.4 -5.06 13.31 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.418 -0.896 . . . . 72.5 112.825 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 32' ' ' MET . 44.6 mt -84.79 125.12 40.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.086 0.469 . . . . 73.12 110.298 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.05 -178.0 2.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.687 -0.688 . . . . 62.34 110.91 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -68.51 116.45 9.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.077 -0.51 . . . . 74.45 110.897 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.14 -2.47 44.01 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.887 -0.597 . . . . 61.02 113.018 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.9 m -75.72 148.34 38.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.858 0.329 . . . . 54.03 110.126 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -95.81 125.22 40.22 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.087 -0.506 . . . . 73.2 110.193 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.7 mt -100.66 114.83 40.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.475 -0.784 . . . . 72.41 109.748 176.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.777 ' HD1' ' HG2' ' A' ' 15' ' ' LYS . 37.1 t80 -91.26 105.09 17.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.121 -0.491 . . . . 74.32 110.105 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.652 HD11 HD11 ' A' ' 7' ' ' LEU . 47.8 mm -80.53 96.37 2.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.071 -0.714 . . . . 75.11 109.071 175.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.05 -26.89 33.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.983 0.421 . . . . 72.42 110.708 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.05 176.84 47.72 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.32 -0.943 . . . . 61.0 112.57 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.772 ' HG2' HG23 ' A' ' 54' ' ' ILE . 56.2 mtpt -133.62 158.22 43.76 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.756 -0.831 . . . . 73.02 108.756 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.85 156.84 63.97 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.501 -0.185 . . . . 52.31 110.501 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.98 -33.74 73.98 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.809 2.339 . . . . 72.4 112.729 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.1 ttm -87.68 -7.65 57.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.134 0.492 . . . . 72.33 110.875 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.89 -15.3 60.88 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 121.13 -0.557 . . . . 71.32 112.075 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -140.3 131.54 14.15 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.38 -0.6 . . . . 73.22 109.38 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.06 -170.08 7.94 Favored 'Cis proline' 0 CA--C 1.531 0.33 0 C-N-CA 124.124 -1.199 . . . . 64.43 113.217 1.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.772 HG23 ' HG2' ' A' ' 47' ' ' LYS . 41.1 mt -110.07 145.08 17.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.766 -0.652 . . . . 60.34 110.005 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.89 104.16 15.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.197 0.523 . . . . 61.05 110.706 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.944 HD21 HD21 ' A' ' 7' ' ' LEU . 7.9 mp -99.93 164.01 12.2 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.477 -0.783 . . . . 71.51 110.27 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 27.8 ttm180 -142.35 111.73 6.59 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.703 -0.851 . . . . 74.21 108.703 171.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.531 ' N ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -136.5 149.48 48.19 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.793 0.33 . . . . 71.24 110.823 -177.336 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 62.89 2.72 1.04 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.581 -0.736 . . . . 64.23 111.676 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.67 -14.2 11.69 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.803 -0.713 . . . . 61.31 112.861 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.414 ' CD1' HD21 ' A' ' 63' ' ' LEU . 7.5 p90 -128.01 150.73 49.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.447 0.642 . . . . 62.04 112.385 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 47.9 t -84.46 144.63 28.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.093 -0.958 . . . . 54.04 111.969 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.476 HD22 ' C ' ' A' ' 62' ' ' SER . 3.4 mm? -135.11 144.37 47.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.897 -1.047 . . . . 73.44 109.757 177.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.47 110.01 21.41 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.349 -0.387 . . . . 74.21 110.194 175.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.58 HD21 HD22 ' A' ' 56' ' ' LEU . 2.9 pp -124.55 160.77 27.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.76 0.314 . . . . 63.51 110.46 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 6.1 mpt_? -80.17 161.98 24.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.564 0.697 . . . . 73.12 112.214 -169.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -57.89 -54.85 42.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.725 -1.125 . . . . 71.44 111.459 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.0 m -75.4 -11.71 60.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.033 0.444 . . . . 73.45 111.175 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 66' ' ' ARG . 20.8 tt0 -79.76 -42.45 24.5 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.835 -0.802 . . . . 73.54 108.835 176.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 7' ' ' LEU . . . -69.71 -21.15 63.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.817 -1.083 . . . . 64.34 111.157 174.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -59.01 -26.61 64.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.86 -0.609 . . . . 72.4 112.017 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.4 -3.19 57.31 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.331 0.586 . . . . 54.41 110.622 -177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.504 HG22 HG13 ' A' ' 75' ' ' VAL . 51.7 mt -101.83 128.58 54.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.104 -0.498 . . . . 33.0 110.722 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.0 mt -106.7 118.01 35.55 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.847 -0.427 . . . . 75.11 109.847 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 15.3 m -129.15 146.13 34.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.935 0.398 . . . . 72.53 111.957 -174.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.695 ' HB3' HD11 ' A' ' 19' ' ' ILE . 9.7 pt-20 -100.67 139.06 36.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.852 -0.613 . . . . 73.15 110.164 176.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.651 ' HA ' HG12 ' A' ' 16' ' ' VAL . 39.5 t -75.12 112.11 12.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.149 -0.478 . . . . 50.25 110.572 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 17' ' ' LYS . 90.6 mt . . . . . 0 C--N 1.327 -0.375 0 CA-C-O 121.249 0.547 . . . . 73.22 110.918 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.8 mtt . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.073 0.463 . . . . 74.33 110.903 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.9 p -148.7 -178.33 6.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.58 -0.736 . . . . 74.1 109.314 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.01 111.13 2.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.088 -0.708 . . . . 64.44 109.088 171.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.419 ' HA3' HD12 ' A' ' 19' ' ' ILE . . . -71.3 141.75 33.01 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.551 -0.749 . . . . 64.44 113.672 -170.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.1 pt -106.8 174.77 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.448 -0.945 . . . . 65.02 108.448 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.75 147.73 28.23 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 119.811 -1.185 . . . . 74.5 111.267 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.482 HD21 HD21 ' A' ' 56' ' ' LEU . 44.0 tp -62.65 -17.97 61.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.369 0.604 . . . . 74.43 110.94 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.706 HD22 ' HA ' ' A' ' 71' ' ' LYS . 7.8 p30 -75.44 -10.99 59.94 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.572 -0.74 . . . . 70.54 110.895 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -101.81 9.53 40.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.044 -0.525 . . . . 73.43 110.747 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.1 t -103.19 160.27 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.01 -0.541 . . . . 72.54 109.602 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.473 ' CG ' ' H ' ' A' ' 12' ' ' ILE . 12.6 tt0 -112.13 -176.85 3.02 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.226 -0.287 . . . . 73.33 110.226 -177.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.473 ' H ' ' CG ' ' A' ' 11' ' ' GLU . 40.8 pt -66.85 150.38 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.709 0.633 . . . . 73.02 112.709 -171.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 68.3 mttm 51.93 48.99 21.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.078 -0.965 . . . . 60.34 112.343 174.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.7 m -127.37 153.7 45.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.705 -0.68 . . . . 64.42 109.6 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' H ' HD12 ' A' ' 79' ' ' LEU . 91.1 mttt -112.45 129.23 56.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.237 0.541 . . . . 60.25 111.023 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 77' ' ' VAL . 15.4 m -137.47 152.65 27.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.114 -0.948 . . . . 65.32 109.795 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.741 ' HB2' HD11 ' A' ' 78' ' ' LEU . 1.9 tmtp? -105.94 140.85 38.32 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.112 -0.495 . . . . 74.42 110.27 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -77.75 95.16 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.314 -0.857 . . . . 74.5 110.207 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.869 HD11 ' HB3' ' A' ' 76' ' ' GLU . 17.3 mt -63.49 -55.95 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.595 -0.729 . . . . 63.31 110.004 175.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.22 -177.19 33.1 Favored Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 120.398 -0.905 . . . . 51.41 112.91 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.496 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 22.4 mt -129.08 161.52 38.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.392 -0.966 . . . . 55.11 108.392 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.44 90.56 1.03 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.683 0.754 . . . . 71.35 109.582 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.878 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 36.6 Cg_endo -61.43 162.45 20.61 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.412 2.741 . . . . 64.45 113.864 -167.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 65.38 5.68 3.28 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.903 -1.044 . . . . 75.14 112.193 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.538 ' HB3' HG22 ' A' ' 27' ' ' VAL . 1.0 OUTLIER -77.15 -4.67 45.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.69 0.281 . . . . 64.22 111.503 179.076 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 88.6 tttt 71.24 -45.66 0.62 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.494 0.718 . . . . 71.14 110.941 -174.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 25' ' ' SER . 31.5 m -66.72 -16.73 21.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.069 0.461 . . . . 74.2 109.92 173.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.878 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 4.4 tmt_? -57.87 -37.96 74.89 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.115 -0.698 . . . . 75.21 109.115 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 6.3 tpp180 -64.82 -46.22 82.89 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 115.62 -0.718 . . . . 72.4 109.969 174.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -55.41 -48.74 73.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.609 -0.723 . . . . 71.03 110.834 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.498 HD11 ' HB3' ' A' ' 72' ' ' ASP . 78.3 mt -59.89 -48.65 86.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.957 -0.565 . . . . 74.34 111.139 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -38.17 90.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 64.31 110.837 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.86 -32.9 74.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.788 -0.642 . . . . 74.5 111.048 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -17.74 64.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.046 -0.525 . . . . 62.54 111.09 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.25 12.51 29.05 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.513 -0.851 . . . . 71.31 112.558 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.1 mt -91.51 126.71 44.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.079 0.466 . . . . 74.05 110.035 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.11 169.79 21.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.671 -0.695 . . . . 75.42 111.014 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -61.33 109.12 1.05 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.825 -0.625 . . . . 73.35 110.562 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.677 ' HA2' ' HE3' ' A' ' 17' ' ' LYS . . . 119.64 -9.85 11.53 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.761 -0.733 . . . . 63.12 113.092 178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 m -71.48 149.24 46.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.02 0.438 . . . . 75.52 110.737 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -98.08 132.77 43.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.726 -0.67 . . . . 74.13 110.147 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.455 ' HB ' HG23 ' A' ' 16' ' ' VAL . 45.0 mm -108.93 121.66 62.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.461 -0.791 . . . . 73.13 110.343 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -111.31 112.15 23.72 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.329 -0.619 . . . . 74.45 109.329 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 7' ' ' LEU . 51.3 mm -75.59 121.22 26.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.351 -0.611 . . . . 75.2 109.351 176.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.56 -53.25 6.42 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.847 -0.798 . . . . 52.43 108.847 178.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.452 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . -172.77 179.05 44.5 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.731 -0.947 . . . . 73.4 110.731 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -118.37 156.96 28.03 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.166 -0.679 . . . . 73.13 109.166 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.27 157.37 77.76 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 110.038 -0.356 . . . . 53.42 110.038 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -59.18 -12.38 15.84 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.734 2.289 . . . . 74.13 112.77 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.5 mmt -99.89 -2.35 35.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.48 . . . . 71.33 110.486 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.01 -16.06 56.42 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.197 -0.525 . . . . 73.33 111.894 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -150.52 137.76 11.68 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 108.64 -0.874 . . . . 60.24 108.64 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.04 -164.95 4.02 Favored 'Cis proline' 0 CA--C 1.531 0.36 0 C-N-CA 123.734 -1.361 . . . . 71.1 113.25 1.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.4 mt -119.03 147.34 22.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.862 -0.608 . . . . 64.24 109.975 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.89 119.45 36.52 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.089 -0.337 . . . . 53.22 110.089 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.482 HD21 HD21 ' A' ' 7' ' ' LEU . 5.9 mp -117.04 154.65 30.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.816 0.341 . . . . 62.31 110.731 -176.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -128.28 105.13 8.13 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.337 -0.616 . . . . 74.23 109.337 170.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.462 ' N ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -142.6 160.33 40.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.197 -0.911 . . . . 74.24 109.871 -175.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? 75.15 -56.91 0.61 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.973 0.795 . . . . 72.11 109.574 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 173.91 -1.01 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.71 -0.677 . . . . 74.12 111.901 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -142.46 155.09 45.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.236 0.541 . . . . 75.34 111.956 -173.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.2 m -86.81 135.8 33.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.312 -0.858 . . . . 73.3 111.011 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.445 HD13 ' CD2' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -160.36 158.38 29.53 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.324 -0.398 . . . . 52.43 110.197 175.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.8 t -102.76 123.77 47.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.452 0.644 . . . . 73.42 111.62 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.445 ' CD2' HD13 ' A' ' 63' ' ' LEU . 4.1 mm? -112.64 158.0 20.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.924 -1.035 . . . . 73.35 108.812 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -86.51 159.35 19.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.057 0.455 . . . . 73.45 110.521 -175.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.52 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 0.9 OUTLIER -58.95 -28.74 66.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.682 -0.69 . . . . 74.2 110.026 176.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.5 m -59.2 -46.73 87.66 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.126 -0.488 . . . . 60.01 111.248 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -68.43 -41.99 79.56 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.186 0.517 . . . . 74.14 110.241 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.64 -21.55 64.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.661 -0.699 . . . . 65.34 111.304 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.706 ' HA ' HD22 ' A' ' 8' ' ' ASN . 54.2 tttm -79.4 -18.43 52.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.348 -0.387 . . . . 73.42 110.9 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.498 ' HB3' HD11 ' A' ' 31' ' ' ILE . 4.1 t70 -97.25 -9.8 27.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.246 0.546 . . . . 74.41 110.582 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.413 HG12 HD13 ' A' ' 31' ' ' ILE . 58.4 mt -96.78 121.99 47.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.982 -0.554 . . . . 74.24 110.481 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.8 mt -99.34 118.65 36.45 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.865 -0.42 . . . . 61.45 109.865 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.551 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 24.1 m -124.26 159.14 30.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.423 0.63 . . . . 65.4 112.474 -173.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.869 ' HB3' HD11 ' A' ' 19' ' ' ILE . 9.3 pt-20 -111.89 138.54 48.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.215 -0.902 . . . . 61.4 110.147 176.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.553 ' HA ' HG12 ' A' ' 16' ' ' VAL . 43.2 t -75.06 121.49 26.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.404 -0.362 . . . . 72.25 110.267 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.741 HD11 ' HB2' ' A' ' 17' ' ' LYS . 82.2 mt -99.37 -25.07 14.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.313 0.578 . . . . 71.34 111.313 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.418 HD12 ' H ' ' A' ' 15' ' ' LYS . 37.6 mt -96.29 113.93 25.57 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.595 -0.73 . . . . 65.43 112.405 -174.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -142.83 115.11 8.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.59 -0.732 . . . . 73.22 109.247 168.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -149.23 -75.64 0.16 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.621 -0.511 . . . . 71.33 109.621 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -173.16 83.86 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.801 -0.814 . . . . 64.53 108.801 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -54.4 134.1 45.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.25 -0.886 . . . . 71.34 112.339 -170.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.81 121.12 18.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.26 -0.882 . . . . 74.15 109.962 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -92.52 -7.87 46.08 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.702 -0.399 . . . . 73.35 110.653 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.9 m170 . . . . . 0 C--O 1.246 0.919 0 CA-C-O 118.577 -0.725 . . . . 74.11 109.229 171.908 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.795 0.331 . . . . 61.35 110.576 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.681 HG21 HG12 ' A' ' 77' ' ' VAL . 25.7 m -66.26 137.86 57.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.347 -0.388 . . . . 64.1 110.226 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.3 148.86 29.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.295 -0.411 . . . . 75.02 110.635 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.21 112.02 3.43 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.869 -0.681 . . . . 73.44 112.453 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.0 pt -105.45 171.77 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.451 -0.574 . . . . 64.22 109.451 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.02 156.35 35.96 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 119.974 -1.108 . . . . 60.4 111.717 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.589 HD23 HG11 ' A' ' 75' ' ' VAL . 3.0 tm? -59.88 -26.52 65.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.508 0.67 . . . . 73.33 109.718 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.56 ' HB2' ' HG2' ' A' ' 67' ' ' LYS . 9.2 p30 -73.23 -8.94 57.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.499 -0.773 . . . . 65.31 111.417 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -103.47 1.0 31.84 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.496 -0.32 . . . . 73.41 111.612 -174.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 11' ' ' GLU . 20.9 t -81.54 157.31 4.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 61.12 111.501 -174.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.408 ' N ' HG12 ' A' ' 10' ' ' VAL . 8.0 tp10 -80.59 164.77 22.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.25 -0.886 . . . . 73.44 110.127 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.0 pt -79.25 138.09 20.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.102 -0.499 . . . . 71.24 111.116 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt 59.69 44.17 14.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.534 -0.757 . . . . 73.54 111.422 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.8 t -113.67 171.13 7.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.406 -0.815 . . . . 72.23 109.692 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -129.02 113.31 15.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.207 -0.451 . . . . 65.54 109.886 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 77' ' ' VAL . 18.4 m -123.01 160.35 25.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.449 0.642 . . . . 64.22 112.252 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -106.75 144.09 33.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.747 -1.115 . . . . 74.11 110.303 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.5 t -86.12 104.05 13.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.049 -0.523 . . . . 71.52 109.731 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.6 mt -59.37 -49.46 83.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.541 -0.754 . . . . 74.21 110.33 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.24 175.34 43.52 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.777 -0.725 . . . . 54.23 112.438 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.663 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 22.0 mt -97.6 159.79 3.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.307 -0.627 . . . . 64.22 109.307 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.42 90.84 1.27 Allowed Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 109.555 -0.535 . . . . 73.41 109.555 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.945 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 33.1 Cg_exo -58.19 167.25 4.79 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.932 3.088 . . . . 75.45 114.165 -170.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 64.59 15.99 10.02 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.79 -1.096 . . . . 71.4 110.828 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.584 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 23.3 t -87.5 165.12 15.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.607 -0.724 . . . . 73.43 110.067 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.12 -21.83 46.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.944 -0.391 . . . . 63.34 109.944 175.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 31' ' ' ILE . 35.2 m -104.74 -3.69 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.285 -0.416 . . . . 71.4 111.554 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.945 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 3.6 tmm_? -50.73 -51.6 48.35 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.093 0.245 . . . . 61.52 110.929 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -63.85 -45.63 88.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.59 -0.277 . . . . 74.03 110.535 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -50.45 -53.48 29.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 52.43 111.129 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.553 HD12 HD11 ' A' ' 73' ' ' ILE . 46.7 mm -58.68 -47.81 87.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.631 -0.713 . . . . 74.51 111.752 -177.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.607 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 4.6 ppp? -73.86 -28.17 61.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.916 0.388 . . . . 61.42 111.072 -177.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.89 -28.65 64.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.276 0.56 . . . . 75.22 109.883 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 81.0 mtp -81.49 1.03 35.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.294 -0.866 . . . . 75.44 111.44 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.66 -7.53 53.53 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.616 -0.802 . . . . 71.33 113.132 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 32' ' ' MET . 21.6 mt -84.08 130.36 36.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.772 0.32 . . . . 61.04 110.232 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.612 HG23 ' H ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -148.05 -85.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.182 -0.463 . . . . 61.14 111.473 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.612 ' H ' HG23 ' A' ' 37' ' ' VAL . 17.9 mtp180 -145.44 131.23 19.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.232 -0.44 . . . . 75.32 109.922 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.03 -4.08 86.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.567 -0.825 . . . . 60.25 112.156 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 m -64.29 144.07 57.42 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.607 -0.516 . . . . 41.1 109.607 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -117.47 133.93 55.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.968 0.413 . . . . 74.21 110.94 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.854 HG12 HD13 ' A' ' 58' ' ' LEU . 74.4 mt -119.68 136.06 58.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.599 -0.728 . . . . 73.05 111.312 -174.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -98.12 116.43 30.32 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.727 -0.471 . . . . 52.14 109.727 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.532 HD11 HD21 ' A' ' 7' ' ' LEU . 50.5 mm -82.64 104.61 11.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.623 -0.51 . . . . 62.41 109.623 177.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -76.85 -34.03 57.87 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.91 0.386 . . . . 74.14 110.724 -177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.35 171.56 31.72 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.564 -0.827 . . . . 64.23 112.196 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.609 ' HG2' HG23 ' A' ' 54' ' ' ILE . 40.6 mtmt -124.39 148.63 47.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.012 -0.736 . . . . 75.41 109.012 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.47 156.94 49.59 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.093 -0.336 . . . . 74.22 110.093 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.65 -14.17 25.04 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.525 2.15 . . . . 63.01 112.456 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.9 mtt -93.76 -6.17 46.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 73.4 110.205 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.67 -10.37 59.84 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.378 -0.689 . . . . 55.5 111.378 -173.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -145.43 133.01 10.33 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 108.981 -0.748 . . . . 60.34 108.981 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -84.7 -172.32 9.18 Favored 'Cis proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.341 -1.524 . . . . 52.22 112.866 -0.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.609 HG23 ' HG2' ' A' ' 47' ' ' LYS . 59.4 mt -114.21 142.07 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.232 -0.44 . . . . 72.13 110.11 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.07 115.55 30.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.071 0.462 . . . . 75.52 110.415 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.644 HD23 HG21 ' A' ' 42' ' ' ILE . 5.7 mp -113.13 156.42 23.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.968 -0.56 . . . . 71.52 110.327 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 16.4 ttm180 -119.08 106.73 12.69 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.18 -1.044 . . . . 64.23 108.18 167.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.854 HD13 HG12 ' A' ' 42' ' ' ILE . 41.8 tp -137.36 146.75 44.9 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.579 -0.737 . . . . 73.31 110.219 -173.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.443 ' HD3' ' OH ' ' A' ' 61' ' ' TYR . 53.1 ttt180 65.67 12.48 8.3 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.37 -0.832 . . . . 71.24 110.646 176.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.5 -12.12 36.04 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 121.009 -0.615 . . . . 61.03 113.116 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.443 ' OH ' ' HD3' ' A' ' 59' ' ' ARG . 27.4 p90 -134.52 155.85 49.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.635 0.731 . . . . 53.14 112.448 -177.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -79.96 143.26 34.32 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.933 -1.03 . . . . 74.5 110.974 175.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -157.57 151.31 24.09 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.255 -0.646 . . . . 72.13 109.255 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -113.95 134.15 55.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.07 0.462 . . . . 65.23 110.952 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 pp -133.13 167.09 20.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.671 -0.695 . . . . 75.14 109.697 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -77.71 148.53 34.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.202 0.525 . . . . 71.32 111.766 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.56 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 14.8 tmtt? -62.31 -35.52 79.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.197 -0.911 . . . . 64.02 111.355 -176.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 60.2 m -67.86 -30.77 70.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.689 0.255 . . . . 73.05 111.689 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.25 -31.82 55.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.153 0.502 . . . . 61.54 109.809 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' A' ' 7' ' ' LEU . . . -65.51 -21.53 66.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.758 -0.656 . . . . 72.04 110.712 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.47 ' HE3' ' HB3' ' A' ' 71' ' ' LYS . 0.9 OUTLIER -69.55 -30.87 68.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.853 -0.612 . . . . 73.23 110.44 176.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.8 2.63 22.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.046 -0.525 . . . . 73.24 111.399 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.553 HD11 HD12 ' A' ' 31' ' ' ILE . 59.5 mt -115.98 114.96 47.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.99 -0.55 . . . . 74.5 109.81 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.0 mt -94.71 121.9 36.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.338 -0.392 . . . . 71.31 110.079 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.589 HG11 HD23 ' A' ' 7' ' ' LEU . 30.3 m -120.98 158.89 23.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.78 0.8 . . . . 63.4 112.424 -173.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.94 126.58 47.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.444 -1.253 . . . . 73.14 109.206 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.681 HG12 HG21 ' A' ' 2' ' ' THR . 11.0 p -74.59 127.07 36.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 115.902 -0.59 . . . . 74.2 110.51 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.2 mt -92.71 -11.23 34.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.341 0.591 . . . . 71.24 110.898 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.1 tt -81.48 79.54 8.06 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.697 -0.683 . . . . 54.43 109.24 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.84 82.16 2.37 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.363 -0.835 . . . . 74.33 109.718 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -84.7 -47.71 10.19 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.413 -1.329 . . . . 72.34 107.413 172.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -155.79 130.66 9.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.218 -1.355 . . . . 73.41 108.148 167.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -58.27 -22.24 51.78 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 123.215 0.322 . . . . 72.22 110.914 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 t60 67.89 89.27 0.1 Allowed 'General case' 0 C--O 1.23 0.071 0 CA-C-N 115.842 -0.617 . . . . 74.02 111.679 166.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -86.69 -39.08 16.38 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.55 -0.537 . . . . 74.12 109.55 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.0 m170 . . . . . 0 C--O 1.244 0.799 0 CA-C-N 115.379 -0.828 . . . . 61.01 109.536 175.585 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 110.069 -0.345 . . . . 70.12 110.069 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.2 p -75.6 82.54 2.61 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.668 0.747 . . . . 61.15 111.411 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -112.89 78.71 1.15 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.337 -0.847 . . . . 71.55 109.609 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 76' ' ' GLU . . . -120.12 125.83 6.44 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.034 -0.984 . . . . 74.04 111.956 -175.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.3 pt -133.03 179.49 4.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.782 -0.451 . . . . 74.25 109.782 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.17 151.01 48.2 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.263 -0.97 . . . . 40.12 111.008 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.58 HD11 HD21 ' A' ' 56' ' ' LEU . 3.1 tm? -57.06 -33.15 66.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.028 0.442 . . . . 42.41 110.461 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -77.13 -10.15 59.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.33 -0.396 . . . . 71.33 111.762 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -93.37 -9.81 37.47 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.975 0.417 . . . . 64.23 110.953 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.6 t -77.94 159.42 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.973 -0.558 . . . . 75.14 110.406 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 29.9 tt0 -103.42 173.97 6.07 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.146 -0.316 . . . . 73.51 110.146 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.585 HG22 ' HA2' ' A' ' 46' ' ' GLY . 40.2 pt -72.99 153.78 7.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 112.21 0.448 . . . . 71.25 112.21 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt 51.4 49.24 21.41 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.194 -0.912 . . . . 72.44 111.998 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.473 ' HA ' HD12 ' A' ' 79' ' ' LEU . 17.9 m -134.06 152.8 52.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.282 -0.872 . . . . 73.52 109.001 174.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -109.34 140.85 42.5 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.318 -0.553 . . . . 74.54 110.254 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 77' ' ' VAL . 29.3 m -132.57 174.86 12.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.793 -0.639 . . . . 61.11 110.677 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.405 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 84.3 tttt -134.34 139.11 45.42 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.0 -0.546 . . . . 73.14 110.324 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.688 ' HA ' HG12 ' A' ' 75' ' ' VAL . 35.0 t -75.54 93.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.428 -0.805 . . . . 72.34 110.257 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.531 HD11 ' OE2' ' A' ' 76' ' ' GLU . 47.9 mm -80.94 -56.8 5.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.553 -0.749 . . . . 73.41 111.312 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.86 158.97 22.84 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.23 -0.986 . . . . 42.43 112.908 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.651 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 68.7 mt -127.43 156.34 39.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.757 -0.831 . . . . 73.52 108.757 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.5 t -103.14 90.21 2.36 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 120.748 0.309 . . . . 74.25 110.33 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.651 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 29.2 Cg_exo -61.18 171.51 3.95 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.147 2.565 . . . . 63.11 112.441 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 63.81 21.14 12.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.873 -0.603 . . . . 63.33 111.007 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.795 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 22.6 t -88.54 153.39 21.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.907 -0.588 . . . . 70.34 109.702 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -93.28 -3.1 54.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.901 0.382 . . . . 73.22 110.069 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.509 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 32.8 m -113.5 -2.42 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 116.145 -0.479 . . . . 73.21 110.537 174.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.795 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 15.0 ttp180 -54.09 -42.4 69.33 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.927 0.394 . . . . 73.33 110.285 175.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.52 -38.96 92.0 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 115.98 -0.555 . . . . 64.44 110.958 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.667 ' HG2' ' OE2' ' A' ' 69' ' ' GLU . 21.1 tptm -55.41 -54.02 48.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.294 0.568 . . . . 71.13 110.363 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.696 HG23 HD12 ' A' ' 36' ' ' ILE . 65.3 mt -62.78 -40.98 90.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.055 -0.975 . . . . 74.52 110.939 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ttt -67.65 -32.4 73.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.968 -0.56 . . . . 75.53 110.985 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -73.12 -26.29 61.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.083 -0.508 . . . . 73.15 110.114 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 60.9 mtt -69.12 -27.66 65.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.4 0.619 . . . . 61.45 110.167 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.08 18.82 11.51 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.641 -0.709 . . . . 54.51 112.12 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.696 HD12 HG23 ' A' ' 31' ' ' ILE . 39.5 mt -88.93 124.27 41.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.162 0.506 . . . . 54.52 110.118 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -134.01 161.12 41.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.349 -0.841 . . . . 75.13 109.438 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -64.23 121.57 14.58 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.201 -0.296 . . . . 44.43 110.201 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.97 -20.32 11.63 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.866 -0.683 . . . . 74.32 111.929 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.4 m -72.92 147.97 44.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.199 -0.297 . . . . 72.4 110.199 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -105.85 144.86 31.98 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.786 -0.45 . . . . 53.53 109.786 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.658 HG21 HD23 ' A' ' 56' ' ' LEU . 73.0 mt -129.89 128.53 65.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.209 -0.45 . . . . 63.25 111.213 -174.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.547 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 69.4 t80 -96.69 108.08 20.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.145 -0.48 . . . . 71.21 109.866 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.469 HD11 HD21 ' A' ' 7' ' ' LEU . 46.3 mm -75.68 111.75 12.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.92 -0.4 . . . . 44.21 109.92 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -73.59 -53.25 10.93 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.636 -0.505 . . . . 62.52 109.636 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.585 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 179.23 177.54 47.74 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.396 -0.82 . . . . 70.31 111.772 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -123.02 143.22 50.09 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.283 -0.636 . . . . 74.33 109.283 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.402 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -59.99 156.59 36.06 Favored Pre-proline 0 C--N 1.326 -0.421 0 O-C-N 123.186 0.304 . . . . 73.24 110.206 177.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.402 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 10.6 Cg_endo -54.41 -24.85 37.07 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.096 2.53 . . . . 70.21 113.105 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.5 mtt -84.41 -13.33 52.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.117 0.484 . . . . 72.3 110.796 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.82 -2.68 80.26 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.338 -0.705 . . . . 43.45 111.338 -173.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.753 ' HB2' ' HB2' ' A' ' 67' ' ' LYS . 5.4 t70 -151.15 135.17 9.46 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.267 -0.642 . . . . 74.31 109.267 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -82.67 179.91 25.14 Favored 'Cis proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.564 -1.432 . . . . 74.41 112.436 -1.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 54' ' ' ILE . 4.5 mp -109.02 141.71 23.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.327 -0.62 . . . . 55.42 109.327 177.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.84 113.38 26.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.985 0.421 . . . . 63.0 110.834 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.658 HD23 HG21 ' A' ' 42' ' ' ILE . 2.2 mp -117.43 133.85 55.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.04 -0.527 . . . . 72.22 110.201 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.704 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 46.3 ttt180 -97.47 105.48 17.63 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.887 -0.782 . . . . 72.35 108.887 173.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.557 ' HB3' HG12 ' A' ' 42' ' ' ILE . 3.3 pp -139.86 151.71 45.88 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.279 -0.419 . . . . 73.33 110.75 -174.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 71.44 -19.93 0.24 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.065 0.546 . . . . 73.11 111.703 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 150.58 -26.65 1.07 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.27 -0.49 . . . . 51.11 112.212 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -140.85 166.86 23.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.001 0.429 . . . . 74.5 111.182 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.704 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.3 m -85.58 138.45 32.17 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.107 -0.497 . . . . 61.43 111.871 -176.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.9 mt -134.54 159.06 42.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.558 -0.746 . . . . 75.25 109.471 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p -104.73 122.2 45.2 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.154 0.502 . . . . 74.1 111.361 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.9 tp -109.19 145.47 35.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.861 -0.609 . . . . 62.54 109.504 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -77.53 149.3 34.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.601 0.239 . . . . 75.14 110.541 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.753 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 13.3 tmtt? -57.81 -36.96 72.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 62.43 110.646 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.3 m -62.84 -48.1 80.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.97 -0.559 . . . . 51.2 110.49 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.667 ' OE2' ' HG2' ' A' ' 30' ' ' LYS . 36.9 mt-10 -67.13 -30.96 71.1 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.788 -0.642 . . . . 73.41 110.551 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.68 -21.26 62.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.316 -0.856 . . . . 62.14 111.876 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -81.31 -23.73 37.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.926 0.394 . . . . 75.22 110.532 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.34 -5.45 47.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.073 -0.512 . . . . 52.24 111.445 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.534 HG22 HG13 ' A' ' 75' ' ' VAL . 43.8 mm -122.22 126.22 73.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.516 -0.311 . . . . 71.22 110.772 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.1 mt -108.15 120.79 43.36 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.052 -0.522 . . . . 72.54 109.969 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 18' ' ' VAL . 22.0 m -126.47 151.26 32.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.127 -0.488 . . . . 71.44 111.531 -173.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.531 ' OE2' HD11 ' A' ' 19' ' ' ILE . 14.6 pt-20 -91.39 138.78 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.437 -0.579 . . . . 73.53 109.437 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.663 ' HA ' HG12 ' A' ' 16' ' ' VAL . 24.3 t -87.64 109.9 20.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 120.916 0.388 . . . . 63.45 110.454 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.3 mt -78.56 -25.59 45.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.318 0.58 . . . . 45.54 110.695 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 14' ' ' SER . 62.4 mt -111.51 83.94 1.86 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.543 -0.753 . . . . 52.31 110.993 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -136.3 130.94 33.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.685 -0.689 . . . . 75.14 109.389 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -134.29 89.18 2.53 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.692 -0.855 . . . . 65.54 108.692 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -49.14 109.82 0.3 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.069 -0.969 . . . . 72.21 113.601 -169.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -135.74 -80.66 0.42 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.07 -0.968 . . . . 75.32 109.605 169.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -102.16 58.94 0.82 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.371 -0.603 . . . . 63.53 109.371 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -164.64 102.01 0.81 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.572 -0.74 . . . . 74.33 110.443 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 . . . . . 0 C--O 1.245 0.862 0 CA-C-O 118.122 -0.942 . . . . 62.13 109.867 175.915 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.0 ttp . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.854 -0.424 . . . . 60.12 109.854 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.5 m -96.64 132.07 42.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.615 -0.513 . . . . 62.41 109.615 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -126.82 98.12 5.24 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.849 -0.426 . . . . 72.12 109.849 -176.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.482 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . -67.03 108.71 2.55 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.787 -0.642 . . . . 64.13 112.812 -177.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.4 pt -101.67 160.83 3.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.614 -0.513 . . . . 63.21 109.614 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.01 147.53 30.59 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.142 -1.028 . . . . 54.31 111.283 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.726 HD11 HD11 ' A' ' 44' ' ' ILE . 36.9 tp -60.01 -26.81 66.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.017 0.437 . . . . 73.22 110.853 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.435 HD22 ' HA ' ' A' ' 71' ' ' LYS . 9.2 p30 -78.14 -9.8 59.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.148 -0.478 . . . . 73.01 111.011 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -90.34 -13.96 34.08 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.16 0.505 . . . . 75.42 109.932 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.5 t -77.86 154.88 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.613 -0.721 . . . . 71.14 110.49 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -103.76 170.87 7.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.741 -0.663 . . . . 73.41 110.278 -175.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.3 pt -71.72 146.91 11.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.012 -0.54 . . . . 72.44 111.116 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 13' ' ' LYS . 33.7 ttmt 59.04 63.96 1.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.8 0.81 . . . . 75.52 110.333 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 m -136.0 151.2 49.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.034 -0.985 . . . . 63.42 109.836 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -118.14 110.88 18.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.136 0.493 . . . . 72.52 110.017 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 77' ' ' VAL . 27.0 m -123.69 167.38 17.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.719 -0.673 . . . . 70.01 111.801 -173.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.619 ' HB2' HD21 ' A' ' 78' ' ' LEU . 81.0 tttt -117.96 145.83 44.42 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.094 -0.957 . . . . 61.33 110.126 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.594 ' HA ' HG12 ' A' ' 75' ' ' VAL . 45.9 t -82.15 97.96 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.131 -0.486 . . . . 65.1 110.266 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.872 HD11 ' HB2' ' A' ' 76' ' ' GLU . 42.6 mt -61.03 -48.59 88.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.816 -0.629 . . . . 70.44 109.991 175.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.68 160.73 31.03 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.489 -0.778 . . . . 62.03 112.31 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.701 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 58.5 mt -98.04 157.6 3.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.164 -0.68 . . . . 73.15 109.164 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.9 t -102.45 89.71 1.85 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 120.982 0.42 . . . . 72.34 110.144 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.932 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 21.1 Cg_exo -64.93 170.05 10.86 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.026 2.484 . . . . 71.51 112.367 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 64.25 7.55 3.59 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.638 -0.71 . . . . 75.24 111.879 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.607 ' O ' ' HB3' ' A' ' 28' ' ' ARG . 1.3 m -91.7 154.19 19.15 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.648 -0.871 . . . . 75.14 108.648 170.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -69.61 -45.59 68.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.702 0.287 . . . . 62.33 111.065 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.544 ' HB ' ' HG3' ' A' ' 69' ' ' GLU . 24.5 m -78.03 -6.79 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.065 0.46 . . . . 62.44 110.815 -177.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.932 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -57.07 -36.7 70.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.682 -0.69 . . . . 65.05 111.373 178.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -67.23 -39.27 86.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.117 0.484 . . . . 51.54 110.007 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 34' ' ' MET . 85.3 tttt -63.12 -46.67 86.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.384 -0.826 . . . . 72.24 110.107 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 27' ' ' VAL . 68.9 mt -57.55 -48.2 83.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.603 -0.726 . . . . 71.32 111.445 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.61 -37.19 85.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.958 0.409 . . . . 60.31 110.81 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.26 -30.99 69.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 61.41 110.562 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 62.0 mtt -58.6 -32.29 68.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.047 -0.524 . . . . 71.23 110.887 176.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.41 1.82 7.71 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.617 -0.802 . . . . 64.53 112.208 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.456 HG23 HG21 ' A' ' 18' ' ' VAL . 63.1 mt -84.65 133.1 30.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.873 0.368 . . . . 64.32 110.31 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.748 HG23 ' H ' ' A' ' 38' ' ' ARG . 1.4 m -129.04 -74.86 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.911 -0.586 . . . . 74.11 111.03 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.748 ' H ' HG23 ' A' ' 37' ' ' VAL . 49.2 ttp180 -169.12 138.29 2.09 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.22 -0.659 . . . . 73.3 109.22 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.04 17.22 77.0 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.578 -0.82 . . . . 42.11 111.671 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 m -81.44 151.03 28.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.936 -0.394 . . . . 72.52 109.936 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -95.62 133.32 39.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.898 0.38 . . . . 63.35 110.728 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.4 mt -123.55 116.06 47.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.803 -0.635 . . . . 62.31 110.381 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.528 ' HE2' ' HG2' ' A' ' 45' ' ' GLU . 44.5 t80 -95.15 108.06 20.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.007 -0.542 . . . . 73.43 109.569 174.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.726 HD11 HD11 ' A' ' 7' ' ' LEU . 49.1 mm -75.3 105.87 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.119 -0.697 . . . . 71.35 109.119 176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.528 ' HG2' ' HE2' ' A' ' 43' ' ' TYR . 0.4 OUTLIER -73.83 -61.14 1.95 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.123 -0.695 . . . . 72.24 109.123 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.01 162.56 35.9 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.649 -0.786 . . . . 70.24 112.203 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -125.52 153.0 44.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.202 -0.666 . . . . 70.35 109.202 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.72 156.42 89.12 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 109.589 -0.522 . . . . 72.34 109.589 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.68 -35.39 57.37 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.701 2.267 . . . . 75.11 112.574 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 tpt -65.43 -22.85 66.81 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.182 0.515 . . . . 71.52 111.264 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.27 -2.98 63.67 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 111.024 -0.831 . . . . 40.5 111.024 -174.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -143.32 132.75 11.71 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.996 -0.742 . . . . 72.02 108.996 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -89.56 176.63 20.01 Favored 'Cis proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.704 -1.373 . . . . 74.02 113.023 0.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 64' ' ' SER . 4.6 mp -105.75 130.97 56.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.728 -0.669 . . . . 65.43 109.804 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -107.66 113.6 26.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.501 -0.318 . . . . 74.24 110.248 176.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.635 HD21 HD21 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -129.49 172.15 11.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.459 -0.337 . . . . 74.42 110.938 -178.029 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.677 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 35.4 ttm180 -129.23 117.24 20.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.841 -0.429 . . . . 71.54 109.841 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.547 HD13 ' H ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -135.95 148.7 48.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.54 -0.3 . . . . 71.32 110.58 -177.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.6 tpt85 69.09 -19.59 0.17 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.22 0.608 . . . . 72.22 111.997 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 143.34 -24.27 2.2 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.606 -0.598 . . . . 41.24 111.606 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -115.49 156.76 25.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.098 0.475 . . . . 71.53 111.401 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 46.7 t -93.8 146.81 23.61 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.751 -0.659 . . . . 61.43 110.477 176.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.3 mt -144.82 160.25 41.57 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.284 -0.871 . . . . 61.32 109.571 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 35.8 t -118.89 128.04 54.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.679 -0.489 . . . . 54.44 109.679 176.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.635 HD21 HD21 ' A' ' 56' ' ' LEU . 2.0 pp -125.94 166.91 16.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.251 -0.432 . . . . 72.02 111.268 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.58 163.11 24.9 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.562 -0.745 . . . . 73.01 111.191 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.81 -22.39 64.11 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.404 -0.816 . . . . 62.12 109.998 174.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.2 m -66.14 -50.97 62.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.815 -0.629 . . . . 75.21 110.99 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.544 ' HG3' ' HB ' ' A' ' 27' ' ' VAL . 1.6 mp0 -58.26 -40.73 82.59 Favored 'General case' 0 N--CA 1.46 0.066 0 CA-C-O 121.075 0.464 . . . . 71.44 110.359 175.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HA ' ' HB3' ' A' ' 7' ' ' LEU . . . -62.03 -21.66 65.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.85 -0.614 . . . . 61.21 111.511 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.435 ' HA ' HD22 ' A' ' 8' ' ' ASN . 1.2 tmmt? -83.25 -32.29 26.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.285 -0.416 . . . . 65.3 110.633 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -96.95 9.33 42.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.285 0.476 . . . . 73.03 112.285 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.52 HG22 HG13 ' A' ' 75' ' ' VAL . 79.9 mt -113.24 120.85 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.22 -0.289 . . . . 72.33 110.22 174.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.0 mt -105.56 121.37 43.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.251 -0.431 . . . . 70.41 109.95 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.594 HG12 ' HA ' ' A' ' 18' ' ' VAL . 23.6 m -132.54 174.59 13.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.027 -0.533 . . . . 73.13 111.643 -174.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.872 ' HB2' HD11 ' A' ' 19' ' ' ILE . 35.4 tt0 -143.14 145.08 32.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.271 -0.877 . . . . 52.41 108.891 175.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.687 HG22 ' H ' ' A' ' 79' ' ' LEU . 11.1 p -71.92 141.01 17.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.0 0.429 . . . . 71.34 110.661 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' A' ' 17' ' ' LYS . 68.1 mt -85.75 -0.18 54.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.116 -0.493 . . . . 73.24 111.527 -178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.687 ' H ' HG22 ' A' ' 77' ' ' VAL . 3.9 tt -72.46 90.24 1.3 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.702 -0.681 . . . . 75.21 110.147 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 68.51 120.25 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 O-C-N 124.126 0.891 . . . . 74.55 111.153 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -83.66 35.34 0.51 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.043 -0.526 . . . . 73.35 110.89 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -136.25 121.99 19.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.239 -0.652 . . . . 72.44 109.239 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -88.84 104.29 16.79 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.37 0.605 . . . . 63.54 111.726 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -87.62 75.64 9.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.37 -0.832 . . . . 64.24 109.19 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -79.09 -3.19 44.15 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.681 -0.69 . . . . 74.43 112.148 -173.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.267 -0.873 . . . . 75.31 109.696 173.188 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.496 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.767 -0.457 . . . . 64.31 109.767 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.8 m -79.33 105.58 10.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.914 0.388 . . . . 75.41 111.207 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -138.63 120.44 15.34 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.627 -0.508 . . . . 74.42 109.627 174.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.92 145.49 16.19 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.445 -0.883 . . . . 74.34 112.154 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.1 pt -109.84 169.91 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.757 -0.46 . . . . 72.23 109.757 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.95 158.21 46.14 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.11 -1.043 . . . . 65.23 111.294 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.3 tp -65.81 -18.39 65.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.761 0.315 . . . . 61.13 111.214 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 33.8 p30 -92.63 0.16 57.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.797 0.332 . . . . 53.21 111.311 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.48 5.98 31.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.926 0.393 . . . . 65.42 110.684 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 t -88.72 157.34 3.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.01 0.433 . . . . 54.13 110.951 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -101.74 164.55 11.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.663 -0.698 . . . . 71.11 110.166 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.439 HG22 ' HA2' ' A' ' 46' ' ' GLY . 36.2 pt -75.87 166.53 2.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.951 -0.568 . . . . 63.11 111.16 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.3 mttm 65.91 9.42 6.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.783 -0.644 . . . . 74.5 111.41 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 m -111.7 148.23 33.88 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.226 -0.443 . . . . 71.02 110.811 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 41' ' ' GLU . 81.9 tttt -105.73 123.93 48.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.812 -0.631 . . . . 74.13 109.496 175.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 77' ' ' VAL . 21.5 m -119.17 167.81 12.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.132 -0.485 . . . . 72.33 110.57 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.578 ' HB2' HD21 ' A' ' 78' ' ' LEU . 84.3 tttt -133.58 141.12 47.54 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.768 -0.651 . . . . 73.42 109.982 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.591 ' HA ' HG12 ' A' ' 75' ' ' VAL . 43.4 t -76.52 95.74 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.377 -0.829 . . . . 73.31 110.2 -177.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.79 HD11 ' HB2' ' A' ' 76' ' ' GLU . 36.2 mt -57.46 -49.83 79.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.569 -0.741 . . . . 62.34 109.639 174.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.594 ' HA2' ' HG2' ' A' ' 38' ' ' ARG . . . -173.26 164.57 36.44 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.659 -0.781 . . . . 62.23 112.622 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.701 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 37.9 mt -85.38 158.97 3.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.733 -0.84 . . . . 74.52 108.733 176.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.3 91.71 1.84 Allowed Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.679 -0.489 . . . . 61.42 109.679 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.701 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 72.1 Cg_exo -49.62 169.08 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 124.226 3.284 . . . . 70.41 114.073 -173.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 66.27 19.93 11.04 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.953 -1.021 . . . . 73.43 109.302 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 1.032 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 42.1 t -84.03 152.06 24.62 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.489 -1.232 . . . . 61.14 110.248 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 26' ' ' LYS . 11.1 mptt -98.11 -23.56 15.68 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.159 -0.682 . . . . 65.2 109.159 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -97.25 -7.81 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.559 -0.746 . . . . 62.42 111.039 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 1.032 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 8.4 tmm_? -46.77 -47.92 20.71 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.079 0.4 . . . . 75.21 112.079 176.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -70.27 -28.47 65.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.962 0.41 . . . . 64.33 110.455 -177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -73.46 -48.26 34.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.726 -0.67 . . . . 50.4 110.364 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.54 HD13 HD11 ' A' ' 73' ' ' ILE . 85.7 mt -60.5 -42.1 90.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.525 -0.761 . . . . 53.1 111.182 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.0 ttt -65.9 -30.1 70.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 60.33 110.579 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.75 -32.88 70.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.889 -0.596 . . . . 54.12 110.146 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.8 mtt -63.24 -29.07 70.48 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.934 -0.576 . . . . 72.11 110.43 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.5 5.1 12.92 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.79 -0.641 . . . . 74.44 112.365 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.507 ' HB ' HG22 ' A' ' 31' ' ' ILE . 43.3 mt -90.42 126.59 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.992 0.425 . . . . 72.15 110.436 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.1 m -141.1 -177.67 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.489 -0.778 . . . . 65.32 110.268 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.594 ' HG2' ' HA2' ' A' ' 20' ' ' GLY . 46.0 mtt85 -69.78 114.75 8.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 72.42 110.313 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.39 -8.67 22.5 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.534 -0.841 . . . . 63.14 112.812 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 m -70.41 142.69 52.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.041 0.448 . . . . 72.42 110.412 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.402 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 47.0 mt-10 -106.45 137.47 44.37 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.61 -0.723 . . . . 72.13 110.218 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.763 HG12 ' HB3' ' A' ' 58' ' ' LEU . 66.1 mt -129.5 131.41 67.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.71 -0.677 . . . . 71.25 111.293 -172.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.536 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 53.3 t80 -96.95 125.9 41.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.696 -0.483 . . . . 64.11 109.696 171.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.6 mm -87.24 99.48 8.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.574 -0.528 . . . . 73.23 109.574 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.15 -41.94 24.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.653 -0.703 . . . . 65.02 110.497 -176.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.439 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 172.74 -172.91 45.32 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.432 -0.667 . . . . 34.01 111.432 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.881 ' HE2' ' HA2' ' A' ' 51' ' ' GLY . 13.9 ptmt -151.0 165.89 32.36 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.246 -0.65 . . . . 73.03 109.246 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.47 156.42 82.23 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.771 -0.455 . . . . 64.01 109.771 173.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.49 -32.14 51.71 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.797 2.331 . . . . 74.54 113.086 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 45.5 ttm -86.6 -8.67 57.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.426 0.631 . . . . 75.14 110.367 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.881 ' HA2' ' HE2' ' A' ' 47' ' ' LYS . . . 95.71 -11.27 68.35 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.618 -0.719 . . . . 52.43 112.477 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -131.87 127.53 21.26 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-O 120.841 0.353 . . . . 71.14 110.271 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -83.61 170.33 53.17 Favored 'Cis proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.918 -1.701 . . . . 60.43 112.718 -1.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.52 HG23 ' HB3' ' A' ' 47' ' ' LYS . 41.0 mt -98.57 141.99 15.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.849 -0.797 . . . . 75.42 108.849 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.99 102.9 14.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.033 0.444 . . . . 74.34 110.313 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.721 HD23 HG21 ' A' ' 42' ' ' ILE . 4.5 mp -108.4 162.01 14.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.0 -0.545 . . . . 65.0 109.941 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.696 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 75.3 ttt180 -132.51 100.66 5.04 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.878 -0.786 . . . . 63.14 108.878 173.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.763 ' HB3' HG12 ' A' ' 42' ' ' ILE . 2.9 pp -127.36 149.76 49.91 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.827 -0.624 . . . . 73.11 110.856 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.464 ' HD3' ' OH ' ' A' ' 61' ' ' TYR . 52.4 ttt180 70.26 -22.44 0.17 Allowed 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.532 0.52 . . . . 72.42 112.13 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 141.52 -3.58 2.13 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.927 -0.654 . . . . 61.43 112.141 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.464 ' OH ' ' HD3' ' A' ' 59' ' ' ARG . 16.9 p90 -138.28 158.33 44.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.162 0.506 . . . . 72.41 111.328 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 34.8 t -87.14 147.15 25.75 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.532 -0.758 . . . . 73.43 110.126 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 54.1 tp -155.52 147.73 23.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.579 -0.737 . . . . 71.11 109.775 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 4.1 m -97.48 133.55 41.91 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.07 0.462 . . . . 63.31 110.71 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.702 HD23 HD13 ' A' ' 56' ' ' LEU . 3.8 mm? -123.09 150.12 43.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.609 -0.723 . . . . 70.43 110.178 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 66' ' ' ARG . 22.9 mmt180 -81.87 161.44 23.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.141 0.496 . . . . 63.44 111.222 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.39 -36.89 85.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 71.4 110.898 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.9 m -70.33 -43.27 70.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.442 . . . . 50.42 111.005 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.15 -35.07 79.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.261 0.553 . . . . 60.2 110.482 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 8' ' ' ASN . . . -68.03 -22.19 64.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.525 -0.761 . . . . 61.42 111.358 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -76.36 -29.23 57.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.168 0.508 . . . . 73.22 110.267 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.11 9.18 5.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.751 -0.659 . . . . 62.32 111.629 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.54 HD11 HD13 ' A' ' 31' ' ' ILE . 62.5 mt -128.23 131.27 69.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.327 -0.397 . . . . 64.23 110.55 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.2 mt -107.23 125.71 51.47 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.275 -0.421 . . . . 72.23 109.87 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 18' ' ' VAL . 27.4 m -129.81 160.31 40.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.307 0.575 . . . . 62.04 111.948 -175.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.79 ' HB2' HD11 ' A' ' 19' ' ' ILE . 6.5 tp10 -120.76 146.6 46.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.956 -1.02 . . . . 72.31 109.104 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.622 HG22 ' H ' ' A' ' 79' ' ' LEU . 10.0 p -91.09 133.63 32.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.911 0.386 . . . . 74.52 110.094 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 17' ' ' LYS . 4.0 mm? -78.01 -18.22 56.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.09 0.471 . . . . 74.05 111.342 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.622 ' H ' HG22 ' A' ' 77' ' ' VAL . 89.1 mt -72.6 149.0 44.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.587 -0.733 . . . . 75.23 109.776 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.403 ' C ' ' H ' ' A' ' 82' ' ' HIS . 2.6 mp0 -52.06 136.07 30.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.542 0.527 . . . . 71.34 110.564 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -77.58 38.49 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.163 0.506 . . . . 75.02 111.69 -175.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.403 ' H ' ' C ' ' A' ' 80' ' ' GLU . 61.8 t60 -151.45 -25.58 0.2 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.29 -0.868 . . . . 74.23 108.743 174.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -66.66 -29.64 69.71 Favored 'General case' 0 N--CA 1.46 0.033 0 CA-C-N 115.605 -0.725 . . . . 74.34 109.152 173.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.3 99.66 8.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.939 -0.763 . . . . 73.13 108.939 174.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 86' ' ' HIS . 42.3 t-80 -107.07 -40.73 5.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.668 -0.697 . . . . 75.31 112.246 -169.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 85' ' ' HIS . 19.3 m-70 . . . . . 0 C--O 1.246 0.872 0 N-CA-C 109.079 -0.712 . . . . 71.24 109.079 -167.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.9 mtt . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 110.02 -0.363 . . . . 74.53 110.02 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.5 m -73.37 104.58 4.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.295 -0.411 . . . . 74.32 111.203 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -132.89 158.65 42.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.797 -0.446 . . . . 62.31 109.797 173.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.61 153.99 26.14 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.844 -0.693 . . . . 74.12 112.046 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 pt -124.89 179.41 3.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.389 -0.597 . . . . 75.13 109.389 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.42 154.13 41.91 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.464 -1.35 . . . . 61.44 111.598 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.9 tp -60.67 -27.56 67.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.964 0.411 . . . . 70.14 110.796 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -71.86 -15.16 62.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 53.41 111.533 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.26 -3.9 54.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.877 0.37 . . . . 74.12 110.823 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.7 t -90.36 159.39 2.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.345 -0.389 . . . . 64.44 110.375 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.609 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 22.1 tt0 -98.29 171.97 7.86 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.502 -0.555 . . . . 75.14 109.502 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.609 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 38.4 pt -79.83 177.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.457 -0.338 . . . . 61.54 110.474 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 pttm 52.79 21.16 1.83 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.414 1.085 . . . . 41.31 112.423 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.41 ' HA ' HD12 ' A' ' 79' ' ' LEU . 16.2 m -121.53 153.03 38.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.8 0.334 . . . . 62.51 110.726 -178.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -108.97 132.0 54.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.081 0.467 . . . . 71.14 109.843 176.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.853 HG12 ' HA ' ' A' ' 77' ' ' VAL . 33.7 m -129.79 162.51 37.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.696 -0.684 . . . . 72.35 110.495 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.478 ' HB3' HD12 ' A' ' 78' ' ' LEU . 39.0 ttmt -115.6 143.86 44.73 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.281 -0.872 . . . . 65.42 109.231 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.822 ' HA ' HG12 ' A' ' 75' ' ' VAL . 53.8 t -73.53 95.87 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.855 -0.611 . . . . 71.13 109.947 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.4 mm -64.84 -40.98 90.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.247 -0.888 . . . . 72.14 109.891 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.97 -178.36 44.77 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.466 -0.873 . . . . 74.53 112.334 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.697 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 48.9 mt -128.34 159.3 39.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.364 -0.976 . . . . 70.21 108.364 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.3 t -100.1 90.81 1.44 Allowed Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.864 0.364 . . . . 52.5 110.157 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.697 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 17.5 Cg_exo -65.23 -178.56 0.86 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.335 2.69 . . . . 73.11 112.903 -173.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 61.97 25.52 15.32 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.816 0.817 . . . . 64.41 109.77 -173.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.866 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 10.8 t -115.02 150.66 35.5 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.59 -1.186 . . . . 72.42 109.64 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 3.8 mppt? -81.63 -32.73 31.81 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.597 -0.52 . . . . 73.05 109.597 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 31' ' ' ILE . 27.2 m -79.22 -19.95 12.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 64.22 110.652 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.866 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 5.7 tmm_? -52.28 -43.37 64.39 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.076 0.465 . . . . 74.45 109.826 172.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -59.41 -47.35 85.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.459 -0.792 . . . . 64.34 110.42 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 34' ' ' MET . 87.0 tttt -57.39 -47.19 82.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.209 -0.905 . . . . 71.45 111.028 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.489 HG22 ' HB ' ' A' ' 36' ' ' ILE . 75.9 mt -58.18 -44.77 88.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.566 -0.743 . . . . 34.34 111.409 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 55.2 mtt -71.59 -28.76 64.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.466 -0.334 . . . . 75.44 111.179 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.2 -31.96 72.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.237 0.541 . . . . 75.14 110.003 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 97.6 mmm -73.64 -9.18 58.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.462 -0.79 . . . . 74.22 111.057 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.5 -3.38 46.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.771 -0.728 . . . . 54.11 112.508 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.663 HG23 HG21 ' A' ' 18' ' ' VAL . 58.7 mt -88.06 129.72 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.911 0.386 . . . . 65.11 110.403 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.741 HG23 ' H ' ' A' ' 38' ' ' ARG . 1.0 OUTLIER -144.21 -75.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.837 -0.62 . . . . 75.24 111.437 -178.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.741 ' H ' HG23 ' A' ' 37' ' ' VAL . 24.7 ttt180 -150.86 140.18 21.34 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.602 -0.518 . . . . 73.11 109.602 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.06 19.25 69.82 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.776 -0.726 . . . . 54.3 112.106 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 m -85.28 146.72 26.91 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.948 -0.39 . . . . 62.34 109.948 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -90.99 127.8 36.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.866 0.365 . . . . 74.14 111.067 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.8 mm -126.22 114.87 40.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.44 -0.8 . . . . 75.25 109.609 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.825 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 39.3 t80 -106.3 119.34 38.99 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.559 -0.534 . . . . 75.12 109.559 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.434 HD13 HD12 ' A' ' 56' ' ' LEU . 14.6 mm -82.01 99.18 4.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.297 -0.41 . . . . 74.22 110.029 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -82.95 -22.58 33.73 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.154 -0.618 . . . . 73.42 110.364 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.79 -173.93 34.47 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.81 -0.71 . . . . 74.33 112.139 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.783 ' HG2' HG23 ' A' ' 54' ' ' ILE . 53.1 mtpt -126.8 160.3 31.28 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.442 -0.577 . . . . 53.32 109.442 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.18 151.23 94.24 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.712 -0.477 . . . . 51.44 109.712 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -51.4 -30.81 35.91 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.965 2.443 . . . . 61.43 113.215 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.0 tpt -76.09 -19.85 58.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.121 0.486 . . . . 65.01 111.223 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.58 -7.6 57.95 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.213 -0.755 . . . . 41.34 111.213 -174.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -152.42 132.61 7.35 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 108.9 -0.778 . . . . 74.24 108.9 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.71 -172.52 10.31 Favored 'Cis proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.567 -1.431 . . . . 53.44 112.98 0.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.783 HG23 ' HG2' ' A' ' 47' ' ' LYS . 53.5 mt -109.02 141.85 23.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.764 -0.653 . . . . 73.22 109.325 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.12 106.2 18.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.962 0.41 . . . . 70.42 110.998 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.447 ' N ' HD22 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -105.72 135.77 46.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.132 -0.486 . . . . 61.23 110.059 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.825 ' HB3' ' HB3' ' A' ' 43' ' ' TYR . 2.3 tmt_? -86.56 114.37 23.24 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.794 -0.817 . . . . 72.4 108.794 175.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.6 tp -136.57 146.82 46.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.726 -0.67 . . . . 74.21 110.271 -175.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 71.05 -56.75 0.62 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.487 0.715 . . . . 65.0 110.762 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.51 -36.94 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.41 -0.676 . . . . 51.44 111.41 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.42 ' HE2' HD21 ' A' ' 63' ' ' LEU . 29.6 p90 -124.34 176.59 6.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.759 0.314 . . . . 74.23 110.4 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.784 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -93.11 140.81 29.11 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.491 0.552 . . . . 63.44 112.491 -175.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.42 HD21 ' HE2' ' A' ' 61' ' ' TYR . 75.6 mt -137.04 148.12 46.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.267 -0.879 . . . . 64.25 109.28 174.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 5.7 p -88.52 128.68 35.56 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.291 0.567 . . . . 64.14 111.829 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.0 tp -121.5 157.76 29.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.253 -1.017 . . . . 73.42 108.253 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -80.22 156.34 26.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.56 0.695 . . . . 73.11 112.159 -169.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 67' ' ' LYS . 6.6 ttpm? -57.46 -28.19 63.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.669 -1.151 . . . . 71.24 110.975 174.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.1 m -61.25 -51.82 67.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.858 -0.61 . . . . 63.31 110.395 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' O ' HG13 ' A' ' 73' ' ' ILE . 1.7 mp0 -63.52 -30.54 71.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.94 -0.573 . . . . 72.21 111.111 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.16 -21.79 62.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.335 -0.393 . . . . 63.42 111.69 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.08 -42.45 38.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.398 0.618 . . . . 72.43 109.642 177.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -87.09 -10.37 53.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.392 -0.822 . . . . 54.42 112.018 -170.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.531 HG22 HG13 ' A' ' 75' ' ' VAL . 74.2 mt -90.27 113.09 25.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.923 -0.399 . . . . 74.03 109.923 174.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.5 mt -97.01 112.07 24.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.243 0.545 . . . . 52.03 110.484 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.822 HG12 ' HA ' ' A' ' 18' ' ' VAL . 29.4 m -132.34 167.7 25.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.758 -0.655 . . . . 72.4 110.203 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -140.23 145.96 38.04 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.123 -0.695 . . . . 74.4 109.123 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.853 ' HA ' HG12 ' A' ' 16' ' ' VAL . 47.9 t -67.88 103.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.019 -0.537 . . . . 63.25 110.415 -177.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 17' ' ' LYS . 26.6 mt -102.39 5.42 39.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.759 -0.655 . . . . 71.04 111.184 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 14' ' ' SER . 4.7 tt -58.82 112.79 1.77 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.556 -1.276 . . . . 62.12 107.556 167.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -33.88 95.46 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 124.689 1.243 . . . . 71.25 113.74 -169.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -130.23 78.53 1.85 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.527 -1.215 . . . . 74.53 108.284 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.447 ' O ' ' HB3' ' A' ' 83' ' ' HIS . 33.3 t60 -66.14 130.0 41.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.31 -0.859 . . . . 51.41 109.821 -175.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.447 ' HB3' ' O ' ' A' ' 82' ' ' HIS . 18.9 t-80 70.22 97.25 0.07 Allowed 'General case' 0 CA--C 1.535 0.377 0 O-C-N 123.829 0.706 . . . . 74.3 109.11 -174.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -49.29 -56.31 9.85 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.293 -0.867 . . . . 62.02 113.024 -169.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -132.19 137.69 47.7 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.751 -0.379 . . . . 63.15 110.372 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.312 -0.852 . . . . 73.03 110.419 175.919 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptp . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.608 0.242 . . . . 73.44 111.22 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.2 p -79.79 75.44 6.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.418 0.628 . . . . 74.15 111.783 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -142.86 98.73 3.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.231 -0.895 . . . . 74.11 109.934 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.43 123.15 2.82 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.505 -0.77 . . . . 42.24 111.441 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.7 pt -107.88 163.07 5.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 110.176 -0.305 . . . . 73.24 110.176 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.26 157.83 53.51 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.732 -0.747 . . . . 61.01 111.755 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.559 HD21 HD11 ' A' ' 56' ' ' LEU . 52.4 tp -61.52 -23.47 65.95 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.938 0.399 . . . . 73.32 111.195 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -87.15 -7.12 58.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.562 -0.29 . . . . 52.44 111.192 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -95.97 0.14 51.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.913 0.387 . . . . 71.15 110.67 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.624 HG11 HG11 ' A' ' 16' ' ' VAL . 12.1 t -90.0 163.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 65.35 110.812 -176.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.437 ' N ' HG12 ' A' ' 10' ' ' VAL . 30.4 tt0 -83.53 165.12 19.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.259 -0.428 . . . . 62.31 109.988 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.7 pt -85.93 163.18 2.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.076 -0.511 . . . . 54.1 110.826 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm 59.45 25.21 13.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.005 0.431 . . . . 73.31 111.301 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.7 m -108.87 159.95 16.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.182 -0.463 . . . . 45.2 110.511 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.605 ' H ' HD13 ' A' ' 79' ' ' LEU . 42.2 tttm -116.48 119.23 34.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.716 -0.846 . . . . 74.05 108.716 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.624 HG11 HG11 ' A' ' 10' ' ' VAL . 28.8 m -125.19 155.86 34.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.038 0.447 . . . . 64.41 112.011 -170.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -117.4 142.63 46.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.478 -0.783 . . . . 73.41 110.27 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.825 ' HA ' HG12 ' A' ' 75' ' ' VAL . 68.0 t -83.06 97.68 4.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.735 -0.666 . . . . 63.11 110.617 -176.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.4 mt -58.09 -54.38 33.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.2 -0.909 . . . . 63.5 110.358 173.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.36 165.66 34.46 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.375 -0.917 . . . . 33.41 113.076 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.42 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 58.6 mt -119.75 158.8 21.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.879 -0.786 . . . . 70.15 108.879 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 25' ' ' SER . 62.0 t -99.96 91.75 1.75 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.018 0.437 . . . . 74.01 110.028 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.692 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 37.6 Cg_endo -62.53 171.23 5.81 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.211 2.607 . . . . 34.3 113.308 -173.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 66.1 -15.73 0.12 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.004 0.922 . . . . 74.3 112.486 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -66.72 154.3 41.05 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 110.116 -0.327 . . . . 74.24 110.116 175.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' A' ' 26' ' ' LYS . 72.1 mmtt -69.01 -30.51 68.92 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 111.942 0.349 . . . . 74.04 111.942 -175.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.712 HG21 ' HA ' ' A' ' 69' ' ' GLU . 20.5 m -83.39 -13.41 11.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.886 -0.326 . . . . 74.34 111.336 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.692 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 1.3 tmt_? -58.03 -48.41 80.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.379 -0.373 . . . . 74.14 111.085 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -62.48 -36.34 82.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.094 0.473 . . . . 73.24 110.79 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 34' ' ' MET . 61.5 tttm -66.29 -50.2 64.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.469 -0.787 . . . . 75.33 110.683 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.703 HD13 HD11 ' A' ' 73' ' ' ILE . 70.7 mt -66.37 -42.05 89.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.757 -0.656 . . . . 74.3 111.478 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 83.8 mtp -70.44 -28.75 65.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.633 0.254 . . . . 65.44 111.17 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -67.59 -28.21 67.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.199 0.523 . . . . 71.11 109.891 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.521 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 91.7 mmm -73.82 -16.44 61.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.524 -0.762 . . . . 74.44 111.062 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.3 -13.94 21.05 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.592 -0.813 . . . . 63.43 112.865 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.401 ' HB ' HG22 ' A' ' 31' ' ' ILE . 40.0 mt -78.64 129.33 37.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.71 0.291 . . . . 44.4 110.418 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.777 HG23 ' H ' ' A' ' 38' ' ' ARG . 2.1 m -139.21 -77.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.992 -0.549 . . . . 63.45 111.972 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.777 ' H ' HG23 ' A' ' 37' ' ' VAL . 1.4 tmm_? -149.44 125.44 10.62 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.048 -0.723 . . . . 71.32 109.048 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.33 -14.33 59.69 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.713 -0.756 . . . . 75.33 111.988 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.12 138.31 58.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.32 -0.622 . . . . 71.15 109.32 176.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -123.34 147.45 47.02 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.359 0.6 . . . . 54.53 111.258 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.782 HG21 ' HB3' ' A' ' 56' ' ' LEU . 44.3 mt -136.35 152.66 30.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.116 -0.947 . . . . 73.24 110.046 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -99.65 137.7 37.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.76 -0.459 . . . . 65.54 109.76 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.4 mm -87.76 103.12 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.431 -0.35 . . . . 71.34 110.585 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 57' ' ' ARG . 17.9 mm-40 -71.67 -39.06 70.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.123 -0.489 . . . . 71.44 110.423 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.73 -175.95 34.92 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.93 -0.652 . . . . 51.14 111.927 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -127.65 152.28 47.87 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.001 -0.37 . . . . 73.53 110.001 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -65.28 165.55 17.1 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.157 -0.474 . . . . 62.24 110.444 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 9.5 Cg_endo -51.53 -32.59 44.33 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.903 2.402 . . . . 64.03 113.014 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.5 mtt -89.52 -4.15 58.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.978 0.418 . . . . 74.21 110.991 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.32 5.83 89.55 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.219 -0.752 . . . . 74.45 111.219 -173.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 52.9 t0 -148.39 121.15 4.56 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.9 -0.778 . . . . 70.1 108.9 -176.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HB3' ' HD2' ' A' ' 66' ' ' ARG . 91.5 Cg_endo -86.41 -169.9 6.28 Favored 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.537 -1.443 . . . . 64.22 113.311 1.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 54' ' ' ILE . 4.4 mp -112.63 145.61 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.424 -0.807 . . . . 72.03 109.504 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.45 108.15 20.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.873 0.368 . . . . 75.04 110.798 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.782 ' HB3' HG21 ' A' ' 42' ' ' ILE . 2.2 mm? -102.06 146.14 28.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.464 -0.569 . . . . 64.24 109.464 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 21.8 ttt180 -116.79 114.17 23.57 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.478 -0.489 . . . . 70.34 110.442 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 60' ' ' GLY . 6.0 tt -149.23 156.02 41.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.895 -0.78 . . . . 71.01 108.895 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 58' ' ' LEU . 79.6 ttt180 74.64 -21.84 0.28 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.309 0.576 . . . . 74.21 110.412 -178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 58' ' ' LEU . . . 146.88 -40.92 0.99 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.719 -0.673 . . . . 73.41 111.6 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.4 ' HE2' HD21 ' A' ' 63' ' ' LEU . 23.9 p90 -116.57 168.55 10.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.143 0.497 . . . . 73.42 111.201 -175.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.2 m -85.74 139.03 31.68 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.395 -0.82 . . . . 64.35 111.556 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.4 HD21 ' HE2' ' A' ' 61' ' ' TYR . 76.4 mt -134.49 158.75 43.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.669 -0.696 . . . . 60.43 109.309 175.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.1 m -100.85 138.48 37.84 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.072 0.463 . . . . 64.01 111.305 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.4 mt -127.76 134.64 49.51 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.357 -0.838 . . . . 52.01 108.909 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.536 ' HD2' ' HB3' ' A' ' 53' ' ' PRO . 25.3 mmm180 -64.9 153.5 40.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.686 -0.233 . . . . 71.04 110.655 -176.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.94 -33.86 67.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.782 0.325 . . . . 65.31 110.192 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.4 m -57.66 -45.8 85.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.932 -0.577 . . . . 43.21 110.711 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.712 ' HA ' HG21 ' A' ' 27' ' ' VAL . 32.6 mt-10 -66.29 -44.54 83.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.227 0.537 . . . . 73.23 109.856 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.33 -22.31 66.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.486 -0.779 . . . . 62.12 111.614 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -81.31 -24.53 37.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.134 0.493 . . . . 74.23 110.608 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -95.25 12.81 27.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.255 0.55 . . . . 65.12 110.599 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.703 HD11 HD13 ' A' ' 31' ' ' ILE . 65.2 mt -121.6 119.57 59.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.65 -0.705 . . . . 71.22 109.669 176.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.7 mt -102.64 122.35 44.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.7 -0.482 . . . . 65.44 109.7 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.825 HG12 ' HA ' ' A' ' 18' ' ' VAL . 31.0 m -132.97 173.13 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.276 0.56 . . . . 74.03 112.3 -172.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.68 160.46 38.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.153 -0.93 . . . . 64.22 109.449 174.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.613 HG22 ' H ' ' A' ' 79' ' ' LEU . 13.3 p -99.61 134.06 40.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.13 0.49 . . . . 74.51 111.534 -174.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.52 HD12 ' HG2' ' A' ' 15' ' ' LYS . 81.6 mt -82.01 -18.73 42.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.842 -0.617 . . . . 74.01 110.978 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.613 ' H ' HG22 ' A' ' 77' ' ' VAL . 11.2 mp -68.65 114.68 7.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.327 -0.851 . . . . 74.35 110.173 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -81.36 74.6 8.35 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.647 0.737 . . . . 73.22 110.506 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -136.58 99.75 4.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.815 -1.084 . . . . 64.32 108.287 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -75.01 63.55 1.24 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.046 0.758 . . . . 71.32 113.046 -172.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -83.22 97.06 8.66 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.92 -0.77 . . . . 64.12 108.92 172.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -76.03 105.05 6.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.631 -0.713 . . . . 73.51 111.755 -170.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 32.9 t60 63.06 13.62 6.92 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.647 -0.706 . . . . 65.14 111.364 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.181 -0.914 . . . . 73.23 109.441 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 110.151 -0.314 . . . . 62.33 110.151 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 23.7 p -80.6 -60.39 2.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.604 -0.271 . . . . 75.43 110.589 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 3' ' ' LYS . 31.2 mtpt 68.74 169.16 0.28 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.897 0.748 . . . . 73.3 112.52 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 60.94 -164.52 17.33 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.026 -0.988 . . . . 51.14 113.892 173.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 pt -137.03 176.33 8.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.055 -1.091 . . . . 71.32 108.055 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.77 148.71 42.07 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.7 -1.238 . . . . 75.5 111.054 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.642 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 2.0 tm? -57.24 -29.82 64.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.504 0.668 . . . . 73.42 109.799 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.675 HD22 ' HA ' ' A' ' 71' ' ' LYS . 8.7 p30 -71.36 -14.11 62.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.482 -0.781 . . . . 61.13 111.364 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -101.59 3.99 40.5 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.417 -0.356 . . . . 70.34 111.06 -174.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.9 t -83.74 155.45 3.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.112 0.482 . . . . 72.33 110.236 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.548 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 17.3 tt0 -95.02 175.09 6.77 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.798 -0.637 . . . . 74.42 110.452 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.548 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 23.7 pt -75.09 145.69 10.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.236 -0.438 . . . . 62.34 111.69 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 59.12 24.42 12.76 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.433 -0.803 . . . . 72.23 112.17 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 m -108.45 147.54 31.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.082 -0.508 . . . . 62.2 109.831 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -109.66 149.83 29.15 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.954 -0.387 . . . . 74.24 109.954 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.942 HG12 ' HA ' ' A' ' 77' ' ' VAL . 28.4 m -140.25 178.3 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.14 0.495 . . . . 75.42 110.987 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.672 ' HB2' HD11 ' A' ' 78' ' ' LEU . 7.1 ttpm? -133.06 140.4 47.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.545 -0.752 . . . . 72.32 110.138 176.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.682 ' HA ' HG12 ' A' ' 75' ' ' VAL . 47.6 t -73.14 97.67 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.605 -0.725 . . . . 63.11 110.073 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.7 mm -79.75 -49.34 19.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.693 -0.685 . . . . 73.43 110.951 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -152.55 168.08 31.54 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.818 -1.182 . . . . 53.33 113.646 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.65 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 50.0 mm -124.39 157.42 31.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.023 -1.103 . . . . 64.34 108.023 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.9 t -102.62 90.32 2.18 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 120.849 0.357 . . . . 73.24 110.218 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.65 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 74.2 Cg_exo -49.71 159.33 1.54 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.774 2.983 . . . . 73.21 113.875 -171.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 64.84 69.86 0.49 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.308 -0.86 . . . . 70.4 110.945 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.69 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 9.3 t -149.57 162.98 39.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.366 -0.834 . . . . 73.25 109.137 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -73.27 -45.13 57.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.358 0.599 . . . . 74.25 109.55 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.457 HG11 ' HG2' ' A' ' 69' ' ' GLU . 27.8 m -78.71 -20.54 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.488 -0.778 . . . . 63.11 111.573 -176.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.69 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 2.1 tmt_? -50.87 -43.98 59.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.257 0.551 . . . . 70.23 109.654 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.45 HH11 ' HD3' ' A' ' 29' ' ' ARG . 8.5 tpt180 -71.8 -44.21 64.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.591 -0.731 . . . . 71.52 110.614 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -60.59 -45.96 92.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.429 -0.805 . . . . 63.15 111.926 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 34' ' ' MET . 65.8 mt -68.68 -41.19 82.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.062 -0.517 . . . . 72.23 111.181 -177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.1 ttt -72.26 -28.47 63.15 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.66 -0.416 . . . . 75.5 110.371 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.8 -38.94 87.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.131 0.491 . . . . 40.32 109.944 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 6.9 mmt -56.81 -29.42 62.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.262 -0.881 . . . . 55.51 111.363 176.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.51 13.31 22.82 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.763 -0.732 . . . . 52.04 111.975 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -90.51 134.17 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.925 -0.398 . . . . 75.33 109.925 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 m -137.48 -177.86 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.081 -0.509 . . . . 72.34 110.547 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 54.8 ttp180 -64.52 131.46 47.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.366 -0.379 . . . . 74.11 110.119 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.61 -21.58 36.35 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.556 -0.831 . . . . 74.4 112.56 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.1 m -68.2 146.49 53.33 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.896 0.379 . . . . 72.5 110.342 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -95.88 132.06 41.56 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.472 0.653 . . . . 53.42 110.916 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.599 HD12 ' HB3' ' A' ' 58' ' ' LEU . 48.7 mm -121.11 122.49 67.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.059 -0.973 . . . . 74.13 109.458 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.693 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 14.9 t80 -102.47 118.35 36.67 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.702 -0.481 . . . . 73.43 109.702 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 mm -85.19 100.16 8.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.487 -0.561 . . . . 73.31 109.487 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.38 -42.0 65.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.207 -0.664 . . . . 73.42 109.207 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.52 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 170.27 -169.44 42.25 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.243 -0.743 . . . . 64.41 111.243 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.749 ' HG3' ' HA2' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -146.1 162.92 36.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.395 -0.594 . . . . 64.3 109.395 175.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -61.28 160.83 20.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 O-C-N 123.486 0.491 . . . . 42.44 110.315 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 9.3 Cg_endo -52.81 -26.54 31.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.151 2.567 . . . . 73.53 113.47 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.8 ttt -93.45 -7.64 43.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.087 0.47 . . . . 62.01 110.877 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.749 ' HA2' ' HG3' ' A' ' 47' ' ' LYS . . . 89.05 -1.54 83.09 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.923 -0.656 . . . . 41.13 112.092 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -145.71 125.86 7.09 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.216 -0.661 . . . . 61.05 109.216 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.93 178.56 31.54 Favored 'Cis proline' 0 C--O 1.236 0.382 0 C-N-CA 123.029 -1.655 . . . . 64.03 112.842 -0.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.712 HG23 ' HB3' ' A' ' 47' ' ' LYS . 19.8 mt -114.92 141.83 30.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 72.24 109.813 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.59 109.73 21.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.995 0.426 . . . . 62.43 110.322 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.6 mt -120.58 135.58 55.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.293 -0.412 . . . . 52.13 110.945 -173.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.693 ' HB3' ' HB3' ' A' ' 43' ' ' TYR . 4.2 tmt_? -92.34 100.83 13.33 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.986 -1.116 . . . . 71.34 107.986 172.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.599 ' HB3' HD12 ' A' ' 42' ' ' ILE . 2.0 pp -138.78 156.59 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.643 -0.708 . . . . 73.2 110.811 -174.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? 71.34 -44.76 0.6 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.909 0.756 . . . . 75.33 110.707 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.69 -19.13 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 116.23 -0.441 . . . . 54.44 112.02 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -137.96 168.9 18.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.988 0.423 . . . . 74.1 111.436 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.652 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.2 m -85.27 126.71 33.92 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.627 -0.715 . . . . 74.0 110.534 175.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 52.9 tp -145.23 148.87 33.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.657 -0.702 . . . . 74.15 109.224 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 21.8 t -95.01 125.96 40.02 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.181 0.515 . . . . 70.45 110.99 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -120.12 168.18 11.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.266 -0.879 . . . . 73.21 109.397 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.48 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 30.4 mmt180 -77.53 153.48 33.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.157 0.503 . . . . 71.31 111.673 -177.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -60.08 -34.78 73.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.525 -0.761 . . . . 75.35 109.986 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.4 m -61.66 -36.26 80.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.302 -0.863 . . . . 73.04 110.91 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.48 ' HG3' ' HB2' ' A' ' 66' ' ' ARG . 40.7 mt-10 -69.97 -41.89 73.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.458 0.647 . . . . 75.52 110.079 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.77 -21.52 66.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.212 -0.904 . . . . 75.22 111.497 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.675 ' HA ' HD22 ' A' ' 8' ' ' ASN . 61.2 tttm -71.32 -25.21 62.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.792 0.33 . . . . 61.14 111.226 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.61 -4.47 57.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.074 0.464 . . . . 74.45 111.194 -174.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.642 ' HB ' ' HB2' ' A' ' 7' ' ' LEU . 21.1 mt -104.54 125.4 59.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.15 -0.477 . . . . 72.22 110.655 -178.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.1 mt -102.99 115.77 31.24 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.52 -0.548 . . . . 62.52 109.52 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.682 HG12 ' HA ' ' A' ' 18' ' ' VAL . 19.7 m -130.65 150.1 34.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.142 -0.481 . . . . 72.35 111.461 -174.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -99.49 139.87 34.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.453 -0.573 . . . . 55.02 109.453 171.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.942 ' HA ' HG12 ' A' ' 16' ' ' VAL . 40.9 t -73.95 113.63 12.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.033 0.444 . . . . 73.22 110.583 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' A' ' 17' ' ' LYS . 47.5 mt -85.78 -6.51 59.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.964 -0.562 . . . . 75.12 110.939 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.8 tp -76.94 86.89 3.48 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 107.268 -1.382 . . . . 72.11 107.268 166.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -68.91 100.53 1.21 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.181 -0.918 . . . . 71.33 112.52 -166.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -123.97 130.22 52.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.058 -0.974 . . . . 73.33 108.839 172.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -82.77 54.0 2.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.293 0.568 . . . . 75.31 111.163 -172.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -146.68 114.45 6.46 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.161 -0.681 . . . . 63.21 109.161 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -88.61 129.86 35.4 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.332 0.493 . . . . 71.33 112.332 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -88.91 -42.92 11.54 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.369 -0.974 . . . . 72.51 108.369 169.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 30.1 t60 . . . . . 0 C--O 1.245 0.847 0 CA-C-N 114.605 -1.179 . . . . 70.3 108.519 177.394 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 120.981 0.42 . . . . 54.33 110.63 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.4 m -143.38 91.43 2.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.689 -0.687 . . . . 71.01 109.205 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -106.91 -155.61 0.55 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.365 -0.834 . . . . 73.2 109.966 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.69 109.3 0.4 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 119.913 -1.137 . . . . 53.33 113.271 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.4 pt -97.91 167.34 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.499 -0.926 . . . . 74.51 108.499 172.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.46 143.46 29.37 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 119.276 -1.44 . . . . 41.33 111.482 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.414 ' O ' HD23 ' A' ' 7' ' ' LEU . 8.2 tt -61.73 -26.84 68.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.32 0.581 . . . . 65.11 109.935 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.611 HD22 ' HA ' ' A' ' 71' ' ' LYS . 6.8 p30 -67.76 -14.63 63.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 73.45 110.7 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.97 -2.95 39.33 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.115 -0.493 . . . . 74.43 111.309 -176.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.451 HG21 HG21 ' A' ' 16' ' ' VAL . 34.1 t -78.09 159.69 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.956 0.408 . . . . 73.13 110.459 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.452 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 28.0 tt0 -102.61 173.77 6.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.873 -0.603 . . . . 73.13 110.169 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.59 HG22 ' HA2' ' A' ' 46' ' ' GLY . 33.9 pt -76.42 149.8 6.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.35 0.5 . . . . 71.04 112.35 -173.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 53.8 31.02 12.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.174 -0.921 . . . . 75.4 112.142 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.7 m -121.2 145.86 47.39 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.261 -0.644 . . . . 70.21 109.261 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -110.45 137.97 47.46 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.343 0.592 . . . . 74.41 111.727 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' A' ' 77' ' ' VAL . 16.2 m -137.5 163.63 30.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.167 -0.924 . . . . 74.24 109.247 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 41' ' ' GLU . 38.4 ttpt -118.96 141.55 48.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.059 0.457 . . . . 74.22 111.241 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.512 ' HA ' HG12 ' A' ' 75' ' ' VAL . 47.0 t -73.91 93.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.995 -1.002 . . . . 75.3 110.121 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.1 -38.85 56.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.538 -0.755 . . . . 54.44 110.445 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.42 153.27 24.59 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.087 -1.054 . . . . 74.23 113.441 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.0 mt -114.7 158.25 15.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.177 -1.046 . . . . 73.43 108.177 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 22' ' ' VAL . 7.5 p -100.18 91.84 1.86 Allowed Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 121.761 0.791 . . . . 62.02 110.243 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.945 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 29.3 Cg_endo -60.01 166.67 8.41 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.907 2.404 . . . . 74.1 112.544 -174.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 66.52 11.9 8.38 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.388 -0.824 . . . . 73.1 111.226 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.859 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 34.7 t -85.51 157.45 20.42 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.429 -0.582 . . . . 62.53 109.429 174.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -69.0 -43.83 74.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.162 -0.681 . . . . 71.31 109.162 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.3 m -77.94 -15.68 14.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.353 -0.84 . . . . 75.1 110.969 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.945 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -52.46 -43.17 64.78 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.592 -0.276 . . . . 55.32 110.311 176.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -71.06 -41.64 70.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.413 . . . . 65.42 110.956 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -54.1 -45.12 71.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.315 0.579 . . . . 75.33 110.945 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.776 HD13 HD11 ' A' ' 73' ' ' ILE . 86.9 mt -65.8 -46.85 87.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.042 -0.981 . . . . 64.11 112.054 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 51.1 mtt -73.33 -29.37 62.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.726 0.298 . . . . 73.44 111.121 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -65.89 -28.69 69.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.266 0.555 . . . . 73.41 110.109 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 20.8 ttm -76.87 -20.78 55.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.597 -0.729 . . . . 75.02 110.69 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.7 15.23 15.57 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.659 -0.781 . . . . 50.41 112.901 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.519 ' HB ' HG22 ' A' ' 31' ' ' ILE . 25.8 mt -96.3 129.25 46.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.849 0.357 . . . . 74.35 110.298 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.6 m -134.28 -177.96 2.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.932 -0.576 . . . . 61.25 110.592 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -67.78 139.6 56.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.263 -0.273 . . . . 70.12 110.263 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.35 -2.17 87.46 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.035 -0.603 . . . . 34.24 112.789 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m -75.44 133.88 41.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.166 -0.679 . . . . 71.22 109.166 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 17' ' ' LYS . 5.1 pt-20 -104.57 129.07 52.69 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.28 0.562 . . . . 70.13 109.934 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.638 ' CG2' ' HB3' ' A' ' 56' ' ' LEU . 63.0 mt -118.17 132.84 66.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.023 -0.989 . . . . 54.25 110.578 -171.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -92.01 104.12 16.56 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.056 -0.72 . . . . 75.12 109.056 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.8 mm -74.21 97.47 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.183 -0.673 . . . . 63.44 109.183 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.436 ' OE2' ' HB2' ' A' ' 57' ' ' ARG . 50.0 mt-10 -66.47 -39.5 88.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.885 0.374 . . . . 74.3 110.618 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.59 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 170.19 172.69 36.89 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.355 -0.926 . . . . 73.31 112.215 177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.639 ' HG2' HG12 ' A' ' 54' ' ' ILE . 46.1 mtmt -110.0 165.05 12.03 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.331 -0.618 . . . . 71.44 109.331 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -66.79 164.54 32.96 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.844 -0.428 . . . . 74.11 109.844 174.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.502 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 84.9 Cg_exo -42.79 -49.16 6.91 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.223 2.616 . . . . 74.41 113.704 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.3 ttt -84.96 -10.86 56.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.893 0.378 . . . . 74.21 111.028 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.98 2.92 39.39 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.917 -0.659 . . . . 73.24 112.774 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -151.68 128.51 5.43 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 110.074 -0.343 . . . . 61.03 110.074 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -82.72 -165.85 4.54 Favored 'Cis proline' 0 CA--C 1.532 0.392 0 C-N-CA 123.414 -1.494 . . . . 72.14 113.088 2.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.639 HG12 ' HG2' ' A' ' 47' ' ' LYS . 52.7 mt -120.51 147.46 24.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.448 -178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -103.11 111.23 23.49 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.836 0.351 . . . . 51.31 110.351 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.638 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 2.2 mp -117.07 129.99 56.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.184 -0.462 . . . . 74.43 110.006 -176.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.764 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 23.8 ttm180 -101.43 115.28 30.14 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.647 -0.421 . . . . 60.45 110.402 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.566 ' HG ' HG12 ' A' ' 42' ' ' ILE . 5.5 mp -116.76 145.88 43.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.868 -0.605 . . . . 63.3 109.748 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 64.2 -77.97 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.729 0.643 . . . . 75.33 110.852 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.13 9.57 0.35 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.348 -0.453 . . . . 71.31 112.068 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -147.28 154.97 41.61 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.298 0.57 . . . . 63.41 111.137 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.764 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 21.8 t -93.7 144.32 25.51 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.508 -0.769 . . . . 63.04 111.855 -175.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.4 154.74 44.65 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.488 -1.233 . . . . 60.44 108.767 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -116.12 114.53 24.63 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 120.972 0.415 . . . . 74.44 111.916 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.543 ' HG ' HD13 ' A' ' 56' ' ' LEU . 3.6 pp -122.25 167.23 13.48 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.484 -0.562 . . . . 64.01 109.484 174.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 -86.34 163.93 17.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.518 0.675 . . . . 72.23 112.27 -174.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.496 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 1.4 tmtp? -64.5 -20.94 66.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.953 -1.021 . . . . 72.23 110.277 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 m -69.1 -50.92 43.84 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.12 -0.491 . . . . 63.02 110.652 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.76 -36.46 78.99 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.3 0.571 . . . . 54.13 109.956 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.94 -21.68 66.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.336 -0.847 . . . . 75.51 111.862 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.611 ' HA ' HD22 ' A' ' 8' ' ' ASN . 88.8 tttt -84.28 -22.9 30.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.152 0.501 . . . . 74.34 110.526 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.478 ' HB3' HG12 ' A' ' 22' ' ' VAL . 4.6 m-20 -87.09 -14.18 42.14 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.875 -0.602 . . . . 72.1 110.919 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.776 HD11 HD13 ' A' ' 31' ' ' ILE . 40.1 mm -95.92 122.61 47.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.128 -0.487 . . . . 62.24 110.546 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.2 mt -100.61 114.96 29.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.053 -0.521 . . . . 60.04 109.871 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.568 HG13 HG22 ' A' ' 73' ' ' ILE . 24.9 m -118.71 161.12 17.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.087 -0.506 . . . . 73.1 111.241 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -118.75 145.56 45.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.713 -0.676 . . . . 65.33 109.305 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.756 ' HA ' HG12 ' A' ' 16' ' ' VAL . 39.3 t -72.34 123.01 26.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.76 -0.654 . . . . 64.04 110.545 -176.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.1 mt -85.12 -0.86 55.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 75.23 111.593 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.61 ' H ' HG12 ' A' ' 77' ' ' VAL . 10.9 mp -71.21 175.97 4.89 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.92 -0.582 . . . . 54.14 111.383 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.7 16.06 18.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.825 -0.625 . . . . 64.44 111.708 -174.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -75.01 102.85 4.97 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.879 -0.415 . . . . 75.2 109.879 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -86.34 -10.33 54.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.144 -0.48 . . . . 64.22 110.284 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -84.73 70.69 10.84 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.554 -0.906 . . . . 74.52 108.554 174.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -85.56 66.16 9.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.828 -0.624 . . . . 71.02 110.214 -174.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.3 t60 70.04 -77.03 0.06 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.383 -0.826 . . . . 63.22 110.995 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.004 -0.998 . . . . 73.14 109.612 -176.446 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.9 mtt . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.013 -0.366 . . . . 72.13 110.013 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.7 p -111.11 134.51 52.65 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.066 0.46 . . . . 74.44 111.082 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -79.74 -2.0 41.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.7 0.762 . . . . 70.51 109.546 175.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.52 179.65 52.84 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 114.989 -1.005 . . . . 72.33 112.687 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.5 pt -122.77 179.22 2.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.89 -0.781 . . . . 63.21 108.89 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 73' ' ' ILE . . . -77.45 151.7 38.49 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 119.805 -1.188 . . . . 52.12 111.884 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 7' ' ' LEU . 2.9 tm? -60.09 -32.62 71.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.297 0.57 . . . . 71.34 109.483 177.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.597 HD22 ' HA ' ' A' ' 71' ' ' LYS . 8.6 p30 -70.27 -15.59 62.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.461 -0.79 . . . . 74.32 111.094 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -92.58 -3.9 54.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.074 0.464 . . . . 74.13 110.658 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.4 t -91.33 158.79 2.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.98 -0.748 . . . . 63.3 108.98 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.588 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 24.8 tt0 -108.01 175.52 5.45 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.239 -0.282 . . . . 71.54 110.239 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.588 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 32.5 pt -68.83 153.59 8.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.24 -0.436 . . . . 64.23 111.691 -175.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 60.64 41.21 15.57 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.301 -0.863 . . . . 72.31 110.914 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 m -128.56 149.77 50.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.149 -0.932 . . . . 75.43 109.638 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.475 ' HG2' HD12 ' A' ' 78' ' ' LEU . 85.8 tttt -115.37 132.4 56.63 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.043 -0.354 . . . . 50.45 110.043 177.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.813 HG12 ' HA ' ' A' ' 77' ' ' VAL . 26.6 m -133.04 162.62 39.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.254 0.55 . . . . 74.22 111.226 -176.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.614 ' HB2' HD21 ' A' ' 78' ' ' LEU . 19.8 ttmm -112.22 138.75 48.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.415 -0.811 . . . . 75.32 109.435 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.76 ' HA ' HG12 ' A' ' 75' ' ' VAL . 60.7 t -75.65 95.96 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.619 -0.719 . . . . 72.23 110.038 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.6 mm -61.05 -40.44 85.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.678 -0.692 . . . . 54.34 109.823 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.75 168.65 39.74 Favored Glycine 0 N--CA 1.439 -1.116 0 C-N-CA 120.416 -0.897 . . . . 70.44 112.32 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.713 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 43.9 mt -105.28 159.38 5.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 108.606 -0.886 . . . . 74.42 108.606 176.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 25' ' ' SER . 58.4 t -99.22 92.36 1.71 Allowed Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.106 0.479 . . . . 73.11 110.471 -177.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.713 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 27.8 Cg_exo -60.53 178.31 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.561 2.841 . . . . 72.5 112.816 -174.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 66.73 -32.2 0.18 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.461 0.705 . . . . 63.13 112.026 -173.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.487 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 1.3 m -63.24 153.36 34.88 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 120.97 0.414 . . . . 32.13 110.86 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -71.92 -49.25 39.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.789 -0.641 . . . . 64.54 110.493 -174.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.564 HG11 ' HG2' ' A' ' 69' ' ' GLU . 11.5 m -72.99 -15.44 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.39 -0.368 . . . . 74.2 110.831 -174.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.655 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -53.8 -45.87 70.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.907 -0.588 . . . . 63.45 111.003 178.149 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -72.25 -33.01 67.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.369 0.604 . . . . 64.03 110.17 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -63.8 -41.85 97.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.378 -0.828 . . . . 65.53 110.508 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.511 HG22 ' HB ' ' A' ' 36' ' ' ILE . 82.9 mt -64.39 -36.42 77.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.713 -0.676 . . . . 74.54 110.9 177.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 67.7 mtt -67.67 -32.61 73.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 73.45 110.629 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -63.34 -31.89 73.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.946 -0.57 . . . . 54.13 110.492 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.9 mtm -76.53 -23.98 53.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.962 -0.563 . . . . 61.12 111.169 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.02 36.68 2.12 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.297 -0.954 . . . . 71.32 113.358 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.511 ' HB ' HG22 ' A' ' 31' ' ' ILE . 63.7 mt -122.14 136.1 60.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.468 -0.568 . . . . 73.34 109.468 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.745 HG23 ' H ' ' A' ' 38' ' ' ARG . 1.6 m -135.67 -84.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.321 0.489 . . . . 63.4 112.321 -176.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.745 ' H ' HG23 ' A' ' 37' ' ' VAL . 43.5 ttp180 -156.56 141.12 16.83 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.362 -0.607 . . . . 74.1 109.362 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.71 -0.29 65.89 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 111.429 -0.669 . . . . 73.32 111.429 -176.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.472 HG22 HD21 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -72.6 142.67 48.39 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.387 -0.598 . . . . 73.31 109.387 178.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.49 130.98 52.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.167 0.508 . . . . 73.43 111.606 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.563 HG21 HD23 ' A' ' 56' ' ' LEU . 25.6 mm -120.24 128.16 75.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.34 -0.845 . . . . 71.51 110.898 -176.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -101.12 120.67 40.56 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.447 -0.575 . . . . 75.44 109.447 171.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 44' ' ' ILE . 3.9 mp -85.45 101.62 10.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.226 -0.657 . . . . 64.42 109.226 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -67.84 -53.29 27.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.275 0.56 . . . . 74.15 110.383 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.26 -177.37 41.01 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.673 -0.694 . . . . 52.51 111.773 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HG2' HG23 ' A' ' 54' ' ' ILE . 52.0 mtpt -133.26 152.0 51.92 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.136 -0.69 . . . . 62.52 109.136 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.49 156.34 71.16 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.575 -0.528 . . . . 51.33 109.575 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.35 -30.14 19.42 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.77 2.313 . . . . 60.24 113.176 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.429 ' CE ' ' HA ' ' A' ' 50' ' ' MET . 23.2 mmt -91.29 0.98 57.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.489 -0.323 . . . . 71.51 111.697 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.01 -9.14 73.55 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.892 -0.67 . . . . 64.03 111.999 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 22.7 t70 -144.01 130.54 10.19 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.685 -0.487 . . . . 74.53 109.685 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.553 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . 91.6 Cg_endo -84.11 -169.26 6.65 Favored 'Cis proline' 0 CA--C 1.533 0.44 0 C-N-CA 123.474 -1.469 . . . . 64.13 112.918 0.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.461 HG23 ' HG2' ' A' ' 47' ' ' LYS . 60.7 mt -119.3 143.2 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.896 -0.593 . . . . 71.31 110.284 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.09 111.83 24.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.896 0.379 . . . . 73.4 110.808 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.563 HD23 HG21 ' A' ' 42' ' ' ILE . 5.9 mp -105.68 171.92 7.08 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.136 -0.69 . . . . 71.12 109.136 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 23.7 ttt180 -151.18 128.79 11.48 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.242 -0.651 . . . . 75.22 109.242 176.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.597 HD22 ' HG3' ' A' ' 59' ' ' ARG . 1.2 tt -131.93 137.41 47.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.01 -0.541 . . . . 74.51 109.83 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.597 ' HG3' HD22 ' A' ' 58' ' ' LEU . 55.8 mtt180 61.15 -80.25 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.795 -1.093 . . . . 53.21 111.667 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -147.78 14.75 1.37 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.016 -0.611 . . . . 74.25 111.759 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -140.01 145.96 38.46 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.677 0.751 . . . . 73.43 111.899 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 33.5 t -74.22 155.22 38.54 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.396 -1.275 . . . . 72.51 110.667 176.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.8 mt -139.7 140.21 36.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.783 -0.644 . . . . 71.13 109.424 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.8 t -118.99 130.2 55.55 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.811 0.339 . . . . 62.44 110.735 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 pp -144.65 164.64 30.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.76 -0.655 . . . . 72.55 110.386 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.553 ' HD3' ' HB3' ' A' ' 53' ' ' PRO . 25.9 mmt180 -83.73 158.68 21.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.37 0.605 . . . . 61.02 111.616 -176.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -39.47 70.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.95 -1.023 . . . . 72.44 111.117 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.8 m -65.38 -34.45 78.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.302 -0.408 . . . . 74.32 111.233 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.564 ' HG2' HG11 ' A' ' 27' ' ' VAL . 33.9 mt-10 -74.38 -32.76 62.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.297 0.57 . . . . 74.4 109.86 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.99 -21.1 65.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.452 -0.795 . . . . 75.45 111.19 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.597 ' HA ' HD22 ' A' ' 8' ' ' ASN . 22.1 ttmm -74.32 -34.17 63.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.494 . . . . 72.51 110.392 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -85.51 14.59 5.38 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.196 -0.456 . . . . 60.25 111.574 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.491 HG22 HG13 ' A' ' 75' ' ' VAL . 60.4 mt -118.96 124.23 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.381 . . . . 72.42 110.222 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 99.0 mt -103.47 120.73 41.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 75.55 110.243 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.76 HG12 ' HA ' ' A' ' 18' ' ' VAL . 22.4 m -133.95 157.51 41.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.207 0.527 . . . . 71.22 111.791 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -117.82 143.32 46.38 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.958 -0.756 . . . . 70.43 108.958 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.813 ' HA ' HG12 ' A' ' 16' ' ' VAL . 38.5 t -70.94 125.55 29.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.128 -0.487 . . . . 61.15 110.595 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 17' ' ' LYS . 56.3 mt -82.64 -9.56 59.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 75.42 111.008 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.588 ' H ' HG12 ' A' ' 77' ' ' VAL . 91.6 mt -72.1 147.04 47.1 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.843 -0.617 . . . . 74.3 109.472 174.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -86.82 3.5 45.02 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.083 0.468 . . . . 64.51 110.748 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -90.77 83.18 5.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.812 -0.631 . . . . 74.53 110.248 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -83.19 91.74 7.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.288 0.566 . . . . 74.31 110.317 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -87.99 103.89 16.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.595 0.712 . . . . 73.12 110.361 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -86.51 133.03 33.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.838 -0.619 . . . . 71.31 109.852 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 69.3 -76.75 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.552 -0.749 . . . . 73.0 110.206 -173.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.125 -0.94 . . . . 73.44 109.006 -176.041 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.84 0.352 . . . . 64.43 110.506 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.7 p -114.99 113.08 23.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.144 -0.48 . . . . 61.03 110.648 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 61.14 43.69 10.85 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.427 0.454 . . . . 65.01 110.997 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.42 128.09 34.7 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.551 -0.749 . . . . 71.43 112.757 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.8 pt -110.11 171.44 2.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.689 0.281 . . . . 62.14 110.304 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 73' ' ' ILE . . . -76.91 153.11 41.51 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 120.47 -0.871 . . . . 43.42 111.22 177.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' A' ' 56' ' ' LEU . 50.1 tp -59.21 -28.01 66.26 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.185 0.517 . . . . 75.4 110.684 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.452 ' ND2' ' HG3' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -75.38 -4.53 39.92 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.86 -0.609 . . . . 73.33 111.831 178.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.452 ' HG3' ' ND2' ' A' ' 8' ' ' ASN . 44.5 mt-10 -102.1 5.87 40.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.931 0.396 . . . . 72.2 110.801 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 t -97.03 157.32 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.064 -0.517 . . . . 61.13 109.967 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -99.64 164.89 11.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.62 0.247 . . . . 71.24 110.341 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.7 pt -69.39 151.03 10.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.444 . . . . 71.55 111.048 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt 60.26 51.45 5.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.948 0.88 . . . . 62.15 110.536 -177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 m -132.37 153.08 51.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.142 -0.935 . . . . 70.14 109.759 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -113.44 119.09 36.39 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.803 -0.443 . . . . 65.35 109.803 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.772 HG12 ' HA ' ' A' ' 77' ' ' VAL . 29.1 m -130.76 179.56 4.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.11 -0.495 . . . . 65.41 110.503 -178.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.75 ' HB2' HD11 ' A' ' 78' ' ' LEU . 39.3 ttpt -143.04 144.53 32.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.876 0.37 . . . . 75.03 111.064 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.67 ' HA ' HG12 ' A' ' 75' ' ' VAL . 45.8 t -76.9 95.66 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.598 -0.728 . . . . 74.31 110.673 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.927 HD11 ' HB2' ' A' ' 76' ' ' GLU . 50.1 mt -57.33 -49.33 80.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 64.31 109.988 173.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.59 149.16 7.22 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.54 -0.755 . . . . 74.11 112.258 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.643 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 56.9 mt -83.95 159.68 3.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.516 -0.55 . . . . 75.13 109.516 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 25' ' ' SER . 48.3 t -99.17 93.71 2.29 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 122.757 0.423 . . . . 73.03 110.03 -177.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 1.022 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 77.6 Cg_exo -49.27 164.26 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.911 3.074 . . . . 72.32 114.271 -173.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 67.28 -11.96 0.27 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.116 0.967 . . . . 75.5 112.92 -175.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 1.2 m -63.72 155.1 31.12 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 120.926 0.393 . . . . 73.22 110.822 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -69.46 -17.29 63.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.16 -0.473 . . . . 75.43 112.164 -173.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.443 HG21 ' HA ' ' A' ' 69' ' ' GLU . 30.9 m -112.47 6.32 8.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.664 -0.244 . . . . 74.14 111.43 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 1.022 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 5.2 tmm_? -58.76 -57.18 14.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.877 0.37 . . . . 74.3 110.771 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 29' ' ' ARG . 42.0 ttm180 -71.5 -36.1 70.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.041 -0.527 . . . . 75.24 110.123 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -58.77 -46.39 87.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.266 -0.879 . . . . 73.33 111.276 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.622 HD13 HD11 ' A' ' 73' ' ' ILE . 99.4 mt -66.51 -42.34 89.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.048 0.452 . . . . 75.12 111.278 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 63.7 mtt -67.53 -36.67 81.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.336 -0.393 . . . . 63.43 110.781 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.01 -30.14 68.46 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.895 -0.593 . . . . 54.22 110.445 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.3 ttt -63.04 -34.6 77.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.615 -0.721 . . . . 54.42 110.859 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.67 20.26 1.74 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.307 -0.949 . . . . 51.1 113.178 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.525 HD12 HG23 ' A' ' 31' ' ' ILE . 61.1 mt -105.51 134.84 45.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.719 -0.475 . . . . 53.45 109.719 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.73 177.56 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.389 -0.369 . . . . 72.32 110.835 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -78.7 128.97 34.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.079 0.466 . . . . 43.4 110.26 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.75 5.61 66.38 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.802 -0.713 . . . . 44.01 112.235 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.5 m -68.8 138.65 54.97 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.501 -0.555 . . . . 64.35 109.501 175.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -96.14 125.45 40.68 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.855 -0.611 . . . . 71.54 109.449 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.2 mt -107.36 120.57 58.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.347 -0.842 . . . . 65.23 110.969 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.566 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 74.4 t80 -93.52 106.88 18.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.821 -0.807 . . . . 64.41 108.821 173.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.441 HD13 HD22 ' A' ' 56' ' ' LEU . 18.6 mm -70.04 104.01 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.183 -0.673 . . . . 72.45 109.183 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -76.38 -61.51 1.93 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.832 0.349 . . . . 72.24 110.401 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.21 158.55 29.13 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.227 -0.987 . . . . 61.42 112.356 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.603 ' HG2' HG12 ' A' ' 54' ' ' ILE . 54.2 mtpt -97.55 151.83 19.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.258 -0.645 . . . . 74.13 109.258 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.53 156.35 32.6 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 110.131 -0.322 . . . . 65.11 110.131 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.0 -32.51 18.32 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.246 2.63 . . . . 52.22 113.752 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.8 ttm -89.42 -11.35 43.38 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.936 0.398 . . . . 73.44 111.172 -177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.45 -14.7 32.81 Favored Glycine 0 C--N 1.328 0.115 0 C-N-CA 120.909 -0.662 . . . . 50.54 112.513 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -149.41 138.96 12.93 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.44 -0.578 . . . . 71.25 109.44 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.8 -164.73 3.94 Favored 'Cis proline' 0 C--N 1.346 0.429 0 C-N-CA 124.15 -1.188 . . . . 73.1 112.636 -0.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.603 HG12 ' HG2' ' A' ' 47' ' ' LYS . 38.2 mt -123.97 134.98 65.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.095 -0.502 . . . . 74.03 110.416 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -91.44 118.93 30.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.372 -0.376 . . . . 34.14 110.255 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.506 ' CD1' HD21 ' A' ' 7' ' ' LEU . 23.1 mt -121.22 137.02 54.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.213 -0.449 . . . . 63.51 110.747 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.603 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 3.9 tmt_? -101.45 109.36 21.18 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.73 -0.841 . . . . 62.1 108.73 175.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 pp -144.64 152.12 40.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.318 -0.401 . . . . 73.02 110.96 -175.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? 72.51 -45.29 0.62 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.931 0.77 . . . . 75.5 111.379 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.58 -21.84 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.064 -0.588 . . . . 72.11 112.355 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -145.0 172.4 13.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.01 0.433 . . . . 72.33 111.188 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -84.91 140.88 30.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.539 -0.755 . . . . 65.14 111.208 175.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.2 tp -143.5 154.66 43.86 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.452 -0.573 . . . . 71.14 109.452 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.7 p -91.81 121.24 33.25 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.923 0.392 . . . . 74.14 111.767 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.418 HD23 HD12 ' A' ' 56' ' ' LEU . 3.9 mm? -118.59 141.98 48.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.144 -0.48 . . . . 72.4 109.851 175.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.45 162.15 15.89 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.767 0.318 . . . . 74.33 110.722 -177.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -55.85 -33.0 64.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.643 -0.708 . . . . 72.25 110.999 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.1 m -59.48 -56.57 20.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 64.5 110.739 177.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.443 ' HA ' HG21 ' A' ' 27' ' ' VAL . 2.5 mp0 -64.94 -36.79 85.53 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.081 0.467 . . . . 63.14 110.713 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.43 -22.2 66.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.648 -0.706 . . . . 61.1 111.813 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -83.01 -32.21 27.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.684 0.278 . . . . 74.5 110.9 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -84.38 -2.05 56.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.26 -0.427 . . . . 34.24 111.706 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.622 HD11 HD13 ' A' ' 31' ' ' ILE . 68.8 mt -106.42 122.7 60.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.572 -0.285 . . . . 73.01 110.582 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.5 mt -95.03 122.25 37.49 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.913 0.387 . . . . 55.32 110.216 176.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 18' ' ' VAL . 28.3 m -129.74 167.45 24.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.944 -0.571 . . . . 62.15 111.142 -176.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.927 ' HB2' HD11 ' A' ' 19' ' ' ILE . 41.9 tt0 -129.07 146.01 51.13 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.227 -0.657 . . . . 53.34 109.227 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.772 ' HA ' HG12 ' A' ' 16' ' ' VAL . 10.3 p -76.14 129.5 37.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.275 0.56 . . . . 31.35 110.682 -178.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' A' ' 17' ' ' LYS . 86.2 mt -96.64 -14.14 22.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.879 -0.6 . . . . 75.2 109.997 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 tt -59.49 104.74 0.29 Allowed 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.787 -1.097 . . . . 73.43 108.926 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 67.24 105.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.207 -0.906 . . . . 75.31 110.338 -172.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.471 ' O ' ' HD2' ' A' ' 83' ' ' HIS . 51.7 t-80 -71.02 -9.39 57.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.501 -0.772 . . . . 63.14 111.477 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -77.12 99.97 5.56 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.771 0.32 . . . . 65.4 110.639 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.471 ' HD2' ' O ' ' A' ' 81' ' ' HIS . 5.4 p80 -135.24 149.79 49.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.012 -0.366 . . . . 74.4 110.012 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -107.44 129.57 54.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.123 -0.325 . . . . 71.45 110.123 -173.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.04 44.12 1.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.263 0.554 . . . . 73.32 111.599 -176.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 66.9 t-80 . . . . . 0 C--O 1.241 0.642 0 CA-C-N 115.76 -0.655 . . . . 74.15 109.467 175.302 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 121.044 0.449 . . . . 62.04 110.747 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.428 HG21 ' HB2' ' A' ' 76' ' ' GLU . 9.0 t -120.43 10.14 11.11 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.071 -0.393 . . . . 54.42 110.541 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.74 89.67 0.09 Allowed 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 115.896 -0.593 . . . . 62.33 109.877 -174.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.45 123.1 28.55 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.554 -0.748 . . . . 54.11 112.507 -177.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.0 pt -107.19 174.32 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.789 -0.448 . . . . 75.41 109.789 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.62 156.66 35.2 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.107 -1.044 . . . . 63.34 111.654 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.556 HD13 HG21 ' A' ' 16' ' ' VAL . 61.6 tp -61.62 -26.25 67.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.237 0.542 . . . . 64.13 110.635 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -72.83 -10.87 60.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.734 -0.666 . . . . 65.22 111.217 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -98.16 0.34 45.75 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.92 0.39 . . . . 75.14 110.885 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.513 HG21 HG11 ' A' ' 16' ' ' VAL . 6.1 t -103.18 158.1 4.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.393 -0.595 . . . . 63.32 109.393 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -106.1 170.58 7.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.103 0.478 . . . . 42.41 111.241 -176.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 31.7 pt -64.02 157.82 4.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.427 -0.806 . . . . 70.31 113.154 -171.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 60.69 32.1 20.23 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.34 -0.845 . . . . 70.14 111.918 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.4 m -124.36 151.49 44.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.957 -0.565 . . . . 74.12 109.784 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HB2' ' CD2' ' A' ' 43' ' ' TYR . 36.5 ttmt -103.44 130.18 50.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.956 0.407 . . . . 71.52 110.287 176.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.556 HG21 HD13 ' A' ' 7' ' ' LEU . 33.1 m -119.01 165.79 13.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.864 -0.607 . . . . 73.34 110.628 177.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.634 ' HB2' HD11 ' A' ' 78' ' ' LEU . 69.2 tttt -123.07 135.65 54.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.638 -0.71 . . . . 64.4 110.205 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.77 95.38 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.309 -0.859 . . . . 53.41 110.7 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.832 HD11 ' HB3' ' A' ' 76' ' ' GLU . 28.7 mt -65.64 -49.06 80.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.766 -0.652 . . . . 70.24 109.75 174.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.52 176.31 44.77 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.601 -0.809 . . . . 75.5 112.74 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.673 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 54.6 mt -120.48 159.24 22.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.275 -1.009 . . . . 70.01 108.275 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.564 ' HB ' ' OD2' ' A' ' 72' ' ' ASP . 48.8 t -100.41 90.14 1.34 Allowed Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 121.363 0.602 . . . . 74.21 109.618 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.673 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 34.8 Cg_exo -56.57 163.33 7.03 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.6 2.866 . . . . 72.53 113.698 -170.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 65.96 16.62 10.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.624 -1.171 . . . . 53.2 111.24 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 28' ' ' ARG . 1.3 m -88.65 151.8 22.23 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.397 -0.594 . . . . 52.24 109.397 171.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -75.38 -38.96 59.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.895 0.379 . . . . 74.13 110.145 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 31' ' ' ILE . 33.9 m -67.25 -19.6 25.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 72.2 110.771 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 25' ' ' SER . 3.1 tmm_? -58.29 -32.49 68.47 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.689 -0.687 . . . . 73.41 110.25 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -64.8 -47.39 78.23 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.385 -0.598 . . . . 71.44 109.385 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -60.47 -50.01 75.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.492 -0.776 . . . . 64.51 110.637 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 27' ' ' VAL . 86.5 mt -53.34 -52.79 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.545 -0.752 . . . . 73.02 111.917 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 64.5 mtt -70.62 -33.01 70.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.557 -0.292 . . . . 54.43 111.305 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -72.03 -22.44 61.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.408 0.623 . . . . 62.45 110.135 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.8 tpt -78.29 -22.35 48.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.434 -0.803 . . . . 64.23 110.563 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.55 5.49 20.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.758 -0.734 . . . . 73.15 112.831 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.419 HG12 ' HG ' ' A' ' 58' ' ' LEU . 41.2 mt -93.56 129.47 43.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.821 -0.437 . . . . 54.11 109.821 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.737 HG23 ' H ' ' A' ' 38' ' ' ARG . 2.8 m -133.05 -74.83 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.623 0.601 . . . . 72.43 112.623 -176.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.737 ' H ' HG23 ' A' ' 37' ' ' VAL . 61.6 ttt180 -165.28 128.62 2.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.955 -0.387 . . . . 74.15 109.955 -174.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.29 5.97 73.68 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.961 -0.638 . . . . 74.11 112.006 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.5 m -74.04 144.92 44.87 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.987 -0.375 . . . . 72.12 109.987 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -94.27 129.8 40.78 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.053 0.454 . . . . 73.23 110.282 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.773 HG12 HD23 ' A' ' 58' ' ' LEU . 73.8 mt -119.83 116.37 50.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.523 -0.762 . . . . 71.04 109.899 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.416 ' CD2' ' HB2' ' A' ' 15' ' ' LYS . 9.0 t80 -100.92 119.44 38.7 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.175 -0.676 . . . . 62.42 109.175 177.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.5 mt -77.03 125.02 36.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 120.703 0.287 . . . . 64.22 110.233 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -85.65 -59.54 2.28 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.839 0.352 . . . . 64.22 110.346 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.67 171.92 42.34 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.813 -0.708 . . . . 74.12 112.109 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -123.56 145.1 49.14 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.012 -0.366 . . . . 72.12 110.012 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.561 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -69.29 163.66 56.01 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.188 -0.46 . . . . 54.15 109.778 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.561 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 8.1 Cg_endo -50.66 -38.51 55.8 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 123.027 2.485 . . . . 73.23 113.468 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.426 ' HE2' ' HB3' ' A' ' 52' ' ' ASP . 50.7 ttp -86.14 -10.74 54.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.216 0.532 . . . . 73.13 110.659 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.87 -2.95 73.27 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.564 -0.614 . . . . 41.24 111.564 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.426 ' HB3' ' HE2' ' A' ' 50' ' ' MET . 11.8 t70 -141.36 132.12 13.25 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 108.889 -0.782 . . . . 73.14 108.889 177.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.57 -179.96 27.11 Favored 'Cis proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.036 -1.652 . . . . 72.52 112.391 -0.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.7 mt -113.48 145.37 19.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.167 -0.47 . . . . 71.14 110.03 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.29 119.39 38.68 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.036 -0.357 . . . . 72.32 110.036 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.539 HD21 HD21 ' A' ' 7' ' ' LEU . 5.4 mp -118.11 167.59 11.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.141 -0.481 . . . . 63.14 109.895 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.661 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 33.0 ttt-85 -125.59 105.7 9.21 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.893 -1.151 . . . . 72.54 107.893 167.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.773 HD23 HG12 ' A' ' 42' ' ' ILE . 3.2 tm? -122.84 145.57 48.32 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.674 -0.693 . . . . 73.12 109.967 -170.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.612 ' HB2' HD13 ' A' ' 58' ' ' LEU . 2.4 tmt_? 70.51 -69.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.214 -0.903 . . . . 71.42 110.021 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.69 2.08 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.905 -0.664 . . . . 63.22 112.52 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -148.49 165.26 31.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.859 0.361 . . . . 74.41 110.799 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.661 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 32.1 t -75.78 145.08 41.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.511 0.672 . . . . 74.31 111.347 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.5 mt -146.2 157.04 43.8 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.696 -1.138 . . . . 73.34 108.598 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 t -120.62 125.27 47.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.299 0.571 . . . . 64.14 110.721 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 mp -121.27 175.85 5.93 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.314 -0.857 . . . . 74.44 109.312 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.634 ' HB2' ' OE1' ' A' ' 69' ' ' GLU . 41.7 mmt180 -90.75 167.09 12.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.103 0.478 . . . . 73.42 110.31 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.43 -22.59 67.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.582 -0.735 . . . . 73.12 109.604 174.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.7 m -64.1 -52.32 59.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.242 -0.89 . . . . 65.54 110.97 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.634 ' OE1' ' HB2' ' A' ' 66' ' ' ARG . 1.9 mp0 -60.16 -41.95 93.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.153 0.502 . . . . 53.31 110.675 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.77 -22.5 67.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.56 -0.745 . . . . 73.42 111.504 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -75.2 -34.92 61.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.409 -0.36 . . . . 64.42 111.114 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.564 ' OD2' ' HB ' ' A' ' 22' ' ' VAL . 14.5 t70 -80.26 -44.69 19.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 73.25 111.421 -174.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.472 HG22 HG13 ' A' ' 75' ' ' VAL . 48.3 mt -61.42 118.5 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.97 -0.559 . . . . 73.22 111.44 -176.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.2 mt -91.24 119.4 31.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 73.24 109.871 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.547 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 23.7 m -129.08 158.17 41.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.927 0.394 . . . . 70.32 111.964 -174.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.832 ' HB3' HD11 ' A' ' 19' ' ' ILE . 19.3 pt-20 -115.11 151.72 33.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.831 -0.622 . . . . 72.31 109.632 173.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.2 t -80.26 115.84 23.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.988 0.423 . . . . 62.22 111.109 -174.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' A' ' 17' ' ' LYS . 40.2 mt -89.81 -1.48 58.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.898 -0.592 . . . . 71.52 111.53 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.0 mt -57.22 115.6 2.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.039 -0.528 . . . . 73.42 110.467 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -73.74 123.56 24.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.519 -0.764 . . . . 74.2 111.34 -175.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -161.96 148.46 13.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.013 -0.539 . . . . 65.55 110.19 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -74.88 134.53 41.63 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.805 -0.443 . . . . 61.11 109.805 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -141.96 91.45 2.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.051 0.453 . . . . 65.54 111.199 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -137.09 119.39 15.69 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.652 -0.87 . . . . 63.52 108.652 170.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -66.74 122.16 17.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.217 -0.447 . . . . 64.45 109.953 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.8 p80 . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.667 -0.682 . . . . 71.31 109.828 -179.64 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 121.169 0.509 . . . . 55.25 110.574 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.1 m -140.92 130.17 23.58 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.635 -0.712 . . . . 53.25 109.869 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -128.88 112.26 13.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.8 0.334 . . . . 74.1 110.254 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.04 102.96 1.5 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.649 -0.786 . . . . 44.45 112.092 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.6 pt -96.04 163.29 2.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.752 -0.462 . . . . 74.21 109.752 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.23 137.58 45.49 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.466 -0.873 . . . . 70.42 112.209 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 75' ' ' VAL . 44.7 tp -60.25 -25.02 65.35 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 122.986 0.515 . . . . 52.14 112.022 -175.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -78.46 -9.81 59.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.721 0.296 . . . . 74.25 110.857 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -99.31 -7.44 26.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.277 -0.42 . . . . 75.35 111.071 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.723 HG11 HG11 ' A' ' 16' ' ' VAL . 14.4 t -77.72 160.3 4.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.93 -0.577 . . . . 61.03 110.293 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.418 ' N ' HG12 ' A' ' 10' ' ' VAL . 31.7 tt0 -80.41 168.44 18.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.083 0.468 . . . . 62.12 110.448 -177.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.408 ' HA ' ' CG2' ' A' ' 44' ' ' ILE . 33.5 pt -93.5 161.08 2.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.005 -0.543 . . . . 75.34 110.954 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 69.3 5.07 4.92 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.164 0.586 . . . . 63.25 111.611 177.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 p -107.12 156.89 18.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.851 0.358 . . . . 54.2 110.993 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.521 ' HB2' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -107.91 130.97 54.99 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.008 -0.542 . . . . 61.41 110.341 178.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' A' ' 77' ' ' VAL . 27.2 m -127.6 161.31 35.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.739 -0.664 . . . . 73.22 110.911 -177.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.761 ' HD3' ' HG2' ' A' ' 41' ' ' GLU . 9.7 tptm -113.26 138.53 49.87 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.596 -0.729 . . . . 64.4 109.922 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.946 ' HA ' HG12 ' A' ' 75' ' ' VAL . 60.1 t -80.58 94.24 2.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.517 -0.765 . . . . 73.11 109.902 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.36 -52.69 34.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.013 -0.994 . . . . 73.14 110.106 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 38' ' ' ARG . . . -155.23 133.95 4.0 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 119.966 -1.111 . . . . 74.15 113.245 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.454 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 68.3 mt -80.64 158.19 4.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 107.598 -1.26 . . . . 74.34 107.598 169.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 25' ' ' SER . 49.8 t -100.27 91.13 1.59 Allowed Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 121.015 0.436 . . . . 50.33 110.086 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 25' ' ' SER . 35.8 Cg_endo -62.57 178.51 0.92 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.397 2.732 . . . . 51.3 113.061 -173.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 67.02 -16.19 0.14 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.436 -0.802 . . . . 72.21 111.741 -174.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -73.13 161.87 30.1 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.938 0.399 . . . . 72.33 110.926 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -78.84 -46.24 19.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.991 -0.55 . . . . 65.31 110.61 -176.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.688 HG21 ' HA ' ' A' ' 69' ' ' GLU . 23.3 m -68.13 -18.0 22.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.908 -0.587 . . . . 73.22 110.648 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.454 ' HE ' ' HB3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -53.7 -34.33 58.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.35 -0.841 . . . . 74.0 111.296 178.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -68.37 -42.07 79.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.45 -0.341 . . . . 54.22 111.06 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.447 ' O ' ' HG3' ' A' ' 34' ' ' MET . 34.0 tttp -73.56 -33.31 64.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.459 -0.337 . . . . 71.21 110.399 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 27' ' ' VAL . 88.5 mt -59.62 -48.31 87.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.174 -0.466 . . . . 51.21 110.719 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 64.9 mtt -68.79 -28.6 66.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 63.32 110.626 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.51 -40.57 76.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 71.32 110.429 176.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.447 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 65.6 mtt -61.93 -34.05 75.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.594 -0.73 . . . . 74.25 110.588 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.69 17.99 5.82 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.818 -0.706 . . . . 62.5 112.248 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.825 HD11 HD22 ' A' ' 58' ' ' LEU . 47.8 mt -101.03 127.46 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.197 0.523 . . . . 65.52 110.386 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.27 -176.53 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.273 -0.876 . . . . 53.23 110.084 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HG2' ' HA2' ' A' ' 20' ' ' GLY . 84.8 mtm180 -70.6 109.45 4.88 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.867 -0.419 . . . . 73.24 109.867 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.424 ' O ' ' HE3' ' A' ' 17' ' ' LYS . . . 120.8 -9.24 10.58 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 121.042 -0.599 . . . . 53.33 111.739 -176.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.4 m -73.63 149.57 41.94 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.663 -0.495 . . . . 74.2 109.663 174.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.761 ' HG2' ' HD3' ' A' ' 17' ' ' LYS . 55.5 mt-10 -115.69 134.85 54.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 116.215 -0.448 . . . . 70.35 110.102 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.575 HG21 HD23 ' A' ' 56' ' ' LEU . 48.2 mm -118.66 126.02 74.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.468 -0.787 . . . . 70.05 110.757 -173.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 57' ' ' ARG . 9.8 t80 -104.57 115.79 30.96 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.796 -0.816 . . . . 74.01 108.796 173.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.408 ' CG2' ' HA ' ' A' ' 12' ' ' ILE . 44.5 mm -73.35 106.39 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.92 0.391 . . . . 71.14 110.702 -176.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -75.73 -36.65 59.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.181 -0.674 . . . . 73.0 109.181 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.63 -179.47 39.33 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.783 -0.723 . . . . 61.33 112.371 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -126.59 150.64 48.76 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.442 -0.577 . . . . 72.12 109.442 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.28 165.48 17.4 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.412 -0.358 . . . . 73.44 111.453 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.0 -31.85 83.8 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.571 2.181 . . . . 74.33 112.094 175.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -86.11 -5.31 59.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.207 0.527 . . . . 71.21 110.262 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.48 -34.45 5.65 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.212 -0.755 . . . . 34.11 111.212 -174.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 4.2 p-10 -137.97 152.31 71.86 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 108.959 -0.756 . . . . 75.03 108.959 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 73.0 Cg_endo -72.26 173.3 53.47 Favored 'Cis proline' 0 C--O 1.234 0.288 0 C-N-CA 123.457 -1.476 . . . . 73.53 113.158 4.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.655 ' HB ' HD11 ' A' ' 56' ' ' LEU . 16.3 mm -97.04 147.32 6.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.514 -0.766 . . . . 73.43 109.304 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -105.51 111.24 23.88 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.314 -0.624 . . . . 61.51 109.314 174.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.655 HD11 ' HB ' ' A' ' 54' ' ' ILE . 2.3 mp -121.88 144.92 48.56 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.516 -0.311 . . . . 65.35 110.292 -175.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 54.9 mtt180 -100.1 108.14 20.22 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.344 -0.984 . . . . 63.43 108.344 166.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.825 HD22 HD11 ' A' ' 36' ' ' ILE . 2.4 pp -121.78 134.3 54.92 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.602 -0.727 . . . . 73.55 110.858 -173.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.485 ' HD3' ' OH ' ' A' ' 61' ' ' TYR . 50.3 ttt180 65.02 6.06 3.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.283 -0.872 . . . . 74.41 110.839 178.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.58 -19.58 9.72 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 116.019 -0.537 . . . . 64.34 112.794 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.485 ' OH ' ' HD3' ' A' ' 59' ' ' ARG . 4.4 p90 -127.67 148.97 50.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.359 0.599 . . . . 71.12 112.213 -177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.3 m -70.8 137.68 49.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.186 -0.915 . . . . 50.52 111.989 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.702 ' HB3' HD21 ' A' ' 58' ' ' LEU . 9.4 tt -150.99 148.86 28.89 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.689 -0.856 . . . . 65.02 108.689 176.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.1 t -115.07 132.14 56.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.179 0.514 . . . . 72.44 111.566 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.403 ' CD2' HD13 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -134.04 165.49 24.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.351 -0.841 . . . . 62.14 109.391 174.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -84.45 169.33 14.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.453 0.644 . . . . 72.12 112.384 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 37.0 ttmt -54.49 -35.09 62.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.751 -1.113 . . . . 73.31 111.704 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.1 t -66.15 -46.24 78.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.58 -0.282 . . . . 63.43 110.647 -176.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.688 ' HA ' HG21 ' A' ' 27' ' ' VAL . 1.9 mp0 -63.33 -43.92 96.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.942 0.401 . . . . 74.01 110.347 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.49 -22.03 66.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 62.11 111.27 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -74.69 -29.04 61.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.102 -0.499 . . . . 71.45 110.883 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -93.46 19.72 8.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.946 0.403 . . . . 73.02 111.109 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.428 HG22 HG13 ' A' ' 75' ' ' VAL . 69.5 mt -126.04 117.6 49.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.602 -0.518 . . . . 63.13 109.602 174.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.7 mt -103.15 121.41 42.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.745 0.307 . . . . 73.41 110.205 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.946 HG12 ' HA ' ' A' ' 18' ' ' VAL . 35.6 m -137.09 172.58 14.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.968 0.414 . . . . 72.01 111.78 -174.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -143.37 156.68 44.74 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.427 -0.953 . . . . 75.42 108.427 171.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.756 ' HA ' HG12 ' A' ' 16' ' ' VAL . 11.8 p -64.71 147.92 12.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.003 0.43 . . . . 54.03 111.548 -175.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.615 HD21 ' HB2' ' A' ' 17' ' ' LYS . 23.5 mt -75.4 3.8 8.47 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.038 -0.528 . . . . 63.44 112.394 -177.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.407 ' HG ' HG22 ' A' ' 77' ' ' VAL . 88.5 mt -67.28 96.0 0.46 Allowed 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.822 -0.436 . . . . 64.32 109.822 175.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -56.4 -51.62 67.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.005 -0.543 . . . . 62.32 111.656 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -87.38 86.9 7.29 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.55 -0.537 . . . . 75.54 109.55 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -130.59 142.98 50.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.11 -0.496 . . . . 54.42 110.453 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -100.46 128.41 46.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.85 -0.614 . . . . 55.42 110.468 -177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -81.29 107.93 14.49 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.058 -1.09 . . . . 73.33 108.058 172.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -78.2 121.52 24.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.487 0.661 . . . . 65.21 112.425 -165.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 C--O 1.251 1.143 0 CA-C-N 114.859 -1.064 . . . . 50.24 109.329 172.05 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.231 -0.285 . . . . 72.33 110.231 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.7 m -72.01 -53.18 13.77 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.267 -1.012 . . . . 52.21 108.267 167.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.632 ' HG2' HG21 ' A' ' 19' ' ' ILE . 26.4 ttmt 59.18 98.59 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 114.86 -1.064 . . . . 73.15 111.426 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.03 109.46 1.35 Allowed Glycine 0 N--CA 1.437 -1.233 0 CA-C-N 115.078 -0.964 . . . . 55.25 111.605 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.2 pt -85.03 167.76 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.688 -0.856 . . . . 73.13 108.688 175.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.75 146.83 40.79 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 119.429 -1.367 . . . . 52.15 111.076 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.413 HD21 HD13 ' A' ' 56' ' ' LEU . 27.4 tp -65.28 -17.79 64.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.309 0.576 . . . . 64.51 110.173 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -76.56 -20.54 56.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.749 -0.659 . . . . 74.52 110.358 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -89.09 -10.68 46.46 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.173 -0.467 . . . . 70.44 110.532 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.1 t -84.45 160.43 3.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.906 -0.588 . . . . 72.31 110.087 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.842 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 28.5 tt0 -122.44 -173.58 2.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.668 0.27 . . . . 63.22 110.409 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.842 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 40.8 pt -68.93 154.04 8.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 113.322 0.86 . . . . 73.44 113.322 -170.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.4 mttt 59.86 22.14 11.09 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.57 -1.196 . . . . 74.55 113.256 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.663 ' HA ' HD12 ' A' ' 79' ' ' LEU . 16.5 m -104.74 155.4 18.92 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.428 -0.582 . . . . 54.32 109.428 174.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -115.06 136.7 52.83 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.488 -0.485 . . . . 72.04 110.0 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.839 HG12 ' HA ' ' A' ' 77' ' ' VAL . 29.9 m -140.17 -179.57 2.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.698 -0.683 . . . . 72.45 110.167 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -148.99 146.17 27.67 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.832 -0.432 . . . . 73.45 109.832 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.539 ' HA ' HG12 ' A' ' 75' ' ' VAL . 26.1 t -74.01 93.14 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.238 0.542 . . . . 71.14 110.146 -178.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.632 HG21 ' HG2' ' A' ' 3' ' ' LYS . 38.4 mm -81.64 -38.94 16.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.341 -0.845 . . . . 75.54 110.283 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.4 169.6 25.82 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.569 -0.824 . . . . 64.53 112.881 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.657 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 69.7 mt -136.9 155.26 32.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.613 -0.884 . . . . 73.21 108.613 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.0 t -103.26 91.37 3.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.872 0.368 . . . . 52.21 110.584 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.657 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 35.9 Cg_exo -59.06 172.99 1.43 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.375 2.717 . . . . 73.31 113.03 -175.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 60.18 26.3 15.71 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.715 -0.675 . . . . 72.01 111.328 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.801 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 15.6 t -104.15 142.77 33.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.228 -0.442 . . . . 72.13 110.412 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -79.04 -27.03 43.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.874 0.368 . . . . 64.33 110.222 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.6 m -84.97 -19.93 8.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 65.42 110.62 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.801 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 2.0 tmt_? -54.21 -35.15 62.08 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.426 -0.352 . . . . 75.32 110.641 174.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -57.03 -56.64 19.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.992 -0.549 . . . . 74.51 110.444 174.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -54.6 -46.82 73.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.475 -0.784 . . . . 71.41 111.135 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.497 HG22 ' HB ' ' A' ' 36' ' ' ILE . 96.1 mt -57.54 -53.45 44.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.331 -0.849 . . . . 74.02 111.806 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.455 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 77.1 mtp -75.04 -28.45 60.44 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.769 -0.372 . . . . 75.43 111.093 -176.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.54 -32.16 73.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.329 0.585 . . . . 75.42 109.932 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.2 mtt -78.23 -3.81 44.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.359 -0.837 . . . . 65.22 111.774 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.65 4.7 45.86 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.635 -0.793 . . . . 64.01 112.947 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.497 ' HB ' HG22 ' A' ' 31' ' ' ILE . 30.1 mt -89.08 124.04 41.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.975 0.417 . . . . 64.34 110.395 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.1 m -143.81 168.81 11.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.581 -0.736 . . . . 74.14 110.055 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -66.96 108.39 2.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.052 0.453 . . . . 75.53 110.232 176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.5 -18.69 4.6 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.823 -0.704 . . . . 63.51 111.855 -178.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.2 m -75.27 143.87 42.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.927 0.394 . . . . 75.35 110.47 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -102.76 142.52 33.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.995 -0.548 . . . . 71.21 109.736 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.812 HG12 HD12 ' A' ' 58' ' ' LEU . 65.1 mt -123.96 126.1 71.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.817 -0.629 . . . . 74.25 110.939 -173.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -106.58 117.11 33.2 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.038 -0.727 . . . . 75.41 109.038 174.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.7 mm -76.47 114.95 17.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.842 0.353 . . . . 71.44 110.432 -177.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -76.97 -46.51 23.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.251 0.548 . . . . 74.13 109.936 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.652 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 170.82 -170.94 43.56 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.606 -0.725 . . . . 71.43 111.668 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.633 ' HG2' HG23 ' A' ' 54' ' ' ILE . 51.7 mtpt -132.83 137.17 46.65 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.026 -0.731 . . . . 72.24 109.026 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . -58.87 158.48 16.32 Favored Pre-proline 0 C--N 1.328 -0.359 0 O-C-N 123.422 0.451 . . . . 75.13 110.943 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' ' 48' ' ' ALA . 9.2 Cg_endo -52.91 -30.96 50.34 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.349 2.699 . . . . 71.23 113.625 -177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.9 ttt -94.48 4.62 53.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.425 0.631 . . . . 70.23 110.433 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.28 3.65 90.61 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 116.035 -0.53 . . . . 75.14 112.38 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -154.04 132.73 6.88 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.288 -0.634 . . . . 54.13 109.288 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.77 -178.03 21.59 Favored 'Cis proline' 0 C--O 1.235 0.373 0 C-N-CA 123.076 -1.635 . . . . 71.24 112.59 0.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.633 HG23 ' HG2' ' A' ' 47' ' ' LYS . 52.6 mt -104.24 126.46 58.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.576 -0.527 . . . . 73.21 109.576 177.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.51 102.84 9.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.183 0.516 . . . . 62.11 110.249 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 62' ' ' SER . 32.5 mt -112.81 146.05 39.52 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.781 -0.645 . . . . 55.32 110.399 -177.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 45.3 ttt180 -114.21 102.92 10.59 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.581 -0.896 . . . . 71.32 108.581 169.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.812 HD12 HG12 ' A' ' 42' ' ' ILE . 8.3 tt -123.7 147.01 47.84 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.35 -0.841 . . . . 74.55 110.351 -173.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.521 ' HB2' HD23 ' A' ' 58' ' ' LEU . 3.2 tmt_? 71.03 -51.68 0.68 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.306 -0.861 . . . . 64.55 110.907 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.67 -18.23 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.178 -0.534 . . . . 70.13 112.141 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -131.43 166.19 21.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.279 0.561 . . . . 75.03 110.974 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 41.9 t -82.79 144.61 30.03 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.16 -0.927 . . . . 75.34 110.401 177.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 48.6 tp -148.77 147.97 29.43 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.177 -0.92 . . . . 73.02 109.369 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.5 m -93.69 112.27 24.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.456 0.646 . . . . 71.3 110.805 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.465 HD23 HD12 ' A' ' 56' ' ' LEU . 4.0 mm? -111.06 144.1 40.73 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.153 -0.93 . . . . 61.41 109.218 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -87.86 170.09 11.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.123 0.487 . . . . 62.55 111.123 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -58.26 -33.07 68.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.31 -0.859 . . . . 72.45 110.571 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.46 ' HB2' ' OE1' ' A' ' 69' ' ' GLU . 10.3 m -57.62 -55.33 36.2 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.614 -0.721 . . . . 72.2 110.905 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.46 ' OE1' ' HB2' ' A' ' 68' ' ' SER . 1.9 mp0 -65.74 -40.1 91.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 73.32 110.749 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.57 -30.66 69.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.926 -0.579 . . . . 65.15 111.292 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -66.15 -38.58 88.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.008 0.433 . . . . 73.14 111.098 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.17 9.06 29.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.933 -0.576 . . . . 74.53 112.122 -173.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.598 HG22 HG13 ' A' ' 75' ' ' VAL . 66.8 mt -112.41 117.0 54.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.893 -0.41 . . . . 74.11 109.893 175.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.7 mt -97.82 111.7 23.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.039 0.447 . . . . 71.33 110.171 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.598 HG13 HG22 ' A' ' 73' ' ' ILE . 29.4 m -126.88 146.15 33.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.155 -0.475 . . . . 73.35 111.268 -176.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -107.18 139.8 41.04 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.398 -0.593 . . . . 63.43 109.398 174.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.839 ' HA ' HG12 ' A' ' 16' ' ' VAL . 40.8 t -71.22 104.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.093 -0.503 . . . . 73.2 110.369 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 78' ' ' LEU . 28.8 mt -93.31 5.71 50.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.989 -0.551 . . . . 72.4 111.375 -177.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.663 HD12 ' HA ' ' A' ' 14' ' ' SER . 4.3 tt -56.18 107.88 0.41 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.736 -0.838 . . . . 72.23 108.736 173.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.18 -178.05 6.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.971 -0.558 . . . . 74.0 111.745 -173.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 42.6 m80 65.54 -145.72 0.21 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.428 -0.806 . . . . 63.43 109.436 -173.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -167.25 -172.96 2.13 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.115 -0.698 . . . . 62.4 109.115 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -64.91 107.21 1.41 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.925 -0.769 . . . . 74.31 108.925 175.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -88.41 23.77 2.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.998 0.428 . . . . 74.32 110.972 -174.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -169.15 166.9 10.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.58 -0.896 . . . . 75.24 108.58 176.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.4 p80 . . . . . 0 C--O 1.245 0.827 0 CA-C-O 119.319 -0.372 . . . . 71.23 110.298 175.744 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.797 0.332 . . . . 74.24 110.221 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.9 m -83.78 100.04 10.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.023 0.439 . . . . 65.34 110.009 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -126.23 -4.84 6.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.826 -0.625 . . . . 62.0 110.26 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.73 129.8 30.52 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.205 -0.907 . . . . 23.1 112.884 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.8 pt -100.84 167.09 2.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.404 -0.591 . . . . 73.55 109.404 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 73' ' ' ILE . . . -69.61 145.84 42.72 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.19 -1.005 . . . . 73.24 111.704 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.511 HD21 HD11 ' A' ' 44' ' ' ILE . 2.2 tm? -54.95 -38.19 67.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.335 0.588 . . . . 74.04 109.909 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 70' ' ' ALA . 34.9 t30 -61.54 -18.92 61.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.498 -0.774 . . . . 73.14 111.499 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -105.52 5.86 31.82 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.283 -0.417 . . . . 75.22 111.775 -171.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 11' ' ' GLU . 21.5 t -86.2 159.52 3.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.42 -0.355 . . . . 71.31 110.103 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.502 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 25.2 tt0 -85.42 171.75 11.57 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.626 -0.509 . . . . 73.2 109.626 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.502 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 35.7 pt -86.83 150.63 3.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.942 0.401 . . . . 75.14 111.72 -173.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 56.55 66.17 1.25 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.138 -0.937 . . . . 64.43 111.596 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.503 ' HA ' HD12 ' A' ' 79' ' ' LEU . 67.5 m -152.02 158.32 42.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.662 -1.154 . . . . 74.42 109.339 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HG2' ' HD1' ' A' ' 43' ' ' TYR . 65.6 mttp -105.76 131.25 53.34 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.843 0.354 . . . . 74.34 110.183 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.672 HG12 ' HA ' ' A' ' 77' ' ' VAL . 30.9 m -128.03 155.59 39.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.033 -0.53 . . . . 70.41 110.691 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -119.59 141.44 49.28 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.819 -0.628 . . . . 73.45 109.961 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.66 ' HA ' HG12 ' A' ' 75' ' ' VAL . 42.0 t -74.63 97.05 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.454 -0.794 . . . . 72.3 110.428 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.83 HD11 ' HB2' ' A' ' 76' ' ' GLU . 27.9 mt -62.67 -41.8 93.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.476 -0.784 . . . . 73.23 109.991 173.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -173.92 166.01 38.0 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.528 -0.844 . . . . 70.11 112.662 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.692 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 54.5 mt -107.62 160.32 6.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.595 -0.891 . . . . 73.22 108.595 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.3 t -99.11 90.8 1.19 Allowed Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.594 -0.521 . . . . 64.52 109.594 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 34.3 Cg_exo -56.59 167.01 3.1 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.882 3.055 . . . . 73.34 113.564 -170.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 65.17 15.26 9.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.186 -0.915 . . . . 72.53 110.208 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.952 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 37.0 t -67.6 152.87 44.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.075 -0.966 . . . . 75.53 109.732 176.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 26' ' ' LYS . 20.4 tptp -87.74 -16.44 34.22 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.171 -0.678 . . . . 54.44 109.171 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.4 m -113.12 3.15 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.615 -0.721 . . . . 73.55 111.71 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.952 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 4.7 tmt_? -52.04 -40.85 61.71 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 110.11 -0.33 . . . . 64.1 110.11 173.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -58.41 -44.07 88.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.503 . . . . 63.14 110.611 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.464 ' HD3' ' HG2' ' A' ' 69' ' ' GLU . 88.8 tttt -62.86 -46.49 87.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.256 0.55 . . . . 71.0 110.258 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.541 HG23 HD12 ' A' ' 36' ' ' ILE . 82.6 mt -62.23 -46.14 97.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.298 -0.865 . . . . 74.55 111.262 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -39.84 93.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.055 -0.52 . . . . 73.24 110.553 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.82 -39.86 95.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.805 -0.634 . . . . 72.01 110.945 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.547 ' SD ' HD11 ' A' ' 65' ' ' LEU . 52.9 mtt -69.84 -13.23 62.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.181 -0.463 . . . . 74.34 111.557 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.412 ' HA3' ' HG3' ' A' ' 59' ' ' ARG . . . 94.78 36.9 5.4 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.626 -0.797 . . . . 50.34 112.89 174.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.541 HD12 HG23 ' A' ' 31' ' ' ILE . 40.4 mt -110.03 124.75 67.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.868 0.366 . . . . 73.33 110.333 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -145.09 177.38 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.606 -0.724 . . . . 74.32 109.693 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.444 ' C ' ' HD3' ' A' ' 38' ' ' ARG . 4.2 tmt_? -64.53 130.28 43.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.856 0.36 . . . . 74.21 110.145 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.01 -15.93 60.02 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.96 -0.638 . . . . 71.32 112.612 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.7 m -79.37 148.74 31.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.962 -0.385 . . . . 65.4 109.962 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -104.08 148.36 26.34 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.164 0.507 . . . . 74.23 110.734 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.43 HG12 ' HB3' ' A' ' 58' ' ' LEU . 79.6 mt -127.91 123.9 61.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.265 -0.88 . . . . 74.41 109.423 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.767 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 50.8 t80 -88.78 114.36 25.32 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.97 0.414 . . . . 55.23 110.378 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.511 HD11 HD21 ' A' ' 7' ' ' LEU . 21.1 mm -81.34 107.03 13.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.803 -0.635 . . . . 75.51 109.302 176.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -83.16 -53.26 5.91 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.776 -0.824 . . . . 64.14 108.776 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.76 147.43 6.56 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.311 -0.947 . . . . 33.11 112.607 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.586 ' HG2' HG23 ' A' ' 54' ' ' ILE . 51.6 mtpt -88.67 149.14 23.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.353 -0.98 . . . . 73.3 108.353 173.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.77 156.42 24.86 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 110.491 -0.189 . . . . 72.42 110.491 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.88 -16.84 27.57 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.681 2.254 . . . . 75.15 111.94 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.1 ttm -92.43 -12.55 31.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.65 -0.704 . . . . 75.03 110.275 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.75 -29.38 11.44 Favored Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 115.846 -0.616 . . . . 54.33 111.869 -177.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -142.17 147.56 44.49 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 108.923 -0.769 . . . . 73.55 108.923 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -79.71 -179.27 25.71 Favored 'Cis proline' 0 C--O 1.236 0.381 0 C-N-CA 123.317 -1.535 . . . . 74.1 112.472 -0.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.586 HG23 ' HG2' ' A' ' 47' ' ' LYS . 33.3 mt -113.23 124.75 70.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.92 -0.4 . . . . 65.44 109.92 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.08 106.78 11.36 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.908 0.385 . . . . 73.11 110.61 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 62' ' ' SER . 63.8 mt -119.64 142.26 48.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.098 -0.501 . . . . 74.12 110.808 -175.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.767 ' HB3' ' HB3' ' A' ' 43' ' ' TYR . 36.1 ttt180 -110.97 100.97 9.58 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.67 -0.863 . . . . 73.41 108.67 171.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.43 ' HB3' HG12 ' A' ' 42' ' ' ILE . 3.2 pp -131.41 151.21 51.74 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.81 -0.632 . . . . 63.02 110.616 -173.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.412 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 3.2 tmt_? 71.66 -39.39 0.45 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.37 0.668 . . . . 73.04 111.174 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.64 -27.35 0.11 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.152 -0.547 . . . . 74.44 112.262 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -124.46 169.15 12.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.971 0.415 . . . . 75.03 111.346 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.64 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 46.5 t -99.48 146.8 25.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.583 -0.735 . . . . 30.54 110.894 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 63' ' ' LEU . 2.4 pt? -164.6 161.3 20.92 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.282 -0.872 . . . . 75.01 109.425 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.94 116.89 31.07 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.07 0.462 . . . . 64.21 111.625 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.547 HD11 ' SD ' ' A' ' 34' ' ' MET . 4.1 mm? -98.15 158.84 15.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.757 -0.656 . . . . 63.4 110.881 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -81.87 156.19 24.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.15 -0.477 . . . . 63.53 111.383 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -53.83 -45.21 70.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.728 -0.669 . . . . 70.31 110.982 173.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.2 m -57.77 -50.39 73.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.592 -0.731 . . . . 51.3 111.958 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.464 ' HG2' ' HD3' ' A' ' 30' ' ' LYS . 2.2 mp0 -71.79 -31.06 66.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 74.25 111.536 -175.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 8' ' ' ASN . . . -68.69 -23.11 64.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.25 0.463 . . . . 70.42 112.25 -173.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -87.19 -11.28 50.31 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.957 -0.697 . . . . 35.33 110.682 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.56 0.93 35.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.179 -0.464 . . . . 72.32 111.021 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.481 ' O ' ' HA2' ' A' ' 6' ' ' GLY . 59.5 mt -118.52 126.48 75.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.951 -0.568 . . . . 64.31 109.984 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 93.2 mt -103.15 122.32 44.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.072 -0.344 . . . . 75.34 110.072 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.66 HG12 ' HA ' ' A' ' 18' ' ' VAL . 29.8 m -131.38 164.3 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.714 0.635 . . . . 75.34 112.714 -172.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.83 ' HB2' HD11 ' A' ' 19' ' ' ILE . 3.7 tp10 -111.21 136.9 49.61 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.916 -1.038 . . . . 73.11 109.477 173.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.672 ' HA ' HG12 ' A' ' 16' ' ' VAL . 46.8 t -82.66 104.67 11.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.534 -0.543 . . . . 42.13 109.534 178.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.8 mt -74.79 -25.18 58.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.224 0.535 . . . . 44.13 110.938 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 14' ' ' SER . 38.8 mt -92.04 84.66 5.34 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.593 -0.73 . . . . 64.54 111.292 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -94.56 13.08 25.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.476 -0.564 . . . . 65.31 109.476 174.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 69.34 159.04 0.17 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.833 -1.076 . . . . 55.11 111.319 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.42 ' HD2' ' CD2' ' A' ' 83' ' ' HIS . 7.9 t60 -79.43 -33.72 42.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.102 -0.499 . . . . 55.14 109.986 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.42 ' CD2' ' HD2' ' A' ' 82' ' ' HIS . 11.2 m-70 -125.09 145.66 49.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.065 -0.516 . . . . 64.45 109.757 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -74.59 94.91 2.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.88 0.848 . . . . 72.12 110.564 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -94.27 143.99 25.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.2 -0.909 . . . . 63.25 110.509 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.6 t60 . . . . . 0 C--O 1.244 0.804 0 CA-C-O 118.325 -0.845 . . . . 65.23 109.579 176.355 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.903 0.382 . . . . 72.11 110.712 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.4 m -87.79 106.47 18.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.896 0.379 . . . . 62.51 110.943 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.69 147.58 42.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.178 -0.465 . . . . 62.23 110.118 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.02 146.21 16.04 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.753 -0.737 . . . . 74.02 112.097 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.2 pt -134.02 173.64 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.685 0.279 . . . . 71.14 110.318 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.65 157.85 38.48 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.59 -0.814 . . . . 64.03 111.099 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 7' ' ' LEU . 2.0 tm? -54.65 -35.22 63.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.089 0.471 . . . . 73.32 110.67 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -71.58 -11.95 61.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.126 -0.488 . . . . 73.25 111.871 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -99.26 -5.6 29.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.765 0.317 . . . . 72.53 111.259 -174.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 11' ' ' GLU . 15.5 t -77.21 162.57 4.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.259 -0.428 . . . . 72.04 110.564 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.428 ' N ' HG12 ' A' ' 10' ' ' VAL . 23.4 tt0 -96.74 170.27 9.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.627 -0.508 . . . . 73.22 109.627 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.1 pt -76.65 146.63 8.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.835 0.35 . . . . 54.43 111.533 -174.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 61.16 25.65 15.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.378 -0.828 . . . . 73.44 111.925 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.5 m -105.13 148.1 27.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.928 -0.578 . . . . 63.41 109.592 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.531 ' HG2' HD12 ' A' ' 78' ' ' LEU . 45.5 tttm -105.43 126.1 51.73 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.78 -0.452 . . . . 72.33 109.78 -177.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 17.6 m -131.71 162.87 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.3 0.571 . . . . 70.22 111.634 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.695 ' HE3' ' HA2' ' A' ' 39' ' ' GLY . 2.1 tmtp? -122.36 145.19 48.49 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.5 -0.773 . . . . 72.13 110.094 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.5 t -73.4 97.49 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.094 -0.503 . . . . 71.23 110.872 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.545 HD11 ' HB2' ' A' ' 76' ' ' GLU . 45.6 mt -54.51 -46.96 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 115.619 -0.718 . . . . 62.23 109.616 170.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.46 173.42 39.72 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.328 -0.851 . . . . 71.34 112.451 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.1 mt -96.94 157.9 3.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.36 -0.608 . . . . 51.5 109.36 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.2 91.76 1.83 Allowed Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.764 -0.458 . . . . 44.33 109.764 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.09 165.48 0.88 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 124.055 3.17 . . . . 64.25 113.783 -171.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.529 ' H ' ' NH1' ' A' ' 28' ' ' ARG . 0.5 OUTLIER 64.88 24.06 12.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.093 -0.958 . . . . 74.53 111.486 -177.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.552 ' OG ' HG22 ' A' ' 27' ' ' VAL . 40.7 t -93.14 150.97 20.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.653 -0.703 . . . . 72.25 109.778 173.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -82.39 -18.17 42.95 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.933 -0.395 . . . . 73.11 109.933 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.586 HG21 ' HA ' ' A' ' 69' ' ' GLU . 11.2 m -94.75 -9.44 9.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.34 -0.391 . . . . 55.23 110.343 176.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.529 ' NH1' ' H ' ' A' ' 24' ' ' GLU . 52.2 ttp180 -50.6 -49.09 57.39 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.272 0.558 . . . . 65.15 110.121 170.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -62.06 -37.44 84.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.205 -0.907 . . . . 75.14 110.499 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -62.36 -44.99 95.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.726 -0.67 . . . . 74.14 110.824 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.453 HG13 HD11 ' A' ' 73' ' ' ILE . 47.5 mm -63.91 -48.32 86.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.761 -0.654 . . . . 73.24 111.247 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 20.9 mmt -64.84 -33.41 75.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 75.42 110.732 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.38 -28.14 68.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.871 -0.604 . . . . 61.01 110.361 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 82.6 mmm -81.58 -8.82 59.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.762 -0.654 . . . . 74.43 110.95 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.07 24.79 47.14 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.747 -0.74 . . . . 75.41 112.534 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mt -102.09 134.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.733 -0.469 . . . . 74.13 109.733 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 m -132.14 169.99 20.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.18 0.514 . . . . 62.41 111.598 -175.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.421 ' C ' ' HD3' ' A' ' 38' ' ' ARG . 4.1 tmt_? -68.28 110.49 4.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.783 -0.644 . . . . 53.11 109.541 175.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.695 ' HA2' ' HE3' ' A' ' 17' ' ' LYS . . . 132.32 -16.7 4.87 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.763 -0.732 . . . . 74.42 111.952 -178.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 m -71.12 148.9 46.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.877 0.37 . . . . 74.41 110.547 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.437 ' C ' HD12 ' A' ' 42' ' ' ILE . 40.3 mt-10 -100.04 132.35 45.45 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.962 -0.563 . . . . 74.14 110.361 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.64 HG13 ' HB3' ' A' ' 58' ' ' LEU . 2.0 mp -118.98 122.12 68.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.31 0.576 . . . . 71.31 110.179 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.725 ' HB3' ' HB2' ' A' ' 57' ' ' ARG . 82.3 t80 -96.13 116.78 29.51 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.654 -0.869 . . . . 75.51 108.654 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.2 mm -71.7 101.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.683 -0.488 . . . . 74.11 109.683 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.34 -33.58 69.73 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.365 -0.605 . . . . 74.23 109.365 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.32 150.54 5.6 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.652 -0.785 . . . . 75.34 112.563 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -88.93 154.42 20.25 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.474 -0.936 . . . . 72.45 108.474 173.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.88 151.98 51.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.593 -0.521 . . . . 73.54 109.593 175.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.79 -23.91 61.0 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.49 2.127 . . . . 74.1 111.81 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.0 ttt -86.0 -17.84 34.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.761 -0.654 . . . . 74.14 110.213 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.05 -23.64 20.72 Favored Glycine 0 C--N 1.33 0.2 0 CA-C-N 116.06 -0.518 . . . . 74.34 112.795 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.406 ' OD1' ' HA ' ' A' ' 53' ' ' PRO . 28.9 t70 -145.91 137.0 12.6 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.233 -0.654 . . . . 74.41 109.233 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HA ' ' OD1' ' A' ' 52' ' ' ASP . 4.2 Cg_exo -81.53 -168.84 6.95 Favored 'Cis proline' 0 CA--C 1.534 0.49 0 C-N-CA 124.157 -1.185 . . . . 64.21 113.194 0.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 64' ' ' SER . 57.8 mt -121.17 142.86 35.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 73.12 110.138 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.34 112.95 25.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.928 0.394 . . . . 74.33 110.652 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.639 ' O ' ' HA ' ' A' ' 62' ' ' SER . 4.0 mp -107.7 132.32 53.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 61.42 110.741 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.725 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 27.7 mmt180 -90.33 100.48 13.31 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.27 -0.641 . . . . 65.14 109.27 173.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.64 ' HB3' HG13 ' A' ' 42' ' ' ILE . 2.8 pp -137.66 142.6 41.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.984 -0.553 . . . . 74.4 110.016 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 70.63 -4.12 1.75 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.332 0.587 . . . . 71.14 110.42 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.26 -41.22 1.5 Allowed Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.959 -0.564 . . . . 35.51 112.303 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -113.26 159.53 19.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.46 0.648 . . . . 71.45 111.985 -175.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 36.1 t -82.25 148.09 28.57 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.879 -1.055 . . . . 72.12 110.289 173.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 42.1 tp -151.08 146.38 26.13 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.554 -0.748 . . . . 64.13 109.793 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -89.01 113.99 25.13 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.199 0.524 . . . . 74.3 111.64 -178.404 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.503 HD23 HD13 ' A' ' 56' ' ' LEU . 3.6 mm? -112.89 157.16 21.78 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.067 -0.716 . . . . 73.3 109.067 174.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -84.3 160.8 20.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.864 0.364 . . . . 64.31 111.131 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.492 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 1.6 tmtp? -55.39 -28.44 54.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.627 -0.715 . . . . 43.52 110.667 175.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.8 m -56.6 -56.87 15.94 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.365 -0.38 . . . . 71.11 110.494 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.586 ' HA ' HG21 ' A' ' 27' ' ' VAL . 1.8 mp0 -63.61 -40.19 96.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.095 0.474 . . . . 70.15 110.353 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 67' ' ' LYS . . . -62.86 -20.97 65.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.572 -0.74 . . . . 74.21 111.648 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.474 ' C ' ' HD2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -79.22 -39.05 34.2 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.058 -0.349 . . . . 70.52 110.058 177.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -89.76 8.44 31.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.196 -0.457 . . . . 75.12 112.2 -171.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.453 HD11 HG13 ' A' ' 31' ' ' ILE . 47.1 mm -115.07 113.02 42.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.872 -0.418 . . . . 71.34 109.872 175.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.7 mt -93.45 126.44 38.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.776 -0.453 . . . . 55.02 109.776 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 18.6 m -128.14 153.27 37.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.277 0.561 . . . . 72.41 112.124 -174.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.545 ' HB2' HD11 ' A' ' 19' ' ' ILE . 42.2 tt0 -119.6 144.33 47.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.004 -0.998 . . . . 73.3 108.812 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.576 HG22 ' H ' ' A' ' 79' ' ' LEU . 9.3 p -70.38 136.66 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.071 0.462 . . . . 75.15 111.076 -176.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.579 HD21 ' HB2' ' A' ' 17' ' ' LYS . 40.8 mt -95.74 6.34 49.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.284 0.476 . . . . 64.13 112.284 -176.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.576 ' H ' HG22 ' A' ' 77' ' ' VAL . 94.6 mt -58.19 108.52 0.62 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.829 0.347 . . . . 62.11 110.376 176.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -83.74 78.36 9.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.771 0.796 . . . . 73.45 110.911 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -148.39 130.67 15.57 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.774 -1.103 . . . . 65.51 108.968 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -88.23 -25.5 22.84 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.97 0.414 . . . . 73.1 110.5 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -106.06 85.22 2.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.098 -0.501 . . . . 74.04 109.974 175.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -168.73 131.99 1.41 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.722 -0.672 . . . . 74.33 110.205 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -100.37 -93.46 0.28 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.559 -0.534 . . . . 70.25 109.559 174.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.5 p80 . . . . . 0 C--O 1.247 0.924 0 CA-C-O 119.03 -0.509 . . . . 71.42 110.117 176.011 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 tmm? . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 109.496 -0.557 . . . . 64.22 109.496 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.771 HG22 ' H ' ' A' ' 4' ' ' GLY . 87.9 m -144.22 124.02 13.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.331 -0.395 . . . . 70.21 110.013 175.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -82.5 8.39 11.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 74.31 110.654 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.771 ' H ' HG22 ' A' ' 2' ' ' THR . . . 76.09 -154.53 44.84 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.495 -0.775 . . . . 61.43 111.912 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.8 pt -125.24 168.12 18.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.948 -0.76 . . . . 62.24 108.948 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.24 149.1 50.77 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.027 -1.082 . . . . 55.11 111.033 177.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.688 HD21 HD11 ' A' ' 44' ' ' ILE . 2.7 tm? -54.43 -33.18 58.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.389 0.614 . . . . 73.52 109.89 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.456 ' ND2' ' HA ' ' A' ' 71' ' ' LYS . 8.7 p30 -70.62 -19.46 62.82 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.574 -0.739 . . . . 72.4 111.307 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -92.23 -8.12 46.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.903 0.382 . . . . 74.04 110.789 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.1 t -80.28 157.62 4.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.112 -0.495 . . . . 74.55 110.029 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.584 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 21.1 tt0 -94.81 176.81 6.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.793 -0.447 . . . . 75.12 109.793 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.584 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 39.9 pt -84.73 160.5 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 112.23 0.455 . . . . 61.14 112.23 -173.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 60.59 46.92 8.89 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.121 -0.945 . . . . 64.53 111.998 172.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.7 m -145.53 154.06 41.79 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.583 -0.735 . . . . 73.34 109.636 174.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.786 ' HE2' HD21 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -109.22 130.89 55.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.34 0.59 . . . . 72.44 110.802 178.674 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 77' ' ' VAL . 27.1 m -132.28 163.73 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.133 -0.94 . . . . 63.51 110.343 -177.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.48 ' HB2' HD21 ' A' ' 78' ' ' LEU . 29.8 ttpt -115.48 143.48 45.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.992 -0.549 . . . . 75.21 110.656 -177.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.566 ' HA ' HG12 ' A' ' 75' ' ' VAL . 52.8 t -77.61 98.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.509 -0.768 . . . . 72.43 110.048 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.8 HD11 ' HB3' ' A' ' 76' ' ' GLU . 39.8 mt -57.41 -54.69 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.638 -0.71 . . . . 72.45 110.453 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -161.6 178.01 37.65 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.158 -0.928 . . . . 73.34 111.34 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 53.6 mt -113.2 155.84 14.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.963 -0.384 . . . . 70.03 109.963 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.407 ' HA ' ' HD2' ' A' ' 23' ' ' PRO . 51.8 t -101.82 91.27 2.26 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.213 -0.662 . . . . 75.41 109.213 175.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.717 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 25.7 Cg_endo -59.22 -168.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.844 3.029 . . . . 61.33 113.773 -172.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 68.3 -43.86 0.49 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.571 -0.741 . . . . 74.43 112.371 -173.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.581 ' OG ' HG22 ' A' ' 27' ' ' VAL . 8.6 t -55.57 145.19 23.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.219 0.533 . . . . 71.24 111.725 -176.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.922 ' HD3' ' H ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -71.73 -29.68 64.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.567 -0.742 . . . . 62.43 109.805 173.071 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.691 HG21 ' HA ' ' A' ' 69' ' ' GLU . 11.4 m -79.84 -17.37 12.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.948 0.404 . . . . 75.35 110.049 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.717 ' HG3' ' HA ' ' A' ' 23' ' ' PRO . 2.8 tmm_? -55.18 -36.93 66.4 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.064 -0.516 . . . . 70.45 109.999 169.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -71.48 -40.07 70.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.292 0.568 . . . . 73.41 109.805 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.638 ' HG2' ' OE2' ' A' ' 69' ' ' GLU . 23.5 tptm -53.05 -48.04 67.96 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 114.988 -1.005 . . . . 62.12 111.021 177.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 27' ' ' VAL . 61.5 mt -50.99 -53.29 14.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.566 -0.743 . . . . 73.31 111.386 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 59.3 mtt -66.76 -35.39 79.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.993 -0.549 . . . . 73.42 111.371 -178.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -65.83 -38.58 89.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.943 0.401 . . . . 61.13 110.022 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.6 tpt -65.75 -25.57 67.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.472 -0.786 . . . . 75.32 110.961 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.87 8.09 11.09 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.756 -0.735 . . . . 41.23 112.744 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.425 ' HB ' ' CG2' ' A' ' 31' ' ' ILE . 37.4 mt -104.61 133.28 49.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.711 -0.477 . . . . 71.33 109.711 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.656 HG23 ' H ' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -129.78 -85.89 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 112.092 0.404 . . . . 70.24 112.092 -177.603 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.656 ' H ' HG23 ' A' ' 37' ' ' VAL . 45.4 ttm180 -153.99 117.56 4.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.964 0.412 . . . . 64.44 110.263 -177.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.43 -1.05 68.89 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.492 -0.861 . . . . 74.55 111.534 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.0 m -66.65 140.85 57.94 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.675 -0.491 . . . . 74.34 109.675 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.512 ' HG2' HD11 ' A' ' 78' ' ' LEU . 35.5 mt-10 -107.07 128.15 54.11 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.803 -0.635 . . . . 71.45 110.029 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.682 HG21 HD23 ' A' ' 56' ' ' LEU . 77.5 mt -121.48 136.28 58.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.317 -0.856 . . . . 73.12 110.535 -172.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.657 ' HD1' ' HB3' ' A' ' 15' ' ' LYS . 37.4 t80 -100.87 105.88 17.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.262 -0.426 . . . . 72.43 109.869 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.688 HD11 HD21 ' A' ' 7' ' ' LEU . 50.4 mm -70.54 120.92 19.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.941 -0.392 . . . . 73.42 109.941 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -89.96 -65.82 0.98 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.09 -0.504 . . . . 65.45 110.516 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' A' ' 12' ' ' ILE . . . -159.06 173.44 35.92 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.687 -0.768 . . . . 52.15 112.027 -177.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.496 ' HG2' HG23 ' A' ' 54' ' ' ILE . 58.3 mtpt -129.52 146.98 51.28 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.32 -0.622 . . . . 75.33 109.32 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.67 157.13 68.42 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.497 -0.557 . . . . 64.12 109.497 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -52.3 -29.74 39.76 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.82 2.347 . . . . 73.24 113.196 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -82.43 -7.95 59.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 74.03 110.821 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.11 -8.34 78.62 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.012 -0.835 . . . . 74.54 111.012 -173.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.776 ' HB2' ' HB2' ' A' ' 67' ' ' LYS . 5.9 t70 -139.29 128.98 14.26 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.014 -0.593 . . . . 73.41 109.797 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 97.3 Cg_endo -87.0 -174.32 9.8 Favored 'Cis proline' 0 C--O 1.237 0.459 0 C-N-CA 123.374 -1.511 . . . . 74.12 113.05 0.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.496 HG23 ' HG2' ' A' ' 47' ' ' LYS . 4.6 mp -112.86 140.78 30.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.791 -0.641 . . . . 44.43 109.31 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.65 106.76 19.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.025 0.441 . . . . 61.33 110.839 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.682 HD23 HG21 ' A' ' 42' ' ' ILE . 3.1 mp -105.51 134.27 48.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.836 -0.62 . . . . 74.13 109.381 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 39.6 mtt180 -98.19 119.98 37.81 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.982 0.42 . . . . 72.43 110.114 175.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.432 ' HG ' HD23 ' A' ' 63' ' ' LEU . 3.4 pp -139.43 140.58 37.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.431 -0.804 . . . . 65.52 109.999 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 46.7 ttm-85 65.9 -0.25 1.38 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.31 -0.859 . . . . 63.42 111.993 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.05 -52.02 0.56 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.468 -0.872 . . . . 55.25 113.585 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -120.87 177.33 5.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.871 0.367 . . . . 63.34 111.722 -173.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 30.2 t -88.18 142.9 27.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.596 0.712 . . . . 71.12 112.226 -175.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 62' ' ' SER . 3.2 mm? -134.68 143.54 47.29 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.342 -1.299 . . . . 54.33 108.928 176.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.3 p -99.33 119.91 38.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.078 0.466 . . . . 52.03 111.695 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.526 HD13 HD13 ' A' ' 56' ' ' LEU . 9.0 mp -114.72 151.42 33.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.86 -0.609 . . . . 70.51 109.423 175.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.492 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 46.8 mmm-85 -75.61 159.81 30.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.32 0.581 . . . . 75.22 111.745 -174.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.776 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -61.94 -33.58 74.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.246 -0.888 . . . . 60.34 110.611 179.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 41.7 m -73.3 -35.47 66.13 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.978 -0.555 . . . . 73.23 111.204 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.691 ' HA ' HG21 ' A' ' 27' ' ' VAL . 39.4 mt-10 -70.11 -43.01 71.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.351 0.596 . . . . 65.52 109.401 176.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.71 -21.25 65.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.386 -0.825 . . . . 63.45 111.072 176.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.456 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 1.8 ttpm? -70.74 -35.64 72.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.076 -0.511 . . . . 64.35 110.517 176.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -84.46 14.44 4.51 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.586 -0.734 . . . . 73.44 111.204 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.418 HG12 HD13 ' A' ' 31' ' ' ILE . 54.7 mt -125.8 120.47 57.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.897 -0.592 . . . . 65.05 109.909 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.1 mt -104.01 126.1 50.88 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.955 -0.387 . . . . 75.53 109.955 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 18' ' ' VAL . 23.9 m -129.51 157.44 42.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.318 0.58 . . . . 74.43 112.372 -174.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.8 ' HB3' HD11 ' A' ' 19' ' ' ILE . 14.0 pt-20 -119.22 153.35 35.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.265 -0.88 . . . . 73.03 109.681 176.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.655 HG22 ' H ' ' A' ' 79' ' ' LEU . 13.1 p -77.92 133.09 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.988 0.423 . . . . 54.23 111.024 -177.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.512 HD11 ' HG2' ' A' ' 41' ' ' GLU . 96.9 mt -93.86 -9.63 36.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.362 0.601 . . . . 61.53 110.826 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.786 HD21 ' HE2' ' A' ' 15' ' ' LYS . 86.9 mt -90.04 132.54 35.33 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.259 -0.882 . . . . 75.1 111.553 -177.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.477 ' HG2' ' H ' ' A' ' 81' ' ' HIS . 25.2 tt0 71.56 170.08 0.32 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 124.186 0.929 . . . . 74.0 111.183 175.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.477 ' H ' ' HG2' ' A' ' 80' ' ' GLU . 79.3 m80 -88.41 -8.09 55.56 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.102 -0.703 . . . . 73.1 109.102 171.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.436 ' H ' ' HG2' ' A' ' 80' ' ' GLU . 12.0 t-160 62.56 87.16 0.1 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.614 -1.176 . . . . 73.14 110.735 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -65.49 119.32 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.835 -0.62 . . . . 62.4 111.013 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 53.4 t60 70.6 116.92 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 114.842 -1.072 . . . . 72.42 111.618 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -81.33 115.85 20.89 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.431 -0.804 . . . . 61.13 109.49 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.029 -0.986 . . . . 65.32 110.726 179.731 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' HB ' ' A' ' 2' ' ' THR . 97.7 mmm . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 109.903 -0.406 . . . . 52.21 109.903 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 1' ' ' MET . 88.8 m 75.21 114.23 0.06 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.87 0.731 . . . . 62.33 110.254 -175.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt 66.25 24.53 10.68 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.466 -0.788 . . . . 71.02 110.098 -173.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.97 178.35 33.35 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.349 -0.841 . . . . 52.53 112.6 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.2 pt -115.37 173.07 3.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.808 -0.812 . . . . 71.15 108.808 176.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.45 143.2 29.08 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 119.865 -1.16 . . . . 61.43 111.72 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.507 HD11 HD11 ' A' ' 44' ' ' ILE . 39.5 tp -63.61 -24.71 67.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.2 0.524 . . . . 73.34 110.548 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -76.52 -14.39 60.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.853 -0.612 . . . . 74.51 110.604 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.85 -4.63 56.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.339 0.59 . . . . 74.33 110.012 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.5 t -98.26 162.28 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.505 -0.771 . . . . 62.15 109.399 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.791 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 24.8 tt0 -124.77 -172.0 2.47 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 120.98 -0.288 . . . . 72.44 110.79 -177.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.791 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 31.6 pt -63.35 154.13 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 113.445 0.906 . . . . 73.02 113.445 -170.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 63.02 27.1 15.77 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.965 -1.016 . . . . 62.15 111.962 173.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.843 ' HA ' HD11 ' A' ' 79' ' ' LEU . 19.6 m -102.42 152.66 20.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.259 -0.428 . . . . 65.1 110.53 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -124.17 110.92 15.28 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.235 -0.654 . . . . 71.43 109.235 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 77' ' ' VAL . 30.4 m -128.32 174.17 12.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.534 -0.757 . . . . 70.01 110.687 -174.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 37.5 ttmt -129.18 140.98 51.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.154 -0.475 . . . . 75.23 110.595 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.55 HG13 HG23 ' A' ' 73' ' ' ILE . 48.7 t -73.36 96.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.319 -0.855 . . . . 64.24 110.619 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.8 mm -63.29 -44.9 99.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.76 -0.655 . . . . 65.32 109.908 174.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.93 172.08 44.51 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.233 -0.984 . . . . 74.33 112.671 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.605 ' HB ' ' NH1' ' A' ' 28' ' ' ARG . 49.4 mt -127.77 158.98 39.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 108.068 -1.086 . . . . 73.2 108.068 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 25' ' ' SER . 38.2 t -101.19 91.3 1.96 Allowed Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.058 0.456 . . . . 65.42 111.254 -175.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.612 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 24.4 Cg_endo -59.94 171.55 2.86 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.696 2.264 . . . . 64.42 112.35 -177.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 68.93 -5.28 1.05 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.682 -0.69 . . . . 74.33 111.488 -175.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 22' ' ' VAL . 1.2 m -78.74 156.77 28.72 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.955 -0.387 . . . . 54.04 109.955 173.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -75.33 -31.43 60.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.894 0.378 . . . . 75.22 110.599 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.525 ' HB ' ' HG3' ' A' ' 69' ' ' GLU . 29.6 m -81.47 -21.61 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 70.34 110.77 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.612 ' HG2' ' HA ' ' A' ' 23' ' ' PRO . 17.7 tpt180 -53.02 -43.78 66.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.94 -0.573 . . . . 54.33 110.465 175.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -59.43 -44.65 92.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.587 -0.733 . . . . 64.33 110.771 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 34' ' ' MET . 88.6 tttt -63.85 -48.93 74.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.818 -0.628 . . . . 62.23 110.931 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 27' ' ' VAL . 82.1 mt -57.33 -45.81 85.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.822 -0.627 . . . . 71.01 111.392 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 95.4 mmm -68.57 -35.5 77.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.795 0.331 . . . . 71.31 110.593 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -66.32 -39.96 89.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.99 -0.55 . . . . 74.42 110.255 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 91.0 mmm -60.52 -34.73 74.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.818 -0.628 . . . . 74.22 110.735 176.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.58 13.82 9.29 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.64 -0.791 . . . . 73.45 112.894 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.7 mt -89.64 127.1 42.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.86 0.362 . . . . 74.32 110.052 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.36 173.13 14.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.722 -0.672 . . . . 60.52 110.675 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.59 135.27 57.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.185 -0.461 . . . . 74.52 110.619 178.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.24 -12.09 66.89 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.908 -0.587 . . . . 71.12 112.662 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.3 m -73.29 142.24 47.17 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.859 -0.423 . . . . 71.12 109.859 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -94.39 136.14 35.02 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.065 0.459 . . . . 61.23 109.785 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.2 mm -116.74 117.82 56.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.643 -0.708 . . . . 75.1 110.463 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 63.4 t80 -95.52 119.48 34.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.854 -0.612 . . . . 74.54 109.436 174.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.507 HD11 HD11 ' A' ' 7' ' ' LEU . 26.3 mm -76.3 101.88 2.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.612 -0.514 . . . . 51.13 109.612 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -70.35 -42.83 71.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.934 -0.575 . . . . 71.11 109.601 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' HG22 ' A' ' 12' ' ' ILE . . . 169.75 177.78 40.42 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.889 -0.672 . . . . 75.34 111.956 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -117.97 143.09 46.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.132 -0.692 . . . . 72.34 109.132 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.64 158.46 31.13 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.605 -0.271 . . . . 63.55 110.394 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -45.41 -41.73 17.8 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.201 2.6 . . . . 72.21 113.419 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.7 ttt -71.22 -21.97 62.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 74.35 111.382 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.59 -7.22 42.31 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.728 -0.949 . . . . 71.01 110.728 -172.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.483 ' OD1' ' HA ' ' A' ' 53' ' ' PRO . 21.8 t70 -155.54 139.25 11.2 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.838 -0.801 . . . . 74.15 108.838 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HB3' ' HA ' ' A' ' 66' ' ' ARG . 4.1 Cg_exo -79.45 -170.19 8.51 Favored 'Cis proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.829 -1.321 . . . . 75.24 113.05 2.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.5 mt -116.39 137.5 49.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.713 -0.676 . . . . 74.23 109.904 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.03 111.65 20.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.291 -0.413 . . . . 60.24 110.287 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.6 mt -114.04 135.96 53.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.967 -0.561 . . . . 71.43 109.903 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.715 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 44.4 ttt180 -94.83 107.4 19.41 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.698 -0.482 . . . . 73.22 109.698 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.557 HD13 ' H ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -132.69 153.63 50.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.271 -0.422 . . . . 73.24 110.288 -177.539 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.543 ' HB2' HD22 ' A' ' 58' ' ' LEU . 0.2 OUTLIER 70.62 -55.63 0.63 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.773 0.671 . . . . 51.13 110.631 -178.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.53 -33.03 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 116.116 -0.493 . . . . 64.41 111.956 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -125.85 165.58 18.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.822 0.344 . . . . 75.4 110.938 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.715 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 47.7 t -86.28 145.82 26.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.243 0.544 . . . . 72.4 110.973 -178.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.1 mt -145.31 161.22 40.14 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.052 -0.976 . . . . 62.41 109.483 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -97.17 121.18 38.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.044 0.449 . . . . 65.34 110.741 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.42 143.31 49.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.355 -0.839 . . . . 65.43 109.389 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.485 ' HA ' ' HB3' ' A' ' 53' ' ' PRO . 37.4 mmt180 -71.82 155.14 40.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.073 0.463 . . . . 72.23 110.898 -177.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -56.27 -30.9 63.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.381 -0.827 . . . . 72.05 111.045 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 2.9 p -63.81 -37.87 89.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 44.41 111.607 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.525 ' HG3' ' HB ' ' A' ' 27' ' ' VAL . 1.6 mp0 -73.87 -39.39 63.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.003 0.43 . . . . 74.21 110.554 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.16 -23.64 66.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.202 0.525 . . . . 65.54 110.734 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 68' ' ' SER . 7.1 tmtt? -62.99 -33.9 76.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.79 -0.641 . . . . 74.14 111.74 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -88.65 -5.24 58.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.128 0.49 . . . . 72.14 111.78 -168.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.55 HG23 HG13 ' A' ' 18' ' ' VAL . 65.6 mt -105.13 115.58 47.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.192 -0.458 . . . . 61.12 110.899 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.489 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.7 mm? -86.67 126.87 34.83 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.633 -0.506 . . . . 70.24 109.633 174.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.499 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 24.2 m -130.15 153.72 39.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.877 0.37 . . . . 72.11 111.574 -176.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -102.52 148.49 25.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.283 -0.636 . . . . 75.52 109.283 173.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.516 ' HA ' HG12 ' A' ' 16' ' ' VAL . 53.6 t -89.3 114.51 27.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.864 0.364 . . . . 65.41 110.187 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.2 mt -94.23 0.23 55.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.192 0.52 . . . . 64.43 111.343 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.843 HD11 ' HA ' ' A' ' 14' ' ' SER . 87.3 mt -82.17 169.9 16.07 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.797 -0.638 . . . . 62.03 111.512 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -76.08 -164.03 0.34 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.183 -0.917 . . . . 70.13 110.341 174.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -66.4 140.81 58.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.802 0.334 . . . . 73.42 110.218 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -116.72 113.58 22.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.232 0.539 . . . . 74.31 111.299 -173.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -163.81 159.7 21.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.935 -0.575 . . . . 71.14 110.106 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 12.3 t60 59.78 34.3 21.91 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.605 0.717 . . . . 62.52 109.923 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -115.74 103.3 10.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.779 -0.646 . . . . 71.34 111.106 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.1 t60 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.205 -0.902 . . . . 53.03 109.322 177.862 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.965 0.412 . . . . 62.51 110.778 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.59 96.83 8.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.998 -0.546 . . . . 71.22 110.808 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -99.73 -177.84 3.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.182 -0.463 . . . . 73.51 110.542 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.99 116.69 6.95 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.74 -0.743 . . . . 61.03 112.07 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.6 pt -115.74 168.19 7.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.987 -0.375 . . . . 74.04 109.987 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.07 143.65 41.73 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.311 -0.947 . . . . 73.52 111.924 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 7' ' ' LEU . 2.6 tm? -58.3 -34.31 70.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.214 0.53 . . . . 74.42 109.841 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -69.78 -14.36 62.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.73 -0.668 . . . . 45.22 111.387 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -96.12 -2.86 45.66 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.809 0.338 . . . . 73.24 111.122 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.5 t -90.76 159.21 2.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.234 -0.439 . . . . 51.01 110.208 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -89.98 166.0 13.72 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.155 -0.475 . . . . 74.31 110.266 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.9 pt -77.48 162.87 4.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.185 -0.462 . . . . 64.24 110.599 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt 60.55 30.09 19.49 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.192 0.597 . . . . 74.14 111.014 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.6 m -120.88 151.67 39.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.68 -0.691 . . . . 74.21 110.3 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -109.59 127.4 54.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.097 -0.501 . . . . 73.2 109.698 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.447 HG23 ' HB ' ' A' ' 42' ' ' ILE . 22.5 m -128.97 173.54 13.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.261 -0.427 . . . . 63.0 111.099 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.821 ' HE3' HD21 ' A' ' 78' ' ' LEU . 29.9 ttmt -126.5 140.29 52.57 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.907 -0.588 . . . . 63.42 110.689 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.88 96.85 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.604 -0.726 . . . . 74.12 110.345 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.439 HD11 ' HD2' ' A' ' 17' ' ' LYS . 38.1 mm -92.36 -52.77 9.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.405 -0.816 . . . . 60.32 110.894 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.81 160.55 22.83 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.207 -0.997 . . . . 72.11 112.945 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.716 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 71.8 mt -142.4 158.12 19.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.801 -1.185 . . . . 72.21 107.801 -178.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.0 t -100.62 91.42 1.81 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.65 0.262 . . . . 74.12 110.65 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.716 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 31.4 Cg_exo -57.57 159.06 17.63 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.26 2.64 . . . . 65.03 112.732 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 62.62 74.5 0.43 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.521 -0.763 . . . . 75.43 110.155 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 28.9 t -159.26 153.52 23.81 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.134 -0.939 . . . . 62.34 109.599 -176.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -68.97 -22.6 64.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.833 0.349 . . . . 72.15 110.344 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 31' ' ' ILE . 25.2 m -95.77 -20.34 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.495 -0.32 . . . . 72.24 110.684 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.605 ' CD ' ' HA ' ' A' ' 23' ' ' PRO . 2.0 tpm_? -50.33 -54.45 21.41 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.184 -0.462 . . . . 74.13 111.074 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -65.61 -37.07 85.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.971 -0.559 . . . . 63.22 110.992 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -66.32 -45.05 81.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.327 -0.397 . . . . 54.44 111.23 -174.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.446 ' HA ' ' HE2' ' A' ' 34' ' ' MET . 79.2 mt -59.71 -45.83 94.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.347 -0.388 . . . . 75.12 110.834 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.584 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 2.2 ttt -71.98 -33.16 67.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.328 -0.397 . . . . 71.42 110.675 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -68.27 -24.66 64.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.031 -0.531 . . . . 63.13 110.079 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.446 ' HE2' ' HA ' ' A' ' 31' ' ' ILE . 63.0 mtm -79.64 2.32 22.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.786 -0.643 . . . . 63.44 111.441 178.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.63 -8.06 59.81 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.696 -0.764 . . . . 22.13 112.763 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 32' ' ' MET . 63.2 mt -81.5 137.42 21.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.864 0.364 . . . . 74.2 110.371 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.763 HG23 ' H ' ' A' ' 38' ' ' ARG . 1.9 m -133.78 -85.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.201 -0.454 . . . . 72.31 111.152 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.763 ' H ' HG23 ' A' ' 37' ' ' VAL . 17.8 ttm180 -153.37 140.68 19.59 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.985 -0.746 . . . . 73.21 108.985 175.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.58 -9.81 69.66 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.634 -0.793 . . . . 73.14 111.278 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -64.82 147.09 53.89 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.755 -0.461 . . . . 72.43 109.755 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -97.28 147.4 24.18 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.234 0.54 . . . . 61.2 111.541 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.603 HG12 ' HB3' ' A' ' 58' ' ' LEU . 64.5 mt -130.81 118.23 41.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.027 -0.988 . . . . 70.32 109.479 175.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.617 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 64.0 t80 -105.0 106.18 16.56 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.317 -0.401 . . . . 74.22 109.985 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.573 HG12 HD22 ' A' ' 56' ' ' LEU . 52.6 mt -75.31 102.35 2.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.235 -0.654 . . . . 74.51 109.235 177.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -85.54 -24.62 27.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.968 0.413 . . . . 71.52 110.906 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.12 -172.09 40.66 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.844 -0.693 . . . . 65.44 112.265 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.687 ' HG2' HG23 ' A' ' 54' ' ' ILE . 54.5 mtpt -123.49 159.08 29.85 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.737 -0.838 . . . . 74.43 108.737 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.82 152.14 87.44 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.64 -0.504 . . . . 75.34 109.64 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.91 -9.66 12.53 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.816 2.344 . . . . 34.11 112.999 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 55.7 ttp -97.29 -4.62 38.39 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.325 0.583 . . . . 74.5 110.318 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.67 -12.74 67.67 Favored Glycine 0 N--CA 1.454 -0.128 0 CA-C-N 115.988 -0.551 . . . . 71.25 111.958 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.559 ' OD2' ' HB2' ' A' ' 67' ' ' LYS . 11.4 t70 -152.32 136.51 10.22 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.344 -0.984 . . . . 70.11 108.344 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.466 ' HB3' ' HA ' ' A' ' 66' ' ' ARG . 3.5 Cg_exo -81.25 -167.96 6.31 Favored 'Cis proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.817 -1.326 . . . . 72.23 112.401 -1.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.687 HG23 ' HG2' ' A' ' 47' ' ' LYS . 46.8 mt -109.98 134.1 53.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.991 -0.55 . . . . 75.01 110.091 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.51 107.29 18.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.021 0.439 . . . . 43.24 110.167 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.573 HD22 HG12 ' A' ' 44' ' ' ILE . 28.8 mt -120.21 131.97 55.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.041 -0.527 . . . . 60.03 110.295 -177.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.813 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 27.9 ttt-85 -93.29 99.97 12.41 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.765 -0.828 . . . . 64.22 108.765 171.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.603 ' HB3' HG12 ' A' ' 42' ' ' ILE . 1.1 pp -119.13 146.0 45.49 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.084 -0.507 . . . . 74.11 110.461 -176.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 73.01 -45.87 0.63 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.895 0.747 . . . . 72.14 111.069 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.47 -26.42 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.293 -0.479 . . . . 74.45 112.152 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -121.45 157.74 29.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.855 0.36 . . . . 75.14 111.147 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.813 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 1.4 m -89.61 133.41 34.64 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.891 -0.595 . . . . 65.3 111.361 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.4 mt -141.98 152.02 43.06 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.552 -0.749 . . . . 71.22 109.475 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.5 p -88.86 110.81 21.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.203 0.525 . . . . 71.4 110.886 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.83 145.8 28.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.501 -0.772 . . . . 74.21 108.963 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.466 ' HA ' ' HB3' ' A' ' 53' ' ' PRO . 10.3 mpt_? -80.68 163.34 23.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.977 0.418 . . . . 75.51 110.338 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.559 ' HB2' ' OD2' ' A' ' 52' ' ' ASP . 4.5 ttmp? -47.76 -38.39 15.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.349 -0.841 . . . . 71.41 111.917 176.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.5 m -59.46 -50.78 72.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.251 -0.432 . . . . 74.32 111.766 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 73' ' ' ILE . 1.8 mp0 -63.66 -49.0 74.91 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.29 0.369 . . . . 74.22 110.795 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.55 -22.55 65.26 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.157 0.503 . . . . 65.53 111.481 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.595 ' HB3' ' HZ2' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -78.95 -23.2 44.75 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.0 -0.546 . . . . 55.43 110.705 -179.169 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -102.48 12.86 35.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 74.12 111.736 -175.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.463 HG22 HG13 ' A' ' 75' ' ' VAL . 61.9 mt -113.57 127.26 71.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.293 -0.412 . . . . 71.4 110.212 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.71 123.27 49.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.044 0.45 . . . . 73.24 109.923 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.463 HG13 HG22 ' A' ' 73' ' ' ILE . 28.2 m -129.56 160.04 40.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 112.324 0.49 . . . . 61.23 112.324 -170.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -106.28 159.02 16.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.591 -0.731 . . . . 63.4 109.305 172.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 79' ' ' LEU . 48.2 t -83.75 124.61 39.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.775 0.322 . . . . 74.43 110.668 -177.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.821 HD21 ' HE3' ' A' ' 17' ' ' LYS . 46.3 mt -94.87 -4.19 47.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.923 0.392 . . . . 45.43 111.01 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.418 ' H ' HG12 ' A' ' 77' ' ' VAL . 87.4 mt -68.97 90.89 0.45 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.676 -0.693 . . . . 74.24 110.89 178.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -101.74 155.17 18.29 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.956 -0.757 . . . . 61.31 108.956 176.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 72.2 108.59 0.07 Allowed 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.896 0.747 . . . . 72.25 109.229 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 77.15 125.74 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 O-C-N 124.163 0.915 . . . . 75.25 109.579 -171.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -80.94 161.17 24.43 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.926 -0.579 . . . . 44.44 110.543 -173.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -148.12 96.65 2.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.089 0.471 . . . . 70.1 111.318 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -150.43 128.75 12.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.547 -0.751 . . . . 73.21 109.815 175.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.8 p80 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.58 -0.724 . . . . 55.5 109.805 178.325 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.749 0.309 . . . . 70.23 110.485 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.9 m -96.13 -84.82 0.35 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.39 -0.368 . . . . 63.44 110.856 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -146.18 172.33 13.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.634 0.254 . . . . 74.13 110.442 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.53 160.77 13.11 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.507 -0.854 . . . . 42.25 112.95 -176.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.2 pt -125.97 179.33 3.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.185 -0.672 . . . . 74.24 109.185 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.93 145.49 31.18 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.024 -1.084 . . . . 70.31 110.942 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.944 HD21 HD21 ' A' ' 56' ' ' LEU . 51.7 tp -57.55 -30.85 65.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.982 0.42 . . . . 75.02 111.587 -176.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.543 ' ND2' ' HG3' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -71.25 -6.51 40.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.408 -0.36 . . . . 54.45 111.97 179.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.543 ' HG3' ' ND2' ' A' ' 8' ' ' ASN . 44.1 mt-10 -103.55 2.22 33.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.619 0.247 . . . . 53.24 111.145 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.8 t -88.08 157.55 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.877 0.37 . . . . 71.41 110.797 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.522 ' HG2' ' H ' ' A' ' 12' ' ' ILE . 32.1 tt0 -99.27 176.02 5.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.957 -0.565 . . . . 65.43 110.12 -178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.522 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 40.9 pt -79.95 159.31 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.854 0.359 . . . . 72.31 111.943 -175.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 59.55 35.79 22.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.379 -0.828 . . . . 74.2 111.15 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -130.94 151.27 51.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.269 -0.423 . . . . 70.02 110.809 -177.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.777 ' HG2' ' HD1' ' A' ' 43' ' ' TYR . 32.6 mtmt -109.07 130.18 55.48 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.238 0.542 . . . . 62.01 110.563 176.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 7.0 m -129.4 142.9 42.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.198 -0.91 . . . . 61.22 109.617 176.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.534 ' HB2' HD11 ' A' ' 78' ' ' LEU . 30.5 ttpt -104.5 142.62 34.3 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.059 0.457 . . . . 64.41 110.486 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.514 ' HA ' HG12 ' A' ' 75' ' ' VAL . 37.0 t -74.75 96.6 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.524 -0.762 . . . . 74.24 110.769 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.695 HD11 ' HB3' ' A' ' 76' ' ' GLU . 16.9 mt -58.72 -42.92 86.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.7 0.762 . . . . 72.13 108.951 171.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.29 170.66 39.95 Favored Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 114.55 -1.205 . . . . 72.22 111.911 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.734 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 14.5 mt -114.23 161.92 12.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.399 -1.334 . . . . 70.1 107.399 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.53 91.84 1.15 Allowed Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.252 0.548 . . . . 74.41 110.377 -174.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.734 ' HD3' ' O ' ' A' ' 21' ' ' ILE . 31.6 Cg_exo -57.26 169.83 1.95 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.812 3.008 . . . . 73.42 113.414 -170.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 65.89 13.61 9.12 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.18 -0.918 . . . . 54.53 110.113 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 14.7 t -98.89 134.9 41.1 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.566 -0.743 . . . . 55.12 109.354 174.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' A' ' 26' ' ' LYS . 17.4 pttp -68.13 -15.61 63.66 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.334 -0.394 . . . . 75.14 111.295 178.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 31' ' ' ILE . 27.8 m -94.96 -28.14 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.557 -0.457 . . . . 74.51 110.736 174.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' A' ' 25' ' ' SER . 3.8 tmt_? -54.1 -47.0 72.26 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.263 0.554 . . . . 75.21 109.845 174.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.9 ttt-85 -55.77 -47.33 77.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.187 -0.915 . . . . 65.24 110.433 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.58 -44.76 95.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.308 -0.86 . . . . 72.22 111.408 -177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.489 HD13 ' CG1' ' A' ' 73' ' ' ILE . 60.3 mt -64.74 -47.62 87.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.516 -0.766 . . . . 61.31 111.411 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.434 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 2.3 ttt -68.48 -32.87 73.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.089 0.471 . . . . 64.31 110.545 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.07 -23.62 64.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.815 -0.63 . . . . 54.24 110.612 177.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 22.2 ttm -75.62 -19.62 59.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.835 -0.621 . . . . 75.42 110.65 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.4 -5.06 13.31 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.418 -0.896 . . . . 72.5 112.825 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 32' ' ' MET . 44.6 mt -84.79 125.12 40.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.086 0.469 . . . . 73.12 110.298 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.05 -178.0 2.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.687 -0.688 . . . . 62.34 110.91 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -68.51 116.45 9.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.077 -0.51 . . . . 74.45 110.897 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.14 -2.47 44.01 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.887 -0.597 . . . . 61.02 113.018 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.9 m -75.72 148.34 38.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.858 0.329 . . . . 54.03 110.126 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -95.81 125.22 40.22 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.087 -0.506 . . . . 73.2 110.193 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.7 mt -100.66 114.83 40.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.475 -0.784 . . . . 72.41 109.748 176.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.777 ' HD1' ' HG2' ' A' ' 15' ' ' LYS . 37.1 t80 -91.26 105.09 17.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.121 -0.491 . . . . 74.32 110.105 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.652 HD11 HD11 ' A' ' 7' ' ' LEU . 47.8 mm -80.53 96.37 2.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.071 -0.714 . . . . 75.11 109.071 175.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.05 -26.89 33.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.983 0.421 . . . . 72.42 110.708 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.05 176.84 47.72 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.32 -0.943 . . . . 61.0 112.57 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.772 ' HG2' HG23 ' A' ' 54' ' ' ILE . 56.2 mtpt -133.62 158.22 43.76 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.756 -0.831 . . . . 73.02 108.756 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.85 156.84 63.97 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.501 -0.185 . . . . 52.31 110.501 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.98 -33.74 73.98 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.809 2.339 . . . . 72.4 112.729 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.1 ttm -87.68 -7.65 57.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.134 0.492 . . . . 72.33 110.875 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.89 -15.3 60.88 Favored Glycine 0 C--N 1.329 0.145 0 C-N-CA 121.13 -0.557 . . . . 71.32 112.075 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -140.3 131.54 14.15 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.38 -0.6 . . . . 73.22 109.38 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.06 -170.08 7.94 Favored 'Cis proline' 0 CA--C 1.531 0.33 0 C-N-CA 124.124 -1.199 . . . . 64.43 113.217 1.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.772 HG23 ' HG2' ' A' ' 47' ' ' LYS . 41.1 mt -110.07 145.08 17.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.766 -0.652 . . . . 60.34 110.005 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.89 104.16 15.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.197 0.523 . . . . 61.05 110.706 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.944 HD21 HD21 ' A' ' 7' ' ' LEU . 7.9 mp -99.93 164.01 12.2 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.477 -0.783 . . . . 71.51 110.27 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 27.8 ttm180 -142.35 111.73 6.59 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.703 -0.851 . . . . 74.21 108.703 171.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.531 ' N ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -136.5 149.48 48.19 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.793 0.33 . . . . 71.24 110.823 -177.336 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 62.89 2.72 1.04 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.581 -0.736 . . . . 64.23 111.676 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.67 -14.2 11.69 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.803 -0.713 . . . . 61.31 112.861 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.414 ' CD1' HD21 ' A' ' 63' ' ' LEU . 7.5 p90 -128.01 150.73 49.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.447 0.642 . . . . 62.04 112.385 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 47.9 t -84.46 144.63 28.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.093 -0.958 . . . . 54.04 111.969 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.476 HD22 ' C ' ' A' ' 62' ' ' SER . 3.4 mm? -135.11 144.37 47.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.897 -1.047 . . . . 73.44 109.757 177.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.47 110.01 21.41 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.349 -0.387 . . . . 74.21 110.194 175.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.58 HD21 HD22 ' A' ' 56' ' ' LEU . 2.9 pp -124.55 160.77 27.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.76 0.314 . . . . 63.51 110.46 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 6.1 mpt_? -80.17 161.98 24.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.564 0.697 . . . . 73.12 112.214 -169.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -57.89 -54.85 42.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.725 -1.125 . . . . 71.44 111.459 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.0 m -75.4 -11.71 60.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.033 0.444 . . . . 73.45 111.175 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 66' ' ' ARG . 20.8 tt0 -79.76 -42.45 24.5 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.835 -0.802 . . . . 73.54 108.835 176.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 7' ' ' LEU . . . -69.71 -21.15 63.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.817 -1.083 . . . . 64.34 111.157 174.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -59.01 -26.61 64.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.86 -0.609 . . . . 72.4 112.017 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.4 -3.19 57.31 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.331 0.586 . . . . 54.41 110.622 -177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.504 HG22 HG13 ' A' ' 75' ' ' VAL . 51.7 mt -101.83 128.58 54.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.104 -0.498 . . . . 33.0 110.722 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.0 mt -106.7 118.01 35.55 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.847 -0.427 . . . . 75.11 109.847 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 16' ' ' VAL . 15.3 m -129.15 146.13 34.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.935 0.398 . . . . 72.53 111.957 -174.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.695 ' HB3' HD11 ' A' ' 19' ' ' ILE . 9.7 pt-20 -100.67 139.06 36.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.852 -0.613 . . . . 73.15 110.164 176.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.651 ' HA ' HG12 ' A' ' 16' ' ' VAL . 39.5 t -75.12 112.11 12.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.149 -0.478 . . . . 50.25 110.572 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 17' ' ' LYS . 90.6 mt -77.6 -17.97 57.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.249 0.547 . . . . 73.22 110.918 -177.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.3 mt -91.78 19.42 6.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.615 -0.72 . . . . 74.21 111.994 -176.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 61.01 -154.72 0.36 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.168 -0.469 . . . . 65.0 111.761 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.3 t60 80.1 -21.15 0.34 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.066 0.946 . . . . 72.21 111.905 173.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.9 p80 35.37 82.68 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.11 0.964 . . . . 72.31 112.814 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -74.21 141.76 45.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.186 -0.916 . . . . 73.3 111.435 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -117.14 153.44 32.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.913 -0.585 . . . . 70.4 110.399 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -79.79 -62.35 1.71 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.899 -0.778 . . . . 73.12 108.899 172.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 52.5 m80 . . . . . 0 C--O 1.246 0.875 0 CA-C-N 115.291 -0.868 . . . . 72.21 109.29 174.575 . . . . . . . . 0 0 . 1 stop_ save_